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DIRECTOR'S
REPORT
The horrible events in September of 2001 in New York, Washington, and Pennsylvania changed
our nation forever. No longer can we assume that those who are ignorant of decency and what
America stands for will not interrupt our way of life. For those of us who work on research to
improve the lives of people, it is difficult to understand how anyone could get to the point of
needlessly killing so many. Immediately following September 11, our research goals seemed
pale compared to the efforts of those who stood in the face of terrorism and who worked in the
rescue efforts. But it did not take long to realize that our mission to fight cancer and other dis-
eases is equally important. The paradox is that the nation which provides the most benefits to
mankind through biomedical research is the one that is attacked because of what it stands for.
But giving in to tyranny is not in the ethos of this nation. The best way to answer terrorism is to
continue to do what we do best, and that is to help those who cannot help themselves. This is
particularly true for those with cancer.
The modern era of our nation's effort to understand and treat cancer, which began with the
signing of a new National Cancer Institute Act by President Nixon in December of 1971, is now
30 years old. Although the National Cancer Institute first came into existence in 1937 with the
signing of an act by President Franklin D. Roosevelt, only a revolution in biological research in
the latter half of the twentieth century enabled cancer to be studied in a rational way and with
confidence that success might be possible. During the past 20 years, basic research into the
causes that underlie cancer has opened the door to opportunities for diagnosis and treatment
such that now, as we enter a new era in cancer research, meaningful progress is possible. To
fully exploit these opportunities, however, academic research institutions and the private sector
must approach the cancer problem in a fundamentally new way. Although investigator-initiated
research should remain the backbone of publicly funded research, large projects that move
basic research results into the clinic, commonly called "translational research," require close
cooperation between academia and the private sector. Interdisciplinary approaches are the
future for research that will make a real difference to patients, but achieving ambitious goals sole-
ly with public funds may not be possible. It is now time to re-think how translational cancer
research should be assessed, supported, and performed.
The roots of the modern understanding of cancer came from a number of sources. Prominent
among these was the study of viruses that caused tumors at the site of inoculation in experi-
mental animals. These viruses carried genes that could change a normal cell into a cancer cell.
Research using both RNA and DNA tumor viruses, with Cold Spring Harbor Laboratory preem-
inent among institutes studying DNA tumor viruses, showed that a small set of genes could
transform otherwise healthy cells into cells that grew into a lethal tumor, eventually metastasiz-
ing and killing the animal. But relatively few virus genes proved to have any part in inducing
human cancers. Notable exceptions were the transforming genes present in the DNA-contain-
ing papillomaviruses that, when carried into the epithelial or glandular cells of the cervix, initiate
cervical cancer in women.
A few cancer-causing genes were found in RNA tumor viruses that had direct orthologs in
human cells. These virus-related human genes, when altered by mutation or when overex-
pressed, contributed to human cancer. Michael Wig ler codiscovered here at CSHL, at the same
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time as Robert Weinberg at the Massachusetts Institute of Technology, one such gene in 1981,
the so-called ras oncogene. Another notable example was the v-myc gene that was first defined
in an avian retrovirus that caused myelocytic leukemia in chickens. Later, a related human gene
called c-myc was found to be overexpressed in a variety of tumors, including lymphomas,
leukemias, and lung, cervical, ovarian, breast, and gastric cancers. The c-myc gene was con-
verted into an oncogene either as a result of chromosome translocation (the aberrant exchange
between two unrelated chromosomes), by gene amplification, or by mutation directly in the gene
itself.
Cancer progression can occur when another type of human cancer gene, called a tumor sup-
pressor gene, is deleted in the cancer tissue, again contributing to the tumor cell's ability to pro-
liferate uncontrollably. This type of cancer gene was first appreciated by studying the inherited
predisposition of cancer in families that had a high incidence of rare cancers. Later, in the late
1980s and early 1990s, familial cancer genetics identified a series of important oncogenes and
tumor suppressor genes, including the now well-studied BRCA1 breast cancer susceptibility
gene. Recent research, however, has shown that the number of people who have a higher prob-
ability of succumbing to a particular type of cancer by inheriting a defective gene from their par-
ents is relatively small compared to those who have no obvious inherited predisposition, but
nonetheless get the disease. It is therefore more likely that the main burden of cancer in our pop-
ulation occurs because of the accumulation of genetic changes that occur within a person's life-
time. Some of these changes may be promoted by environmental factors such as cigarette
smoking, but others are a result of normal damage to the genome over time. Our longevity plays
in favor of acquiring the necessary genetic changes that can result in cancer. In a quirk of fate,
some cancer-promoting mutations actually cause further genome instability, thereby accelerat-
ing the process of acquiring more genetic changes and, ultimately, cancer.
During the past few years, a new view of cancer has emerged which suggests that the can-
cer cell itself, with all its genetic changes, is not the only culprit in the progression to metastatic
tumor growth. This view of cancer has been best put forward in a review by Cold Spring Harbor
Laboratory alumnus Douglas Hanahan and Robert Weinberg. They pointed out that for a tumor
to develop to the stage where it is a clinical problem, the tumor must have a number of acquired
characteristics. These include changes that allow the cancer cells themselves to produce and
receive growth signals, to avoid being killed by a process called apoptosis, to proliferate with lim-
itless potential, to attract a blood supply to sustain the increase in cell mass, and to invade and
escape from the surrounding tissue. I would add another acquired characteristic-that of escap-
ing from the body's immune surveillance that almost certainly helps in suppressing tumor
growth, but of which little is known.
There are many ways of collecting the set of acquired tumor characteristics, and clearly accu-
mulating genetic changes in the cancer cell is the primary driving force. But as Hanahan and
Weinberg point out, cells that surround the cancer, such as invading immune system cells and
the surrounding "normal" tissue, can provide many of the factors necessary to sustain and even
change a cancer cell. Importantly, this new view of cancer progression offers a new way of think-
ing about cancer therapy. If the acquired characteristics are necessary to create a clinically dan-
gerous tumor, then attacking one of them should provide new hope for cancer treatment.
Attacking two different acquired characteristics might provide a benefit greater than the sum of
the two alone, and so on. We are just entering an era where this thinking is being tested in the
development of new cancer therapies.
The most common method of treating cancers now is to treat the tumor with agents that
cause catastrophic damage to cells, such as chemotherapy with DNA intercalating drugs, with
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drugs that damage the apparatus that ensures accurate segregation of chromosomes, or with
radiation that both damages DNA and causes chromosome mis-segregation. These methods
take advantage of the loss in cancer cells of the normal response to such external stresses,
allowing the cancer cell to proliferate and eventually die due to the catastrophic accumulation
of damage. But as we well know, such therapies are toxic to normal cells as well, and the win-
dow between killing cancer cells and normal proliferating cells is often all too small. Moreover,
as clearly shown by Scott Lowe and his colleagues here at CSHL, cancer mutations such as
those in the p53 tumor suppressor pathway can cause resistance to such treatments. This is
why cancer therapies must be multidimensional, attacking the tumor from different angles.
These new approaches include targeting the proteins in a cancer cell that initiate the tumor to
proliferate in the first place, inhibiting the blood supply by anti-angiogenesis therapy, and induc-
ing an immune reaction to the tumor cells.
A priori, it might seem that the protein products of the genetic changes that occur in a can-
cer cell might not be good targets for cancer therapy because they usually occur early in the life
of the cancer cell. Since many genetic changes occur during the life of cancer cells, there is no
guarantee that inhibiting one oncogene product will be sufficient to inhibit growth of the cancer
cell and even shrink the tumor. But recent results from both basic and clinical research suggest
that there is hope for this approach.
Recent research from Michael Bishop, one of the pioneers of cancer genetics, and his col-
leagues suggests that the primary changes in a cancer cell may well be an Achilles' heel. They
created tumor cells that overexpressed the c-myc gene under conditions where it could be
turned off at will. In experimental animals, c-myc-dependent tumors arose with predictable fre-
quencies, but interestingly, and for many people unexpectedly, when the c-myc gene was turned
off, not only did the tumors stop growing, but the cancer cells died and the tumor regressed.
Thus, although a cancer might require multiple genetic changes, targeting a single oncogene
product might be sufficient for therapy.
Concomitant with this basic research, a new, targeted therapy for chronic myeloid leukemia
(CML) emerged with the advent of the Novartis drug GleevecTM, producing remarkable clinical
effects. This small-molecule drug inhibits an enzyme produced by the BCR-ABL oncogene that
is the principal cause of CML. Early in the clinical studies, patients responded dramatically,
demonstrating that a therapy against a single oncogene product can be most effective. Later,
however, some patients developed resistance to the drug and their tumors relapsed. When
examined at the molecular level, the BCR-ABL oncogene either had further mutated or was now
overexpressed at higher than initial levels. Although this was not good for the patients con-
cerned, it proved a very important scientific point-that the drug was really making a difference
by targeting the BCR-ABL oncogene that caused the tumor, rather than a combination of
unknown targets that might be related to BCR-ABL. These clinical results validated the concept
of single-target, specific anticancer cell therapy and rightly caused much excitement.
As I described in last year's Annual Report, Michael Wig ler, Robert Lucito, and their col-
leagues here at CSHL, in collaboration with Scott Power's group at a nearby biotechnology
company, have undertaken a large project to identify many of the genetic changes that occur in
primary human tumors. Initially focusing on breast cancer in collaboration with clinical colleagues
at Memorial Sloan-Kettering and Duke University School of Medicine, they developed tech-
niques that are applicable to all cancers, given sufficient resources. The overrepresented or
amplified oncogenes in cancer cells, like c-myc, are readily detected in cancer DNA derived from
primary cancer biopsies. During the past year, this joint program between an academic research
institution and the private sector has been enormously successful, with the identification of many
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new human oncogenes that have the potential to become targets for anticancer therapy. Indeed,
some of the gene products are already under preclinical investigation. Paradoxically, the success
of the project points to a fundamental problem of how to fund such large cancer research pro-
jects.
In the not-too-distant past, basic research emerging from academic research laboratories
would be published in the scientific literature. Only much later would private industry incorpo-
rate the published results into their disease programs. With the advent of the biotechnology
industry, biotech companies more rapidly acquired the results from basic research laboratories
and, with the help of the significant financial resources from venture capital, they could add
commercial value and, in a very few cases, take products into the clinic. But very few basic
research results are immediately applicable to clinical advances, and it often takes years of addi-
tional research to reach the stage where large pharmaceutical companies would invest the con-
siderable sums needed to develop a drug. In the vast majority of cases, translational research
is conducted, further developing the initial research so that it can be applicable in the clinic. The
problem that arises, however, is that translational research is expensive and involves scale-up
of the basic research capabilities that is beyond the resources of public funding mechanisms
such as grants from the National Institutes of Health (NIH). A typical, investigator-initiated
research grant from the NIH could not support such translational research, since it often
involves the use of chemistry and other resources only available to large pharmaceutical com-
panies. Bridging this large gap must be a high priority in disease-based research.
Mechanisms are needed that radically change the way such projects are viewed and sup-
ported. Clearly, public funds from granting agencies are not going to keep pace with the rising
costs of research. Even though venture capital resources have grown significantly in the past
decade, they will not carry the entire burden of the rapidly expanding biomedical research enter-
prise. The pharmaceutical industry is already inundated with drug targets, and they will only
occasionally invest in the earliest stages of research outside of their internal programs. It seems
that the most efficient method for translating interesting new research ideas into the preclinical
stage is an intimate interaction between the biotechnology industry and academia.
Although interactions between academia and the biotech industry are going on all the time,
and in many ways changing the research landscape, there are inadequate funding mechanisms
to allow seamless cooperation. Individuals obtaining relatively small research grants for specific
projects support the vast majority of traditional academic cancer research. This should contin-
ue, but the NIH should introduce new mechanisms that allow rapid scale-up of research when
it is appropriate and at the same time allow seamless integration of funds from private sources,
be they from private foundations or industry. Currently, it is very difficult to present a large trans-
lational research program to the panels that review smaller, investigator-initiated research grants.
Large, multifaceted projects that need resources from the NIH and industry should be present-
ed and reviewed as a single project, with the NIH grant funds supporting some of the research.
The NIH already has the capacity to support clinical trials in collaboration with industry, but it is
translational research, which links basic and clinical research and advances new ideas, that is
not now planned and reviewed in the most efficient way. Many opportunities are being missed
because of the lack of suitable funding mechanisms and flexibility.
There also needs to be a change in the way such projects are viewed by the NIH. Most can-
cer research in the United States occurs in Cancer Centers. These Centers receive core support
based primarily on the grant funds that derive from the National Cancer Institute (NCI) and other
peer-reviewed cancer research from public sources. But under current NCI guidelines, research
supported by funds from private sources is not considered relevant for core funding when a
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Cancer Center is periodically assessed for what it is doing in translating basic research into the
clinic. As private-public cooperation in research funding increases, and it must in this new era,
such impediments to translational research should not deter what Cancer Centers might do in
the future.
Thirty years after initiating the modern era of cancer research, the NCI is in excellent shape
and has the capability to rapidly respond to the opportunities made possible by the huge
advances in basic research. I had the privilege of serving on an oversight board at the NCI for
the past 6 years, the last 2 years as chairman, and seeing firsthand how large projects could
work. Under the direction of Rick Klausner, the NCI was revitalized. Many opportunities were
advanced with great success, particularly those that took advantage of the concomitant
sequencing of the human genome. Now is the time to apply some of the same strategies to
translational research, such as discovering new technologies for early diagnosis and, most
importantly, for cancer treatment.
There has been a call for a complete rewriting of the National Cancer Institute Act to revital-
ize the nation's effort on cancer. The stated goals are to expand the number of researchers
studying cancer, particularly those in translational research; to encourage the private sector to
focus on cancers that as yet do not have standard therapies; to improve the number and effi-
ciency of cancer trials; to increase research on cancer prevention; and to improve patient care.
These are all laudable goals, but in achieving them, the mission of the NCI must be underpinned
by strong basic research. As basic research provides opportunities for many new treatments, no
amount of public funds will support the infrastructure to test all of the potentially beneficial
approaches. A better mechanism for public-private cooperation is needed.
The new proposed legislation calls for an expansion of the Cancer Centers program to estab-
lish translational cancer centers to help move drugs and technologies into clinical trials. Again,
this seems to be a valuable goal, but it is already the mission of existing Comprehensive Cancer
Centers who are required to combine basic and clinical research. Effective translational research
should be accomplished by the nation's best Comprehensive Cancer Centers. It is far from clear
whether a new and potentially expensive physical infrastructure is needed. Furthermore, there is
no guarantee that the most promising research applications will emerge from within the pro-
posed new translational centers. Equally likely is that centers such as our own will contribute
valuable new approaches that will have a large impact on translational cancer research.
More effective ways are needed to integrate vast private resources into partnerships with aca-
demic cancer research centers, and in a manner that will not penalize the core support for the
Cancer Center. The existing peer-review mechanism for small, investigator-initiated research,
which can take up to 1 year or more before a new proposal may be supported, is not adequate.
Since academic institutions do not by themselves have the resources to establish such large
translational programs in the hope that a proposal might be supported in 1 year's time, many
opportunities are lost. One simple and effective way for such cooperative programs to be imple-
mented is to institute a separate peer-review mechanism that can appreciate and assess trans-
lational research, particularly research that involves private and academic interactions.
Precedents have been set at the National Institute of Human Genome Research, where very
large, goal-oriented, peer-reviewed research involves industry and academic laboratories, with
industry often assuming a large portion of the costs. Other institutes such as the NCI should
rapidly move in this direction, establishing new mechanisms that could easily handle issues such
as conflicts of interest and the expected large multicomponent budgets, and yet still move with
a pace that is expected by a public calling out for meaningful action against cancer.
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HIGHLIGHTS OF THE YEAR
The research and education programs at Cold Spring Harbor Laboratory continue their strong
momentum. The Watson School of Biological Sciences recruited its third class of students this
year, and the DNA Learning Center expanded both its physical plant and its educational objec-
tives. The Meetings and Courses program and Banbury Center continue to be invaluable
resources for scientific information, and the Cold Spring Harbor Laboratory Press added several
new projects and properties to its long list of titles. Cold Spring Harbor Laboratory was once again
a bustling center of scientific activity, discovery, and education.
Research
Bioinformatics
On February 15, 2001, some 20 genome research centers around the world, including W. Richard
McCombie's group at Cold Spring Harbor Laboratory, jointly published the first draft of the com-
plete human genome sequence and made it freely available to researchers throughout the world.
The finished sequence is scheduled to be released in 2003, coincident with the 50th anniversary
of the discovery of the structure of DNA. The complete human genome sequence can be used in
a great many ways (see below) and has already fueled an explosion of biological and biomedical
research-much of it directed toward improving human health.
Analysis of the raw DNA sequence through the use of various bioinformatics (computer-based)
methods revealed several interesting features of the human genome, including the preliminary find-
ing that our genome contains approximately 30,000-40,000 protein-coding genes. A similar analy-
sis of restricted raw data by a private concern revealed most of the same features.
In a companion study that accompanied the publication of the human genome first draft,
Lincoln Stein, his CSHL colleagues, and other members of the International SNP Map Working
Group identified some 1.4 million single nucleotide polymorphisms (or SNPs)
distributed throughout the human genome. The high-density map of human
DNA sequence variation will become useful for identifying disease-related
genes, for tailoring therapies to those patients who are most likely to respond,
and for several other applications. Importantly, this project was jointly funded by
a consortium of pharmaceutical companies, private foundations, and the feder-
al government, providing a model for future ways of funding large projects and
making the data freely available to the broader scientific community.
To study and manipulate genes for a wide variety of research, diagnostic, or
therapeutic purposes, scientists need to determine the precise fine structure of
genes against a backdrop of what is frequently a vast and complex genetic
landscape. Conventional bioinformatics software fails when it comes to detect-
ing two important features of genes-the very first segments of genes, and the
nearby "on" switches of genes called promoters.
Michael Zhang and his colleagues have developed a computer program called First Exon Finder
(or FirstEF) that is especially good at finding these first segments and "on" switches of genes. The
program is tailored toward detecting these features in the human genome sequence, but it is also
useful for annotating other mammalian genomes. Although the total number of genes in an organ-
ism's genome depends on subtle, nonuniversal definitions of what constitutes a gene, on the basis
Lincoln Stein
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of his analysis of the human genome using FirstEF, Michael believes that there
are 50,000-60,000 fundamental protein-coding human genes and that the pre-
liminary estimate of 30,000-40,000 human genes is too low.
We will test these computer predictions and have established a joint
research initiative involving the laboratories of Michael Zhang, Greg Hannon,
and Dick McCombie. These laboratories will experimentally verify the new pre-
dicted genes. Greg will incorporate the findings into a project whose goal is to
determine the function of human genes that have heretofore not been assigned
a function.
Cancer Michael Zhang
Michael Wig ler, Robert Lucito, and their colleagues are developing a reproducible, high-resolution
technique for detecting changes in gene copy number that are associated with the initiation of
breast, ovarian, and prostate cancer or with the progression of these cancers
from a noninvasive to an invasive or metastatic state.
The technique, called representational oligonucleotide microarray analysis,
or ROMA, combines DNA microarray technology with a method Michael previ-
ously invented to simplify the search for differences between two sets of DNA
(representational difference analysis). Using ROMA, Robert and Michael can
scan the entire genomes of both normal cells and cancer cells taken from the
same patient and can detect the genetic differences between the two. To apply
ROMA to the study of breast cancer, a needle biopsy of as few as
1,000-10,000 cells from breast tissue (followed by isolation of the normal and
cancer cell DNAs) provides sufficient material.
Genes that are amplified (potential oncogenes) or deleted (potential tumor
Michael Wigler suppressor genes) in cancer cells-or in invasive/metastatic versus noninva-
sive tumors-are prime targets for improved methods to diagnose and treat cancer. A strong team
has been established to develop this project: Robert and Michael are joined in several of their stud-
ies by clinical colleagues at Memorial Sloan-Kettering Cancer Center (Larry Norton), bioinformat-
ics colleagues at CSHL (Bud Mishra, who holds a joint appointment at the
Courant Institute of Mathematical Sciences at New York University), and
Jonathan Me lamed (also at the Courant Institute), and the local division of Tularik,
Inc., a biotechnology company (Scott Powers). To date, these researchers have
identified some 20 candidate genes associated with cancer by using ROMA and
other genomics approaches.
Remarkably, the major limitation at this stage in the development of ROMA
is neither theoretical nor technical, but economic. Robert and Michael estimate
that the cost of synthesizing sufficient numbers of DNA oligonucleotides to reli-
ably detect small deletions in the genomes of cancer cells is on the order of $2
million. However, once these oligonucleotides are available, they will be sufficient
to fabricate 40,000 individual ROMA microarrays, enough to study many
human cancers.Rob Lucito
Epigenetics
Epigenetics is commonly defined as the study of heritable changes in chromosome structure or
gene function (e.g., transcriptional activity) that occur without changes in DNA sequence. As work
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at CSHL and elsewhere has shown, proper functioning of epigenetic mechanisms of inheritance,
such as maintaining stable gene silencing over many cell divisions, is essential to many aspects of
normal biology. Moreover, CSHL researchers have linked abnormal silencing of tumor suppressor
genes to cancer.
In the past year, work in my own laboratory (in collaboration with Rui-Ming Xu), as well as stud-
ies by Greg Hannon, Shiv Grewal, David Spector, and Rob Martienssen, has revealed several mol-
ecular features of epigenetic phenomena.
Working with yeast, worms, flies, plants, and mammals, CSHL researchers are establishing
comprehensive models for different aspects of epigenetic inheritance, including RNA interference,
the modification of histone proteins and DNA (e.g., by methylation), and importantly, how these
processes work together to establish and maintain silent versus active chromatin (DNA plus pro-
tein architecture). These models unify many genetic and biochemical observations and have a sig-
nificant impact on how we view the biology of DNA.
RNA Interference: Double-stranded RNA triggers potent, specific gene silencing through a
process called RNA interference (RNAi). A central component of RNAi is a nuclease, composed of
both RNA and protein, which Greg Hannon and his colleagues first character-
ized and dubbed RISC (RNA-induced silencing complex). This nuclease seeks
and destroys other RNA molecules (e.g., messenger RNA) homologous to the
short guide RNAs or "siRNAs" (small interfering RNAs) it carries.
In 2001, members of Greg's lab reported two significant RISC-related
observations. First, they showed that the siRNA molecules within RISC are
derived from longer, double-stranded RNA through the action of an enzyme
they aptly named Dicer. They noted that Dicer is evolutionarily conserved in
yeast, worms, flies, plants, and mammals. Second, through biochemical purifi-
cation of RISC, they showed that RISC itself contains a different RNA-cleaving
enzyme, plus a protein called Argonaute2, which Greg believes is one of sev-
eral such components that targets RISC-mediated inhibition of gene expres-
sion to various biochemical pathways. These findings are among several links
being forged at CSHL between the genetics and biochemistry of RNAi, and between RNAi (post-
transcriptional silencing) and other epigenetic phenomena such as transcriptional silencing and
transposon activity.
As often happens, basic research on biology opens doors that are unexpected. It is now pos-
sible to synthesize RNAi molecules and to use them to individually and specifically shut off the
expression of virtually every human gene. Greg Hannon and his colleagues have developed some
of these technologies and have established a large project to use RNAi to investigate the function
of human genes. The technology has spread like wildfire around the Cold Spring Harbor campus,
and rightly so, because it has the potential to change how we study mammalian biology.
Transcriptional Silencing: By studying transcriptional silencing of mating-type genes in fission
yeast, Shiv Grewal and his colleagues have shown that seemingly small differences between two
varieties of histone H3 have profound effects on chromatin structure, gene expression, and recom-
bination. They found that silent regions of chromatin-where genes are kept off and DNA resists
genetic recombination-contain a particular variety of histone H3 (H3 Lys-9-methyl). In contrast,
they observed that active regions of chromatin-where genes can be easily switched on and DNA
can readily recombine-contain a different variety of histone H3 (H3 Lys-4-methyl). Through this
and other work, Shiv has defined a highly conserved pathway wherein enzymes that modify his-
tones (deacetylases and methyltransferases) act cooperatively to establish a "histone code" lead-
ing to epigenetic silencing.
Greg Hannon
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In addition, Shiv showed that deleting "boundary elements" that mark the
transition between silent and active chromatin allows the spreading of H3 Lys-
9-methyl, and hence a silent chromosome architecture, into neighboring DNA
normally occupied by H3 Lys-4-methyl. This finding has important implications
for genetic disease caused by abnormal gene silencing. Indeed, in 2001, Scott
Lowe, Yuri Lazebnik, and colleagues found that abnormal silencing of the tumor
suppressor gene Apaf-1 leads to malignant melanoma.
My own laboratory has uncovered mechanisms of inheritance of epigeneti-
cally determined states of gene expression and has provided links to DNA repli-
cation proteins. Recently, in collaboration with Rui-Ming Xu, we have determined
the three-dimensional structure of part of the origin recognition complex (ORC)
that recruits gene silencing proteins to specific loci in the yeast genome. ORC
was discovered here 10 years ago as a key regulator of genome duplication. Shiv Grewal
X Inactivation: In species such as humans, where females have two X chromosomes and males
have one, the proper proportion of X chromosome gene expression ("dosage compensation") is
maintained in females through the global inactivation of one of the two X chromosomes. X inactiva-
tion stems from the initiation (at a locus called the X-inactivation center or )0c) and spread ofan inac-
tive chromatin state. Establishment of the inactive chromatin state begins with the coating of the X
chromosome by "Xist" RNA molecules, followed by large-scale remodeling of chromatin structure.
Until recently, little was known about either the molecular partners of Xist RNA that enable it to
coat the X chromosome, or the precise nature of the chromatin remodeling induced by this coat-
ing. Visiting scientist Edith Heard suspected that the same histone H3 variety that Shiv Grewal
found to establish silent chromatin in fission yeast (H3 Lys-9-methyl) might also mediate X inacti-
vation. Using mouse embryonic stem cells, Edith and David Spector showed this to be true by
measuring when and where (relative to other events) H3 Lys-9-methyl appears on X chromosomes
marked for inactivation. They found that Lys-9 methylation of histone H3 occurs immediately after
the coating of the X chromosome by Xist RNA and before the silencing of X-linkedgenes. Thus,
Edith and David could conclude that Lys-9 methylation of histone H3 is a definitive early event in
the X inactivation process.
DNA Methylation and Transposon Activity: Rob Martienssen explores the role of transposable
elements (transposons) in epigenetic regulation and genome organization using both maize and
the mustard relative, Arabidopsis. In plants and many other organisms, the DNA of inactive trans-
posons is generally methylated, whereas the DNA of canonical genes and active transposons is
generally unmethylated. One of Rob's interests is to determine how these methylated and
unmethylated regions of chromatin are established and maintained, and to explore the biological
consequences of normal and abnormal states of DNA methylation.
Several years ago, Rob isolated an Arabidopsis mutant called ddml (decrease in DNAmethy-
lation) in which methylation of DNA was decreased. In 2001, Rob and his colleaguesshowed that
transposons become demethylated in ddml mutants and that such transposons become both
transcriptionally active and activated for movement from place to place in the genome. Next, Rob
and visiting scientist Vincent Co lot showed that inactive transposons are preferentially associated
with (you guessed it) the same variety of histone H3 that Shiv found ito be associated with silent
regions of chromatin in fission yeast, and which Edith and David found to be involved in X inacti-
vation (H3 Lys-9-methyl). Rob and Vincent also showed that transposons activated in Arabidopsis
ddml mutants become preferentially associated with the variety of histone H3 that Shiv found to
be associated with active regions of chromatin in fission yeast (H3 Lys-4-methyl).
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Finally, working together, Rob, Shiv, and their colleagues showed that fission yeast homologs of
the RNAi components Dicer and Argonaute are involved in silencing ancient relics of transposons
known as centromeric repeats. Moreover, dicer and argonaute mutations in fission yeast, like
ddml mutations in Arabidopsis, lead to the replacement of the silent chromatin-associated variety
of histone H3 (H3 Lys-9-methyl) by the active chromatin-associated variety (H3 Lys-4-methyl).
These observations suggest a model in which components of the RNAi machinery target his-
tone-modifying enzymes to regions of chromatin to be silenced or kept silent (centromeric repeats,
transposons, and possibly other regions such as inactive X chromosomes in female mammals).
Furthermore, Rob suspects that in those situations where DNA methylation is involved in epige-
netic inheritance, the silent chromatin-associated variety of histone H3 (H3 Lys-9-methyl) may indi-
rectly recruit enzymes that methylate DNA.
Molecular Biology
In the United States, approximately 70,000 deaths from cancer per year are associated with
genetic alterations in the myc oncogene. This gene encodes a protein-the Myc transcription fac-
tor-that is a potent stimulator of cell proliferation. Because Myc is a potent growth stimulator, the
level of Myc within cells is normally tightly regulated. This level is determined by how much Myc is
synthesized in a given time frame and by how quickly it is destroyed.
William Tansey and his colleagues are studying how the destruction of the
Myc protein is regulated and how defects in this process lead to abnormally
high levels of Myc and to cancer. In so doing, they have uncovered an intrigu-
ing connection between two seemingly unrelated processes-protein degra-
dation and transcriptional activation. Bill's findings support a "licensing" mech-
anism in which a particular protein modification (ubiquitylation) simultaneously
activates transcription factors that switch on gene expression and primes
them for destruction. The net result of this licensing mechanism is to limit how
long genes remain switched on. Bill suspects that this mechanism is an effi-
cient way for the cell to limit the effects of many of its most potent transcrip-
tion factors.
Bill Tansey Moreover, work in Bill's lab indicates that a link between transcription and
protein degradation has been conserved since the evolutionary divergence of yeast and mammals
approximately 1 billion years ago. Thus, Bill and his colleagues appear to have uncovered a phe-
nomenon of fundamental biological importance.
Tim Tully
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Neuroscience
Learning & Memory: Josh Dubnau and Tim Tully have used a genetic strategy
in fruit flies to switch electrical activity on and off at will in the "learning center"
of the insect's brain called the mushroom body. In so doing, they have made
the surprising discovery that switching off electrical activity in this part of the fly
brain blocks memory recall but not the initial formation of a particular kind of
memory.
In some respects, fruit fly brains work very much as do the brains of other
animals, including humans. Both flies and humans are capable of the kind of
"associative learning" made famous by Pavlov's dogs. (After ringing a bell and
presenting dogs with food several times over a few days, the Russian physiol-
ogist Ivan Pavlov [1849-1936] found that eventually his dogs would display dinnertime behavior
[drooling, excitement] upon hearing the sound of the bell alone.)
Josh and Tim study olfactory associative learning by training flies to avoid a particular odor and
later measuring the flies' odor avoidance behavior. They found that memories based on olfactory
associative learning can be acquired and stored in the absence of electrical activity in mushroom
bodies. However, those memories cannot be recalled in the absence of such electrical activity.
These results suggest that memories are acquired and stored by chemical processes in mush-
room bodies, and that electrical activity in this part of the brain is necessary only to recall those
memories. In some instances, when it comes to learning and memory, the fly brain (and perhaps
ours) must function electrically to recall what is stored chemically.
Brain Imaging: Karel Svoboda continues to pioneer the application of a high-resolution, real-time
imaging technique called two-photon microscopy to brain research. Recently, Karel and his col-
leagues have used two-photon microscopy to examine abnormalities during brain development in
a mouse model of Fragile X syndrome. In humans, Fragile X syndrome is the most commonly
inherited cause of mental impairment. The syndrome is typically caused by a mutation in the FMR1
gene leading to absence of the Fragile X mental retardation protein or FMRP.
By using two-photon microscopy to compare the earliest stages of postnatal brain develop-
ment in normal and FMR1 knock-out mice, Karel and Esther Nimchinsky have detected dramatic
differences in the density and length of all-important neuronal structures called dendritic spines.
Such spines form the familiar connections between neurons called synapses. When examined 1
week after birth, the "barrel" cortex in the brains of Fragile X mice displayed significantly increased
density and length of spines. (Barrel cortex interprets neurological signals from the whiskers of
newborn animals as they explore their world for the first time.) However, by 4 weeks after birth, dif-
ferences in the density and length of spines between normal and Fragile X mice were largely unde-
tectable. The transient nature of the spine abnormality in Fragile X mice suggests that FMRP func-
tions soon after birth during a critical window of opportunity for brain development. In addition,
Karel's findings indicate that FMRP probably has a role in linking experience (e.g., whisker signals)
to the growth of dendritic spines and that such links are required to specify the elaboration of a
fully functional neuronal architecture in the brain.
Awards and Honors
Several members of the Laboratory community were honored in 2001 for their
work and achievements.
CSHL Professor Nick Tonks was appointed a Fellow of
the Royal Society of London, England's National Academy of
Sciences. Since 1660, election to the Fellowship has been
recognized as one of the highest honors in science. Dr. Tonks
joins CSHL President Jim Watson and myself as CSHL's
Fellows of the Royal Society. Nick Tonks
Laboratory President James Watson received an honorary knighthood from
the Queen of England in the New Year's Honours List. This is a rare honor for a
United States citizen, and recognizes Dr. Watson's accomplishments from the
double helix to the human genome, among others.
CSHL Professor Scott Lowe, the Deputy Director of the Cold Spring Harbor
Laboratory Cancer Center, was honored this year with the Cornelius P. Rhoads
Memorial Award of the American Association for Cancer Research (AACR). TheScott Lowe
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award recognizes groundbreaking contributions to cancer research and was
established in 1979
to honor the memory of Dr. Cornelius P. Rhoads, the founder and
first director of the Sloan-
Kettering Institute for Cancer Research.
Song-Hai Shi, a 2000 graduate of the joint Genetics Program at Cold
Spring Harbor Laboratory and Stony Brook University, was awarded the
2001 Amersham Biosciences and Science Grand Prize for work he carried
out in the neuroscience lab of Robert Malinow at Cold
Spring Harbor
Laboratory. The award recognizes the most outstanding Ph.D.
thesis among
graduate students in molecular biology. He received the award in
Stockholm
at the time of the Nobel Prize ceremonies in December.
I was pleased this year to be elected as a foreign
member of The
European Molecular Biology Organization (EMBO), the
organization that
leads, guides, and promotes biological sciences in 24 European
countries.
Song-Hai Shi
Symposium LXVI
From May 31 to June 5, an enthusiastic group gathered
for the 66th annual CSHL Symposium,
titled "The Ribosome." On Sunday, June 3,
meeting attendee Dr. Venki Ramakrishnan, of
the
Laboratory of Molecular Biology, MRC, Cambridge,
delivered the annual Dorcas Cummings
Memorial Lecture to a scientific and public
audience. This very successful annual event is
hosted
"Sir" James Watson
Jim Watson and Venki Ramakrishnan
by the CSHL Association. Dr. Ramakrishnan's talk, "Protein Factories and Antibiotics," was timely
and appealed to the broad range of interests represented in the audience. The Symposium cele-
brated recent, major breakthroughs in understanding how proteins are made in
cells, a fundamental aspect of molecular biology.
Watson School of Biological Sciences
CSHL's graduate school-the Watson School of Biological Sciences-wel-
comed its third class of students this fall. On August 28, six new students joined
the Watson School's ranks. Hailing from across the country and around the
world, the students dove quickly into their rigorous programs, enrolling in the
core courses and beginning the laboratory rotations that mark their first year of
study.
On November 2, Cold Spring Harbor Laboratory held its 2001 Convocation in
Grace Auditorium to celebrate service to science. Before an audience of nearly
300 people, the Watson School bestowed honorary degrees upon William
Maxwell Cowan, Robert J. Glaser, and David L. Luke III, in recognition of their
continuing service to science. All three honorees have made a vast difference to
the world of scientific education and research, and the convocation provided an
excellent opportunity to honor these individuals. Gail Mandel, a professor of
Neurobiology and Behavior at Stony Brook University and an investigator for the
Howard Hughes Medical Institute, gave the keynote address.
Lilian Gann, the Assistant Dean of the Watson School of Biological Sciences,
was also appointed this year to Associate Dean, in recognition of her work in
developing the programs and offerings of the Watson School.
James D. Watson, president of CSHL, spent a busy year promoting his
newest book, Genes, Girls and Gamow. The book, a follow-up to the critically
acclaimed Double Helix, profiles Jim's life after the landmark discovery.
William Maxwell Cowan
Robert J. Glaser
David L. Luke Ill
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Banbury Center
From time to time, Banbury Center holds a meeting on what might be called "science policy," i.e.,
discussions of topics that affect the way biomedical research is done. One of the most interesting,
held in 2001, was on the ways in which the Internet is making, and provoking, changes in the dis-
semination of scientific information and data. Electronic Access to the Scientific Literature exam-
ined the initiatives intended to lower the barriers to electronic access to the scientific literature, for
example, by providing free access to the full collection of scientific papers within a short period of
publication. This is a highly controversial topic, and although no resolution was reached at the
meeting, the discussions involving scientists, publishers of society journals, and commercial pub-
lishers were useful.
Cancer figured strongly in the Banbury Center program in 2001, with four meetings dealing with
important issues in cancer treatment. Two discussed the current status of interferon therapy in
cancer and were particularly interesting in that they reviewed the actions of interferon in virus infec-
tions as well as in multiple sclerosis. The third meeting on New Concepts for Clinical Cancer Trials
discussed new findings indicating that the manner in which cancer treatments are given is impor-
tant. It seems that different dosing schedules combined with lower doses could increase the effi-
cacy and reduce the toxicity and side effects of traditional cytotoxic drugs, and perhaps also of
radiotherapy and some investigational drugs. These topics were so interesting that we decided to
make Controlling Cancer the subject of the 2001 Executives Conference. It was a great success,
and we are very grateful to David Deming and JPMorgan H&C) for their continuing support of the
meeting.
We turned to a neuroscience topic with strong psychological and philosophical underpinnings
with Can A Machine Be Conscious? A wealth of new experimental information about the brain has
been gathered by neuroscientists, these data require a revision of
classic thinking on consciousness. The participants were a most interesting mix, from philoso-
phers and neuroscientists, to builders of robots, to robots themselves!
Robertson Research Fund
Since 1973, the Robertson Research Fund has been the primary in-house support for our scien-
tists. The fund has grown from its original 1973 total of $8 million to more than $95 million. During
2001, Robertson funds supported cancer research in the labs of Shivinder Grewal, David Helfman,
Winship Herr, Tatsuya Hirano, Yuri Lazebnik, Dick McCombie, Jacek Skowronski, William Tansey,
and Rui-Ming Xu; neurobiology research in the labs of Grigori Enikolopov, Dimitri Chklovskii, Josh
Huang, Roberto Malinow, Zachary Mainen, Anthony Zador, and Yi Zhong; and plant research in
the labs of Robert Martienssen and David Jackson. Robertson funds also supported several new
investigators, including Carlos Brody, Alea Mills, Bud Mishra, and Senthil Muthuswamy.
The Marie H. Robertson Memorial Fund, devoted to neuroscience, provided support for Grigori
Enikolopov and Zachary Mainen, and also for a neurobiology seminar program and Banbury
Meeting.
Cold Spring Harbor Laboratory Board of Trustees
Cold Spring Harbor Laboratory's Board of Trustees led the Lab through another challenging and
eventful year, continuing to shape the direction and vision of this institution.
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William E. Murray
This year, the Board welcomed the addition of three new trustees to its
ranks: Eduardo G. Mestre, Vice Chairman of Salomon Smith Barney and
Chairman of its Investment Banking Division; Douglas P. Morris, Chairman and
CEO of Universal Music Group; and Thomas C. Quick, Vice Chairman of Quick
& Reilly/Fleet Securities, Inc.
William E. Murray and Whitney D. Pidot both reached the end of their allot-
ted terms as trustees and were honored at the board's November meeting for
their outstanding service to the Laboratory. In early 2002, William E. Murraywas
elected as Honorary Trustee.
CSHL Association
The CSHL Association (CSHLA) continues to support the wide range of
research and education programs at Cold Spring Harbor Laboratory. The
CSHLA is particularly important in funding the research of junior scientists in the
formative years of their careers, when it is most difficult to obtain federal grants.
Through its fund-raising efforts and community interaction, the CSHLA is vital
to the Laboratory's success.
The CSHLA held its annual meeting on February 4, featuring a lecture by Dr.
Shirley Tilghman on "Genomic Imprinting." Dr. Tilghman, at that time a profes-
sor at Princeton University, is a former trustee of Cold Spring Harbor Laboratory
and has since been appointed as President of Princeton University. We extend
congratulations to our former trustee and good friend.
I encourage you to closely review the report of the Cold Spring Harbor
Laboratory Association, found later in this Annual Report, for a more compre-
hensive view of the many functions and successes of this special group. I
extend my thanks to David H. Deming, President of the CSHLA, and Annette
Gangitano, Executive Director of the CSHLA, for their hard work in making this
another banner year for our Association.
Whitney D. Pidot
Shirley Tilghman
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DNA Learning Center
The DNA Learning Center (DNALC) had an exhil-
arating year. On June 8, the BioMedia Addition
to the Center was dedicated, and the entire
building was renamed the Dolan DNA Learning
Center. The expanded administrative offices,
additional teaching lab, computer lab, a lunch-
room, and additional exhibition space were
made possible primarily through the generosity
of the Dolan Family Foundation, established by
former and current CSHL Trustees Charles and
Helen Dolan.
In addition to its expansion, the Dolan DNALC
continued its heralded "Great Moments in
Science" lecture series this year, and launched a
new Web Site, "Your Genes, Your Health." The
comprehensive Site profiles genetic diseases
and explains their intricacies on an easy-to-understand level. The Site, which receives thousands
of visitors each month, is quickly becoming a valuable resource for families and patients with
genetic diseases. I encourage you to review the Dolan DNALC report in its entirety, later in this
Annual Report.
Charles and Helen Dolan with Dr. Peter Bruns (Right)
CSHL Press
For Cold Spring Harbor Laboratory Press, 2001 was a year of new beginnings. The entirely rewrit-
ten, third edition of its classic Molecular Cloning: A Laboratory Manual, by Joe Sambrook and
David Russell, recaptured its place as a best-selling, essential information tool in experimental biol-
ogy. David Mount's Bioinformatics captured the suddenly burgeoning interest in this topic at the
undergraduate level to become the textbook of choice at over 50 schools in the United States. A
second textbook, the idea-driven Genes & Signals, by CSHL Trustee Mark Ptashne and staff
member Alex Gann, was published to high praise in December. Among the other successes in a
list of unusually interesting new titles was Elof Carlson's The Unfit, a history of the concept of
eugenics, and Kathy Barker's At The Helm, a unique source of guidance for newly appointed lead-
ers of research teams. Among the journals, Genome Research advanced strongly in circulation
and manuscript submission, and the newly acquired Protein Science, being published for The
Protein Society, was relaunched very successfully, with substantial increases in subscriptions and
advertising sales. Amid all this activity, 40 members of the Press staff relocated to handsome new
offices on the Woodbury campus, where for the first time in its history, all its key functions could
be conducted under one roof, with ease and efficiency.
CSHL Library and Archives
In 2001, the CSHL Library continued its work toward creating a "virtual" library. To that end, it has
maintained and substantially increased its digital library that includes all the necessary publications,
software, and databases for the multidisciplinary research of the Laboratory's scientific staff. The
Library continues its membership in consortia with two other major research institutions that began
in 2001: Rockefeller University and Memorial Sloan-Kettering Cancer Center. Membership in these
consortia provides our scientists electronic access to many journals from these institutions. In addi-
tion, the Biolnformation Synthesis Collaborative Consortia was formed with the libraries of the Woods
Hole Marine Biological Laboratory, The Rockefeller University, and the American Museum of Natural
History. The purpose of the consortia is to share human and information resources so that the col-
lective strengths support and advance the research and learning of the members' constituents.
The Library enjoyed the second year of its automated cataloging system called Sirsi, which pro-
vides the Library's electronic catalog called Web Cat, containing the library collection. Work on cre-
ating a new comprehensive database of all of the scientific laboratory's publications began this
year. It will cover the period from its inception in 1890 to 1965 (pre Pub Med). Two new digital pro-
jects were initiated this year: James D. Watson's Photo Archives and the CSHL Symposium photo
collection. This collection contains a remarkable history of biology in the latter two thirds of the
20th century and into the new millennium.
New Major Gifts
2001 was a challenging year for fund-raising. Several major campaigns continue to be success-
ful, despite the changed economy and the aftermath of the tragic events on September 11. The
campaign to fund the Genome Research Center, the BioMedia Addition to the Dolan DNA
Learning Center, and a continuing campaign for the Watson School of Biological Sciences were
our major concerns, as was the ongoing effort to fund the cancer gene discovery program. We
are very fortunate to have such generous and supportive friends at Cold Spring Harbor Laboratory,
but for us to remain at the forefront of all areas of research and education, we need to increase
support. Cold Spring Harbor Laboratory appreciates the major investment for these campaigns
that provide the basis for many innovative initiatives. Through private funding, the Laboratory is
changing the way we think about disease to provide a better future.
Institutional Advancement
The thoughtful commitment of $750,000 from Helen and Charles Dolan has enabled the planning
and execution of initiatives to advance our education and research programs.
Watson School of Biological Sciences
The main focus of fund-raising for 2001 was the continuing campaign for the Watson School of
Biological Sciences led by Laboratory Honorary Trustee David L. Luke III. New support was
secured this year to fund student fellowships, lectureships, and courses. We are grateful for new
gifts from Mr. and Mrs. Norris Darrell, Jr. for $200,000; The William Stamps Farish Fund for
$200,000; the Annette Kade Charitable Trust for $100,000; Pfizer Global Research & Development
for $300,000; Mr. and Mrs. Julian H. Robertson for $100,000; The Seraph Foundation for
$75,000; and the Ziering Family Foundation for $300,000. A generous challenge gift of $350,000
was also made to the Watson School by an anonymous donor.
The Genome Research Center
This year heralded the completion of the 65,000-square foot Genome Research Center in
Woodbury. The Center, just occupied in the middle of this year, is now running at close-to-full
capacity, housing a Bioinformatics Center, a Cancer Research Center, the Genome Sequencing
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Center, the Plant Genomics Center, the Cold Spring Harbor Laboratory Press, and the
Laboratory's Purchasing Department. We are grateful for major new contributions to the facility in
nearby Woodbury from the Goldfield Family Charitable Trust for $100,000 and the William and
Maude Pritchard Charitable Trust for $280,000. The largest gift to date for this facility and its pro-
grams was $3,500,000 received from a generous donation of real estate by Kenyon Gillespie.
Dolan DNA Learning Center
Major support to fund the new BioMedia Addition continued this year with gifts from The Booth
Ferris Foundation for $150,000 and $165,000 from the estate of Mrs. Dorothy H. Hirshon.
Rotating exhibit space in The Genes We Share installation was made possible by a generous
$150,000 pledge from Dr. Laurie J. Landeau. Once again, Brinkmann Instruments, InclEppendorf
AG has donated new lab equipment, this year valued at $75,000. We are also grateful to Arrow
Electronics for their generous gift of $30,000; to Fisher Scientific International for $27,000 worth
of equipment; and to Mr. and Mrs. Stephen A. Paolino/JPC Contracting for their gift of $10,000.
Private Research Support
Private funding in 2001 facilitated important research initiatives incancer, neuroscience, and other
areas, with major gifts in the $100,000 and above category, including the Oliver and Jennie
Donaldson Trust for $250,000; the Louis Morin Charitable Trust for $125,000; the David and Lucille
Packard Foundation for $970,000; the St. Giles Foundation for $183,000; Ann and Herb Siegel
for $1,000,000; and the Whitehall Foundation for $225,000. The generosity of these and numer-
ous other major private benefactors of Cold Spring Harbor Laboratory is crucial to our mission to
perform the highest-quality basic research.
Breast Cancer Support
We greatly appreciate the support received in 2001 for breast cancer research from a number of
breast cancer groups, including The Breast Cancer Research Foundation; the Long Beach Breast
Cancer Coalition; Long Islanders Against Breast Cancer (L.I.A.B.C.); the Michael Scott Barish
Human Cancer Grant sponsored by 1 in 9: The Long Island Breast Cancer Action Coalition; and
the proceeds from Breast Cancer Awareness day in memory of Elizabeth McFarland. We remain
grateful to and inspired by the dedicated individuals who donate their time and energy to advance
cancer research through these organizations.
CSHL Planned Giving Advisory Board
The Cold Spring Harbor Laboratory Planned Giving Advisory Board was convened in 2001. Its
members-drawn from the financial services, accounting and legal professions-total more than
20. The Board consists of bank officers, trust officers, investment advisors, investment bankers,
accountants, tax advisors, and lawyers, representing 13 firms located on Long Island, in New York
City, and in Connecticut. The purpose of the Board is to report to this influential group the
Laboratory's activities and accomplishments and to engage Board members in the support ofthe
Laboratory's goals. We welcome the board members to the Laboratory community.
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President's Council
As in previous years, Jim Watson invited members of the President's Council to a 1-day meeting
at the Laboratory, to meet the young scientists supported by the Council members and to hear
about interesting advances in biomedical research. The topics for these meetings are carefully
chosen for a combination of high-quality research and general interest, and for 2001 we selected
a topic of importance to everyone-Nutrition: Facts and Myths.
The Council began with a talk by Nancy Etcoff (Massachusetts General Hospital) on "The
Evolutionary Basis of Beauty," discussing why we find certain body forms attractive and showing
that there are some fundamental forms that are cross-cultural. She was fol-
lowed by Walter Willett (Harvard School of Public Health) who spoke on
"Nutrition and Health" and gave us many good suggestions for improving our
health through our diet-including some suggestions that were against our
current wisdoms. Diet and cancer is a very controversial topic, but Bruce
Ames (University of California, Berkeley) presented convincing data that
micronutrients really do have a protective effect against cancer. With "Diets:
Reality and Hype," Marc Jacobson (North Shore-Long Island Jewish Health
System) reviewed diets and what does and does not work, and George Roth
(National Institute on Aging) described how diet affects life span. This was a
truly fascinating meeting and one that had a lasting impact on all participants.
Bruce Ames
Gavin Borden Visiting Fellow
Joan A. Steitz, Ph.D., Sterling Professor and Chair of
Molecular Biophysics and Biochemistry at Yale University,
was the Laboratory's 7th Gavin Borden Visiting Fellow. A
former Trustee of CSHL, Dr. Steitz presented a lecture titled
"Mechanisms of mRNA Export and Stability" on April 23 in
Grace Auditorium. The Gavin Borden Lecture series was
named in memory of Gavin Borden, a publisher whose
Molecular Biology of the Cell and other books made a last-
ing impression on many scientists, both old and new.
Building Projects
Joan A. Steitz
Cold Spring Harbor Laboratory obtained some much-needed space this year, with the completion
of two major projects.
On June 8, the Laboratory dedicated the Dolan DNA Learning Center, named for Helen and
Charles Dolan. The Center is significantly expanded, with new administrative, laboratory, auditori-
um, and lunchroom space for school-aged visitors. In addition, the Learning Center nearly dou-
bled its existing exhibit space and is in the process of designing new exhibits related to the histo-
ry and future of biology.
Renovations were completed this year on the Genome Research Center in nearby Woodbury.
The building, a 65,000-square-foot facility, now houses four research components: a
19
The Genome Research Center (top) and the Dolan DNA Learning Center (bottom).
Bioinformatics Center, a Cancer Research Center, a Genome Sequencing Center, and a Plant
Genomics Center, as well as new administrative space for the CSHL Press and other administra-
tive departments.
Community Outreach
Grateful for the overwhelming support that CSHL receives, a number of employees set out this
year to "give back" to the Long Island community.
CSHL was well-represented at the annual Chase Corporate Challenge, held at Jones Beach on
July 31. More than 32 Laboratory runners were on hand at the event. The CSHL Men's team
placed 12th and the Women's team placed 59th in the 3.5-mile race. Top performers included
Holly Cline, Linda Van Aelst, and No Grosse.
CSHL "road-runners" were also on hand at the Cigna 5K Walk/Run, to support 1 in 9: The Long
Island Breast Cancer Action Coalition, held at Eisenhower Park in East Meadow on August 23.
The CSHL group-grateful for more than 10 years of support from 1 in 9-performed well
despite the rain. In all, the event raised more than $60,000.
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Special Events
Harbor Lecture Series
This year, the Laboratory hosted its first Harbor Lecture Series, three
public lectures that attracted more than 900 visitors to Grace Auditorium.
The first lecture was given by Dr. Francis Collins, M.D., Ph.D., Director of
the National Human Genome Research Institute, on May 8. Dr. Collins's
lecture, "Medical and Societal Consequences of the Human Genome
Project," was well attended and much enjoyed. On May 21, John Coffin,
Ph.D., the Director of the HIV Drug Resistance Program at the National
Cancer Institute and the American Cancer Society Research Professor at
Tufts University School of Medicine in Boston, delivered a lecture titled
"HIV: Can This Disease Be Controlled or Cured?" The timely topic was
fascinating for all participants. The final lecture, delivered on September
10, was by Jeffrey M. Friedman, M.D., Ph.D., a professor at The
Rockefeller University in New York and an investigator for the Howard Francis Collins
Hughes Medical Institute. Dr. Friedman addressed the audience about weight and body mass in
an appealing lecture titled, "Molecular Mechanisms Regulating Body Weight."
Other Lectures
CSHL continued to host the Huntington Hospital Lecture Series, which ran from February to June.
This year's topic was "Cardiac Health," part of Huntington Hospital's Heart Health Lecture program.
Cold Spring Harbor Laboratory expanded its popular West Side School Lectures Program,
designed for students in local schools in grades four through six. Four CSHL Professors-Holly
Cline, Eli Hatchwell, Yuri Lazebnik, and Robert Malinow-delivered entertaining and informative
lectures to the budding scientists. The lectures, already a success, will again be expanded in 2002.
On March 23, Dr. Tom Kirkwood, a professor at the University of Newcastle in the United
Kingdom, delivered a fascinating lecture on aging and genetics titled "Thread of Life: The Role of
DNA in the Aging Process."
Holly Cline delivering a West Side School lecture.
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Concerts and Exhibits
As part of the Laboratory's Music of the Harbor Concert Series, several concerts were held this
year. Attended by the participants of CSHL's Meetings program and the public, the concert series
was a huge success. The concerts included:
March 9
May 5
May 19
May 26
August 18
August 25
September 1
September 8
September 22
October 6
Cathie Ryan, Traditional Irish Female Vocalist
Stella Simakova, Pianist
Melvin Chen, Pianist
Jonathan Biss, Pianist
Anna Stoytcheva, Pianist
Alexis Pia Gerlach, Cellist
Antonio Pompa-Baldi, Pianist
Claremont Trio
Anthony Molinaro, Pianist
Eric Johnson, Jazz Guitar/Donald Axinn Poetry Reading
The Claremont Trio (top) and Cathie Ryan, Vocalist (bottom)
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In addition to the concert series, the Laboratory hosted "Foto Lab I," a collection of works from
Laboratory staff and students. The event, inspired by Watson School student Rebecca Ewald,
included Doug Fogelson, a Chicago-based photographer, as the "official" photographer in resi-
dence. Doug helped the staff and students select and capture their best work for the exhibit. Doug
also gave special lectures and master classes during the exhibit, which ran in the Bush Auditorium
from June 30 through August 5.
Laboratory Employees
Long-term Service
On June 22, employees celebrating milestone anniversaries with the Laboratory were honored at
a special dinner at Robertson House, on the Banbury Center property. Congratulations to all!
Honorees included:
30 Years William Keen and John Maroney
25 Years Guy Cozza, Joseph Ellis, Roberta Salant, Peter Stahl, Margaret Wallace,
and Patricia Wendel
20 Years Dorothy Brown, Rodney Chisum, David Helfman, Patricia Kurfess,
Joseph Pirnak, and Philip Renna
15 Years Russell Allen, Jennifer Blovsky, Mary Cozza, Nouria Hernandez,
Christopher Hubert, Adrian Krainer, Susan Lauter, Carol Marcincuk,
Vincent Meschan, Timothy Mulligan, Jacek Skowronski, and Diane Tighe
Back row (left to right): David Helfman, Russell Allen, Patricia Wendel, Adrian Krainer, Joseph Ellis, Peter Stahl, Jacek
Skowronski, Bruce Stillman, Dill Ayres
Middle row (left to right): Susan Lauter, Howls Hernandez, Roberta Salant, William Keen, Timothy Mulligan, John Maroney
Front row (left to right): Philip Renna, Carol Marcincuk, Margaret Wallace, Mary Cozza, Dorothy Brown, Guy Cozza, Jennifer
Blovsky, Chris Hubert
Not pictured: Diane Tighe, Rodney Chisum, Patricia Kurfess, Joseph Pirnak, and Vincent Meschan
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Carlos Brody
Promotions
Alea Mills Senthil Muthuswamy
New Faculty and Staff
Carlos Brody, Alea Mills, and
Senthil Muthuswamy joined the
Laboratory this year as assistant
professors.
Michael Myers and Marja Timmermans were both promoted to assistant professor this year. Shiv
Grewal, David Jackson, and Andrew Neuwald were promoted to associate professors, and Dick
McCombie was promoted to professor.
Departures
Departures this year included Ryuji Kobayashi, an associate professor; Edward Stern, a senior fel-
low; and Clifford Yen, a research investigator.
Visiting Scientists
Three visiting scientists joined us this year: Ann-Shyn Chiang joined the lab of Tim Tully; Xiaomin
Wang joined the lab of Grigori Enikolopov; and Tilak Sharma joined the lab of W. Richard
McCombie. Four scientists also wrapped up their stays at Cold Spring Harbor Laboratory:
Antonius Holtmaat, Vincent Co lot, Edith Heard, and Mary Sabatini.
Concluding Remarks
Science moves at a rapid pace at Cold Spring Harbor Laboratory-perhaps faster than at many
places-for three principal reasons. First, our focus has always been on nurturing young scientists
who are in the formative years of their scientific careers, giving them the reins and letting them go
where they will. We are constantly surprised by what they achieve. Second, we teach in our cours-
es program the latest research technologies to active scientists who visit from all over the globe.
Third, administration and support staff are solely geared to the support of science. When com-
bined, these factors make CSHL a center for truly innovative research. This is one of the reasons
I decided to stay at CSHL after arriving as a postdoctoral fellow (not too long ago). Scientific
research, by its very nature, is always moving into the unknown, trying to explain the ways of
nature and how it can go wrong in diseases that afflict so many. I am confident that our approach
will win the fight against some of the most important problems in biology and biomedicine.
With the slowing economy and the ever-increasing cost of high-technology-based science, our
ability to support all that we need to do is a challenge that keeps me constantly worrying how we
might "make ends meet" at the end of each year. The opportunities are significant, and I hope that
as we move forward into a new year, we might feel more comfortable that at least the very best of
what we do will receive the necessary funds. Ultimately, it is the fruits of this science that will ben-
efit us, our children, and our children's children.
Bruce Stillman
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ADMINISTRATION
It is impossible to reflect on the year 2001 without one's thoughts going immediately to
September 11. The "where were you when?" syndrome will be as strong for this moment as for
any of the others in our history that are so indelibly inscribed in the national psyche. When my
assistant, Judi Smith, came into my office at 8:45 that Tuesday morning to tell me that there
was a fire burning at the Trade Center-apparently due to an airplane crash-a sense of fore-
boding began to set in. It was a brilliant fall morning in Cold Spring Harbor with bright blue sky
and water-not conditions where I could imagine an aircraft accidentally crashing into the tow-
ers. I went immediately to the Richards conference room where there was already a group from
the Facilities Department huddled around the television set. There, we watched in disbelief as
the cascade of horrific images and events unfolded before our eyes on live television. Shaken
and numb after the collapse of the second tower, I returned to my office. Immediate thoughts
were of how many families of Laboratory personnel would be directly affected and how many
friends who worked in the Trade Center were in their offices that morning. With 850 employees
and their families living and working 35 miles from the site of such massive loss of life, it seemed
highly unlikely that our community would be spared.
My concern about Laboratory personnel was sadly confirmed. Chief Facilities Officer Art
Brings called to tell me that two of his veteran employees had sons missing. Joey Ellis' son
Mark was a New York City Transit Authority police officer who had rushed to the scene to take
part in the rescue effort. Lou Jagoda's son Jake worked for the ill-fated bond house, Cantor
Fitzgerald. Such loss is tragic beyond description and our hearts go out to Joey, Lou, and their
families. A long-time friend and supporter of the Laboratory also lost his life at the Trade Center.
Lindsay Herkness, an executive at Morgan Stanley Dean Witter, was a familiar and popular fig-
ure at Symposium lectures and dinner parties. He will be sorely missed by the Laboratory com-
munity, his family, and his wide network of loving friends in New York City and Long Island.
On a brighter note, the science at the Laboratory gets more exciting by the moment. Having
the complete human genome sequenced allows our investigators to use novel techniques to
compare diseased and normal tissue and to identify genes associated with cancer and other
diseases. The good news for the nonscientists among us is that the progress of the research
is getting us closer to the clinic. It is becoming easier to make the connection between the basic
research being done in our laboratories and practical and promising therapeutics being devel-
oped for human disease. The heretofore challenging job of answering the familiar question-
What is it that goes on at Cold Spring Harbor Laboratory?-has become easier to handle. Our
Director of Public Affairs, Jeff Picarello, has done a commendable job communicating the
Laboratory's work and mission. Articles on the Laboratory itself and on the field of molecular
biology were more prevalent during the past year-witness cover stories in national publications
such as Time, Newsweek, and Forbes.
Our graduate program, The Watson School of Biological Sciences, continues to thrive under
the leadership of Dean Winship Herr. The third class of Ph.D. students arrived in the fall. The
student body-now totaling 20 Watson School students, 50 SUNY Stony Brook students, and
140 postdoctoral fellows-provides an academically charged and stimulating atmosphere char-
acteristic of an elite university. The campus is more alive than ever before, and the students add
a welcome dimension of vitality to the daily life of the Laboratory.
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Two substantial projects were completed over the course of the year, the most challenging
being the renovation and expansion of the Genome Research Center at Woodbury. The process
of redesigning, gutting, and rebuilding this 65,000-square-foot building was complex to say the
least. This is a very high-tech facility, housing not only the offices of the Cold Spring Harbor
Laboratory Press and the Laboratory Purchasing Department, but also state-of-the-art labora-
tories with robotics and other sophisticated scientific equipment to facilitate genome sequenc-
ing, cancer gene discovery, and plant biology. The Center is already home to 120 employees,
and our Food Services Department, led by Jim Hope, has opened an attractive new dining facil-
ity on site. This research facility is the Laboratory's first away from the main campus, and con-
certed effort has been made to make employees there still feel part of a cohesive and integrat-
ed community. Much credit for the success of this project goes to our own Facilities Department
for their planning, execution, and oversight and to Centerbrook Architects and Fortunato Sons,
Inc. for their work on the project.
The other successful project completed was the renovation and addition to the Dolan DNA
Learning Center. Thanks to the generosity of the Dolan family and others, this innovative edu-
cational facility has undergone a complete facelift and has virtually doubled in size. The new Bio-
Media addition includes a state-of-the-art computer laboratory for the students, new exhibit
space, additional wet labs, a student lunchroom, and much-needed office space for staff. The
innovative high school and middle school programs continue to attract thousands of eager stu-
dents and teachers each year. Visits to the award-winning educational Web Sites developed by
the Center's talented team are increasing rapidly. In June, the opening of the building was cel-
ebrated at a well-attended dedication featuring remarks by both Charles and Helen Dolan and
followed by an operatic performance.
The library at the Laboratory is becoming an increasingly dynamic place. Mila Pollock,
Director of Library Services, and her colleagues have undertaken an effort to create a state-of-
the-art digital library to meet the growing requirements of our research scientists and students.
Also in 2001, Jim Watson formally donated his book and reprint collection to the Laboratory
Archives. With the help of a generous grant from Lewis Lehrmann, archivists are in the process
of organizing the vast and valuable collection of Dr. Watson's manuscripts, letters, and other
materials for the eventual benefit of scholars from around the world.
As always, we are indebted to our Cold Spring Harbor Laboratory Association Directors and
other volunteers who do so much to draw positive attention to the Laboratory. The third Jazz at
the Lab concert in April, organized by Joe Donohue, Susan Ho llo, Cathy Soref, and Gil Ott, was
a huge success from every perspective. Staffers Charlie Prizzi and Annette Gangitano both did
superb jobs in working with the committee and managing the logistics of the event. Thanks are
also due to the Corporate Advisory Board of the Dolan DNA Learning Center, led by Ed
Chernoff, which organized another successful golf tournament at Piping Rock in June.
It has become evident that the field of biomedical research is at a turning point and that
advances against human disease are likely to change our lives during the next few decades.
This revolution, and Cold Spring Harbor Laboratory's central role in it, has been the catalyst for
a new push in strategic planning. Over the course of the year, a great deal of effort was expend-
ed on the development of a long-term "master plan" for the Laboratory's future. This initiative
was led by Drs. Stillman and Watson, who have both articulated a compelling vision. The
process entailed mapping the future direction of the research and educational programs and
then creating and developing an infrastructure plan to accommodate the growth. A team,
including Trustees Helen Dolan and Mary Lindsay, was formed to work with Centerbrook
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Architects. We are pleased with the resulting plan for a new research and academic cluster at
the west end of our main campus. Great care was taken to preserve the lawns and open
spaces at the eastern end of the property and to design buildings with the traditional "whaling
village" character of the campus. The plan is well within the stringent zoning guidelines set out
by the Village of Laurel Hollow in 1995 and has the enthusiastic support of our Board of
Trustees. Needless to say, this project requires a large and comprehensive fund-raising cam-
paign that must be well under way before any work begins. To that end, two new appointments
have been made. As Vice President of Institutional Advancement, Rod Miller-who joined us
from Brooklyn Polytechnic-will oversee the planning and execution of the campaign. Diane
Fagiola, a Locust Valley native, has succeeded Rick Cosnotti as Director of Development.
Again, we express our appreciation to the Dolan family for their generous grant enabling the
groundwork for the master plan and for the campaign plan development.
Two other managerial changes of note took place at the end of the year. Cheryl Sinclair,
Director of Human Resources, retired after 12 years of loyal service. During her tenure, the
employee population grew from 463 to 850. Cheryl met the many challenges presented by this
growth with grace and professionalism. We wish her well in her retirement. Katie Raftery was
recruited from the Ericsson Corp. as our new Director of Human Resources. Katie is an expe-
rienced manager who has transitioned into the job with great energy and enthusiasm. Jerry
Latter, our Director of Information Technology, was recruited to Rockefeller University in
October. We were fortunate, in this case, to draw on existing talent and to promote Mark
Kilarjian to the Director position.
As we face new challenges, the leadership and support of our Board of Trustees become
increasingly important. In identifying potential Board members, we look for bright, prominent,
and influential individuals who will take an active interest in the Laboratory. We welcome and
look forward to working with newly elected Trustees Tom Quick and Eduardo Mestre. We also
express our gratitude to two Board members whose terms expired at the end of the year. Both
Bill Murray and Whitney Pidot served with great distinction, and their contributions will long be
felt at Cold Spring Harbor Laboratory.
The Laboratory had a satisfactory year financially. There were concerns as we began the year
that it would be a difficult one in which to achieve break-even results with our operating bud-
get. I am pleased to report that results were better than forecasted and we were able to break
even after $4.6 million in depreciation expense. Having said that, there was no operating sur-
plus as in past years, and it was necessary to utilize $800,000 of an existing $2.3 million reserve
account to achieve these results. Revenues grew 10% to $76,691,000, and $3.8 million in pos-
itive cash flow from operations was available for capital expenditures. A number of factors con-
tributed to the better-than-expected performance. The Cold Spring Harbor Laboratory Press
had an excellent year due in part to strong sales of the third edition of its popular laboratory
manual Molecular Cloning. Royalty and licensing income also exceeded expectations, thanks
to the hard work of John Maroney and the Technology Transfer Department. Good cost control
by a number of administrative departments also contributed to the upside. These positives were
enough to outweigh effects directly and indirectly related to the events of September 11. Two
of our largest scientific meetings following 9/11 had to be postponed. Meetings and Courses
Director David Stewart did an admirable job in rescheduling and conducting the meetings, but
attendance was understandably down. We believe that our Annual Fund was also negatively
impacted. The number of gifts was down substantially, and only as a result of a generous and
concerted effort by our Board of Trustees were we able to avoid a commensurate decline in the
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total dollars raised. Finally, we were most disappointed to cancel a gala fund-raising concert
featuring Luciano Pavarotti. This event had been generously arranged and supported by
Laboratory Trustee Doug Morris, CEO of Universal Music.
The Laboratory's endowment funds suffered this year, reflecting the poor performance of the
public equity markets. At year end 2001, the endowment totaled $212 million, down from $227
million at the previous year end. The asset allocation of our managed funds is approximately
53%147% equities to fixed income investments. Total return on these funds was a negative
4.8%, comparable to benchmark indices of similarly allocated funds. Most equity managers had
a difficult year and ours were no exception. Our "growth" strategy equity managers, Vanguard
Primecap and Essex Management, both underperformed the Standard & Poor's 500. "Value"
manager U.S. Trust was able to outperform the Standard & Poor, but it was still down for the
year. On the other hand, our fixed income manager, Miller Anderson, achieved excellent results
and outpaced market indices. The Laboratory continues its relatively conservative policy of
drawing down 4% per annum from the endowment based on the 3-year moving average of
year-end market value. We rely on these funds to supplement government support of cutting
edge research and to ensure a secure financial future for the Laboratory. Over time, the
Laboratory has managed the endowment prudently and successfully and has achieved out-
standing growth. The Finance and Investment Committee, chaired by Trustee Lola Grace,
meets regularly to evaluate, review, and determine investment policy and guidelines. This
responsibility is undertaken with diligence, especially in times of poor markets.
We face another year of financial challenges as we look ahead to 2002. The markets and the
economy remain murky in the short term. At the Laboratory, the opening of the Genome
Research Center, while exciting, carries with it substantial increases in operating costs and
depreciation expense, not all of which is yet supported by new grant income. We are antici-
pating a difficult year and are taking measures to conserve cash. These measures include an
administrative hiring freeze and a 2.5% cap on administrative salary increases, as well as a
salary freeze for senior management. In addition, we are planning to spend $800,000 less than
the budgeted depreciation expense on capital expenditures. The Laboratory is a healthy insti-
tution financially because it has been managed prudently and diligently. It is our intention to
maintain this practice. I am indebted to Chief Financial Officer Morgan Browne and Comptroller
Lari Russo for their counsel, wisdom, and leadership in this ongoing effort.
In the midst of this challenging environment, we have developed an ambitious plan that will
require a capital-raising effort of unprecedented scope for the Laboratory. From a fund-raising
perspective, the timing may not be perfect. From a scientific standpoint, the time is clearly now.
Our research and education programs are of the very highest caliber because we have the best
people and the best minds in the business. It is imperative that we provide them with the best
facilities and the resources necessary to achieve their objectives. Cold Spring Harbor
Laboratory did not gain the prominence it enjoys today without bold vision. In 1968, Jim Watson
assumed the leadership of an institution with no endowment and an uncertain future. An oppor-
tunity was seized. Today, we face another turning point and yet another opportunity. Onward
and upward!
W. Dillaway Ayres, Jr.
Chief Operating Officer
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RESEARCH
CANCER: GENE EXPRESSION
The investigators in the Gene Expression Group are unified by a shared interest in understanding the
mechanisms of control of gene expression. These shared interests result in a highly interactive unit. The
members of this group study the following topics.
Shiv Grewal studies the epigenetic control of gene expression in the yeast Schizosaccharomyces
pombe.
Nouria Hernandez studies the regulation of small nuclear RNA gene transcription in human cells and
thus addresses the mechanisms of RNA polymerase selectivity.
Winship Herr studies the regulation of gene transcription in human cells using herpes simplex virus
as a model system.
Leemor Joshua-Tor studies the structural basis of regulation of proteolysis and DNA functions.
Adrian Krainer studies the control of pre-mRNA splicing, and thus an important mechanism for the
generation of diversity in gene function.
Mike Myers uses proteomic approaches to study how protein complexes regulate cell signaling and
tumor progression.
William Tansey studies the proteolytic destruction of the oncoprotein transcription factor Myc and
the involvement of the ubiquitin-proteasome pathway in transcriptional control.
Jacek Skowronski studies how the human and simian immunodeficiency viruses disrupt signal
transduction and the expression of cell surface receptors in infected T cells.
Rui-Ming Xu studies the structural basis of pre-mRNA splicing and transcriptional silencing.
See previous page for photos of the following scientific staff.
Row 1: Farida Emran; Eric Allemand; Tatsuhiko Kawaguchi; Laura Schramm; Linda Van Aelst; Chih-Chi
Yuan
Row 2: Xavier Roma, Andriy Tovkach; Peter O'Brien; Jannic Boehn; Christine Von Klitzing, Masaaki
Hamaguchi; Hirac Gurden; David Roberts
Row 3: Guy Karger; Lee Henry; Benjamin Boettner; Santanu Chakraborty, Sachin Ranade
Row 4: Ashish Samna; Gowan Tervo; Tom Volpe; Koichi lijima, Kanae lijima; Julius Zhu
Row 5: Catherine Zhang; Ying-hua Zhu; Esteban Araya; Ingrid Ehrlich
Row 6: Ken -Ichi Noma; Christine Von Klitzing; Ed Ruthazer; Mike Wehr
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EPIGENETIC CONTROL OF GENE EXPRESSION
S. Grewal I. Hall K. Noma
A. Malikzay G. Shankaranarayana
J. Nakayama G. Xiao
Research in our laboratory is focused on the epigenet-
ic control of higher-order chromatin assembly. The
organization of chromatin into higher-order structures
governs diverse processes ranging from stable inheri-
tance of gene expression patterns to other aspects of
global chromosome structure essential for preserving
genomic integrity. To understand the molecular mech-
anism of establishment and maintenance of higher-
order chromatin structures, we are studying a gene-
repression mechanism known as "silencing" at the
mating-type region and centromeres of the fission
yeast Schizosaccharomyces pombe. Our earlier studies
have revealed that an epigenetic imprint marking the
mating-type region contributes to maintenance of a
higher-order chromatin structure, which controls
silencing and recombinational suppression throughout
the 20-kb silent mating-type interval. A chromo-
domain-containing protein Swi6, which shares struc-
tural and functional similarities to HP1 from higher
eukaryotes, was found to remain stably associated
with the silent mating-type region throughout the cell
cycle, presumably providing a molecular bookmark to
clonally propagate a specific chromatin configuration
during cell division. We provided direct evidence
showing that the Mendelian unit of inheritance, the
gene, at the mat locus comprises DNA plus the asso-
ciated Swi6-containing protein complex(es).
Differences in chromatin structure have been
linked with distinct covalent modifications, such as
acetylation, phosphorylation, ubiquitination, and
methylation of histone amino-terminal tails that regu-
late transcription and influence chromosome conden-
sation and segregation. Mutations in histone-modify-
ing factors such as the methyltransferase C1r4 and
deacetylases C1r3 and Clr6 affect silent chromatin
assembly at centromeres and the mating-type region.
How these histone modifications participate in the
modulation of chromatin structure and the precise
sequence of events leading to assembly of higher-order
chromatin structures have remained elusive. One pos-
sible explanation is that they directly alter nucleosomal
structure, thereby influencing histone-DNA and his-
tone-histone interactions. Another attractive possibility
is that distinct combinations of covalent histone modi-
fications, also referred to as the "histone code," provide
a mark on the histone tails to recruit other chromatin-
modifying proteins. During the past year, we have
made significant progress toward understanding the
epigenetic control of higher-order chromatin assembly.
MOLECULAR MECHANISM OF HETEROCHROMATIN
ASSEMBLY
Our work addressed the key molecular events leading
to the assembly of higher-order chromatin structures.
The covalent modifications of histone tails by
deacetylase and methyltransferase activities are
believed to act in concert to establish the histone code
essential for heterochromatin assembly at centromeres
and mating-type region of fission yeast. We provided
the first in vivo evidence that methylation of histone
H3 tails has a central role in heterochromatin-mediat-
ed silencing of large chromosomal domains. In collab-
oration with David Allis's laboratory (University of
Virginia), we showed that lysine 9 of histone H3 (H3
Lys-9) is preferentially methylated at the silenced
chromosomal regions. Clr4 protein, a homolog of
mammalian SUV39H1, which contains the amino-ter-
minal chromodomain and a carboxy-terminal SET
domain, is the H3 Lys-9-specific histone methyltrans-
ferase (HMTase) in fission yeast. Although the highly
conserved SET domain and surrounding cysteine-rich
regions of C1r4 are sufficient for its HMTase activity,
we found that both its chromo and SET domains are
required in vivo. Methylation of H3 Lys-9 by the Clr4
enzyme is dependent on another factor, Rikl, which
contains 11 WD40 repeat-like domains. It has been
suggested that Rikl might form a complex with C1r4 ,
to recruit its HMTase activity to heterochromatic loci.
Interestingly, the localization of Swi6 to the hete-
rochromatic loci is tightly linked to H3 Lys-9 methy-
lation. More importantly, we found that an H3 Lys -14-
specific deacetylase C1r3 seems to be required for H3
Lys-9 methylation by C1r4 and Swi6 localization.
Although methylation of H3 Lys-9 is required for
heterochromatin association of Swi6, mutations in
Swi6 have no effect on H3 Lys-9 methylation, sug-
gesting that Swi6 is dispensable for H3 Lys-9 methy-
lation and most likely acts downstream from C1r4.
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FIGURE 1 A stepwise model for epigenetic control of heterochromatin assembly in fission yeast. Histone
deacetylase and methyltransferase enzymes cooperate with each other to establish a specialized histone
code essential for heterochromatin assembly. C1r6/C1r3 deacetylases are believed to remove acetyl groups
on lysines 9 and 14 of H3, whereas the C1r4/Rik1 complex methylates lysine 9 of H3. The chromodomain
of Swi6 binds specifically to methylated H3 Lys-9 to continue heterochromatin assembly. The dimerization
of Swi6 is believed to provide an interface for its interaction with other proteins, including histone-modify-
ing enzymes, and might be a key to spreading as well as inheritance of heterochromatic structures.
Collectively, these studies helped us define a temporal
sequence of events leading to heterochromatin assem-
bly that may be conserved from fission yeast to
humans (Fig. 1). The deacetylation of the histone H3
tail likely precedes the methylation of H3 Lys-9,
which creates a binding site for recruitment of Swi6.
The binding of Swi6 chromodomain to H3 Lys -9-
methylated tails and the dimerization of Swi6 through
its chromo shadow domain likely promote formation
of heterochromatic structures.
BOUNDARIES OF HETEROCHROMATIN
DOMAINS
Eukaryotic genomes are believed to be organized into
discrete structural and functional chromatin domains
that help separate independently regulated parts of the
genome. Specialized DNA elements, known as insula-
tors or boundary elements, have been suggested to act
as barriers against the effects of enhancer and silencer
elements from neighboring regions. However, the
mechanism that prevents the spreading of heterochro-
matin into euchromatin in a natural chromosomal con-
text is not well understood.
To address these fundamental questions related to
genome organization, we created a 47-kb high-resolu-
tion map of the heterochromatin complexes at the mat-
ing-type locus of fission yeast. We found that a hete-
rochromatic domain can be easily distinguished from a
neighboring euchromatic domain on the basis of their
distinct histone H3 methylation patterns. Our analyses
revealed that histone H3 methylated at lysine 9 and its
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interacting Swi6 protein are strictly localized to a 20-
kb heterochromatic domain (Fig. 2). In contrast, H3
methylated at lysine 4 (H3 Lys-4), only a few amino
acids away, is specific to the surrounding euchromatic
regions. Remarkably, we discovered that two inverted
repeats (IR-L and IR-R) flanking the silent interval
serve as boundary elements to mark the borders
between heterochromatin and euchromatin. Deletions
of these boundary elements lead to spreading of H3
Lys-9 methylation and Swi6 into neighboring
sequences. We also showed that the H3 Lys-9-methyl
modification and corresponding heterochromatin-
associated complexes prevent H3 Lys-4 methylation in
the silent domain. This study suggests that boundary
elements might help separate specialized chromatin
domains with distinct histone codes. Our work also
supports the idea that position effect variegation in
higher eukaryotes, such as Drosophila, results from the
spreading of heterochromatin complexes into adjacent
euchromatic regions. How boundary elements protect
against encroachment of repressive heterochromatin
complexes into euchromatic regions containing genes
is the focus of our current research.
HETEROCHROMATIN AND CHROMOSOME
DYNAMICS
Previous studies have shown that heterochromatin at
centromeres has a pivotal role in proper kinetochore
function and chromosome segregation. Mutations in
heterochromatin proteins such as Swi6 result in defec-
tive centromeres leading to missegregation of chromo-
somes, although the precise mechanism is not clear. In
collaboration with Yoshi Watanabe's lab (University of
Tokyo), we showed that cohesin protein complexes,
which are essential for sister chromatid cohesin and
proper chromosome segregation, are preferentially
enriched at heterochromatic regions in S. pombe.
Moreover, cohesin enrichment at heterochromatic loci
is dependent on Swi6, which directly interacts with
cohesin subunit Psc3. Therefore, the role of hete-
rochromatin in chromosome segregation might be
coupled to its involvement in preferential recruitment
of cohesin. We also found that cohesin is enriched at
the silent mating-type region in a manner that depends
on Swi6 and it is required to preserve the genomic
integrity of this locus.
ROLE OF RNAi MACHINERY IN HETEROCHROMATIN
ASSEMBLY
What defines a specific chromosomal domain as a pre-
ferred site of heterochromatin assembly? It has been
suggested that heterochromatin formation might have
originated in response to defense against transposable
elements. According to this hypothesis, heterochro-
matin assembly might be linked to the presence of
repeated DNA sequences, rather than any specific
DNA sequence identifying these loci. Alternatively,
aberrant RNA transcripts produced from repetitive
DNA, such as present at S. pombe centromeres, might
be recognized by RNA-mediated interference process-
es and serve as a trigger, targeting chromatin modifiers
to the corresponding genomic locations. Interestingly,
factors known to be involved in RNA interference
(RNAi), such as RNA-dependent RNA polymerase
(rdpl), Dicer (dcrl), and Argonaute (agol), present in
higher eukayotes with complex genomes, are present
in S. pombe. Although it remains to be demonstrated
whether RNAi exists in S. pombe, in collaboration
with R. Martienssen's group here at CSHL, we have
shown that deletion of rdpl, dcrl, or agol affects
silencing and heterochromatin assembly at cen-
tromeres. Specifically, RNAi machinery is essential
for the targeting of histone-modifying activities and
Swi6 to centromeric repeats. Consistent with a role for
centromeric repeat sequences in heterochromatin for-
mation, we also showed that these sequences possess
the ability to recruit heterochromatin complexes and
promote silencing at an ectopic site.
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FIGURE 2 Distribution of Swi6 and distinct site-specific histone
H3 methylation patterns marking the euchromatic and hete-
rochromatic domains at the S. pombe mating-type region.
Shown is a physical map of the mating-type region with mats,
mat2, and mat3 loci. (Thick arrows) IR-L and IR-R inverted
repeats flanking the mat2-mat3 interval. cenH represents
sequences sharing homology with the centromeric repeats.
(Open boxes) Location of open reading frames; (arrows) direc-
tion of transcription. The graphs below represent results from
high-resolution mapping of Swi6, H3 Lys-9 methylation, or H3
Lys-4 methylation levels determined by chromatin immunopre-
cipitation experiments. H3 Lys-9 methylation and Swi6 are
specifically enriched throughout the 20-kb heterochromatic
interval that displays transcriptional silencing and suppression
of recombination. In contrast, H3 Lys-4 methylation is enriched
in transcriptionally poised euchromatic regions containing
genes. IR-L and IR-R inverted repeats act as boundaries of the
heterochromatin domain and prevent spreading of repressive
chromatin complexes into neighboring areas.
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MECHANISMS OF TRANSCRIPTION
N. Hernandez E Emran S. Mayilvahanan A. Saxena C.-C. Yuan
P. Hu P.S. Pendergrast L.M. Schramm X. Zhao
B. Ma K. Samudre Y. Sun A. Zia
The specific transcription of genes is accomplished
through a combinatorial mechanism in which differ-
ent configurations of protein-DNA and protein-pro-
tein interactions are used to recruit the correct RNA
polymerase at the correct place and the correct time.
We use the human small nuclear RNA (snRNA) genes
and the human immunodeficiency virus type-1 long
terminal repeat (HIV-1 LTR) as model systems to
study mechanisms of transcription. Most snRNA
genes are transcribed by RNA polymerase II, but
some are transcribed by RNA polymerase III. Yet, all
snRNA promoters are quite similar to each other and
recruit several common transcription factors. Thus, in
this system, transcription initiation complexes that
recruit different RNA polymerases are very similar
and can be compared to identify determinants of RNA
polymerase specificity.
The core RNA polymerase II and III snRNA pro-
moters contain a proximal sequence element or PSE,
which recruits a multisubunit complex we refer to as
SNAP. The RNA polymerase III core snRNA promot-
ers contain, in addition, a TATA box located down-
stream from the PSE that recruits the TATA-box-bind-
ing protein (TBP). SNAP and TBP recruit at least two
additional proteins referred to as 13" and BRFU. BRFU
is an interesting protein because it is related to both
TFIIB, which in RNA polymerase II mRNA promoters
bridges the promoter-binding proteins and RNA poly-
merase II, and BRF, which is involved in transcription
from gene-internal RNA polymerase III promoters. The
RNA polymerase II snRNA promoters require many of
the factors involved in transcription from RNA poly-
merase II mRNA promoters including TBP, TFIIA,
TFIIB, TFIIF, and TFIIE. However, it is not clear how
these factors are recruited to the TATA-less RNA poly-
merase II snRNA promoters. We are characterizing the
remaining factors required to reconstitute RNA poly-
merase II and RNA polymerase III transcription from
snRNA promoters and studying how the RNA poly-
merase II and III snRNA initiation complexes assemble.
The HIV-1 promoter generates two types of tran-
scripts: full-length transcripts and prematurely termi-
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nated transcripts. We have continued the characteriza-
tion of FBI-1, a transcription factor that binds to the
HIV-1 promoter element (the inducer of short tran-
scripts or IST) that activates the formation of short
HIV-1 transcripts.
Analysis of the Functional Domains
of BRFU and TFIIB
L.M. Schramm, Y. Sun, N. Hernandez
The U6 snRNA promoter recruits SNAP, TBP, B",
and BRFU. As mentioned above, BRFU is related in
sequence to TFIIB. In TATA-box-containing RNA
polymerase II mRNA promoters, TFIIB recognizes
TBP or TFIID bound to the TATA box and recruits,
through direct protein-protein contacts, RNA poly-
merase II complexed with TFIIF. Thus, it seems likely
that BRFU has a similar role in bridging promoter-
bound factors and, in this case, RNA polymerase III.
Since the RNA polymerase II snRNA promoters, like
mRNA promoter, require TFIIB for transcription, this
in turn implies that the determination of RNA poly-
merase specificity is ultimately governed by the
recruitment of either TFIIB or BRFU. We have con-
structed chimeric TFIIB-BRFU proteins and are deter-
mining which regions of these proteins provide the
specificity of RNA polymerase recruitment.
Characterization of BRFU-containing
Complexes
A. Zia, N. Hernandez
We isolated a cDNA encoding BRFU through data-
base searches of proteins related to TFIIB and BRF. To
determine whether BRFU exists in the cell as part of
one or several complexes, we are purifying BRFU
from HeLa cells.
Characterization of Endogenous
Er and FBI-1
K. Samudre, N. Hernandez
13'. is implicated in RNA polymerase III transcription.
The gene from which it is derived appears to encode a
number of other proteins as a result of alternative
splicing patterns. We are interested in determining
which of these proteins are actually present in the cell
and what their functions are. We are also interested in
determining whether FBI-1, which binds to the HIV-1
IST, is present as a complex in cells.
Cooperative Interactions
between SNAP and TBP
on the U6 snRNA Promoter
B. Ma, N. Hernandez
SNAP, and TBP bind cooperatively to the human U6
promoter. By assembling subcomplexes of SNAP, that
lack either entire subunits or subunit parts, we are
mapping the regions in SNAP, required for coopera-
tive binding with TBP and testing the role of these
regions for transcription.
Mechanism of SNAPS
Auto-regulation of DNA Binding
A. Saxena, N. Hernandez
SNAP, on its own binds poorly to DNA, but a sub-
complex of SNAP, called mini-SNAP, and consisting
of the amino-terminal third of SNAP190, SNAP43,
and SNAP50 binds efficiently to the PSE. We are
studying the mechanisms by which the full complex
down-regulates its own binding to DNA.
Identification of SNAP- associated
Factors
F. Emran, N. Hernandez
Some of the transcription factors required for RNA
polymerase II and III snRNA gene transcription are
likely to associate with SNAP,. We are developing a
yeast screen as well as cell lines to identify such
SNAP,-associated factors.
Reconstitution of Transcription from
the Human U6 snRNA Promoter
with Four Recombinant Factors
and a Partially Purified RNA
Polymerase III Complex
S. Sepehri Chong, P. Hu, N. Hernandez
We know that U6 transcription requires SNAP TBP,
BRFU, and B ". In an effort to characterize the remain-
ing factors required for basal U6 transcription in vitro,
we developed antibodies directed against RNA poly-
merase III. We cloned a cDNA corresponding to the
largest RNA polymerase III subunit, RPC155, and
characterized a cDNA corresponding to one of the
subunits unique to RNA polymerase III, RPC53
(BN51). We then used the predicted protein sequences
to generate antipeptide antibodies directed against
both subunits. With such reagents, we were able to
show that an anti-RPC53 immunoprecipitate could
direct U6 transcription when combined with a SNAP,
fraction and TBP.
To determine which components in the RNA
polymerase III fraction were required for U6 tran-
scription, we used conventional chromatography to
purify RNA polymerase III. The assay was reconstitu-
tion of transcription in the presence of the SNAP,
fraction and TBP. A whole-cell extract was fractionat-
ed by successive ammonium sulfate precipitation,
phosphocellulose, mono S and mono Q chromatogra-
phy, and sucrose gradient centrifugation. In the last
step, U6 transcription activity was recovered after the
669-kD size marker in a broad peak, which coincided
with the elution profile of both the largest subunit and
the RPC53 subunit of RNA polymerase III. These
results suggested copurification of the U6 transcrip-
tional activity with the bulk of RNA polymerase III.
Furthermore, the recovery of U6 transcription activi-
ty in a single peak after sucrose gradient centrifuga-
tion suggested that the activity was contained within
a complex, consistent with the observation that it
could be immunoprecipitated with antibodies directed
against an RNA polymerase III subunit.
To identify the components required in the SNAP,
fraction, we combined the highly purified sucrose gra-
dient RNA polymerase III fraction with recombinant
SNAP, and TBP. This combination was inactive. U6
transcription could be reconstituted, however, with a
combination of sucrose gradient RNA polymerase III
fraction, recombinant TBP, recombinant SNAP,
recombinant B", and recombinant BRFU. These
results confirm the essential roles of B" and BRFU in
U6 transcription and open the way to reconstitution of
U6 transcription from entirely defined components.
Characterization of a Minimal
System for Basal U6
Transcription In Vitro
P. Hu, N. Hernandez
Basal levels of U6 transcription can be reconstituted in
vitro with a combination of an RNA polymerase III
complex and recombinant SNAP,, TBP, BRFU, and
B " ". We are purifying the RNA polymerase III com-
plex such that all of its components can be defined and
functionally characterized.
Protein-Protein Interactions
in the U6 Transcription
Initiation Complex
C.-C. Yuan, N. Hernandez
We are close to having an entirely defined system for
U6 transcription. This gives us the opportunity to
understand how the different members of the U6 tran-
scription initiation complex assemble, in particular
how RNA polymerase III is recruited. We are studying
protein-protein interactions between RNA polymerase
III subunits and members of the U6 transcription initi-
ation complex.
A Positioned Nucleosome on
the Human U6 Promoter Allows
Recruitment of SNAP, by
the Oct-1 POU Domain
X. Zhao, P.S. Pendergrast, N. Hernandez
Oct-1 and SNAP, bind cooperatively to probes with a
closely spaced octamer sequence and PSE. Cooper-
ative binding is dependent on a direct protein-protein
contact involving a glutamic acid at position 7 within
the POU domain and a lysine at position 900 within
SNAP190, the largest subunit of SNAP,. In the natur-
al snRNA promoters, however, the spacing between
the octamer sequence and the PSE is typically about
150 base pairs, raising the question of how Oct-1 and
SNAP, interact with each other in vivo on natural
snRNA promoters.
To characterize the role of Oct-1 in natural snRNA
promoters, we first performed some in vivo analyses.
We used chromatin immunoprecipitations to show that
both Oct-1 and SNAP, are found in close proximity to
the endogenous RNA polymerase II U1 and RNA
polymerase III U6 snRNA promoters, as expected if
these factors are indeed used for snRNA gene tran-
scription in vivo. Furthermore, the DNA between the
octamer and the PSE in the U6 and Ul snRNA pro-
moters was resistant to micrococcal nuclease digestion
in exponentially growing cells, consistent with the
idea that some kind of structure, perhaps a nucleo-
some, is located between the PSE and the octamer
sequence in vivo.
We then performed in vitro chromatin assembly
assays. Assembly of the U6 promoter into chromatin
in an extract from Drosophila embryos resulted in a
positioned nucleosome between the octamer and the
PSE, regardless of whether the Oct-1 POU domain
was included in the chromatin assembly reaction. This
positioned nucleosome allowed cooperative binding of
Oct-1 and SNAP, to the natural U6 promoter, and this
cooperative binding required the same protein-protein
contact as cooperative binding to closely spaced
octamer and PSE sequences on naked DNA. We could
also show that assembly of the chromatin template in
the presence of the wild-type Oct-1 POU domain, but
not an Oct-1 POU domain carrying a mutation at posi-
tion 7, activated transcription. Together, these results
suggest that the positioned nucleosome brings Oct-1
and SNAP, into close proximity, thus mediating a
direct protein-protein contact that allows cooperative
binding of the two factors. This is a striking example
of a positioned nucleosome playing a positive archi-
tectural role that mediates efficient assembly of a tran-
scription initiation complex.
Protein Transduction
S. Mayilvahanan, N. Hernandez
Proteins fused to a small peptide derived from the
HIV-1 Tat protein can enter cells. We are using this
technique to test the ability of various fusion proteins
to enter cells and elicit a biological response.
Function of FBI-1
P.S. Pendergrast, N. Hernandez
FBI-1 is a POZ domain protein that binds to the HIV-1 IST. In transfection experiments,
overexpression of
FBI-1 can modulate Tat-activated HIV-1 transcription,
but both the mechanism by which this is accomplished
and the cellular function of FBI-1 are unclear. In col-
laboration with Dr. S. Huang (Northwestern Univer-
sity Medical School, Chicago),
we have examined the
nuclear sublocalization ofFBI-1. FBI-1 partially colo-
calizes with both Tat and the Tat cellular cofactor
PTEFb within the splicing-factor-rich
nuclear speckledomain. An insoluble
subpopulation of FBI-1 displays
a "peri-speckle" pattern of localization, which isdependent on the FBI-1 DNA-binding domain, on thepresence of cellular DNA, and on active transcription.
Together, these results suggest that FBI-1 is targeted tc
active chromatin and are consistent with the idea that
FBI-1 modulates HIV-1 transcription elongation.
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TRANSCRIPTIONAL REGULATION
W. Herr D. Aufiero M. Mangone
A. Bubulya A. Miller
E. Julien P. Reilly
S. Lee
T. Tubon
J. Wysocka
X. Zhao
Soon, the complete sequence of the human genome
will be determined and with it we will have the com-
plete set of instructions-the blueprint-for human
development. We are interested in how cells differen-
tially access this complete set of instructions, which
they nearly all possess, to generate the cellular com-
plexity of the human body. We study this question by
uncovering mechanisms of transcriptional regulation
in human cells. We use the human herpes simplex
virus (HSV) as a probe to uncover these mechanisms,
by studying virushost cell interactions. Viruses pro-
vide simple regulatory networks in which the cellular
transcriptional machinery is manipulated to achieve
the goals of virus infection. In a cell infected by HSV,
the virus can grow lytically or remain latent for many
years. In the lytic cycle, HSV-gene expression is initi-
ated by a viral transcription factor called VP16, which
is carried in the infecting virion. Before activating
transcription, VP16 forms a multiprotein-DNA com-
plex-the VP16-induced complex-on viral immedi-
ate-early promoters with two cellular proteins: HCF-1,
an abundant chromatin-associated protein that regu-
lates cell proliferation, and Oct-1, a POU-homeo-
domain transcription factor. Once the VP16-induced
complex is assembled, VP16 initiates viral-gene tran-
scription through a potent transcriptional activation
domain.
Our research focuses on three principal issues: (1)
How do transcriptional regulators activate the basal
transcriptional machinery? (2) How do transcription
factors, as in the VP16-induced complex, modify their
transcriptional activity through selective protein-pro-
tein and protein-DNA interactions? (3) What are the
natural cellular roles of HCF-1 and Oct-1, and how do
they influence HSV infection? Our studies in each of
these three areas continue to elucidate new mecha-
nisms for transcriptional regulation in human cells.
Below is a description of two important discoveries we
had this year that involve the activity of the basal tran-
scription factors TBP and TFIIB in the first instance
and the structure and function of the family of HCF
proteins in the second instance.
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A REGULATED TWO-STEP MECHANISM OF
TBP BINDING TO DNA: A SOLVENT-EXPOSED
SURFACE OF TBP INHIBITS TATA-BOX
RECOGNITION
A key to understanding transcriptional regulation is
how transcription is initiated at the correct positions in
the genome. One of the central players in the correct
initiation of transcription is the TATA-box-binding
factor TBP. TBP is involved in transcription by all
three eukaryotic nuclear RNA polymerases-pol I, pol
II, and pol III-whether or not the promoter contains
a TATA-box core element. On TATA-box-containing
promoters, however, the direct interaction between
TBP and the TATA box is one of the key steps in the
initiation of transcription.
Human TBP contains a bipartite structure. The
TATA-box-recognition domain of TBP is a highly con-
served 180-amino-acid carboxy-terminal domain,
commonly referred to as the TBP core (TBP,oRE), and
crystallographic studies have shown that when the
TBPcour is bound to the TATA box, it unwinds and
sharply bends the DNA to form a unique saddle-
shaped structure over the bent DNA. In addition to the
highly conserved TBP., human TBP contains a
highly diverged species-specific amino-terminal
region, which varies in both sequence and length. The
structure of this region of TBP is not known and how
it might influence TBP binding to the TATA box is not
clear.
We have an on-going collaboration with Dr. N.
Hernandez here at CSHL in which we have been
examining the activities of full-length human TBP
molecules with mutations located across the surface of
the TBP.RE in pol II and pol III transcription. During
the course of these experiments, Xuemei Zhao discov-
ered that some substitutions of solvent-exposed
residues of the TATA-box-bound TBPcour induce the
formation of an abundant TBPTATA-box complex
during electrophoretic mobility retardation analysis.
By further mutagenesis, we discovered a solvent-
exposed surface of the structured TBP.RE domain that
is important for inhibition of DNA binding and DNA
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FIGURE 1 The DNA in the activated TBPi.a complex, but not
the wild-type TBP complex, is bent. (4) Schematic representa-
tion of the five probes used for the bending assay. The position
of the TATA box is indicated. (8) Circular permutation analysis of
wild-type (lanes 6-10) and R188E mutant (lanes 11-15) TBP
molecules bound to the TATA box. Lanes 1-5 contained no
TBP. The set of DNA-bending probes is as indicated in A.
bending by full-length wild-type TBP. Full-length
wild-type TBP initially binds the TATA box to form an
unstable complex containing unbent DNA and then
slowly forms a stable complex containing bent DNA.
The two complexes are shown in Figure 1, in which
the binding activity of full-length wild-type human
TBP is compared to a mutant R188E-in which the
arginine at position 188 on the TBPcow surface has
been replaced by a glutamic acid residue-on a set of
"bending" probes.
When DNA is bent, its mobility during polyacryl-
amide gel electrophoresis is retarded, and the retarda-
tion becomes more significant the closer the bend is
to the center of the DNA molecule. Therefore, if a
protein bends DNA when bound to it, it will cause the
mobility of the protein-DNA complex to decrease the
closer the protein-binding site is to the center of the
DNA molecule. Thus, the bending activity of a DNA-
binding protein can be assessed by comparing the
mobility of the protein-DNA complexes on a series of
DNA probes in which the protein-binding site is pro-
gressively moved from one end of the DNA molecule
to the other. Figure lA shows such a probe set in
which the position of the TATA box has been pro-
gressively moved, and Figure 1B shows the results of
using this set of radiolabeled probes with wild-type
and the R188E mutant TBP in an electrophoretic
mobility retardation assay. The wild-type TBP formed
a single complex, modest in quantity, with an identi-
cal mobility on all five probes, indicating that under
these conditions, TBP is not bending the DNA. In
contrast, the mutant TBP binds very effectively under
these conditions and bends the DNA as indicated by
the characteristic bell-shaped mobility exhibited by
the mutant TBP-DNA complexes. Thus, the R188E
mutation-as well as many others at neighboring
positions-activates both DNA binding and DNA
bending by TBP. We refer to the wild-type surface of
the TBP.RE, which inhibits TATA-box binding and
bending, as the inhibitory DNA-binding (IDB) sur-
face.
The basal factor TFIIB associates with TBP on
DNA, and we have found that it greatly accelerates
TBP binding to bent DNA in the form of a
TFIIBTBPTATA box complex. The IDB surface of
TBP, by inhibiting DNA binding by TBP in the
absence of TFIIB, contributes to the cooperativity of
binding with TFIIB. Using TBP and TFIIB, we showed
that TBP can bind the TATA box to form first the
unbent TATA-box complex and then transition into a
bent complex without leaving the DNA. The transition
from an unbent complex to a bent complex promoted
by TFIIB may be an important step for TBP to direct
the correct formation of an active initiation complex.
We suggest that through this two-step unbent-to-bent
TBP-binding mechanism, TBP may constantly probe
the genome for TATA-box-like sequences without
committing itself to forming an active bent complex.
Once multiple signals are received (e.g., interaction
with TFIIB), then an appropriate bent TATA-box com-
plex can form. We are intrigued by the possibility that
the ability of TBP to recognize unbent DNA may per-
mit it to recognize a TATA box in DNA that cannot
undergo the gross deformation involved in TBP bend-
ing of DNA, as, for example, might be expected of a
TATA box within a nucleosome in a cell. Then through
the action of other proteins recruited by TBP, the
nucleosome could be destabilized and permit bent
TBPTATA box complex formation and subsequent
transcriptional initiation.
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STABILIZATION BUT NOT THE TRANSCRIPTIONAL
ACTIVITY OF HSV VP16-INDUCED COMPLEXES
IS EVOLUTIONARILY CONSERVED AMONG
HCF FAMILY MEMBERS
In the second discovery, Soyoung Lee found that the
ability of HCF proteins to stabilize the VP16-induced
complex has been conserved among HCF family
members but not their ability to support transcription-
al activation by VP16. The VP16-associated factor
HCF-1 is an unusual protein. It is translated as a large
polypeptide of 2035 amino acids which undergoes
proteolysis at a series of centrally located 26-amino-
acid repeats; the resulting amino- and carboxy-termi-
nal polypeptides are stable and remain noncovalently
associated. At its amino terminus, HCF-1 contains a
predicted 0-propeller structure which is responsible
for binding VP16 and sufficient to stabilize the VP16-
induced complex.
Consistent with the role of HCF-1 in cell prolifer-
ation, elements of HCF-1 are highly conserved in
metazoans. For example, extracts from worms and
insects can replace HCF-1 in VP16-induced complex
formation, implying the presence of functional HCF-1
homologs in these organisms. Indeed, the worm
Caenorhabditis elegans contains a functional HCF-1
homolog called CeHCF that can support VP16-
induced Human HCF-1, however,
differs in some respects from CeHCF: Although the
amino- and carboxy-terminal regions of HCF-1 are
highly conserved in CeHCF, the middle of the protein
with its processing repeats is missing in CeHCF. Thus,
CeHCF is much smaller than HCF-1 (782 vs. 2035
amino acids) and does not undergo proteolytic pro-
cessing.
A second human HCF protein called HCF-2 has
been described by A. Wilson and colleagues (New
York University) that, like CeHCF, is smaller than
HCF-1, and in which the amino- and carboxy-terminal
regions, but not the middle of the protein, are con-
served. Unlike HCF-1 and CeHCF, however, the inter-
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action of HCF-2 with VP16 was reportedly weak,
which led to the conclusion that HCF-2 is unlikely to
have a role in transcriptional activation by VP16 and
HSV infection.
To understand better the relationship of HCF-1
and HCF-2 to each other and to CeHCF, we compared
all three proteins directly in both in vitro and in vivo
assays. We found, unexpectedly, that all three full-
length HCF proteins can associate with VP16 and sta-
bilize the VP16-induced complex effectively, demon-
strating that this is a conserved function of these mol-
ecules. Unlike HCF-1 and CeHCF, however, HCF-2
failed to support VP16-induced transcriptional activa-
tion effectively in vivo. Thus, in this instance, an HCF
protein can promote VP16-induced complex forma-
tion, but the resulting complex is inactive. These
results suggest that HCF-2 might interfere with VP16
activation of HSV gene expression and therefore
HCF-2 could have a negative effect on HSV infection.
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STRUCTURAL BIOLOGY OF REGULATION OF DNA REGULATORY
MOLECULES AND PROTEOLYSIS
L. Joshua-Tor A. Auster P. O'Farrell H. Zhou
E. Enemark N. Tolia S. Bechis (URP)
T. Messick E. Zarkowski 0. Martin (PFF)
P.R. Kumar
We study the molecular basis of cell regulatory process-
es, combining the tools of structural biology and bio-
chemistry, to examine the molecular interactions asso-
ciated with these processes. X-ray crystallography
enables us to obtain the three-dimensional structures of
individual proteins and their complexes with other mol-
ecules. We use biochemistry and molecular biology to
characterize properties that can be correlated to protein
structure, and we use information from molecular biol-
ogy and genetics to study protein function.
Our current efforts center around two distinct
themes. The first involves structural studies of protein
complexes involved in DNA regulatory processes. The
second theme in the lab is the regulation of proteoly-
sis. Here, we are studying caspase activation in apo-
ptosis and a conserved family of oligomeric self-com-
partmentalizing intracellular proteases, the bleomycin
are involved in drug resistance.
DNA Binding and Assembly of the
Papillomavirus Initiator Protein El
E. Enemark, A. Auster, S. Bechis [in collaboration
with A. Stenlund, Cold Spring Harbor Laboratory]
Papillomaviruses are a large family of closely related
viruses that give rise to warts in their hosts. Infection of
the genital tract by the human papillomaviruses (HPV)
from this group represents one of the few firmly estab-
lished links between viral infection and the develop-
ment of cervical cancer, as HPV DNA is found in prac-
tically all cervical carcinomas. The El protein belongs
to a family of multifunctional viral proteins whose main
function is related to viral DNA replication. These pro-
teins bind to the origin of DNA replication, melt the
DNA duplex, possess DNA helicase activity, and recruit
other cellular replication proteins such as DNA poly-
merase a and replication protein A (RPA). Most likely,
different oligomeric forms of the two proteins are
responsible for the different activities, and the sequen-
tial assembly of T antigen and El complexes ensures an
ordered transition between these different activities.
Ultimately, El forms a hexameric ring helicase on each
strand that serves as replicative DNA helicases that
unwind the DNA in front of the replication fork.
In collaboration with Arne Stenlund's group here
at CSHL, we embarked on structural studies to provide
high-resolution structural information about El, its
DNA-binding activity, and its assembly on DNA.
These would provide general insight into the bio-
chemical events that are involved in viral DNA repli-
cation. They can also provide a basis for the develop-
ment of clinical intervention strategies. Second, the
viral DNA replication machinery itself represents an
obvious target for antiviral therapy, and detailed infor-
mation such as high-resolution structures of viral pro-
teins required for replication will greatly facilitate the
development and testing of antiviral agents.
The initial binding of an El dimer together with
E2 serves the double-stranded origin of
replication (ori) with high specificity. The subsequent
binding of additional El molecules leads to on melt-
ing, most likely through the positioning of El mole-
cules in the proper arrangement necessary for melting
of double-stranded DNA. Ultimately, two hexameric
rings are formed on the ori that could unwind the
DNA double helix. Thus, the transition between these
complexes represents a transition from a tethering
function for El to a function that modifies the DNA
structure. We have captured structural snapshots of
two sequential steps in the assembly process (Fig. 1).
Loading of an initial El dimer on the origin occurs at
adjacent major grooves on one face of the helix.
Subsequently, a second dimer is loaded on another
face of the helix. Binding occurs through two DNA-
binding modules, a DNA-binding loop (DBL), and a
DNA-binding helix (DBH), that bind to the two sepa-
rate strands of DNA. The majority of contacts are
made by the DBL, a long loop that is preorganized for
binding. Binding of two individual strands by separate
regions of the protein can provide a basis for a transi-
tion from double-stranded to single-stranded DNA
binding, leading to strand separation, with protein
maintaining binding to one strand while dissociating
from the other. Additional subunit-subunit contacts
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BFIGURE 1 Crystal structures of two intermediates in the assembly of El -DBD subunits on the ori-
gin of replication. VI) Structure of the El -DBD dimer bound to sites 2 and 4 determined from the
[(E1-DBD15g_3),(DNAd)] crystal structure. (8) Structure of the El -DBD tetramer bound to E1-bind-
ing sites 1-4 determined from the [(E1-DBD.,,,,,,3)4(DNA,)] crystal structure viewed perpendicular
and parallel to the DNA helical axis.
formed in the assembly of the hexameric ring would
then compensate for lost protein-DNA interactions. A
more common recognition motif, such as "helix in the
groove," in which the same structural element con-
tacts both strands on either side of the groove, would
not allow such a facile transition. Since interactions
between DNA and the DBH are less extensive than
interactions with the DBL, the DBL is a more likely
candidate for the binding module that retains binding.
Moreover, in the tetramer, the two DBLs of the
upstream monomers of each dimer bind to the top
strand, whereas the DBLs of the downstream
monomers of each dimer bind to the bottom strand.
We therefore suggest that one hexameric helicase
assembles around the top strand on one side of the on
from the proteins at sites 3 and 4, and the other hexa-
meric helicase assembles around the bottom strand on
the other side of the on from the proteins at sites 1 and
2. As the hexameric helicases travel in opposite direc-
tions around their respective strands, the correct
3'->5' polarity would occur (Fig. 2).
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Bleomycin Hydrolases
P. O'Farrell [in collaboration with F. Gonzalez and
S.A. Johnston, University of Texas-Southwestern
Medical Center, and S.J. Keding and D.H. Rich,
University of Wisconsin, Madison]
Bleomycin hydrolase (BH) is a 300-kD cysteine pro-
tease with unusual structural and biological features. It
was discovered due to its ability to deactivate the gly-
copeptide antibiotic, bleomycin, which is used as a
therapeutic agent in the treatment of a number of dif-
ferent forms of cancer. The clinical use of bleomycin
is limited due to drug resistance and dose-dependent
production of pulmonary fibrosis. The endogenous
enzyme, BH, is overexpressed in some tumor cells and
is thought to be a major cause of tumor cell resistance
to bleomycin therapy. It was shown that in both yeast
and mammalian cells, BH is the only enzyme with
bleomycin deamidation activity. Interest in its clinical
relevance was heightened by a recent report of the
FIGURE 2 Schematic diagram of the proposed role of the DBL
in strand selection. A cartoon depicting a model for the assem-
bly of two hexameric helicases around single strands at the ori.
The two DBLs (black) of the upstream monomers of each dimer
bind to the top (black) strand, whereas the DBLs of the down-
stream monomers of each dimer bind to the bottom strand
(white). One hexameric helicase assembles from the upstream
monomers at sites 3 and 4 (dark gray) around the top strand,
and the other hexameric helicase assembles from the down-
stream monomers at sites 1 and 2 (light gray). This arrangement
would result in the correct 3"-->5" polarity for the helicases.
genetic linkage of an allelic variant to the nonfamilial
form of Alzheimer's disease. BH was also found to
bind amyloid precursor protein (APP).
Since mammals rarely encounter bleomycin,
bleomycin hydrolysis is probably not the normal func-
tion of the enzyme. On the basis of studies with BH
knockout mice, it was shown that BH is important for
neonatal survival. BH is widely distributed throughout
nature. There are homologs in bacteria, yeast, birds,
and mammals, with high sequence identity between
the different forms. The yeast form negatively regu-
lates the galactose metabolism system and also binds
single-stranded DNA and RNA with high affinity.
Nucleic-acid-binding activity was also reported for
other members of the family.
Previously, we determined the crystal structures of
the yeast BH, Ga16, and the human enzyme (hBH).
These structures revealed several unique features of
these proteases. They both have a hexameric ring-bar-
rel structure with the active sites embedded in a cen-
tral cavity. The only access to the active sites is
through the cavity. BH has little substrate specificity
so it is reasonable to assume that this sequestration of
the active sites is necessary to prevent indiscriminate
proteolysis. This places BH in the class of "self-com-
partmentalizing proteases" with, for example, the pro-
teasome and the tricorn protease. The carboxyl termi-
nus of BH lies in the active site, in much the same
position as that taken by inhibitors complexed with
papain. Our previous work on the yeast BH, Ga16, has
shown that it acts as a carboxypeptidase on its car-
boxyl terminus to convert itself to an aminopeptidase
and peptide ligase. The carboxyl terminus anchors the
substrate into the active site and confers "positional"
specificity. This model also serves to explain the
unique ability of BH/Gal6 to inactivate bleomycin.
In collaboration with Dan Rich's laboratory at the
University of Wisconsin, Madison, we embarked on an
iterative study to design specific tight-binding active
site inhibitors of BH activity to increase the efficacy of
bleomycin, and perhaps reduce dosage levels in cancer
treatment. The emerging link between hBH and
Alzheimer's disease is another incentive, since an
inhibitor to hBH may be useful in understanding this
connection and may also be useful in therapy. We are
using our crystal structure to create novel inhibitors by
use of computerized structure-generating programs.
Using this approach, we can create both peptide-like
and nonpeptide inhibitors by a combinatorial process.
We identified four compounds in our initial screens
that are good inhibitors and have solved two cocrystal
structures of hBH with these compounds. These struc-
tures are the basis of further drug design.
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PROTEIN CHEMISTRY
R. Kobayashi A. Ahmed S. Lopez
L. Hurton D. Wurtz
Our laboratory has focused on the analysis of the pri-
mary structure of novel proteins and posttranslational
modification. The combination of mass spectrometry
and genome sequence database has allowed us high-
throughput identification of proteins. Our electro-
spray ionization ion-trap mass spectrometer showed
its power through sensitivity and high-throughput
identification. With this tandem mass spectrometry
analysis, one can identify many proteins in a large
complex that interact with a specific protein. We hope
that identification and characterization of the proteins
will contribute to our fundamental understanding of
biology.
We continued to collaborate with scientists at Cold
Spring Harbor Laboratory. We identified protein com-
plexes of the p88 ORC-binding protein of Saccharo-
myces cerevisiae in collaboration with Bruce Stillman;
protein complexes of human RNA polymerase III in
collaboration with Nouns Hernandez; and human cas-
pase 9 complexes and XIAP complexes in collabora-
tion with Yuri Lazebnik. We also identified the first
RNAi components of Drosophila in collaboration with
Greg Hannon.
This is my last annual report at Cold Spring
Harbor Laboratory. I closed my lab in August after
working here for ten and a half years. I accepted a
position at the University of Texas M.D. Anderson
Cancer Center in April. Aysha Ahmed went back to
Montreal in May and found a job at McGill University.
Lenka Hurton went on to graduate school at the
Virginia Polytechnic Institute and State University in
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June to study marine biology. Denise Wurtz and I left
Cold Spring Harbor Laboratory at the end of August.
Stacy Lopez decided to stay at the Protein Chemistry
Facility with Mike Myers. My experiences at Cold
Spring Harbor Laboratory were extremely valuable
and my stay here was a stimulating period in my life. I
had a very fruitful time here thanks to my colleagues
and friends at Cold Spring Harbor Laboratory.
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RNA SPLICING
A.R. Krainer E. Allemand L. Manche R Smith
L. Cartegni H. Okunola Q.-S. Zhang
L. Friend X. Roca J. Zhu
M. Hastings S. Shaw
MECHANISMS OF CONSTITUTIVE AND ALTERNATIVE
PRE -MRNA SPLICING
RNA splicing is an essential step for the expression of
most eukaryotic protein-coding genes. The selection
and pairing of authentic splice sites within the spliceo-
some occur with extremely high fidelity, requiring pre-
cise interpretation of limited and dispersed sequence
information present throughout introns and exons. In
humans, -60% of genes are expressed via alternative
splicing, giving rise to multiple protein isoforms. The
choice of alternative splice sites is commonly regulat-
ed to alter gene expression, either tissue-specifically or
in response to a developmental program or to extracel-
lular signals. The fact that multiple protein isoforms
can be expressed from individual genes demonstrates
that the classic "one gene-one enzyme" paradigm is
no longer valid, and provides an explanation for the
unexpectedly small number of genes uncovered by
genome-sequencing projects.
Both constitutive and alternative splicing mecha-
nisms involve multiple protein components, as well as
RNA components that are part of small nuclear
ribonucleoprotein (snRNP) particles. The work in our
lab focuses on the identification and molecular char-
acterization of protein factors and sequence elements
that are necessary for the catalysis and fidelity of
splicing and/or for the regulation of alternative splice-
site selection. Our recent progress in understanding
how exons are identified by the spliceosome is sum-
marized below.
MECHANISMS OF SPLICING SILENCING
We investigated the mechanisms of splicing silencing
mediated by elements present in the exons of a human
immunodeficiency virus (HIV) tat pre-mRNA.
Splicing enhancer elements are present near the 5' end
of exon 3, and a splicing silencing element is located
near the 3' end of the same exon. Interestingly, splic-
ing of exons 2 and 3 is efficient in the presence of the
SR protein SF2/ASF, but it does not occur in the pres-
ence of a different SR protein, SC35; however, when
the silencer element was mutated, efficient splicing
could take place in the presence of either SR protein.
This type of selective silencing is probably important
for modulating alternative splicing in different cell
types, according to the levels of each SR protein pres-
ent, and also for allowing inefficient splicing, which is
necessary for retroviral replication and gene expres-
sion. We found that heterogeneous nuclear RNP
(hnRNP) Al and closely related proteins recognize the
silencer and repress recognition of the exon, depend-
ing on which SR protein is present. Selective depletion
of hnRNP Al -type proteins from splicing extracts
derepressed splicing, as did deletion of the silencer
element (Fig. 1). Adding back recombinant hnRNP Al
restored silencing in the presence of a wild-type
silencer. Moreover, hnRNP Al bound specifically to
an RNA fragment encompassing a wild-type, but not a
mutant, silencer (not shown).
Silencing required the carboxy-terminal domain of
hnRNP Al, which is necessary for cooperative bind-
ing to RNA. This and other observations led us to pro-
pose that initial binding of hnRNP Al to a high-affin-
ity binding site within the silencer is followed by
cooperative binding of additional hnRNP Al mole-
cules, which propagate toward the 5' end of the exon
(Fig. 2). To test this model, UV cross-linking experi-
ments were carried out with RNA probes assembled
by ligation of labeled and unlabeled fragments. The
results demonstrated that hnRNP Al binding to the
upstream region of the exon depends on the presence
of a wild-type silencer in the downstream region.
Moreover, cooperative binding of hnRNP Al was
blocked in the presence of wild-type SF2/ASF but not
SC35 (Fig. 2), which correlates with the activities of
these proteins in splicing of the tat pre-mRNA. The
RS domain of SF2/ASF is not required for blocking
hnRNP Al binding upstream or for splicing of this
substrate. We presume that as hnRNP A 1 polymerizes,
SC35 binding to a splicing enhancer motif is prevent-
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FIGURE 1 hnRNP Al specifically silences tat pre-mRNA splic-
ing. (a) Depletion of hnRNP Al measured by immunoblotting.
HeLa cell nuclear extract (NE) was depleted of hnRNP NB pro-
teins by selective binding to immobilized single-stranded telo-
meric DNA oligonucleotide; mock depletion was carried out
with a control oligonucleotide. hnRNP Al, or as a control, SF2/
ASF, was measured in the indicated extracts by immunoblotting
with the appropriate monoclonal antibody. (b) In vitro splicing of
radiolabeled transcripts from an HIV tat minigene (Tat23) and
from a mutant in which the exonic splicing silencer in exon 3
was deleted (AS3). The reactions were carried out in untreated
extract (NE; lanes 1 and 5), mock-depleted extract (lanes 2 and
6), hnRNP Al -depleted extract (AA1) alone (lanes 3 and 7), or
in the presence of recombinant hnRNP Al (lanes 4 and 8). The
positions of the pre-mRNA, mRNA, and exon 1 intermediate are
indicated; the asterisk indicates a band that results from aber-
rant RNA cleavage unrelated to splicing.
ed, whereas tighter binding of SF2/ASF to its cognate
enhancer motif blocks the propagation of hnRNP Al.
Indeed, strengthening the interaction of SC35 with the
exon by improving the binding site allows SC35 to
promote splicing in the presence of the silencer ele-
ment and hnRNP Al (not shown).
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FIGURE 2 Mechanism of splicing silencing. The model shows
a molecule of hnRNP Al (bold circle) bound to a high-affinity
site within the silencer near the 3' end of tat exon 3. Initial bind-
ing of hnRNP Al is followed by cooperative nonspecific binding
of additional hnRNP Al molecules along the exon. To test that
binding of hnRNP Al upstream depends on initial binding at the
silencer, two RNA probes were designed for cross-linking
experiments. Each probe was constructed by ligating two sep-
arate RNA fragments: the 78-nucleotide 5' fragment is identical
for both probes and was uniformly labeled with 321.; the 23-
nucleotide 3' fragment is unlabeled and has either a wild-type
silencer (E3 probe) or a mutant silencer with seven point muta-
tions (E3m probe). Each probe was incubated in HeLa S100
extract with or without SR proteins under splicing conditions,
followed by irradiation with UV light. The RNA was digested with
RNase and the protein-oligonucleotide covalent adducts were
immunoprecipitated with hnRNP Al monoclonal antibody and
analyzed by SDS-PAGE and autoradiography. Labeled hnRNP
Al was recovered from the S100 extract with the E3 probe
(lane 1), but much less efficiently with the E3m probe (lane 5).
SF2/ASF with or without (ARS) its RS domain blocked cooper-
ative binding of hnRNP Al to the upstream region of the exon
(lanes 2 and 3), whereas SC35 had little effect (lane 4).
EXON-SKIPPING MUTATIONS AND MECHANISMS
We completed a mechanistic study of a nonsense
mutation in exon 18 of the BRCA1 breast cancer sus-
ceptibility gene which causes skipping of that exon.
The phenomenon of nonsense-associated altered
splicing (NAS) has been observed for many alleles in
human disease genes, and various models have been
proposed to explain it. We were able to reproduce NAS
in vitro and demonstrated that the BRCA1 nonsense
mutation inactivates a splicing enhancer heptamer
motif that is recognized by the SR protein SF2/ASF.
We further showed that not all nonsense mutations
cause skipping and, conversely, that some missense
mutations do cause skipping; it is the inactivation of
the degenerate SR protein motif that determines
whether the exon can no longer be recognized as such.
We also applied the analysis of SR protein recog-
nition motifs to the SMN1 and SMN2 genes, which are
involved in spinal muscular atrophy (SMA), a com-
mon pediatric neurodegenerative disease. SMA
patients lack a functional SMNI gene but possess at
least one copy of the nearly identical SMN2 gene. It
was known that exon 7 in SMN1 is constitutively
included, whereas exon 7 in SMN2 is skipped 80% of
the time, giving rise to a defective protein. Moreover,
this difference between the two homologous exons is
due to a single, translationally silent point mutation.
The low level of functional SMN protein arising from
the 20% ofSMN2 pre-mRNA that is spliced correctly
is essential for viability but is not sufficient to prevent
the disease. We demonstrated that the single-base
change between SMN1 and SMN2 exon 7 inactivates a
splicing enhancer motif recognized by SF2/ASF. We
tested our ability to predict the presence of functional
enhancer motifs by introducing a compensatory muta-
tion five nucleotides downstream of the variant site to
restore a high-score SF2/ASF motif in SMN2; this sec-
ond-site suppressor mutation effectively restored
inclusion of exon 7.
These studies can explain how single-base changes
in exons allow genes to evolve, e.g., transforming a
constitutive exon into an alternative one, or vice versa.
A further implication is that many mutations tradition-
ally classified as nonsense, missense, or silent, as well
as some polymorphisms, can give rise to exon skip-
ping, such that the mutant or variant site is no longer
present in some or all of the mature mRNA. Thus, the
effect of the mutation or polymorphism on the protein
product is very different from, and usually more dras-
tic than, what would be predicted from analysis of the
genomic sequence. Analysis of mRNA splicing can
therefore be critical for correct disease diagnosis and
assessment of phenotypic risk in individuals with
familial predispositions. Finally, the mechanistic
understanding of exon definition may lead to new
therapies for SMA and for certain alleles in other
genetic diseases.
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PROTEOMIC APPROACHES TO STUDYING SIGNAL
TRANSDUCTION
M. Myers S. Lopez
L. Schmidt
The completion of the human genome has ushered in
a new era of discovery. Essentially, this accomplish-
ment has identified all of the primary players govern-
ing human biology. Now the important work of assign-
ing functions to this myriad of proteins has become the
principal task of modern biology. Although the func-
tions of some of these proteins will be assigned by
genetic or computational means, the lion's share of the
functional characterization of these proteins will be
determined by proteomics-a new word that describes
the fusion of biochemistry and analytical chemistry.
I left Nicholas K. Tonks' lab this year to start
working on proteomics approaches to signal transduc-
tion and tumorigenesis. This transition was part of the
natural progression from the work that I was perform-
ing with Nick on the role of protein tyrosine phos-
phatases (PTPs) in signal transduction, especially
related to their function during tumorigenesis. As part
of this transition, I also took over the Protein
Chemistry facility from Ryuji Kobayashi who left this
year. Although much of Ryuji's staff also left this year,
I was pleased when Stacy Lopez decided to stay and
when Lise Late Schmidt decided to join the lab.
Since my appointment in August of this year my
work has focused on finishing up studies on PTP sub-
strate specificity that were initiated while I was a
member of the Tonks lab and in improving the mass
spectrometry facilities at Cold Spring Harbor
Laboratory.
Optimization of Protein
Characterization
S. Lopez, L. Schmidt
Most of our efforts this year have been in optimizing
protein analysis by mass spectrometry (MS). When I
took over the mass spectrometry facility, 100-200
fmoles of protein was considered to be the lower limit
for protein identification; in other words, 200 fmoles
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might give you an answer... if you were lucky. To max-
imize the sensitivity and the speed (throughput) of the
analysis, it was necessary to rework every step, from
the way the samples were processed to the way the
data are analyzed. In fact, these improvements
required that several pieces of equipment be com-
pletely replaced or retooled in order to maximize the
sensitivity of our analyses. Currently, we are able to
successfully analyze most samples at the 100-fmole
level, and we estimate that the lower limit for success-
ful analysis is in the 5-10-fmole range. Examples of
some typical chromatograms before and after opti-
mization are shown in Figure 1.
Proteomic Approaches
for the Analysis of
PTP Function
M. Myers [in collaboration with N. Tonks, Cold
Spring Harbor Laboratory]
The phosphorylation of tyrosine residues in proteins is
often the key event in controlling signaling cascades.
Importantly, these modifications are removed through
the action of the PTP family of enzymes. Fortunately,
all the members of this family have an easily recog-
nizable catalytic core, which is also called the PTP sig-
nature motif. Studies of the human genome, utilizing
this signature, have revealed approximately 90 mem-
bers of the PTP family. In an on-going collaboration
with Nick Tonks, we are attempting to enrich this
genomic information by developing a proteomics-
based strategy for defining the complement of PTPs
from various cellular or subcellular sources.
Importantly, this analysis is expected to lead to
insights into PTP function, as well as allowing us to
examine the roles of PTPs in various pathological con-
ditions, such as diabetes and cancer, or as targets for
therapeutic intervention. The strategy takes advantage
of the chemical nature of the PTPs and is based on a
FIGURE 1 Optimization results in a significant improvement in sensitivity. Both chromatograms represent a high-performance liquid
chromatography (HPLC)-reverse phase separation of 200 fmoles of a tryptic digest of carbonic anhydrase using the LCQ-ion trap
mass spectrometer as a detector. The upper chromatogram was produced prior to the optimization procedure, whereas the lower
chromatogram was produced postoptimization. Please note that the y axis is normalized to the tallest peak in the chromatogram
and the value used for this normalization level (N.L. in the upper left corner of each chromatogram) is indicative of the strength of the
signal. The N.L. value for the postoptimization chromatogram is 20-fold greater than for the preoptimization chromatogram, indicat-
ing a 20-fold increase in sensitivity.
battery of PTP inhibitors, which bind to a catalytical-
ly required cysteine found in the signature motif.
Importantly, these inhibitors can be used as affinity
reagents, and we have successfully adapted them for
the visualization of PTP family members. In the past
year, we have been optimizing this strategy and have
begun to identify the proteins that are enriched by this
scheme and to further optimize this strategy.
Substrate Specificity of PTP1 B
M. Myers [in collaboration with N. Tonks and J. Andersen,
Cold Spring Harbor Laboratory]
The substrate specificity of protein kinases has long
been established; however, the substrate specificity of
the PTPs is a much more controversial issue. The con-
troversy is largely fueled by in vitro studies in which
members of the PTP family traditionally exhibit weak
intrinsic substrate specificity. This year, we extended
findings from the previous year, which suggested that
PTP IB preferred substrates with a tandem phosphor-
ylation motif. From this study, we were able to devel-
op a consensus dephosphorylation motif for PTP1B
(E/D-pY-pY-R/K). A search of the human database
with this motif uncovered more than 700 proteins that
contain this motif. Somewhat surprisingly, this search
identified a large proportion of the tyrosine.
Importantly, this motif was sound in the activation
loop of these kinases where phosphorylation of the
tandem tyrosine residues is required for kinase acti-
vation, suggesting that PTP1B has a major role in
antagonizing these tyrosine kinases. We focused our
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analysis on the JAK/TYK2 subfamily, in which JAK2
(E-pY-pY-R) and TYK2 (E-pY-pY-K) represent per-
fect matches to the motif, whereas JAK1 (E-pY-pY-T)
does not meet the consensus. In response to the
cytokine interferon-a (IFN-a), JAK1 and TYK2 are
activated by cross-phosphorylation. Similarly, in
response to IFN-y, JAK1 and JAK2 become activated.
Since these cytokines are simultaneously activating
kinases, which do (JAK2 or TYK2) or do not (JAK1)
fit the predicted PTP1B consensus dephosphorylation
site, stimulation with IFN-a or IFN-y provides the
perfect opportunity to study the in vivo substrate
specificity of PTP1B. In fact, substrate trapping
experiments with PTP1B revealed that TYK2 and
JAK2 are in vivo substrates of PTP1B, whereas JAK1
does not become associated with PTP1B trapping
mutants in response to either IFN-a or INF-y.
Importantly, PTP I B-deficient mouse embryo fibro-
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blasts exhibit enhanced sensitivity to INF-a or INF-y
stimulation, indicating that PTP1B is required to
antagonize these responses. This study demonstrated
that it is possible to use consensus dephosphorylation
motifs to predict PTP substrates, as well as demon-
strating that PTP1B acts as a negative regulator of
INF-a, INF-y, and other cytokine signals.
PUBLICATIONS
Myers M.P., Andersen J.N., Cheng A., Tremblay M.L., Horvath
C.M., Parisien J. -P., Salmeen A., Barford D., and Tonks
N.K. 2001. TYK2 and JAK2 are substrates of protein-
tyrosine phosphatase 1B. J. Biol. Chem. 276: 47771-
47774.
Wen S., Stolarov J., Myers M.P., Su J.D., Wigler M.H., Tonks
N.K., and Durden D.L. 2001. PTEN controls tumor-induced
angiogenesis. Proc. Natl. Acad. Sci. 98: 4622-4627.
Mike Myers
CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski M. Greenberg A. Janardhan
F. Herschke M. Kwofie
B. Hill T. Swigut
Our interest is in defining the molecular mechanisms
underlying the pathogenesis of AIDS, and in particu-
lar, understanding the functional consequences of
interactions between viral proteins and the cellular
regulatory machinery. The focus of our research is to
delineate the functions of Nef, a regulatory protein of
human and simian immunodeficiency viruses (HIV
and SIV), which is an important determinant of viru-
lence. Viruses with defects in Nef replicate poorly in
the host, and this correlates with attenuated develop-
ment of AIDS.
NEF FUNCTIONS
Natural Nef protein isolates have several conserved
classes of effects on signal transduction and protein-
sorting machineries that probably enhance virulence
in vivo. In T cells, Nef disrupts antigen-specific signal
transduction machinery. This is accomplished both by
down-regulating cell surface CD4, an essential com-
ponent of the T-cell antigen receptor (TCR) on class II
major histocompatibility complex (MHC)-restricted T
lymphocytes, and by blocking aspects of signal trans-
duction via the CD3 signaling component of the TCR.
At the same time, Nef activates downstream signaling
cascades, thereby likely bypassing the events that nor-
mally control the functional activation of T lympho-
cytes. In macrophages, Nef promotes the production
of chemokines that attract T lymphocytes to infected
cells, thus facilitating the spread of the virus (the
infectious process). Additionally, Nef disrupts the
antiviral response of the host by decreasing the expres-
sion of class I MHC on the surface of HIV-1/SIV
infected cells. Class I MHC molecules constitute the
critical element of the immune system detection
machinery that allows elimination of virally infected
cells. This effect of Nef may enable infected cells to
evade the immune response in the infected host.
Finally, Nef also stimulates SIV/HIV particle infectiv-
ity and replication in primary T cells, which probably
reflects Nef effects on signal transduction and protein-
sorting machineries.
In previous years, we probed and described the
molecular mechanisms that mediate the effects of
HIV-1 Nef on CD4 and class I MHC expression and
initiated structure-function analysis of the Nef protein
encoded by a pathogenic strain of SIV. More recently,
our research focused on three major areas:
We discovered that Nef down-regulates cell sur-
face expression of the CD28 molecule, a major co-
stimulatory receptor that is necessary for effective
T cell activation, and described the underlying
mechanism.
We initiated biochemical purification of protein
complexes that associate with Nef in T cells and
antigen-presenting cells. We anticipate that this
approach will lead us to identification of novel Nef
effectors in these cell types.
We developed novel transgenic mouse models to
study and genetically dissect the effects of Nef on
the function of T cells and antigen-presenting
cells. These two latter sets of experiments will
continue to be the major focus of our research in
the future.
NEF DOWN-REGULATES THE CELL SURFACE
EXPRESSION OF CD28: THE MAJOR
COSTIMULATORY RECEPTOR OF
CD4-POSITIVE T CELLS
Nef proteins were found to disrupt two separate
aspects of normal antigen recognition machinery by
interfering with the expression of the CD4 and by
interfering with expression and/or signaling of the
CD3/TCR complex. Productive antigen-initiated
response, in addition to CD4 and TCR/CD3, also
requires the CD28 receptor. CD28 is the major co-
stimulatory receptor of CD4-positive T cells, and
interference with the CD28 signaling pathway could
result in suppression of the immune response and
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anergy. Given the conserved effects of Nef proteins on
other aspects of antigen-specific signaling machinery,
we suspected that Nef might also interfere with the
expression or signaling of CD28, and we set up exper-
iments to address this possibility. These experiments
revealed that both HIV-1 and SW Nef proteins down-
regulate the cell surface expression of the CD28 mol-
ecule.
The ability of Nef to down-regulate CD28 cell sur-
face expression is genetically separable from other
known functions of Nef such as CD4, CD3, and class
I MHC down-regulation, and from its ability to asso-
ciate with serine/threonine kinases. Hence, CD28
down-regulation is selected independently from those
other Nef functions.
MECHANISM FOR DOWN-REGULATION
OF CD28 BY NEF
We studied the mechanisms underlying the down-regu-
lation of CD28 expression on the cell surface by HIV-1
and SW Nef proteins. Genetic and functional evidence
from our studies indicates that Nef induces CD28 endo-
cytosis via an AP-2 clathrin-adaptor-dependent path-
way and that this is mediated by direct interactions
between Nef, AP-2, and CD28. To further address the
interactions between Nef, CD28, and the endocytic
machinery, we studied amino acids in the cytoplasmic
domain of CD28 that are required for the effects of the
HIV-1 and SW Nef proteins. Interestingly, we found
that the induction of CD28 endocytosis by SW and
HIV-1 Nef proteins requires partially overlapping but
distinct sets of amino acid residues in the cytoplasmic
domain of CD28. The use of different target sites in the
CD28 cytoplasmic domain by HIV -1 and SW Nef pro-
teins implies that they contact CD28 directly and argues
against the possibility that they bind CD28 via a com-
mon bridging protein.
Interestingly, the Nef target sites in CD28 are
located in a close proximity to the native endocytic
signals in the cytoplasmic domain yet do not overlap
these signals. That Nef target sites are located close to
the likely normal site of interaction of CD28 with the
endocytic machinery suggests that CD28 contacts the
endocytic machinery in a similar manner in the
absence or presence of the viral protein, and Nef prob-
ably strengthens these normal interactions. This
model is reminiscent of previous data which indicate
that Nef-induced endocytosis of CD4 and class I
MHC requires intact native endocytic signals in these
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target molecules. Thus, it appears that in all cases, Nef
facilitates the normal interactions of these molecules
with AP-2, or with other components of the endocytic
machinery that are normally required for constitutive
endocytosis, rather than replacing these interactions
with new ones. Our observations have begun to pro-
vide new general insights into the mechanisms used by
Nef to recruit target molecules to the endocytic
machinery.
BIOCHEMICAL PURIFICATION OF NEF
EFFECTORS
Identification of cellular proteins that mediate Nef
functions is critical for our understanding of the mo-
lecular mechanisms that mediate various Nef func-
tions and for our ability to develop drugs that disrupt
Nef's function(s). Previous approaches to identify Nef
effectors in T cells and macrophages that relied on
binding of Nef to candidate proteins in heterologous
systems such as yeast or in vitro in biochemical assays
using GST-fusion proteins failed to identify down-
stream effectors for several Nef functions. To identify
additional critical effectors of Nef, we developed a
protocol to biochemically purify protein complexes
that associate with HIV-1 and SIV Nef in T cells.
For these studies, we used the SIV mac239 and
HIV-1 NA7 natural Nef proteins, which have been
studied extensively in our laboratory during the last
several years. Both Nef proteins were tagged at the car-
boxyl terminus with heterologous peptide-epitopes to
which high-affinity monoclonal antibodies are avail-
able in quantity. We confirmed that the addition of car-
boxy-terminal epitopes does not negatively affect con-
served functions of Nef such as the ability to down-reg-
ulate cell surface expression of class I MHC, CD4,
CD28 (and CD3 by SIV Nef), or Nef's ability to asso-
ciate with PAK2 kinase.
Genes encoding epitope-tagged Nef proteins were
stably expressed in a Jurkat-derived T-lymphoblastic
cell line. Cell proteins associated with Nef were puri-
fied from cytoplasmic detergent extracts by immuno-
affinity chromatography using monoclonal antibodies
specific for the epitope tags. Using this technique, we
consistently detect a set of approximately eight
polypeptides having molecular masses between 20 kD
and 300 kD that copurify with both the HIV-1 and SW
Nef proteins. We are presently focusing on purification
of Nef-associated proteins in quantities required for
their identification using mass spectrometry. We are
also extending this approach to study Nef-associated
proteins in macrophage cell lines.
INDUCIBLE EXPRESSION OF NEF IN
T CELLS AND ANTIGEN-PRESENTING
CELLS IN TRANSGENIC MICE
The benefit of reducing levels of CD28 on the surface
of Nef-expressing T cells for SIV/HIV replication in
the host has not yet been investigated, but can be spec-
ulated based on known functions of CD28 and on
known modulating effects of Nef on signal transduc-
tion in T cells. During antigen presentation, T cells
form tight conjugates with antigen-presenting cells
(APCs). CD4, CD28, and T-cell antigen receptor are
critical components of the immunologic synapse, a
macromolecular structure that mediates the interac-
tions of T cell with APCs. These interactions and anti-
gen-initiated signaling regulate several important
aspects of T-cell biology, such as entry into cell cycle,
clonal expansion, effector responses, and apoptosis of
the expanded T-cell clones, that underlie the immune
response. The concerted down-modulation of CD28
and CD4 by both HIV-1 and SIV Nef, and of CD3 by
SIV Nef, probably limits the adhesion of a Nef-
expressing T cell to the APC following a productive
antigen-presentation event. Furthermore, it could pro-
mote the disengagement of the activated T cell from
the APC and its subsequent movement to other APCs,
thus facilitating the spread of the virus. Another possi-
ble consequence of the coordinated down-modulation
of CD3, CD4, and CD28 is compromised duration and
strength of antigen-specific signaling in the infected T
cell.
To address the impact of Nef and the contribution
of its individual functions on T-cell biology, we direct-
ed inducible expression of HIV- 1 Nef to T cells and
APCs in transgenic mice. We anticipate that these ani-
mals will provide important novel insights into the
consequences of Nef expression in these cells, conse-
quences that are likely critical for the progression of
HIV -1 infection in humans.
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TRANSCRIPTION AND PROTEOLYSIS
W.P. Tansey R. Chen S.Y. Kim S. Salghetti
E. Ejkova M. Muratani K. Tworkowski
A. Herbst
Normal cellular growth and development depend on
processes that regulate the abundance, distribution,
and activity of proteins within the cell. Transcription
and proteolysis are two processes that have key roles
in regulating protein abundance. Transcription is the
first step in the life of a protein and is fundamental in
determining when a protein will be synthesized and at
what level. Proteolysis is the last step in the life of a
protein, and it is ultimately responsible for establish-
ing correct steady-state protein levels. As "bookends"
in the life of any protein, these two processes have
apparently very little in common, yet it is the connec-
tion between transcription and proteolysis that is the
focal point of our research. We study how the proteins
that control transcription-transcriptional activators-
are regulated at the level of their own stability, and
how these proteins use components of the proteolytic
system to regulate gene expression.
MYC
As a paradigm for transcription factor destruction, we
study Myc. Myc is a basic helix-loop-helix transcrip-
tion factor that features prominently in the regulation
of cell proliferation and in cancer. Myc is also a high-
ly unstable protein that is destroyed within minutes of
its synthesis. The rapid destruction of Myc plays an
important part in keeping intracellular levels of the
Myc protein low and responsive to environmental
stimuli. We have previously shown that Myc is an
unstable protein because it is destroyed by ubiquitin-
mediated proteolysis, a process in which covalent
attachment of Myc to ubiquitin (Ub) signals Myc
destruction by the proteasome.
Protein ubiquitylation is a highly specific process
that begins when an element within the target protein-
termed a "degron"-is recognized by a Ub-ligase. The
Ub-ligase binds to the degron and catalyzes the transfer
of Ub to a lysine residue within the target protein. This
process is then repeated many times to produce a high-
ly ubiquitylated substrate that is rapidly destroyed by
the proteasome. For Myc, the degron lies within the
amino terminus of the protein, overlapping the tran-
scriptional activation domain (TAD) and two highly
conserved elements called Myc boxes I and II.
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Curiously, although the degron has a crucial role in
Myc proteolysis, it is not the only element that con-
tributes to Myc turnover. Within the interior of Myc-
overlapping highly conserved Myc box III-there is an
element (the D-element) that collaborates with the
degron to facilitate efficient Myc destruction. The inter-
actions between the Myc degron and the D-element
demonstrate that Myc destruction is regulated at multi-
ple levels and reinforce the notion that the stability of
Myc is governed by the actions of the most highly con-
served regions of the protein.
A CONSERVED PROTEOLYTIC MACHINERY
SIGNALS MYC DESTRUCTION
A number of years ago, we discovered that the Myc
degron can signal Ub-mediated proteolysis in the
yeast Saccharomyces cerevisiae. This was a surpris-
ing discovery because yeast have no direct homolog
of the Myc protein, and it suggests that Myc proteol-
ysis proceeds through a highly conserved mechanism
shared by yeast and humans. In the last year, we have
further probed the evolutionary conservation of Myc
destruction. We have discovered that cancer-associat-
ed and transforming mutations within the degron that
stabilize Myc in human cells also stabilize Myc in
yeast, and we have found that the recently identified
D-element can also function to direct Myc proteolysis
in this species. Moreover, we have characterized the
cellular machinery that targets Myc for Ub-mediated
destruction in yeast and found that this, too, is con-
served. Using a directed genetic approach, we have
identified a number of genes that are required for
Myc proteolysis in yeast. These genes encode mem-
bers of a conserved Ub-ligase complex called SCFG"'.
At the heart of this complex is the Grrl protein, which
is directly responsible for mediating substrate recog-
nition. Yeast with mutations in Grrl (or indeed any
other component of the SCFGrd complex) are defec-
tive for Myc proteolysis. We have used this defect to
search for human proteins that can direct Myc
turnover in yeast and have identified a human
homolog of Grrl that complements loss of Grrl and
directs a rapid rate of Myc destruction in yeast cells.
The interchangeability of human and yeast proteins in
this way further reinforces the conservation of the
mechanism that directs Myc destruction and provides
valuable insight into the mechanistic basis of Myc
proteolysis.
IDENTIFICATION OF A METABOLICALLY
STABLE POOL OF MYC PROTEIN
One of the reasons we study Myc destruction is
because Myc is an exceptionally unstable protein; the
typical half-life of Myc in a human cell is approxi-
mately 20 minutes. The importance of rapid Myc
turnover is evidenced not only by the evolutionary con-
servation of Myc destruction processes, but also by the
link between increased Myc stability and oncogenic
transformation by Myc: Mutations within Myc that
increase its stability increase its transforming ability.
Given the extreme instability of Myc, therefore, we
were surprised to find a pool of Myc protein, present
in many cells, that escapes rapid proteolysis.
The identification of this metabolically stable pool
of Myc protein was made during our attempts to under-
stand the complicated kinetics of Myc destruction. We
have known for some time that the rate of Myc decay in
many cells does not obey simple first-order kinetics.
Rather, Myc destruction appears to be biphasic; there is
an initial phase in which the rate of Myc destruction is
very rapid, followed by a latter phase in which the rate
of Myc decay is quite slow (Fig. 1A). Using a deter-
gent-extraction process, we have learned that this
biphasic decay is due to the existence of two distinct
forms of Myc (Fig. 1B): An extractable pool that decays
rapidly and with first-order kinetics (the "Si" pool),
and an extraction-resistant pool that decays more slow-
ly ("S2"). The partitioning of Myc into the S2 pool
occurs rapidly following Myc synthesis, although the
relative amount of Myc that enters S2 is dependent on
the cell type. In some cell types, greater than 10% of
newly synthesized Myc enters S2; in other cell types,
Myc is restricted exclusively to the S1 pool. We have
identified a carboxy-terminal element within Myc that
is responsible for this partitioning and have shown that
proteins which interact with Myc in this region differ-
entially affect S 1 /S2 partitioning. Curiously, we have
also found that Myc in the S2 pool is efficiently ubiq-
uitylated, despite its stability. Together, these observa-
tions suggest that the proteasomal destruction of Myc
can be regulated by environmental partitioning, and
raise the interesting issue of why some cells would
maintain a portion of the Myc protein in a ubiquitylat-
ed, but metabolically stable, state.
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FIGURE 1 Myc protein exists in two forms with different meta-
bolic stabilities. Myc decay is biphasic. (Top panel) Pulse-
chase experiment showing the decay of total radioactively
labeled, epitope-tagged, human Myc in HeLa cells. CT refers
to "chase-time," in minutes. (Bottom panel) Graphical repre-
sentation of the above pulse-chase experiment. The percent-
age of radioactively labeled Myc protein present at each time
point is shown on a logarithmic scale. In this representation, if
Myc decayed with first-order kinetics, we would expect to see
a straight line. Instead, we observe that there is an initial rapid
phase of decay (fast), followed by a later, slower, phase of
decay (slow). (B) Two forms of Myc exist with different meta-
bolic stabilities. Pulse-chase experiment showing the decay of
radioactively labeled, epitope-tagged, human Myc in HeLa
cells. For this experiment, labeled cell extracts were separated
into detergent-extractable (S1) and detergent-resistant (S2)
pools prior to recovery of Myc proteins by immunoprecipita-
tion. Note that Myc is partitioned into both pools, but that the
rate of decay of Myc in each pool is very different.
TRANSCRIPTION FACTOR LICENSING
BY UBIQUITIN
In addition to dissecting the molecular basis of how
Myc is destroyed, one of the research objectives in our
laboratory is to understand why Myc is destroyed. Many
transcription factors, particularly those involved in the
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control of cell growth (e.g., p53 and E2F), are unstable
proteins that are destroyed by Ub-mediated proteolysis.
In almost all of these proteins (including Myc), the ele-
ment that signals their destruction overlaps with the
transcriptional activation domain. Indeed, the overlap
between TADs and degrons is intimate, and we have not
been able to separate these two activities in a number of
transcription factors that we have examined. The curi-
ous relationship between TADs and degrons suggests
some involvement of the Ub-proteasome pathway in
transcriptional activation, but until recently, we have not
understood the nature of this involvement.
To determine why transcriptional activation
domains signal Ub-mediated proteolysis, we have
examined the role that components of the Ub-protea-
some pathway have in transcriptional activation. For
these studies, we fused the prototypical acidic activa-
tion domain from VP16 to the bacterial LexA DNA-
binding protein and expressed the chimeric protein in
yeast where it potently activates transcription and is
rapidly destroyed by Ub-mediated proteolysis. Using a
directed approach, we found that the Ub-ligase
required for LexA-VP16 destruction is an SCF com-
plex, SCFmet", the substrate-recognition component of
which is Met30. We found that Met30 associates
specifically with the VP16 TAD-and not other acti-
vation domains examined-and that deletion of Met30
not only stabilizes LexA-VP16 in vivo, but also blocks
its ability to activate transcription. Remarkably, the
requirement for Met30 in transcription can be circum-
vented by direct fusion of Ub to the LexA-VP16 pro-
tein (Fig. 2). This result suggests that in order to acti-
vate transcription, LexA-VP16 must be ubiquitylated
(either by SCFm'"' or by some other process). The
requirement for activator ubiquitylation provides a
simple explanation for why it is that transcription fac-
tors are destroyed so readily-because they cannot
activate transcription unless they have first signaled
their own ubiquitylation.
But why would a transcription factor need to be
primed for destruction in order to stimulate transcrip-
tion? We suggest that the requirement for ubiquityla-
tion serves to tightly couple transcription factor activ-
ity and destruction. By using the same signal-ubiq-
uitin-both to activate and to destroy a transcription
factor, the cell is in effect granting a "license" to that
transcription factor for a limited period of activity
before it gets destroyed. We suspect that this is a
mechanism which prevents unlimited activation by
any one promoter-bound transcriptional activator and
links continual gene activation to the ongoing synthe-
sis and activation of transcription factors.
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FIGURE 2 Regulation of VP16 activation domain function by
ubiquitin. (4) Structure of chimeric activators. To probe the rela-
tionship between transcription and proteolysis, we generated
synthetic activators consisting of the bacterial LexA DNA-bind-
ing protein fused to the prototypical acidic activation domain
from VP16. Where indicated, we also fused ubiquitin (Ub) to
these proteins. (8) Transcriptional activity of LexA-VP16
depends on ubiquitylation. The LexA fusion proteins shown
above were expressed in yeast strains either expressing (-F) or
not expressing (-) Met30, the Ub-ligase for the VP16 activation
domain. (Top panel) Transcriptional activity, in arbitrary units.
(Bottom panel) Steady-state protein levels, as determined by
immunoblotting. Note that the LexA-VP16 fusion protein is tran-
scriptionally inactive in the absence of Met30 (lane 6) but that its
activity can be rescued by direct fusion to ubiquitin (lane 8).
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STRUCTURAL BIOLOGY
R.-M. Xu J. Min J. Vitali
0. Merkel Y. Zhang
H. Shi
During 2001, Olaf Merkel returned to Austria and
Jacqueline Vitale completed her 1-year appointment as
a visiting scientist. After spending 4 years as a
research technician in my laboratory, Ying Zhang
joined the Novartis Pharmaceuticals Corporation in
New Jersey.
We continued to focus our attention on structural
studies of proteins involved in pre-mRNA splicing and
proteins that affect chromatin structure and dynamics.
We completed a high-resolution structural analysis of
the RNA-binding domain of the heterogeneous
nuclear ribonucleoprotein (hnRNP) Al (UP1) in col-
laboration with Adrian Krainer here at CSHL, and in
collaboration with Zhiguo Zhang in Bruce Stillman's
lab, we carried out structural and functional studies of
the amino-terminal bromo-adjacent homology (BAH) -
containing domain of ORC I in transcriptional silenc-
ing in Saccharomyces cerevisiae. These studies are
highlighted below.
HIGH-RESOLUTION ANALYSIS OF THE
RNA-RECOGNITION MOTIF OF HNRNP Al
Human hnRNP Al is an abundant nuclear protein that
has been implicated in many cellular processes,
including packaging of nascent RNA polymerase II
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transcripts in the nucleus, regulating alternative 5'
splice-site selection in pre-mRNA splicing, mediating
the splicing-inhibitory effects of certain exonic splic-
ing silencers, nuclear-cytoplasm transport, RNA
annealing, and telomere-length regulation. The protein
consists of 320 amino acids and has two RNA recog-
nition motif (RRM) consensus sequences at the amino
terminus, followed by a glycine-rich carboxy-terminal
region. Both the amino-terminal domain, known as
UP1 and the carboxy-terminal domain are required for
the function of hnRNP Al in alternative splicing.
We have previously solved the crystal structures of
UP1 and its complex with single-stranded human
telomeric DNA. In the present study, we extended the
resolution to 1.1 A, the highest-resolution structure for
any RRM-containing proteins. The 1.1-A revealed that
several critical residues involved in RNA binding have
alternative side-chain conformations (Fig. 1). These
residues, Phe-17, Phe-59, and Val-44, are all located in
the RRM1. Furthermore, the alternative conforma-
tions of these residues are spatially correlated, namely,
alternative conformation of one residue also forces the
others to adopt alternative conformations. The newly
observed side-chain conformations are incompatible
with the observed mode of RRM-RNA interactions
studied to date. It is not clear at this point whether this
new conformation of these residues inhibits RNA
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FIGURE 1 Stereoview of the electron density
map showing correlated alternative side-chain
conformations of Phe-17, Phe-59, and Val-44.
The amino acid side chains are numbered and
shown in a stick model. Different side-chain
conformations are denoted with the suffixes A,
B, and C. The electron density map is a aA
map contoured at 1.2 o level.
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binding or utilizes a new mode of RRM-RNA interac-
tion. Interestingly, amino acids located in the closely
related RRM2 of hnRNP Al do not have alternative
conformations. Previous studies in Adrian Krainer's
lab showed that the two RRMs have distinct functions
in pre-mRNA splicing. Different conformational
states in RRM1 and RRM2 may contribute to the
functional differences between the two RRMs. Given
that RRM is the most common RNA-binding motif, it
is likely that the observed alternative side-chain con-
formation of the conserved aromatic residues also
occurs in other RRM-containing proteins. In future
studies, it will be of interest to determine the effects of
alternative side-chain conformation on RNA binding
directly.
STRUCTURAL STUDY OF THE BAH-CONTAINING
DOMAIN OF ORC1P IN EPIGENETIC SILENCING
Genes located in certain regions of eukaryotic chro-
mosomes are permanently repressed. This heritable,
transcriptionally silent state is caused by an altered
chromatin structure that can be propagated from one
generation to the next. In S. cerevisiae, silencing is
observed for at least three genomic loci: the silent
mating-type loci, HML and HMR, telomeres, and the
ribosomal DNA region. Several protein complexes are
known to be critical for the establishment and mainte-
nance of transcriptional silencing in yeast, including
the silent information regulator (SIR) proteins, Sirlp,
Sir2p, Sir3p, and Sir4p, and several sequence-specific
DNA-binding proteins, the origin recognition com-
plex (ORC), Rap 1p, and Abflp.
The amino-terminal domain of Orclp, the largest
subunit of ORC, functions specifically in transcrip-
tional silencing, but it is dispensable for DNA replica-
tion. This silencing domain of Orclp shares about
50% identity with the amino-terminal region of Sir3p.
This Orclp domain interacts with Sirlp, and in
Drosophila, the corresponding region of dORC I
interacts with HP1. In all species, this region of Orclp
contains a BAH domain that is also present in Sir3p,
and other chromatin-associated proteins such as mam-
malian DNA-(cytosine-5)-methyltransferases, compo-
nents of the yeast RISC chromatin-remodeling com-
plex, and histone deacetylase complexes.
We have solved the crystal structure of the amino-
terminal domain of Orclp (amino acids 1-235) to
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FIGURE 2 Crystal structure of the amino-terminal domain of
Orc1p is shown in a ribbon representation.
2.2-A resolution using the multi-wavelength anom-
alous diffraction (MAD) method. The structure has an
elongated shape consisting of two domains: a large
domain composed of mainly 13 strands and a small
helical domain (Fig. 2). The BAH domain is in the
large domain and it forms the core of the structure.
The small, nonconserved helical domain, referred to
as the H-domain, is inserted between two 13 strands,
136 and 137, of the BAH domain. In collaboration with
Zhiguo Zhang in Bruce Stillman's lab, we showed that
the H-domain interacts with Sirlp and is necessary for
targeting the SIR protein complex to the silent mat-
ing-type loci. In the future, we plan to carry out struc-
tural studies of this Orclp domain in complex with
Sirlp.
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CANCER: GENETICS
The highlights of efforts in this group are described below.
Dr. Masaaki Hamaguchi's group has discovered a new tumor suppressor candidate, DBC2, a mem-
ber of RAS-BTB family, that is likely to be involved in breast cancer development and was discov-
ered by application of RDA.
Dr. Greg Hannon's group has made significant strides toward understanding the mechanisms of
double-stranded RNA-induced gene silencing (RNAi) with the cloning of the initiating enzyme, Dicer.
Genetic studies of Dicer mutants in worms have led to the realization that RNAi may represent a
common mode of cellular gene regulation in addition to its role in the response to exogenous dou-
ble-stranded RNAs and endogenous mobile genetic elements. These advances in understanding
the mechanisms of RNAi have led to the development of RNAi as a powerful tool for manipulating
gene expression in mammalian cells.
Dr. Eli Hatchwell and collaborators have recently discovered a small microdeletion on chromosome
8q24.3 in a patient with Kabuki syndrome, a condition originally described more than 20 years ago,
for which no genetic clue had previously been uncovered.
Dr. Yuri Lazebnik's lab has continued to develop approaches to dissect oncogene-dependent apop-
tosis.
Dr. Scott Lowe's group has continued to refine and deepen their models for the role of p53 in sen-
scence, apoptosis, and drug resistance.
Dr. Rob Lucito and collaborators have made strides in developing arrays of oligonucleotide-based
microarrays useful for measuring gene copy number.
Dr. Alea Mills, who has recently joined CSHL, has continued collaborations to create mouse mod-
els of human disease using chromosome engineering. She has also developed a model system that
will be used to study the role of p63 in stem cell maintenance, differentiation, and cancer.
Dr. Vivek Mittal, in collaboration with Robert Benezra and Marianna Russinova (Memorial Sloan-
Kettering Cancer Center, New York) have been exploring the helix-loop-helix protein Id which is
required to support angiogenesis in tumors. They have discovered novel candidates, such as
Pleiotrophin, a 6b4 integrin, and their receptor Laminin 5, which may mediate its action.
Dr. Michael Wigler's group has continued the development of methods for the representational
analysis of complex genomes. In collaboration with Rob Lucito, they have shown that low-com-
plexity representations and oligonucleotide microarrays can be used to measure gene copy num-
bers in cancers and mutant humans. They have developed methods for annotating a genome with
the frequency of its constituent mers and are using this method to develop new insights into
genome evolution and to design of hybridization probes. They have also demonstrated the use of
transcription profiling to observe cell-cell interactions.
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TUMOR SUPPRESSOR GENES INVOLVED IN BREAST
CANCER DEVELOPMENT
M. Hamaguchi M. Kanis M. Reimels
J. Meth D. Roberts
T. Odawara R. Von Roeschlaub
Our lab is interested in the discovery and characteriza-
tion of cancer-related genes, especially tumor suppres-
sor genes that are ablated in cancer cells. The recent
history of tumor suppressor gene investigation has
been revolutionary. The identification of these genes
and subsequent studies into their biological and patho-
logical functions have provided vast new insights into
the development of cancer. A great deal is now known
about the relationship between cancer development
and cellular functions.
In the case of breast cancer, the isolation of tumor
suppressor genes BRCA1 and BRCA2 has had an
impact on several aspects of cancer treatments as well
as cancer research. BRCA1 and BRCA2 genes can be
utilized for identification of individuals at high risk of
developing breast cancers. This has been crucial in the
development of risk assessment. There are also differ-
ences in clinical outcomes between breast cancers
with BRCA1 mutations and those with BRCA2 muta-
tions. These findings suggest that specific types of
breast cancers require specific screening methods and
therapeutic approaches. However, tumor suppressor
genes responsible for sporadic breast cancer remain to
be discovered. We have investigated genetic alter-
ations, especially deletions in breast cancer, to discov-
er new tumor suppressor genes. Among the candidate
tumor suppressors we isolated, DBC2 (deleted in
breast cancer 2) seems promising. It is homozygously
deleted in 3.5% (7/200) of breast tumor samples and
silenced in 55% (12/22) of breast cancer cell lines.
Activation of DBC2 in a breast cancer cell line result-
ed in growth arrest of the cells. Our mutation and
expression analyses of two neighboring genes implied
that they were unlikely to be tumor suppressor genes.
Studies of the other genes from this region have been
well characterized and no relation to breast cancer has
been inferred. These data led to the conclusion that
DBC2 is the best candidate for a tumor suppressor in
this region. One of our research goals is to validate
DBC2 as a tumor suppressor gene and to elucidate its
role in breast cancer development.
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FIGURE 1 Structure of DBC2. Predicted functional domains of
DBC2. The numbers refer to the deduced amino acid sequence
of DBC2. The asterisks denote missense mutations we have
discovered.
DBC2 is a member of a new gene family RAS-
BTB (Fig. 1). The RAS domain shows highest homol-
ogy with RRAS family members (Fig. 2). The
BTB/POZ (broad complex tramtrack bric-a-brac/
poxvirus and zinc finger) is a putative protein-protein
interacting domain. DBC2 also has a DNA-binding
domain (MYND) at its carboxyl terminus. We hypoth-
esize that it is a G-protein-coupled transcription factor.
Another goal of our research is to understand the phys-
iological function of DBC2 and other RAS-BTB pro-
teins.
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FIGURE 2 The phylogenic tree demonstrates overall homology
between DBC2 and RAS family members. A table of the pair-
wise distances between the genes was prepared by the GCG
Wisconsin Package, and a phylogram was then created from
the table using the neighbor-joining method. The length of a
horizontal line is proportional to estimated divergence along
each branch.
Mutation Analysis of DBC2
M. Hamaguchi, J. Meth
Tumor suppressor genes are frequently inactivated by
mutations. The first step of validating DBC2 as a
tumor suppressor was mutation analysis. The coding
region of DBC2 was screened for mutations by
DHPLC (denatured high-performance liquid chro-
matography) and SSCP (single-strand conformation
polymorphisms). The detected mutations were con-
firmed by sequencing. The mutation analysis of cell
lines revealed two missense mutations in the
BTB/POZ domain, found in lung and breast cancer
cell lines. Then, 95 primary tumors and matched nor-
mals were screened by either DHPLC or SSCP for
mutations in either of these two genes. Samples show-
ing variants in retention time (DHPLC) or mobility
shifts (SSCP) were sequenced, and tumors were com-
pared to matched normals. Two missense mutations
were again discovered within tumors (but not in
matched normals), one in the BTB/POZ domain. In
total, four missense mutations in the coding region of
DBC2 were found from cell lines and tumors (Fig. 1).
Expression of DBC2
M. Hamaguchi, M. Reimels
Tumor suppressor genes are inactivated by transcrip-
tional suppression in some cases. In fact, DBC2
expression is extinguished in more than half of breast
tumors while its expression is detected in other types
of cancer. On the contrary, other genes in the same
region were expressed in at least 80% of all tumors.
These results indicated that DBC2 was inactivated at a
transcriptional level specifically in breast cancer.
Hypermethylation of the promoter region has been
demonstrated to cause transcriptional inactivation.
The promoter region of DBC2 was screened for
methylation status. First, we determined the genomic
sequence of DBC2 including the 5' end (GenBank
accession number AF315385). We then located CpG
islands and found one approximately 500 by upstream
of exon 1. We examined two cell lines, T-47D, which
does not express DBC2, and HeLa, which does, for
methylation status. We analyzed methylation status by
a bisulfite modification that converts only unmethy-
lated cytosines to uracil but not methylated cytosines.
As a result, sequences of the modified fragments were
different depending on the methylation status. The dif-
ferences were detected by polymerase chain reaction
(PCR) and then confirmed by sequencing. CpG
islands of T-47D cells were hypermethylated but those
of HeLa cells were not. Our findings suggest that
hypermethylation may have an important role in inac-
tivation of DBC2 in at least one of the breast cancer
cell lines. Other breast cancer cell lines with DBC2
silencing have not yet been examined.
Transcriptional inactivation by hypermethylation
can be reversed in many cases when methylation is
chemically blocked. A commonly used chemical for
this purpose is 5-aza-2'-deoxycytidine (5-Aza-C). We
cultured both HeLa and T-47D cells with 5-Aza-C.
Neither DBC2 expression nor growth of HeLa cells
was affected by addition of 5-Aza-C. T-47D cells treat-
ed with 5-Aza-C demonstrated only weak expression
of DBC2. As we describe below, induction of DBC2
hindered the growth of T-47D, and the negative selec-
tion might have contributed to the observation of the
faint expression of DBC2.
Characterization of DBC2
M. Hamaguchi, T. Odawara, D. Roberts [in collaboration
with M. Wigler, Cold Spring Harbor Laboratory]
We utilized an inducible gene expression system
developed in Dr. Wigler's lab here at CSHL to study
DBC2 function in breast cancer cells. With this sys-
tem, DBC2 expression can be regulated by adminis-
tration of an inducer, Muristerone A. We first analyzed
HeLa cells, which expressed endogenous DBC2.
Induction of foreign DBC2 did not cause noticeable
phenotypic changes of the HeLa cells. When breast
cancer cell line T-47D was examined, induction of
DBC2 hindered the growth of T-47D.
To determine the subcellular localization of
DBC2, we fused it with green fluorescent protein
(GFP). Both GFP and DBC2-GFP fusion protein were
expressed in a mammalian cell line. Signals of the
fusion protein were observed primarily in the nucleus,
whereas those of GFP were observed in both the
cytosol and nucleus. We concluded that DBC2 was
localized in the nucleus at least under certain condi-
tions. However, it remains to be investigated whether
DBC2 shuttles between the nucleus and the cytoplasm
like some G-proteins including human RAN and
Dictyostelium Rac B.
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Mouse DBC2
M. Hamaguchi, M. Kanis, R. Von Roeschlaub [in collaboration
with M. Zhang, Cold Spring Harbor Laboratory]
Isolation of mouse counterparts has two purposes: to
take advantage of well-studied mouse genetics and to
prepare materials to establish mouse models.
Evolutionary conservation of DBC2 between the
human and mouse was first confirmed by zoo blot
analysis with human and mouse DNAs. The mouse
counterpart of DBC2 was then cloned by cDNA
library screening and database searches. There are
three RAS-BTB proteins in both human and mouse.
The genes were compared using "distance analysis" of
the GCG Wisconsin package. A mouse gene,
AF420001, demonstrated by far the highest homology
with human DBC2, and therefore, it is considered the
mouse counterpart of DBC2. The genomic sequence
of mouse DBC2 was also determined by sequencing of
BAC (bacterial artificial chromosome) clones
(GenBank accession number AF420002).
Jennifer Meth
RNA!: MECHANISMS AND APPLICATIONS
G. Hannon E. Bernstein A. Gaudy J. Du Y. Seger
S. Boettcher D. Conklin S. Hammond J. Silva
M. Carmel' A. Den li P. Paddison I. Sulks
My laboratory continues to pursue two parallel inter-
ests. First, we strive to understand the process of neo-
plastic transformation using cultured normal and can-
cer cells as models. Second, we investigate the mech-
anistic basis of double-stranded RNA-induced gene
silencing (RNAi) in experimental systems ranging
from fungi to mammals.
This year, we have made considerable progress in
deciphering the mechanism of RNA interference
(RNAi) with the cloning of several proteins that are
key to this gene silencing process (see Fig. 1). Among
these was Dicer, the enzyme that initiates RNAi by
processing double-stranded RNAs into discrete -22-
nucleotide small interfering RNAs (siRNAs). Genetic
studies of Dicer in Caenorhabditis elegans, in collab-
oration with Ronald Plasterk of the Hubrecht
Laboratories in Holland, revealed that Dicer had a role
in regulating endogenous genes which control devel-
opmental timing (see report by Bernstein below). This
prompted a paradigm shift in the field which now rec-
ognizes that the RNAi machinery may have a broad
role in regulating cellular gene expression. An under-
standing of the enzymology of Dicer also led to two
key discoveries, which may ultimately enable a fusion
FIGURE 1 A mechanistic model for RNAi.
of our two core interests. Other laboratories (Elbashir
and colleagues at the Max-Planck Institute in
Germany) demonstrated that chemically synthesized
Dicer products are effective inducers of gene silencing
in mammalian cells. The use of siRNAs is rapidly
becoming a standard methodology for probing gene
function in mammals We have extended their seminal
discovery through the development of cost-effective,
high-throughput methodologies for constructing
siRNAs and are now beginning a project to assess
loss-of-function phenotypes on a whole-genome scale.
We have recently found (see report by P. Paddison, D.
Conklin below) that the endogenous triggers of the
RNAi pathway, which were linked to RNAi via genet-
ic analyses of Dicer, can be retargeted to suppress a
gene of interest. These small hairpin RNAs (shRNAs)
can be stably expressed in vivo to create continuous
cell lines, and perhaps even animals, in which RNAi is
used to create a gene knock-out (or more precisely,
knock-down).
One goal of these studies is to develop tools that
will allow us to dissect the mechanisms of neoplastic
transformation through the use of genetics in cell cul-
ture. A prerequisite to such an approach is the devel-
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opment of genetically defined human cancer models.
During the past 2 years, we have identified a combi-
nation of viral and cellular oncogenes that can trans-
form normal human cells into cancer cells in vitro
(see report by Y. Seger below). We can now combine
these defined models with RNAi-based loss-of-func-
tion approaches to search for genes that are essential
to the survival and proliferation of cancer cells.
Through such approaches, we hope to define new
potential targets for selective anticancer therapies.
Characterization of RISC,
the RNAi Effector Complex
S. Hammond
This project is centered on the purification of the RISC
(RNA-induced silencing complex) effector nuclease of
RNAi. During the past year, I identified a putative pro-
tein component of this complex, Argonaute2, and have
further characterized the role of Argonaute2 in the
RISC complex. I generated antibodies to Argonaute2,
confirming that it cofractionated with RISC nuclease
activity. Interestingly, the protein shifts from a 300-kD
complex to a 500 -kD active complex after exposure to
double-stranded RNA. I cloned the full-length coding
sequence of Argonaute2 and expressed it transiently in
Drosophila S2 cells. Affinity purification of this pro-
tein yielded active material, confirming its presence in
the RISC complex. Argonaute2 coimmunoprecipitates
with the enzyme Dicer, another component of the
RNAi machinery. This suggests cross-talk between the
two mechanistic steps of RNAi, i.e., the double-strand-
ed RNA processing step and the effector (RISC) step.
My efforts at this time are directed at identification of
remaining components of the RISC complex, and how
they accomplish the mRNA degradation aspects of
RNAi.
Dicer: Does It Control Everything?
E. Bernstein
The mechanism of RNAi is not fully understood, but it
has recently begun to be elucidated. The field of RNAi
has been advanced by various methods, including bio-
chemical purification, genetics, and candidate gene
approaches. These systems have yielded the identities
of key players in the silencing process.
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In particular, we have identified the enzyme Dicer
from Drosophila embryo extracts, which is responsi-
ble for cleaving the double-stranded RNA into small
fragments of approximately 22 nucleotides (siRNAs).
These species, which were first observed in plants
undergoing silencing, presumably confer target speci-
ficity to the interference process through their incor-
poration into the effector nuclease complex, RISC.
The Dicer protein has a unique domain structure
and is highly conserved in evolution. Homologs exist in
organisms such as Arabidopsis, C. elegans, Neurospora,
Schizosaccharomyces pombe, mouse, and humans. To
probe the biological function of this gene and confirm
its role in RNAi, we sought out the C. elegans Dicer
mutant.
der-1 mutants are indeed RNAi-deficient in cer-
tain tissues and show a range of developmental abnor-
malities. These phenotypes are similar to those caused
by loss of function of let-7, a gene encoding a small
temporal RNA (stRNA) necessary for the proper tim-
ing of C. elegans development. stRNAs are thought to
interact with their target genes at the 3' UTR and to
negatively regulate gene expression at the translation-
al level. The let-7 precursor RNA forms a stem-loop
structure of approximately 70 bp, which is processed
into a mature form that is 21 nucleotides in length.
Dicer can into its mature
form in vitro, and der-1 mutant animals have
increased levels of precursor let-7 accompanied by
reduced levels of the mature form in vivo. This sug-
gests a role for Dicer in processing stRNAs as well as
double-stranded RNAs, two regulatory molecules
involved in mechanisms with distinct outcomes.
Several laboratories have recently demonstrated
that let-7 is a prototype for a large family of endoge-
nously encoded small RNAs. To date, more than 300
have been characterized in Drosophila, C. elegans,
and mammals. This has led to the notion that regula-
tion of gene expression by small RNAs may be a com-
mon motif in the control of gene function, which was
not even suspected to exist only 1 year ago.
RNAi: Multiple Silencing
Triggers and Distinct
Effector Complexes?
A. Gaudy
For several years, we have anticipated the existence of
cellular genes that would be regulated by RNAi. This
was confirmed by findings from several laboratories,
including our own (see report by E. Bernstein above).
On the basis of this hypothesis, I devised a method for
cloning small RNAs from cells with the hope of iden-
tifying endogenous targets of RNAi. I identified
sequences corresponding to viruses and transposons,
which had been predicted targets of RNA interference
based on genetic evidence from plants and worms. I
also identified some microRNAs, which are small
RNAs that may regulate translation through a mecha-
nism related to RNAi.
These data led to an interest in how different RNAi
complexes might regulate expression through different
effector pathways, translation and RNA degradation. I
have therefore been purifying complexes that contain
microRNAs from Drosophila and human cells. I have
found that microRNAs associate with a specific mem-
ber of the Argonaute gene family, Ago-1. Other work-
ers in the lab have shown that a different Argonaute
family member, Ago-2, is part of the complex that
specifically degrades messenger RNA. From genetic
work in C. elegans, we predict that the microRNAs in
the Ago-1 complex may regulate message translation
rather than initiating message degradation. Efforts are
under way to identify the proteins associated with this
complex and the manner in which it may regulate gene
expression.
Human Cell Transformation:
Shortened Telomeres and
Extended Graduate Careers
Y. Seger [in collaboration with R. Maestro,
CRO-Aviano, Italy]
One long-standing interest in our lab is the elucidation
of the minimum genetic requirements for the transfor-
mation of human cells. Utilizing the technique of
retroviral gene transduction, we have previously
shown that normal human fibroblasts could be trans-
formed with the oncogene combination of adenovirus
El A, MDM2, and Ha-RasV12. This transformation
model is significantly different from those previously
published in that there is a distinct absence of telom-
erase expression, either through direct introduction of
the catalytic subunit, hTERT, or by an oncogene capa-
ble of activating hTERT. Analysis of telomerase status
in these engineered cells and the resultant primary
tumors indicates that telomerase is not activated, indi-
cating that telomerase activity is not essential in the
initial transformation event.
Upon explantation into culture, however, cells
derived from these primary tumors undergo wide-
spread apoptosis and senescence, phenomena indica-
tive of telomere crisis, although a small percentage of
explanted cells are able to survive this crisis event.
Interestingly enough, the cells that survive after
explantation are telomerase-positive. When these cells
are injected into a second nude mouse, the kinetics of
tumor formation are similar to those of the primary
tumors, indicating that no additional genetic alterations
were acquired in vivo or in vitro other than telomerase
activation. It is interesting to note that telomerase acti-
vation does not appear to enhance tumorigenicity, but
serves as an enabling event to prevent telomere short-
ening and widespread genomic instability characteris-
tic of cells undergoing mitotic crisis.
Through our studies utilizing this E1A-based sys-
tem, we have begun to elucidate the minimum genetic
alterations that must occur to transform a normal
human cell into one that is cancerous. Currently, we
are focusing on taking this tractable transformation
system and adapting it for use in an epithelial cell sys-
tem to more accurately model events that lead to
tumorigenesis. In addition, we are continuing to make
progress on the development of a human cell transfor-
mation model composed entirely of cellular onco-
genes.
Short-hairpin-activated Gene
Silencing (SHAGging): A New
Approach to Functional Genomics
and Nucleic Acid-based
Therapies
P. Paddison, D. Conklin
RNAi was first recognized in C. elegans as a biologi-
cal response to exogenous double-stranded RNA,
which induces sequence-specific gene silencing.
RNAi represents a conserved regulatory motif, which
is present in a wide range of eukaryotic organisms.
Recently, we (Ketting et al. 2001) and other investiga-
tors have demonstrated that endogenously encoded
triggers of gene silencing act through elements of the
RNAi machinery to regulate the expression of protein-
coding genes. These stRNAs are transcribed as small
hairpin precursors (-70 nucleotides), processed into
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active, 21-nucleotide RNAs by Dicer, and recognize
target mRNAs via base-pairing interactions. We have
found that small hairpin RNAs (shRNAs) can be engi-
neered to suppress the expression of desired genes in
cultured Drosophila and mammalian cells. shRNAs
can be synthesized exogenously or can be transcribed
from RNA polymerase III promoters in vivo, thus per-
mitting the construction of continuous cell lines or
transgenic animals in which RNAi enforces stable and
heritable gene silencing. The ability to encode a con-
stitutive silencing signal may also permit the marriage
of shRNA-induced silencing with in vivo and ex vivo
gene delivery methods for therapeutic approaches
based on stable RNAi in humans.
Centrosome
Duplication
J. Du
In the past year, we have continued to probe centro-
some function by studying the centrosomal kinase
STK15, a serine/threonine kinase, which upon ectopic
expression in mammalian cell culture causes centro-
some amplification, aneuploidy, and cellular transfor-
mation. Through a two-hybrid screen using STK15
full-length coding sequence as the bait, we isolated
several gene products with which STK15 potentially
interacts. Of these, we chose two for further study.
One of them is Nm23, a putative tumor suppressor
gene. We found STK15 and Nm23 not only interact in
the two-hybrid system, they also coimmunoprecipitate
with each other and cofractionate on a gel-filtration
column (Superose 6). Both proteins localize to the
centrosome. The colocalization appears most signifi-
cantly during the mitotic phase of the cell cycle, when
both proteins significantly increase at the centrosome.
The other protein that shows interaction with
STK15 is DEEPEST. This is a mitotic spindle-associ-
ated protein that associates with the centrosome and
its surrounding mitotic microtubule structure at the M
phase but not at the interphase. DEEPEST is an
STK15 kinase substrate in vitro. Overexpression of
DEEPEST in human IMR90 cells induces premature
senescence and causes centrosome amplification in
about 40% of the cells. We are currently testing path-
ways through which DEEPEST induces these effects.
We also continue our effort to purify the STK15
complex (STK15-associated factor, SAF) in normal
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human cells. We isolated and characterized nine pro-
teins that coimmunoprecipitate specifically with
STK15 and identified them through mass spectrome-
try analysis (SAF-160: p160 ROCK1; SAF-68:
DDX3; SAF-55: CDC20*; SAF-50: p54 RCK; SAF -
44: STK15; SAF-38/36: pyrroline-5 carboxylate
reductase 1 /reductase; SAF-30: HSP27; SAF-20:
HSP20). p160 ROCK1 can be phosphorylated by
STK15 in vivo.
Dicer Proteins from
Fungi to Plants
A. Dent
RNAi is a highly conserved gene silencing mecha-
nism. Genetic studies have mainly been done in plants
and C. elegans, whereas a good biochemical system
has been set up only in Drosophila, by our lab and oth-
ers. My main interest has been setting up a system that
will have the advantages of bringing genetic and bio-
chemical approaches together.
Many gene-silencing mutants have been isolated
in plants, making plants a good system in which to
pursue biochemical studies. I started working on
tobacco suspension cells, which have the advantage of
offering enough material for biochemistry. An addi-
tional advantage of this model is that tobacco is a host
for many viruses that encode suppressors of gene
silencing, which may help us to map the details of the
silencing pathways. To that end, we prepared cell
extracts which have dicer activity that can cut the long
double-stranded RNAs into short RNAs. Presence of
small (-21-25 nucleotides) RNAs is a hallmark of
RNAi. In plants, two kinds of small RNAs are present.
Other investigators have suggested that these two pop-
ulations seem to be involved in different aspects of
silencing. In our hands, the activities producing these
different populations seem to be biochemically sepa-
rable.
Another organism with good genetics is
Neurospora, in which different gene-silencing mecha-
nisms have been described. We were able to prepare
dicer extracts from Neurospora as well. These extracts
may help us map some genetic components upstream
of dicer in the silencing pathways. Recently, we have
started working on S. pombe in collaboration with the
Martienssen group here at CSHL. We are interested in
setting up a biochemical system in S. pombe, which
offers many advantages, especially the lack of redun-
dancy of genes involved in RNAi. Overall, I am hop-
ing to contribute to the characterization of RNAi
mechanism.
Functional Analysis
of the Argonaute
Family in Mice
M. Carmel)
Argonaute family members have been shown to be
essential for RNAi/PTGS in several organisms,
including Neurospora (QDE-2), Arabidopsis (AG01),
and C. elegans (rde-1). In Drosophila, Scott Ham-
mond has shown that Ago2 is a component of the
RISC complex and interacts with Dicer. Interestingly,
argonaute proteins have also been implicated in con-
trol of development in several organisms. Arabidopsis
AGO1 is necessary for meristem cell maintenance,
and mutants have pleiotropic developmental defects.
In addition, PIWI, one of four argonaute proteins in
Drosophila, is required for maintenance of germ-line
stem cells. It is unknown what roles of the RISC com-
plex are mediated by argonaute family members and
whether these developmental phenotypes result from
loss of discrete regulatory functions or from a more
general misregulation of silencing mechanisms.
I have been working on characterizing the arg-
onaute family in humans and mice with the ultimate
goal of creating knockout mice for each member. Each
argonaute protein, of which there are seven in human
and eight in mice, has a PAZ domain (thought to medi-
ate interaction with Dicer), and a carboxy-terminal
300-amino-acid PIWI domain of unknown function.
Along with Zhenyu Xuan in Michael Zhang's lab here
at CSHL, we have determined the chromosomal loca-
tions, gene structures, predicted cDNAs and protein
sequences, as well as the ortholog and paralog rela-
tionships among the genes. In addition, I am currently
investigating the expression pattern of each gene using
multiple-tissue northern blots.
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SPORADIC HUMAN GENETIC DISEASE
E. Hatchwell S. Kantarci
T. Lee
Much of the success in dissecting human genetic dis-
ease at the molecular level has been restricted to
Mendelian (familial) disorders. This is in large part
because a robust algorithm exists that allows disease-
associated loci to be mapped to specific chromosome
regions, namely, linkage analysis. The availability of
genome-wide polymorphic DNA markers has made
linkage studies almost routine.
No general algorithm, however, exists for the
analysis of sporadic disorders in humans. Since by
definition, such disorders are not familial, linkage
analysis is of no value. Any approach that is likely to
succeed in defining causative genetic lesions in such
disorders must allow for an objective assessment of
the whole genome of an individual. Furthermore, it is
likely that alternative technologies will be developed
for each category of mutation (from single-base
changes to large chromosomal rearrangements).
Historically, for those sporadic conditions whose etiol-
ogy is known, that information has invariably relied on
serendipity. For example, Williams syndrome, a con-
dition that results in short stature, moderate mental
retardation, and highly specific behavioral abnormali-
ties, is now known to result in more than 95% of cases
from a submicroscopic deletion (encompassing -1.5
Mb) at chromosome 7811.23. The deletion is almost
always de novo, having arisen in a parental germ cell.
The chance discovery, in 1993, of a balanced translo-
cation involving chromosome 7q11.23 segregating
with affected individuals from a unique family with a
forme fruste of Williams syndrome led to the suspi-
cion that chromosome 7q11.23 might be implicated in
this condition. Had that family not been ascertained, it
is almost certain that Williams syndrome would still
be idiopathic today. The emphasis of this laboratory is
twofold:
To develop methodologies that will allow whole
genomes to be screened for subtle copy number
variations of the type known to be important in
conditions such as Williams syndrome. Such
methodologies must permit genome scanning at
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high resolution and be able to differentiate dosage
ratios of 2:1 and eventually, 3:2 (for detection of
duplications). The most robust technology current-
ly appears to be large clone genomic microarrays,
made with DNA isolated from bacterial artificial
chromosomes (BACs). We are currently designing
and testing "homemade" BAC arrays, in collabora-
tion with colleagues at the University of California
at San Francisco and the Sanger Centre, United
Kingdom.
To screen selected patient groups and analyze in
detail any abnormalities that are discovered.
We recently detected an interstitial deletion at
chromosome 8q24.3 in a patient with Kabuki syn-
drome. This condition results in moderate learning dif-
ficulties, short stature, typical facies, and very high
rates of congenital heart disease (50 times that of the
general population). The deletion was initially detect-
ed on a genome-wide BAC array, and subsequently
confirmed by FISH (fluorescence in situ hybridiza-
tion) analysis of metaphase chromosomes from the
FIGURE 1 BAC array output for chromosome 8 in a child with
Kabuki syndrome. One BAC located near the end of the long
arm of chromosome 8 appears to be deleted. This was subse-
quently confirmed on FISH analysis (see Fig. 2).
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FIGURE 2 FISH analysis of metaphase chromosomes from a patient with Kabuki syndrome.
Two clones were used: One maps to chromosome 8ptel (a signal is seen on both homologs)
and the other to chromosome 8q24.3, the region suspected to be deleted on the BAC array.
This probe only yields one signal, consistent with the presence of a heterozygous deletion in
this patient.
patient. We have begun a detailed molecular analysis
of this microdeletion and estimate its size to be no
greater than 500 kb, well below the level of cytoge-
netic resolution. We plan to analyze as many Kabuki
patients as possible in order to determine the frequen-
cy of this deletion in that population, as well as the
background frequency in the general population. To
this end, we are designing an array that will contain a
very dense set of DNA markers in the affected region
and that will allow analysis at a resolution of 10 kb.
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REGULATION OF APOPTOSIS IN CANCER CELLS
Y. Lazebnik D. Duelli X. Opitz-Araya
L. Faleiro J. Raychaudhuri
P. Lassus J. Rodriguez
S.-C. Lin A. Matapurkar
Apoptosis is a type of cell death that is critical for
maintaining tissue homeostasis. An intense effort to
understand apoptosis has been fueled in large part by
the hope of using the apoptotic machinery for curing
cancer. The accumulated knowledge is sufficient to
design and implement tools that kill cells quickly and
efficiently by inducing apoptosis. However, because
the apoptotic machinery is present in most if not all
mammalian cells, the major problem is how to induce
apoptosis in cancer cells selectively. One approach to
solving this problem is to learn how apoptosis is
induced by oncogenic transformation. This approach
is based on a paradoxical observation that some onco-
genes, including myc and adenovirus ElA, either
induce apoptosis or sensitize cells to cytotoxic agents,
including those used for chemotherapy. One implica-
tion of this observation is that some oncoproteins are
pro-apoptotic activities that are specific for trans-
formed cells. We think that understanding how the
apoptotic machinery is activated in response to the
expression of oncogenes, and how apoptosis is pre-
vented in transformed cells, will help to develop ways
to kill cancer cells selectively.
Central to the apoptotic machinery are caspases, a
family of cysteine proteases. Caspases are activated at
the onset of apoptosis and cause death by cleaving a
number of proteins in coordinated manner. If caspase
activation is prevented, a cell can become drug-resis-
tant. Caspase activation occurs in two steps. At the
first step, pro-apoptotic signals lead to autocatalytic
activation of caspases that are called initiators.
Activated initiator caspases process effector caspases,
which in turn cause cell collapse by cleaving a specif-
ic set of substrates. Each initiator caspase is activated
in response to a subset of signals, indicating that a pre-
requisite for understanding how a specific signal acti-
vates apoptosis is finding the initiator caspase that
mediates it. We investigate which caspases are
involved in apoptosis and study how they are activat-
ed, how this activation leads to cell death, and what
prevents this activation in drug-resistant cells. The
ultimate goal is to understand how caspases can be
activated selectively in cancer cells.
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To investigate how caspases are activated by onco-
gene expression, we previously developed a cell-free
system that mimics apoptosis dependent on expression
of E1A, an adenoviral oncogene. Using this system, we
found that E1A- dependent apoptosis is mediated by
caspase-9 and that the expression of E1A sensitizes
cells to apoptosis by facilitating activation of this cas-
pase. This is achieved by at least two ways: (1) facili-
tating the release from mitochondria of cytochrome c, a
cofactor required for caspase-9 activation, and (2) reg-
ulation of an unidentified subsequent step in caspase-9
processing.
Our subsequent experiments suggested that E1A
regulates cytochrome c release both by promoting
activation of proteins that can permeabilize mitochon-
dria and by inactivating an activity, which we named
IODA (inhibitor of oncogene-dependent apoptosis)
that prevents cytochrome c release. One of the goals of
our laboratory during the last year was to develop
approaches to identify IODA.
MONOCLONAL ANTIBODIES AS A TOOL TO
IDENTIFY MOLECULES THAT REGULATE
MITOCHONDRIAL PERMEABILITY
The current view is that cytochrome c release from
mitochondria is regulated by interactions between
cytosolic proteins, such as Bax and Bad, and as yet
unidentified receptors on the mitochondrial surface. To
us, this is reminiscent of the interaction between
cytokines and their cellular receptors in the immune
system. We then reasoned that a significant number of
these receptors were identified by producing mono-
clonal antibodies to complex cell populations and then
testing the antibodies for interaction with a particular
subset of cells. Therefore, we thought that by using a
similar approach, we may be able to identify mito-
chondria-associated proteins that are involved in regu-
lation of apoptosis and that mediate the response to
E1A. This approach seemed to be particularly attractive
because of our substantial experience in making mon-
oclonal and polyclonal antibodies by producing and
DN
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FIGURE 1 Expression of ode and primus (pr) depends on
expression of ElA as detected by immunoblotting.
characterizing more than 150 antibodies to caspases,
APAF-1, and other proteins involved in apoptosis.
As a result of our first attempt, we identified mul-
tiple antigens that change their localization, mobility
on SDS-PAGE, or expression, depending on EIA
expression or drug treatment. For example, an antigen
called primus is a protein that is localized at mito-
chondria and is repressed in cells expressing EIA,
whereas the antigen ode is induced by E1A (Fig. 1).
Although the majority of antigens are associated with
mitochondria, we also found a number of antigens
affected by E1A that are located in other cellular com-
partments. We have been identifying the antigens and
are beginning to investigate their role in apoptosis.
This task will be substantially facilitated by the advent
of RNA interference as a technology that will allow us
to easily obtain cells that lack a protein of interest.
BCL-2 PROTEINS AS TRANSMEMBRANE
TRANSLOCATORS
Because Bcl -2 proteins, which are inhibitors of apop-
tosis, regulate mitochondria permeability, there is a
possibility that IODA is a known or yet to be identi-
fied Bcl -2 -like protein. How Bcl -2 and its relatives
function is not known. The observation that the Bcl -2
family regulates the release of pro-apoptotic proteins
from mitochondria led to the concept that the family
controls cell survival by regulating permeability of
these organelles.
Several models have been proposed to explain
how this regulation is achieved. A popular model
comes from the intriguing observation that the tertiary
structure of the Bcl -2 proteins is reminiscent of that of
colicins and diphtheria toxin (DT), which are bacteri-
al toxins. Colicins kill other bacterial strains, whereas
diphtheria toxin is toxic to humans. Because these tox-
ins can make pores in lipid membranes, it was sug-
gested that the Bcl -2 proteins function by making
pores in mitochondrial membranes.
Although some Bcl -2 proteins were indeed found to
form pores in synthetic lipid membranes, the model has
been facing substantial challenges. For example, the
structures of Bax and BcI-x (Bcl -2 relative) are remark-
ably similar, suggesting that if one of the proteins
makes the pores, another would likely make them as
well. Yet, Bax promotes the release of pro-apoptotic
molecules from mitochondria, whereas Bcl-x prevents
it. This puzzle has not been made easier by the difficul-
ty of explaining how Bcl-x or Bcl -2 would prevent
release of proteins from mitochondria by making pores.
These and other unexplained observations argue
that either the similarity between the Bcl -2 family and
the toxins is a coincidence or they share a common
function that is unrelated to the formation of pores. We
proposed that the structural similarity between the
Bc1-2 proteins and the diphtheria toxin translocation
domain indicates that the common function of these
proteins is to translocate other molecules or them-
selves through membranes, rather than to form pores.
This hypothesis is yet to be tested.
MITOCHONDRIAL ACTIVATORS OF APOPTOSIS
This work was done in collaboration with Emad
Alnemri, Kimmel Cancer Center. Our interest in
IODA led us to investigate whether mitochondria con-
tain unidentified molecules that regulate apoptosis. In
collaboration with Dr. Emad Alnemri, we found that a
mitochondrial protease called Omi is released along
with cytochrome c and promotes apoptosis, apparent-
ly by inactivating inhibitors of caspases. We also iden-
tified another protein whose function we are currently
investigating.
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REGULATION OF APOPTOSIS AND SENESCENCE
BY CANCER GENES
S. Lowe E. de Stanchina M. McCurrach S. Nunez A. Samuelson
G. Ferbeyre Z. Nahle E. Querido C. Schmitt
J. Fridman M. Narita C.S. Ray M. Soengas
A. Lin M. Narita C. Rosenthal J. Zilfou
Apoptosis is a genetically controlled form of cell
death that is important for normal development and
tissue homeostasis. Senescence produces "genetic
death" in that the senescent cell is incapable of further
propagation. Both processes are frequently disrupted
in cancer cells, implying that each can limit tumor
development. Moreover, radiation and many chemo-
therapeutic agents can induce either apoptosis or
senescence, raising the possibility that the integrity of
these programmed responses influences the outcome
of cancer therapy in patients. The goal of our research
is to understand how cancer genes control apoptosis
and senescence in normal cells, and how mutations
that disrupt these processes affect tumor development
and therapy. Our approach emphasizes genetics, and
we typically exploit simple cellular systems to study
cancer gene function. More recently, we have studied
human tumors and animal models to confirm the rele-
vance of our simple systems for tumor development
and cancer therapy in vivo.
Oncogene-induced Apoptosis
E. de Stanchina, M. McCurrach, Z. Nahle, S. Nunez,
A. Samuelson [in collaboration with Y. Lazebnik,
Cold Spring Harbor Laboratory]
Normal cells possess natural fail-safe mechanisms
that limit the consequences of aberrant proliferation.
One of these mechanisms involves their ability to cou-
ple excessive proliferation to cell death. For example,
deregulation of either the c-Myc or Rb pathway in nor-
mal cells can force aberrant S-phase entry and predis-
pose cells to apoptotic cell death. This increased sen-
sitivity to apoptosis appears to limit tumor develop-
ment and, as a consequence, mutations that disable
oncogene-induced apoptosis can contribute to carcino-
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genesis. Consistent with this view, we have previously
shown that oncogenes can engage the ARF-p53 path-
way to promote apoptosis and that disruption of this
pathway cooperates with oncogenes to promote onco-
genic transformation in vitro and tumor development
in vivo.
We are currently using a primary fibroblast system
as well as innovative gene expression technologies to
identify additional components of the apoptotic and
senescent processes and how they function in a "tumor
suppressor network." Our current questions include:
What are the cellular targets of E1A in promoting
apoptosis? How does p 19A" couple oncogenes to
p53? How do oncogenes promote apoptosis indepen-
dently of p53? To what extent does disruption of onco-
gene-induced apoptosis contribute to tumor develop-
ment in vivo?
One example of our progress in this area involves
demonstrating how different signaling pathways
cooperate to promote apoptotic cell death. The aden-
ovirus E1A oncogene sensitizes cells to apoptosis, in
part by deregulating normal cell cycle control to acti-
vate the ARF-p53 tumor suppressor pathway. Previ-
ously, we showed that at least two separate functions
of ElA are required to promote apoptosis, one involv-
ing deregulation of the pathway and the other thought
to be required for E1A to physically associate with
the p300/CBP transcriptional coactivators. However,
we now have shown that E1A promotes apoptosis
through its interaction with the p400-TRRAP chro-
matin remodeling complex and not its interaction
with p300/CBP. Significantly, the p400-TRRAP com-
plex is also an essential cofactor for the c-Myc onco-
protein and, interestingly, c-Myc rescues the apoptot-
ic defect of E1A mutants unable to interact with
p400-TRRAP.
The results described above suggest that E1A pro-
motes apoptosis by deregulating two endogenous
pathways intimately involved in cell cycle control, the
Rb and c-Myc pathways. Consistent with this notion,
c-Myc and cyclin E (which also deregulates the Rb
pathway) cooperate to induce ARF and p53 and to
sensitize primary cells to apoptosis. Thus, by study-
ing El A, we show that Myc activation and disruption
of the Rb pathway act synergistically to promote cell
death. This suggests that the c-Myc and Rb pathways
do not act in a simple linear manner, but rather target
distinct steps in the apoptotic program. The molecu-
lar nature of these targets is currently being investi-
gated.
p53 Effector Functions
J. Fridman, C. Schmitt, M. Soengas, J. Zilfou
[in collaboration with Y. Lazebnik and D. McCombie,
Cold Spring Harbor Laboratory; J. Herman, Johns
Hopkins University; W. Gerald and C. Cordon-Cardo,
Memorial Sloan-Kettering Cancer Center; A. Giaccia,
Stanford University]
The p53 tumor suppressor participates in several cell-
cycle checkpoints, DNA repair, senescence, apopto-
sis, angiogenesis, and the surveillance of genomic
integrity. In principle, the simultaneous inactivation of
all p53-associated activities could provide a multilat-
eral advantage to a developing tumor cell that mutates
p53; conversely, inactivation of only some p53 func-
tions may provide an essential new capability, where-
as others may simply be by-products of p53 loss. A
major effort of our laboratory is to understand how
p53 executes different biological programs, and which
of its many activities is relevant to tumor suppression
in vivo. Our current questions include: How does p53
execute its apoptotic and senescence programs? What
factors determine which process will be engaged upon
p53 activation? What p53 activities are essential for
p53 tumor suppressor function in vivo?
Because mutations in cancers necessarily produce
a selective advantage to emerging tumor cells, the
identification of mutated components and their fre-
quency of mutation highlight critical regulatory points
in survival and proliferative processes. Therefore, one
way to determine the contribution of specific p53
effector functions in tumor suppression is to see
whether molecules that act specifically in one process
are mutated or altered in human tumors. In this regard,
we have shown that apaf-1--a downstream effector of
p53 in apoptosis-is silenced in a substantial percent-
age of human melanomas (Soengas et al. 2001).
Interestingly, p53 mutations are rare in melanoma, and
those melanoma cell lines are resistant to p53-depen-
dent apoptosis in response to chemotherapy and fol-
lowing overexpression of p53 itself. This suggests that
some melanomas disable the p53 pathway by disrupt-
ing apoptosis downstream from p53 and provide an
example where disruption of the apoptotic function of
p53 may be essential for tumorigenesis. This result is
supported by a separate series of experiments in which
we have examined the contribution of apoptosis to
p53-mediated tumor suppression in Eµ -myc trans-
genic mice (C.A. Schmitt et al., in press).
We are also interested in how p53 executes its bio-
logical functions. Previously, with L. Attardi and T.
Jacks, we showed that the ability of p53 to trans-acti-
vate target genes was essential for its ability to promote
apoptosis. This year, with A. Giaccia, we see that tran-
scriptional repression can be an important component
of apoptotic function of p53, particularly in cells
responding to hypoxia (Koumenis et al. 2001). Future
work will continue to evaluate the contribution of spe-
cific p53 effector molecules to apoptotic cell death, and
to explore how the senescence program is executed.
Control of Cellular
Senescence
E. de Stanchina, G. Ferbeyre, A. Lin, M. McCurrach,
M. Narita, M. Narita, E. Querido [in collaboration
with G. Hannon, Cold Spring Harbor Laboratory]
Cellular senescence was originally described as the
process that accompanies replicative exhaustion in
cultured human fibroblasts and is characterized by a
series of poorly understood markers. Senescent cells
remain metabolically active, but are unable to prolifer-
ate, and they display changes in gene expression that
could alter tissue physiology. As such, they are genet-
ically "dead" and cannot contribute to tumor develop-
ment. Although "replicative" senescence is triggered
by telomere attrition and can be prevented by telom-
erase, an identical endpoint can be produced acutely in
response to activated oncogenes, DNA damage, oxida-
tive stress, and suboptimal cell culture conditions.
We have proposed that senescence acts in parallel
with apoptosis as a cellular response to stress. Like
apoptosis, senescence can be induced by diverse stim-
uli that appear to engage a common effector program.
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For this reason, our studies on apoptosis have guided
those on senescence. We are currently addressing sev-
eral questions: How does Ras signaling activate a per-
manent cell cycle arrest? How do tumor suppressors
such as p53, p16, and pl9ARF initiate and maintain this
arrest? How do epithelial cells respond to Ras? How
do cells maintain the senescent state?
This year, we have shown that as in fibroblasts,
oncogenic ras induces keratinocyte cell cycle arrest in
a manner involving the p 1 9ARF, p16'NK", and p53
tumor suppressors (Lin et al. 2001). This arrest clear-
ly limits tumor development, since ARF-null ker-
atinocytes expressing oncogenic ras rapidly formed
carcinomas in immunocompromised mice, whereas
their wild-type counterparts were not tumorigenic.
These results establish the importance of the ARF-
p53 pathway in epithelial cells and imply that senes-
cence-like processes suppress epithelial cell transfor-
mation.
Using a conditional p53 expression system, we
have begun to evaluate the contribution of p53 to the
initiation and maintenance of ras-induced senescence
(G. Ferbeyre et al., in press). Interestingly, p53 acti-
vation efficiently induced a reversible cell cycle
arrest but was unable to induce features of senes-
cence. In contrast, coexpression of oncogenic ras or
an activated mekl with p.53 produced an irreversible
cell cycle arrest that displayed features of cellular
senescence. These results indicate that oncogenic
activation of the MAP kinase pathway in murine
fibroblasts converts p53 into a senescence inducer.
Future work will continue to investigate how p53 ini-
tiates senescence and the factors that contribute to the
maintenance process.
Molecular Genetics of Drug
Sensitivity and Resistance
J. Fridman, Z. Nahle, C.S. Ray, C. Rosenthal, C. Schmitt
[in collaboration with R. Hoffman, AntiCancer, Inc.,
San Diego, California]
A major goal of our research is to understand the bio-
logical and molecular basis of drug sensitivity and
resistance in tumors. Conventional approaches to
identify factors that dictate treatment sensitivity rely
on human tumor cell lines treated in vitro or as ectopic
xenografts. As an alternative approach, we are using
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FIGURE 1 Imaging lymphomas in live mice. Primary lym-
phomas arising in Eµ -myc transgenic mice are "tagged" with a
GFP-expressing retrovirus ex vivo, and then injected into an
immunocompetent recipient. After several weeks, a lymphoma
forms that is histopathologically similar to the original transgenic
animal, but now can be monitored using whole-body fluores-
cence imaging. The images were produced in collaboration
with R. Hoffman (AntiCancer, Inc., San Diego, California).
transgenic mouse models to study drug action in spon-
taneous tumors. Our system exploits the ER-rnyc
transgenic mouse, which develops B-cell lymphomas
at short latency with high penetrance. Using this sys-
tem, we have identified biologic (apoptosis) and
genetic (p53, bc12, INK4a/ARF) determinants of treat-
ment sensitivity in vivo. We continue to identify new
processes and genes that modulate treatment sensitiv-
ity, and we are gearing up to use our mice as a physi-
ologic system to test novel compounds that might cir-
cumvent conventional resistance mechanisms.
Most of our progress in the last year has been with
improving the technology for manipulating the genet-
ics of primary lymphomas and for monitoring treat-
ment responses. This year, we have (1) adapted retro-
viral gene transfer methods to introduce genes into
hematopoietic stem cells from transgenic and knock-
out mice, allowing rapid generation of tumors with
compound genetic lesions (C.A. Schmitt et al., in
press); (2) made practical advances in studying treat-
ment responses and producing drug-resistant tumors
(Schmitt and Lowe 2001); and (3) shown that tumor
behavior can be monitored by whole-body fluores-
cence imaging (Fig. 1). The latter approach will allow
both spatial and temporal monitoring of lymphoma
behavior in live mice, for example, during tumor pro-
gression or following cancer therapy.
With support from the Ann L. and Herbert J.
Siegel Philanthropic Fund, we are scaling up our
efforts to study drug action in mice. Although the
extent to which these models will be predictive of
responses in human cancer remains to be determined,
we believe that the intractable nature of the resistance
problem demands new thinking and new experimental
approaches. With this in mind, our goal is to use these
mouse models to provide a rational framework for
predicting response of human tumors to therapy and
developing strategies to overcome or circumvent
resistance.
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GENOMIC MICROARRAY ANALYSIS
R. Lucito S. Rostan A. Bug lino
A. Brady J. Healy
J. Alexander R. McCombie
Progression of cancer is a multistep process. Mutations
occur in the genome of precancerous cells and accu-
mulate until the growth of these cells proceeds
unchecked. The large majority of these mutations
occur sporadically, i.e., they are not inherited. The
genes responsible for sporadic cancer must be identi-
fied if we are to understand why a cell becomes can-
cerous. To identify and characterize other genes affect-
ed by sporadic mutation, we can look to the genome of
the cancer cell, identifying regions that have undergone
increased or decreased gene copy number, namely,
amplifications or deletions, since these changes can be
used as markers for the locations of oncogenes or
tumor suppressor genes, respectively. Once these
regions are identified and tumor suppressors and onco-
genes are found, their function can be investigated to
understand the role that these genes have in the pro-
gression to tumorigenesis. The regions themselves can
be used for studies in prognosis and diagnosis.
To facilitate the identification of prognostic and
diagnostic indicators and new genes involved in tumor
progression, it is critical to be able to survey gene copy
number changes over the whole genome of the tumor.
We have developed a genomic microarray technique,
borrowing the methodology of complexity-reducing
representations developed for representational differ-
ence analysis (RDA) to increase hybridization efficien-
cy and increase signal-to-noise ratio. A representation
is a reproducible sampling of the genome, produced by
first cleaving the genome with a restriction enzyme
such as BglII, ligating the adapters, and amplifying by
polymerase chain reaction (PCR). Amplification in the
presence of many fragments results in preferential
amplification of the smaller fragments, so that the size
range of the representation is 200-1200 bp. Many of
the restricted fragments are lost during this preferential
size selection caused by the PCR amplification, result-
ing in a reduction in complexity of approximately 3%
of the genome.
By taking full advantage of the sequence of the
human genome, the array can be designed so that it is
composed of oligos derived from BglII fragments.
BglII representations of tumor and normal differential-
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ly labeled with two different fluorescent tags are com-
pared on such an array. The intensity of the fluorescent
tag in each channel is measured, and the ratio one-to-
the-other is indicative of copy number measurement of
the gene. The resolution of this type of array can be
increased simply by adding more BglII fragment-
derived oligos, up to an average of one probe every 20
kb at theoretical maximum. Furthermore, if this is not
enough coverage or if there is a region poor in BglII
fragments, a second array can be constructed based on
a second enzyme. The oligos are designed in collabo-
ration with M. Wigler here at CSHL who, with John
Healy, has designed a program that identifies the
repeat nature of a BglII fragment and also designs the
best 70-nucleotide oligo. This allows us to design non-
repetitive oligos from fragments that contain highly
repetitive elements.
We have constructed an oligo array with five loci
represented at a resolution of one probe every 75 kb to
test the ability of the format to detect gene copy num-
ber fluctuations. These loci are erbB2, c-myc, a region
on 8p22 found deleted in breast cancer, a region on
8q24 found amplified independently of c-myc in
breast cancer, and a region on chromosome 22q11 that
is lost hemizygously in patients with velo cardio facial
syndrome. These arrays have been hybridized to sam-
ples that have been characterized by us or other inves-
tigators as being mutated for these regions, to deter-
mine how accurately this method can identify gene
copy number fluctuations.
Analysis of a tumor cell line published to have
genomic amplification of erbB2 and c-myc at 8q24,
and 17q21 or c-myc and erbB2, respectively, demon-
strated that our method is robust and can detect ampli-
fications as well as the more standard techniques can.
The genomic profiles easily identified the two loci as
being amplified, with regions of single copy on either
side of the amplicon. Analysis was performed on a pri-
mary breast tumor. The tumor was separated by fluo-
rescence-activated cell sorting (FACS) analysis into
aneuploid and diploid, which were used as tumor and
normal, respectively. This tumor was identified as hav-
ing an 8q24 region amplified by other methods. When
analyzed on the array, it became apparent that there
were several amplicons in this region and a possible
deletion. Two of the regions have been identified pre-
viously in other tumor samples and are being followed
further. The method is also sensitive enough to detect
deletions of one out of two alleles, or hemizygous
deletions. By comparing a son with velo cardio facial
syndrome to his unaffected mother, we have shown
that one copy of the 3 Mb that is commonly deleted is
missing in the affected son, and the regions flanking
this 3-Mb region are retained.
We are planning to expand the array to a genome-
wide scale; 70-mer oligonucleotides are designed
from representational Bg111 fragments such that they
have the least repetitive content. Eventually, we will
reach 60,000-90,000 oligos distributed throughout
the genome, giving us a resolution of one probe every
30-50 kb. The oligonucleotides must also be charac-
terized to determine which will yield the most reliable
data. We are utilizing a combination of genomic clone
pooling, restriction-killed representations, and
genomic fractionation strategies.
Although this microarray method will be used to
categorize the mutations that occur in many tumor
types, we will use this method initially to analyze pri-
marily two tumor types. Breast cancer will be ana-
lyzed addressing two questions: The first question is
the amplification of erbB2 and the treatment with
Herceptin, a monoclonal antibody to the erbB gene
product. Herceptin is prescribed as a treatment for
patients who test positive for erbB gene amplification,
but only in a minority of cases do patients respond
completely to Herceptin and chemotherapy. It is our
intention to take a set of patients who are erbB2-posi-
tive and have had varied response to Herceptin, to
identify other genomic mutations and to make corre-
lations between the mutations and response. The sec-
ond question will address the conflicting evidence of
whether ductal carcinoma in situ (DCIS) is the pre-
cursor lesion to invasive ductal carcinoma (IDC). It
seems likely from the literature that DCIS sometimes
progresses to IDC. If this were the case, it would be
useful to identify which cases of DCIS will progress
to invasiveness. We hope to identify regions of the
genome that can serve as markers for the clinician to
identify patients with DCIS that will progress to IDC
so that they can be treated more aggressively.
The second cancer we will focus on is prostate
cancer. When a patient presents with a high prostate-
specific antigen (PSA) level, a radical prostatectomy
is performed. Within this group, there is a subgroup in
which the PSA levels again rise after -1 year , often as
a result of metastasis. We will go back to the original
tumor samples, classified aggressive, and compare
these to a set that does not metastasize. By comparing
the genomes of these two classes of primary tumors,
those that have recurrent PSA expression with those
that do not, we hope to identify useful markers that can
distinguish between the two groups. If a correlation
can be made between the profiles obtained and the
clinical information, the clinician can use this infor-
mation to judge how to treat the patient.
The regions identified from these studies will
serve as valuable diagnostic and prognostic indicators.
Of equal importance, these regions will serve to iden-
tify new oncogenes and tumor suppressor candidate
genes. The advantage to using genome-wide analysis
on a large set of tumors is that the time-consuming
step of positional cloning will be done, although it will
be necessary to compile the data. Once compiled, the
epicenter, or common region of mutation, will be
located and candidate genes identified informatically
in collaboration with R. McCombie here at CSHL.
Colon Cancer
A. Brady, S. Gass [in collaboration with M. Wigler and
R. McCombie, Cold Spring Harbor Laboratory]
We are currently investigating a possible tumor sup-
pressor gene candidate located on chromosome 20p12.
This region of the genome is rarely found homozy-
gously deleted in cancer unless the tumor is of gas-
trointestinal origin. In the GI tumor cell lines that were
tested, the deletion frequency approaches 4%, quite
high for homozygous deletions. The deletion patterns
of the cell lines were mapped and compared to identi-
fy the epicenter, or the minimal region of deletion.
Once identified, the region was used for high-quality
sequencing in collaboration with R. McCombie. The
sequence generated was used for gene finding using
several programs, but no gene candidates were identi-
fied. After the draft of the human genome sequence
was completed, the region was used for the informatic
identification of gene candidates. No known genes
were identified in the region, and only one spliced
expressed sequence tag (EST) was identified. It was
identified as a spliced EST because the sequence of the
EST splits into eight pieces and each maps to the
genome. This EST, a 5' read, is -700 bp, but spreads
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across a region of -500 kb. The coding region does not
have any clear homology. The exons were tested for
their presence or absence in eight of the cell lines
which have homozygous deletions. Six of the eight
tumor cell lines have a deletion of exons 1 and 2. We
are presently amplifying the EST sequence to use it to
probe northern blots to identify the size of the full-
length product. It may be necessary to clone the full-
length gene by RACE or phage library screening. Once
identified, the sequence will be used to initiate screen-
ing of primary colon tumor samples to identify point
mutations. We already have approximately 100 tumor
samples that can be used for this purpose.
RAC SIGNALING
This work was done in collaboration with Linda Van
Aelst and Arndt Schmitz here at CSHL. We have
employed cDNA-RDA as a procedure to identify
genes that are regulated by the Rac protein. This
method is based on the genomic technique RDA,
established in Michael Wig ler's laboratory. This tech-
nique is a subtractive hybridization method used to
compare two mRNA populations. The technique relies
on making a representation of the samples being com-
pared. Representations are prepared from the mRNA
by converting to cDNA, digesting with a restriction
enzyme, ligating adapters, and amplifying by PCR.
The representations are compared by hybridization,
and the differences are identified by PCR amplifica-
tion and then subcloning. A cell line with an inducible
RacV12 gene, a constitutively active form of the gene,
was used to compare uninduced to the induction of
Rac. To increase the throughput of screening the
clones isolated as differences, approximately 1500
clones were grown in 96-well plates processed and
arrayed on glass slides. These slides were screened for
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true differences by hybridizing differentially labeled
representations from the uninduced and induced cells.
We are currently characterizing the genes that show
expression changes due to the presence of the Rac
gene.
MAIZE MUTAGENESIS LIBRARY SCREENING
This work, being done in collaboration with Robert
Martienssen, Pablo Rabinowicz, and Erik Vollbrecht
here at CSHL, is the development of a high-through-
put screen of a maize insertion mutagenesis library.
The probes on the array are picked from a gene-
enriched methyl-filtering library. This library relies on
the fact that much of the maize genome is methylated
repeat sequences, but the gene-rich regions are not
methylated. This method enriches the genes represent-
ed by subcloning unmethylated genomic regions. The
mutant plant library was produced by random inser-
tion of a transposable element. The samples are pro-
duced by first pooling the individual plant DNAs in a
plate-wise fashion accumulating 50 individual plants
per pool. Representations are prepared from these
samples by PCR amplification on this pool using one
oligo to the transposable element inserted and a sec-
ond random oligo. The representations are then used
for hybridization to the arrays to identify which indi-
vidual plants have a gene insertion. This information
will be cross-referenced to phenotypic data to identify
the gene regions with transposon insertions.
In Press
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MAMMALIAN FUNCTIONAL GENOMICS
A. Mills J. Kui
E. Garcia
A. Bagchi
Our goal is to understand the genetic basis of human
disease. Although genome sequencing efforts have
generated an impressive amount of information about
the content of the mammalian genome, we know rela-
tively little about how specific genes function. Thus,
functional genomics-dissecting the genome by deter-
mining the role of specific genes-is essential for
understanding normal development and the disease
process.
We are using the mouse as a model system to
probe the function of human genes. The mouse pro-
vides an excellent opportunity to explore gene func-
tion because of its reproductive, anatomical, physio-
logical, and genomic similarity to humans. Our ability
to genetically modify the mouse genome makes it pos-
sible to create mouse models that allow us to address
a multitude of specific biological questions.
In our laboratory, we use gene targeting in embry-
onic stem cells to generate mouse strains that have
precise modifications of the genome; these strains
serve as experimental models that allow us to define
gene function. We are using two different approaches
to achieve this goal: (1) analyzing the role of groups of
genes within specific regions of the genome and (2)
analyzing the role of individual genes known to be
associated with the disease process. The first approach
uses chromosome engineering to generate mouse
strains that have precise chromosome rearrangements
which mimic those found in human diseases. These
mouse strains are useful for providing models of
human disease and for determining the function of
genes within specific regions of the genome. The sec-
ond research emphasis in the laboratory is to perform
an in-depth exploration of a single gene known to be
causal in several human disease syndromes. This gene,
p63, is related to the p53 tumor suppressor gene-a
gene that is mutated in approximately one half of all
human cancers. Understanding the molecular and
genetic mechanisms ofp63 action will allow us to gain
insight into the processes of development, differentia-
tion, stem cell maintenance, and cancer.
Generation of Megabase
Chromosome Rearrangements:
human chromosome 1p
A. Bagchi
A substantial number of human diseases are associat-
ed with chromosomal rearrangements such as dele-
tions, duplications, and inversions. These abnormali-
ties are complex because they affect large numbers of
genes within specific chromosomal regions. To under-
stand how these rearrangements cause disease, we can
make mouse strains that have the same rearrangement
as those found in human patients.
Defined chromosome rearrangements are made
using chromosome engineering-an approach that
combines the power of gene targeting
technology. Similarities between the human and
mouse genome make it possible to generate relevant
models of human disease. We are currently using this
approach to generate models for hereditary cancer
syndromes. We are focusing our efforts on human
chromosome 1p-a region containing several as yet
unidentified tumor suppressor genes. A diverse array
of human tumors have deletions at 1p, suggesting that
genes underlying the tumorigenic process are located
in this region of the genome. We are creating models
of hereditary cancer by creating mouse strains that
have the same deletions as those found in human
tumors. We first make specific deletions in embryon-
ic stem cells, and then use these cells to generate mice
that transmit the modified allele in the germ line. To
make this approach feasible on a genome-wide scale,
we have created a system that greatly reduces the sub-
stantial amount of effort required for generating gene-
targeting constructs. This system is composed of two
genomic libraries of essentially pre-made gene-target-
ing vectors that contain all of the features required for
generating Cre-induced chromosome rearrangements.
In addition, constructs isolated from these libraries
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contain genes that alter the color of mice that harbor
them; this feature has the advantage that mice con-
taining a specific rearrangement in their genomes are
visibly distinguishable from normal mice. This great-
ly reduces the cost and labor that are normally
required for maintaining mouse colonies and also
allows these models to be implemented in genetic
screens.
Analyzing the Role of
Specific Disease Genes:
The p63 Locus
J. Kui, E. Garcia
The p.53 tumor suppressor gene has an important role
in cancer progression. Approximately one half of all
human cancers either have lost p53 altogether or have
inactivated it by mutation. Although mice lacking p53
are viable, they develop tumors at a very early age.
Thus, p53-deficient models are extremely valuable for
investigating the molecular and genetic events associ-
ated with tumor formation.
We discovered p63, a gene that has striking simi-
larity to the p53 tumor suppressor gene. We used gene
targeting to create mice that lack p63; these mice have
severe developmental defects that affect craniofacial,
limb, and skin development. Mice lacking p63 are
devoid of all structures that are normally derived from
the ectoderm during development; they lack hair,
teeth, mammary and sebaceous glands, nails, and
prostate. These observations provided an important
clue which led to the discovery that mutations in p63
cause the human developmental syndrome ectrodacty-
ly ectodermal dysplasia clefting (EEC syndrome).
We are currently investigating the role of p63 in
morphogenesis of the ectoderm and its related struc-
tures. We have generated a conditional p63 model that
allows us to first generate viable mice, and then to
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ablate p63 function within specific tissues at particu-
lar stages of development. Using this approach, we
will examine the role of p63 within the adult to assess
how it functions in stem cell maintenance, differentia-
tion, and cancer.
We are also using several mutagenesis approaches
to determine how specific alterations of p63 affect its
function. The first approach is to use site-specific
mutagenesis to generate mouse models which have the
same p63 mutations that are present in EEC patients.
We used gene targeting to replace the normal copy of
p63 with this mutated version. This model will allow
us to determine how mutations in p63 lead to the
abnormalities found in individuals afflicted with EEC
syndrome.
We are also investigating the role of p63 using a
phenotype-driven mutagenesis strategy-one that
makes random mutations throughout the entire
genome. The mutagen that we use is ENU; it is a
potent mouse mutagen that typically generates single-
nucleotide mutations. If an ENU-induced mutation
happens to occur within the p63 gene, it will be
detectable in the screen because a visible phenotype
can be observed. This approach is extremely valuable
because it is random; it is unbiased because it is based
entirely on the resulting phenotype and not on our
understanding of gene structure. This approach will
provide a series of mouse models that harbor different
p63 mutations. This resource will be invaluable for
assessing the role of p63.
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DNA MICROARRAY TECHNOLOGY AND CELLULAR PATHWAYS
V. Mittal R. Kumar
R. Schoer
K. La Vine
A. Pirro
0. Morris
D. Chertoff
R. Lindsay
DNA microarray technology is a powerful tool for
functional genomic research. The transcriptional pro-
filing by microarray analysis holds the promise of
yielding excellent molecular markers for the clinical
classification of tumors. In particular, the patterns of
genes expressed in a tumor can indicate important bio-
logical features such as responsiveness to therapy,
predilection to invasion and metastasis, and the long-
term survival of the patient. Several studies have
recently shown how DNA arrays can be applied to the
analysis and classification of cancers like leukemia,
lymphoma, and melanoma.
My laboratory is interested in using the DNA
microarray technology in understanding cellular
pathways in mammalian cells. Below is a brief
description of individual projects being pursued in
my laboratory.
DNA Array Technology:
Fabrication and Methods
Development
K. La Vine, A. Pirro, 0. Morris
We have set up a reliable system for the fabrication of
high-density human and mouse expression arrays and
developed informatics tools for quantitative analyses
of the array data. We have assembled a collection of
15,000 mouse cDNAs and expressed sequence tags
(ESTs) from the National Institute of Aging and
40,000 human cDNAs and ESTs from the Image
Consortium. These clones have been processed, and
microarrays of greater than 20,000 cDNA probes have
been successfully printed, hybridized, and analyzed.
Last year, we focused mainly on developing standards
for all steps in the process including microarray
design, printing, sample preparation, labeling,
hybridization, and data analysis.
Delineating Angiogeneic
Pathways in Tumors
R. Schoer [in collaboration with Marianna Russinova and
Robert Benezra, Memorial Sloan-Kettering Cancer Center,
New York]
The Id family of proteins is essentially dominant-neg-
ative helix-loop-helix transcription factors. Normand
expression is required to support angiogenesis and
vascularization of tumor xenografts. Blood vessels in
Id knockout mice lack the ability to branch and sprout
to support growth or metastasis of tumors, and any
tumor growth present shows poor vascularization and
extensive necrosis. We are interested in understanding
the molecular mechanisms by which Id exerts its
effects on angiogenesis.
Two in vivo mouse model systems were used:
wild-type (PTEN +/-, Id +/+) that forms lymphoma
and a mutant (PTEN +/-, Id -/-) that forms lymphoma
but lacks the ability to form blood vessels. Tumors
were excised from these animals and RNA was isolat-
ed. RNAs from these tumors were differentially
labeled with fluorescent dyes and hybridized to
murine cDNA microarrays containing 15,000 mouse
cDNAs and ESTs. Informatics analysis was used to
identify differentially expressed genes. These were
subjected to hierarchical clustering methods to deci-
pher inherent patterns of coexpressions.
The candidate genes are undergoing validation by
an independent method such as northern blotting.
Their localization is being confirmed by in situ
hybridization of tumor sections. We will next explore
the various connections between these genes and order
the genes into the specific, complex pathways of
angiogenesis. The resulting gene set will advance
understanding of the molecular mechanisms of angio-
genesis and will pinpoint ideal targets for specific
therapeutic initiatives.
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Pathways in Stem Cell
Differentiation
R. Kumar [in collaboration with Sang Yang Kim,
Cold Spring Harbor Laboratory]
In multicellular organisms, cell-cell communication
has an important role in the regulation of fundamental
biological processes such as proliferation, differentia-
tion, and development. This communication involves
a variety of intercellular and intracellular signaling
events that operate through a complex system of bio-
chemical pathways whose functioning is poorly
understood. Although available molecular and genetic
tools have revealed many of the players involved in
these processes, an overall integrated and unified view
of the complex responses and their dynamic interac-
tions is clearly lacking. We are developing methods
for deciphering complex systems of interacting signal
transduction pathways by using cell coculture experi-
ments, high-density DNA microarrays, and bioinfor-
matics to reconstruct precise gene interaction net-
works from large-scale gene expression data. We are
applying this approach to understand the mechanism
of stem cell fate determination in response to
microenvironment cues. We have begun generating
double-transgenic mice in which a progenitor cell-
specific promoter drives expression of green fluores-
cent protein (GFP) and a differentiated cell-specific
promoter drives expression of a red fluorescent pro-
tein (RFP). Stem cells from these double transgenics
will be isolated and enriched by fluorescence-activat-
ed cell sorting (FACS). Clonally derived stem cells (as
judged from their ability to self-renew) will be grown
alone or cocultured with equal proportions of differ-
entiated adult cells. Transplantation of differentiated
stem cells has considerable therapeutic potential for
debilitating diseases such as muscular dystrophy,
Parkinson's, and other degenerative diseases.
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Functional Analysis of
Cancer Genes
V. Mittal [in collaboration with M. Wigler,
Cold Spring Harbor Laboratory]
We are interested in understanding the mechanistic
role of tumor suppressors and oncogenes in cancer by
determining their specific cellular and physiological
functions. In collaboration with the Wigler laboratory
here at CSHL, we are examining the mechanistic role
of the human tumor suppressor, PTEN (protein tyro-
sine phosphatase family member). A robust ecdysone-
inducible mammalian expression system was devel-
oped for these studies. The effects of wild-type PTEN
induction on transcription shared common signatures
with the effects of inhibition of PI3-kinase, consistent
with the model positioning PTEN as an inhibitor of
PI3-kinase signaling. A majority of PTEN-regulated
genes were involved in cell proliferation, cytoskeleton
restructuring, and signal transduction pathways.
Strikingly, at least five genes in the cluster were
involved in the sterol biosynthesis pathway. The role
of this pathway in the pathophysiology of the PTEN
loss is under investigation. These results illustrate the
power of a robust inducible expression system in con-
junction with cDNA microarrays in understanding
gene expression patterns induced by a tumor suppres-
sor gene. Such an approach is directly applicable to
the functional analysis of other cancer genes.
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MAMMALIAN CELL GENETICS
M. Wig ler J. Alexander M. Chi
A. Brady J. Douglas
J. Brodsky D. Esposito
A. Bug lino S. Gass
K. Chang J. Healy
THE CENTRAL PROBLEM OF CANCER
R. Lucito
A. Reiner
M. Riggs
L. Rodgers
S. Rostan
Cancer is a disease caused by genetic mutations. The
particular combinations of genes mutated in the dif-
ferent tissues of origin probably determine the charac-
teristics of individual cancers: their degree of malig-
nancy and their particular therapeutic vulnerabilities.
Science knows some of the genes that become mutat-
ed in cancer, much about the cellular pathways on
which they act, and a little about the way that cancer
cells interact with the host. Molecular oncology has
finally begun to make very promising contributions to
the treatment and diagnosis of cancers. So it is beguil-
ing to think that the "Cancer Problem" has been
solved, or will be solved by the routine cranking of the
wheel, and thus be tempted to turn one's attention else-
where, to other biological or biomedical problems that
appear to hold greater mystery. This would be a grave
mistake. The adequate treatment, diagnosis, and pre-
vention of cancer in patients will require a detailed
understanding of the specific molecular mechanisms
that go awry in specific cancers, both within the can-
cerous cell and between the cancer and the host.
Without this knowledge, we cannot improve diagnosis,
prognosis, and treatment.
Science is far from having a complete list of either
oncogenes or tumor suppressor genes that are mutated
in even the most common types of cancer. Our work
during the past years attests to this, as do the efforts of
our direct collaborators and other scientists using sim-
ilar approaches. Major new oncogenes and tumor sup-
pressor genes abound, and, probably, relevant new cel-
lular pathways. Science does not yet have a significant
handle on the ways in which cancer cells interact with
their host, or the cooperative ways in which cancer
cells within a tumor may help one another. Moreover,
medicine does not yet have a practical method for
assessing the mutations of individual cancers. During
the past years, we have developed new approaches to
these problems that we expect will translate into
E. Thomas
J. Troge
R. von Roeschlaub
J. West
improved diagnosis, prognosis, and treatment. We
expect that the same approaches we are developing
will lead to solutions for other complex human genet-
ic diseases, problems in genomic mapping, and
genome evolution.
REPRESENTATIONAL GENOMIC ANALYSIS
In the early 1990s, we developed a powerful approach
to genomic analysis called RDA (representational dif-
ference analysis). RDA was designed to solve this
problem: Find A when one genome is X + A and the
other genome is X (Lisitsyn et al., Science 258: 946
[1993]). Many biological searches can be reformulat-
ed as this problem, including the search for oncogenes,
tumor suppressors, pathogens, or even genetic differ-
ences between individuals. Essentially, RDA was a
combination of a new method for difference cloning,
based on differential DNA hybridization, and a
method for reducing the complexity of genomes.
Complexity reduction was achieved using a process
that we call representation (see Fig. 1), in which a
reproducible subset of the genome is derived from the
entirety. The value of representations lies in the
Human GenomIc DNA
Digest with 6 base pair cutter
127,17:Ztr:
-011gonucleotittes
Genomle DNA
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-
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FIGURE 1 Schematic of the preparation of a low-complexity
(upper panel) and high-complexity representation (lower panel).
In designing the array, we chose probes from the amplified rep-
resentational fragments.
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Are Arrayed
FIGURE 2 A typical format for our gene copy number arrays.
enabling of many protocols dependent on hybridiza-
tion of genomic DNA. The entire human genome is
just too complex in sequence to hybridize efficiently
and specifically.
RDA led to the discovery of several new onco-
genes and tumor suppressor genes by our collabora-
tors and us. One of these, DBC-2, is reported jointly
with Hamaguchi and another, DIGIT, by Lucito, both
in this Annual Report. PTEN, which was discovered
jointly with Ramon Parson's group at Columbia (Li et
al., Science 275: 1943 [1997]), is described here.
Additionally, many candidate oncogenes were found
with our collaborators at Tularik. Several of these
oncogenes belong to novel classes of gene families
and have gone into drug discovery screens at Tularik.
They will not be discussed here.
Although RDA has been a useful method for find-
ing genetic lesions in cancer, and more effective than
any technique before it, it is not sufficiently powerful
to satisfy the needs of the cancer problem. We there-
fore began to fashion a microarray-based version of
RDA wherein representations of two samples are com-
pared by array hybridization (see Fig. 2). Our array
method builds upon the success of microarrays to ana-
lyze gene expression (Schena et al., Science 270: 467
[1995]; Chee et al., Science 274: 510 [1996]), the use
of long oligonucleotide probes (Van't Veer et al.,
Nature 415: 530 [2002]), and comparative genomic
hybridization, as originally developed by Joe Gray and
his group for chromosomal analysis (Kallioniemi et
al., Sem. Cancer Biol. 1: 41 [1993]). Unlike those
groups, we use representations to create a system of
unparalleled resolution that can examine the imbal-
ances in the genome from minute samples of diseased
(cancerous) tissues. The same methodology can also
be used to study other complex human genetic dis-
eases, assemble physical maps of probes from any
genome, and enable us to compare the genomes of
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related species. Such comparative genomic studies will
provide maps of rearrangements, segmental duplica-
tions, and deletions between related organisms.
OTHER RELATED PROJECTS
Our representational analysis using microarrays has
led us, by necessity, to develop a novel genome-infor-
matics algorithm for examining exact sequence
matches within a genome. The application of this tool
to genome analysis has led to a series of unexplained
and interesting observations about genome and gene
structure. We will describe our method and observa-
tions below, together with some theories. Finally, we
describe a new effort to use expression microarray
profiling to study the important and largely neglected
subject of cancer cell communication: the study of
the messages that cancer cells send and receive that
may influence their persistence, growth, and spread
in the host, and their cooperativity during tumor for-
mation.
PTEN
The PTEN tumor suppressor gene was identified as a
collaboration between Ramon Parson's laboratory at
Columbia University and our own (Li et al., Science
275: 1943 [1997]). A deletion locus was first detected
using RDA on breast cancer biopsies, which was then
recognized as coincident with a locus implicated in a
rare genetic disease, Cowden's syndrome, that predis-
poses affecteds to breast cancers. The PTEN gene was
found to be mutated in a number of other cancer types,
particularly brain cancers (glioblastomas) (Wang et
al., Cancer Res. 19: 4183 [1997]). The gene has
homology with protein phosphatases, and subsequent-
ly, Nick Tonks and Mike Myers here at CSHL showed
that PTEN encodes a protein and phosphatidyl inositol
(PIP3) phosphatase (Myers et al., Proc. Natl. Acad.
Sci. 94: 9052 [1997]; Myers et al., Proc. Natl. Acad.
Sci. 95: 13513 [1998]). In a collaboration with our
group, the PIP3 phosphatase activity of PTEN, which
opposes the action of PI3 kinase, a known oncogene
and a candidate effector for the Ras oncogenes, was
determined to be the most likely function that sup-
presses tumorigenicity.
Last year, in a collaboration with Vivek Mittal here
at CSHL, we published a gene expression array analy-
sis of PTEN (Stolarov et al. 2001). Using an efficient
ecdysone-inducible promoter derived from the work
of Evans and co-workers (No et al., Proc. Natl. Acad.
Sci. 93: 3346 [1996]) and a retrovirus-mediated deliv-
ery system, we showed that the genes which were
under the control of PTEN, both positively and nega-
tively, are also the genes under the control of a small
molecule inhibitor of PI3 kinase. These experiments
perhaps most clearly demonstrate that PTEN acts by
controlling the PI3 kinase pathway. Among the genes
that we observed to be negatively controlled by PTEN
were those encoding transforming growth factor-13
(TGF-(3) and genes of the cholesterol biosynthesis
pathway, including HIVIG-coA synthase and reductase,
and squalene synthetase. Since PTEN may have a role
in opposing the insulin response (Butler et al., Diabetes
4: 1028 [2002]), it is possible that these observations
may indicate a link between the insulin signaling path-
way and elevated cholesterol biosynthesis.
We have pursued these studies by investigating the
role of TGF-P in the response of cells to PTEN. TGF-I3
is a growth factor that has a role in development and
differentiation and has been suggested to have a role in
tumor development and angiogenesis. When PTEN is
induced in a glioblastoma cell line, the cells flatten out
and form adherent sheets. In fact, these morphological
effects are reversed by the administration of TGF-13.
However, expression analysis has so far failed to pro-
vide a convincing link between TGF-I3 and PTEN. The
genes controlled by both are a partially overlapping set,
but the transcriptional effects of PTEN induction are
not reversed by administering TGF-P. In fact, many of
the PTEN responses are enhanced. The interaction
between TGF-13 and PTEN is thus likely to be complex.
Last year, we reported the development of an
effective ecdysone-inducible viral vector system, the
system that was used in the above studies. Initially, we
were unable to determine if the system would function
in vivo. That difficulty was illusory and has been over-
come (Fig. 3). Tumors that carry an ecdysone-
inducible 5 -GAL gene can be induced to express that
gene upon injection of an ecdysone homolog into the
peritoneum of tumor-bearing mice (Fig. 3, top). This
has enabled us to test the expression of PTEN in the
glioblastoma cell line U87MG that has deleted its
endogenous PTEN gene. The growth curves shown in
Figure 3 (middle) suggest that expression of PTEN
can arrest tumor growth. Considering that U87MG has
been maintained in cell culture for many years after its
removal from a patient, this is quite remarkable. Our
observations support one of the fundamental hypothe-
ses of cancer genetics: that pharmacological correc-
tion of the critical genetic defects of a cancer can lead
to a cure. Figure 3 (bottom) shows the reverse result,
as a control: When an oncogene (H-ras) is induced in
U87MG, the cells form tumors more rapidly. These
studies illustrate the utility of the ecdysone-inducible
system for assaying both tumor suppressor genes and
oncogenes in vivo.
REPRESENTATIONAL MICROARRAY
ANALYSIS OF THE GENETIC
LESIONS IN CANCERS
The majority of our research effort is, in fact, directed
to the use of microarray analysis to determine the
genetic defects of cancer cells. As mentioned in the
introduction, this effort has evolved from our early
RDA studies, which clearly indicated that there were
many oncogenes and tumor suppressor genes that had
not yet been discovered. The essential core of our
approach is the representation, which simplifies a
complex genome so that its analysis by hybridization
becomes more feasible. As illustrated in Figure 1, and
described in past Annual Reports, we make represen-
tations by cleaving genomic DNA with a restriction
endonuclease and then select only small DNA frag-
ments by polymerase chain reaction (PCR) amplifica-
tion. This enables us to reduce complexity in a com-
putationally predictable manner and also analyze
genomic DNA from minute amounts of specimen. A
long history of the application of representations sup-
ports its reproducibility and reliability (Lisitsyn et al.,
Proc. Natl. Acad. Sci. 92: 151 [1995]; Lucito et al.,
Proc. Natl. Acad. Sci. 95: 4487 [1998]). If a sequence
is present in a representation made with a particular
restriction endonuclease, it derives from a small
restriction fragment, and if a sequence is in a small
restriction fragment, it is in the representation made
with that enzyme.
The application of representations to microarray
analysis is illustrated in Figure 2. Samples are repre-
sented and hybridized to arrays of probes that are pres-
ent in representations. We call this RMA, for repre-
sentational microarray analysis.
In our earlier studies, we made libraries from rep-
resentations and arrayed fragments from the library as
probes (Lucito et al., Genome Res. 10: 1726 [2000]).
Our first experiments, published in 2000, demonstrat-
ed the feasibility of our approach. There were several
problems with this approach, however. First, it was
necessary to derive map positions for our probes. We
accomplished this by sequencing (a collaboration with
Richard McCombie here at CSHL). Second, these
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point in the graphs is the average of four measurements at each probe. Probes have been arranged according to their chromosomal
position. Gene amplification is seen on the vertical axis as values in the negative range.
studies indicated that repeats were more widely dis-
tributed in the genome than we had expected, and
probes with repeats were not useful for measuring
gene copy number in a sequence-specific way. As a
consequence, fewer probes were usable than we had
expected. A third disadvantage of our first approach
was that our probe set was randomly distributed in the
genome, and hence we could not focus probes in
regions of interest. Fourth, the infrastructure of main-
taining large physical collections of probes was daunt-
ing. Finally, the arrays made from fragments are gen-
erally of a variable quality.
We were encouraged by the success of arrays of
long oligonucleotide probes, which had been used by
other investigators for expression analysis. Our first
test of oligo arrays was successful (see Fig. 4).
Importantly, we can design oligonucleotide probes
directly from the published human genome assembly
inferred to be in representations (see Fig. 1). In this
way, we can avoid repeats and have many more probes
that are usable. We can therefore make arrays with
higher resolving power. In addition, we can place
oligonucleotide probes at will near genes of interest,
and thus increase our resolution in important regions
of the genome. We call this procedure ROMA, for rep-
resentational oligonucleotide microarray analysis.
Figure 4 illustrates results of the microarray analy-
sis of two breast cancer specimens. The microarrays
were designed with probes distributed over a region
containing the c-Myc oncogene on chromosome 8 and
the ErbB-2 gene on chromosome 17, as well as con-
centrations of probes from elsewhere on the genome.
As can be readily seen from the figure, amplification
at these loci, and at another locus distant from c-Myc,
can be readily detected. These arrays contain about
2000 probes, arranged in chromosomal order of the
horizontal axis. The vertical axis displays the concen-
tration in the cancer sample relative to their concen-
tration in a normal sample for each probe, measured as
a ratio of intensity of cancer to normal. From the peak
of Figure 4 (left), we can see this patient has an ampli-
fication at ErbB-2 and one at the c-Myc locus. Figure
4 (right) shows the analysis of a tumor from a patient
with amplification around c-Myc and another locus at
the other end of that segment, but no amplification
about ErbB-2. These experiments demonstrate the
ability of our microarray system to characterize the
cancers of patients, and at the same time, point to new
loci that are likely to be relevant to our understanding
and treatment of breast cancer.
Although amplification is a hallmark of oncogenes,
deletion is a hallmark of tumor suppressor genes. In
Figure 5 (top), we demonstrate the ability to detect (the
equivalent of) homozygous deletions. We prepared two
representations, a BgIII rep and a BglII rep "killed"
with EcoRl. The latter is a BgIII representation from
which fragments containing EcoRl sites are mainly
destroyed. On the left of the figure are all of the probes
derived from BgIII fragments containing EcoRI sites,
and on the right are those derived from BglII fragments
that do not contain EcoRl sites. The vertical axis is the
ratio of hybridization signal, one representation versus
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FIGURE 5 (Top) Actual data from a control experiment. In this
control experiment, probes are not in chromosomal order.
Rather, probes that are expected to show increased ratios,
because they derive from BglIl fragments with EcoRl cleavage
sites, are on the left. (Bottom) Simulation of the top panel,
based on sampled probe parameters.
the other. It is clear that the probes set on the right
"report" differently from those on the left.
SIMULATION OF ARRAY RESULTS:
PREDICTIONS OF PERFORMANCE
It is clear from Figure 5 (top) that not all probes report
equally well. Some probes fail to perform. There are a
variety of possible reasons for this: Some oligonu-
cleotides are not properly synthesized, some BglII
fragments do not amplify well, the genome sequence
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from which we derive our probes is inaccurate, some
probes recognize repeat sequences, and some probes
hybridize poorly due to subtleties of their secondary
structure. However, microarray hybridizations such as
that shown in Figure 5 (top) enable us to characterize
our probes, and future results can be corrected for the
performance character of each probe.
Experiments such as Figure 5 (top) also allow us to
simulate overall array performance, using statistical
sampling protocols. We assume that the basic equation
for probe hybridization is given by
I = a(Ax + B)+ p
where, for each channel, I is hybridization intensity, a
is a multiplicative system noise, A is the specific
hybridization parameter of the probe, x is the concen-
tration of complementary sequence to the probe in the
sample, B is the nonspecific hybridization parameter,
and 13 is the additive system noise. We can then simu-
late array performance for any number of probes,
assuming that the distribution of probe parameters A
and B of the probes we have sampled will be repre-
sentative. Figure 5 (bottom) illustrates a simulation of
the data shown in the top panel.
We can judge from our simulations how many
probes with what probe parameters enable us to detect
which kinds of lesions. For example, a 60K probe set
with the characteristics of our current probe set will be
able to detect reliable fivefold amplification of a 400 -
kb region, similar-sized homozygous deletions, and 3-
Mb hemizygous deletions. However, if we use 120K
probes with twice the performance characteristics of
our current set, we will be able to detect even 150-kb
hemizygous deletions. If probes are arranged six to a
gene, we believe we can detect hemizygous deletion of
a single gene. These predictions have important appli-
cations to the analysis of the genome in individuals
with inherited genetic disease.
APPLICATIONS OF ROMA TO GENETIC DISEASE
The applications of ROMA for the analysis of cancer
have been illustrated. The method provides a rapid
way to define the regions of the chromosome of can-
cer cells where amplifications and deletions take
place. This analysis can proceed in a highly parallel
manner, at high resolution, from small amounts of
cancer biopsies. The benefits from this study would be
a catalog of lesions that contain oncogenes and tumor
suppressors and could quickly narrow the search for
those genes involved in human cancer. My estimate is
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FIGURE 6 Hamming distance. Horizontal is Euclidean distance
between probes. Vertical is Hamming distance. The Hamming
distance provides a local metric.
that we know fewer than a quarter of the genes that are
frequently mutated in cancers. When these data are
correlated with clinical data, then we also derive
knowledge about which genes are most commonly
mutated in which kinds of cancer, and which muta-
tions or combinations of mutations have the greatest
value in predicting malignancy and outcome to partic-
ular therapies. Knowledge of the new oncogenes and
tumor suppressor genes is likely to lead to new thera-
peutic approaches to cancer and new forms of diagno-
sis and detection.
The applications of ROMA, however, are likely to
extend beyond cancer to gene identification in other
complex human genetic diseases. Many of the mutant
genes that cause genetic disease are mutated by dele-
tion. I estimate that 5-10% of loci associated with dis-
ease are lost through deletion rather than point muta-
tion. With our method, we can detect hemizygous
deletion. We compared a patient with velo-facial car-
dio-syndrome with a normal. This patient had a 3-Mb
deletion of chromosome 22, which was readily seen by
array hybridization. Our simulations predict that with
a dense enough microarray, we will be able to detect
hemizygosity at individual genes. Thus, we could be in
a position to scan the entire genome of affected and
unaffected humans for such deletion events. This may
be an efficient way to analyze humans with sponta-
neous deletions in the germ line, or with complex
genetic diseases, as it is postulated that the aggrega-
tion of nonlethal mutations (e.g., hemizygous loss) of
genes with a common function can lead to disease sus-
ceptibility. For example, a cohort of unrelated schizo-
phrenics might show a statistically high level of hem-
izygous deletion of certain genes critical in brain func-
tion.
PHYSICAL MAPPING OF GENOMES
AND COMPARATIVE GENOMICS
There are major applications of ROMA to the physical
mapping of the genome. It is widely recognized that
the publicly available sequence assembly of the human
genome is quite flawed. Many regions of the genome
are misassembled, there are large gaps, and in particu-
lar, the duplicated regions are poorly assembled. The
extent of the defects of assembly is largely unknown
but could adversely affect the techniques we have
developed, in particular since our oligo-based repre-
sentational methods are strongly dependent on the
colocalization of probes by map position.
Last year, in a collaboration with Bhubaneswar
Mishra and Will Casey of the Courant Institute of
Applied Mathematics at New York University, we
described algorithms whereby the order of arrayed
probes could be inferred from a series of hybridizations
of arrays with random pools of BACs (bacterial artifi-
cial chromosomes). The central concept is that probe
proximity will be inferred by a similar pattern of
hybridization signals from nearby probes throughout
the series of hybridizations. Probes less than a BAC's
length away will tend to show related patterns, and the
closer the probes, the closer their patterns will match.
The Hamming distance gives a quantitative measure of
pattern matching, and for nearby probes, the Hamming
distance is proportional to Euclidean distance (see Fig.
6) over the short range. The Hamming distance pro-
vides a local metric from which large stretches of
ordered linear map information may be inferred (Casey
et al. 2001).
We estimate that on the order of 100 hybridizations
are sufficient to create correctly ordered contigs of
about 75 probes, assuming an average arrayed probe
density of five probes per BAC. The boundaries of
regions of segmental duplications should also be evi-
dent from the analysis. The relative order of the contigs
can be established by a variety of other methods. We
can also map regions of the genome that have not yet
been entered into the public databases, as we have a set
of sequences from representations that are not yet in the
published databases (a collaboration with McCombie,
CSHL).
Sequences between humans and primates are suf-
ficiently close that the same arrays we make for
91
>chr7:157303476-157304001.L1MEc.- from 8 to 508
Exons
Repeats
100
75
50
25
0 1
108 150 200 2s0 300 358 408
>chr1:18067744-18068244
Exons
Repeats
100
75
50
25
300
15 0
18
210
24
350 400 450
0 15
111 18
0 21
24
FIGURE 7 (Top) Region annotated as repeat, but with low mer frequencies. (Bottom) Reverse of the top panel, a sequence of chro-
mosome 1 that is not annotated as a repeat, but that has high mer frequencies. The sequence in the bottom panel is found repeat-
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FIGURE 8 Probes that are complementary to genes that are expressed relatively abundantly in the carcinoma are in the upper left
of the left panel; those complementary to genes that are abundant in the sarcoma are in the upper left of the middle panel; those
complementary to genes that are induced upon coculture of the two cell lines are in the lower right of the right panel; and those com-
plementary to genes that are repressed upon coculture are in the upper left of the same panel.
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humans can be used to map primates. All that is need-
ed are BAC libraries of the primate genomes. From
such studies, the points of rearrangements between
the genomes can be inferred. Perhaps of greater
importance, and more accessible, the comparison of
patterns resulting from array hybridization of primate
and human genomes can indicate which regions of the
genomes have been duplicated or deleted in the
respective species recently in evolution.
GENOME ANNOTATION BY EXACT MATCHING
The oligonucleotide probes we use in ROMA are 70
mers. To maximize probe performance (i.e., specific
to nonspecific hybridization), we decided to minimize
the coincident exact matches between smaller "mers"
of the 70 mers and other regions of the genome. We
accomplished this by creating algorithms that can
compute the number of exact matches for mers of any
length in a given genome. We then select the best 70
mers for each member of a representation that mini-
mize the number of exact 15-mer matches elsewhere.
We demonstrated that 70 mers with frequent 15-mer
matches do indeed have poor specific to nonspecific
hybridization characteristics.
When we compared our method to repeat
masker-a standard method for determining homolo-
gy of sequences to known repeats-we observed that
some mers with matches of high frequency are not
annotated as repeats and, conversely, that some
sequences which are annotated as repeats have low
frequencies of extraneous matches in the genome
(Fig. 7). We are now exploring the use of our algo-
rithm for automated annotation of the genome and are
finding new families of repeats, many of which are
chromosome-specific. Many other features of gene
structure and genome evolution become apparent
when the genome is annotated this way, and we are
continuing genomic analysis with this tool.
CELL-CELL COMMUNICATION
One of the most neglected areas of cancer biology is
the study of host-cancer cell and cancer cell-cancer
cell interactions. Although angiogenesis has received
a lot of attention, many other host-cancer interactions
will be important for tumor growth and spread.
Furthermore, although most cancers are monoclonal,
they are not clonal monoliths. They are genetically
heterogeneous, and perhaps functionally heteroge-
neous and interdependent. We therefore have sought to
devise a method to examine cell-cell communication,
starting initially with a model system based on carci-
noma-sarcoma interactions.
Through the use of expression microarrays, we
may detect whether cocultivation of cells alters their
joint transcriptional state. To test this idea, we profiled
the transcriptional state of two colon carcinomas and
one fibrosarcoma cell line, each grown independently.
We then cocultivated them in all pairs and examined
the joint transcriptional state. The results (see, e.g.,
Fig. 8) indicate that the colon carcinoma cell lines do
not alter each other's transcriptional state, whereas
cocultivation of the sarcoma with either carcinoma
results in new transcriptional states. We observe both
gene repression and induction and are in the process of
determining which changes occur in which cells. The
effects we observe may be mediated by soluble fac-
tors, or interaction between molecules on the surfaces
of the cells, or even be the consequence of differential
modulation of the culture medium. These experiments
suggest that we can at least observe retention of the
capacity for cancer cell communication, and they
encourage us to believe that we can use this technique
to catalog and correlate interactions.
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CANCER: CELL BIOLOGY
This section comprises labs studying a diverse set of interests encompassing signal transduction events
that regulate gene expression and, ultimately, growth and proliferation in normal and cancer cells.
David Helfman's group is studying how specific actin assemblies are organized and regulated and how
alterations in actin filament assembly contribute to abnormal cell growth control in cancer. They have
found that two functionally different oncogenes, namely, the small GTPase Ras and the tyrosine kinase
v-Src, use similar biochemical pathways to achieve transformation-associated changes in the actin
cytoskeleton, i.e., inactivation of Rho-mediated stress fiber assembly through activation of MEK.
Tatsuya Hirano's laboratory studies the molecular mechanisms of chromosome cohesion and conden-
sation in eukaryotic and prokaryotic systems. During the last year, they have successfully visualized the
molecular architecture of condensin and cohesin and have obtained important insights into the regula-
tory network that coordinates their dynamic interaction with chromosomes during the cell cycle.
Senthil Muthuswamy joined Cold Spring Harbor Laboratory in 2001. His research interests address the
mechanisms by which oncogenes, particularly the ErbB family of receptor protein tyrosine kinases, ini-
tiate transformation of mammary epithelial cells in the development of breast cancer. He has developed
novel methods to examine the dimerization and activation of these receptors and cell culture proce-
dures to allow epithelial cells to form three-dimensional acini-like structures that are reminiscent of the
physiological situation. He is using these approaches to characterize the signal transduction pathways
that are important for transformation of mammary epithelial cells.
David Spector's laboratory studies the structural-functional organization of the mammalian cell nucle-
us. During the last year, they demonstrated that a subset of PML nuclear bodies move within the nude-
oplasm via a metabolic energy-dependent mechanism and that methylation of histone H3 at Lys-9 is
an early mark on the X chromosome during X-inactivation.
Arne Stenlund's group analyzes the assembly of viral replication initiator complexes. The highlights for
the past year include the definition of the recognition sequence for the El initiator and determination
of how the multiple El -binding sites are arranged in the viral origin of DNA replication. The arrange-
ment of El -binding sites provides a blueprint for the assembly of El complexes involved in unwinding
and helicase activity and determines both the order of assembly and the final architecture of the bio-
logically active El complexes.
Bruce Stillman's laboratory continues to study the replication of chromosomal DNA in eukaryotic cells.
During the past year, he has expanded its focus to include the interaction between DNA replication and
other cellular events, including gene silencing, nutrition, and the production of new ribosomes.
Nick Tonks' laboratory studies the structure, regulation, and function of the protein tyrosine phos-
phatase (PTP) family of enzymes. They defined a consensus substrate recognition motif for PTP1B and
identified the JAK protein tyrosine kinases as physiological substrates of the enzyme. These observa-
tions suggest that PTP1B may be a regulator of leptin signaling and thus a target for treatment of obe-
sity. They also developed approaches for the study of regulation of PTP function by reversible oxida-
tion. These approaches are expected to provide insights into the function of PTPs as regulators of a
variety of signal transduction pathways.
Research in the laboratory of Linda Van Aelst is focused on defining the role and mechanisms by which
Ras and Rho GTPases exert their effects on specific aspects of tumorigenesis and neuronal develop-
ment. During the last year, they have observed that the Ras-GAP-associated protein, p62d.k, functions
as a negative regulator of growth-factor-induced proliferation and BCR-ABL-induced oncogenic trans-
formation, at least in part by negatively influencing the Ras/MAPK pathway. They further obtained evi-
dence for a role of the Ras-related GTPase, Rapt , in epithelial morphogenesis and obtained important
insights into the underlying mechanism.
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THE CYTOSKELETON AND ONCOGENIC TRANSFORMATION
D.M. Helfman E. Araya E. Kim G. Pawlak
L. Connell S.-W. Lee X. Wang
We are interested in the relationship between the
cytoskeleton, oncogenic transformation, and tumor
suppression. It is well known that transformation of
cells in tissue culture results in a variety of cellular
changes, including alterations in cell growth, adhesive-
ness, motility, morphology, and organization of the
cytoskeleton. Morphological and cytoskeletal changes
are perhaps the most readily apparent features of trans-
formed cells. Studies by us and other investigators have
demonstrated that changes in the organization of actin
filaments are causally related to both abnormal growth
and tumorigenicity, indicating critical functions for
actin filaments in cell growth control. Changes in the
expression patterns of various cytoskeletal proteins and
their regulators, e.g., kinases and small GTPases, have
been observed in a number of transformed cells. In
some cases, the loss of specific proteins was found to
be causally related to the transformed phenotype,
because restoring their expression was accompanied by
reversion of the transformed phenotype. Likewise,
antisense experiments have demonstrated that inhibit-
ing the expression of specific cytoskeletal proteins also
resulted in properties associated with transformation.
Thus, the cytoskeleton has important roles in the regu-
lation of various cellular processes linked to transfor-
mation, including proliferation, contact inhibition,
anchorage-independent cell growth, and programmed
cell death (apoptosis). We are directing our efforts to
determine how alterations in actin filament assembly
contribute mechanistically to aberrant cell growth con-
trol and how specific actin structures are deregulated
following oncogenic transformation. Below is a
description of our studies during the past year to better
understand the role of the cytoskeleton in normal and
transformed cells.
MEK Mediates Ras- and v-Src-induced
Morphological Transformation and
Inactivation of Rho-dependent
Stress Fiber Formation
G. Pawlak
Alterations in actin filament assembly are a common
characteristic of transformed cells and are believed to
contribute to aberrant cell growth. We investigated
Ras-dependent signaling pathways involved in
cytoskeleton disruption and demonstrated the involve-
ment of the Ras/MEK (mitogen extracellular-regulated
protein kinase) pathway in this process. Oncogenic
activation of this pathway in normal NRK fibroblasts is
sufficient to disrupt stress fibers and focal contacts,
whereas inhibition of this pathway in Ras-transformed
NRK cells restores stress fibers and focal contacts.
While investigating the mechanism by which activation
of MEK can lead to cytoskeleton disruption, we found
that chronic activation of MEK in NRK/ras cells
induces down-regulation of ROCKI and ROCKII
expression, two downstream effectors of Rho required
for stress fiber assembly. Upon MEK inhibition,
ROCK expression and cofilin phosphorylation were
increased, demonstrating that the ROCK/LIMK/cofilin
pathway was functionally restored. Finally, using dom-
inant-negative or constitutively active mutants, we
that expression of ROCK was both nec-
essary and sufficient to promote cytoskeleton reorgani-
zation in NRK/ras cells. These findings establish the
Ras/MEK pathway as the critical pathway involved in
cytoskeleton disruption during Ras transformation and
suggest a new mechanism, involving alteration in
ROCK expression, by which oncogenic Ras can uncou-
ple Rho from stress fiber formation and therefore
achieve morphological transformation of the cells.
We extended this study to v-Src-transformed
fibroblasts and reached the same conclusion that MEK
is an effector of v-Src-induced morphological trans-
formation, participating in v-Src-mediated inactiva-
tion of the Rho-ROCK-LIMK pathway. This work,
together with other studies, demonstrates that two
functionally different oncogenes, namely, the small
GTPase Ras and the tyrosine kinase v-Src, use the
same signaling pathway to achieve morphological
transformation of fibroblasts, i.e., inactivation of Rho-
mediated stress fiber assembly through activation of
MEK. Further characterization of the pathway linking
MEK to Rho-dependent signaling is therefore a cru-
cial step toward understanding the morphological
effects of these oncogenes, and experiments are in
progress to elucidate this link, both in Ras-trans-
formed and in v-Src-transformed cells.
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Regulation of Caldesmon Expression
and Function in Normal and
Ras-transformed Fibroblasts
S.-W. Lee
Caldesmon is a cytoskeleton protein containing actin-,
myosin-, and tropomyosin-binding domains. It is
known that nonmuscle caldesmon contributes to the
stabilization of actin stress fiber structures in normal
cells. Consistently, Ha-RasV12-transformed NIH-3T3
cells in which stress fibers are disorganized have sig-
nificantly decreased expression of caldesmon. RasV12
is known to activate three distinct effectors, namely,
Raf, phosphatidylinositol 3-kinase (PI3K), and
Ra1GDS. We have studied the contribution of these dif-
ferent signaling pathways in regard to disruption of the
actin cytoskeleton and down-regulation of caldesmon.
Interestingly, treatment of Ha- RasVl2- transformed
cells with a MEK inhibitor, U0126 (25 gm), caused
reversion to normal phenotype (e.g., restoration of
actin stress fibers) as well as an increased level of
caldesmon. This indicates that sustained MEK/ERK
activation in Ras-transformed cells contributes to the
suppression of caldesmon, thereby possibly leading to
disruption of actin stress fibers. It is well established
that signaling pathways mediated by ROCKI/II, which
lead to stress fiber formation, are compromised during
Ras transformation. Consistently, inhibition of the
MEK/ERK pathway failed to restore actin stress fiber
when dominant-negative ROCKI was expressed or the
ROCKI/II inhibitor (Y27632) was applied. This sug-
gests that restoration of the ROCKI/II pathway is nec-
essary for the phenotypic reversion caused by MEK
inhibition. Furthermore, we found that the inhibition of
the MEK/ERK pathway caused up-regulation of
caldesmon at the mRNA level. Work is in progress to
determine if the restored RhoA/ROCKI/II pathway is
directly involved in the transcriptional regulation of
caldesmon. We also have been applying an RNAi
approach for knocking out caldesmon in mammalian
cells to determine if caldesmon is necessary for the
maintenance of the actin cytoskeleton.
Oncogenic-mediated Alterations in the
Cytoskeleton and Cell Adhesion
X. Wang
Transformation of cells in tissue culture results in a
variety of cellular changes, including alterations in
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cell growth, adhesiveness, motility, morphology, and
organization of the cytoskeleton. In transformed cells,
microfilament bundles exist in a more dispersed state
and are reduced in both size and number. These
changes in microfilament structure are highly related
to both anchorage-independent growth and cellular
tumorigenicity. In addition, adhesion of cells to the
extracellular matrix (ECM) and neighboring cells has
a critical role in various cellular processes, including
differentiation, growth, motility, and programmed cell
death (apoptosis). We are studying two aspects of
oncogene-mediated transformation. First, we are
studying signaling pathways that contribute to alter-
ations in the actin cytoskeleton. Second, we are inves-
tigating the regulation and role of P-catenin signaling
in src-transformed cells. 13-catenin, together with cad-
herins and ot-catenin, has a critical role in the structur-
al organization of cell-cell adhesions. In addition, 13-
catenin is involved in transcriptional control of various
target genes including c-myc and cyclin DI following
its translocation to the nucleus. In particular, we are
studying which signals contribute to translocation of
13-catenin to the nucleus and thus activate critical reg-
ulators of cell proliferation.
The Cytoskeleton and
Programmed Cell Death
L. Connell
The ability of a tumor cell to grow outside its local
environment (metastasize) is a major problem in the
development and therapeutic treatment of cancer.
Attachment of cells to the ECM is important for the
generation of signals that regulate normal cell prolif-
eration and programmed cell death (apoptosis). The
loss of the requirement for cell-matrix interactions has
a critical role in the development of cancer. Normal
epithelial and endothelial cells require attachment to
the ECM not only for proliferation, but also for sur-
vival, as disruption of cell-ECM interactions can result
in irreversible cell growth arrest and induction of apo-
ptosis, a phenomenon termed "anoikis." Elucidating
the mechanisms by which the interactions of cells with
the ECM generate and regulate downstream signals
that promote cell growth and survival is critical to
understanding cancer. Previous work by us and other
investigators has demonstrated that activation of
myosin II (actomyosin contractility) is an essential
step during adhesion-dependent signaling. On the
basis of this observation, we hypothesize that changes
observed in transformed cells in cellular proteins
involved in the regulation of myosin function will lead
to constitutive activation of actomyosin contractility
and the corresponding downstream signaling path-
ways that contribute to aberrant growth control and the
insensitivity of cells to undergo apoptosis following
detachment from the ECM. Thus, when normal cells
detach from the extracellular matrix, they undergo
apoptosis. Transformed cells do not undergo apopto-
sis, and loss of anchorage dependence in cells corre-
lates with tumor growth. By utilizing pharmacological
agents and dominant-negative proteins that can inhib-
it myosin, we are studying the role of myosin and the
actin cytoskeleton in the generation of survival signals
in normal and transformed epithelial cells.
When normal MDCK cells are grown in suspen-
sion, the cells undergo anoikis. By contrast, MDCK
cells transformed with Ras are resistant to anoikis. One
downstream target of Ras is myosin II. Therefore, we
hypothesized that the resistance of MDCK Ras cells to
undergo anoikis may be due in part to the activation of
downstream signals that protect cells from apoptosis
via activation of myosin II. To determine if myosin and
actin contribute to survival signals, we have studied
whether the inhibition of myosin or actin leads to apo-
ptosis in normal MDCK or MDCK Ras cells using
myosin and actin inhibitors. Using agents that disrupt
actin filaments (latrunculin A and cytochalasin D), or
inhibit myosin (BDM and ML-7), we have found that
both normal and transformed epithelial cells undergo
apoptosis following disruption of actin filaments or
inhibition of myosin. These results suggest that myosin
and actin filaments have an important role in genera-
tion of survival signals. We are currently investigating
whether Ras acts directly upstream of myosin and the
role of integrins in this process.
Characterization of the
Metastasis-associated Protein,
S100A4
E. Kim
Distinct changes occur to propel a tumor from benign
to malignant. Increased motility, invasiveness, and
survival in foreign environments are some of the
changes that confer a metastatic phenotype. One
potentially key protein involved in generating these
changes is S100A4, a member of the S100 family of
small calcium-binding proteins. Although the proteins
in this family share relatively high homology, their
expression distribution, protein partners, and putative
roles are quite diverse. Elevation of A4 expression has
been correlated with increased invasiveness and with a
worse prognosis in the case of breast cancer. In addi-
tion, increased levels of S100A4 have been reported in
metastatic colon, pancreatic, and bladder cancers, sug-
gesting a critical role for this protein in a number of
different human cancers. In vitro biochemical assays
have suggested calcium-dependent protein-protein
interactions between A4 and three cytoskeletal pro-
teins: actin, tropomyosin, and myosin. We have con-
firmed a calcium-dependent interaction between A4
and the heavy chain of nonmuscle myosin in vivo.
Specifically, we have demonstrated that A4 interacts
with the myosin heavy-chain II-A isoform preferen-
tially over the II-B isoform in vivo. A mutant A4 that
is incapable of binding to calcium is unable to interact
with myosin heavy-chain II-A.
To further characterize the effect of A4 in breast
cancer cells, we have established clonal MCF7 sub-
lines that stably express the A4 protein. These sublines
are being characterized in both in vitro and in vivo
metastasis-related assays. In comparison to both the
parental cell line and sublines stably expressing the
mutant A4 incapable of binding calcium, the wild-type
A4-expressing cells appear to be more motile in vitro.
Analysis of the in vivo metastatic capacity of these
different sublines when transplanted orthotopically
into nude mice is currently under way.
Molecular Organization and
Regulation of Actin Filaments
E. Araya [in collaboration with Christine Berthier,
University of Lyon, France]
In nonmuscle cells, the formation of actin filaments
and their assembly into various structures, e.g., stress
fibers, contractile ring, filopodia, and lamellipodia,
are dynamic processes. How these different structures
are formed and regulated within a single cell is not
known. In addition to actin and its associated motor
molecules (myosin I and II), other actin-filament-
associated proteins, such as tropomyosin (TMs), have
essential roles in the assembly, function, and regula-
tion of these structures. We have been studying the
dynamic localization of tropomyosin isoforms using
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GFP-tagged constructs. Tropomyosins are a family of
actin-binding proteins that bind to both grooves of fil-
amentous actin. Although they are expressed in all
eukaryotic cells, different forms are characteristic of
specific cell types. In fibroblasts, TMs exist as high-
molecular-weight isoforms (HMW) containing 284
amino acids (TM-1, TM-2, and TM-3) or low-molec-
ular-weight isoforms (LMW), containing 248 amino
acids (TM-4, TM-5[NM-1], TM-5a, and TM-5b). The
multiple TMs found in fibroblasts are an integral part
of the actin filaments, although how the different iso-
forms contribute to actin filament assembly and func-
tion is poorly understood. In addition, in fibroblasts,
HMW TMs exist as homodimers, whereas LMW TMs
can exist as heterodimers. How these coiled-coiled
interactions are regulated and how they affect the
interaction of TMs with actin filaments and their sub-
sequent cellular function are under study. We have
found that specific TM isoforms are involved in dif-
ferent subsets of actin filaments. For example, we
have found that during cytokinesis, only a subset of
tropomyosin isoforms are found in the contractile
ring. The mechanism(s) involved in isoform-specific
sorting is currently under study. We anticipate that
elucidating the molecular basis for the differential
localization of the specific TM isoforms during vari-
ous cellular events involving reorganization of the
actin cytoskeleton will provide important new insights
into the regulation of distinct actin structures.
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We have begun to use RNAi to inhibit the expres-
sion of specific isoforms of tropomyosin as well as
other cytoskeletal proteins. By using RNAi technology,
we plan to carry out a systematic screen targeted to
structural and regulatory components of the cytoskele-
ton. These studies will determine the effects of disrupt-
ing the expression of specific proteins. For example,
we will determine if loss in the expression of specific
proteins leads to changes in the structure of the actin
cytoskeleton, focal contacts and cell-cell contacts, as
well as the growth properties of cells. It is anticipated
that these studies will identify key components of the
cytoskeleton involved in growth control.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano 0. Cuvier A. Losada
P. Gillespie D. Mac Callum
M. Hirano
Our laboratory is interested in understanding the mo-
lecular mechanisms that regulate higher-order chro-
mosome dynamics in eukaryotic cells. Our previous
efforts, primarily using a cell-free extract derived from
Xenopus laevis eggs, have identified two protein com-
plexes, condensin and cohesin, that have central roles
in chromosome condensation and sister chromatid
cohesion, respectively. Each of the complexes contains
a different pair of SMC (structural maintenance of
chromosomes) subunits, implicating a functional con-
nection between condensation and cohesion. The long-
term goal in our laboratory is to understand how the
two eukaryotic SMC protein complexes work at a
mechanistic level, and how they interact with other
proteins to execute their essential functions in the cell.
We also use a bacterial SMC homodimer as a model
system to dissect the basic mechanisms of SMC
actions.
Molecular Architecture of
Condensin and Cohesin
A. Losada, T. Hirano [in collaboration with H.P. Erickson,
Duke University]
Previous electron microscopy revealed that a bacterial
SMC homodimer has a V-shaped structure in which
two long coiled-coil arms are connected by a flexible
hinge. During the past year, we have collaborated with
H. Erickson's group to determine the molecular archi-
tecture of condensin and cohesin. Both complexes are
purified from HeLa cell nuclear extracts or Xenopus
egg extracts, rotary-shadowed, and visualized by elec-
tron microscopy. We find that condensin and cohesin
display the two-armed structure characteristic of SMC
proteins, but their conformations are remarkably dif-
ferent. The hinge of condensin is closed, and the
coiled-coil arms are placed close together. In contrast,
the hinge of cohesin is wide open, and the coiled-coils
are spread apart from each other. The non-SMC sub-
units of both condensin and cohesin form a globular
complex bound to the catalytic domains of the SMC
heterodimers. We propose that condensin and cohesin
are structurally differentiated to support their special-
ized biochemical and cellular functions. In the case of
condensin, the two catalytic domains of the closed
SMC dimer would bind to contiguous DNA segments,
thereby allowing the complex to act as an intramolec-
ular DNA cross-linker. In the case of cohesin, an open
hinge would facilitate the interaction of the two cat-
alytic ends of the SMC dimer with noncontiguous
DNA segments, allowing the complex to function as
an intermolecular DNA cross-linker.
Role of Aurora B in Chromosome
Condensation and Chromatin
Remodeling
D. MacCallum, A. Losada, T. Hirano
Histone H3 is phosphorylated at Ser-10 during mitosis
in many, if not all, eukaryotic organisms. Spatial and
temporal distribution of this modification is tightly
correlated with chromosome condensation. Emerging
lines of evidence suggest that a protein kinase, known
as aurora B, is responsible for the mitosis-specific
phosphorylation of histone H3. To test whether H3
phosphorylation by aurora B is directly involved in
condensation, we have immunodepleted this kinase
from Xenopus egg extracts. In the absence of aurora B
and its binding partner INCENP, mitosis-specific
phosphorylation of histone H3 is drastically reduced.
We find, however, that neither chromosome condensa-
tion nor chromosomal targeting of condensin is com-
promised under this condition. We find instead that
depletion of aurora B and INCENP suppresses disso-
ciation of ISWI chromatin-remodeling complexes
from chromosomes during mitosis. Our results sug-
gest that H3 phosphorylation by aurora B does not
99
have a direct role in recruiting condensin to chromo-
somes in the cell-free extracts. Thus, the role of H3
phosphorylation in chromosome dynamics appears to
be more complex than previously anticipated.
Regulation of Vertebrate
Cohesin by Mitotic Kinases
A. Losada, T. Hirano
Cohesin is a highly conserved protein complex essen-
tial for the establishment and maintenance of sister
chromatid cohesion. In Saccharomyces cerevisiae, a
cysteine-protease, known as separase, cleaves one of
the cohesin subunits at the onset of anaphase, thereby
promoting a single-step separation of sister chro-
matids. In vertebrate cells, however, cohesion is dis-
solved by a two-step mechanism. The first step takes
place during prophase when -95% of cohesin is disso-
ciated from chromosomes in a separase-independent
manner. The second step occurs at the metaphase-
anaphase transition when the residual population of
cohesin is cleaved by a separase-mediated mechanism
similar to that observed in yeast. Our effort is now
focused on understanding how the first step of cohesin
dissociation is regulated during prophase in vertebrate
cells. Our previous results suggested that this process
correlates with phosphorylation of the XSA1 subunit
of cohesin. Purified cdc2-cyclin B could phosphory-
late XSA1 in vitro, but it was not sufficient to induce
dissociation of cohesin from chromosomes. It is there-
fore likely that an additional chromosome-associated
kinase(s) has a critical role in regulating this process.
A prominent candidate is aurora B that distributes
along chromosome arms in prophase and is concen-
trated on centromeres by metaphase. A second candi-
date is Plxl, a member of the family of polo-like
kinases that have a variety of roles in mitotic progres-
sion. We have initiated the biochemical and functional
characterization of the two mitotic kinases in the egg
extracts. In vitro phosphorylation assays with purified
components as well as immunodepletion experiments
are under way to determine whether the activities of
these kinases might affect the behavior of cohesin. We
hope to be able to depict a comprehensive molecular
picture of the regulatory network that regulates coor-
dinated structural changes of chromosomes during
mitosis.
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Establishment of Sister
Chromatid Cohesion
P. Gillespie, T. Hirano
The establishment of sister chromatid cohesion is a
complex process that involves at least two separable
steps. The first is the binding of cohesin to chro-
matin, which occurs in late G, independently of
DNA replication. The second step is the construction
of a cohesin-mediated linkage between the sister
chromatids during S phase. Although several gene
products required for each step have been identified
in yeast and fungi, it remains totally elusive, at a
mechanistic level, how they functionally interact
with each other in establishing sister chromatid
cohesion. To address this question, we focus on three
conserved factors: Scc2, Eco 1, and DNA polymerase
a (Pol a).
Scc2: Genetic studies in yeast suggest that Scc2
plays a part in directing the association of cohesin
with chromatin. Sequence analysis shows that
Scc2 is composed of multiple HEAT repeats, tan-
dem repeats of an a-helical structural unit. Since
HEAT repeats are also found in two non-SMC
subunits of the condensin complex, we speculate
that HEAT proteins may regulate the SMC sub-
units of cohesin and condensin by a common
mechanism.
Pol a: Pol a is a Pol-13-like DNA polymerase
whose mutations cause a defect in sister chromatid
cohesion in S. cerevisiae. Characterization of this
protein in Xenopus egg extracts should provide
new insights into how the establishment of cohe-
sion is functionally coupled with DNA replication.
Ecol: This protein is unique in that it is required
solely for the establishment of cohesion during S
phase, but not for its maintenance in G2 phase. Our
sequence analysis reveals that Xenopus and
humans have two different Ecol isotypes (desig-
nated EcolA and Eco 1B). Each of the vertebrate
Ecol paralogs has a carboxy-terminal domain that
shares a similarity to yeast Ecol, but also contains
a unique amino-terminal domain that is missing in
the yeast counterpart.
We have cloned Xenopus cDNAs for these putative
cohesion factors. Preparation of specific antibodies
against synthetic peptides and recombinant fragments
is in progress. Once these immunological tools are
available, we will characterize these proteins bio-
chemically and determine their specific roles in sister
chromatid cohesion by using powerful Xenopus egg-
cell-free extracts.
Structural and Functional
Dissection of Mitotic
Chromosomes
0. Cuvier, T. Hirano
Our previous studies suggested that condensin and
topoisomerase II (topo II) make distinct contributions
to the establishment and maintenance of mitotic chro-
mosome condensation in Xenopus egg extracts. The
precise actions of the two condensation factors in
these processes, however, remain to be determined.
During the past year, we have extended our efforts to
gain new insights into the structure of mitotic chro-
mosomes. Depletion of either condensin or topo II
from the extracts prevents the formation of mitotic
chromosomes in a morphologically distinctive man-
ner. The loss of higher-order structure is correlated
with an increased accessibility of chromosomal DNA
to nucleases, although nucleosome assembly is appar-
ently normal even in the absence of condensin or topo
II. When mitotic chromosomes are exposed to dextran
sulfate (or high salt) after their assembly is completed,
a large halo of DNA is formed around an "axial core"
structure of chromosomes. Under this condition, his-
tones and most of topo II dissociate from the structure,
whereas condensin remains bound to the core. We
interpret this core-like structure to be artificially
induced as a result of protein aggregation (possibly
condensin itself) accompanying a loss of topo II and
histones. Interestingly, the formation of the core struc-
ture can be prevented when chromosomes are pre-
treated with AMP-PNP, a nonhydrolyzable ATP ana-
log, before being exposed to dextran sulfate. Under
this condition, bulk histones are removed, but no DNA
halo is observed. topo II remains bound to chromo-
somes and colocalizes with condensin on a helical
domain within chromosomes, a structure that is often
observed in unextracted, intact chromosomes.
Pretreatment of chromosomes with ICRF, a specific
inhibitor of topo II, has a similar, yet weaker effect.
Furthermore, we find that condensin, but not topo II,
is preferentially removed from chromosomes when
they are exposed to ethidium bromide, a DNA interca-
lating agent. This treatment induces a drastic disrup-
tion of the overall shape of chromosomes. These
results provide strong evidence that condensin has a
central role in maintaining higher-order chromosome
structure in this cell-free system. They also suggest
that stabilization of topo II prevents chromosomes
from undergoing artificial structural changes under
certain extraction conditions.
Structural Dissection of
Bacterial and Eukaryotic
SMC Dimers
M. Hirano, T. Hirano
On the basis of electron microscopy of a bacterial
SMC homodimer from Bacillus subtilis (BsSMC), it
was proposed that SMC proteins dimerize by coiled-
coil interactions between the two different subunits
(Fig. 1, Model I). We have unexpectedly found, how-
ever, that introduction of point mutations into the
hinge domain of BsSMC results in a conversion from
dimers to monomers. This observation leads us to pro-
pose an alternative model of SMC dimerization: The
two subunits may be self-folded to form two separate
coiled-coil rods, which in turn dimerize by a hinge-
mediated interaction (Fig. 1, Model II). To distinguish
between the two models, we have taken two comple-
mentary approaches. In the first approach, we employ
protein-protein cross-linking of BsSMC using a cross-
linker specific for free sulfhydryl groups. We have
Model I: coiled coil-
mediated dimerization
Model II: hinge-mediated
dimerization
FIGURE 1 Two models for dimerization of SMC proteins.
Coiled-coil interactions between two different subunits may
mediate dimerization (Model I). Alternatively, two self-folded sub-
units may dimerize by a hinge-mediated interaction (Model II).
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first replaced all cysteine residues present in BsSMC
with serines, making a cysteine-less mutant. We are
now introducing artificial cysteines into specific sites
of this mutant so that intra- and intersubunit cross-
linking products can be distinguished by their distinct
electophoretic mobility in a gel. As a second
approach, we have taken advantage of the het-
erodimeric nature of eukaryotic SMC proteins. For
example, SMC2 and SMC4 form a heterodimer that
functions as the core of the condensin complex. If
Model I is correct, the amino terminus of SMC4
would interact with the carboxyl terminus of SMC2.
Likewise, the amino terminus of SMC2 would associ-
ate with the carboxyl terminus of SMC4. If Model II
is correct, then the amino terminus of SMC4 (and
SMC2) would interact with its own carboxyl terminus.
We are expressing a number of truncation fragments
of SMC2 and SMC4 in vitro and testing their recipro-
cal interactions by coimmunoprecipitation.
Single DNA Molecule
Manipulation
T. Hirano, M. Hirano [in collaboration with T. Strick,
Cold Spring Harbor Laboratory]
In collaboration with Terence Strick's group here at
CSHL, we study the interaction of BsSMC with DNA
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by an approach involving single DNA molecule
manipulation. This powerful technique is also being
used to understand the action of the condensin com-
plex at a single molecule resolution.
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EPITHELIAL CELL POLARITY AND CANCER
S. Muthuswamy T. Haire
B. Xiang
EARLY EVENTS IN BREAST CANCER
Almost all malignant breast cancers originate from
epithelial cells. Several oncogenes and tumor suppres-
sor genes have been implicated in breast cancer; how-
ever, we do not understand the mechanisms by which
oncogenes initiate transformation of mammary epithe-
lial cells (MEC) that line the ducts and alveoli in the
breast (Fig. 1). Early lesions, characterized by uncon-
trolled proliferation and disruption of epithelial archi-
tecture, are currently defined by histological features,
and their prognosis is imprecisely determined.
Although lesions within a category look alike, they
must possess molecular differences that allow some to
become malignant and others to remain benign.
Understanding the molecular mechanisms involved in
initiation of carcinoma will not only identify early
diagnostic markers, but also identify drug targets for
treating premalignant disease.
Conventional transformation assays (foci forma-
tion, soft agar growth, and tumor formation in nude
A
mice) do not allow us to investigate the cellular and
molecular changes that take place in polarized epithe-
lia that line the ducts and alveoli in vivo. We have
adapted a cell culture technique where nontrans-
formed MECs form three-dimensional acini-like
structures containing a single layer of polarized,
growth-arrested epithelial cells when grown within a
matrix rich in laminin and collagen (Matrigel) (Fig. 1).
The epithelial cells in these structures, unlike cells
grown on plastic dishes, share several properties with
those that line the ducts and lobules in an adult breast.
Interestingly, tumor-derived epithelial cell lines or
epithelial cell lines transformed in culture fail to form
acini-like structures in three dimensions. They either
form filled spheroids or do not growth-arrest, or both,
suggesting that acini-like structures formed by non-
transformed MEC possess unique properties that are
lost during transformation.
Oncogenes in the ErbB family of receptor tyrosine
kinases have important roles in breast cancer. Among
its four members, ErbB2 overexpression is observed
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FIGURE 1 (A) Epithelial cells in an adult breast. The epithelia are organized as ducts and lobules. The lobules comprise multiple indi-
vidual units referred to as the acinus. (8) An acinus. The acini have a central luminal space surrounded by a single layer of polarized
luminal epithelial cells. (C) Polarized epithelia. Polarized epithelial cells have an apical surface facing the luminal space, a lateral sur-
face that is in contact with its neighbor, and a basal surface that contacts the basal myoepithelial cells and the basement membrane.
Several junctional complexes are spatially separated along the lateral and basal surfaces of polarized epithelia. Tight junctions sepa-
rate the apical and lateral membranes.
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in 25-35% of breast cancers and correlates with poor
clinical prognosis. ErbB2 is targeted for therapy using
anti-ErbB2 antibodies, i.e., Herceptin. ErbB3 is co-
overexpressed with ErbB2. Despite the compelling
evidence for the role of the ErbB family in breast can-
cer, it has been challenging to decipher the signaling
and biological specificities of ErbB receptor activa-
tion, because MECs express multiple ErbB receptors,
and homo- and heterodimerization of ErbB receptors
complicate our ability to determine how specific ErbB
dimers transform mammary epithelia.
We have developed a novel method to control
dimerization and activation of ErbB receptors without
contribution from endogenous receptors. This method,
for the first time, will allow us to dissect-out the
mechanisms by which specific ErbB homo- and het-
erodimers transform normal mammary epithelial
cells. We have successfully integrated the controlled
dimerization strategy and the three-dimensional cell
culture method. Using this powerful and unique sys-
tem, we can now activate specific ErbB dimers of
choice in three-dimensional epithelial structures that
share several properties with cells that line the ducts
and alveoli in vivo. We believe that this approach will
take us a step closer to conditions in vivo and will
allow us to uncover molecular mechanisms involved
initiation of transformation that cannot be readily
determined under regular culture conditions or using
animal models.
ACTIVATING ERBB RECEPTOR DIMERS
IN THREE-DIMENSIONAL ACINI
We have analyzed the differential effects of activating
ErbB1 and ErbB2 receptors in preformed, growth-
arrested, polarized acinar structures to mimic the
conditions in which ErbB receptors are amplified and
activated in vivo. Activation of ErbB2 in preformed
mammary epithelial acini results in reinitiation of
proliferation, loss of polarized organization, and for-
mation of structures containing multiple acinar units.
Each acinus within these structures had a filled
lumen, surrounded by an intact basement membrane,
and did not display any invasive properties. In addi-
tion, activation of ErbB2 homodimers disrupted cell
polarity in polarized epithelial monolayers. Thus,
ErbB2 dimerization in differentiated acini induces a
phenotype that displays some properties of a prema-
lignant stage of breast cancer in vivo referred to as
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carcinoma in situ. In contrast, neither EGF stimula-
tion nor activation of ErbB1 homodimers was suffi-
cient to induce reinitiation of proliferation, alterations
in the organization of preformed mammary epithelial
acini, or disruption of epithelial cell polarity. These
results suggest that ErbB2 homodimers are uniquely
able to disrupt normal regulation of mammary epithe-
lial cell proliferation and organization, and that this
activity of ErbB2 may contribute to the phenotype of
ductal carcinoma in situ under conditions where its
expression is significantly amplified. We are investi-
gating (1) the effect of activating different ErbB
dimers in three-dimensional acini; (2) identification
of the signaling pathways that are required for the
ability of ErbB dimers to transform an epithelial aci-
nus; and (3) how growth control is achieved in three-
dimensional acinar structures and how activation of
ErbB receptors disrupts growth control.
ERBB RECEPTORS AND EPITHELIAL
CELL POLARITY
Activation of ErbB2 but not ErbB1 induces disruption
of cell polarity as monitored by its ability to induce
mislocalization of tight junction-associated proteins,
ZO-1 and AF-6, and apical membrane-associated pro-
tein gp135 (Fig. 1).
Recent studies have identified a protein complex
conserved in Drosophila, Caenorhabditis elegans, and
mammals that regulates establishment of epithelial cell
polarity. The PDZ domain containing protein Par-3 (for
partitioning defective)/Bazooka/ASIP, associates with
atypical PKC (5 and X), and the amino-terminal regu-
latory domain of aPKC associates with another PDZ-
CRIB domain containing protein, Par-6. Par6 in turn
associates with GTP-bound form CDC42, thus form-
ing the Par-3:aPKC:Par-6:CDC42 tetrameric complex
referred to as the Par complex. The Par complex is
required for establishment of the tight junction com-
plex in epithelial cells. Misexpression of active CDC42
induces mislocalization of the tight junction complex
along the lateral membrane, and overexpression or
expression of dominant-interfering mutants of Par3 or
Par6 inhibits tight junction assembly. Whether the Par
complex is regulated during carcinogeneis is not
known. We will determine (1) how activation of differ-
ent ErbB dimers affects epithelial architecture and
polarity and (2) the role played by the Par protein com-
plex in ErbB-mediated effects on cell polarity.
REGULATION OF EPITHELIAL POLARITY
IN EARLY STAGES OF BREAST
CANCER
We are also investigating whether the observed
changes in cell polarity markers are seen in the early
hyperplastic lesion of breast tissue. For instance, we
can immunostain for lesions that are categorized as
proliferative lesions without atypia (PDWA); atypical
ductal hyperplasia (ADH), and ductal hyperplasia in
situ (DCIS) to determine whether there is a relation-
ship between changes in localization and organization
of selected polarity markers and patient outcome.
Such an analysis will identify early markers for lesions
with premalignant or metastatic potential.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector E. Heard G. Lark
S. Hearn P. Sacco-Bubulya
S.M. Janicki H. Sunwoo
P. Kannanganattu
Studies in our laboratory are focused on the structur-
al-functional organization of the mammalian cell
nucleus with particular emphasis on gene expression.
During the past year, we were joined by Edith Heard
whose research efforts are focused on chromatin mod-
ifications associated with X-inactivation. She has now
started her own group at the Curie Institute in Paris.
The microscopy core facility has been used extensive-
ly during the past year, and numerous collaborations
were pursued with the excellent technical expertise of
Stephen Hearn. Stephen has moved on to assume a
position in Toronto, Canada.
Metabolic Energy-dependent
Movement of PML Bodies
within the Mammalian
Cell Nucleus
M. Muratani, S.M. Janicki [in collaboration with
D. Gerlich, M. Gebhard, and R. Eils, German
Cancer Research Center, Heidelberg, Germany]
The mammalian cell nucleus contains a large number
of nuclear bodies (organdies) that are thought to func-
tion in a variety of nuclear processes. PML nuclear
bodies have received much attention because they dis-
play a more dispersed intranuclear pattern in blast
cells from individuals with acute promyelocytic
leukemia carrying a t(15,17) translocation involving a
fusion of the PML protein and the retinoic acid recep-
tor a. Retinoic acid treatment can induce complete
remission of the disease and results in reformation of
the PML bodies. In addition, PML bodies are modu-
lated by interferon or heat shock treatments. They are
associated with the sites of initial DNA tumor virus
transcription/replication in infected cells and are sub-
sequently disrupted at later stages in the infectious
cycle. Numerous proteins have been localized to PML
bodies, including Sp100, SUMO-1, USP7, CBP,
Daxx, pRB, p53, and BLM. A variety of functions
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have been suggested for PML bodies, including tran-
scriptional activation, repression, protein storage, and
interferon-induced antiviral defense (for a review, see
Maul, Bioessays 20: 660 [1998]; Zhong et al., Nature
Cell Biol. 2: E85 [2000]). Furthermore, prior work
from our laboratory suggested that PML bodies may
function to detect and mark local accumulations of
proteins or protein nucleic acid complexes that are for-
eign or "suspicious" (i.e., misfolded or aggregated) to
the nucleus. Such a broad range of potential functions
is consistent with the possibility of multiple classes of
PML bodies and/or that these bodies may be dynamic.
In an effort to examine these possibilities, we
examined during the past year PML body dynamics in
living BHK cells. Analysis of BHK cells expressing an
EYFP-Sp100 fusion protein by time-lapse microscopy
allowed us to distinguish between three different class-
es of PML bodies on the basis of their nuclear dynam-
ics (see movie at www.cshl.org/labs/spector). One
class of PML bodies (-25%) was stationary, exhibit-
ing little movement over 12-minute time periods (Fig.
1, arrows) suggesting that these bodies may be
restricted in their movement due to either an associa-
tion with other nuclear components or their location in
a region of the nucleus that limits their migration. The
lack of dynamic behavior was not size-dependent,
however, as immobile bodies ranging in diameter from
0.2 gm to 2.0 gm were observed. A second class of
PML bodies (-63%) exhibited very localized move-
ments that were somewhat similar in their ranges to
those previously observed for nuclear speckles and
Cajal bodies. This type of localized movement was
observed in 100% of the cells examined (n = 56).
Most interestingly, the third class of PML bodies
exhibited rapid and more extended movements in the
nucleoplasm that could be seen to start and stop sev-
eral times over the course of 12-minute observation
periods (Fig. 1, arrowheads). On average, one to two
PML bodies/nucleus (-12% of the PML bodies)
exhibited this type of movement during any given time
period, although we did observe nuclei with 10-12
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FIGURE 1 PML bodies can be classified into three groups on the basis of their nuclear dynamics. Time-lapse fluorescent images of
BHK cells expressing the EYFP-Sp100 protein were taken every 5 seconds for 12 minutes. Selected images are shown to demon-
strate the observed dynamics. One population of PML bodies (white arrows) exhibited no movements. A second set of PML bodies
exhibited limited localized movement. A third set of PML bodies (white arrowheads) exhibited rapid nuclear movements. Scale bars:
(a -i) 5 gm; (ay') 2.5 gm.
rapidly moving PML bodies and others where none
were observed. Of the cells (n = 56) examined, 55%
showed one or more PML bodies exhibiting this rapid
movement. The rapidly moving PML bodies traversed
the nucleoplasm at an average velocity of 4.0-7.2
p.m/minute with a maximum magnitude of -18.0
tm/minute; this movement was metabolic-energy-
dependent (see movie at www.cshl.org/labs/spector).
Different PML bodies in the same nucleus appeared to
be active during different observation periods. Neither
the localized nor the more extended dynamics were
sensitive to inhibition of RNA polymerase II activity
by a-amanitin. The three classes of PML bodies were
also observed in primary mouse embryonic fibroblasts
and mouse ES cells. The rapidly moving PML bodies,
although small at any given time, may act as nuclear
"sensors" traveling within nuclear regions and associ-
ating with populations of foreign or "suspect" pro-
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teins, including viral proteins. Future studies will
examine the biochemical composition of these nuclear
bodies.
Methylation of Histone H3 at Lys-9
Is an Early Mark on the X Chromosome
during X-inactivation
E. Heard [in collaboration with C. Rougeulle, D. Arnaud,
and P. Avner, Pasteur Institute, Paris, France, and C.D. Allis,
University of Virginia Health System, Charlottesville, Virginia]
In female mammals, one of the two X chromosomes is
converted from an active euchromatic state into tran-
scriptionally inert heterochromatin by a process
known as X-chromosome inactivation. This results in
the transcriptional silencing of several thousand genes
and ensures dosage compensation for X-linked gene
products between XX females and XY males. When
initiation of X inactivation is induced during differen-
tiation, Xist transcript levels are up-regulated from the
chromosome that will become the inactive X, and this
untranslated RNA coats the inactive X chromosome.
Since X inactivation is tightly coupled to cellular dif-
ferentiation during early embryogenesis, female
embryonic stem (ES) cells represent a useful model
system with which to study this process.
Nothing is known about the partners, protein or
nucleic acid, of the Xist transcript that enable it to coat
a chromosome in cis, or about the early changes in
chromatin structure that lead to the transcriptional
shut-down of genes during X inactivation. Covalent
modifications of histones such as acetylation, methy-
lation, and phosphorylation represent an important
means of epigenetic control in eukaryotes, enabling
heritable but reversible changes in gene expression.
Different combinations of these modifications may act
synergistically or antagonistically to enable finely
tuned gene regulation in response to specific develop-
mental or cellular cues. During the past year, we
assessed the potential involvement of histone H3 Lys-
9 methylation in the establishment of X inactivation by
examining its localization on the X chromosome in
female ES cells before and after differentiation. In
addition, we sought to determine whether histone H3
Lys-9 methylation could be implicated in the initiation
and propagation of X inactivation. We have identified
a constitutive and uniquely enriched "hot spot" of H3
Lys-9 methylation located upstream of the Xist gene,
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and we have been able to demonstrate that chromo-
some-wide methylation of H3 Lys-9 is a very early
event in the X-inactivation process, occurring simulta-
neously with or immediately after the coating of the X
chromosome by Xist RNA. Hypoacetylation of H3
Lys-9 and hypomethylation of H3 Lys-4 occur with
the same kinetics as H3 Lys-9 methylation. These
three histone H3 modifications therefore represent the
earliest known chromatin changes in the X-inactiva-
tion process. Importantly, transcriptional inactivation
occurs subsequent to X-chromosome-wide H3 Lys-9
methylation. On the basis of these findings, we pro-
pose that H3 Lys-9 methylation and the factors that
bind to it constitute the "spreading signal" responsible
for propagating the inactive state along the X chromo-
some under the action of the Xist transcript. In this
context, the hot spot of H3 Lys-9 methylation identi-
fied upstream of Xist might provide some insight into
the nature of X inactivation relay elements. Given its
location at Xic, its hypermethylation prior to X inacti-
vation, and the potential role of H3 Lys-9 methylation
in spreading heterochromatin, this hot spot may be a
nucleation center from which heterochromatin could
spread into neighboring regions. The fact that it is pre-
sent constitutively, but becomes more enriched in H3
Lys-9 methylation during the window of time that Xist
RNA can induce silencing, that it can only
function as a nucleation center when Xist RNA
becomes stabilized and starts to accumulate on the X
chromosome. These findings provide novel insights
into the dynamic changes in chromatin structure that
are induced by the Xist transcript during X inactiva-
tion. In particular, methylation of H3 Lys-9 is likely to
be an important epigenetic marker both for the initial
silencing process that spreads from the Xic and for the
mitotically heritable transmission of the inactive state,
once it is established.
Differential Entry of the Gene
Expression Machinery into
Daughter Cell Nuclei
after Mitosis
P. Kannanganattu, P. Sacco-Bubulya
In eukaryotic cells, RNA polymerase II transcription
and RNA processing are coordinated events, involving
a large number of factors. Our emphasis has been to
address how these factors are organized during mito-
sis, when there is global repression of transcription, and
how they are recruited to daughter nuclei after mitosis.
Immunofluorescence studies using antibodies against
several transcription and RNA processing factors in
mitotic HeLa cells revealed their differential localiza-
tion during various stages of mitosis. In prophase cells,
transcription and splicing factors showed a homoge-
neous cytoplasmic staining. In metaphase cells, splic-
ing factors (B", SF2-ASF, m3G) and the hyperphos-
phorylated form (Ser-2 of the CTD) of the large sub-
unit of RNA polymerase II (H5) localized in mitotic
interchromatin granules (MIGs), structures analogous
to the interphase interchromatin granule clusters
(IGCs), along with homogeneous cytoplasmic staining.
The number and size of MIGs increased from
metaphase to telophase. The staining of MIGs with the
above-mentioned antibodies decreased differentially in
late telophase cells, the time point when these factors
reentered the daughter nuclei. Interestingly, the tran-
scription and RNA processing factors studied were
found to have a low turnover rate during mitosis and
seemed to be recycled.
To directly visualize the dynamics of these factors
in living cells, SR splicing factors SF2/ASF or SC35
tagged with yellow fluorescent protein were transient-
ly expressed in HeLa cells, and their distribution in
living mitotic cells was studied. During anaphase, the
splicing factor SC35-EYFP was seen in a diffuse
cytosolic pool in addition to multiple large MIGs.
When cells reached telophase, SC35 entered the
nucleus and the MIG signal decreased simultaneously.
Similar results were seen with SF2/ASF. This is con-
sistent with recycling of SR splicing factors from
MIGs to the nucleus.
Many of the transcription/RNA-processing factors
studied were found to enter the daughter nuclei during
different time points in telophase, and not as a unitary
complex. Their nuclear transport occurred after
nuclear lamina and nuclear envelope formation, sug-
gesting that at least some of them enter via an energy-
dependent mechanism. Coimmunolocalization studies
using an antibody that primarily recognizes the initia-
tion-competent form of the large subunit of RNA
polymerase II (H14; hyperphosphorylated at Ser-5 on
the CTD) labeled the daughter nuclei prior to RNA
processing factors (B", SF2/ASF, m3G, linRNPs,
SCAF10, PAB II, etc.). However, the elongation-com-
petent form of the large subunit of RNA polymerase II
(H5; hyperphosphorylated at Ser-2 on the CTD) was
detected in the daughter nuclei only after the entry of
RNA-processing factors.
To visualize the onset of global transcription in the
daughter nuclei with respect to the differential entry of
the various transcription and RNA-processing factors,
in situ bromo-UTP incorporation assays were carried
out in mitotic HeLa cells. Prior to entry of RNA poly-
merase II, transcription was not detectable in situ by
bromo-UTP incorporation. At the time that the initia-
tion-competent form of RNA polymerase II (H14 epi-
tope) was first detectable in daughter nuclei during
telophase, global transcription was detected by bromo-
UTP incorporation as weak, punctate foci throughout
the nuclei. However, at the time when the elongation-
competent form of RNA polymerase II (H5 epitope)
was detected in daughter nuclei, bromo-UTP incorpo-
ration dramatically increased, consistent with the elon-
gation of transcripts at this stage. Using a stable HeLa
cell line expressing a P-tropomyosin minigene, we
have been able to demonstrate that in telophase cells,
splicing factors colocalize with the nascent reporter
transcripts, suggesting that transcription and splicing
occur immediately upon nuclear entry of RNA poly-
merase II and splicing factors.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund C. Sanders M. Blennau
G. Karger M. Kadaja
A. Lee
The papillomaviruses are a group of viruses that infect
and transform the basal epithelium-inducing prolifer-
ation of the cells at the site of infection. The resulting
tumors (warts) are in most cases benign and will usu-
ally regress after some time, but certain types of
human papillomaviruses (HPVs) give rise to tumors
that are prone to progress toward malignancy, espe-
cially frequently, cervical carcinoma. Indeed, HPV
infection appears to be a necessary cause of invasive
cervical carcinoma and thus represents one of the few
firmly established links between viral infections and
the development of cancer.
An impediment to the study of papillomaviruses
has been the inability to define simple in vitro cell cul-
ture systems for analysis of the viral life cycle. These
viruses normally require specialized differentiating
cells that can be generated in cell culture only with dif-
ficulty. However, for a bovine papillomavirus (BPV-1),
a convenient cell culture system exists where viral gene
expression, oncogenic transformation, and viral DNA
replication can be studied. Thus, BPV has become a
useful model for these aspects of the viral life cycle.
The DNA replication properties of the papillomavirus-
es show some unique and interesting characteristics. As
part of their normal life cycle, these viruses can exist in
a state of latency, which is characterized by mainte-
nance of the viral DNA as a multicopy plasmid in
infected cells. The copy number of the viral DNA is
tightly controlled and the viral DNA is stably inherited
under these conditions. Papillomaviruses therefore
provide a unique opportunity to study plasmid replica-
tion in mammalian cells. In addition, the viral DNA
replication machinery represents one of the most
promising targets for antiviral therapy.
In previous years, we have reported the character-
ization of the papillomavirus replicon and the identifi-
cation of the viral components that are required for
viral DNA replication. In recent years, we have direct-
ed our attention toward the biochemical events that are
associated with initiation of DNA replication. We are
studying the biochemical properties of the viral El
and E2 proteins and how these two proteins interact
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with the viral origin of DNA replication and with the
cellular replication machinery to generate initiation
complexes. Our studies demonstrate that the El pro-
tein has all of the characteristics of an initiator protein,
including on recognition, DNA-dependent ATPase
activity, and DNA helicase activity. The transcription
factor E2, whose precise function has remained more
elusive, appears to serve largely as a loading factor for
El. Through direct physical interactions with both El
and the ori, E2 provides sequence specificity for the
formation of the initiation complex.
We are currently attempting to show how the El
and E2 proteins orchestrate the precise biochemical
events that precede initiation of DNA replication at the
viral ori. These events include binding of the initiator
to the ori, the initial opening of the DNA duplex, and
the assembly and loading of the El replicative helicase
at the replication fork. Our studies
these activities are generated in an ordered process
that involves the sequential assembly of El molecules
on the ori. This sequential assembly generates differ-
ent complexes with different properties that in turn
recognize ori, destabilize the double helix, and func-
tion as the replicative DNA helicase.
RECOGNITION OF THE ORI BY El
The El- binding site in the ori consists of an 18-bp
inverted repeat. We have previously proposed that this
El-binding site actually consists of multiple El recog-
nition sequences that are arranged in an overlapping
array. To determine what sequence constitutes a bind-
ing site for a single El molecule, we took advantage of
our previous observation which demonstrated that a
monomer of the El DBD (DNA-binding domain)
forms a stable complex when bound cooperatively with
the E2 DBD. This complex can be detected by the elec-
trophoretic mobility shift assay (EMSA). Using this
assay and extensive mutational analysis, we could
demonstrate that a monomer of El recognizes the
hexanucleotide sequence AACAAT, a sequence which
with slight variations occurs six times in the 18 bp. Due
to these variations, these sites have different affinities
for El. Four of the sites are arranged pairwise and are
bound pair-wise by dimers of El DBD. Thus, two
dimers of El can bind simultaneously to four overlap-
ping sites, occupying different faces of the DNA helix,
separated by approximately 100 degrees. Recent struc-
tural studies (in collaboration with E.J. Enemark and L.
Joshua-Tor here at CSHL) support this manner of
binding and provide a detailed view of how the base
sequence is recognized. Interestingly, by utilizing the
binding site consensus sequence derived from the
mutational analysis, we have been able to identify a
similar arrangement of binding sites in many other
papillomaviruses, indicating that the arrangement of
El- binding sites is an important conserved feature of
the origin of DNA replication.
STRUCTURAL CHANGES IN THE ORI INDUCED BY
BINDING OF El
The mutational analysis of the El -binding site in the
ori demonstrated that six putative overlapping El-
binding sites are present. To determine whether the
overlapping sites could bind El simultaneously, we
examined DNA binding by the El DBD utilizing
high-resolution OH radical footprinting. The results
from these studies demonstrated that binding of the
E1 DBD to the El- binding sites follows a particular
sequence. At low concentration, a dimer of El DBD
binds to sites 2 and 4. At higher concentrations of E 1
DBD, the overlapping sites 1 and 3 are also filled,
generating a structure where two dimers of the E 1
DBD bind to the ori but on different faces of the DNA
helix. Two observations indicate that the binding of
four molecules of El results in significant changes in
the DNA structure. First, formation of a stable com-
plex containing four molecules of El occurs only on
short probes, indicating that the ability to deform the
DNA is of importance for complex formation.
Second, the binding of four El DBD molecules results
in significant OH radical hypersensitivity outside the
ori. These results indicate that DNA binding by the El
DBD provides initial structural changes in the tem-
plate likely related to subsequent melting of the ori.
Although full-scale melting depends on ATP hydroly-
sis by El, limited base opening can be observed upon
DNA binding by the full-length El protein even in the
absence of ATP.
INITIATOR COMPLEX ASSEMBLY
An intriguing aspect of viral initiator proteins is their
ability to perform several different, seemingly unrelat-
ed, biochemical functions. Our model to explain how
these activities can reside in one single polypeptide is
that different oligomeric forms of the protein may have
different activities. In agreement with such a model,
we have previously demonstrated that a dimeric form
of El recognizes the on together with E2 and that the
form of El which has helicase activity is a hexamer.
Our current understanding of the assembly pathway of
these complexes is that a sequence-specific complex
of a dimer of El and a dimer of E2 together bind to the
on and initially recognizes the ori. In an ATP-depen-
dent manner the E2 dimer is displaced and additional
El molecules are added to the complex. These are
bound sequence-specifically, forming a tetramer on
the four paired El-binding sites in the core. The role of
E2 in the initiation process thus is limited to the early
steps of initiation. An interesting, and possibly impor-
tant, difference between different types of papillo-
maviruses is the arrangement of E2-binding sites in the
vicinity of the ori. The human genital papillomavirus-
es that are the cause of widespread disease lack the
proximal E2-binding site that is present in the bovine
papillomavirus. To determine whether the role of E2 as
a loading factor for El that we have established for the
bovine virus can also be applied to the human papillo-
maviruses, we tested the ability of the E2 protein to
load El from a distal E2-binding site. These results
demonstrated clearly that E2 functions in a similar
manner from the distal E2-binding site, indicating that
the function of E2 is the same in both systems. E2 is
responsible for the initial recruitment of El and also
assists in the further assembly of El complexes
through protein-protein interactions between the El
and E2 proteins.
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DNA REPLICATION AND CHROMATIN INHERITANCE
B. Stillman K. Braun J. Mendez C. Speck
V. Ellison S.G. Prasanth Z. Zhang
M. Hoek Y.-J. Sheu Y.-C.N. Du
While we continued to study the replication of chro-
mosomal DNA in eukaryotic cells, our research during
the past year has been expanding its focus to include
the interaction between DNA replication and other
cellular events, such as gene silencing and even nutri-
tion and the production of new ribosomes. It seems
remarkable that 10 years after the discovery of the ori-
gin recognition complex (ORC), we are still learning
new functions for this interesting protein, perhaps
reflecting its importance to many cellular processes.
INITIATION OF CHROMOSOME REPLICATION
Forming the prereplication complex in yeast and
human cells. We reported in these pages last year that
Cdc6 in Saccharomyces cerevisiae interacts with the
ORC in an ATP-dependent manner to increase the DNA
sequence specificity of ORC and recruit the minichro-
mosome maintenance (MCM) proteins. Continued
studies on this interaction have shown that regions of
Cdc6p that are predicted to control ATP hydrolysis are
required for the remodeling of ORC on the DNA. In the
past year, research from other laboratories using
Schizosaccharomyces pombe and Xenopus egg extracts
has shown that a protein called Cdt 1 is required for
loading of the six-protein MCM complex onto chro-
matin to form a prereplication complex (pre-RC) that
allows chromosomes to initiate DNA replication in S
phase. Although it was initially reported that there was
no obvious ortholog of the Cdtlp in the budding yeast,
we (and other workers) found a protein encoded by the
YJR046W open reading frame in the yeast genome
sequence that had some similarity to the S. pombe and
Xenopus Cdtlp. Normally viable mutations in this open
reading frame have been reported to be lethal when
strains carrying mutations in the gene encoding topo-
isomerase 1 are also present. Topoisomerase 1 most
likely interacts with the DNA replication fork machin-
ery to relieve torsional stress in the double helix as
DNA begins to initiate DNA replication, similar to the
interaction between SV40 large-T antigen and topoi-
som-erase 1 we have reported previously. Subsequent
purification of a molecular tagged version of Cdtlp
showed that it formed a stable complex with the six
MCM proteins. The complex required low levels of
Zn-E-' because the MCM proteins require Zn'' to form a
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hexamer containing all of the MCM proteins. The func-
tions of this complex are under investigation.
Yeast Cdc6p is associated with chromatin only in
the G, phase of the cell cycle, but in human cells,
Cdc6p is regulated differently, being degraded as cells
pass through late mitosis, the time when the MCM pro-
teins are loaded onto chromatin. In proliferating cells,
Cdc6p is then resynthesized and loaded onto chromatin
as cells progress through the cell cycle. We also found
that the human Orcl protein, unlike its yeast homolog,
is degraded at the Gi- to S-phase boundary and then
resynthesized later in the cell cycle and loaded onto
chromatin as cells exit mitosis. We showed that Skp2p,
an E3 ligase for the ubiquitin-conjugating complex, is
in part responsible for adding ubiquitin to human Orcl.
Interestingly, the ubiquitylated Orc 1 was associated
with chromatin. We have also shown that cyclin
E/CDK2 and cyclin A/Cdk2 can phosphorylate Orcl,
and removal of the region that contains the numerous
phosphorylation sites stabilizes the protein on chro-
matin in human cells. This raises the interesting possi-
bility that ubiquitylation of ORC might have some role
in activation of DNA replication, much as Bill Tansey's
lab here at CSHL has shown for the transcriptional acti-
vation of c-Myc and other transcription factors. The
variation in the levels of Orcl in human cells reflects
the pattern seen for Cdc6p in yeast, raising the possi-
bility that these two proteins, which share significant
sequence similarity, have partially swapped functions
during the time separating yeast and human cells from
a common ancestor (Fig. 1).
Possible links between cell proliferation control,
DNA replication, and ribosome biosynthesis. It is
already known that ORC functions in heterochromatin
formation in Drosophila and in transcriptional gene
silencing in yeast. Although cell cycle regulation of
the assembly of the pre-RC has been well studied, we
hypothesized that ORC might interact with other pro-
teins that function in either DNA replication or other
cellular processes. Therefore, a search for ORC inter-
acting proteins was initiated.
Immunoprecipitation of S. cerevisiae ORC using
monoclonal antibodies revealed a small number of
coprecipitating proteins that were of unknown func-
tion. One of these, called Yphlp, was related to a gene
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FIGURE 1 (Top) Comparison of the sequence similarity between Orci and Cdc6 in different species. (Bottom) Abundance of
different DNA replication proteins throughout the cell cycle in yeast and human cells. Line indicates protein is present.
product in zebrafish called pescadillo that was con-
served and contained a BRCT motif which is present
in many proteins involved in maintaining genome sta-
bility or cell cycle checkpoint control. Yphlp bound
directly to ORC, and we showed that the protein was
predominantly a nucleolar protein, although some
Yphlp was found in the nuclear soluble pool. A tem-
perature-sensitive mutant that causes the destruction
of Yphlp at the nonpermissive temperature causes
cells to arrest in either Gi or G2 phase, with no cells in
S phase. Furthermore, when cells were blocked in S
phase with hydroxyurea and released at the nonper-
missive temperature, S phase was greatly prolonged
compared to wild-type cells. The data suggested that
Yphlp has a role in S-phase progression. Interestingly,
the interaction between Yphlp and ORC was increased
threefold in a strain that lacked the NAD-dependent
histone deacetylase Sir2p, a protein which regulates
the rDNA locus that makes ribosomal RNA. Sir2p also
provides a potential link between sensing of energy
levels in the cell and regulation of rDNA replication.
Because of the location of Yphlp in the nucleolus,
we tested its role in ribosome biosynthesis and found
that Yphlp mutants were defective in production of
60S pre-ribosomal particles, but not 40S pre-riboso-
mal particles. Moreover, at the nonpermissive temper-
ature, strains lacking Yphlp accumulate 80S ribo-
somes that were depleted of polysomes. Thus, we con-
dude that Yphlp is required for 60S ribosome biosyn-
thesis and possibly for efficient translation of mRNAs
on polysomes, or for initiation of translation. Indeed,
Yphlp was specifically degraded from an 88-1eD pro-
tein present on 80S ribosomes to a 70-1(13 protein asso-
ciated with polysomes, suggesting that proteolytic
cleavage ofYphlp is coupled to translation regulation.
We were concerned that the effect on DNA replica-
tion mentioned above was indirect due to defects in
ribosome biogenesis or translation. However, cells
arrested in HU and released from the HU block in the
presence of translation inhibitors or other mutants
defective for ribosome biogenesis still progressed
through S phase normally. Thus, Yphlp had an effect
on DNA replication independent of its role in ribosome
biogenesis or translation. We suggest that Yphlp links
DNA replication and ribosome biosynthesis, possibly
via coupling replication of rDNA genes with active
rDNA transcription in proliferating cells.
Yphlp was biochemically purified and shown to
form two complexes, a small complex containing three
proteins and a much larger complex containing the pro-
teins from the small complex as well as many other pro-
teins. Some of these proteins have recently been shown
to be involved in ribosome biosynthesis, but others, like
ORC and the MCM proteins, are involved in DNA repli-
cation and might be required to replicate rDNA genes.
One of the Yphlp-associated proteins present in
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the large and small complexes is a protein of unknown
function in yeast, but Lester Laue's lab has shown that
a dominant-negative version of its murine ortholog
arrests mouse cells in the G1 phase of the cell cycle.
This arrest only occurs in cells containing a wild-type
version of the p53 tumor suppressor protein. We sug-
gest, based on the links between Yphlp and ribosome
biosynthesis and possibly translation control, that p53
regulates these processes in vivo under conditions of
cell stress.
Finally, we have shown that in yeast, Yphlp levels
in cells were controlled by the type of carbon source.
Furthermore, Yphlp levels drop as yeast cells move
from a nutrient environment of high glucose to low glu-
cose, a shift coupled with a switch from glycolysis to
gluconeogenesis and respiration. This suggests a funda-
mental link between energy production and cell prolif-
eration to processes such as DNA replication, ribosome
biosynthesis, and possibly translation control.
CHROMATIN ASSEMBLY AND INHERITANCE
ORC functions in establishment and inheritance of the
silent mating-type loci by binding to the silencer ele-
ments that flank the HM loci. We have previously
shown that the amino terminus of Orclp is not essential
for the DNA replication functions of ORC, but instead
is required for efficient HM gene silencing. In collabo-
ration with Rui-Ming Xu's lab here at CSHL, the crys-
tal structure of the S. cerevisiae Orclp amino-terminal
domain was determined. This domain contains a con-
served BAH (bromo-associated homology domain) and
interacts with the yeast silencing protein Sirlp.
The structure shows that the BAH domain, which
is also found in Orc 1 protein from human cells, the
silencing protein Sir3p, and DNA (cytosine) methyl
transferase, consists mostly of (3 sheets that form a sur-
face which might interact with the tails of histone pro-
teins. Mutations in a helical subdomain of the BAH
domain (H domain) that is not conserved in sequence
among the various BAH-domain-containing proteins
failed to bind to Sirlp, suggesting that Sirlp interacts
specifically with Orclp via this domain.
Mutations in the BAH domain had a phenotype
similar to the phenotype found in cells lacking Sirlp.
In such cells, genetically identical cells in a population
had different repression states at the silent mating-type
HM loci. Approximately 15% of the cells in a popula-
tion had the HMLa genes repressed, whereas the other
cells expressed the HMLa genes. This demonstrated
that the BAH domain contributed to epigenetic inher-
itance of gene expression in yeast.
Four SIR proteins are essential for efficient silenc-
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ing of genes in yeast: Sirlp, Sir2p, Sir3p, and Sir4p. We
determined whether the BAH domain mutations affect-
ed the location of SIR proteins at specific DNA
sequences across the two mating-type loci, HMR and
HML. In wild-type cells, Sirlp localized to the E
silences at both HML and HMR, whereas Sir2p, Sir3p,
and Sir4p localized across the entire loci. In the absence
of the Orclp BAH domain, Sirlp no longer localized to
the silencers, but surprisingly, at the HML locus, the
pattern of Sir2p, Sir3p, and Sir4p was identical to that
found in wild-type cells, except that the levels of the
protein present at the locus were lower. The results sug-
gest that in the -15% of cells that retained HML repres-
sion, Sir2p, Sir3p, and Sir4p localized normally in the
absence of Sirlp and the Orclp BAH domain.
The fact that a normal distribution of Sir2p, Sir3p,
and Sir4p was observed in the absence of Sirlp or the
Ore 1 p BAH domain shows that the latter proteins are
not required for the spreading of the silencing com-
plex at HML. Sirlp and the Orclp BAH domain either
are required for establishing the repressive complex
efficiently or are required for efficiently inheriting the
SIR complex over many generations once it is formed.
We plan to distinguish between these two possibilities.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL OF
CELLULAR SIGNALING RESPONSES
N.K. Tonks J.N. Andersen T.C. Meng
D.A. Buckley M.P. Myers
H.H. Chen H.L. Palka
R.L. Del Vecchio K.A. Pennino
T. Fukada
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L. Zhang
The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes, including cell proliferation and differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed
in a target substrate reflects not only the activity of the
kinases that phosphorylate it, but also the competing
action of protein phosphatases that catalyze the
dephosphorylation reaction. We study the expanding
family of protein tyrosine phosphatases (PTPs) which,
like the kinases, comprise both transmembrane recep-
tor-linked forms and nontransmembrane cytosolic
species and represent a major family of signaling
enzymes. The structures of the PTPs indicate impor-
tant roles in the control of key cellular functions. We
are utilizing a variety of strategies to characterize the
normal physiological function of several members of
the PTP family. Disruption of normal patterns of tyro-
sine phosphorylation has been implicated as a contrib-
utor to several human diseases. Therefore, insights
into the mechanisms involved in modulating PTP
function may ultimately yield important information
to help counter such diseases.
During the last year, Yu Shen left the lab to take
up a position as a Research Scientist at Abbott Labo-
ratories, and Mike Myers accepted an independent
position on the faculty here at Cold Spring Harbor
Laboratory. Deirdre Buckley joined the lab as a post-
doctoral fellow. Jannik Andersen completed the acad-
emic component of his industrial Ph.D. Educational
Program in our lab, sponsored by the Danish
Academy of Technical Sciences, and is now continu-
ing his studies as a postdoctoral fellow. Josema
Torres, a graduate student from Rafael Pulido's lab in
Valencia, Spain, spent 4 months working in the lab
over the summer as a visiting scientist. Kim Pennino
left the lab to enjoy time with her baby son, and her
position has been taken by Mianjia (Jennifer) Ye.
PTP1B: A THERAPEUTIC TARGET FOR THE
TREATMENT OF DIABETES AND OBESITY
It is now apparent that the insulin receptor (IR) is a
major physiological substrate of PTPIB. Interestingly,
targeted disruption of the PTPIB gene in mice yield-
ed a dramatic phenotype-the animals displayed
enhanced sensitivity to insulin and resistance to obesi-
ty when placed on a high-fat diet. (Elchelby et al.,
Science 283: 1544 [1999]; Klaman et al., Ma Cell.
Biol. 20: 5479 [2000]). These and other data linking
PTP1B to the regulation of IR signaling highlight the
potential of this PTP as a target for novel strategies for
therapeutic intervention on diabetes and obesity, two
of the major, and fastest growing, global diseases. In
collaboration with David Barford (Institute of Cancer
Research, London, United Kingdom), we analyzed the
recognition of the activation loop of the IR as a sub-
strate by PTP1B. By integrating crystallographic,
kinetic, and peptide-binding studies, we defined the
molecular basis of specificity in the interaction
between PTPIB and activation loop of the IR. We
observed that the sequence E/D-pY-pY-R/K was
important for optimal recognition of the IR by PTP1B.
Of particular importance is the presence of tandem pY
residues; PTP1B displays 70-fold higher affinity for
tandem pY-containing peptides derived from the IR
activation loop relative to mono-pY derivatives.
In light of this observation, we tested whether the
presence of the motif could be used to predict other
physiological substrates of PTP1B. We identified all
proteins in the SwissProt database that contained two
adjacent tyrosine residues flanked by acidic and basic
amino acids. This search retrieved more than 800 pro-
teins, but the subset of these that is tyrosine-phospho-
rylated is not yet annotated. However, we noted that 7
of the 22 subtypes of PTKs contained this motif in
their activation loop. We focused our analysis on the
JAK subfamily of PTKs and have now shown that
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JAK2 and TYK2 are physiological substrates of
PTP1B. We observed that a substrate-trapping mutant
of PTP1B formed a stable interaction with JAK2 and
TYK2 in response to interferon stimulation.
Expression of the wild-type or substrate-trapping
mutant PTP1B inhibited interferon-dependent tran-
scriptional activation. Finally, mouse embryo fibro-
blasts deficient in PTP1B displayed subtle changes in
tyrosine phosphorylation, including hyperphosphory-
lation of JAK2. These data illustrate that PTP1B may
be an important physiological regulator of cytokine
signaling.
Interestingly, the satiety hormone leptin exerts its
effects through a receptor in the hypothalamus that
displays the hallmarks of a cytokine receptor. Our
data, demonstrating recognition of JAK2 and TYK2 as
substrates by PTP1B, suggest that the PTP may nor-
mally function as a negative regulator of leptin signal-
ing in the brain and that the resistance of PTP1B
knockout mice to high-fat-diet-induced obesity may
arise from defects in leptin signaling. Thus, aberrant
down-regulation of members of the JAK subfamily of
PTKs may contribute to the resistance to weight gain
displayed by PTP1B-deficient mice. Furthermore, our
data illustrate that DIE-pY-pY-K/R is a consensus sub-
strate recognition site for PTP1B. The definition of
consensus phosphorylation sites has proven to be an
important tool in signal transduction research for the
identification of substrates for protein kinases. Our
study demonstrates for the first time that this concept
may also be applicable to protein phosphatases, such
as PTP1B, and that consensus recognition sites may
also exist for other PTPs. Perhaps it may be possible
in the future to use this approach to expand the reper-
toire of physiological substrates of other members of
the PTP family of enzymes.
In addition to the above, we have been examining
PTP1B function through characterization of its pro-
moter. It had been noted that the levels of PTP1B are
altered in several human diseases, particularly those
associated with dysfunctional tyrosine phosphoryla-
tion. We had shown previously that expression of
PTP1B was induced specifically by the p210bcr-abl
oncoprotein, a PTK that is directly responsible for the
initial manifestations of chronic myelogenous
leukemia, and that PTP1B antagonizes p210bcr-abl-
induced transformation. We have now demonstrated
that the effects of p210bcr-abl on expression of the
PTP1B gene are manifested at the transcriptional
level. To define the mechanism by which PTP1B gene
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expression is regulated, we cloned the 5'-flanking
region of the human gene. We found two elements that
are important for expression from the human PTP1B
promoter. A sequence motif that possesses features of
a site of interaction with GATA-binding proteins was
identified at -167 to -151 by from the transcription
start site. Disruption of this site inhibited promoter
activity in the presence of p210 bcr-abl, but respon-
siveness to the oncoprotein PTK was maintained.
However, a p210 bcr-abl responsive sequence, termed
PRS, which was important for stimulation of activity
in response to the PTK, was identified at -49 to -37
by from the transcription start site. The PRS is con-
tained in a sequence that displays features of a stress
response element, a feature originally identified in
Saccharomyces cerevisiae and which functions as a
binding site for C2H2 zinc finger proteins. In our study,
we showed that three mammalian C2H2 zinc finger
proteins, Egr-1, Spl, and Sp3, bind to PRS. Of these,
both Spl and Sp3 function as positive regulators,
whereas Egr-1 represses Sp3-mediated trans-activa-
tion of the PTPIB gene. Furthermore, expression of
p210 bcr-abl results in down-regulation of the levels of
Egr-1. Our data illustrate that the reciprocal actions of
the Spl/Sp3 and Egr-1 C2H2 zinc finger transcription
factors are an important aspect of the regulation of
PTP1B expression in response to the p210 bcr-abl
oncoprotein.
In collaboration with Tony Tiganis, a former post-
doctoral fellow in the lab now on the faculty at
Monash University, Melbourne, Australia, we have
continued to examine the regulation of TCPTP, the
closest relative to PTP1B. There are two spliced vari-
ants of TCPTP, which share the same catalytic domain
but differ at their carboxyl termini and are targeted to
different subcellular locations. TC48 is found in the
endoplasmic reticulum, whereas TC45 is nuclear in
the basal state but exits the nucleus in response to var-
ious stimuli including cellular stress. We have shown
that nuclear exit of TC45 may occur passively, with
cellular stress inducing cytoplasmic accumulation by
inhibiting nuclear import. We noted that only those
stresses that stimulated the metabolic stress-sensing
enzyme AMP-activated protein kinase (AMPK)
induced the redistribution of TC45. In addition, spe-
cific pharmacological activation of AMPK was suffi-
cient to cause the accumulation of TC45 in the cyto-
plasm. Thus, specific signaling pathways involving
AMPK may regulate the subcellular location, and
function, of TC45 in response to cellular stresses.
RECEPTOR PTPS AND CELL ADHESION
Our studies have focused on two receptor PTPs. PTP1.1,
which displays features of an immunoglobulin (Ig)
super family cell adhesion molecule, is expressed at
high levels in endothelial cells. In subconfluent cul-
tures, the level of PTP1.1 is low, found particularly in
intracellular membranes, including the Golgi.
However, in confluent cells, the level of PTPµ is dra-
matically upregulated and the protein accumulates on
the cell surface, particularly in junctional complexes.
PTPii was the first RPTP for which a physiological
ligand was identified, through our observation that the
extracellular segment of the enzyme participates in
homophilic binding interactions; thus, one molecule
of PTPp, recognizes another PT141 molecule on the
surface of an apposing cell. Furthermore, we showed
that PTPR interacts with cadherin-catenin cell adhe-
sion complexes, in tissues and in epithelial cell cul-
tures. These observations suggest that PTP1.1 may be
positioned to regulate cell adhesion by controlling the
tyrosine phosphorylation status of junctional proteins.
It appears that in endothelial cells, PTI3µ can associate
with both cell-cell and cell-matrix junctions. We are
performing a structure-function analysis to examine
the importance of activity and homophilic binding of
PTPI.t in survival and adhesion of endothelial cells.
For example, we examined the effects of expressing a
PTPI.t mutant in which the Ig domain had been delet-
ed from the extracellular segment and which, there-
fore, has lost its ability to participate in homophilic
binding. This mutant appears to be directed to the
leading edge of cells where it disrupts formation of
focal contacts and appears to result in enhanced tyro-
sine phosphorylation. We are currently examining the
effects of various forms of PTPtt and trying to link
those effects to the dephosphorylation of defined pro-
tein substrates.
We originally identified DEP-1 (density-enhanced
PTP) as the first PTP to be shown to display enhanced
expression in confluent, compared to subconfluent,
cell cultures. There are now several lines of evidence
to implicate DEP-1 in contact inhibition of cell
growth. Therefore, we have been trying to derive
insights into the mechanism of action of DEP-1
through the identification of its physiological sub-
strates. We have been using the method developed in
our lab involving production of mutant PTPs that
maintain a high affinity for substrate but do not cat-
alyze dephosphorylation effectively ("substrate
traps"). Following expression in cells or in affinity
chromatography in vitro, the mutant PTP binds to its
physiological substrates but, because it is unable to
dephosphorylate the target efficiently, the mutant and
substrate form a complex. Upon isolation of this com-
plex, the substrate(s) can be identified, yielding
important insights into the function of the PTP. We
have focused on two different human breast tumor
lines, MDA-MB-231 and T47D. Sequence data on one
of the trapped proteins identified it as p120 catenin.
Originally identified as a substrate of Src, p120
catenin is a component of adherens junctions. It inter-
acts with classical cadherins, such as E-cadherin,
which are cell-cell adhesion molecules that have been
implicated in the inhibition of tumor growth and inva-
sion. Recently, DEP-1 was shown to colocalize with
VE-cadherin in endothelial cells (Takashaki et al., .1
Am. Soc. Nephrol. 10: 2135 [1999]). However,
although DEP-1 recognized p120 catenin as a sub-
strate, it did not trap E-cadherin. In addition, although
we detected an interaction with the cadherin-associat-
ed proteins 13-catenin and plakoglobin, this interaction
was not phosphorylation-dependent and was observed
with both wild-type and trapping mutant forms of
DEP-1. Interestingly, our data also suggest that the
receptor PTK Met, the receptor for hepatocyte growth
factor/scatter factor, is a substrate of DEP-1.
Currently, we are characterizing these interactions to
obtain insights into the signaling function of DEP-1.
DUAL SPECIFICITY PHOSPHATASES AND THE
CONTROL OF CELL SIGNALING
The mitogen-activated protein kinases (MAPKs) are
integral to the mechanisms by which cells respond to
diverse stimuli from growth factors, hormones, and
cytokines to a wide variety of environmental stresses.
MAPKs are stimulated by phosphorylation of a TXY
motif in their activation loop and are components of
signal transduction cascades in which sequential acti-
vation of a series of protein kinases culminates in their
activation and their subsequent phosphorylation of
various effector proteins that mediate the physiologi-
cal response. Several dual specificity phosphatases
(DSPs) have been implicated in the dephosphorylation
and inactivation of MAPKs. In a collaborative project
with Ralf Luche and Bo Wei at CEPTYR Inc., we have
identified and isolated full-length cDNA clones for a
variety of novel DSPs. We have made the unprece-
dented observation that one of these novel DSPs did
not inactivate MAPKs, but instead functioned as a
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specific activator of the JNK subfamily of MAPKs.
We have named the enzyme JSP-1, for JNK-stimula-
tory phosphatase-1. Our data indicate that JSP-1
induced the activation of MKK4, a MAP kinase
kinase (MAPKK) immediately upstream of JNK in
the signaling pathway. The effects of the JSP-1 were
blocked by a dominant-negative mutant form of
MKK4, suggesting that JSP-1 acts upstream of the
MAPKKs in the signaling pathway. We have now
identified several proteins that have the potential to
function as regulators of JSP-1 and are combining the
characterization of these proteins with the use of such
techniques as RNA interference to define the mecha-
nism of action of this DSP. Aberrant activation of JNK
has been linked to several human diseases, raising the
possibility that JSP-1 may prove to be a novel thera-
peutic target.
The production of distinct proteins from alternate
reading frames at the same gene locus is unusual in
higher eukaryotes. A classic example is the Ink4a-Arf
locus, encoding the unrelated proteins p 1 6Ink4a, which
functions as an inhibitor of cyclin-D-dependent kinas-
es, and pl9Arf, which binds to and inactivates MDM2,
thereby potentiating the activity of p53. We have iden-
tified a novel example in which the two open reading
frames encode closely related, VH1-like DSPs cur-
rently termed DSP7 and DSP17. The presence of
mRNA for DSP7 and DSP17 has been shown by
northern blotting and reverse transcriptase-poly-
merase chain reaction (RT-PCR), with both of these
DSPs expressed specifically in skeletal muscle.
Currently, we are characterizing these DSP proteins,
including attempts to identify their physiological sub-
strates.
REGULATION OF PTP FUNCTION BY
REVERSIBLE OXIDATION
The signature motif, [I/V]HCXXGXXR[STI], which
defines the PTP family of enzymes, contains an
invariant cysteine residue that functions as a nude-
ophile in catalysis. Due to the environment of the
active site, this cysteine residue has an unusually low
pKa that enhances its nucleophilic properties but ren-
ders it susceptible to oxidation. A variety of studies
have illustrated the potential for regulation of PTP
function by oxidation and its importance for optimal
tyrosine-phosphorylation-dependent signaling. To
examine this issue further, we have developed a mod-
ified "in-gel" PTP assay to visualize the oxidation of
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PTPs in response to a stimulus in a cellular context.
We observed the reversible oxidation of multiple PTPs
in response to treatment of Rat 1 cells with H202 and
demonstrated that this oxidation was required for the
mitogenic effects of H202. We also demonstrated that
stimulation of Rat 1 fibroblasts with platelet-derived
growth factor (PDGF) led to the production of reactive
oxygen species (ROS), which induced the rapid and
reversible oxidation of the PTP SHP2. Ligand-induced
autophosphorylation of the PDGF receptor (PDGF-R)
produces docking sites for various signaling proteins,
including SHP2. We showed that mutant forms of the
PDGF-R that were unable to bind to SHP2 displayed
enhanced autophosphorylation and enhanced activa-
tion of MAP kinase. Thus, SHP2 appears to be an
inhibitor of PDGF-R signaling Interestingly, it was
only the population of SHP2 that was bound to the
PDGF-R which was susceptible to reversible oxidation
and inhibition. Thus, we propose that the PDGF-
induced production of ROS leads to the rapid oxida-
tion of the pool of SHP2 which has been recruited into
a complex with the PDGF-R. This augments auto-
phosphorylation of the receptor and the initiation of
the signaling response. The transient nature of the oxi-
dation results in reduction and reactivation of the pool
of SHP2, which promotes dephosphorylation of the
PDGF-R and termination of the signal. These data
illustrate how PTK-induced production of ROS may
augment tyrosine-phosphorylation-dependent signal-
ing through inactivation of PTPs (Fig. 1) and defines
the mechanism by which SHP2 functions as an antag-
onist of PDGF-R function. We have also observed the
production of ROS in response to various other stim-
uli, including hormones such as insulin and activators
of G-protein-coupled receptors, that lead to PTK acti-
vation. Currently we are attempting to apply this strat-
egy to utilize stimulus-induced oxidation as a means
of "tagging" and identifying those PTPs that are inte-
gral to the regulation of the signaling events triggered
by that stimulus. Hopefully, this will provide further
insights into the physiological function of other mem-
bers of the PTP family.
A GENOMIC PERSPECTIVE ON THE PTPS
The availability of sequence data on the whole
genomes of various organisms, including the first
draft of the human genome, offers the potential to
expand protein families and study evolutionary rela-
tionships. To provide a framework for a genome-wide
FIGURE 1 Regulation of PTP activity by reversible oxidation. Ligand-dependent activation of a receptor
protein tyrosine kinase (RTK) triggers the activity of a Rac-dependent NADPH oxidase leading to pro-
duction of reactive oxygen species (ROS). ROS oxidizes the active-site cysteine residue of members of
the PTP family, converting it from a thiolate ion (the active form) to sulfinic acid. Oxidation results in inhi-
bition of PTP activity, thereby promoting tyrosine phosphorylation. However, due to the action of glu-
tathione or thioredoxin, oxidation of the PTPs is transient. Restoration of PTP activity following reduction
back to the thiolate form of the active site cysteine residue terminates the tyrosine-phosphorylation-
dependent signal. A variety of growth factors, hormones, and cytokines induce ROS production and stim-
ulate tyrosine phosphorylation. We are developing methods to identify which PTPs become oxidized in
response to a physiological stimulus as a way of establishing links between particular PTPs and the reg-
ulation of defined signaling pathways.
analysis of the PTPs, we have compiled a comprehen-
sive on-line resource for sequence analysis of the
pTyr-specific members of the PTP family. The Web
Site includes amino acid sequence alignments, phylo-
genetic classification of family members into 17 PTP
subtypes, and evaluation of amino acid conservation
in three dimensions using X-ray crystal structures of
PTP domains and low resolution homology modeling.
The PTP database is available under CSHL databases
at http://intron.cshl.org/biocomp/ or at the Web Site
www.science.novonordisk.com/ptp. In the future, we
plan to expand this resource to include intron/exon
organization, splice variants as well as mutations,
polymorphisms, and disease linkages. In addition, we
have been conducting a genome-wide analysis of
DSPs. In collaboration with Benjamin C. Kirkup at
Yale University, we conducted a phylogenetic analysis
of all known DSPs, including the novel enzymes we
have identified, using parsimony to assess evolution-
ary relationships. Preliminary analysis indicates a high
degree of diversification, with many of the novel
DSPs forming distinct subfamilies, suggestive of a
wide range of functions. Interestingly, many of the dis-
ease linkages established to date for the PTP family
involve the DSPs. Currently, we are working in col-
laboration with Ravi Sachidanadam here at CSHL to
collect and organize the data on the DSPs, in conjunc-
tion with our analysis of the PTPs, to set up an inter-
active database.
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Research in my laboratory is focused on the role of the
Ras and Rho GTPase family members in signal trans-
duction. Members of these families encode low-mole-
cular-weight guanine nucleotide-binding proteins that
function as binary switches by cycling between an
active GTP-bound state and an inactive GDP-bound
state. It is only in their GTP-bound state that they are
able to interact with downstream effector molecules
which mediate their effects. The ratio of the two forms
is regulated by the opposing effects of guanine
nucleotide exchange factors (GEFs) that promote the
exchange of bound GDP for GTP, and the GTPase-
activating proteins (GAPs) that stimulate hydrolysis of
bound GTE. Alterations that affect proper Ras and Rho
function have been found to result in the development
of several disease processes, including cancer, inflam-
mation, neuropathological disorders, and bacterial
infections. Efforts in my laboratory have been focused
on defining the role and mechanisms by which these
GTPases exert their effects on (1) specific aspects of
tumorigenesis and (2) neuronal development.
The cancer studies are focused on three aspects of
tumorigenesis. One project involves defining the
mechanisms by which Rac 1 , a Rho family member,
contributes to cell growth and invasiveness. The second
project aims to gain insights into the molecular basis by
which the Ras-related GTPase Rapt and its effector
AF-6 affect epithelial cell shape changes and the coor-
dinated movements of cells, which are pivotal alter-
ations governing tumor progression and wound healing
processes. The third project involves the functional
characterization of p62da, a Ras-GAP-associated pro-
tein, which was found to be constitutively tyrosine-
phosphorylated in chronic myelogenous leukemia
(CML) progenitor cells. A more recently initiated focus
in our lab involves investigating the role of the Ras and
Rho GTPases in neuronal development and synaptic
transmission. Of particular interest to my lab is to
understand how a lack of oligophrenin-1, a potential
Rho-GAP and regulator of GTPases, results in mental
retardation.
SIGNAL TRANSDUCTION PATHWAYS MEDIATING
EFFECTS OF RAC1 ON CELL GROWTH
AND INVASIVENESS
Several lines of evidence have indicated the involve-
ment of the Rho GTPases, and in particular Racl, in
cellular events such as proliferation, adhesion, and
invasion. However, a major challenge remains to
define the signaling pathways mediating these effects.
To this end, we have made use of the yeast two-hybrid
system to isolate Racl- interacting proteins. This
resulted in the identification of several putative Racl
effectors (see previous report), as well as a novel class
of Racl activators, which contain a region of homolo-
gy with Dock180. The latter protein has previously
been shown to activate Racl and to have a role in
phagocytosis, cell migration, and invasion of tumor
cells. We have designated the two novel proteins,
Darcl and 2 (for Dock180-like activator of Racl) and
are currently investigating their roles in cell motility
and invasion. As an additional approach, we employed
cDNA-RDA (representational difference analysis) in
combination with microarray analysis to identify tar-
get genes of Racl, whose expression is altered as a
result of constitutively active Racl (Rac1V12) expres-
sion. These experiments were assisted by Dr. R. Lucito
here at CSHL. Among the cDNAs isolated were cyclo-
oxygenase 2 (COX-2) and cyclin D1, two genes whose
expression has been previously shown to be up-regu-
lated in many tumors. We found that the expression
levels of both of these genes are up-regulated in
Rac I V12-expressing epithelial and glioblastoma cells.
Further characterization of the other cDNAs is likely
to identify additional relevant Racl targets and is
presently ongoing in my lab.
ROLE OF RAP1 AND AF-6 IN EPITHELIAL
MORPHOGENESIS
Several studies suggest a relationship between loss of
epithelial cell polarity and loss of growth control.
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Studies using mammalian epithelial cells have sug-
gested a role for Rapl, a member of the Ras family,
and the junctional protein AF-6, which associates with
GTP-bound Rap, in the regulation of epithelial cell
shape changes and cell adhesion. Due to the finding
that AF-6 is largely refractory to both loss-of-function
and gain-of-function analyses, we decided to explore
this hypothesis in the genetically more tractable
Drosophila system.
In Drosophila, a process called dorsal closure
(DC) relies on the elongation and migration of epithe-
lial cells and has proved to be an excellent model sys-
tem for the study of the molecular basis underlying
epithelial cell shape changes. In collaboration with U.
Gaul (Rockefeller University), we recently provided
evidence that Canoe (Drosophila orthologs of AF-6)
acts as a Drosophila Rapl effector in the process of
dorsal closure. To date, no other protein has been
reported to act as a mediator or direct effector of the
small GTPase Rapl in a physiological context.
Furthermore, we obtained evidence that Canoe partic-
ipates in DC through two cellular pathways: One is
controlled by DRapl and is independent of the INK
cascade, whereas the second is not activated by
DRapl and feeds into INK signaling. We are current-
ly planning to identify additional Canoe-interacting
proteins to obtain further insights into Canoe's mode
of action in dorsal closure. To complement these stud-
ies, we are planning to assess a role for the mam-
malian counterparts of these Drosophila proteins in
mammary epithelial polarity and invasive behavior.
These studies will contribute to a better understanding
of the fundamental mechanisms that drive cell shape
changes and migration.
P62°0< IS A NEGATIVE REGULATOR
OF GROWTH-FACTOR AND
P210.c.-ABL-INDUCED CELL PROLIFERATION
p62"k is a protein initially identified as a prominent 62-
kD constitutively tyrosine-phosphorylated, RasGAP-
associated protein, in p2106cr-abLexpressing cells. This
protein was termed Dok (downstream of kinases),
since it was also found to be a common substrate of
many receptor- and membrane-associated tyrosine
kinases. To investigate the role of p62"", we made use
of different cell types derived from p62°" null mice,
generated by P.P. Pandolfi (Memorial Sloan-Kettering
Cancer Center, New York). In collaboration with
Pandolfi's group, we obtained evidence that p62d"
acts as a negative regulator of growth-factor-induced
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cell proliferation, since p62"k-deficient cells possess a
higher proliferation rate in response to growth factors.
The increase in cell proliferation in p62d"-/- cells can
be suppressed by ectopic expression of p62d".
Furthermore, p62d* inactivation causes a significant
shortening of the latency of the fatal myeloprolifera-
tive disease induced by retrovirus-mediated transduc-
tion of p210"r-abi in bone marrow cells. We have also
obtained data suggesting that p62"" exerts its negative
effect on growth-factor-induced cell proliferation at
least in part by negatively influencing the Ras/MAPK
(mitogen-activated protein kinase) pathway. We have
shown that in order for p62"k to act as a negative reg-
ulator of the Ras/MAPK pathway, p62d" must be
recruited to the membrane. This platelet-derived
growth factor (PDGF)-triggered translocation of
p62d" to the plasma membrane involves the activation
of phosphatidylinositol -3 kinase (PI3-kinase) and
binding of its PH domain to 3 "-phosphorylated phos-
phoinositides. We are presently investigating the
underlying mechanism by which p62d" inhibits the
Ras/MAPK pathway, and growth factor and p2106"-abi
mediated signaling.
FUNCTIONAL CHARACTERIZATION
OF OLIGOPHRENIN IN THE BRAIN
Recent studies revealed that four of the nine genes
thus far identified to be involved in nonspecific X-
linked mental retardation (MRX) are regulators or
effectors of Ras-related small GTPases. These include
oligophrenin-1, which is a putative RhoGAP; PAK3,
which is a downstream serine/threonine target of Rac
and Cdc42; and a novel exchange factor for Rac,
called PIX. At present, there is a lack of understand-
ing as to how these proteins contribute to MRX.
However, there is compelling evidence that perturbing
the activity of the Rho GTPases results in alterations
in the formation of neuronal processes. In collabora-
tion with H. Cline here at CSHL, we investigated
whether Rho GTPases regulate branch dynamics and
branch extensions in optic tectal neurons in live
Xenopus tadpoles. These studies indicated that the
three members of the Rho GTPases have distinct
effects on dendritic arbor development: Rac and
Cdc42 regulate branch additions and retractions,
whereas RhoA regulates the elongation of existing
branches. In addition, my lab used organotypic slices
of developing hippocampus to demonstrate the role of
GTPases in the development of dendritic structures of
pyramidal neurons. To study the function of oligo-
phrenin-1 in the developing central nervous system,
we have established that oligophrenin-1 is highly
expressed in the developing rat hippocampus and is
expressed in axons, dendrites, and dendritic spines of
pyramidal hippocampal cells. In addition, we have
demonstrated that oligophrenin-1 functions as a GAP
for RhoA, Rae, and Cdc42 in a cellular context. We
are currently testing what effect the ectopic expres-
sion or absence of oligophrenin-1 has on the cellular
morphology in developing neurons using organotypic
hippocampal slices as an assay system. In addition,
we recently identified a novel oligophrenin- I-inter-
acting protein. Future studies are geared to address
this interaction and its functional significance in
determining cell morphology and synaptic plasticity.
These studies will provide a better understanding of
neuronal development and how disregulation of mol-
ecules intimately involved with Rho GTPases con-
tributes to MRX.
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BIOINFORMATICS AND GENOMICS
The Bioinformatics and Genomics group is composed of diverse investigators who are addressing
many of the crucial problems in modern biology. They interact with large numbers of investigators at
both Cold Spring Harbor Laboratory and elsewhere. While diverse in their interests and approaches,
they share a common interface: the intersection of biology and computation. These interactions
increasingly form an iterative cycle where computational biologists suggest an experiment in the lab,
the results of which refine the computational tools.
The Mishra lab is developing and testing algorithms for mapping genomes. With the completion of
reference genome sequences and high-resolution physical maps, the ability to rapidly map changes
in the genomes of individuals will become a key to deciphering the genomic changes in cancer and
many other genetic diseases.
The Neuwald lab continues to make progress in their efforts to develop and use computational tools
to determine the correlation between protein structure and function. They have continued to
enhance the performance of their comparative hierarchical alignment and interaction network
(CHAIN). Using CHAIN, they have discovered that certain weak atomic interactions are conserved
among members of the Ras-like GTPase family and are crucial to their function.
The Stein lab has maintained their efforts in genome visualization databases with the SNP database
and Worm Base (CaenorhabditiS elegans). They have also extended these efforts to plant genomes
with Gramene. Their efforts are leading to next-generation databases such as the Genome-
KnowledgeBase which they are developing and the distributed annotation server (DAS) architecture
which they had a major role in popularizing.
The Zhang lab has continued developing algorithms for the analysis of genomic DNA sequence
data. They have evolved from developing gene prediction algorithms to focusing largely on devel-
oping algorithms for the prediction of promoters and first exons of genes. This is a difficult and
important informatics challenge. Their newly published analysis using these tools on the human
genome predicts as many as 56,000 genes, nearly doubling some previous estimates. These types
of analyses are providing and will continue to provide the focal point for exciting discoveries as com-
putational and "wet lab" scientists interact.
As important reference genomes are being completed, the McCombie lab is focusing on develop-
ing comparative approaches to decipher their meaning. They are using Brassica as a model for the
plant Arabidopsis and the dog as a model for the human genome. They are sequencing from these
genomes and have developed interactive, Web-based viewers to look at the comparisons between
the pairs of genomes.
Notably, this year also saw the publication of the first draft sequence of the human genome and the
first high-resolution polymorphism map of the human genome. The McCombie and Stein labs con-
tributed respectively to these landmarks.
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GENOME SEQUENCE ANALYSIS
W.R. McCombie M. de la Bastide
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Our work in past years has focused on developing
strategies and tools to facilitate the analysis of large
genomes. Increasingly, this has led us in the direction
of comparative genomics and developing new tools
and strategies for use in these analyses. This year, we
want to highlight several areas that contribute to those
long-term goals: (1) the generation of raw sequence
data that we have substantially automated in the past
year, (2) our efforts in collaboration with colleagues at
SUNY Stony Brook to test a new DNA sequencer, and
(3) the use of comparative genomics to analyze the
Arabidopsis and human genome sequences, which we
helped to complete.
Production Sequence
Generation
T. Zutavern, B. Miller, S. Muller, F. Katzenberger,
L Nascimento, V. Balija
Upon moving into the Genome Research Facility in
August of 2001, we accelerated our efforts to auto-
mate much of our production sequencing process.
This ongoing process had reached a limit due to space
constraints. Since the move, we have automated a
number of steps on a Biomek FX robot, including
reaction setup, polymerase chain reaction (PCR),
archive creation, and reaction precipitation. We have
also automated reaction setup, and the rearranging of
reactions for loading on a Tomtec Quadra. This pro-
vides necessary backup for the Biomek. As a result of
this automation, we can now carry out up to about
20,000 reactions per week with a staff of four (includ-
ing the group leader). In 1996, we were performing
about 800 reactions per week with a staff of seven.
Moreover, in most cases, the automated steps are more
consistent than those carried out manually.
This production sequencing group provides the
engine that drives most of our other activities. The raw
data produced in the production group in the past year
fuel our sequencing efforts in rice and mouse. They
S. Muller L. Santos
L. Nascimento L. Spiegel
A. O'Shaughnessy C. Yang
L.E. Palmer M. Yu
R. Preston T. Zutavern
also generate the data for our Brassica sequencing
described below. In years past, the production group
has also provided data for human genome sequencing.
The results of the human genome sequencing effort, to
which we contributed, were published in the past year
(The International Human Genome Sequencing
Consortium 2001).
Testing of a Novel, Ultrahigh
Sensitivity DNA Sequencer
V. Balija, L. King , L. Spiegel [in collaboration with
V. Gorfinkel, SUNY Stony Brook]
A group in the electrical engineering department at
SUNY Stony Brook has developed sensitive
DNA sequencing instrument. The detection capability
of the instrument, tentatively named the Stony Brook
(SB) Sequencer, far surpasses the two most common-
ly used DNA sequencers, namely, the ABI 3700 and
the Amersham Pharmacia MegaBACE 1000. We have
been testing these instruments in collaboration with
the SB group. The detection design of the SB Sequen-
cer was tested using dilutions of commercially avail-
able DNA sequencing standards. Compared to the ABI
and Amersham platforms, which were incapable of
producing resolved trace data from dilutions greater
than 1:25, the SB Sequencer was able to routinely
detect dilutions of greater than 1:100. We also tested
the instrument using standard samples generated by
our production group. Dilutions of 1:100 were consis-
tently detected, indicating that the amount of sequenc-
ing reagent currently used in sequencing reactions
could be theoretically reduced by that amount. The
quality and reliability of the data were tested by using
the instrument to sequence a cDNA clone.
A clone from a canine expressed sequence tag
(EST) library was chosen, and the 5' and 3' ends were
sequenced using universal primers. The trace data pro-
duced were then used to choose primers to walk into
the sequence. In this manner, the entire gene was
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FIGURE 1 The figure shows a detailed view
of the alignments to the Arabidopsis
genome. Here, each alignment track is an
individual sequence. The first track contains
three regions of similarity from one Brassica
read. Two of the regions are upstream of an
annotated gene. This demonstrates the
ability to find regulatory regions and 5"UTR
using comparative genomics. The second
track shows one read spanning over two
exons, but the intron does not show a sig-
nificant match. This demonstrates the con-
servation of coding sequence between the
Brassica and Arabidopsis. The last two
black tracks are the same reads discussed
above, but aligning to the gene at a protein
level.
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sequenced, which established the efficacy of this
instrument. The accuracy of the sequence was con-
firmed by sequencing the same clone using standard
instruments and techniques in our lab. This represents
the first real utilization of this potentially exciting new
generation sequencing instrument.
Comparative Analyses of the
Brassica and Arabidopsis
Genomes
M. Katari, N. Dedhia [in collaboration with Rob Martienssen,
Cold Spring Harbor Laboratory; the Washington University
Genome Sequencing Center; and The Institute for Genomic
Research]
Brassica oleracea and Arabidopsis thaliana belong to
the mustard family, Brassicacea, and diverged 16-19
million years ago. Sequence identity between the
genomes is much higher in the coding regions (85%)
than in the noncoding regions. This makes Brassica an
excellent species to improve the Arabidopsis annotation.
In the current annotation of the Arabidopsis
genome, predicted genes that are not supported by any
experimental evidence or sequence similarity are anno-
tated as hypothetical (24% of 25,772). ESTs are useful
in determining gene structure; however, only 60% of
the predicted genes contain similarity to ESTs. We
have suggested that an analysis of the Brassica genome
could help fill this gap in the analysis of Arabidopsis.
Our group, which includes the Washington University
Genome Sequencing Center in collaboration with The
Institute for Genomic Research, has been testing this
concept. These reads are useful for improving the
structure of predicted genes, suggesting the presence of
hypothetical genes, and for discovering overlooked
genes. They can also help characterize regulatory ele-
ments and discover noncoding genes.
We have created a Web-based Arabidopsis-
Brassica genome viewer (http://www.cshl.org/gen-
bin/cgi-bin/manny/vicogenta.cgi) to view the current
Arabidopsis genome annotation and the positions of
the alignment of the Brassica reads. Read and EST
matches can be added to the viewer as separate tracks.
This makes the viewer a useful tool for annotating the
Arabidopsis genome by comparing conserved
sequences from other species. It is also useful in iden-
tifying reads and ESTs that align to regions of interest
in the Arabidopsis genome. Screen shots from the
viewer are shown in Figure 1.
Sequencing and Analysis of Canine ESTs
L.E. Palmer, T. Zutavern, L. Santos, L. Nascimento,
R. Preston, W.R. McCombie [in collaboration with
Greg Hannon, Cold Spring Harbor Laboratory]
The completion of the draft for the human genome has
presented the scientific community with many biolog-
ical challenges and opportunities. The human draft
sequence enables the use of comparative approaches
to further understand the human genome through
analysis of other species. Cold Spring Harbor
Laboratory's Genome Center has undertaken a project
to sequence canine ESTs from a variety of canine tis-
sues and disease models. To date, the CSHL group has
sequenced and made available to the public more than
5000 canine ESTs. Currently, an analysis of the
sequence is under way with the use of an automated
pipeline.
The ESTs have been mapped to both the human
genome (using the Blat server at the University of
California, Santa Cruz) and the human proteome
(using Blastx vs. a nonredundant set of human pro-
teins). Using these data, we have assigned Gene
Ontology terms as well as probable names to the ESTs.
This information has been stored in a relational data-
base for easy retrieval and analysis. Most ESTs match
to the human genome and/or proteome. However, there
are a number of ESTs that do not match either. These
ESTs will be analyzed further to determine whether
they can be used to identify unknown human genes. A
Web-based interface has been developed to allow out-
side users to view the annotations that we have
assigned to the ESTs. The interface and the data can be
accessed at the Web Site: www.cshl.org/genbin/cgi-
bin/golden_retriever.cgi. A screen shot of a portion of
the display available on this site is seen in Figure 2.
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COMPUTATIONAL BIOLOGY, GENOMICS, AND BIOINFORMATICS
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At the interface of mathematics and biology, there
have emerged many challenging questions requiring
consilience of elegant ideas and concepts from applied
mathematics, theoretical computer science, logic, and
physical modeling. The impulse has come from a bet-
ter understanding of processes involved at the molec-
ular level, technology at a meso- and nanoscale, the
ability to perform high-throughput experiments, and
the amount of genomic and proteomic data that can
now be generated and made publicly available for pro-
cessing. In response to these challenges, a group of
scientists and mathematicians from Cold Spring
Harbor Laboratory and the Courant Institute, an inter-
national leader in applied mathematics, has begun to
focus its collective attention on these questions. In the
past, this group has developed several sophisticated
algorithms and statistical analysis tools to attack bio-
logical problems that range from deciphering the
genome of pathogens (e.g., Escherichia coli, Plasmo-
dium falciparum) to understanding chromosomal
aberrations implicated in cancer.
Various projects pursued by this group are described
below. These projects fall into four different categories:
(1) physical mapping, (2) genomics and proteomics, (3)
cell modeling, and (4) genome evolution.
MAPPING
The study of genetics relies on complete nucleotide
sequences of the organism, together with a description
of their structural organization. Although this infor-
mation at its finest level is not always available, even
a sparse collection of fragmentary data with unrecog-
nized assembly and sequencing errors can be of enor-
mous practical utility when combined with genomic
physical maps, as these maps provide a natural struc-
ture for organizing, verifying, and deciphering the
genetic data about chromosomes.
Our group has developed algorithmic foundations
for two physical mapping approaches: (1) array-based
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correspondence and linear mapping and (2) optical
mapping, which are described below in more detail.
ARRAY MAPPING: CORRESPONDENCE AND
LINEAR MAPPING
In principle, microarrays are ideal tools for mapping
genomes because a large amount of information can
be gathered in parallel from a single hybridization. In
particular, probes can be assigned to pools of BACS,
and the statistical performance of the underlying pro-
tocols can be modeled faithfully. On the basis of these
models and supporting experiments, our group
devised the algorithmic, mathematical, and statistical
tools needed to utilize microarray hybridization to
bacterial artificial chromosome (BAC) pools to estab-
lish "correspondence maps," the assignment of probes
to individual BACs. Subsequently, the effectiveness of
the algorithms was demonstrated in simulations, and
this led to the definition of the experimental parame-
ters required for successful mapping. The applications
of correspondence mapping are many and important,
as they include finding transcribed regions of the
genome, filling gaps in assembled genomic sequence,
and integrating the annotations of two probe sets.
The preliminary experiments and simulations are
sufficient to indicate that binary partition/hybridiza-
tion can be used for correspondence mapping, even
without reflective representations. Similar ideas can
be further generalized to measure distances between
every pair of probes (in a statistical sense with accu-
rate error models) and then integrated to assign chro-
mosomal locations to all of the probes. These ideas led
to an even more powerful physical mapping algorithm,
called linear mapping, and is not discussed here in
details (see Casey et al. 2001). The accuracy and reso-
lution of these maps depend on the number of
hybridization experiments and the number of probes
and can be improved by judiciously increasing these
numbers. Other related ideas include statistical models
of hybridization needed to measure the copy number
fluctuations of various genomic regions of interest
(e.g., genomic amplifications and deletions) (see R.
Lucito et al., Genome Res. 10: 1726 [2000]).
OPTICAL MAPPING
Optical mapping is another older physical mapping
approach that provides an ordered enumeration of the
restriction fragments along the genome. The physico-
chemical approach underlying optical mapping is
based on immobilizing long single DNA molecules on
an open glass surface, digesting the molecules on the
surface and visualizing the gaps created by restriction
activities using fluorescence microscopy. The corrupt-
ing effects of many independent sources of errors
affect the accuracy of an optical map created from one
single DNA molecule but can be tamed by combining
the optical maps of many single molecules covering
completely or partially the same genomic region and
by exploiting accurate statistical models of the error
sources. To a rough approximation, the resolution and
accuracy of an optical map can be arbitrarily improved
by simply increasing the number of enzymes and
number of molecules, respectively.
STATISTICAL MODELS AND BAYESIAN ALGORITHMS
FOR OPTICAL MAPPING
The main error sources limiting the accuracy of an
optical map are either due to incorrect identification
of restriction sites or due to incorrect estimation of the
restriction fragment lengths. Since these error sources
interact in a complex manner and involve resolution of
the microscopy, imaging and illumination systems,
surface conditions, image processing algorithm,
digestion rate of the restriction enzyme, and intensity
distribution along the DNA molecule, statistical
Bayesian approaches are used to construct an ensem-
ble consensus map from a large number of imperfect
maps of single molecules. In the Bayesian approach,
the prior conditional pdf models the restriction frag-
ment sizing error in terms of a Gaussian distribution,
the missing restriction site event (due to partial diges-
tion) as a Bernoulli trial, and the appearance of false
restriction sites as a Poisson process. Using the Bayes'
formula, the posterior conditional can be computed
and used to provide the means for searching for the
best hypothetical model given the set of single-mole-
cule experimental data. Since the underlying hypothe-
sis space is high dimensional and the distributions are
multi-modal, a naive computational search must be
avoided. An efficient implementation involves
approximating the modes of the posterior distribution
of the parameters and accurate local search imple-
mented using dynamic programming (Anantharaman
et al., 1 Comp. Biol. 4: 91 [1997]). The correctness of
the constructed map depends crucially on the choice of
the experimental parameters (e.g., sizing error, diges-
tion rate, and number of molecules). Thus, the feasi-
bility of the entire method can be ensured only by a
proper experimental design, thus guaranteeing suc-
cessful application of this technology even with low-
quality chemical data.
The algorithms developed to create optical maps
of clones (cosmids, BACs, and YACs) as well as
genome-wide maps of microorganisms (e.g., Plasmo-
dium falciparum, Escherichia coli, Deinococcus
radiodurans), involve essentially the same Bayesian
approach and the same error models, but vary in how
they employ various local approximations in control-
ling the algorithmic complexity (see Aston et al.
Trends Biotechnol. 17: 297 [1999]; Lin et al., Science
285: 1558 [1999]; Lai et al., Nat. Genet. 23: 309
[1999]). The current implementation of the Bayesian
algorithm "Gentig" and a body of associated software
continue to be routinely used by biologists for map-
ping various pathogens, rice and humans.
BIOINFORMATICS: VALIS AND
NYUMAD
Comparative functional genomics relies on the fact
that, with advances from modern computation, com-
plex sequences for many different organisms can now
be read. Our group's effort is centered around the goal
of providing the computational tools to complete this
genomics revolution, through the development of
computational algorithms and tool kits that will allow
biologists to discern, from vast data sets, the very
basic genetic similarities and differences among these
organisms. Toward this end, our group is constructing
and developing a large bioinformatics computer sys-
tem known as Valis, a unique computing environment
consisting of three components: database, hardware,
and algorithms. At this point, a pilot hardware compo-
nent has been built, a detailed database has been
designed, and a large software library implementing
many crucial sequence analysis algorithms is in place.
Instead of developing each genomic software tool
ab initio, the Valis team's strategy is to create a base of
low-level tools out of which rapid prototyping soft-
ware can be created. The low-level tools include string
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FIGURE 1 A screenshot of the Valis Bioinformatics system being used to analyze repeats. In the top-
left corner appear the 12 lines of Valis code (in Java Script) needed to achieve this task.
algorithms, statistical subroutines, map manipulation
routines, image processing routines, visualization wid-
gets, and database tools. A possible high-level applica-
tion is in large-scale statistical tests to infer the effects
of genomic evolutionary processes operating at differ-
ent scales and with different statistical distributions.
In a related project, this group has also developed a
versatile Microarray Database (NYUMAD). Its func-
tionality ranges from the storage of the data in relation-
al database management systems to front-end capabili-
ties for the presentation and maintenance of the data.
The database is a unified platform to understand
the microarray-based gene expression data. The data
can be output to a wide class of clustering algorithms,
based on various "similarity measures" and various
approaches to grouping. Particularly, our group has
developed a new statistically robust similarity measure
based on James-Stein Shrinkage estimators and pro-
vided a Bayesian explanation for its superior perfor-
mance. Additional research is focused on incorporat-
ing statistical tests for validation and measuring the
significance (e.g., jackknife and bootstrap tests).
Finally, the database will be augmented with an exper-
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iment design module, which suggests how the future
array experiments should be organized, given that one
understands how the past experiments have per-
formed. Most of the underlying DB schema design
follows closely the specifications put forth by the
Microarray Gene Expression Database group (http://
cs.nyu.edu/faculty/mishra/ or http://bioinformatics.
cat.nyu.edu/), especially when it comes to the XML-
based MAML exchange format.
SYSTEMS BIOLOGY
This group has recently initiated a systems biology
project with the ultimate aim of providing mathemati-
cal and computational tools to study population of
cells, individual cells, and intracellular processes. The
group's approaches are soundly based on realistic
modeling, analysis, simulation, and visualization of
these biological processes at multiple scales both tem-
porally and spatially. Their plan is to devise algorithms
and implementations that allow both qualitative and
quantitative analyses and combine with the for-
malisms developed to study hybrid (discrete and con-
tinuous time) systems.
Note that although many of the group's
approaches are based on well-studied mathematical
frameworks arising in the context of logic (modal
logic, proof systems, model checkers, etc.), dynami-
cal systems (ODEs, kinetic analysis, control theory,
etc.), and computational theory (discrete event sys-
tems, hybrid systems, complexity theory, etc.), their
main innovations are in effectively integrating these
tools to study complex systems at multiple spa-
tiotemporal scales and in automatically designing
experiments that can falsify and eventually revise
existing models.
The group is currently studying various models of
cell-to-cell communication, primarily in the context of
cell signaling involved in cancer. The models can then
be used to interpret the data generated by cocultiva-
tion experiments where cells from two cancer cell
lines are cultured separately and then in combination;
in each case, the transcriptional states of the cells are
measured by microarray experiments in order to gen-
erate the data for model-based interpretation.
COLLABORATIONS
The research work described here has benefited from
close and productive collaborations with other labora-
tories: the Wig ler lab here at CSHL (array mapping),
T.S. Anantharaman and D.C. Schwartz at Op Gen and
the University of Wisconsin (optical mapping), G.
Coruzzi of New York University (NYUIVIAD project),
and the Wigler lab here at CSHL and Weinstein lab at
Mr. Sinai School of Medicine (modeling cellular
processes).
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PREDICTION OF PROTEIN STRUCTURE AND FUNCTION
A.F. Neuwald A. Poleksic
N. Kannan
Our aim is to better understand cellular processes
through computational analysis of the proteins medi-
ating those processes. Because progress in biology is
typically driven by technological breakthroughs, we
also focus heavily on developing algorithmic and sta-
tistical methods that address specific biological ques-
tions of interest. This year marked continued progress
on two major projects involving the development of
such methods. First, we have further developed heuris-
tic procedures relating to hidden Markov models-a
mathematical formalism used to represent protein
characteristics and thereby predict which sequences
are likely to share those characteristics. In addition, we
have further developed our CHAIN (comparative hier-
archical alignment and interaction network) analysis
procedures, which allow us to predict specific struc-
tural roles for individual residues within a protein
sequence. Progress on the CHAIN analysis procedures
has been closely coupled to their application to the
study of various protein superfamilies, the most
notable of which are Ras-like GTPases. Finally, we
have initiated studies of the structural principles
underlying protein function, which has helped us both
to better understand how specific families of proteins
work and to improve our computational methods.
Fast and Sensitive Hidden
Markov Model Searches
A. Poleksic, A.F. Neuwald
We are continuing research on incorporating BLAST
heuristics into hidden Markov model (HMM) se-
quence alignment procedures, which is allowing us to
speed up various HMM programs by more than an
order of magnitude. We recently released a test version
of "HMM-BLAST," a program that uses these heuris-
tics to compare a query sequence against a database of
HMMs. For an average length sequence, HMM-
BLAST is about 20 times faster than comparable non-
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heuristic programs. Several people affiliated with the
Pfam and SMART databases have received copies of
this program for testing. We are also performing our
own tests on this version of HMM-BLAST, which,
because of its speed and its domain architecture visu-
alization capability, allows us to quickly characterize
various protein families of interest. At the same time,
we are working on further improvements, including
the development of a mathematically rigorous heuris-
tic fitting algorithm that will allow us to optimize the
search speed and sensitivity for each HMM individu-
ally, rather than using standard heuristic settings for
every HMM. This heuristic fitting algorithm is also
applicable to the standard gapped BLAST/PSI-
BLAST program and may therefore lead to significant
improvements in this popular sequence analysis tool.
We have already found it to be important for HMMs,
for which using standard heuristic settings may lead to
a loss of sensitivity.
CHAIN Analysis of
Ras-like GTPases
A.F. Neuwald, N. Kannan, A. Poleksic [in collaboration with
Jun Liu, Department of Statistics, Harvard University]
Another application of the HMM and BLAST heuris-
tic procedures is their incorporation into our CHAIN
analysis programs. This is because CHAIN analysis
uses the PSI-BLAST search engine, along with other
sequence, taxonomic, and structural analysis proce-
dures, to detect, align, and cluster a typically large
superfamily of proteins. Most importantly, when
structural data are available, it compares conserved
patterns in the alignment with corresponding structur-
al features, thereby facilitating prediction of the spe-
cific functional roles of individual residues. The
CHAIN analysis project is a centerpiece of our
research inasmuch as it brings together nearly every
developed or acquired tool at our disposal with a view
to fully characterizing specific protein superfamilies.
During the last year, for example, we have incorporat-
ed a Gibbs sampling multiple alignment procedure
into the CHAIN analysis PSI-BLAST algorithm in
order to help eliminate sequence alignment errors,
which can hinder the analysis. (Gibbs sampling is a
powerful statistical optimization method, which, in
our applications, helps identify subtle, but biological-
ly significant patterns in sequences.) We have also
developed, in collaboration with Dr. Jun Liu, another
Gibbs sampling procedure, called Bayesian clustering
with column selection, which optimally clusters the
aligned sequences into functionally related sets. We
have found that both of these Gibbs sampling proce-
dures are important for accurate functional assign-
ment of conserved residues.
A major current application of our CHAIN pro-
grams is the analysis of Ras-like GTPases, which func-
tion as molecular switches in the regulation of cellular
signaling pathways. This analysis reveals that several
Ras-like GTPase families, namely, Ras, Rho, Ran, and
Rab, share functionally critical sequence and structur-
al features. It also shows that the Rab 1 subfamily is
most typical of the superfamily, implying that the pre-
decessor of these GTPases was a Rab 1 -like protein,
from which Ras and these other related GTPases were
derived via divergent evolution. Interestingly, the con-
served structural features shared by these families
often involve weak atomic interactions between
residues, including CH -O, CH-N, and CH-Tc hydrogen
bonds, whose role in protein structure has only recent-
ly been appreciated. This discovery has broad implica-
tions inasmuch as this sort of information currently is
ignored by structural refinement and homology mod-
eling programs. A similar study, focusing on the Ran
family, predicts several specific structural mechanisms
underlying Ran's interaction with importin-p, an effec-
tor molecule required for its role in nuclear transport,
and with its exchange factor RCC1, which functions in
Ran activation.
Structural Principles Critical
to Protein Function
N. Kannan, A.F. Neuwald
Another focus of our research this year has been the
study of basic principles underlying protein structure,
which relies heavily on hints contained in multiple
sequence alignments. As a starting point in this analy-
sis, we have developed preliminary procedures for
searching the sequence and structural databases for
conserved patterns that correspond to residues that
contact each other in corresponding protein structures.
We have also relied on CHAIN analysis to identify
structurally conserved features, as was mentioned
above regarding weak atomic interactions. These
analyses were combined with extensive surveys of the
chemical and structural literature. A key discovery is
the association of aromatic-assisted proline cis-trans
isomerization with important protein conformational
changes. Aromatic-assisted proline isomerization has
been reported for short peptides in the chemical liter-
ature in recent years, but it has not yet been reported
for proteins, concerning which we now have several
striking examples. These include protease inhibitor
conformational switching upon binding to their pro-
tease targets and Rho-family GTPase effector loop
switching in the absence of Mr and in complex with
its exchange factor. As this area of research continues
to expand, it should contribute substantially to our pro-
tein modeling efforts and, more generally, to our
understanding of protein structure and function.
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COMMUNITY ACCESS TO GENOME RESOURCES
L.D. Stein A. Arva
P. Carter
K. Chang
N. Chen
A. Day
T. Harris
J. Kakol
L. Lee
E. Nickerson
X. Pan
GRAMENE: A COMPARATIVE MAPPING
RESOURCE FOR GRAINS
J. Paolino
R. Sachidanandam
S. Schmidt
L. Teytelman
The Gramene database (www.gramene.org) is a com-
parative mapping resource for rice and other grains.
Gramene allows researchers to compare the genetic and
physical maps of the major monocot crops, namely,
maize, barley, oats, sorghum, and wheat, to the emerg-
ing rice genomic sequence. This allows researchers to
identify candidate genes in the rice genome that corre-
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G. Thorisson
P. Van Buren
D. Ware
G. Wu
D. Wurtz
F. Yen
R. Zhang
W. Zhao
spond to genetically mapped mutants and quantitative
traits in the non-rice crop they are studying. Hence, the
resource allows researchers studying traits in maize,
barley, and so forth the benefit of genomic sequencing
without waiting for the sequencing of these much larg-
er genomes.
In addition to comparative maps, Gramene offers
up-to-date genomic annotation of the rice genome,
including both predicted and confirmed genes, and the
current physical maps of rice and sorghum. We have
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FIGURE 1 The Gramene comparative map viewer relates the genetic map of rice chromosome 1, shown on the left,
to the genetic map of maize chromosome 8, shown on the right.
mapped more than 600,000 monocot expressed
sequence tags (ESTs) to the rice genome, allowing
gene predictions to be further refined based on cross-
species comparisons.
Curation is an important component ofGramene.
In collaboration with Susan McCouch's laboratory at
Cornell, we have curated more than 10,000 rice pro-
teins, assigning them classifications in the Gene
Ontology (www.geneontology.org). In addition, we
have classified more than 600 rice mutants using a
trait ontology that we have developed. We are current-
ly curating the rice biological literature, much of
which is in non-English languages, and making this
information available via Gramene as well.
Version 1.00 of Gramene went live in December
2001. Much of the software developed for Gramene is
novel and includes such useful software modules as a
comparative map viewer (Fig. 1), an ontology brows-
er, and a physical map viewer.
The work on Gramene resulted in a publication in
Nucleic Acids Research in 2001.
A HIGH-DENSITY MAP OF HUMAN
SINGLE-NUCLEOTIDE POLYMORPHISMS
Single-nucleotide polymorphisms, or SNPs, are the
most common source of geneticdiversity in mankind,
accounting for more than 90% of the differences
between individuals' genomes. These single-base-pair
changes occur approximately once every 1300
nucleotides and are usually silent. However, SNPs are
of keen medical and research interest because they
provide a fast and convenient way of mapping and
identifying the genes responsible for genetically
linked diseases.
The ability of geneticists to identify the genes
responsible for human disease is directlyproportional
to the density of available genetic maps. The current
generation of human genetic maps is based on the
older technologies of restriction fragment length poly-
morphisms (RFLPs) and simple sequence repeats
(SSRs). These maps typically contain several thousand
mapped markers, providing a resolution of at most 1
Mb. This means that even after establishing tight
genetic linkage between a trait and a map marker, the
researcher still must search through a million or more
bases of DNA sequence data in order to identify can-
didate genes that might be responsible for the trait.
In contrast, by virtue of the abundance of SNPs,
an SNP-based map can contain hundreds of thousands
or millions of markers, giving the map a theoretical
resolution of a few thousand bases. This means that
researchers can skip the tedious search for candidate
genes and immediately hone in on the gene of interest.
Furthermore, a highly dense genetic map allows
researchers to design studies that take advantage of
linkage disequilibrium in isolated populations. This
technique obviates the need to collect large detailed
family pedigrees; instead, it allows geneticists to
search for association between an SNP and a genetic
trait in the general population.
Other uses for SNPs include the design and devel-
opment of diagnostic tests for genetically linked dis-
orders, and as a potent tool for studying the evolution
and migration of human populations.
Under a grant from The SNP Consortium, our lab
is coordinating a large multicenter study to identify
SNPs in human sequences. The identified SNPs are
verified, archived, and mapped to the human genome
using the emerging working draft sequence. After
mapping, the data are released into the public domain
and to GenBank and other major sequence databases.
To date, we have identified and mapped more than
1.6 million SNPs. These mapped SNPs have been
combined with data from other publicly financed
SNP-discovery efforts and with gene prediction data
from the human working draft, to yield an integrated
map containing more than 1,430,000 SNPs. This map
contains one SNP every 2.3 kb of DNA on average,
and represents a two orders ofmagnitude increase in
resolution over previous maps of the genome. This
work resulted in a major publication in the journal
Nature, "A High-Density SNP Map of the Human
Genome" in February 2001.
WORMBASE: A RESOURCE FOR C. ELEGANS
GENOME AND BIOLOGY
During the past year, our lab received a major grant to
develop WormBase, an on-line resource for the small
free-living nematode, Caenorhabditis elegans. This
organism is favored as a simple model animal because
of its small genome size, experimental malleability,
and well-understood cellular anatomy. WormBase is a
curated model organism database developed as part of
an international collaboration with the California
Institute of Technology Washington University at St.
Louis, and the Sanger Centre. Our lab is responsible
for the Web Site, user interface, and software architec-
ture for the project.
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The resource, which is available to the public at
www.wormbase.org, contains the complete C. elegans
genome and key annotations, including predicted
genes, alternative splicing patterns, oligonucleotide
probes, and evolutionarily conserved segments. It also
contains many other types of biological information,
including the C. elegans cell pedigree, the organism's
neuroanatomy, its genetic map, and the physical map
from which the genomic sequence was derived.
During 2001, we added the following key features
to Wormbase:
An expression pattern browser, which allows
researchers to compare the microarray-based
expression patterns of genes.
Information on and the display of transposon-
based insertions and single-nucleotide polymor-
phisms in the C. elegans genome.
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A comparative sequence viewer that relates the C.
elegans genome to the Caenorhabditis briggsae
genome (Fig. 2). C. briggsae diverged from C. ele-
gans approximately 100,000 years ago; by com-
paring the two genomes, one can identify con-
served coding and regulatory regions.
A neuroanatomy browser that allows researchers
to explore the synaptic map of the C. elegans ner-
vous system.
DISTRIBUTED SEQUENCE ANNOTATION SYSTEM
DAS, the distributed sequence annotation system, is a
software architecture that allows researchers from
around the world to share and exchange annotations
on the genome without the need for the error-prone
and time-consuming reformatting that is currently
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FIGURE 2 WormBase now displays alignments between C. elegans and the related nematode C. briggsae. The box
labeled "c01200171.contig2" shows regions of high and low similarity between the two species and highlights coding
regions as well as a potential regulatory region upstream of a gene. Also shown in this view is a single-nucleotide poly-
morphism (SNP) located in the last intron of the gene.
required. This year saw the widespread adoption of
DAS. It is now in use as the data exchange format by
the EBI/Sanger EnsEMBL project, the UCSC
Genome Browser, TIGR, Fly Base, Worm Base, JGI at
OakRidge, and the Whitehead Institute.
The year 2001 was marked by the release of
LDAS, a lightweight distributed annotation system
client, and Omniview (written by our collaborators at
Whitehead Institute), a flexible DAS viewer and
browser application. The DAS project resulted in a
publication in BMC Bioinformatics.
GENOME KNOWLEDGEBASE
The Genome Knowledge Base (GKB) is a new project
begun during the summer of 2001. In collaboration
with Ewan Birney of the EBI and Suzanna Lewis of
the Gene Ontology Consortium, we are developing a
Web-accessible resource for curated information
about biological processes.
The GKB is organized like a review journal.
Practicing biologists are invited to create "summa-
tions" that summarize a particular aspect of their
field. Early summations that we have worked on are
"DNA replication" and "Cell Cycle Checkpoints."
Summations are similar to minireviews, except that
each paragraph of text is reduced to a series of logical
assertions that is entered into a database of processes
and macromolecules. The database is then used to
drive a Web Site. The Web Site can be browsed like a
textbook or searched with queries to discover path-
ways and connections. The first version of GKB went
on-line in September 2001, and it is available at
www.genomeknowledge.org.
GENERIC MODEL ORGANISM SYSTEM PROJECT
Another new project is the Generic Model Organism
Database Project (GMOD). In collaboration with the
model organism system databases FlyBase, SGD, and
MGD, the project will be developing a set of database
schemas, applications, and interfaces suitable for cre-
ating a model organism system database. The hope is
to significantly reduce the time and expense required
to create new databases to curate genomic information
coming out of various model organism system
sequencing projects (e.g., rat, Diciyostelium, Plasmo-
dium). In 2001, we released the following modules:
GBrowse, a genome browser and annotation tool.
Bio::Graphics, a middleware layer for rendering
genomic annotations.
LabDoc, a system for creating and maintaining
standard operating procedure documents.
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COMPUTATIONAL GENOMICS
M.Q. Zhang R.V. Davuluri (Postdoc)
N. Hata (Postdoc)
N. Banerjee (Grad. Student)
J. Jaeger (Grad. Student)
A. Kel (Visiting Scientist)
T. Zhang (Postdoc) Z.Y. Xuan (Postdoc)
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I. Grosse
Dr. T. Zhang left in April for a scientist position at
Merck Research Institute and Dr. R.V. Davuluri started
as a tenured-track assistant professor at Ohio State
University in August. Our research interest continues to
be identification and characterization of the genetic
elements in nucleic acid sequences by computational
means. As the Human Genome Project is about to fin-
ish sequencing the human genome, developing effi-
cient computational methods for identification of genes
and their control/regulatory elements has become
extremely important. Knowing the organization of a
gene often becomes the prerequisite for further func-
tional studies. In the past, we studied statistical charac-
teristics of exons and introns in protein-coding regions
and developed coding-exon prediction programs by
applying multivariate statistical pattern recognition
techniques. Recently, we started looking into more dif-
ficult problems of finding regulatory cis elements in
noncoding regions. This year, our main achievement is
to develop the FirstEF algorithm. For the descriptions
of our collaborative works, see the reports of our col-
leagues KraMer, Huang, Tully, Wigler, Lowe, and
Hannon in this Annual Report.
predict 86% of the first exons with 17% false positives.
We also demonstrated its prediction accuracy on the
genome level by applying it to the finished sequences
of human chromosomes 21 and 22 and by comparing
the predictions with the experimentally verified first
exons. Finally, we presented analysis of the predicted
first exons along with the nearest CpG island for all 24
chromosomes of the human genome. Our analysis pre-
dicts that there are about 56,000 human genes which
almost double the previous estimates.
PEG: A Computer Tool for Automatic
Extraction of Promoter
Sequences from GenBank
T. Zhang, M.Q. Zhang
Promoter extraction from GenBank (PEG) extracts
promoter sequences for large sets of genes using infor-
mation present in GenBank. For a gene whose promot-
er sequence is not found, PEG will attempt to extract
promoter sequences of the orthologous genes instead.
FirstEF: The First Algorithm
for Identification of Human
Promoters and the First Exons
R.V. Davuluri, I. Grosse, M.Q. Zhang
Identification of promoters and first exons has been the
most difficult problem in gene finding. Here, we pre-
sent a set of discriminant functions that can recognize
structural and compositional features such as CpG
islands, promoter regions, and first donor sites. We
explain the implementation of the discriminant func-
tions into a decision tree that constitutes a new program
called FirstEF. We used different models to predict
CpG-related and non-CpG-related first exons. We
showed, by cross-validation, that the program could
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Use of Chromatin
Immunoprecipitation to Clone
Novel E2f Target Promoters
T. Zhang, M.Q. Zhang [in collaboration with the P.J. Farnham
Lab at the University of Wisconsin Medical School]
Using a ChIP assay, we have cloned nine chromatin
fragments that represent both strong and weak in vivo
E2F-binding sites. Further characterization of three of
the cloned fragments revealed that they are bound in
vivo not only by E2Fs, but also by members of the
retinoblastoma tumor suppressor protein family and
by RNA polymerase II, suggesting that these frag-
ments represent promoters regulated by E2F transcrip-
tion complexes. In fact, database analysis indicates
that all three fragments correspond to genomic DNA
located just upstream of start sites for previously iden-
tified mRNAs. One clone, ChET4, corresponds to the
promoter region for Beclinl , a candidate tumor sup-
pressor protein. We demonstrated that another of the
clones, ChET8, is strongly bound by E2F family
members in vivo but does not contain a consensus
E2F-binding site. However, this fragment functions as
a promoter whose activity can be repressed by E2F1.
Finally, we demonstrated that the ChET9 promoter
contains a consensus E2F-binding site, can be activat-
ed by E2F1, and drives expression of an mRNA that is
up-regulated in colon and liver tumors. Interestingly,
the characterized ChET promoters do not display reg-
ulation patterns typical of known E2F target genes in
a U937 differentiation system.
GFScan: A Gene Family Search
Tool at the Genomic DNA Level
Z.Y. Xuan, M.Q. Zhang [in collaboration with
W.R. McCombie, Cold Spring Harbor Laboratory]
A gene family search tool at the genomic DNA level,
GFScan, was developed based on motif and matrix
searches. Two human gene families were tested: neu-
rotransmitter-gated ion channels and carbonic anhy-
drases. All known members of these families with
motif regions in genomic DNA were found, whereas
some new motif locations were also found that
revealed novel members in these families. Compared
with other methods, GFScan can find all true positives
and with very few false positives at the same time. We
also used the human motifs in these two families to
search the mouse genome.
Evaluation and Comparison
of Clustering Algorithms
G.X. Chen, N. Banerjee, M.O. Zhang [in collaboration
with the Ko Lab, NIA, National Institutes of Health]
Many clustering algorithms have been used to analyze
microarray gene expression data. Given the embryon-
ic stem cell gene expression data, we applied several
indices to evaluate the performance of several cluster-
ing algorithms including hierarchical clustering, k-
means, PAM, and SOM. The indices were homogene-
ity and separation scores, silhouette width, redundant
score (based on redundant genes), and WADP (testing
robustness of clustering results after small perturba-
tion). The results showed that the embryonic stem cell
data set posed a challenging situation for the cluster
analysis in that the clusters generated by different
methods were only partially consistent. Using this real
data set, we were able to evaluate the advantages and
weaknesses of these algorithms with respect to both
internal and external quality measures. This study may
provide a guideline on how to select suitable clustering
algorithms for a specific data set and can help to raise
relevant issues in trying to extract meaningful biologi-
cal information from microarray expression data.
Large-scale Analysis of Gene
Expression Profile in Developmental
Human Hippocampus
M.Q. Zhang [in collaboration with the Shen Lab,
Chinese Academy of Medical Sciences and PUMC]
The gene expression profile of the developmental
human hippocampus is of particular interest and
importance to biologists devoted to development of the
human brain and development-related diseases. Here
we describe an expression profile of 946 different
genes in developmental human hippocampus. A com-
parison of 14 related human neural cells/tissues identi-
or specifically expressed in the nor-
mal developmental human hippocampus. Some novel
findings appeared unique to our results. It is remark-
able that wnt2b and some disease-related genes (e.g.,
stathmin, APP, and APBP) are highly expressed; these
might be involved in development and differentiation
of normal human hippocampus by coordinated effects.
Toward Classification of Tissue-specific
Genes and Their Promoters
N. Hata, M.Q. Zhang
One of our primary goals is to understand the gene
regulation network in terms of promoter motif interac-
tions. Our approach is to classify gene promoters from
genome-wide microarray expression data and then
identify promoter motifs common in each gene group
by applying a state-of-the-art search algorithm. Since
May, we have been working on algorithm development
and motif search in tissue-specific gene promoters.
Our results include (1) development of statistical tools
for exhaustive motif search, (2) rigorous extensive
tests of our algorithm with Monte Carlo simulations,
and (3) development of graphical tools to visualize
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data. We have applied our method to liver- and heart-
specific promoters, and our initial results were reported
in a poster session of the meeting "Integrating Genome
Sequence, Sequence Variation & Gene Expression"
(CSI-IL, September, 2001). Completion of the algorithm
and large-scale application to tissue-specific expression
data are under way.
On the Origin of Isochores
I. Grosse, M.Q. Zhang [in collaboration with H. Herzel,
Humboldt University]
We are working to find the one possible mechanism
that could explain the dynamic origin of isochores by
using mutation patterns derived from the first draft of
the human genome published in Spring 2001. The key
element of the dynamic model is the strong G+C
dependence of mutation rates. We show that the
observed mutation patterns imply an unstable mutation-
al kinetics. This instability together with equilibrium
smoothing can induce large-scale patterns of G+C vari-
ation. Simulations of the model over a time period of
300 million years show that variations of the G+C con-
tent appear on many length scales, resembling the
observed heterogeneity in human chromosomes. More-
over, we can simulate the correlations of human and
bird isochores by comparing realizations of simulations
that diverged 250 million years ago. Finally, we note
that the proposed mechanism of isochore origination
may explain why G+C variations are much larger in
vertebrates than in other organisms: Due to the typical-
ly short replication time in nonvertebrate organisms, the
G+C dependence of the mutation rate is smaller than
that in vertebrates, leading to a stable mutational equi-
librium and therefore a lack of large fluctuations of
G+C content in nonvertebrate organisms.
DBSD: Drosophila melanogaster
Binding Site Database
M. Hoffman, Z.W. Zhu, M.O. Zhang
We generated data from two sources: databases such
as those listed above and the primary scientific litera-
ture. We wrote Perl programs to extract information
from the databases that met our criteria, unify its coor-
dinate system, and verify its correctness. We read
about 500 papers from 2000 and 2001 to add new data,
although our criteria for inclusion were so strict that
the data from only about 60 of those papers were
included in the database. We verified data from the
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primary literature with the same programs we used for
databases. We then moved the collected data into a
MySQL database. We created an easy-to-use Web
interface to the database, allowing others to use the
collected data. Information collected in the database
for each element includes (1) name of the element, (2)
element sequence, (3) gene loci where the element
exists and its coordinates relative to the start of the
gene, (4) information about the gene and its locus,
including links to other Web pages, (5) links to the pri-
mary sources of the information in the literature, and
(6) links to the secondary source of the information in
another database, if we used a secondary source to get
the information. The database has many internal links
so one can easily find all of the instances of a particu-
lar element or all of the elements on a particular gene.
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NEUROSCIENCE
As basic neuroscience research is fueled increasingly by information from the Human Genome Project,
we continue to identify the molecular machinery of brain function. At an accelerating pace, this effort
is beginning to reveal the biological bases of various forms of cognitive dysfunction and disease.
Molecular-genetic studies recently have suggested that four types of hereditary mental retardation-
Down's syndrome, Fragile X syndrome, Rubinstein-Taybi syndrome, and Neurofibromatosis-actually
may result from biochemical defects fundamental to normal neuronal function. Work here at CSHL
continues to contribute to this emergent view of cognitive dysfunction. Dr. Yi Zhong and co-workers
have established a link between the neurofibromatosis-1 (NF1) protein and cAMP biochemistry
(involved in long-term memory formation), and Dr. R. Malinow's group is investigating a novel role for
t- amyloid peptide (associated with Alzheimer's disease) in the regulation of neuronal activity.
To date, we all have assumed that "mental retardation" results from a development defect and, thus,
is not treatable. If the emerging "biochemical hypothesis" holds true, however, traditional pharmaceu-
tical intervention in fact may help to ameliorate the cognitive dysfunction associated with these
patients.
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COMPUTATIONAL SYSTEMS
C.D. Brody
We pursued three research projects during 2001. The
first is a theoretical exploration of computational roles
for spike time coding in networks of neurons. Neurons
mostly communicate through events that are punctate in
time (spikes). What implications does this have for
computation? The second project focuses on analyzing
data from awake behaving monkeys performing a mem-
ory and decision task. Our goal is to elucidate the nature
and mechanisms of decision-making processes in the
brain. A third project, related to the second one, has
been initiated. It combines the development of neural
network models of short-term memory with experimen-
tal tests of these models, using human psychophysics.
SPIKE TIMING, COMPUTATION, AND PLASTICITY
In the past, our ideas regarding the working of the
brain have often proceeded by analogy with the most
complex man-made systems available at the time: For
example, in the nineteenth century, the brain was
sometimes referred to as a clock-like mechanism, and,
more recently, the brain is often compared to a com-
puter. Yet many prominent aspects of brain function
have only few or distant parallels to man-made sys-
tems. One of the most notable of these aspects is that
neurons mostly communicate with each other follow-
ing punctate events in time, known as "spikes" or
"action potentials." Few man-made systems share this
property; as a consequence, our intuitions regarding
the computations that can be carried out by large net-
works of elements communicating in such a fashion is
limited. Using computer simulations of networks of
spiking neurons, we and John Hopfield (Princeton
University) have searched for computations that are
easily and robustly implemented using spike timing,
but which would be much more difficult to carry out
without it. We have described a computation that we
referred to as a "many are equals" spike-timing-based
computation (Hopfield and Brody, Proc. Natl. Acad.
Sci. 97: 13919 [2000]; Hopfield and Brody 2001).
Connections between model neurons can be easily set
up such that the neurons synchronize their spike gen-
eration times only when the neurons are driven to sim-
ilar spiking rates; spike timing synchronization can
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thus be used as an indicator of similarity across neu-
rons. We illustrated the computational power of this
spike-timing-based operation by building a small sim-
ple network of neurons that was nevertheless capable
of a very complex computation, recognizing the spo-
ken word "one." This network's wiring and connectiv-
ity pattern were handcrafted by us. But in real biolog-
ical systems, networks are automatically wired up,
through what are often referred to as "learning rules."
These are the mechanisms that would lead a network,
when exposed to external stimuli, to appropriately
modify its connections into instantiating a desired
computation. During 2001, we focused our attention
on the question: What biologically plausible learning
rules would automatically wire up our network?
(Brody and Hopfield 2001). We have again explored
our ideas through computer simulations and have
found a local, spike-timing-dependent learning rule
that allows the right connections to develop automati-
cally, so that repeated exposures to the spoken word
"one" are sufficient to generate a network that recog-
nizes this particular word. Our learning rule is illus-
trated in Figure 1, and it is remarkably similar to an
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FIGURE 1 Local learning rule for constructing a network that
recognizes the spoken word "one" using spike-timing-based
computation. This rule is applied to all connections from one
neuron ("presynaptic neuron") to another ("postsynaptic neu-
ron"). The graph represents the change in synaptic strength
connecting one neuron to another following a pair of spikes,
one from each neuron. The two neurons are called the "presy-
naptic" neuron and the "postsynaptic" neuron, respectively,
and the time of the presynaptic spike relative to the postsy-
naptic spike determines whether the synapse should increase
or decrease in strength.
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FIGURE 2 Neuronal responses in somatosensory area S2 to the second stimulus of a sequential stimulus com-
parison task. Two vibrotactile stimuli (fl and f2) were applied to the tip of a finger. In each panel, each dot repre-
sents the response of one neuron to the second stimulus, during the time schematically indicated by the grey box
in the inset above the panel. Responses were fit as linear functions of fl and f2, firing rate = al*fl + a2'f2, and the
resulting fit coefficients al and a2 are shown. As the analysis window moves further in time from panel a to panel
d, responses become more closely aligned with the a2 = -al axis. See text for further explanation.
experimentally observed learning rule (Zhang et al.,
Nature 395: 37 [1997]). More recently, in collabora-
tion with Zachary Mainen here at CSHL, we have also
turned to mapping our "many are equals" computa-
tional operation to properties and computations of the
olfactory bulb; we are now investigating how different
task contexts (word recognition, olfaction) affect the
learning rule that we derived.
SENSORY COMPARISON AND DECISION
PROCESSES
In collaboration with the awake monkey experimental
laboratory of Ranulfo Romo at the National
University of Mexico, we have investigated various
aspects of a somatosensory discrimination task. Two
500-msec-long mechanical vibrations, separated from
each other by 3 seconds, were applied sequentially to
the tip of a monkey's finger. The monkeys were trained
to compare the two vibrations. They had to decide
which one had the higher frequency of vibration, and
then indicate their decision by pressing, with their
unstimulated free hand, one of two pushbuttons in
front of them. Previously, we investigated the short-
term memory component of this task (to compare the
two stimuli, the monkey must remember the frequen-
cy of the first one during the delay between the two;
Romo et al., Nature 399: 470 [1999]). During 2001,
we focused on neuronal responses during the second
stimulus period, when the monkey is comparing the
two stimuli and deciding which of the two is the high-
er. How does this comparison and the ensuing decision
take place? It has generally been thought that such
decision-related processes take place in higher-level
areas of cortex. Neurons of the prefrontal cortex (a
high-level area) and of the second somatosensory cor-
tical area (S2, a relatively early sensory cortex) were
recorded while the monkeys carried out the task. Since
S2 is an early somatosensory cortex, we expected neu-
rons in S2 to simply encode the first stimulus (which
we call fl) during the first stimulus period and encode
the second stimulus (12) during the second stimulus
period. Because of the long delay between the two (3
seconds), we expected no interaction between them.
However, we found that many neurons in S2 appeared
to encode the comparison between fl and 12 and, in
addition, encoded the monkey's resulting decision. We
found this by analyzing the neuronal data by fitting
each neuron's firing rate response as a linear function
of both fl and f2. The coefficients of these fits are
shown, for different time windows during and after the
second stimulus, in Figure 2. As time progressed, neu-
ronal responses gradually became a function of 12-fl
(see Fig. 2c,d, where data points are aligned along the
diagonal dashed line that indicates the 12 -fl axis). Note
that correct performance in the task depends on the
sign of f2 -fl. In other words, during the second stimu-
lus period, the responses of S2 neurons gradually
became correlated with the comparison between 12 and
fl that was necessary for the monkey to make its deci-
sion. Responses similar to those illustrated in Figure 2
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were also recorded in the prefrontal cortex. Since such
responses depend on fl, and information about fl is
not stored in S2, our results suggest that an important
role for feedback pathways to early sensory areas (such
as S2) may be to allow sensory areas to participate
directly in sensory comparisons and decisions.
MODELING AND PSYCHOPHYSICS OF
SHORT-TERM MEMORY
The sensory discrimination task described in the pre-
vious section involves a short-term memory compo-
nent: Subjects that compare two stimuli presented
sequentially in time must maintain a memory of the
first stimulus during the time delay between the two
stimuli. We have begun efforts to develop models of
networks of neurons that can actively maintain such
information in the neurons' firing rates. Some of the
generic properties of such models have implications
that can be tested in human psychophysical experi-
ments. For example, when remembering a stimulus
presented as a continuous analog variable (such as the
frequency of a mechanical vibration), it has been
widely assumed that a corresponding continuum of
possible memories is possible. Yet networks that allow
a continuum of memories are far less robust than net-
works that allow only a discrete set of possible memo-
ries. This has motivated us to search for signatures of
discreteness observable in psychophysical experi-
ments; we are setting up to specifically test for such
signatures.
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PRINCIPLES OF BRAIN DESIGN
D.B. Chklovskii A. Stepanyants
Our goal is to understand the function of the human
brain. We pursue this goal by building quantitative the-
ories that account for existing observations and make
experimentally testable predictions. Our main focus is
on the physical constraints of brain design. The idea is
that any computational strategy used in the brain must
be implemented in biological hardware. Because of
the high computational complexity of many brain
functions, this hardware is very complex. Therefore,
evolution had to solve difficult engineering problems
to come up with a working model. By analyzing vari-
ous constraints on the brain design, we hope to under-
stand which computational strategies the brain is
using. One important constraint on the brain design is
the space, or the so-called wiring economy principle.
By using this principle, we were able to explain many
features of brain design: from neuronal arbor mor-
phology to cortical maps. Recently, we started explor-
ing another important factor in brain design: plasticity
potential of the neuronal circuits. Because the genes
cannot foresee the precise environment that the organ-
ism is born into, the organism must be adaptable.
Adaptability of the neuronal circuits is usually
referred to as plasticity.
Direction Preference Maps
in the Visual Cortex: A Wire Length
Minimization Approach
D.B. Chklovskii [In collaboration with A.A. Koulakov,
University of Utah]
Neurons in the mammalian visual cortex respond to
the movement of objects across their receptive field.
Direction of movement, which evokes the most vigor-
ous response, determines the direction preference of a
neuron. The spatial arrangement of direction of
motion preference on the cortical surface is known as
the direction preference map. Maps of direction pref-
erence vary in appearance between species and corti-
cal areas. We propose that the observed variability in
map appearance reflects the variability in intracortical
circuits as a consequence of wire length minimization.
This hypothesis allows us to bypass a detailed devel-
opmental analysis of map formation. We solve the lay-
out optimization problem numerically for various
intracortical circuits and obtain direction preference
maps that reproduce the observed variability in map
appearance. These results allow one to predict intra-
cortical connectivity from the appearance of direction
preference maps.
Search for Repeating Motifs
in Biological Networks
D.B. Chklovskii [In collaboration with U. Alon,
Weizmann Institute]
The functioning of living organisms relies on numerous
complex networks: from gene transcription regulation to
neuronal circuits in the brain. Although these networks
have been mapped out in simpler cases: Escherichia colt
(transcription regulation) and Caenorhabditis elegans
(synaptic connectivity), their function is not understood.
Identifying functional modules out of subsets of the
whole network may help our understanding of these net-
works. The goal of this project is to search for function-
al modules including several neurons in C. elegans. The
hope is that the modules which have a particular func-
tional role are present more often than by chance. To
find them, we perform a statistical analysis on a real net-
work and compare the outcome with a randomized net-
work. So far, it seems that some connectivity motifs are
statistically significant.
Branching Law for Axons
A. Stepanyants, D.B. Chklovskii
Multicellular organisms have solved the problem of
efficient transport of nutrients and communication
between their body parts by evolving spectacular net-
works: branching trees, blood vessels, bronchs, and
neuronal arbors. These networks consist of segments
bifurcating into thinner and thinner branches.
Understanding of branching in transport networks has
been advanced through the application of the opti-
145
mization theory. Here, we apply the optimization the-
ory to explain the caliber of branching segments in
communication networks, i.e., neuronal axons. We
pursue the hypothesis that the axonal caliber has
evolved to minimize signal propagation delays, while
keeping arbor volume to a minimum. We show for a
general cost function that the optimal diameters of
mother (do) and daughter (c1,,c12) branches at a bifurca-
tion obey a branching law: d,r2 = clj+2 + d2'2. The
derivation relies on the fact that the conduction speed
scales with the axon diameter to the power v (v = 1 for
myelinated axons and v = 0.5 for nonmyelinated
axons). We tested the branching law on the available
experimental data and found a reasonable agreement.
Relationship between Neurite
Diameters and Branching
Angles in Cultured Neurons
D.B. Chklovskii [In collaboration with A. Ayali,
Tel-Aviv University]
The wiring economy principle predicts a relationship
between branching angles of neurites and their diam-
eters. This prediction can be derived by balancing vir-
tual forces on neurite branches and is reminiscent of
the cosine theorem. However, testing this prediction in
vivo is problematic because of the high density of
entangled neurite branches. Therefore, we decided to
perform the test in a low-density neuronal culture.
Neurite diameters can be measured with high preci-
sion by scanning electron microscope, whereas angles
are easily available from optical microscopy. This
allows us to compare the measured angles and diame-
ters with the theoretical predictions.
Structural Plasticity of Dendritic
and Axonal Branching
A. Stepanyants, D.B. Chklovskii
Dendritic and axonal arbors come in a dazzling vari-
ety of different shapes that had been known for more
than a century but remained unexplained. We have
shown in the past that the wiring economy principle
explains the sizes (diameters) of arbors as well as the
typical mesh size. However, the topology of arbors as
characterized by the branching structure remains
unconstrained. We pursue the hypothesis that the
branching structure of neuronal arbors is determined
by the plasticity requirements on synaptic connectivi-
ty. Indeed, neuronal arbors must accommodate the
146
inevitable variability in possible locations of appropri-
ate presynaptic inputs. Branching of the processes
enhances plasticity because branches can be formed or
eliminated locally, without global remodeling of the
arbor shape. We developed two models describing
arbor plasticity: one is potentially more appropriate
for developmental plasticity, and the other, for adult
plasticity. Our predictions can be tested in the experi-
ments done by the Svoboda lab here at CSHL.
Optimal Stimulus Design
D.B. Chklovskii, K. N'Diaye
Neurons in the brain respond to sensory stimuli by fir-
ing action potentials. The firing rate of a particular
neuron depends on which stimulus is presented to the
animal. Stimulus to which a neuron responds with the
highest firing rate is called the optimal stimulus.
Therefore, a neuron can be thought of as a detector for
an optimal stimulus. Although we know what the opti-
mal stimulus is for some neurons, for the majority of
neurons, it remains unknown. Our goal is to design a
computer algorithm that would automatically search
for an optimal stimulus (Fig. 1). This is a very difficult
task because the dimensionality of the stimulus space
is extremely high. We are currently designing an
appropriate algorithm and testing it against a comput-
er model of a neuron with a known optimal stimulus.
Contribution of the Dendritic
Spines to the Structural
Plasticity: A Comparative Study
A. Stepanyants, D.B. Chklovskii [In collaboration with
P.R. Hof, Mount Sinai School of Medicine]
Learning and memory rely on changes in neuronal cir-
cuits, or plasticity. One possible mechanism of plastic-
ity is a dendritic spine retracting from a current presy-
naptic axon and extending toward another axon. Such
switching of presynaptic partners is only possible if
within a spine length of a dendrite there are available
axons, which do not have synapses with the dendrite.
The availability of such adjacent axons relies on their
abundance relative to the number of spines on a given
dendrite (Fig. 2). If the number of axons within a spine
length of a dendrite is equal to the number of spines
(Fig. 2B), then there are no available presynaptic part-
ners and spine remodeling cannot contribute to circuit
reorganization. If the number of adjacent axons is
greater than the number of spines (Fig. 2C), then spine
computer for
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FIGURE 1 Schematic diagram showing procedure for stimulus optimization using a genetic algorithm. A
computer generates an ensemble of auditory stimuli (left box), which are then presented to a rat (middle box)
whose neuronal activity is being monitored (right box). The neural activity is then fed back into the stimulus
generator, where it is used to assess the fitness. Note that although the example described here is auditory,
the approach is general.
remodeling can contribute to circuit reorganization
(Fig. 2D). To determine which scenario (Fig. 2, B or
C) better reflects the real brain, we have derived a
mathematical expression for the ratio of actual synaps-
es to adjacent axons, which we call the filling fraction,
in terms of anatomical parameters that can be mea-
sured by light microscopy. We found that the filling
fraction in mammalian cortical structures (mouse neo-
cortex, rat hippocampus, and macaque visual areas) is
about 0.2. This means that there are roughly five times
more available axons than spines. Therefore, spine
remodeling can contribute to reorganization of cortical
filling fraction, f = ? filling fraction, f = 1
filling fraction, f = 3/7
FIGURE 2 Spine remodeling as a mechanism for circuit reor-
ganization. (A) Spiny dendrite in macaque neocorten visualized
by light microscopy. (8) If the number of adjacent axons is equal
to the number of spines (filling fraction equal to one), spine
remodeling cannot contribute to circuit reorganization. (C) If the
number of adjacent axons is much greater than the number of
spines (low filling fraction), spine remodeling can contribute to
circuit reorganization. Dashed contours show possible spine
locations. (D) Reorganized circuit obtained from C through
spine remodeling.
circuits. In addition, we found significant differences
in the filling fraction between different V1 and other
visual areas of macaque.
Spontaneous Monocular Deprivation
in the Vicinity of Vertical Meridian
Representation in the Visual Cortex
D.B. Chklovskii [In collaboration with M. Rosa,
Monash University]
It is hard to overestimate the importance of the
Blackford bar for the scientific progress at Cold
Spring Harbor Laboratory and the rest of the world.
This project was started by the observation of an inter-
esting feature in the ocular dominance pattern, which
can be observed in a photograph hanging on the wall
of the bar. In particular, the representation of the two
eyes in the vicinity of vertical meridian is biased: One
eye occupies a greater fraction of the territory than the
other. We propose that this bias is a reflection of a
decussation asymmetry in the optic chiasm. This pro-
ject explores whether this asymmetry is a develop-
mental error or a manifestation of a stereopsis strategy.
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ACTIVITY-DEPENDENT NEURONAL DEVELOPMENT
H.T. Cline C.D. Aizenman R. Ewald A. Javaherian E. Rial Verde
C. Akerman E. Fingar (URP) K. Jensen E. Ruthazer
K. Bronson L. Foa Z. Li W.-C. Sin
I. Cantallops K. Haas
We are interested in understanding the function of
neuronal activity in brain development. We address
this issue by examining the development of the visual
system in amphibian tadpoles. These animals are
transparent, which allows us to observe brain develop-
ment in the living animal. Many of the experiments we
perform involve in vivo imaging of neuronal structure
over periods up to several weeks. In addition, we
assess neuronal function using electrophysiological
assays of synaptic connectivity and synaptic plasticity.
We combine these studies with gene transfer methods
that allow us to test the function of genes of interest in
brain development. This range of technical approach-
es allows us to identify key regulatory mechanisms
governing the development of brain structure and
function.
Our experiments have demonstrated the important
role of synaptic activity in promoting the development
of the brain. Therefore, we are devoting considerable
effort to determine the mechanisms of synapse forma-
tion and the role of excitatory and inhibitory inputs in
the formation of retinotectal connections. Another
potential effect of synaptic activity is to induce gene
transcription. The activity-induced genes may then
promote the further development of the brain. We have
continued our investigations of several activity-
induced Fries to test their potential function in brain
development.
Electroporation-mediated
In Vivo Gene Transfer
K. Haas, L. Foa, A. Javaherian, K. Jensen, Z. Li,
W.-C. Sin, H.T. Cline
Electroporation is becoming a popular technique for
gene delivery into neurons within intact tissue. One
advantage of electroporation over other transfection
techniques is the ability to target a particular brain
region, or even single neurons, for transfection.
Several members of the lab have continued our efforts
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to optimize electroporation-mediated gene transfer.
Kurt Haas, working with Ashkan Javaherian, Kendall
Jensen, Zheng Li, and Wun Chey Sin, has improved
methods for single-cell electroporation into neurons
within the optic tectum and spinal cord of living
Xenopus tadpoles. Kurt Haas has also worked with
several scientists visiting Cold Spring Harbor
Laboratory in an effort to optimize electroporation
into cells in other preparations, including intact chick-
en embryos and tissue slices from avian and mam-
malian brain and spinal cord. K. Jensen and L. Foa
have developed methods to restrict transfection to
clusters of cells, or to include large portions of the
brain or retina of the intact Xenopus tadpole.
Restriction of transfection to individual cells aids in
imaging of neuronal morphology, and bulk cell trans-
fection allows examination of the effects of gene
expression on populations of cells by biochemical
assays, imaging, and electrophysiological recording.
Regulation of RhoA GTPases
by Cross-talk and Neuronal
Activity In Vivo
Z. Li, C.D. Aizenman, H.T. Cline [in collaboration with
L. Van Aelst, Cold Spring Harbor Laboratory]
Proper development of neurons depends on synaptic
activity, but the mechanisms of activity-dependent neu-
ronal growth are not well understood. The small
GTPases, RhoA, Rac, and Cdc42, regulate neuronal
morphogenesis by controlling the assembly and stabil-
ity of the actin cytoskeleton. Li previously demonstrat-
ed that expression of mutant forms of GTPases affect-
ed tectal cell dendritic arbor development in vivo. This
year, Li developed an in situ method to determine
endogenous Rho GTPase activity in intact Xenopus
brain. She used this method to provide evidence for
cross-talk between Rho GTPases in optic tectal cells in
vivo. Moreover, Li demonstrated that cross-talk
between the Rho GTPases affects dendritic arbor
development in the intact animal. Finally, Li and C.
Aizenman demonstrated that optic nerve stimulation
regulates Rho GTPase activity in a glutamate receptor-
dependent manner. These data suggest a link between
glutamate receptor function, Rho GTPase activity, and
dendritic arbor growth in the intact animal.
Visual Stimulation Regulates
Dendritic Arborization by a
Mechanism Requiring NMDA-R
Activation and Rho GTPases In Vivo
W.-C. Sin, K. Haas, E. Ruthazer, H.T. Cline
[in collaboration with L. Van Aelat, Cold Spring
Harbor Laboratory]
The mechanisms by which sensory input shapes neu-
ronal development are not known. W. -C. Sin demon-
strated by in vivo time-lapse imaging of Xenopus lae-
vis tadpoles that enhanced visual activity driven by a
light stimulus promotes optic tectal cell dendritic
arbor growth. K. Haas collected images of optic tectal
neurons once an hour over 8 hours with the 2-photon
microscope. These images allowed us to analyze arbor
dynamics during light-induced dendritic arbor
growth. The data show a rapid transition in rates of
branch dynamics when animals are exposed to visual
stimulation. The data analysis of these four dimen-
sional data sets was carried out using macros con-
ceived and written by E. Ruthazer. The stimulus-
induced dendritic arbor growth requires glutamatergic
synaptic transmission, decreased RhoA activity, and
increased Rac activity. Furthermore, we know from
the experiments of Li and Aizenman (see above) that
increasing synaptic activity with optic nerve stimula-
tion down-regulates endogenous RhoA activity and
increases endogenous Rac activity. The results delin-
eate a role for Rho GTPases in the structural plastici-
ty driven by visual stimulus in vivo.
Competition-based Dynamics
of Retinotectal Axon Morphology
in Xenopus Optic Tectum
E. Ruthazer, H.T. Cline
Coactive retinal input activity is required to maintain
the topographic retinal projection into the optic tectum
and other sensory projections; however, the require-
ment for patterned afferent activity in the establishment
of topographic projections is not clear. E. Ruthazer has
carried out experiments to test the requirement for
afferent activity in the formation of organized retino-
topic projections. He uses Xenopus tadpoles in which
both retinas are forced to innervate the same optic tec-
tum. Under these conditions, the inputs from the two
eyes gradually segregate out to form eye-specific
innervation zones. E. Ruthazer used time-lapse imag-
ing with the 2-photon microscope to observe the mor-
phological rearrangements that occur in retinal axon
arbors during competition-based afferent segregation.
He finds that axon branches are selectively stabilized
in regions innervated by other axons from the same
eye, i.e., regions in which there is a relatively high
degree of afferent coactivity. In contrast, branches are
rapidly retracted from zones in which the dominant
input is derived from the other eye, i.e., regions of low
coactivity. The selective stabilization is blocked by N-
methyl-n-aspartate receptor (NMDA-R) antagonists.
This indicated that the NMDA type of glutamate recep-
tor is required for the selective stabilization of axon
branches during the initial formation of eye-specific
zones in the optic tectum.
Visually Driven Modulation
of Glutamatergic Synaptic
Transmission by Intracellular
Polyamines
C.D. Aizenman, G. Munoz, H.T. Cline
Sensory-driven, activity-dependent mechanisms have
been implicated in brain development, yet little is
known about short-term effects of enhanced sensory
experience. C. Aizenman examined the effects of 4
hours of increased visual stimulation on retino-tectal
synapses of developing Xenopus tadpoles. Tectal neu-
rons have Ca++-permeable a-amino-3-hydroxy-5-
methyl-4-isoxazole receptors (AMPA-Rs), as revealed
by kainate-induced Co++ labeling. These receptors are
inwardly rectifying due to an interaction of intracellu-
lar polyamines with negatively charged residues in the
channel pore. Whole-cell voltage-clamp recordings of
optic tectal neurons revealed varying amounts of
inward rectification in AMPA-R-mediated excitatory
postsynaptic currents (EPSCs). Inward rectification
was increased by adding the polyamine, spermine, to
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the recording pipette. This suggests that endogenous
polyamine concentrations are not saturating with
respect to the AMPA-R block and are a possible mech-
anism for synaptic modulation. A 4-hour period of
enhanced visual stimulation also resulted in an overall
increase of inward rectification, an effect that was
occluded by recording with spermine in the pipette.
Ornithine decarboxylase (ODC), the rate-limiting
enzyme in polyamine synthesis, is increased with
activity. Treating tadpoles with difluoromethyl
ornithine (DEMO), an ODC blocker, during light stim-
ulation also prevented light-induced changes in recti-
fication. Together, the data suggest that light can reg-
ulate AMPA-R-mediated transmission via the
polyamine synthesis pathway. This may function to
compensate for increased levels of activity experi-
enced during visual stimulation and thus maintain a
constant level of excitation.
Role of GABAergic Transmission
in Visual System Development
C. Akerman, H.T. Cline
We are using the Xenopus optic tectum to study the
development and interactions sys-
tems during the construction of a functional neuronal
circuit. Previous electrophysiological studies in the
laboratory have focused on synapses that use gluta-
mate, the major excitatory neurotransmitter in the
brain. These studies showed that glutamatergic
synapses follow a developmental sequence in which
immature synapses use predominantly one type of
receptor called the NMDA-R. As these synapses
mature, they acquire a different type of glutamate
receptor called the AMPA-R. Using electrophysiolog-
ical methods, we have now shown that during the same
period of development, tectal cells also express recep-
tors for two further neurotransmitters-glycine and
GABA (7-amino-n-butyric acid). Classically, when
these receptors are activated in the mature brain, they
generate an inhibitory effect. However, our prelimi-
nary studies indicate that intracellular levels of ions in
the immature tectal cells could actually make these
receptors excitatory. Consistent with this, our
immunohistochemistry has shown that these cells do
not yet express the ionic transporters that are believed
to make these transmitters inhibitory. We are now in a
position to test directly the function of these transmit-
ter systems in the development of the tectal circuit.
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CPG15 Regulation of Circuit
Development In Vivo
I. Cantallops, M. Davenne, A. Javaherian,
K. Bronson, H.T Cline [in collaboration with
E. Nedivi, Massachusetts Institute of Technology]
The activity-regulated candidate plasticity gene 15
(cpg15, also known as neuritin) encodes a glyco-
sylphosphatidylinositol (GPI)-linked protein. E.
Nedivi, G.-Y. Wu. and H.T. Cline previously demon-
strated that CPG15 expression in vivo increases the
dendritic arbor growth rate of Xenopus optic tectal
cells. I. Cantallops has shown that CPG15 expression
enhances retinal axon arbor elaboration, and K. Haas
has demonstrated that CPG15 promotes retinotectal
synapse maturation. A thorough understanding of
CPG15 function requires knowledge of the spatiotem-
poral expression of the endogenous protein. A.
Javaherian cloned Xenopus cpg15 and together with E.
Nedivi used RNA in situ hybridization and immuno-
histochemistry to determine the pattern of CPG15
expression. cpg15 mRNA and CPG15 protein are first
detectable in the developing spinal cord and become
widespread as development proceeds. CPG15 is
expressed in sensory regions of the brain, including
the visual, auditory, and olfactory systems. Within the
retina, CPG15 is only expressed in retinal ganglion
cells. CPG15 protein is concentrated in axon tracts,
including retinal axons. These data support a model in
which CPG15 expressed in retinal ganglion cells is
trafficked to retinal axons, where it modulates postsy-
naptic dendritic arbor elaboration and synaptic matu-
ration. To pursue the mechanisms by which CPG15
carries out its growth-promoting action, I. Cantallops
has been examining the trafficking of CPG15 in reti-
nal axons and M. Davenne has attempted to reduce
CPG15 expression in the retina.
Role of Homer Proteins
in Axon Pathfinding In Vivo
L. Foa, E. Fingar, K. Bronson, H.T. Cline
[in collaboration with P. Worley, Johns Hopkins University]
Axon pathfinding during early stages of central ner-
vous system (CNS) development is essential to estab-
lish the fundamental connectivity of the brain.
Mechanisms of axon pathfinding include receptor-
mediated recognition of attractive and repulsive cues
in the environment, which induce changes in the
direction of the axonal growth cone. Homer proteins
are a family of multidomain cytosolic proteins which
have been postulated to serve as scaffold proteins that
affect responses to extracellular signals by regulating
protein-protein interactions. One isoform of Homer
proteins, called Homerl a, is induced by activity in the
rodent and Xenopus. L. Foa tested whether Homer
proteins have a role in axon pathfinding in vivo by
expressing both wild-type and mutant isoforms of
Homer in Xenopus optic tectal neurons. Time-lapse
imaging demonstrated that interfering with the ability
of endogenous Homer to form protein-protein interac-
tions resulted in axon pathfinding errors at stereotyp-
ical choice points.
These data demonstrate a novel function for scaf-
fold proteins such as Homer in axon guidance. Homer
may facilitate signal transduction from cell surface
receptors to intracellular proteins that govern the
establishment of axon trajectories.
Regulation of Cell Proliferation
in Xenopus Brain by Nitric Oxide
H.T. Cline [in collaboration with N. Peunova,
V. Scheinker, and G. Enikolopov, Cold Spring
Harbor Laboratory]
The regulation of the progression from proliferation to
differentiation in the population of precursor cells has
direct bearing on the formation of a functional nervous
system. Nitric oxide (NO) may mediate such a transi-
tion, since it can suppress DNA synthesis and cell pro-
liferation. We cloned the gene encoding the neuronal
isoform ofXenopus NO synthase (XNOS) and found
that in the developing brain of Xenopus tadpoles, a
zone of XNOS- expressing cells lies adjacent to the
zone of dividing neuronal precursors. Exogenous NO,
supplied to the tadpole brain in vivo, decreased the
number of proliferating cells and resulted in an overall
decrease in the total number of cells in the optic tec-
turn. Conversely, inhibition of NOS activity in vivo
increased the number of proliferating cells and the total
number of cells in the optic tectum. This NOS inhibi-
tion yielded larger brains with grossly perturbed orga-
nization. Our results indicate that NO is an essential
negative regulator of neuronal precursor proliferation
during vertebrate brain development.
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SIGNAL TRANSDUCTION AND DIFFERENTIATION
G. Enikolopov J. Hemish J. Mignone
P. Krasnov B. Mish
B. Kuzin (Visiting Sci.) N. Nakaya
M. Maletic-Savatic (Visiting Sci.) M. Packer
T. Michurina N. Peunova
Our laboratory is interested in signaling pathways that
control transitions through the differentiation cascade.
During the last several years, we have demonstrated
that nitric oxide (NO), a versatile signaling molecule,
is an important regulator of progression of stem and
progenitor cells through the cascade. Part of this regu-
lation is due to the antiproliferative properties of NO
that we have demonstrated in several developmental
contexts. We are continuing to work on Drosophila
and Xenopus, and we are characterizing the role of NO
in mammalian development, with a focus on hemato-
poiesis and neurogenesis. We are now concerned with
identifying the molecular and genetic interactions of
the NO signals with the major signaling pathways in
differentiating cells.
Our studies of signaling during development have
led us closer to questions about the biology of stem
and progenitor cells, which have now become an
important new area of interest for our laboratory. We
have generated several mouse models in which select-
ed classes of cells in the brain are marked, and we are
using these animals to investigate the origins and plas-
ticity of stem cells.
NO and Mouse
Hematopoiesis
T. Michurina, P. Krasnov
The proliferative activity of hematopoietic stem cells
in the bone marrow is highly restricted. We wondered
if NO has the potential to mediate stem cell quiescence
since it can alter gene expression and effectively sup-
press cell proliferation. We found that the population
of Sca- I+ cells in mouse bone marrow is strongly
enriched in NO synthase (NOS) mRNA and protein.
When mice are exposed to inhibitors of NOS after
bone marrow transplantation, there is an increase in
the proportion of bone marrow cells carrying markers
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V. Scheinker
Y. Stasiv
A. Vaahtokari
T. Sonbuchner (URP)
of stem and early progenitor cells. Retransplantation of
bone marrow from animals treated with NOS
inhibitors after primary transplantation demonstrates
that the fraction of early hematopoietic precursors
capable of forming colonies in the spleens of the sec-
ondary recipients (pre-CFU-S) is also increased. Upon
cessation of treatment with NOS inhibitors, this
increase is shortly followed by an increase in the num-
ber of neutrophils in the peripheral blood of the ani-
mals. Furthermore, exposure to NOS inhibitors also
strongly affected erythroid and granulocytic differenti-
ation of bone marrow cells and resulted in the accu-
mulation of less mature blast cells. Our results suggest
that NO may act to restrict progression through the cell
cycle at both early and late stages of the cascade of
hematopoietic differentiation.
NO and Neurogenesis
in the Adult Brain
M. Packer [in collaboration with S. Goldman,
Cornell Medical School]
A large number of neurons are continuously generated
in the postnatal mammalian brain. The signaling mes-
sengers that regulate the number of dividing cells in
the adult brain are largely unknown. We blocked pro-
duction of NO by intraventricular infusion of NOS
inhibitor and found that the number of new cells in
both neurogenic and nonneurogenic areas of the adult
brain was greatly increased. Most of these newly gen-
erated cells express neuronal markers. Importantly,
inhibition of NOS activity induced generation of new
cells in the areas of the brain that are not renowned for
persistent adult neurogenesis. One of these regions is
the striatum, a region affected in many degenerative
neurological disorders. Our results indicate that NO
acts as an important negative regulator of cell prolifer-
ation in the adult brain.
NO and Gene Expression
N. Nakaya, J. Hemish
We have found that NO blocks proliferation of NIH
3T3 cells and murine embryonic fibroblasts at various
points of the cell cycle. To understand the mechanisms
of NO-induced cell cycle arrest, we studied the
changes in the gene expression profiles in NIH 3T3
cells treated with NO donors using microarray analy-
sis. These cells stop dividing after treatment with NO
donors without any signs of cell death. The effect of
NO was reversible and cells resumed growth 48 hours
after the treatment. Using microarray hybridization
with about 10,000 genes, in collaboration with V
Mittal here at CSHL, we found that NO induces pro-
found changes in gene expression. We next used quan-
titative real-time reverse transcriptase-polymerase
chain reaction (Q-RT-PCR) to obtain a more precise
estimate of the changes and to analyze the signaling
pathways that mediate NO-induced gene expression.
We found that some genes are induced through NFKB-,
guanylylcyclase-, PI3K-, PKC-, and p53-dependent
pathways. We are currently analyzing the microarray
data to gain insight into the time course of sequential
gene induction by NO.
Some of the expressed sequence tag (EST) clones
induced by NO were analyzed in more detail. In par-
ticular, we focused on a novel gene that we termed
noxin and whose expression was dramatically
increased after exposure to NO. We determined the
complete sequence of the gene, its genomic structure,
and its expression pattern. The noxin gene is expressed
in the developing brain and in several adult tissues.
The noxin protein is highly serine-rich, has ataxia
telangectasia mutated (ATM) and DNA-PK phosphor-
ylation consensus sequences, and carries a potential
nNOS-PDZ interaction domain. It accumulates at spe-
cific points of the cell cycle, and its expression in
fibroblasts is partially dependent on p53. Our results
suggest that noxin may be an important mediator of
NO action in the control of the cell cycle.
NO and Xenopus Brain
Development
N. Peunova, V. Scheinker [in collaboration with
H. Cline, Cold Spring Harbor Laboratory]
Mechanisms controlling the transition from prolifera-
tion to differentiation of neural precursor cells during
brain development determine the distinct anatomical
features of the brain. NO may mediate such a transi-
tion, since it can suppress DNA synthesis and cell pro-
liferation. We cloned two genes encoding Xenopus NO
synthase (XNOS). Both genes code for enzymatically
active protein which is analogous to the neuronal NOS
isoform of mammals. In the developing brain of
Xenopus tadpoles, a zone of XNOS-expressing cells
lies adjacent to the zone of dividing neuronal precur-
sors. Exogenous NO, supplied to the tadpole brain in
vivo, decreased the number of proliferating cells and
the total number of cells in the optic tectum.
Conversely, inhibition of NOS activity in vivo
increased the number of proliferating cells and the
total number of cells in the optic tectum. NOS inhibi-
tion yielded larger brains with grossly perturbed orga-
nization. Our results indicate that NO is an essential
negative regulator of neuronal precursor proliferation
during vertebrate brain development.
NO and Drosophila Development
Y. Stasiv, B. Kuzin [in collaboration with M. Regulski and
T. Tully, Cold Spring Harbor Laboratory]
In the Drosophila genome, NO synthase is encoded by
a single gene (dNOS). Analysis of this gene reveals
that it encodes a family of at least ten transcripts of
different structures. Alternative promoters and alterna-
tive splicing sites are used to produce the observed
RNA diversity. Alternative splicing of the primary
dNOS transcript changes the coding capacity of the
resulting isoforms. Most of the splicing alterations in
the coding region of the dNOS gene lead to premature
termination of the open reading frame. As a result,
none of the alternative transcripts encode enzymati-
cally active protein. However, some of these shorter
DNOS proteins are capable of suppressing enzymatic
activity of the full-length active enzyme (DNOS1)
when coexpressed in cultured mammalian cells. Thus,
these protein isoforms act as dominant-negative regu-
lators of NO synthesis. Using immunoprecipitation,
we demonstrated that these truncated DNOS proteins
form heterodimers with DNOS1, pointing to a physi-
cal basis for the dominant-negative effect. To investi-
gate the biological role of one of the most abundant
dNOS transcripts, dNOS4, we generated transgenic
flies expressing this isoform under the control of dif-
ferent promoters (inducible, tissue- and development-
specific). Analysis of our transgenic models clearly
demonstrates that overproduction of DNOS4 in the
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developing Drosophila suppresses the antiproliferative
action of DNOS1 and causes a hyperproliferative phe-
notype in adult flies. We detected endogenous DNOS4
expression in fly extracts using antibody raised against
its unique carboxyl terminus. Using immunoprecipita-
tion, we were able to detect heterodimeric DNOS1/
DNOS4 complexes formed in vivo, indicating that
DNOS4 acts as an endogenous dominant-negative reg-
ulator of NO synthesis in Drosophila.
Neuronal NOS Knockout Mice
Y. Stasiv
The majority of NOS catalytic activity in the mouse
brain is accounted for by neuronal NOS (nNOS). To
study the role of nNOS in the developing and adult
nervous system, we generated nNOS knockout mice.
We used homologous recombination to delete exon 6
of the gene. This exon encodes a heme-binding site
that is crucial for enzymatic activity. In collaboration
with Heiner Westphal's laboratory (National Institute
of Child Health and Human Development), we gener-
ated homozygous nNOS-/- mutant mice. These ani-
mals lack nNOS, and catalytic NOS activity was not
detectable in their brains. Although these mice do not
show a survival disadvantage as compared with their
wild-type or heterozygous littermates, they display a
significant increase in premature death shortly after
birth. Currently, together with Michael Packer in the
lab, we are studying the role of nNOS in neurogenesis
by analyzing patterns of bromodeoxyuridine (BrdU)
incorporation in embryonic and adult -/- brains. In
collaboration with John Mignone in our lab, we are
now generating nNOS -/- mice that have various lin-
eages of the brain cells differentially marked using
particular fluorescent proteins.
Visualization of Stem, Progenitor,
and Differentiated Cells in the Brain
A. Vaahtokari, M. Maletic-Savatic, B. Mish
Our interest in signal transduction during differentia-
tion prompted us to explore more general issues of
neural stem cell biology. We have generated several
mouse lines in which particular classes of progenitors
and differentiated cells are differentially marked by
expression of fluorescent proteins. We are now able to
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identify, track, and isolate subclasses of cells at spe-
cific points in the differentiation cascade. We are also
using these mice to follow the course of neuronal dif-
ferentiation in the neurogenic areas of the developing
and adult brain.
Neural Stem and Progenitor
Cells in the Developing
and Adult Brain
J. Mignone
We are interested in neurogenesis in the adult brain
and in plasticity of neural stem cells in the adult organ-
ism. By placing green fluorescent protein (GFP) under
the regulatory control of the nestin promoter, we are
able to specifically label a small pool of neural stem
cells throughout the central nervous system. They are
present in the dentate gyms, subventricular zone, and
rostral migratory stream, areas where adult neurogen-
esis is known to be supported. These cells can be char-
acterized both in vivo and in vitro for their ability to
generate neurons, astrocytes, and oligodendrocytes in
the adult brain. We are particularly interested in the
question of quiescence of various stem and progenitor
populations in the adult brain. To discriminate
between various subclasses of neural progenitors, we
are studying the changes in nestin-GFP cells following
exposure of the brain to antimitotic drugs. This work
is further supplemented by the use of transgenic lines
that have been generated in our lab and that use dif-
ferential labeling of various lineages of the brain cells.
By using mice with differentially labeled subgroups of
cells, we will be able to pursue the fate of neural stem
cells. Furthermore, in collaboration with Tatiana
Michurina, we have been transplanting the cells from
nestin-GFP mice to discern the degree to which these
cells possess multipotent properties and their ability to
contribute to various lineages in the organism.
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CONSTRUCTION AND PLASTICITY OF NEOCORTICAL
GABAERGIC CIRCUITS
Z.J. Huang H. Higashiyama Q. Wang
G. diCristo T. Pal
B. Chattopadhyaya J. Walls
S. Kulhman
The cellular architecture of the neocortex is exceed-
ingly complex, yet there are well-defined cell types
and stereotyped synaptic connectivity patterns that are
strikingly conserved between different cortical areas
and among different mammalian species. The forma-
tion and functional tuning of these circuits are deter-
mined by both genetic instructions and epigenetic
influences such as experience. It is likely that the
genetic programs control the time course for the devel-
opment of these circuits and constrain the influence of
experience in shaping neuronal connectivity during an
early postnatal critical period. Characterization of the
neocortical microcircuits is essential to any theory of
cortical function. For decades, however, the cellular
heterogeneity, daunting connectivity, and complexity
have made the cortical circuit impenetrable to the neu-
robiologist due to the lack of appropriate experimental
tools. The rules that govern the wiring and communi-
cation of neurons within the cortex remain largely
unknown. Recent advances in our understanding of
neuronal gene expression, in genetic manipulations,
and in neuronal imaging provide new opportunities to
explore the design of neocortical circuits at unprece-
dented detail.
The GABAergic inhibitory circuits control neu-
ronal excitability and information processing at precise
spatial and temporal domains in neocortex. A fascinat-
ing yet puzzling feature of the cortical GABAergic sys-
tem is the rich array of interneuron cell types. These
cell types often display remarkably distinct morpholo-
gy, intrinsic physiological properties, synaptic input
and output patterns, and gene expression profiles. In
addition, the functional maturation of the GABAergic
system is strongly influenced by experience during
early postnatal ages and, as a result, may contribute to
the experience-dependent refinement of neocortical
circuits. We are using cell-type-specific promoters and
bacterial artificial chromosome (BAC) transgenic mice
to achieve GABAergic cell-type-specific labeling and
manipulations. Combined with physiological and
imaging techniques, we are studying the following set
of questions in the mouse visual cortex: How do dif-
ferent types of interneurons mature morphologically
and physiologically during the critical period of visual
cortical development? What are the effects of visual
deprivation on the maturation of GABAergic circuits?
How do neurotrophic factors regulate the experience-
dependent maturation of GABAergic interneurons?
How do specific types of GABAergic circuits con-
tribute to critical period plasticity?
BAC Transgenic Labeling of Defined
GABAergic Cell Types
H. Higashiyama, J. Walls, Z.J. Huang
In the visual cortex, the fast-spiking (FS) basket-type
interneurons selectively innervate the soma of target
neurons, are capable of high-frequency nonadaptive
firing, and express parvalbumin. On the other hand,
the low-threshold spiking (LTS) bitufted cells selec-
tively innervate the distal dendrites of targets, fire
broader spikes that show pronounced adaptation of fir-
ing frequency, and express somatostatin. How do
GABAergic interneurons develop such distinct mor-
phology, synaptic connectivity, and physiologic prop-
erty? To address these questions, we are using a series
of GABAergic transcriptional promoters to systemati-
cally label specific GABAergic cell types with green
fluorescent protein (GFP) variants using BAC trans-
genic mice. For example, we have generated BAC
transgenic mice expressing GFP driven by the GAD67
promoter (active in all GABAergic neurons) and parv-
albumin promoter (active in basket interneurons). In
these transgenic lines, the morphology of defined
GABAergic interneurons can be visualized at
unprecedented detail, in living brain tissue (Fig. 1). We
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FIGURE 1 (A) Neocortical basket interneurons labeled by BAC transgenic expression of GFP, imaged using confocal microscopy.
(Large arrows) Dendrites; (small arrows) axons; (small arrowheads) putative presynaptic boutons. (B,C) Two-photon imaging of the
development of basket interneuron innervation in visual cortical slice cultures prepared from BAC transgenic mice. (8) At postnatal
day 14 (10 days in vitro), putative basket interneuron boutons (arrowheads) were small and diffusely distributed. (C) At postnal day
23 (19 days in vitro), basket interneuron boutons were large and frequently formed ring-like (arrowheads) structures around the soma
of a target neuron.
are also characterizing several other BAC transgenic
lines expressing GFP variants in other subtypes of
GABAergic neurons expressing a different set of cal-
cium-binding proteins and neuropeptides.
These transgenic mice now allow us (1) to charac-
terize the development of somatic versus distal den-
dritic patterns of synaptic innervation in basket and
bitufted interneurons; (2) to examine the maturation
of distinct firing properties of these interneuron cell
types; and (3) to examine the effects of visual depri-
vation (e.g., dark rearing) on the maturation of these
interneuron cell types.
Morphological Maturation and
Plasticity of Basket
Interneurons in the Visual Cortex
G. diCristo, B. Chattopadhyaya, Z.J. Huang [in collaboration
with Karel Svoboda, Cold Spring Harbor Laboratory]
Basket interneurons are important components of
neorcortical circuits, yet the morphological develop-
ment of basket interneurons is poorly characterized.
The dynamics and structural plasticity of GABAergic
synapses are entirely unknown. In Pv-GFP BAC
transgenic mice, entire dendrites and presynaptic bou-
tons of basket interneurons are intensely labeled.
Using confocal and two-photon laser scanning
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microscopy, we are characterizing development in
dendritic structures and synaptic innervation of basket
interneurons during the critical period of visual cortex
using acute brain slices. We confirm that the majority
of GABAergic synapses made by basket interneurons
target the soma rather than the distal dendrites. The
size and shape and density of presynaptic boutons
mature during the critical period. We have also estab-
lished brain slice cultures from P2 BAC transgenic
mice, which can be grown for 3-4 weeks in vitro.
Therefore, we are now in a position to "watch" the
entire process of functional differentiation and matu-
ration of basket interneurons in both acute and cul-
tured visual cortical slices. We will develop morpho-
metric measurements to quantify the maturation and
dynamics of basket interneuron boutons. We will also
study the morphological plasticity of GABAergic
boutons in response to changes of neuronal activity.
Physiological Maturation and
Plasticity of Basket
Interneurons in the Visual Cortex
S. Kuhlman, Z.J. Huang
At the mature state, basket interneurons are capable of
high-frequency spike transmission and high-frequency
and nonadaptive firing, and they provide strong feed-
forward inhibition. However, the maturation and expe-
rience-dependent plasticity in firing properties and
synaptic transmission of basket interneurons are poor-
ly characterized. Our Pv-GFP BAC transgenic mice
allow, for the first time, reliable and efficient physio-
logical recording of basket interneurons during postna-
tal development. We are characterizing the maturation
of intrinsic firing properties and inhibitory synaptic
transmission of basket interneurons during the critical
period. We will also examine whether and how experi-
ence deprivation such as dark rearing retards such
physiological maturations. In parallel, using another
transgenic line that labels bitufted interneurons, we are
also characterizing the maturation and plasticity of
physiological properties of bitufted interneurons in the
visual cortex.
Role of Basket Interneurons in
Critical Period Plasticity in the
Visual Cortex
B. Chattopadhyaya, Z.J. Huang [in collaboration with
Lamberto Maffei, Institute of Neurophysiology, Italy]
GABAergic inhibitory circuits have been implicated
in the regulation of experience-dependent develop-
ment of the visual cortex. For example, ocular domi-
nance (OD) plasticity, the capacity of visual cortical
neurons to modify their eye preferences following
visual deprivation to either eye, was abolished in mice
deficient in an isoform of the GABA synthetic
enzyme (GAD65). Because GAD65-1- mice show no
critical period plasticity, yet are normal in other
aspects of visual physiology and function, this mutant
strain provides an ideal genetic background to sys-
tematically study the role of specific classes of
interneurons in OD plasticity using a transgenic "res-
cue" approach. We have generated BAC transgenic
mice expressing GAD65 under the control of the parv-
albumin promoter. We will introduce BAC transgenes
expressing GAD65 in basket interneurons into the
GAD65-7- mice by breeding. We will then test
whether expression of GAD65 in a specific class of
interneurons can restore critical period plasticity in
GAD65' mice. In addition, this strategy will allow
us to correlate the specific types of inhibitory mech-
anisms that are restored by cell-type-restricted
expression of GAD65 with the rescue of critical peri-
od plasticity.
BDNF Overexpression Rescue
of Effects of Visual Deprivation
of Visual Development
J. Walls, Z.J. Huang [in collaboration with Lamberto Maffei,
Institute of Neurophysiology, Italy, and Alfredo Kirkwood,
Johns Hopkins University]
Visual deprivation during an early postnatal period
profoundly influences the development and function of
the visual cortex. For example, dark rearing (DR)
decreases visual acuity and prolongs the critical period
for ocular dominance plasticity. In addition, dark rear-
ing also retards the maturation of the GABAergic inhi-
bition in the visual cortex. The molecular signals that
mediate the effects of dark rearing on the development
of the visual cortex are not well defined. The expres-
sion of the brain-derived neurotrophic factor (BDNF)
in the visual cortex is tightly regulated by visual expe-
rience. To test the role of BDNF, we examined the
effects of dark rearing in transgenic mice in which
BDNF expression in the visual cortex was driven by
the calmodulin protein kinase II (CaMKII) promoter,
and therefore was uncoupled from visual experience
and remained elevated under dark-rearing conditions.
In these transgenic mice, the visual acuity and recep-
tive field size of visual cortical neurons developed nor-
mally during dark rearing. More importantly, the
development of critical period for ocular dominance
plasticity was not delayed by dark rearing. Further-
more, intracortical inhibition matured in dark-reared
transgenic mice as in light-reared mice. Therefore,
BDNF overexpression is sufficient for the develop-
ment of several properties of the visual cortex in the
absence of visual experience. These results suggest that
BDNF is a key molecular signal, which links visual
deprivation to the retarded maturation of GABAergic
inhibition and the delayed development of the visual
cortex.
Role of BDNF in Experience-dependent
Maturation of GABAergic Circuits
G. diCristo, Z.J. Huang
The maturation of GABAergic inhibitory circuits in
the visual cortex contributes to the development of the
critical period and is in turn regulated by visual expe-
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rience. BDNF has been proposed to link the pattern
and level of activity to the maturation of GABAergic
interneurons, but the cellular mechanism of BDNF
action is poorly defined. We are producing BAC
transgenic mice in which a BDNF-GFP fusion protein
is expressed under the control of the endogenous
BDNF regulatory mechanism. Using organotypic cul-
ture and two-photon laser scanning microscopy, we
will characterize the dynamics of subcellular localiza-
tion, transport, and trans-synaptic transfer of BDNF-
GFP following different patterns of neuronal activity.
Furthermore, we will visualize defined GABAergic
neurons and synapses by biolistic transfection of red
fluorescent protein (RFP). We will then correlate the
mode and dynamics of BDNF transport (anterograde
vs. retrograde) with its regulation of identified
GABAergic cell types and synapses. These experi-
ments will shed light on the precise cellular mecha-
nisms linking neuronal activity, BDNF expression,
and maturation of GABAergic circuitry.
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Construction of a BAC
Location Database
J. Markson (URP), Z.J. Huang [in collaboration with
Z. Xuan and M. Zhang, Cold Spring Harbor Laboratory]
The completion of mouse genome sequencing has
greatly accelerated the design and execution of mouse
genetic manipulations, including BAC transgenics. In
collaboration with Michael Zhang, we have developed
bioinformatics programs and databases to quickly
identify and map BAC clones containing any genes of
interest.
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THE NEURAL ORGANIZATION OF OLFACTORY BEHAVIOR
Z. Mainen N. Caporale V. Egger
H. Gurden S. Ranade
S. Edgar R. Gasperini
M. Quirk N. Uchida
How do the functions of the brain make it possible for
a creature to find food, mate, and avoid predators, and
how does the malfunction of these same functions
lead to human mental illnesses such as schizophrenia?
With the long-term goal of addressing these ques-
tions, we seek to understand cognitive and affective
aspects of the mind in terms of neural codes and com-
putations, and these, in turn, in terms of biophysics
and biochemistry. Our research program is centered
on understanding the sense of smell and olfactory-
guided behavior in the rat. To integrate information
spanning levels of analysis, we are employing a wide
range of experimental approaches, including behav-
ioral, optical, and electrophysiological techniques, as
well as theoretical approaches such as computational
modeling. Thus, we hope ultimately to understand the
nature of social interactions in the workings of single
synapses.
Neural Representation
of Social Identity
N. Caporale, S. Ranade, Z. Mainen
Recognition and classification of individual members
of a species have been shown to be essential to many
aspects of mammalian social organization, including
selection of mates, communication of diet preference,
establishment of dominance hierarchies, and mainte-
nance of kin relationships. Deciphering the neural rep-
resentation of individual identity is therefore key to
understanding the brain systems responsible for the
organization of social behavior.
In rodents, social recognition relies largely on the
sense of smell. The accessory olfactory (vomeronasal)
system is known to mediate a wide range of instinctu-
al behaviors elicited by pheromones (e.g., pregnancy
block). The main olfactory system, on the other hand,
is known to have a significant role in learned behav-
iors (e.g., social transmission of food preference). It
has been proposed that the main olfactory system is
responsible for the formation of social representations
of individual identity. This idea is supported by a vari-
ety of evidence, including data from our lab showing
that rats will use both naturally secreted and non-nat-
ural chemicals (e.g., perfume) for social identification
(Caporale et al. 2001).
We are interested in how the complex chemical
signatures of animals are encoded in the main olfacto-
ry bulb and especially in how individual and categori-
cal differences (e.g., kinship) are represented. It is
known that the composition of volatile chemicals
released in urine and other secretions is unique to each
individual and can be discriminated by other members
of that species (or other species). Using intrinsic opti-
cal imaging (see below), we are studying spatial acti-
vation patterns evoked by urine in the main olfactory
bulb (Caporale et al. 2001). By comparing activity
maps evoked by urine from different individuals at dif-
ferent times, we can investigate the encoding of indi-
vidual and categorical differences by receptors in the
main olfactory bulb. With multi-electrode recordings,
we plan to follow the processing of social stimuli into
higher-order olfactory structures such as the olfactory
cortex, amygdala, and hypothalamus.
Olfactory Maps and
Odor Quality
N. Uchida, R. Gasperini, S. Edgar, Z. Mainen
[in collaboration with M. Chklovskii, Cold Spring Harbor
Laboratory, and S. Macknik, University College,
London]
Volatile chemicals are encoded in neural activity dis-
tributed across a set of more than 10,000,000 olfacto-
ry receptor neurons, each expressing 1 of 1000 differ-
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ent olfactory receptor types. The sensory neurons pro-
ject to the olfactory bulb, where the axons of cells
corresponding to each receptor type converge at
stereotyped locations to form dense functional units
known as "glomeruli." Consequently, any olfactory
stimulus produces a unique spatial pattern in the
olfactory bulb expressed by specific activation values
across glomeruli.
If the perceptual qualities of olfactory stimuli are
derived from the activity associated with each recep-
tor type, then "smells" can be read by measuring
activity patterns across these glomerular maps. To
read glomerular activation patterns, we are using the
technique of intrinsic optical imaging (Fig. 1, top; see
below). To assay the perceptual similarity of different
chemicals, we are using a two-alternative discrimina-
tion task. Because rats are able to discriminate per-
fectly even the most closely related pure chemicals
that we have tested, we have developed a more sensi-
tive task in which rats are trained to report the domi-
nant chemical in binary mixtures of two chemicals at
different ratios. This task produces a regular psycho-
metric curve similar to that observed commonly in
human and monkey psychophysics experiments.
When fit with a sigmoid, the curve is a sensitive mea-
sure of the discriminability of a given pair of chemi-
cals (Fig. 1, bottom).
Using these assays, we have demonstrated a corre-
lation between the glomerular spatial representation
(optical imaging data) and perceptual odor quality
(psychophysical data) (Uchida et al. 2001). With col-
laborator M. Chklovskii, we are developing computa-
tional methods for optimizing the analysis of these
correlations. With collaborator S. Macknik, we are
performing similar psychophysical tests in humans
that will allow us to compare olfactory perception
across these species.
Neural Population Activity
and Olfactory-guided Behavior
M. Quirk, Z. Mainen [in collaboration with C. Brody,
Cold Spring Harbor Laboratory, and J. Hopfield,
Princeton University]
Sniffing produces coherent oscillations across the
olfactory system, particularly at y and 0 frequencies.
Thus, olfactory representations not only are spatially
distributed, but also may involve the wide-scale tern-
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FIGURE 1 (Top) Intrinsic signal image of glomerular activity in
the rat olfactory bulb produced by the chemical 6 -COON.
(Middle) Activity patterns of four chemicals extracted as for 6-
COOH. Each line corresponds to a white circle in the top image.
(Black) Mean signal; (gray) standard deviation. Cluster plot at
left indicates the relative similarity of patterns. (Bottom)
Psychometric curves for the discrimination of two odor mixtures
by a rat.
poral coordination of activity across populations of
neurons. The distributed nature of these representa-
tions also appears to be preserved in more central
regions of the brain such as the prefrontal cortex,
amygdala, and hippocampus, which are important in
the organization of cognitive and emotional behavior.
Information coded collectively in populations of
neurons is particularly difficult to study through con-
ventional single-neuron electrophysiology. We are
therefore using a tetrode-based multi-electrode
recording system that allows us to monitor the activi-
ty of dozens of single cells simultaneously. With this
system, we can study the temporal relationships
between the activity of neurons within and across
brain regions. In parallel, we are developing computa-
tional models with collaborators C. Brody and J.
Hopfield.
Through this approach, we hope to address two
fundamental questions. First, how does temporal coor-
dination contribute to the production of specific olfac-
tory representations? To this end, we will record in
anesthetized as well as behaving animals and analyze
the relationships between putative collective olfactory
codes and sensory and behavioral events. Second, how
is activity across brain regions coordinated in the ser-
vice of olfactory-guided behavior? To this end, we will
analyze the temporal relationship between neural
activity across various areas of the olfactory system
(including amygdala, pyriform, and orbitofrontal cor-
tex).
We are also particularly interested in the temporal
relationship of this activity to that of the brain stem
nuclei associated with the major diffuse ascending
neuromodulatory projections that have been implicat-
ed in the control of motivation, attention, learning, and
awareness.
Computation and Metabolism
in Olfactory Glomeruli
H. Gurden, N. Uchida, Z. Mainen
The first stage of neural processing in the mammalian
olfactory system occurs within the glomeruli of the
olfactory bulb. A glomerulus is a ball of neuropil
about 100 ism in diameter, targeted by more than 104
sensory afferents, all carrying signals from just one of
the approximately 1000 olfactory receptor types. This
massively convergent signal is not simply relayed to
the principal neurons (mitral cells), but rather is sub-
ject to a complex network of synaptic interactions
occurring within the core of the glomerulus. Some of
these interactions are mediated by periglomerular
(PG) cells, a heterogeneous population of neurons
whose cell bodies form dense shells surrounding each
glomerulus. It is known that PG cells synthesize
dopamine (DA) and y-amino-n-butyric acid (GABA)
and that they mainly mediate intra-glomerular synap-
tic interactions (as well as some longer-range inter-
glomerular interactions), but the functional role of PG
cells is obscure.
Intrinsic optical imaging is a sensitive monitor of
odor-evoked responses in individual glomeruli (see
Fig. 1). Intrinsic signals are believed to reflect meta-
bolic activity, but, as with related techniques such as
functional magnetic resonance imaging (fMRI), the
relationship between these signals and underlying
neural activity is poorly understood. Our first objec-
tive is to describe a quantitative relationship between
neural activity parameters such as presynaptic release
rate and intrinsic signals. To do so, we are using phar-
macology (primarily, specific agonists and antagonists
of neurotransmitter receptors) to dissect the synaptic
circuitry and biochemistry of the glomerulus. We have
found that intrinsic signals are inhibited by GABA-B
and DA receptor activation and insensitive to postsy-
naptic glutamate receptors. Our second objective is to
produce a quantitative model of the function of the
glomerular circuit in the encoding of olfactory stimuli.
To do so, we will combine intrinsic imaging and phar-
macology with computational approaches based on
detailed biophysical modeling.
Calcium Dynamics in
Olfactory Bulb Granule Cells
V. Egger, Z. Mainen [in collaboration with
K. Svoboda, Cold Spring Harbor Laboratory]
Granule cells (GCs) are GABAergic interneurons that
mediate recurrent coupling between the principal neu-
rons (mitral cells) in the olfactory bulb. Although GCs
lack axons, they produce action potentials (APs) that
can admit Caff and hence contribute to synaptic
release via the dendrodendritic mitral-granule cell con-
nection. The behavior of these dendritic action poten-
tials and the associated Ca' transients will therefore
be a key determinant of lateral inhibition and strongly
shape the network properties of olfactory bulb.
To examine the properties of AP propagation with-
in the GC dendritic tree, in collaboration with K.
Svoboda, we imaged AP-evoked dendritic Ca:' tran-
sients in granule cells using 2-photon imaging in rat
olfactory bulb slices (Fig. 2) (Egger et al. 2001).
Interestingly, as APs propagated into GC dendrites, the
size of the evoked Ca'+ transients increased with dis-
tance from the soma, the opposite effect of what is typ-
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FIGURE 2 Granule cell in a slice from the rat olfactory bulb. The
cell was filled with a fluorescent calcium indicator and imaged
using a 2-photon microscope.
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ically seen in excitatory cells. Moreover, this effect
was correlated with the distance of GC somata from
the site of dendrodendritic contacts: The longer the
distance the AP had to travel, the more amplification.
This differential amplification might help to equalize
the impact of AP-evoked transients on dendritic
release among GCs with different laminar positions
within the olfactory bulb.
When GCs were depolarized to near threshold,
both AP-evoked Ca++ transients and a normally strong
afterdepolarization were reduced. Blockers of the
low-threshold, fast-inactivating T-type Ca++ channel
reduced the Ca++ transient amplitudes and blocked
their voltage dependence. These observations suggest
a novel mechanism for regulation of lateral inhibition
in the olfactory bulb: Persistent GC depolarization
during sustained input from mitral cells or centrifugal
afferents may reduce AP-triggered transmitter release
and thus restrict GC-mediated lateral inhibition. We
are currently examining other mechanisms by which
AP propagation in GCs can be regulated, such as by
the action of neuromodulators such as norepineph-
rine.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN
CENTRAL SYNAPSES
R. Malinow A. Barrie
N. Dawkins
I. Ehrlich
R. Ewald
H. Hsieh
J. Esteban
F. Kamenetz
A. Piccini
K. Seidenman
S. Shi
T. Takahashi
J. Zhu
C. Wilson (URP)
Our laboratory addresses issues directed toward an
understanding of learning and memory by studying
the physiology of synapses. We study synaptic trans-
mission and plasticity in rodent brain slices. This
preparation is sufficiently complex to show glimpses
of emergent properties as well as simple enough to
allow hard-nosed biophysical scrutiny. To monitor and
perturb the function of synapses, we use a combina-
tion of electrophysiology, microscopic imaging, and
molecular transfection techniques. This allows us to
examine the cellular and molecular basis for changes
in electrophysiological function. It is our philosophy
that synapses have key properties whose understand-
ing will provide insight into phenomena at higher lev-
els of complexity. Below are examples of the projects
nearing fruition in our laboratory.
INCREASING MOLECULAR REQUIREMENTS FOR
SYNAPTIC PLASTICITY WITH AGE
Synaptic plasticity has important but distinct roles
throughout life. Early in development, synaptic plas-
ticity controls the establishment of neural connections.
Later in life, plasticity controls learning and memory.
Here, we compare the molecular mechanisms control-
ling synaptic plasticity at different ages. We find that
PKA phosphorylation of oe-amino-3-hydroxy-5-
methy1-4-isoazole (AMPA) receptors (AMPA-Rs) has
a key role throughout. Activity-driven PKA phosphor-
ylation of G1uR4 is necessary and sufficient for deliv-
ery of receptors to synapses during early development,
making synapses functional. Phosphorylation relieves
a retention interaction that, in the absence of synaptic
activity, maintains G1uR4-containing receptors away
from synapses. In contrast, phosphorylation of G1uR1
by PKA is necessary but not sufficient for delivery of
receptors to synapses in older animals. Thus, a mech-
anism that mediates plasticity early in development
becomes a gate for plasticity later in life. Increasing
requirements may be one way that plasticity becomes
more specific and also recalcitrant with age.
CRITICAL PDZ INTERACTIONS BY GLUR1 AND
GLUR2 REQUIRED AT DIFFERENT
SUBCELLULAR SITES
Interactions between AMPA-R subunits and PDZ
domains are critical for the proper delivery of recep-
tors to synapses. Synaptic delivery of GluRl-contain-
ing AMPA-Rs can be driven by calcium/calmodulin-
dependent protein kinase II (CaMKII) activity or
long-term potentiation (LTP) and requires an interac-
tion between GluR1 and a type I PDZ domain.
Synaptic delivery of AMPA-Rs with only G1uR2
occurs continuously, and this requires an interaction
between GluR2 and a type II PDZ domain. We now
show that mutations on G1uR1 or G1uR2 that perturb
these critical PDZ domain interactions lead to the
accumulation of these receptors at different subcellu-
lar sites. GluR1 mutants accumulate in the dendrite,
whereas GluR2 mutants accumulate in dendritic
spines. This suggests that the critical PDZ-domain
interactions are required for entry into spines, for
GluR1, and into synapses, for GluR2.
RAS AND RAP CONTROL AMPA RECEPTOR
TRAFFICKING DURING SYNAPTIC PLASTICITY
Recent studies have shown that AMPA-R trafficking
has an important role in synaptic plasticity. However,
the intracellular signaling pathways controlling this
trafficking remain largely unknown. Small GTPases
can signal diverse neuronal processes, and their per-
turbation is responsible for several mental disorders.
Here, we have examined the role of small GTPases
Ras and Rap in the postsynaptic signaling that medi-
ates synaptic plasticity. We show that Ras is the down-
stream effector for N-methyl-n-aspartate (NMDA)
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receptor (NMDA-R) and CaMKII signaling during
LTP. Ras activity drives synaptic delivery of
AMPA-Rs. In contrast, postsynaptic activation of Rap
mediates NMDA-R-dependent removal of synaptic
AMPA-Rs that occurs during long-term depression.
Ras and Rap exert their effects on AMPA-Rs that con-
tain different subunit composition. Thus, Ras and Rap,
whose activity can be controlled by postsynaptic
enzymes, serve as independent regulators for potenti-
ating and depressing central synapses.
CONTROL OF NMDA RECEPTOR TRAFFICKING TO
SYNAPSES BY THE NR2 SUBUNIT
To elucidate mechanisms controlling the number and
subunit composition of synaptic NMDA-Rs in hip-
pocampal slice neurons, the NR1, NR2A, and NR2B
subunits were optically and electrophysiologically
tagged. The NR2 subunit directs delivery of receptors
to synapses with different rules controlling NR2A and
NR2B. NR2B-containing receptors incorporate into
synapses in a manner that is not limited by synaptic
transmission nor enhanced by increased subunit
expression. NR2A-containing receptors, whose
expression normally increases with age, replace
synaptic NR2B-containing receptors. Replacement is
enhanced by increased NR2A expression, requires
synaptic activity, and leads to reduced NMDA-R
responses. Surprisingly, spontaneously released trans-
mitter acting on synaptic NMDA-Rs is sufficient for
replacement. Thus, as with AMPA-Rs, synaptic traf-
ficking of NMDA-Rs is tightly regulated and has
unique rules.
HOMEOSTATIC FEEDBACK BETWEEN NEURONAL
ACTIVITY AND APP PROCESSING
A large body of work implicates the accumulation of
Afi peptides and other derivatives of the amyloid pre-
cursor protein (APP) as central to the pathogenesis of
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Alzheimer's disease. However, little is known regard-
ing the relationship between neuronal electrophysio-
logical function and APP processing. Here, we find
that neuronal activity controls the formation of AP.
Furthermore, increased formation of Af3 reversibly
depresses synaptic function. These results suggest that
APP cleavage products act as negative feedback
homeostatic regulators that keep neuronal hyperactiv-
ity in check. Pathology that disrupts this homeostatic
system could increase the production of Al3 and/or
produce neuronal hyperactivity, events that may con-
tribute to Alzheimer's disease.
In conclusion, we are continuing to elucidate the
basic mechanisms involved in central synaptic trans-
mission and plasticity.
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PLASTICITY OF CORTICAL NEURONS AND THEIR CIRCUITS
K. Svoboda B. Burbach K. Greenwood E. Nimchinsky T. Pologruto R. Yasuda
I. Bureau A. Karpova P. O'Brien B. Sabatini C. Zhang
B. Chen M. Maravall T. Deaner G. Shepherd K. Zito
The cortex underlies most cognitive functions in mam-
mals. Cortical tissue is dauntingly complex: 1 mm3 of
tissue contains nearly a million neurons, each of which
connects to thousands of other neurons. How does
electrical and biochemical dynamics in this awesome
network produce our perception of the world? How
does this network change in response to experience?
Answers to these questions will profoundly change our
understanding of the function and diseases of the brain.
To begin to unravel neocortical function, we are
studying how the basic units of the network, neurons
and their synapses, work within the intact network. For
this purpose, we build and use sensitive optical tools.
2-photon laser scanning microscopy (2PLSM) allows
us to detect the excitation of single synapses in brain
slices and in the intact brain by measuring intracellu-
lar calcium accumulation associated with activation of
synaptic receptors with single receptor sensitivity.
Excitation of neuronal elements by focal uncaging of
neurotransmitters allows us to efficiently probe the
connectivity of neural networks. We combine these
optical methods with electrophysiological measure-
ments of synaptic currents and potentials and molecu-
lar manipulations of neurons.
We use both in vivo measurements to address sys-
tem level questions and in vitro methods to get at
detailed mechanisms. For our in vivo measurements,
we use the rodent barrel cortex. Similar to other sen-
sory areas in the mammalian cortex, the barrel cortex
is arranged in maps. Each whisker is represented by a
small cortical region (barrel). Whisker maps are
shaped by experience during development and
reshaped in the adult. Plasticity in these maps can be
induced by trimming specific whiskers for hours to
days. The cellular mechanisms underlying sensory
map plasticity are likely to share mechanisms with
those underlying learning and memory. Because of the
precision of the barrel map, it is possible to predict
where in the brain experience-dependent changes are
likely to occur, simplifying the search for the cellular,
synaptic, and molecular basis for plasticity. For our in
vitro measurements, we use brain slices from the bar-
rel cortex or hippocampus.
Cellular Basis of
Experience-dependent
Plasticity in the Developing
Cortex In Vivo
I. Bureau
How do the ordered connections of the brain form dur-
ing development? We have begun to address this issue
in layers 2/3 of barrel cortex by recording sensory-
evoked synaptic currents as the network is beginning
to wire up (PND 8-10). To our surprise, we found that
at these early ages, weak but highly ordered sensory
maps already exist and that these are supported by
synapses dominated by N-methyl-D-aspartate recep-
tors (NMDA-Rs). Thus, sensory maps form much ear-
lier than previously thought but are largely electrically
silent. We also found that the structure of maps in lay-
ers 2/3 is strongly shaped by sensory experience.
Cellular Basis of
Experience-dependent
Plasticity in the Developing
Cortex In Vitro
M. Maravall, G. Shepherd [in collaboration with T. Takahashi
and R. Malinow, Cold Spring Harbor Laboratory]
Some experience-dependent changes in cellular prop-
erties are difficult to study in the intact brain, requir-
ing measurements in brain slices. We are comparing
the properties of neocortical pyramidal neurons and
their circuits in brain slices derived from deprived and
control animals over developmental ages spanning the
barrel cortex critical period. To discover possibly
diverse modes of plasticity, we are using a barrage of
electrophysiological and imaging approaches to look
for effects of sensory experience on neuronal Ca-FE
dynamics, excitability, synaptic currents, dendritic
structure, and plasticity potential. For example, we
found that in deprived animals, the spatial distribution
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of branchpoints in dendritic trees is altered. In addi-
tion. we have adopted and improved laser scanning
uncaging of glutamate to rapidly and efficiently probe
the structure and dynamics of neural circuits. Finally,
we are probing the experience-dependent delivery of
glutamate receptors into layer 4 to layer 2/3 synapses.
Experience-dependent
Plasticity in Adult
Cortex In Vivo
B. Chen, J. Trachtenberg
Even in the adult cortex, changes in sensory experi-
ence modulate the properties of cortical maps. It has
long been debated whether changes in neuronal struc-
ture and growth of new synapses underlie such experi-
ence-dependent cortical plasticity. We used time-lapse
2PLSM of layer-5 pyramidal neurons in the adult
mouse barrel cortex to image the structural dynamics
of dendritic spines, the postsynaptic specialization of
synapses. We are using transgenic mice that express
fluorescent proteins in a sparse subpopulation of neu-
rons. These animals allow us to look at the structure of
neurons over chronic time scales at high resolutions.
We find that synapses exist with broadly distributed
lifetimes, up to our measurement time (-2 weeks).
Changes in sensory experience produce increased
turnover of synapses, suggesting that novel experi-
ences are encoded in part by growth of synapses. To
relate these morphological responses to functional
changes at the level of neurons, we are measuring
maps of sensory evoked synaptic potentials.
Experience-dependent
Gene Expression in the
Developing Neocortex
K. Zito, S. Chakraborty, B. Burbach [in collaboration
with F. Naef and M. Magnasco, Rockefeller University]
What molecules are involved in the rapid, experience-
dependent development of neocortical circuitry?
Oligonucleotide arrays offer an opportunity to follow
the expression of thousands of genes as the cortex
wires up and to potentially discover genes (plasticity
genes, pgs) that regulate experience-dependent
aspects of development. We isolate populations of
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neurons from a region of the barrel cortex using
microsurgery techniques. The procedure is brief (20
minutes per animal), allowing large quantities of tis-
sue (hundreds of milligrams) and mRNA (micro-
grams) to be harvested, sufficient for expression array
studies. mRNA is isolated from deprived and control
brains at various developmental ages and used to make
fluorescent probes. The probes are then hybridized to
microarrays. The expression data are analyzed for
"temporal patterns" of expression.
Cellular and Molecular Basis
of the Fragile X Syndrome
K. Zito, E. Nimchinsky, B. Burbach, K. Greenwood,
C. Zhang [in collaboration with W. O'Donnell
and S. Warren, Emory University)
The Fragile X mental retardation syndrome is the most
common form of inherited mental retardation. The
molecular basis of the syndrome is a large expansion of
a triple repeat (CGG) in the 5' UTR of the FMRI gene
that renders it transcriptionally silent. The protein
coded by this gene, called FMRP (Fragile X mental
retardation protein), is an RNA-binding protein of
unknown function. One suggested function is the trans-
port of mRNA out of the nucleus and into neuronal
dendrites. To determine whether FMRP regulates the
expression of other genes, we performed an oligonu-
cleotide array screen to search for genes misexpressed
in FMR1 knock-outs. This screen produced several
hits, including CCL21, a chemokine not previously
shown to be involved in brain development and func-
tion. We are currently analyzing the role of CCL21 in
neuronal function. In addition, we are analyzing the
function of FMRP in brain slices. In these experiments,
FMRP, or one of its mutants, is manipulated in pyrami-
dal neurons by transfection, and its effects on neuronal
structure and function are analyzed.
Molecular Methods to
Reversibly Inactivate
Synapses In Vivo
A. Karpova, C. Zhang, K. Svoboda [in collaboration
with J. Huang, Cold Spring Harbor Laboratory]
A major obstacle in gaining an understanding of neur-
al networks is our inability to selectively modulate
selected circuit elements in vivo. For example,
changes in experience change the amount and quality
of activity seen by most neurons in a given pathway.
Similarly, pharmacological tools are functionally non-
specific.
We are developing genetically deliverable tools
that will allow us to interfere with synaptic function in
a rapidly inducible and reversible manner. These tools
combine recent insights about the molecules regulat-
ing neurotransmitter secretion with chemical genetics.
Using cell culture and brain slice assays, we are cur-
rently testing candidate systems that are designed to
turn synapses off. The ultimate goal is to introduce
these systems into particular neuronal populations
using BAC (bacterial artificial chromsome) transgenic
technology to produce animals in which neuronal sub-
populations can be shut off "at will."
ions in individual dendritic spines. In addition, we
have developed a variety of assays to learn about the
molecular pathways of Ca:' influx, including the
counting of individual Ca++ permeable channels and
receptors in spines.
We have also discovered that the activation voltage
of voltage-gated Ca-' channels in single spines can be
shifted by neuronal activity. This long-term modula-
tion is produced stochastically in single spines and
requires the activity of calcium/calmodulin protein
kinase (CaMKII). Furthermore, all of the channels in
a spine (-10) are modulated together, suggesting that
we are witnessing either the output of a single enzyme
or the result of an autophosphorylation cascade
involving several copies of CaMKII. This provides
strong evidence that individual spines act as function-
ally isolated chemical compartments.
[Ca"] Signaling in Single
Dendritic Spines
R. Yasuda, E. Nimchinsky, B. Sabatini, T. Oertner
Long-term changes in synaptic efficacy are triggered
by increases in [Cal in the postsynaptic neuron. We
have used whole-cell patch clamp recordings and
2PLSM to measure [Cal signals that are evoked in
spines and small dendrites of CAl pyramidal neurons
by back-propagating action potentials and synaptic
stimuli. We have been able to characterize spines as
functionally distinct neuronal compartments for Ca'
signaling. We now understand the life cycle of Ca"-
Optical Studies of
Single Synapses
T. Oertner, E. Nimchinsky, R. Yasuda, T. Pologruto
Synapses release vesicles of glutamate stochastically.
We can detect successes and failures of release at sin-
gle synapses by imaging Ca" in postsynaptic spines
(Fig. 1). By isolating Ca''' entering cells through
NMDA-Rs, we can measure the amount of glutamate
released at single synapses. This allows us to address
old questions in synaptic physiology that have impor-
tant implications for the nature of information trans-
mission in the brain and the mechanisms of plasticity.
FIGURE 1 Stochastic synaptic transmission. A dendritic branch was filled with Ca" indicator and afferent axons were stimulated.
Each frame is the result of a different stimulus trial. Ca" influx associated with synaptic transmission manifests itself as increasing flu-
orescence in spines. (Image courtesy of Thomas Oertner.)
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For example, does a synapse always release a single
vesicle per action potential? Using single spine imag-
ing we find that synapses release multiple vesicles
when strengthened. These measurements show that
the dynamic range of synapses is larger than previ-
ously thought.
Do synapses function as independent information
transmission channels? Or can transmitter released at
one synapse activate receptors of several spines,
destroying synaptic independence? To address this
question, we used NMDA-Rs as "sniffers" of gluta-
mate-monitored Ca" signals in neighboring spines,
often less than 1µm apart. We found that under a wide
range of conditions, glutamate activates only single
synapses. This is surprising because with the fusion of
a single vesicle, a large excess of glutamate is
released. Using knock-out animals and pharmacolog-
ical tools, we have shown that astrocytic glutamate
transporters are significant players in limiting the
spread of glutamate in the extracellular space.
Instrumentation
K. Svoboda, B. Sabatini, T. Pologruto, P. O'Brien,
G. Shepherd [in collaboration with R. Eifert,
Cold Spring Harbor Laboratory]
Our instrumentation efforts during the last year have
focused on getting further microscopy/physiology sta-
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tions working and others updated. We have developed
software tools for image acquisition and microscope
control based on Mat lab. We have built a new system
for laser scanning glutamate uncaging that allows
rapid analysis of neural circuits in brain slices, facili-
tating our analysis-experience-dependent changes of
synapses.
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MOLECULAR NEUROBIOLOGY OF LEARNING AND MEMORY
IN DROSOPHILA
T. Tully J. Barditch J. Dubnau S. Gossweiler
L. Grady J. McNeil M. Regulski
P. Smith S. Xia
By investing in complementary forward- and reverse-
genetic approaches to identify genes involved in mem-
ory formation, we have (1) developed a novel statisti-
cal method to analyze data from DNA microarrays, (2)
identified 141 statistical candidate genes, and (3) val-
idated this approach by assessing memory defects in
mutants of some of these candidates. Along with other
mutants identified from the "Harford screen," we now
have added nearly 200 new genes to the list of those
contributing to memory formation.
Identification of New Genes Involved
with Olfactory Memory
T. Tully, P. Smith, L. Grady, J. Barditch, S. Gossweiler,
J. Dubnau
A behavioral screen (forward genetics) for defects in
olfactory memory has yielded 57 new mutant lines.
Molecular lesions have been identified for 55 of these
57 mutants, defining 47 new genes. These candidate
memory genes (CMGs) include those involved in gene
regulation, RNA processing, translational control,
trafficking, signal transduction, and cell adhesion.
Future experiments will focus on characterizing the
expression and cellular function of these genes. DNA
microarray chips also have been used to identify
CMGs that are transcriptionally regulated during long-
term memory formation. This approach has yielded
141 CMGs, showing statistically significant differ-
ences in levels of transcription between spaced or
massed training at one of three time points after train-
ing (t = 0, 6, or 24 hr).
Importantly, two memory mutants were identified
with independent mutations of the milord gene, and
this gene also was a CMG from the DNA chip experi-
ments at both t = 0 and t = 6 hours after training. These
convergent results strongly implicate milord as a bona
fide memory gene. Several other genes are already
known to participate in the same biological pathway as
milord. Three of these also were identified as memory
mutants from our behavioral screen, and seven others
also were CMGs from the DNA chip experiments.
One of the latter CMGs is known in other biological
systems to interact with milord, and temperature-sen-
sitive alleles of this "milord interacting gene" (MIG)
exist. Hence, our data strongly predicted that disrup-
tion of this gene would block long-term memory for-
mation. It does. Mutant flies were trained as tested at
permissive temperature but were shifted to restrictive
temperature for the 24-hour retention interval after
spaced training. After such treatment, no significant
1-day memory was detected, even though 1-day mem-
ory after spaced training was near normal when the
experiment was conducted entirely at permissive tem-
perature (Fig. 1).
Behavioral Analyses
T. Tully, S. Xia, J. Dubnau, L. Grady
The shibire gene in Drosophila encodes a homolog of
dynamin, a synaptic protein involved in vesicle recy-
cling. We restricted expression of a UAS -shf° trans-
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FIGURE 1 One-day memory after spaced training in normal
flies (wild-type) and temperature-sensitive mutants of a "milord
interacting gene" (MIG; mutant). When MIG is disrupted only
during memory formation, long-term memory is blocked. n = 6
Pls per group.
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gene to the central nervous system and showed that all
locomotion ceased within 1 minute at the restrictive
temperature, suggesting that synaptic transmission
was severely disrupted. When UAS -shi" expression
was further limited to the mushroom body (an
anatomical region of the insect brain known to be
involved in olfactory learning), acquisition of odor-
shock avoidance was unaffected, but subsequent
memory retrieval was blocked.
More refined analyses of various temporal stages
of memory formation have revealed that different
memory phases require synaptic transmission in dif-
ferent anatomical regions of the brain during olfacto-
ry memory formation. These data suggest (1) an
anatomical dissection of genetically distinct memory
phases during memory formation and (2) extend our
knowledge of the "memory circuit" in Drosophila.
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LONG-TERM MEMORY FORMATION IN DROSOPHILA
J. Yin M. Chiarelli J. Horiuchi M. Stebbins
E. Drier K. lijima M. Tel lo
R. Filipkowski C. Margulies P. Wu
E. Friedman
Atypical PKC and Memory
Formation
E. Drier, P. Wu, M. Tel lo
We have shown previously that atypical PKC activity
is sufficient to enhance memory formation and is nec-
essary for the normal process in flies. Inducing gain-
of-function (truncated or PKM) transgenes increases
atypical kinase activity twofold and produces more
memory, whereas inducing dominant-negative trans-
genes interferes with memory formation, without
affecting learning. Enhancement of memory forma-
tion requires persistent kinase activity, since neither a
full-length nor a kinase dead point mutant can enhance
if they are induced.
specific is this enhancement? All PKC pro-
teins require phosphorylation of multiple residues to
activate the proteins, and atypical PKCs require two.
One of these phosphorylations, at the very carboxy-
terminal end of the protein, is an autophosphorylation,
whereas the second one is in the "activation loop." For
atypical PKCs, in fibroblasts, the activation loop phos-
phorylation is thought to be mediated by a kinase cas-
cade consisting of PI3 kinase and PDK. If the mouse
PICK transgene is mutated at the phosphoacceptor
serine residue in the activation loop, the mutant pro-
tein is no longer able to enhance memory formation,
demonstrating that the enhancing protein has similar
requirements in neurons and fibroblasts.
Three subtypes of the PKC genes are distinguished
by their cofactor requirements: conventional, novel,
and atypical. All PKC proteins require phosphatidyl-
serine for activation. Conventional PKC proteins
require calcium and phorbol esters, novel PKC pro-
teins require phorbol esters, and the atypical proteins
do not require either. Induction of a truncated, conven-
tional PKC gene (producing a PKM form) does not
enhance memory formation, demonstrating subtype
specificity in the behavioral enhancement.
The oc-calmodulin-dependent protein kinase II
(CaMKII) is widely touted as a key protein in synaptic
plasticity and memory processes ("the memory mole-
cule"). Truncation of this protein produces a constitu-
tively active isoform, and this reagent has been used
extensively in the neurobiology community. When we
induce this protein, and increase kinase activity seven-
fold, it does not enhance memory formation, demon-
strating that enhancement does not result from simple
overexpression of any plasticity-related kinase.
In summary, we have demonstrated that the
aPKM-mediated enhancement of memory formation
is specific. Enhancement requires proper signal trans-
duction that leads to activation loop phosphorylation,
and it requires that an atypical PKC protein is truncat-
ed to the PKM form. Overexpression of other neu-
ronally important plasticity kinases cannot enhance.
Given our belief that aPKM is acting through its role
in marking and tagging active synapses, it is not sur-
prising that other partially activated or constitutively
active kinases cannot substitute.
Molecular Characterization
of the DaPKC gene
M. Tello, E. Drier [in collaboration with A. Wodarz,
Dilisseldorf University, and T. Sacktor, State University
of New York Health Science Center, Brooklyn]
Northern blot analysis and genomic sequencing shows
that the DaPKC gene consists of eight coding exons,
two of which are alternatively spliced in a mutually
exclusive manner. These exons are spread out over a
30-kb region, which includes a large 12-kb intron
located between coding exons 3 and 4. Northern
analysis shows that three transcripts are made (A, B,
and C). Probes from the 5' end of the gene recognize
transcript C, whereas probes from the 3' end of the
gene identify transcripts A and B. The probe made
from exon 7', one of the two alternatively spliced
exons, also recognizes transcripts A and B. Reverse
transcriptase-polymerase chain reaction (RT-PCR)
analysis using various combinations of primers, and
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northern analysis using probes from across the gene
show that transcripts A and B contain parts of the
large internal intron. Northern blots, RT-PCR, and 5'
RACE suggest the existence of at least one promoter
(for transcript B) located about 3 kb from the
intron/exon 3 border. A P-element insertion is located
about 4 kb from this intron/exon 3 border.
Northern analysis of imprecise excisions from the
P-element led to the localization of the promoter for
transcript B, although we still cannot definitively dis-
tinguish between two of the clusters of 5' ends of
transcripts identified using RACE. These two regions
are about 500 by apart, and in between these two pos-
sible start sites is a very good match to a consensus
CRE site (5' TGACGTaA 3'). We speculate that neu-
ronal activity and dCREB2 may regulate transcrip-
tion initiation from one of these sites or may be
involved in synchronizing the 5' transcription start
site. This promoter organization is almost identical to
what is found in the rat atypical PKC gene (T.
Sacktor, pers. comm.). This gene also contains a large
intron in the middle of the gene, and 5' RACE has
identified a cluster of transcription start sites within
the intron. There are two very good matches to CRE
sites located just upstream of and just downstream
from the major start sites. In rats, this mRNA codes
for a truncated PKIV4 protein, suggesting that the
short protein can also be produced via transcription
initiation.
Multiple antibodies identify two protein bands on
western blots of head proteins. One protein corre-
sponds to the full-length protein, whereas the other
band is approximately the size of the rat PKM protein.
We are characterizing antisera raised from exon-7-
specific and exon-7'-specific peptides.
Multiprotein Complexes and the
Synaptic Tag
E. Drier, K. lijima
In early development, the DaPKC protein participates
in asymmetric cell division and cell polarity. The
involvement in these functions is evolutionarily con-
served and appears to be true for a number of differ-
ent cell types. We hypothesize that postmitotic neu-
rons utilize features of these cellular properties in
synaptic tagging, a recently hypothesized neuronal
function that is critically important in the process of
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long-term memory formation. We are testing other
genes that are known to participate in asymmetric cell
division for their involvement in memory formation.
We are also investigating the feasibility of visualizing
aspects of the tagging hypothesis in neurons.
Tetracycline-mediated
Cell Ablation
M. Stebbins [in collaboration with W. Hillen,
University of Erlangen, G. Byrne, Nextran, Inc.,
and B. Bello, Cambridge University]
Utilizing the improved rtTA/VP16-M2-alt trans-acti-
vator, we have integrated the tetracycline-inducible
system together with the GAL4/UAS system. This tri-
partite system allows both spatially and temporally
regulated gene induction. Using the apoptotic gene
rpr, we have successfully ablated wing and eye tissue
using the salm -GAL4 and sevenless-GAL4 drivers.
When the traditional bipartite salm- GAL4/UAS -rpr
system is used, developmental lethality precludes the
analysis of adult phenotypes. However, when a salm-
GAL4 transgene is combined with UAS-rtTA/VP16-
M2-alt and TetO -rpr transgenes, doxycycline-depen-
dent ablation of wings occurs in a dosage-dependent
manner. Late instar larvae are fed the drug, thus
bypassing lethality due to salm- mediated expression
of rpr early in development in another tissue besides
the wing disc. Thus, the addition of temporal control
allows a late wing phenotype to be revealed. It is like-
ly that many GAL4 drivers express in a number of dif-
ferent tissues throughout development. We will use
this system for ablation of various adult structures in
the adult brain.
Circadian Genes, Sleep,
and Memory Formation
P. Wu, C. Margulies [in collaboration with J. Hendricks and
A. Sehgal, University of Pennsylvania]
Because of the circadian regulation of a CRE-respon-
sive reporter fly, we have been interested in the possi-
ble involvement of the circadian system, and sleep, in
the formation and consolidation of memories. We have
shown that a number of different circadian molecules
participate in memory formation, since we can both
disrupt and enhance the process. However, we have
not yet shown whether these effects are because the
proteins participate in the different processes or
because the various physiologies affect each other.
Regulation of dCREB2
Activity
J. Horiuchi
We have shown that the dCREB2-b protein is largely
cytoplasmic and inhibited from DNA binding.
Inhibition results from phosphorylation on multiple
casein kinase sites located amino-terminal to the well-
characterized Ser-133 site (Ser-230 on the fly protein).
To demonstrate more convincingly that phosphoryla-
tion occurs in vivo prior to extract preparation, we
have developed a tissue solubilization and cell lysis
procedure in 100 mm EDTA, followed by subsequent
analysis of the samples on a native protein gel.
Phosphatase treatment or mutation of the casein
kinase sites results in slower mobility of the protein
relative to untreated samples, supporting the con-
tention that the protein is phosphorylated in vivo prior
to making an extract.
Mouse Behavior
E. Friedman, R. Filipkowski
We have been investigating training parameters for the
Morris water maze and contextual fear conditioning.
Training procedures have been developed whereby
multiple trials are required for the establishment of
long-term memories. The number of trials, the inter-
trial or interblock intervals, and the complexity of con-
textual cues all contribute to the duration of the mem-
ories that are produced. For contextual discrimination,
long-lasting memory requires acute protein synthesis
around the time of training.
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NEURAL SUBSTRATE OF SELECTIVE AUDITORY ATTENTION
IN THE CORTEX
A. Zador M. DeWeese L.-H. Tai
M. Wehr K. Mantzaris
S. Rumpel T. Hromadka
S. Edgar
We use a combination of theoretical and experi-
mental approaches to study how the brain computes.
The brain is able to solve hard computations that
remain far beyond the reach of the fastest computers.
Our goal is to understand this computation at the
synaptic, cellular, behavioral, and algorithmic levels.
One example of such a hard computation is the
"cocktail party problem." When we tune in to one
voice at a cocktail party and tune out the others-a task
that remains beyond the capacity of modern comput-
ers-we are engaging in a form of selective auditory
attention. Our ability to attend selectively is not limit-
ed to the auditory domain: Analogous tasks demand
selective attention in the visual and even somatosenso-
ry domains. In monkeys, visual attention selectively
enhances neural activity even in the most peripheral
(i.e., near the retina) areas of the visual cortex. This
enhancement is surprising because the areas associat-
ed with these first stages of visual processing have tra-
ditionally been thought of as representing the sensory
world faithfully, in a way that depends only on the
properties of the sensory input itself. The discovery of
attentional modulation overturns the notion that the
peripheral sensory cortex is a passive "TV screen"
available for viewing by a "homunculus" buried deep
within the cortex.
The specific projects in our laboratory fall into two
main categories. First, we are interested in how neu-
rons represent auditory stimuli, and how these repre-
sentations are computed from the cochlear inputs half
a dozen synapses away. To address these questions, we
are using electrophysiological and imaging approaches
in anesthetized rats, as well as computational
approaches to characterize the properties of natural
sounds. Second, we are interested in how these repre-
sentations are modified dynamically-within sec-
onds-in awake behaving rats by the demands imposed
by attentional tasks.
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Binary Coding in the
Auditory Cortex
M. DeWeese
Cortical neurons have been reported to use both rate
and temporal codes. We have discovered a novel
mode, in which each neuron generates exactly zero or
one action potential, but not more, in response to a
stimulus. Cortical responses recorded using conven-
tional extracellular techniques typically show respons-
es to be highly variable. However, in our studies, we
have been using a technique adapted from in vitro
studies, cell-attached recording, which has the advan-
tage of ensuring that the recorded responses all arise
from a single neuron. Surprisingly, we have found that
most neurons exhibit binary behavior, with few multi-
spike responses; some responses consist of exactly one
spike in 100% of the trials, with absolutely no trial-to-
trial variability. We are currently investigating the
computational implications of this previously unde-
scribed coding scheme.
Variability of Coding in the
Auditory Cortex
M. DeWeese
Computers rely on extremely precise, low-noise com-
ponents to compute, whereas the components that
make up neural circuits appear to be very noisy.
Nevertheless, brains outperform computers on the
kinds of hard computational problems required for
survival in the real world. To understand how brains
compute in the presence of such high levels of appar-
ent noise, we are characterizing the sources of vari-
ability (i.e., noise) in single neurons. Using in vivo
whole-cell patch-clamp recording techniques, we are
examining the trial-to-trial variability of the postsy-
naptic potential (PSP) elicited by brief tone pips. In
some neurons, trial-to-trial variability in the PSP is
small, consistent with "private" sources limited to
only the neuron under study; but for other neurons,
"shared" sources of variability produce circuit-wide
fluctuations in the synaptic drive to the neuron and
its neighbors, greatly increasing the apparent noise in
the PSP. These stimulus-independent correlations
could provide a substrate for feedback underlying
cognitive processes, such as attention and motiva-
tion.
In Vivo Whole-cell Patch-clamp
Recordings of Sound-evoked
Synaptic Responses in the
Auditory Cortex
M. DeWeese, L-H. Tel
Neurons in the auditory cortex respond to some
sounds but not to others. What determines this selec-
tivity? We are using whole-cell patch-clamp recording
methods in vivo to measure the synaptic currents
elicited by simple and complex auditory stimuli.
Patch-clamp recordings provide a much richer source
of information than do conventional single-unit extra-
cellular recordings because they allow us to monitor
not just the output of the neuron-the spike train-but
the input as well. These data provide clues about the
representations with which the cortex solves hard
problems in auditory processing.
Responses to Complex Stimuli
M. Wehr [in collaboration with C. Machens and C. Brody,
Cold Spring Harbor Laboratory]
How do neurons in the auditory cortex encode com-
plex stimuli, such as animal calls or the sound of rain
falling on leaves? Sensory physiologists often ignore
this question, dismissing it as too difficult to approach
in a systematic fashion. Instead, they often limit their
inquiries to simple stimuli, such as (in the auditory
system) brief tone pips or sweeps. We have adopted a
hybrid approach, in which we probe neuronal respons-
es systematically with a well-defined ensemble of
stimuli ("moving ripple stimuli") and then use these
responses to predict the responses to the more com-
plex sounds found in nature.
Inhibitory and Excitatory
Contributions Underlying
Synaptic Responses
M. Wehr
The cortical responses to sensory stimuli such as
sounds consist of a mix of excitation and inhibition.
Conventional extracellular recording techniques using
tungsten electrodes provide information only about
excitatory responses. We have developed an approach
using whole-cell patch-clamp recording in vivo in
voltage-clamp mode to tease apart the temporal
dynamics of the excitatory and inhibitory drive under-
lying responses to auditory stimuli.
AMPA-receptor Trafficking
during Experience-induced
Plasticity in the Auditory Cortex
S. Rumpel [in collaboration with R. Malinow, Cold Spring
Harbor Laboratory]
Which synapses change during learning? Robert
Malinow's laboratory has developed a collection of
molecular and physiological techniques for monitor-
ing and localizing the changes that synapses in vitro
undergo during long-term potentiation (LTP). LTP is
a leading candidate for the synaptic basis for learning
and memory. We are now applying these techniques
in vivo to look for the synaptic correlates of experi-
ence-induced plasticity and learning in the rat audi-
tory cortex.
Behavioral Paradigm for Studying
Selective Auditory Attention
S. Edgar, L.-H. Tai, M. DeWeese
More than a decade has passed since the first reports
of a neural correlate of selective attention in monkeys,
but the mechanism underlying the enhancement of
neural activity remains a mystery. We are therefore
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developing a simpler preparation within which to
study the mechanism. We are training rodents to per-
form a simple selective auditory attention task. We
will then use extracellular recording methods
(tetrodes) to look for a neural correlate-a change in
the firing rate-of this selective attention in the audi-
tory cortex. This simple rodent preparation will have
many advantages over the existing primate prepara-
tion, as it will permit us to bring to bear the full cellu-
lar and molecular armamentarium available to modern
neurobiology.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong F. Hannan K. lijima I. Hakker
H.-F. Guo J. Tong I. Ho
Y. Wang
We are interested in the neural basis of learning and
memory and are taking an approach of combining
functional analyses with genetic manipulation in the
study of Drosophila. Currently, we are pursuing two
major projects. First, we are establishing Drosophila
models for studying genes involved in human neu-
rodisorders that impair learning and memory. In par-
ticular, we are interested in genes known to contribute
to neurofibromatosis 1 (Nfl) and Alzheimer's disease.
Nfl patients are identified by neurofibromas and other
symptoms including learning defects. We are investi-
gating a hypothesis that the tumor-suppressor gene
Nfl not only acts as a Ras-specific GTPase-activating
protein (GAP), but also is involved in mediating G-
protein-stimulated activation of adenylyl cyclase
(AC), and this NF1-dependent AC pathway is required
for learning. In the case of Alzheimer's disease, our
study has been limited to examining how presenilin
and accumulation of AO affect the age-dependent
decline of learning ability. This approach, on the one
hand, serves as a new way to identify biochemical cas-
cades underlying learning and memory in Drosophila.
On the other hand, it may also provide insights into the
pathogenesis of diseases. Second, we are investigating
how odors are encoded by population neuronal activi-
ty in the fly brain and will ultimately study learning
and memory at the level of population neural activity.
Such study is carried out in living flies via optical
recordings. The specific projects are described below.
Site-directed Mutagenesis
in Human NF1
F Hannan, I. Hakker
The tumor-suppressor gene Nfl encodes a large pro-
tein containing a fragment homologous to Ras-GAPs,
which inhibit Ras activity. Drosophila NF1 is highly
conserved since 60% of its 2803 amino acids are iden-
tical to human NFL Our previous electrophysiologi-
cal, biochemical, and behavioral analyses of
Drosophila NF1 mutants have indicated that in addi-
tion to functioning as a Ras-GAP, NF1 regulates acti-
vation of AC. This NF1-dependent cAMP pathway is
crucial for learning and memory. Our recent effort in
biochemical assay of AC activity has revealed that G-
protein-stimulated AC activity consists of two compo-
nents, i.e., NF1-dependent and NF1-independent. The
NF1-dependent component is largely mediated via the
rutabaga (rut)-encoded AC, which is required for
learning in Drosophila. To understand how NF1 regu-
lates AC activity, we are investigating how point muta-
tions identified in NF1 patients affect cAMP-pathway-
related functions. To do so, we have shown that expres-
sion of the human Nfl gene was capable of rescuing
NF1 mutation-induced phenotype or defects in
Drosophila, including small body size, reduction in G-
protein-stimulated AC activity, and olfactory learning.
Moreover, transgenic flies carrying different muta-
tions, two in the GAP domain (directly relating to Ras
activity) and one outside of the GAP domain, have
been generated. Preliminary data have indicated that
expression of human NF1 with the mutation outside of
the GAP domain was able to increase learning but
failed to rescue the body size phenotype in NF1
mutants. Three further mutations were generated, and
we are in the process of testing how expression of the
mutated human Nfl gene affects its ability to rescue
NF1 defects in mutant flies. We are hoping to gain
insight into whether Ras activity is required for AC
regulation and whether there is a specific domain in
the NF1 molecule designated for AC regulation.
Ras-NFl-regulated cAMP Pathway
J. Tong, F Hannan, I. Ho
We have shown that the NF1 protein is able to regulate
G-protein-dependent activation of AC activity in both
flies and mice. It remains a concern as to whether Ras
has a role in this NF1-dependent AC pathway. In the
process of addressing this problem, we found that
adding Ha-Ras or Ki-Ras to the membrane fraction
extracted from fly heads stimulated AC activity. This
177
stimulation required the presence of NF 1 , because Ras
failed to increase AC activity in NF 1 mutants. Further
studies indicated that a reduction of Ras activity
resulting from the addition of the purified fragment of
NF 1 which contains the GAP domain diminished AC
activity. These lines of evidence suggest that there is a
cross-talk between the Ras and cAMP pathway.
Modeling Alzheimer's Disease in
Drosophila
K. lijima, Y. Wang, Y. Zhong
A major hypothesis concerning the pathogenesis of
Alzheimer's disease (AD) suggests that accumulation
of toxic A, leads to pathologic progression. This is
supported by genetic analysis in which all familial AD
is caused by mutations of genes encoding either APP
or presenilin 1 and 2. APP is the precursor protein of
A[342 peptide, and presenilins 1 and 2 are closely relat-
ed to y-secretase activity which is involved in produc-
tion of A1342. All familial mutations have been shown
to enhance production of A1342. Drosophila has an
APP-like gene and a highly conserved presenilin
gene. By expression of human Ai342 and the presenilin
gene with mutations that are found in AD patients, we
are trying to build a simple Drosophila model for
studying some aspects of AD. The preliminary results
showed that the fly's life span was greatly reduced in
flies expressing A1342 peptides, and learning was also
affected in an age-dependent way. We are continuing
to examine whether expression of these genes will
cause neuronal degeneration.
Notch Neural Plasticity
Guo
Another known target of presenilin is Notch, which
has been shown to be a key signaling molecule in
determination of cell lineage across different species.
It also expresses in the adult nervous system, but its
function in the adult remains to be revealed. As a sub-
strate of presenilin, it has been speculated that Notch
may have an important role in the AD pathogenesis.
However, it has been difficult to investigate Notch's
role in the adult nervous system because of the lethal-
ity induced by mutations in the gene. In Drosophila,
the existence of temperature-sensitive mutants and
heat-shock-inducible active or dominant negative
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Notch may facilitate our understanding of its role in the
adult. Our studies indicated that Notch is critically
involved in mediating activity-dependent nerve termi-
nal plasticity. It has been previously shown that nerve
terminal arborization at larval neuromuscular junctions
is enhanced by hyperexcitability. This activity-depen-
dent arborization is abolished in temperature-sensitive
Notch mutations and by expression of dominant nega-
tive Notch. In addition, expression of constitutively
active Notch led to enhanced arborization. We are now
investigating whether expression of Notch is regulated
by neuronal activity.
Stereotyped Representation of
Odors in Mushroom Bodies
Y. Wang, H.-F. Guo
The organization and functional logic of the early
olfactory system appear to be remarkably similar in
Drosophila and mammals. An outstanding feature of
this system is the topographic map of receptor activity
segregated in glomeruli. Yet, how such spatial patterns
of activity are transformed to higher centers and then
translated into odor perception remains elusive. We are
investigating this problem with the relatively simple
nervous system of Drosophila mushroom bodies. We
have developed an optical method that allows us to
monitor neuronal activity in the mushroom body with
a global view of odor-induced spatially distributed
activity over the entire mushroom body, yet with a res-
olution to single neurons. A green fluorescent protein
(GFP)-based Cal' probe is expressed in mushroom
bodies specifically. Ca++ imaging of the calyx, the den-
dritic region of the mushroom body, revealed that each
odor evoked a specific pattern of spatially distributed
activity and that the spatial pattern of activity remained
the same among different flies. This stereotyped repre-
sentation suggests that spatial information at the
glomerular level is preserved at higher centers.
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PLANT DEVELOPMENT AND GENETICS
The plant group has made significant progress during the last year, especially in exploring the genetic
and epigenetic mechanisms underlying stem cell fate. This has considerable implications for the con-
trol of plant architecture (the number and arrangement of flowers, branches, leaves, and shoots), as
well as for understanding how potentially totipotent meristematic cells arise and are maintained. Dave
Jackson's lab is studying signaling mechanisms, including intercellular protein trafficking. They have
shown that specific proteins have different developmental restraints for intercellular trafficking. They
also continue to characterize novel meristem mutants and their relationship to crop yields. Highlights
of the year include cloning of a cell-surface receptor from maize (fasciated ear 2), related to cly2 in
Arabidopsis, which controls meristem size and function. Marja Timmermans' lab has identified several
proteins that interact with the myb domain protein ROUGH SHEATH2 (RS2). This gene is a homolog
of PHANTASTICA from Antirrhinum and is required to repress meristematic genes in the leaf.
Interestingly, interacting proteins include histones and chromatin remodeling factors, supporting the
conclusion that RS2 acts to epigenetically maintain, rather than establish, the repressed state. They are
continuing their studies of leaf polarity in maize, by isolating new mutations as well as candidate genes
from Arabidopsis.
In my own laboratory, we have isolated several genes required for stem cell fate. Ramosa1, which
encodes a zinc-finger protein, imposes determinancy on stem cells within the maize inflorescence, pre-
venting the formation of long branches. This may be an important factor in the evolution of the grass
inflorescence. ASYMMETRIC LEAVES1 encodes the Arabidopsis homolog of ROUGH SHEATH2, and
mutually negative interactions with meristematic homeobox genes establish a boundary between stem
cells and founder cells that contribute to the leaf. Argonaute is another stem cell mutant in Arabidopsis
and has recently been shown to be required for RNAi (RNA interference). Genetic analysis and micro-
arrays have revealed a number of potential targets, as well as interactions with transcriptional silencing
mechanisms.
In fission yeast, we have shown that argonaute and other RNAi components are required to silence
pericentromeric heterochromatin at the transcriptional level and to maintain its association with modi-
fied histones. In Arabidopsis, we have used chromosomal microarrays to demonstrate that mutants in
the chromatin remodeling factor DECREASE IN DNA METHYLAT /ON1 also activate heterochromatin by
changing the pattern of histone modification and fail to silence transposons. We are pursuing the idea
that chromatin remodeling, DNA methylation, and RNA interference cooperate to silence transposable
elements in large plant genomes and that these mechanisms have somehow been adopted to regu-
late stem cell fate.
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PLANT DEVELOPMENTAL GENETICS
AND FUNCTIONAL GENOMICS
R. Martienssen J.-M. Arroyo C. Kidner
B. Bartelle Z. Lippman
M. Byrne B. May
V. Co lot P. Rabinowicz
A.-V. Gendrel
D. Roh T. Singer
M. Ronemus J. Tang
R. Shen R. Umamahsewari
J. Simorowski M. Vaughn
We are using genomics and developmental genetics to
investigate epigenetic mechanisms of gene regulation,
transposon silencing, and stem cell function in plants.
In the past year, we have generated genomic microar-
rays corresponding to a portion of Arabidopsis chro-
mosome 4, which was sequenced at the Cold Spring
Harbor Genome Research Center. We are using these
arrays to investigate the role of chromatin remodeling,
DNA methylation, and polyploidy in regulating trans-
posons and heterochromatin in plants. We have also
continued genetic studies of asymmetric leavesl,
ramosal, and argonaute, mutations that affect stem
cell function in plants. Argonaute has an important
role in RNA interference (RNAi), and our studies on
argonaute in fission yeast have revealed a role for
RNAi in heterochromatin modification. In 2001, we
were joined by informatics postdoc Matt Vaughn and
Watson School graduate student Zachary Lippman.
During the summer, we were joined by our URP,
Elizabeth Head, and guest postdoc Andreas Madlung
from Seattle. Visiting Scientist Vincent Colot and
graduate student Anne-Valerie Gendrel returned to the
Institute for Plant Genomics in Evry, near Paris, in
August, but they have already returned several times
as part of our collaboration on chromosome 4 microar-
rays. We said goodbye to postdoc Tatjana Singer who
left for a staff position at the Torres Mesa Research
Institute (Syngenta) in La Jolla, California. Ben
Bartelle and Nancy Liu left for graduate school.
DNA Methylation, Genome Organization,
and Transposon Mutagenesis in Maize
P. Rabinowicz, B. May, E. Vollbrecht, D. Roh, R. Martienssen
[in collaboration with L. Stein, R. Lucito, and W.R. McCombie,
Cold Spring Harbor Laboratory]
We have previously shown that the unmethylated por-
tion of the maize genome is highly enriched for genes,
and we have extended these findings to several other
plant genomes. This suggests a strategy for shotgun
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E. Vollbrecht
T. Volpe
C. Yordan
E. Head (URP)
genome sequencing using small inserts propagated in
McrBC+ bacterial strains. However, a significant con-
cern is that many genes might remain in the methylat-
ed portion of the genome. Maize nuclear DNA was
digested with McrBC that only restricts methylated
DNA, and samples were used as a template for poly-
merase chain reaction (PCR). Fifty primer pairs from
exons, introns, and promoters were randomly chosen
from 29 genes and 5 transposons. None of the 5 trans-
posons were amplified efficiently from digested DNA,
whereas more than 90% of exons were amplified,
including at least one exon from every gene tested.
This indicates that all genes will be at least tagged in a
methylation-filtered shotgun library. We are applying
this method to the maize and sorghum genomes on a
pilot scale and are printing selected clones on microar-
rays. These will be used to anchor genes to the physi-
cal map, obtain expression profiles, and perform high-
throughput screening of transposon-tagged mutants
from the maize targeted mutagenesis project (MTM)
(http ://mtm.cshl. org).
MTM is a large Mutator (Mu) transposon popula-
tion and screening service constructed by Cold Spring
Harbor Laboratory, Syngenta, and the University of
Californa, Berkeley, and operated by CSHL. The
screening service is open to the public and has been
fully operational for 18 months. Insertions into genes
of interest are detected by nested PCR on three-dimen-
sionally pooled DNA samples from a collection of
more than 44,000 self-pollinated plants. Approxi-
mately 40% of genes screened in this way have a her-
itable insertion, and these are supplied to researchers
on request. Insertions predominate in the 5' portions
of genes, but no bias for intron or exon sequences is
evident. A description of 8000 mutant lines is avail-
able at http://mtm.cshl.org, but most lethal mutations
are only observed in families that have retained
Mutator activity. This indicates that insertion alleles
are suppressed in lines that have lost activity, an epi-
genetic property that we have previously documented
for insertions in promoters and introns. We are cur-
rently developing PCR representations of pooled
insertions for use in hybridization mapping on filters
and microarrays (see above). In this way, we hope to
map many thousands of insertions in parallel.
Transposable Elements and Chromatin
Remodeling in Arabidopsis
Z. Lippman, A.-V. Gendrel, T. Singer, C. Yordan,
V. Co lot, R. Martienssen [in collaboration with V Mittel
and W.R. McCombie, Cold Spring Harbor Laboratory]
DDM1 (Decrease in DNA methylation 1) was identi-
fied several years ago in a screen for Arabidopsis
mutants resulting in loss of DNA methylation, and it
was found to encode a novel member of the SWI/SNF
ATPase-chromatin remodeling protein family that is
highly conserved in mammals and yeast. We have
shown that loss of DNA methylation in ddml mutants
results in activation of Robertson's Mutator and other
families of transposable elements. This may account
in part for the "mutator" phenotype of these strains.
As part of a collaborative study on the effects of poly-
ploidy in plants, we have constructed genomic
microarrays of heterochromatic regions of Arabidop-
sis chromosome IV. We have used these arrays to pro-
file expression, DNA methylation, and chromatin
modification in ddml. Several transposons and hypo-
thetical genes are activated, whereas known genes do
not alter their expression. To determine methylation
patterns, we used the methylation-dependent enzyme
McrBC to remove heavily methylated sequences from
labeled genomic DNA targets. Two-color microarray
hybridization, along with total DNA targets, revealed
methylated probes. Transposons in the heterochromat-
ic region were heavily methylated in wild-type plants
but unmethylated in ddml mutants. In contrast, known
genes lacked methylation in either genotype, consis-
tent with our observations in maize (see above).
Hypothetical genes, predicted only by computer,
resembled transposons more closely than genes.
In mammalian and fungal systems, histone H3
methylation at Lys-9 (mH3K9) and Lys-4 (mH3K4)
correlates with heterochromatic and euchromatic
DNAs, respectively. Furthermore, in the fungus
Neurospora, DNA methylation requires mH3K9. Thus,
we set out to test whether there was a corresponding
change in histone H3 methylation status in ddml
mutants that correlated with loss of DNA methylation.
We developed a chromatin immunoprecipitation proto-
col for Arabidopsis and tested which loci were associ-
ated with mH3K9 and mH3K4 in wild-type and ddml
mutants. PCR amplification of more than 50 features
indicated that transposons were associated with
mH3K9 in wild-type plants. These same features were
associated with mH3K4 in ddml mutants, as were
known genes in both genotypes. We are currently pur-
suing "ChIP on chip" experiments using genomic
microarrays to establish the specificity of DNA and
histone methylation in heterochromatic domains.
Systematic Investigation of
Redundant and Essential Genes in
Arabidopsis Using Gene Traps
B. May, M. Vaughn, C. Yordan, J. Simorowski,
J.-M. Arroyo, R. Shen, B. Battelle, Y. Liu, R. Martienssen
[in collaboration with W.R. McCombie and L. Stein,
Cold Spring Harbor Laboratory]
Systematic sequencing of close to 10,000 gene- and
enhancer-trap lines has identified multiple insertions
into at least 2700 genes (12% of the Arabidopsis
genome). About 1000 are insertions into unique genes,
whereas the remainder are distributed among gene
families. Each line is routinely screened for early lethal
phenotypes, and a systematic study is under way to
determine expression pattern and genetic function dur-
ing development. The results are entered into a rela-
tional database, and a suite of Web-based
has been written to perform complex searches over the
WWW. The Web Site (http://genetrap.cshl.org) is open
to the public as a resource for functional genomics; 930
lines have an insertion in the sense orientation and
exhibit reporter gene (GUS) expression in specific tis-
sues or cell types. Potential cis-acting regulatory motifs
in the promoter regions of genes sharing a common
expression pattern are being sought using AlignACE,
MEME, and GeneSpring. We are also collaborating
with The Arabidopsis Information Resource (TAIR) to
develop the Arabidopsis Genetic Trait Ontology, a for-
mal but flexible lexicon for describing morphology and
developmental mutations.
Ramosal and Grass
Inflorescence Architecture
E. Vollbrecht, R. Martienssen
Plant architecture, the overall shape and appearance of
a plant, is determined by the number, arrangement, and
relative activity of meristems, groups of stem cells
found at the growing point of branches, flowers, and
shoots. In ramosal (ral) and ramosa2 (ra2) mutants in
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maize, meristem activity is prolonged, leading to long
branches in the ear and tassel. Last year, we reported on
the molecular isolation of the ral gene, and we have
now determined by in situ hybridization that ral
imposes determinacy on the meristem from an adjacent
domain, possibly by specifying the meristem boundary,
whereas rat functions by regulating ral transcript lev-
els. Inflorescence architecture is a key character in the
morphological classification of wild and domesticated
grass species, and we have begun to survey sequence
diversity at the ral locus. ral sequence diversity is
unusually low among strains of maize and markedly
higher in related wild species, consistent with ral
being a target of selection during maize domestication.
In sorghum, whose branched tassel resembles a ramosa
mutant, the orthologous ral gene has been duplicated
and its transcript is barely detectable. These findings
reinforce our fundamental hypothesis that modulation
of the ral pathway leads to architectural changes.
Stem Cell Fate and Organogenesis
in Arabidopsis
M. Byrne, R. Martienssen
The shoot apical meristem comprises undifferentiated
stem cells and their derivatives, which include founder
cells for lateral organs such as leaves. Meristems are
maintained and lateral organs are specified in part by
interactions between the myb domain transcription
factor ASYMMETRIC LEAVES] (AS]) and a group of
closely related homeobox transcription factors (knox
genes). The knox gene SHOOT MERISTEMLESS
(STM) negatively regulates ASI in the meristem
which, in turn, negatively regulates other knox genes,
including K_NAT1 and KNAT2 in lateral organ primor-
dia. A second gene, ASYMMETRIC LEAVES2 (AS2),
acts genetically at the same position in this hierarchy
as AS]. Thus, as] and as2 suppress the shootmeri-
stemless phenotype in double mutants with stm. We
used a second-site suppressor screen to isolate muta-
tions that restore the shootmeristemless phenotype in
these double mutants. Mutations in KNATI were
recovered that correspond to the classic mutation bre-
vipedicellus, which alone has a relatively mild inflo-
rescence phenotype. Thus, KNATI is redundant with
STM in regulating stem cell function, but this redun-
dancy is only revealed in the absence of ASI.
Mutations in KNAT2 show no such interaction, but
gene-trap insertions in another homeobox gene also
restore the shootmeristemless phenotype in aslstm
double mutants. This gene-trap insertion alone (quasi-
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modo) also has a relatively mild phenotype, but is
stunted and has lost apical dominance.
Role of RNAi in Arabidopsis
Development
C. Kidner, M. Ronemus, R. Martienssen
argonaute (ago]) was first isolated as a pleiotropic
mutation in Arabidopsis with defects in organogene-
sis. We have defined an allelic series of agol with
defects in meristem function, organ polarity, and organ
identity. Weak agol phenotypes resemble those found
in carpel factory, a partial loss-of-function mutation in
an RNase III helicase required for floral organogene-
sis. Strong cafl alleles are lethal, as are double
mutants between agol and the partially redundant
homolog, pinhead/zwille. Double mutants with stm,
wuschel, and cup-shaped-cotyledon (cucl cuc2) sug-
gest that AGO] controls meristem function via STM,
whereas double mutants with 0, and ufo show that
AGO] has a role in floral organ identity. Gene-trap
insertions in a third member of the argonaute family
(JASON) are being characterized.
In Caenorhabditis elegans and Drosophila,
homologs of argonaute and carpel factory (rdel and
dicer, respectively) were later found to have key roles
in RNAi. We have shown that weak alleles of cafl
strongly enhance weak alleles of ago], indicating a
common pathway. Enhancers of weak ago] include
as] and revoluta (rev), suggesting a possible role for
RNAi in communication between meristems and later-
al organs. A link between RNAi and transcriptional
gene silencing is suggested by the partial rescue of
strong ago] by loss-of-function mutations in CURLY
LEAF (CLF), a polycomb group gene, and the
enhancement of weak agol by a gene-trap insertion in
the chromomethylase gene cmt3. ARGONAUTE regu-
lates transgene methylation during posttranscriptional
silencing, and we have found two retrotransposons
that are partially demethylated in ago and cafmutants.
Microarray analysis of weak and strong alleles at
two developmental stages has revealed that up to 5%
of the genes in Arabidopsis are mis-regulated in RNAi
mutants. However, the putative transcription factor
genes squamosa promoter binding-protein likel0
(SPBLIO) and SPBLI I are among a handful that are
strongly up-regulated in both agol and cafl. These
genes form an inverted repeat in the genome and may
produce antisense transcripts. A closely related, but
unlinked, family member SPBL2 is also up-regulated.
FIGURE 1 Mutations in the polycomb group gene CURLY LEAF (cif) partially rescue strong argonaute (agol)
alleles. agol -9 alone (left) forms rods instead of flowers, but in a clf background, flowers are formed (middle). The
flowers (right) have fewer organs, carpels are very reduced, but one or two symmetrical ovules are formed. Petals
and stamens cannot be clearly distinguished.
Other members of this gene family affect maize leaf
development and Arabidopsis meristem identity genes,
consistent with a role in the ago and caf phenotypes.
RNAi and Heterochromatin
in Fission Yeast
T. Volpe, C. Kidner, E. Head [URP], R. Martienssen [in
collaboration with S. Grewal, Cold Spring Harbor Laboratory]
Argonaute proteins
in Arabidopsis and other higher eukaryotes. To avoid
genetic redundancy, we are studying argonaute in the
lower eukaryote Schizosaccharomyces pombe (fission
yeast), which has only a single copy of this gene. With
the discovery that argonaute homologs are required
for RNAi, we have extended these studies to genes
encoding a homolog of RNase III helicase (carpel fac-
tory/dicer) and a homolog of RNA-dependent RNA
polymerase (RdRP), each of which is also unique in
the fission yeast genome. Argonaute homologs regu-
late heterochromatic RNA and segregation distortion
in Drosophila, as well as gene silencing. We have
shown that none of the three RNAi genes are essential
in fission yeast, but they are required for transgene
silencing at the centromere, as well as for normal
chromosome segregation. Furthermore, deletion of
each of these genes results in the accumulation of
transcripts from heterochromatic repeats that are nor-
mally silent. Eukaryotic heterochromatin is character-
ized by a high density of transposons and repeats, as
well as by modified chromatin proteins including his-
tones H3 and H4. We have shown that silencing of the
repeats attracts histone H3 Lys-9 methylation, which
may in turn be responsible for transcriptional silenc-
ing at the centromere.
Our results suggest that the sequence specificity
of silent heterochromatin is determined in part by
double-stranded RNA arising from centromeric
repeats. In this sense, these repeats resemble trans-
posons, indicating a role for transposable elements
and RNAi in centromere function.
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PLANT CELL SIGNALING AND GENETICS
D. Jackson U. Au A. Giulini J.Y. Kim
K. Biddle L.-A. Haller C. Lau
M. Cilia J. Hsieh Z. Yuan
K. Aliano
We are interested in how the shape or morphology of
plants is determined. This is a fundamental question in
developmental biology, with downstream applications
in plant productivity and crop yields. Specifically, we
aim to define the molecular and genetic pathways that
control development. Recently, we have been studying
cell-to-cell signaling, or how cells talk to each other,
to coordinate their development and fate. Our two
model organisms are maize, one of the world's most
important crops, and Arabidopsis, a "lab rat" plant that
is ideal for fundamental studies of gene regulation and
cell biology. We are also developing new projects to
extend what we learn from these model systems to
other cereal crop plants, such as wheat, barley, and
rice, to learn how developmental genes have con-
tributed to the selection of these different crop species.
Novel Fasciated Mutants
U. Au, L.-A. Haller, M. Muszynski (Dupont-Pioneer Hibred),
D. Jackson
Fasciation describes the enlargement of the plant apex
by unregulated proliferative growth, analogous to ani-
mal tumors. We are systematically identifying, map-
ping, and characterizing novel fasciated mutants of
maize to figure out how plant growth is normally reg-
ulated. A particularly rich resource has been the Maize
Targeted Mutagenesis collection developed in part by
Rob Martienssen's group here at CSHL. During the
past three summers, we have screened F2. families for
fasciated mutants that affect the growth of the tassel or
ear. We have isolated about ten new mutants that we
are introgressing into selected inbred lines for map-
ping, characterization, and allelism tests. In particular,
we will concentrate on mutants that show a genetic
interaction with fasciated earl (fea2), a gene that we
recently found to encode a leucine-rich repeat recep-
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tor-like protein. We have already identified one fasci-
ated mutant that shows a dominant genetic interaction
with fea2, suggesting that it may encode a component
of the fea2 signaling pathway. We are also characteriz-
ing the mutant compact plant2 (ct2). This mutant is
particularly interesting because it is one of the few that
affect both ear and tassel development. ct2 mutant
plants are short and have thick upright tassel branches
and fasciated ears. We are characterizing a new mutant
from a Mutator transposon screen that is similar to ct2,
and allelism tests are in progress. We also have char-
acterized the development of ct2 ears by scanning
electron microscopy (Fig. 1). In contrast to normal
ears (A), at an early stage of development, the apex of
ct2 ears enlarges into a ring-shaped fasciation (B).
Abnormal development continues throughout the
growth of the ct2 ear. For example, ct2 flowers are
highly abnormal. Normal maize flowers are borne in
pairs, with a forked silk enclosing the conical ovule
primordium (C). In ct2 ears, the ovule is proliferative
and spills out like a protruding tongue from the sur-
rounding silk tissue (D).
We conclude that the ct2 gene is required through-
out ear development for the proper growth of different
meristem types.
Subcellular Localization of an
FEA2-GFP Fusion in
Transgenic Rice Plants
D. Jackson [in collaboration with Fumio Taguchi Shiobara,
NIAR, Tsukuba, Japan]
The FEA2 protein is predicted to localize to the plas-
ma membrane, but localization of this protein or its
orthologs has not been shown. We made a fusion of the
green fluorescent protein (GFP) to the carboxyl termi-
nus of FEA2 and introduced the gene fusion into rice
FIGURE 1 Ear development in normal plants (A, C) and in ct2 mutants (B,D).
plants using Agrobacterium-mediated transformation.
Primary transgenics were imaged in the confocal
microscope. As seen in Figure 2, FEA2-GFP is local-
ized to the cell periphery and to the endoplasmic
reticulum (ER), which forms a characteristic reticu-
late network in the cytoplasm, and shows perinuclear
enrichment. Therefore, these results are consistent
with targeting of FEA2-GFP via the ER to the plasma
membrane. We are generating FEA2-specific antibod-
ies that will be useful in confirming this localization
and for isolating FEA2-interacting proteins.
A Genetic Analysis of Seed Row
Number in Maize
U. Au, L.-A. Haller, D. Jackson [in collaboration with
T. Rocheford, Illinois]
One of the major factors in the human selection of
maize as a crop plant was a massive increase in the
number of seeds produced per plant. This was
achieved by a combination of factors, one of the major
ones being an increase in the number of rows of seed
FIGURE 2 Localization of FEA2-GFP in transgenic rice. Image of the shoot meristem
shows localization of FEA2-GFP fluorescence to the cell periphery and perinuclear sites.
In B, a close-up image shows in addition that FEA2-GFP localizes to the reticulate ER
network.
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on the ear. For example, the wild ancestor of maize,
teosinte, has only a single row of seed, whereas mod-
ern maize cultivars have ears with from 12 to 18 rows.
We found that row number correlates with the size of
the inflorescence meristem, indicating that regulation
of meristem size is an important factor in seed row
number.
Our interest was also sparked by the observation
that fea2, a mutation that controls ear meristem size,
maps close to a quantitative trait locus (QTL) for row
number. In the past, QTL analysis in maize has been a
relatively imprecise method to identify loci controlling
a particular trait, but with relatively low genetic reso-
lution. A new mapping population, the integrated B73
Mo 17 (IBM) population, has now been developed and
is ideal for the fine mapping of quantitative traits. We
have begun to utilize this resource by measuring seed
row number in the different IBM families. B73 and
Mo 17 inbred lines differ significantly in row number,
and we observed a wide range of row numbers in the
IBM families that exceeds the parental range. Our pre-
liminary QTL analysis indicates that row number is
under the control of a small number of loci, some of
which map to a previously identified row number QTL
and some of which are novel. Once we perform the
analysis with the full IBM data set, we hope to clarify
the correspondence between row number QTL and
known mutants affecting row number, such as the fea
mutants. It may be possible to isolate the correspond-
ing genes if a corresponding mutant is available, or in
the future, using a map-based approach.
Tissue-specific Regulation of
Protein Trafficking
J.Y. Kim, M. Cilia, Z. Yuan
We previously reported specific intercellular traffick-
ing of GFP fusions to the maize KNOTTED1 protein,
as well as to known viral movement proteins (MP).
These proteins presumably traffic through plasmodes-
mata (PD), small channels that connect plant cells, to
control development and virus spread, respectively.
We have extended this analysis by expressing these
and other fusion proteins under the control of tissue-
specific promoters, to ask whether there is develop-
mental regulation of PD trafficking. Indeed, we find
that there are specific developmentally regulated
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domains for protein trafficking. For example, the
GFP -KNI fusion protein is able to traffic from
perivascular cells through mesophyll and into epider-
mal cells. However, when expressed in the epidermis,
the fusion protein cannot traffic down into mesophyll
cells. Remarkably, this implies that there is directional
regulation of protein trafficking at the epidermal-mes-
ophyll boundary. This appears to be a specific proper-
ty of GFP-KN1, since the GFP-MP fusion is able to
traffic from epidermal to mesophyll cells. Presumably,
this reflects the virus' ability to overcome the normal
regulation of PD trafficking in the leaf, which is nec-
essary for the virus to spread and cause infection.
We also confirmed prior observations that the GFP
protein itself is able to traffic through PD. We found
that this occurs via a passive mechanism, because
movement can be blocked by fusion of GFP to yellow
fluorescent protein (YFP). The cell-to-cell movement
of GFP is relatively easy to image under low-magnifi-
cation epifluorescence microscopy, and we are using
this phenotype to develop genetic screens for mutants
affecting PD size exclusion limit. PD are still very
poorly characterized, and we envisage that a genetic
approach will allow us to identify regulatory or struc-
tural components of these elusive channels.
Gal4 Reporters for the Shoot
Apical Meristem
K. Biddle, M. Cilia, J.Y. Kim
We are particularly interested in understanding the
regulation of protein trafficking in the shoot apical
meristem, the developmental command center of the
plant. To date, relatively few tools for the analysis of
the shoot meristem have been developed. We are
therefore making specific reporter constructs that will
allow us to drive the expression of any protein in a
restricted domain of the meristem. We have made
these constructs for an L1 and an L3 layer-specific
reporter and have found interesting domain-specific
regulation of protein trafficking in the meristem. For
example, the GFP-KN1 fusion protein is able to traf-
fic from L3 to the Ll layer; however, a viral movement
protein is restricted in its ability to move up from the
L3. This observation helps to explain why some plant
viruses are unable to invade the shoot apical meristem
and provides hope that viral resistance might be
achieved if we can understand how this spatial regula-
tion is achieved. We are extending these studies with
different Ga14 drivers and GFP fusions, for example,
to a movement protein from a virus that does invade
the meristem.
As protein trafficking appears to be an important
regulatory mechanism in plant development, we are
developing these tools to understand how trafficking
is regulated in the meristem. In the future, these tools
will also be useful for the characterization of develop-
mental mutants that may affect protein trafficking or
cell specification.
Isolation of a Candidate Gene
for abphyll
A. Giulini, Z. Yuan
The abphyll mutation affects the geometric pattern of
leaf initiation, leading to plants with opposite leaf
arrangements instead of the usual alternating pattern
found in maize. We have isolated four new alleles of
abphl using Mutator and Spm transposon tagging. We
found a cosegregating DNA band with one allele,
abphl-181, and cloned this fragment. The flanking
sequence was used to probe Southern blots of DNA
from our other abphl alleles. We found that the three
other new alleles are deleted for the whole of the
flanking sequence, which contains a small predicted
gene. This gene is expressed in shoot apex tissues. The
original allele, abphl-0, appears to be rearranged, pos-
sibly tandemly duplicated, for this probe. These data
support the hypothesis that we have cloned the abphl
gene, although we do not know the extent of the dele-
tions in our other transposon alleles. We are currently
isolating new alleles from the MTM collection, as well
as mapping the deletions, to confirm whether we have
isolated the correct gene. The way in which leaf
arrangements are determined is not well understood,
so isolation of the abphl gene should provide unique
insight into this classical biological question.
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PLANT DEVELOPMENTAL GENETICS
M. Timmermans T. Phelps-Durr J. Thomas
M. Juarez J. Plocher (URP)
Plants have the unique property to be able to initiate
new organs, such as leaves and flowers, throughout
their lifetime, which frequently extends over many
years. The growing tips of plants are called meristems,
and they consist of a small group of indeterminate stem
cells. These cells divide to maintain the stem cell pop-
ulation and indeterminate growth of the plant, and to
differentiate into determinate founder cells from which
lateral organs arise. Coincident with their initiation,
lateral organs are patterned along three developmental
axes: (1) the proximodistal axis, which leads to the dif-
ferentiation of distinct tissues and cell types at the base
and the tip of the developing organ; (2) the dorsoven-
tral axis, leading to distinct cell fates in the upper and
lower surfaces of the organ; and (3) the mediolateral
axis, which distinguishes central and marginal domains
of the organ. Early surgical experiments suggested that
signals from the meristem have an important role in the
patterning of lateral organs. However, the genes
involved in the initiation and patterning of lateral
organs in plants are still largely unknown.
We are using forward and reverse genetic approach-
es to generate mutants in maize and Arabidopsis that
affect these processes. In particular, we are studying the
role of Rough sheath2 in the repression of stem cell fate
during organ initiation and growth, and we are analyz-
ing the genetic pathways leading to dorsoventral polar-
ity in leaves and leaf-like lateral organs. A better under-
standing of the function of genes involved in pattern
formation will provide new insights into fundamental
concepts of plant development. Variations in the expres-
sion patterns of such genes are likely to contribute to the
diversity of leaf shapes among many plant species.
More importantly, however, the isolation and character-
ization of genes involved in the patterning of leaves may
facilitate the manipulation of plant architecture, which
has become increasingly more important for aspects of
crop yield such as shade tolerance.
ROLE OF ROUGH SHEATH2 IN THE REPRESSION OF
STEM CELL FATE
The mechanism that distinguishes stem cells from
organ founder cells in the shoot apical meristem
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(SAM) is largely unknown, but the regulation of knot-
tedl-like homeobox (Knox) gene expression appears
to be one of the key determinants. Knox genes are
expressed in the meristem and are required for inde-
terminate growth, i.e., stem cell fate. Initiation of
determinate lateral organs such as leaves is correlated
with the down-regulation of Knox gene expression in
a subset of cells within the meristem, the organ
founder cells.
We have previously shown that the Rough sheath2
(Rs2) gene from maize encodes a MYB-domain pro-
tein that acts as a negative regulator of Knox gene
expression. Recessive mutations in rs2 cause the mis-
expression of KNOX proteins in developing leaf pri-
mordia. This past year, we determined that expression
of at least three of the nine Knox genes in maize is reg-
ulated by Rs2. These include Knotted], Rough
sheath], and Liguleless3. Expression of another Knox
gene, Gnarly], appeared to be regulated independent-
ly of Rs2. Interestingly, KNOX protein accumulation
in leaves of rs2 null mutants occurs in just a subset of
cells that express Rs2 in wild type. KNOX proteins
accumulate in patches with sharp lateral boundaries,
suggesting that rs2 leaves are clonal mosaics of Knox'
and Knox sectors. The numbers and sizes of such sec-
tors vary among leaves and do not correlate with nor-
mal developmental domains. Furthermore, the down-
regulation of Knox gene expression during leaf initia-
tion precedes the onset of Rs2 expression, suggesting
that Rs2 is required for the maintenance of Knox gene
repression. On the basis of these observations, we pro-
posed that Rs2 acts as an epigenetic regulator to keep
Knox genes in an "off" state. Rs2 may thus prevent
differentiated cells within lateral organs from revert-
ing to indeterminate stem cells.
We are studying the mechanism by which Rs2
represses Knox gene expression by identifying genes
that act together with Rs2. We have constructed and
screened a two-hybrid library made from young maize
leaf cDNAs. Results from this screen indicate that
RS2 can homodimerize, but it remains to be deter-
mined whether RS2 acts as a dimer during Knox gene
repression in vivo. In addition, we identified six other
proteins that interact with the non-MYB domain of
RS2 in this screen. These RS2 interacting proteins
(RS2-IPs) have homology with either the protein
phosphatase 2A regulatory subunit A (PP2A-A),
PP2A regulatory subunit B' (PP2A -B'), a zinc-finger
transcription factor, histone 2B (H2B), a known chro-
matin remodeling protein, or a hypothetical protein
from Arabidopsis.
This past year, we have initiated several experi-
ments to confirm our two-hybrid results and to further
characterize the RS2-IPs. To confirm the interactions
between RS2 and the RS2-IPs in vitro in the absence
of other yeast proteins, we are using glutathione-S-
transferase (GST) pull-down assays. We have generat-
ed fusion proteins between GST and several of the
RS2-IPs. These fusion proteins were purified by
affinity chromatography over a glutathione-
Sepharose column and subsequently tested for their
ability to interact with RS2. Results from these exper-
iments indicated that all RS2-IPs tested so far were
indeed able to physically interact with the non-MYB
domain of RS2.
On the basis of the amino acid sequence and the
function of RS2, we would predict that the RS2 com-
plex is localized within the nucleus. Several of the
RS2-IPs, including H2B, the transcription factor, and
the chromatin remodeling protein, are known to be
localized to the nucleus. Amino acid sequence analy-
sis of the remaining RS2-IPs predicts that all three
proteins contain nuclear localization signals. We have
tested the subcellular localization of two of these RS2-
IPs by transiently expressing chimeric proteins con-
sisting of the RS2-IP fused to the green fluorescent
protein (GFP) in leaf tissue. As predicted, fluores-
cence resulting from the GFP was limited to the nucle-
us of expressing cells, indicating that the RS2-IPs nor-
mally function in the nucleus. Interestingly, the fusion
protein between GFP and the RS2-IP with unknown
function was excluded from the nucleolus but was
localized specifically to chromosomes in dividing
cells (Fig. 1). This result together with the confirmed
interaction between RS2, H2B, and the chromatin
remodeling factor would suggest that RS2 maintains
Knox genes silenced by altering the organization of
chromatin at these loci.
To test this model and to determine the roles of the
RS2-IPs in plant development, particularly in stem
cell function, we are screening for mutations in the
genes encoding RS2-IPs. We have obtained the com-
plete sequence of full-length cDNA clones encoding
the different RS2-IPs. Using the reverse genetic tools
available in Arabidopsis, we have obtained mutations
A
C
FIGURE 1 The RS2 complex is required to maintain Knox gene
silencing in the leaf. Proteins that interact with RS2 are there-
fore predicted to localize to the nucleus of the cell. To test this
hypothesis, we transiently expressed fusion proteins of RS2-IPs
to GFP in leaf cells and observed GFP localization by fluores-
cence microscopy. One of the RS2-IPs is highly conserved
between yeast, plants, and mammals; however, its function is
unknown. The GFP fusion to this particular RS2-IP resulted in
fluorescence throughout most of the nucleus of nondividing
cells, but fluorescence was excluded from the nucleolus (4). In
dividing cells, fluorescence marked the condensed chromo-
somes (8). These results suggest that this RS2-IP may be
associated with chromatin, consistent with the predicted role
for RS2.
in several histone genes, in the zinc-finger transcrip-
tion factor, and in the chromatin remodeling protein.
We have also begun to generate transgenic lines over-
expressing the RS2-IPs, but these experiments are
still in a preliminary stage. The outcome of this
research will broaden our understanding of the
process that distinguishes determinate, differentiating
cells from stem cells in plants. It will also contribute
to our understanding of the role of gene silencing
mechanisms in development. Both of these processes
are currently poorly understood.
DORSOVENTRAL PATTERNING OF LATERAL
ORGANS IN MAIZE
Normal maize leaves develop as flattened dorsoven-
tral organs with distinct cell types on the upper/dorsal
and lower/ventral sides. We previously reported that
Leafbladelessl (Lbll) is required for the specification
of dorsal identity in leaves and leaf-like lateral organs
and that dorsoventral polarity in the developing organ
is needed to grow out laterally into a flattened leaf.
Partial loss of Lbll gene function results in the for-
mation of ventralized, radially symmetric leaves or in
ectopic laminar outgrowth surrounding ventralized
sectors on the dorsal leaf surface.
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We have identified three new alleles of lbll from
ethylmethanesulfonate (EMS)- and transposon-muta-
genized populations. The most severe allele of lb 11,
ragged seedlingl (lbll- rgdl), results in embryo lethal-
ity. We are analyzing the embryo lethal phenotype in
more detail. Scanning electron microscope analysis of
developing maize embryos suggests that homozygous
1b11-rgd1 embryos develop a distorted and more
rounded scutellum (comparable to a cotyledon) and
fail to develop any shoot structures. In situ hybridiza-
tion with a knottedl-specific probe indicated that
development of the root axis is delayed in the Ibll-
rgd1 mutant, but the organization of the root remains
normal. In contrast, no SAM was present in immature
mutant embryos. These results suggest that establish-
ment of dorsoventral polarity in the scutellum may be
required to initiate or maintain a SAM. Early surgical
experiments have shown that signals from the SAM
are required to specify the dorsal leaf domain.
Therefore, a mutual relationship may exist between
the dorsal leaf domain and the SAM. Signals from the
dorsal domain of the scutellum or leaf are required to
initiate or maintain normal meristem function, and
signals from the SAM are required to establish dorsal
identity in the next new leaf.
We have recently identified three additional loci
required for dorsoventral patterning. To characterize
Ibll and the new dorsoventral patterning mutants in
more detail, we have cloned the maize homologs of
several Arabidopsis genes that are expressed specifi-
cally in either the dorsal or ventral domains of the leaf.
The Arabidopsis YABBY genes act in the ventral
domain of lateral organs and are thought to be
required for the specification of ventral cell types in
190
the leaf. We have isolated cDNAs for several Yabby
homologs from maize and are analyzing their expres-
sion patterns in wild-type maize and in the different
dorsoventral polarity mutants. As in Arabidopsis, the
maize Yabby genes are expressed throughout the incip-
ient primordium, but interestingly, expression
becomes rapidly restricted to the dorsal side and to the
margins of the leaf. The basis for and the consequence
of the opposite Yabby expression patterns in
Arabidopsis and maize are currently under investiga-
tion. However, the observation that Yabby expression
is restricted to the margins of young leaf primordia
suggests that in maize, these genes may not function to
specify cell fates, since this would require continual
expression until differentiation occurs later in leaf
development. Our results suggest that the Yabby genes
may mediate dorsoventral polarity signals to direct lat-
eral growth at the leaf margins. The establishment of
Yabby-expressing cells next to nonexpressing cells
could be required for lateral growth. If so, there would
be no evolutionary constraints to limit Yabby expres-
sion to, for instance, the ventral side of the leaf.
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COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity for
these young scientists to work independently at the Laboratory for a period of up to 3 years on proj-
ects of their own choosing. Fellows are provided with a salary, research support, and technical assis-
tance so that they can accomplish their goals free of distraction. The interaction among research
groups at the Laboratory and the program of courses and meetings on diverse topics in biology con-
tribute to a research environment that is ideal for innovative science by these Fellows.
Previous Cold Spring Harbor Laboratory Fellows Adrian Krainer (1987) and Scott Lowe (1995) are
currently members of the faculty at the Laboratory. After 9 years at the Laboratory, Carol Greider (1988)
left to join the Department of Molecular Biology and Genetics at Johns Hopkins University School of
Medicine. Eric Richards (1989) is currently in the Department of Biology at Washington University. After
finishing his fellowship, David Barford (1991) returned to the Laboratory of Molecular Biophysics at
Oxford University. Ueli Grossniklaus (1994) was a member of our faculty before leaving to join the
Friedrich Miescher Institut in Basel, Switzerland in 1998. Marja Timmermans, who joined us from Yale
in 1998, ended her fellowship in June of this year, when she became an assistant professor at the
Laboratory.
The two current CSHL Fellows, Gilbert (Lee) Henry and Terence Strick, joined the Laboratory in
2000. Their reports are listed below. Lee joined us from Doug Melton's laboratory at Harvard University
where he earned his Ph.D. for studies on Xenopus development. Lee is studying taste bud develop-
ment and the role of innervation in this process. Terence joined us after earning his Ph.D. in molecular
and cellular biology at Eco le Norma le Superieure in Paris with David Bensimon and Vincent Croquette.
Terence is using single-molecule biophysics to study the mechanical response of DNA to stretching
and twisting by enzymes that alter DNA topology, thus elucidating the properties of these enzymes.
L. Henry
T. Strick
Structural and Functional Studies
of the Vertebrate Taste Bud
L. Henry, A. Samuel, Y. Zhu
The goal of our research is to understand the molecu-
lar mechanisms that are required for the formation of
taste buds during embryogenesis and the maintenance
of their structure and function in the adult. The senso-
ry cells of gustation are housed within ovoid struc-
tures called taste buds, which are embedded in the
epithelium of the tongue, and to a lesser extent, the
epithelium of the palate and upper pharynx.
Consisting of 70-100 cells, the vertebrate taste bud is
a highly dynamic structure that possesses both epithe-
lial and neuronal qualities. Like all other sensory cell
types, the taste receptor cell membrane depolarizes in
the presence of a suitable stimulus. Similar to the
epithelial cells that line the intestine and other areas of
the gut, cells within the bud turn over at a rapid rate
(-8-10 days in rodents). Unlike the olfactory system,
where the axons of newly formed receptor cells pro-
ject for some distance back toward and synapse on to
neurons in the glomeruli of the olfactory bulb, newly
formed taste receptor cells lack classical projections
and synapse on to sensory afferents that are associat-
ed with the taste bud.
Mammalian taste buds are embedded in epithelial
specializations called papillae. On the surface of the
tongue, three classes of papillae are easily distin-
guished. Toward the back of the tongue, there is a cen-
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trally located circumvallate papillae; two groups of
foliate papillae are found to the lateral extremes of the
posterior tongue, and scattered over the anterior
tongue are reddish colored fungiform papillae. The
papillae form late during embryogenesis in the mouse
(E 1 3-E16) as the tongue begins to bud away from the
pharynx. Soon after their formation, sensory afferents
enter the papillae, and approximately 8-10 days after
birth (P8-P10), taste buds form. In rodents, there is a
single bud per fungiform papillae, tens of buds within
the two foliate papillae, and hundreds of buds in the
single circumvallate. An intimate relationship
between both the developing papillae and the mature
taste bud with innervating sensory afferents has been
established through a number of denervation studies.
Papilla formation does not require innervation; how-
ever, the maintenance of these structures does in some
way require contact with sensory afferents. Similarly,
in adult animals, denervation of the tongue leads to
the loss of taste buds.
We are currently employing a number of different
strategies to address three basic issues in taste bud
development and function. How do papillae form in
the appropriate pattern during late gestation, and what
role do innervating sensory afferents have in this
process? How diverse is the cellular environment of
the adult taste bud and what mechanisms are required
to maintain this diversity? How can a dynamic senso-
ry structure maintain a constant level of function?
Although these questions at first seem to be loosely
connected, we expect to learn something about taste
bud function by understanding how taste buds are put
together and vice versa.
HOW MANY TYPES OF CELLS ARE CONTAINED
WITHIN THE DEVELOPING PAPILLAE?
To understand how papillae are formed and innervat-
ed, it is imperative that we first ask what are papillae,
at the molecular level. The papillae of the tongue are
very similar in structure to the various ectodermal pla-
codes that cover the epidermis and give rise to hair,
feathers, and teeth. The secreted signaling factor sonic
hedgehog (shh) is expressed in cells that will form
these structures and that expression is maintained
after the papillae or placode has formed. We plan to
exploit this finding by using the shh locus to ectopi-
cally express green fluorescent protein (GFP) in
developing papillae. Bacterial artificial chromosome
(BAC) clones carrying the shh gene have been isolat-
ed, and using a recently described recombination tech-
nique, a GFP cassette has been inserted into this locus.
Transgenic mice will be generated using modified
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BACs. Single GFP-positive cells from the lingual
epithelium of E12-E17 embryos will be isolated and
transcriptionally profiled using a single-cell cDNA
synthesis method (see below). Profiles will be
obtained by screening microarrays and direct sequenc-
ing of cDNAs. From this work, we hope to determine
the molecular diversity of the papilla during its forma-
tion and innervation. Once we can "fingerprint" the
cells of the papillae in this manner, it should be possi-
ble to analyze the mechanisms that regulate this diver-
sity, in particular, the contribution of innervation to the
development of papillae.
HOW DIVERSE ARE BOTH THE MATURE RECEPTOR
CELL POPULATION AND THE PROGENITOR POOL
FROM WHICH IT IS DERIVED?
Morphologically, there are three types of cells within
the adult taste bud. Highly elongated differentiated
receptor cells are found at the apex of the bud. Mitotic
progenitor cells are found almost entirely at the bud's
base. Packed in between these two cell types are less
elongated immature receptor cells. The recent identifi-
cation of taste-specific seven-transmembrane recep-
tors and heterotrimeric G-proteins has demonstrated
that within the mature receptor cell population, there
is a great deal of cellular diversity, at the level of
expression of these genes.
We would like to analyze the molecular diversity
of both mature receptor and mitotic basal cells in
detail, without a bias toward a particular gene family.
In an approach that is similar to what is planned for the
developing papillae (see above), we will isolate
murine taste buds and generate transcriptional profiles
from single cells.
To produce meaningful profiles from single taste
bud cells, it is first necessary to sort these cells into a
series of meaningful groups or bins. To do this, we have
designed and are in the process of generating a small
microarray that contains approximately 100 clones or
units. The selection of each unit was based on known
cellular and molecular biological properties of taste
buds. Progenitor cells will be identified by a series of
clones that are known to be transcriptionally active in
cells that are actively dividing. The mature receptor cell
possesses four basic molecular properties: quiescence,
a highly polarized cytoarchitecture, an ability to detect
external stimuli or tastants, and a mature synaptic
arrangement with both other receptor cells and senso-
ry afferents. The vast majority of units in the microar-
ray are dedicated to marking these events. For example,
29 seven-transmembrane receptors are known to be
involved in the detection of both bitter and sweet tas-
tants. All of these receptors and the second-messenger
systems that they utilize are represented on our
microarray. Additionally, a number of clones have been
included that mark a cell's ability to produce both
synaptic vesicles and particular neurotransmitters.
During the next year, we hope to screen this array with
probes generated from single taste bud cells.
DEVELOPMENT OF A QUANTITATIVE METHOD FOR
THE ANALYSIS OF mRNA IN SINGLE CELLS?
We are currently developing the means to quantita-
tively profile mRNA in single cells or small groups of
cells. Our approach involves the use of solid-phase-
based cDNA libraries. By anchoring cDNA to a mag-
netic bead, it is possible to perform a variety of manip-
ulations without having to rely on inefficient precipi-
tation and/or column chromatography between the
steps of interest. Additionally, immobilizing the cDNA
to a surface provides a convenient means to produce a
library, from which functional copies of the library can
be generated by either polymerase chain reaction
(PCR) or in vitro transcription, multiple times. We
have succeeded in producing libraries of this sort from
single taste buds and are in the process of performing
similar experiments on single cells from both develop-
ing lingual epithelium and adult taste buds. Using cur-
rently available microarrays, we are assessing the
quantitative abilities of our system.
Single Molecule DNA Analysis
T.R. Strick, T. Kawaguchi
During the past year, our lab has been using single-
molecule techniques to quantitatively study DNA
supercoiling and its interactions with proteins
involved in transcription and replication. Supercoiling
FIGURE 1 Sketch of the experimental
setup. A glass capillary tube is mounted
on an inverted microscope whose focus
is controlled by a computer. The com-
puter also controls the displacements
(translation and rotation) of the magnets
used to manipulate the bead. A CCD
camera connected to the microscope
relays video images of the magnetic
bead to the computer. The computer
extracts from these images the mean
position and the Brownian fluctuations of
the bead, which can be used to deter-
mine the applied stretching force and the
DNA's end-to-end extension.
describes the wrapping of the two strands of DNA one
about the other, as well as the writhing of the double
helix through space (a twisted phone cord is a some-
what useful analogy). Controlled in vivo by the topoi-
somerase enzymes, it appears to be both a regulator
and a by-product of DNA transcription, replication,
and packaging. It is now experimentally possible to
mechanically control the supercoiling of an individual
DNA molecule. The major advantage of performing
such experiments at the level of single molecules is
that it allows observation in real time of the behavior
of the molecule, eventually giving the research access
to the time course of a reaction between the DNA and
a protein. In this report, we briefly introduce the
method used and describe some of our recent results
on the direct observation of denaturation fluctuations
(or "breathing") in DNA and its possible role in tran-
scription initiation.
The single-molecule experiment we have imple-
mented is depicted in Figure 1. An -10-kbp linear DNA
molecule is shown anchored at one end to a glass sur-
face and at the other end to a 1 -lam- diameter magnetic
bead. The field generated by magnets located above the
sample is used to pull on and rotate the magnetic bead,
thus stretching and twisting the tethered DNA. The
stretching force applied to the DNA depends solely on
the distance between the magnets and the sample (the
closer the magnets, the higher the force), and the tor-
sion imparted to the DNA is exactly equal to the num-
ber of clockwise or counterclockwise turns performed
by the magnets. The double helix is thus quantitatively
and reversibly supercoiled. By determining the position
of the magnetic bead, one measures the end-to-end
extension of the DNA molecule, and thus its mechani-
cal response to stretching and twisting.
One topic we pursued in the last year was the study
of the onset of denaturation in DNA. In denatured
DNA, the double-helical structure of the molecule is
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FIGURE 2 (Top) Extension vs. supercoiling curve obtained on a
single DNA molecule for F = 0.4 pN and F = 0.5 pN (1 pN = 10-12
N). Although the extension decreases regularly with winding (at
a rate of about 80 nm/turn) for the lower force, symmetry break-
ing is observed at the higher force. (Middle) Discrete changes in
the DNA's extension (Al = 250 nm) are observed as a function of
time for the negatively supercoiled DNA subjected to a 0.5 pN
force analyzed to extract the free-energy difference between the
two states. (Bottom) The low-extension state corresponds to
that where no denaturation bubble is present, but contains
supercoils (for the sake of the sketch, here we draw four). The
high-extension state occurs when an -30-bp bubble topologi-
cally cancels -3 supercoils, causing the large change in exten-
sion we observe.
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destroyed, and the bases on the opposite strands are no
longer paired. This process is fundamental to the initi-
ation of transcription and replication, as it gives DNA
and RNA polymerases access to the core of the DNA
molecule, which is where the genetic information
encoded by the bases can be most reliably read.
In Figure 2 (top), we show how the end-to-end
extension of a DNA varies with supercoiling for two
different forces. At a force of 0.4 pN, the system con-
tracts regularly for both over- and underwinding. At a
force of 0.5 pN, however, contraction is regular for
overwinding but irregular for underwinding: This
symmetry breaking indicates that the underwound
DNA is undergoing local denaturation.
If the extension of the DNA is measured as a func-
tion of time (see Fig. 2, middle), the system's exten-
sion is seen to alternate between a low-extension state
and a high-extension state. In Figure 2 (bottom), we
provide a schematic explanation of this phenomenon:
The low-extension state is characterized by the exis-
tence of supercoils, whereas in the high-extension
state, three supercoils have been topologically annihi-
lated by the appearance of an 300-bp denaturation
bubble. As one continues to unwind the DNA, the size
of the bubble slowly increases and transitions to the
high-extension (denatured) state become more fre-
quent as well as longer-lived. We also measured the
rates of denaturation and renaturation as a function of
the applied stretching force and the temperature. This
allows us to build a quantitative model which unifies
the effects of torsion, force, and temperature on the
appearance of a denaturation bubble. In essence, ther-
mal agitation is causing the DNA to hop between two
states-one with the bubble present, one without-
and the energy barrier between the two states, as well
as the difference in energy between the two states, can
be adjusted by tuning the mechanical and thermal
constraints on the DNA.
This quantitative understanding of the physical
parameters relevant to DNA denaturation forms the
basis for the study of protein-induced DNA melting.
As an example, we are currently using this knowledge
to directly observe and measure the melting of a tran-
scription promoter sequence under binding of RNA
polymerase.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
DEAN'S REPORT
To say the least, 2001 was an eventful year for the Watson School. It represented our second full year
of academic instruction in which we welcomed a third entering class of doctoral students. It was an
important year for the School as its young and developing curriculum demonstrated its flexibility by
adapting to changes in instruction. The School also expanded to take over responsibility for long-
established Laboratory educational programs that relate to the Laboratory's research endeavors.
These programs extend from the youngest of students in Nature Study to postdoctoral fellows. Finally,
it was a year of successful appraisal as the Watson School excelled in two external reviews, one by the
National Institutes of Health for a doctoral training program and the second by the New York State
Education Department for renewed accreditation. I am pleased to report that the School ended the
year stronger than ever.
The Watson School: A Home for the Nature Study, Partners for the Future,
Undergraduate Research, and Postdoctoral Programs
Although Cold Spring Harbor Laboratory only became a degree-granting institution in 1998, it has had
educational programs since its origins in 1890. Today, the educational programs of the Laboratory can
be divided into two broad categories: those that attract participants from around the world to the
renowned Meetings and Courses program, including the Banbury Center, and those that pertain more
specifically to the Laboratory's in-house research program. This latter set includes the Nature Study,
Partners for the Future, Undergraduate Research, and Postdoctoral programs. The first of these-the
Nature Study Program-began in 1925 under the auspices of the Long Island Biological Association,
the predecessor to the Cold Spring Harbor Laboratory Association, to offer young students an appre-
ciation of nature. Although not directly related to today's on-going research programs, the Nature Study
program is an important investment in tomorrow as many of today's biologists first became interested
in biology by studying nature as children. It certainly brings me fond memories when I see the Nature
Study students each summer walking down Bungtown Road with knee-high boots and nets in hand
eager to see what they might discover in the harbor.
The three of the aforementioned programs that do relate specifically to the Laboratory's ongoing
research programs result in students and trainees working in the research laboratories. The Partners
for the Future program, now in its 12th year, offers a select group of six to eight students from local
high schools a hands-on research experience from October to March. Since its inception in 1990 under
the direction of Susan Cooper, the Public Affairs Department has overseen this program. Each year,
Lynn Hardin of the Public Affairs Department reaches out to Long Island high school students to iden-
tify possible participants and coordinates student participation in the program. In 1999, the Watson
School began an initiative to better integrate the Partners for the Future program with the Laboratory's
research program. One of the first steps was to identify a leader from among the faculty who could
work with the Public Affairs Department to provide programmatic oversight-Yuri Lazebnik has risen to
the occasion. Together with Jeff Picarello, the director of Public Affairs, and Lynn Hardin, Yuri Lazebnik
has initiated important changes to the program. These changes will enable more outstanding students
to participate and, through increased interactions among the students, will provide these students with
a greater sense of the excitement of doing research first hand.
The Undergraduate Research Program was established in 1959 and boasts Nobel Laureate David
Baltimore's participation in its first year. It hosts up to 25-and sometimes more! -undergraduate stu-
dents each summer for a 10-week sojourn in a research laboratory. This program may be the most
sought-after of all of the Laboratory's programs, as more than 500 students from around the world
199
apply to the program each year, and the large majority of those to whom offers are made choose to
join the program. Direction of this program changed hands this year with Michael Hengartner's depar-
ture from the Laboratory. Michael became director of the program in 1995. Fortunately, Michael was
astute enough during his tenure as director to identify a co-director-Leemor Joshua-Tor-to help him
with the program. Thus, upon Michael's departure, we had a new director in Leemor, one with experi-
ence to take over the reins. To help her direct the program, Leemor chose Gregory Hannon to become
associate director. Together, Leemor and Greg did a wonderful job directing the program last summer.
An important ingredient to this success has been and continues to be the devotion to the program of
Jane Reader, the program's administrator. This program's success is important to the Watson School,
as the Undergraduate Research Program has been an outstanding source of students for the School's
doctoral program.
Among the oldest traditions at the Laboratory is postdoctoral research, in which trainees who have
recently been awarded the Ph.D. degree join faculty at the Laboratory to address questions that have
piqued their interest as graduate students. The Laboratory offers these researchers an opportunity to
hone their skills in new areas as a prelude to future career opportunities. Traditionally, postdoctoral edu-
cation has been largely the purview of the individual researcher whose laboratory the postdoctoral fel-
low joins. It is becoming increasingly evident nationwide, however, that a postdoctoral education
involves more than simply research experience in a laboratory-it also involves educating postdoctor-
al fellows in survival skills as a scientist. The Watson School's innovative 4-year Ph.D. program, which
emphasizes teaching students the skills of the research scientist and the identification of an important
problem to attack after the Ph.D., places more importance on the role of the postdoctoral years in the
development of the biologist. The Watson School is therefore eager to participate in discussions of
postdoctoral education. As a first step, Lilian Gann, the School's assistant dean, is chair of a working
group consisting of faculty members Zachary Mainen, Nicholas Tonks, and Linda Van Aelst; postdoc-
toral fellows Frances Hannon, Alyson Kass-Eisler, Michael Packer, and Karen Zito; and Denise Roberts,
the Laboratory research administrator. This postdoc working group will provide recommendations on
ways to enhance the postdoctoral experience at the Laboratory. I also hope to take the opportunity in
the upcoming year to engage faculty in discussions on how best to develop a postdoctoral training pro-
gram. This goal is important, as the largest contingent of researchers at the Laboratory comprises the
postdoctoral fellows.
The Spring Curriculum
In general, the Watson School's curriculum for first-year
students has been met with acclaim. Nevertheless, as
the School grows up, there have been new courses
developed and new students to educate. In 2001, the
year 2000 entering class of nine students participated in
the spring curriculum of a Topics in Biology course,
teaching at the Dolan DNA Learning Center, and labora-
tory rotations.
Topics in Biology Course: Evolution
This year saw our second Topics in Biology course. The
Topics in Biology courses held at the Banbury Center
and organized by Lilian Gann and Jan Witkowski are
rapidly becoming one of the signature courses of the
Watson School. These courses provide our students
with exposure to areas of science that are beyond the
spectrum of research at the Laboratory. Thus, the stu-
dents spend a weeklong retreat at the Banbury Center
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Masafumi Muratani (foreground) and Marco Mango
(left) with Ahmet Den li (right) during the Topics in Biolo
course on Evolution.
with invited instructors to learn a new topic in biology. This year, the 15 first- and second-year students
attended a course on "Evolution" offered by Nipam Patel from the University of Chicago. Nipam pro-
vided an outstanding program as well as a special treat when he arranged for the students to spend a
day at the Museum of Natural History for a behind-the-scenes tour and a lecture on Drosophila speci-
ation by Rob De Salle. The course was very well received, and we hope to have Nipam back in 2003
for our entering classes of 2001 and 2002.
Teaching at the Dolan DNA Learning Center
One of the goals of the Watson School's graduate program is to educate biologists who can commu-
nicate effectively with nonscientists. An important part of achieving this goal is the student participation
in the Dolan DNA Learning Center during the spring of their first year. The DNA Learning Center pro-
vides students hands-on experience in communication to the layperson, and pioneered the teaching
of DNA science with laboratory instruction to high school and middle school students. The Watson
School students are given the opportunity to lead classes at the Center as part of a teaching program
developed especially for them. In the first week of January, DNA Learning Center director David Mick los
met with all of the students and described how the Center's instructors, led by Scott Bronson and Tricia
Maskiell and with help from Veronique Bourdeau, would teach the students how to lead the high school
and middle school classes. The students worked in pairs and began by observing the instructors
before progressing to co-teaching with the instructors and eventually teaching on their own. Once on
their own, the students developed individual strategies to explain the lessons being taught to the young
students and were prepared to answer the questions of the inquisitive minds of young students. As in
the first year, this teaching experience was very popular with the Watson School students.
Laboratory Rotations and Selection of a Research Mentor
Throughout the spring term, students of the entering class of 2000 participated in laboratory rotations
and attended building-wide group meetings. The goals of the 6-week rotations continue to be to pro-
vide students with hands-on laboratory experience, and to give students and faculty opportunities to
get to know each other and to explore possibilities for doctoral thesis research. These rotations are
specifically short, but because the students can devote nearly full-time effort due to the separation of
course work in the fall term and research in the spring term, they have the opportunity to get a good
feel for different laboratory environments and the biological questions being addressed. Although some
of the students chose to perform an additional fourth rotation in the summer, the length of rotation gen-
erally provided students and faculty alike sufficient information to make well-informed choices con-
cerning the selection of a research mentor.
Watson School student Claudia
Feierstein (right) with Postdoctoral
researcher Antonella Piccini during
a rotation in Roberto Malinow's
lab.
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Student
ENTERING CLASS OF 2000
DOCTORAL THESIS RESEARCH
Academic
Mentor
Research
Mentor Thesis Research
Santanu Chakraborty
George A. and Marjorie H.
Anderson Fellow
David Helfman
Michael Wig ler
Elena S. Ejkova Jan Witkowski
Engelhorn Scholar
Rebecca C. Ewald Bruce Stillman
Engelhorn Scholar
Ira Hall Alexander Al. Gann
Beckman Graduate Student
Zachary Bela Lippman William Tansey
Beckman Graduate Student
Marco Mangone Linda Van Aelst
Charles A. Dana Foundation Fellow
Masafumi Muratani
George A. and Marjorie H.
Anderson Fellow
Nouria Hernandez
Patrick J. Paddison Adrian R. Krainer
Beckman Graduate Student
Karel Svoboda
Carlos D. Brody
To be determined
William Tansey Role of the proteasome in
transcription
Hollis Cline
Shiv Grewal
Robert Martienssen
NMDA receptor trafficking and
its impact on neuronal
functionality and morphology
Initiation, assembly, transfer,
and genome-wide distribu-
tion of heterochromatin in
Schizosaccharomyces pombe
Comprehensive analysis of
chromatin status on
Arabidopsis chromosome 4
Winship Herr The role of HCF-1 in cell
proliferation
William Tansey Gene regulation by ubiquitin-
mediated proteolysis
Gregory Hannon An RNAi-based screen in
mouse embryo fibroblasts for
transformation-lethal gene
targets
Qualifying Exam
At the end of June, the entering class of 2000 took the School's oral qualifying exam. This exam tests
the ability of the students to acquire and articulate in-depth scientific information by defending their
knowledge of two assigned topics. The aim of the exam is to assess whether students have learned
how, on their own, to acquire and critically synthesize scientific information on a new topic. With this
goal in mind, as in the previous year, students orally defended their knowledge in two individually
assigned topics over the course of two hours in front of three examiners. One of the assigned topics
was in the area of the student's planned thesis research, whereas the second topic lay outside the the-
sis research area. Students were encouraged to meet with their examiners to discuss the limits and
expectations for the designated topics.
This year, we continued with the approach established in the first year to ensure that the oral exams,
which by their very nature will differ in content and style from one student to the next, are fair and equi-
table to the students. To deal with the larger number of students (nine compared to six the first year),
the Qualifying Exam Committee (QEC), which serves as a parent committee to oversee the process,
was expanded to six members: Gregory Hannon, David Jackson, W. Richard McCombie, Linda Van
Aelst, and Anthony Zador, with me as its chair. The QEC established the list of topics offered to the stu-
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dents for examination and made the final topic selections. The three examiners at each individual qual-
ifying exam were all members of the Watson School faculty, and a QEC member chaired the examin-
ing committees. I sat in on each exam as a nonparticipating observer to ensure parity in the examining
process. This exam process continues to be viewed as a success. Strengths and weaknesses of stu-
dents were revealed through the course of the qualifying exam process, but in the end, all of the stu-
dents successfully completed this element of their curriculum and were able to begin focusing on their
doctoral research in earnest.
The Watson School Loses Its First Student
Although regrettable, it is perhaps a mark of increasing maturity that we lost our first student at the end
of the summer. Guillaume Lettre, who came to us from the Universite de Sherbrooke in Quebec,
Canada, decided to carry out his thesis research with Michael Hengartner, who-also regrettably-had
left Cold Spring Harbor Laboratory for the University of Zurich in the winter of this year. Guillaume was
an outstanding student and he will be sorely missed. We wish him every success.
A Coordinated Fall Term Curriculum
A special feature of the fall term of the Watson School Ph.D. curriculum is intimate instruction in a series
of well-integrated and cohesive courses. By design, this curriculum does not require all the faculty to
participate in lecture courses each year. This design allows for exceptional flexibility in the structure of
the teaching faculty, allowing the faculty to involve themselves at different levels in the instruction of the
first-year students. Thus, it is only a self-selected core group of the faculty-the teaching faculty-that
is intimately involved in the design and organization of the courses. Each course is taught by a team of
faculty whose members work closely together to develop and present a well-organized and cohesive
course. Members of the remainder of the faculty are recruited by the core teaching faculty to lecture in
and Logic (SRL) and Scientific Exposition and Ethics (SEE) core courses and
the Specialized Discipline courses.
This strategy requires considerable coordination, as courses change from year to year. Thus, the
teaching faculty and School administration devote much effort to curriculum coordination, integration,
and evaluation. Much of the coordination is provided by a "Core-Course Coordinating Working Group"
affectionately termed the C3WG. Core-course instruction is the major didactic effort in the fall course
term. These courses are central to teaching the new students the processes of critical and logical bio-
logical thought, communication, and ethical behavior. The importance of these courses to the School
curriculum is emphasized by the presence of the lead instructors of each core course (David Helfman,
Scott Lowe, and William Tansey) on the School's Executive Committee. Together with the dean and
assistant dean, these three core-course instructors form the C3WG. This working group meets during
the spring and summer months to prepare for the fall course curriculum and to integrate the course
instruction. For example, to provide synergy between the SEE and SRL core courses, papers assigned
by the SRL course are also assigned in the SEE core course to study exposition or ethics. The C3WG
also meets with the instructors of the Specialized Disciplines courses to integrate those courses into
the core course instruction and to provide advice on how to structure their course, adjust student work-
load, and what to expect from the students. For example, the teaching of genetic principles to the stu-
dents during the fall term is shared by the SRL core course and The Genome Specialized Disciplines
course. Coordination of this instruction occurs at meetings of the C3WG.
This course coordination was put to the test this year, when, for the first time, a Specialized
Disciplines course was changed-the course on transcription taught by William Tansey and me was
replaced by a course on cellular structure and function taught by David Helfman and David Spector.
The C3WG worked out how to adjust the curriculum of the SRL core course to accommodate this
change. I was very pleased to see that the course coordination was a great success, as both the SRL
and Cellular Structure and Function courses were highly rated.
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Knowing that the courses were well integrated relied on student feedback concerning course
instruction, and the School depends heavily on this student feedback. Under the aegis of Lilian Gann,
students are asked to complete evaluation forms for every course and to evaluate each weekly mod-
ule of the SRL core course. These evaluations are used to improve course lectures and the structure
of the modules. They are also used by the External Advisory Committee to provide the Watson School
faculty with advice on changes to course content and format.
A Guiding Executive Committee
A very important ingredient to the smooth sailing that the Watson School has enjoyed to date is the
School's Executive Committee. Unfortunately, owing to his departure to the University of Zurich in
March, Michael Hengartner, a founding member of the Committee and the first lead instructor of the
SRL course, had to step down from the Committee. The five other fac-
ulty members on the Committee-Hollis Cline, David Helfman, Scott
Lowe, William Tansey, and Jan Witkowski-were thus joined by Lincoln
Stein, a three-time instructor of the Bioinformatics/Genome Specialized
Disciplines course and an expert in the role of the computer in today's
biological investigations. He has proven to be an outstanding selection
and has provided much sage advice and counsel. Fortunately for the
School, we did not lose Michael Hengartner entirely, as he returned in
November to teach a module of the SRL course on his favorite topics,
apoptosis and genetics.
The School also benefited greatly from the two student members on
the Executive Committee-Watson School student Amy Gaudy from
the entering class of 1999 and SUNY Stony Brook student Ajit
Janardhan. Ajit is an M.D./Ph.D. student who is performing his doctor-
al studies with the Stony Brook Genetics Program. Ajit's and Amy's con-
tributions, along with those of the previous student representatives
Michelle Cilia and John Mignone, have been invaluable. In recognition of
the value of their input, this year the Executive Committee decided that
student representatives should receive voting rights. Along the same
vein, the Committee decided that Lilian Gann, the assistant dean,
should also have voting rights as she represents the all-important
School administration. Fortunately, the increase in voting members has
not changed the usual unanimity in Executive Committee decisions!
Ajit Janardhan, the Stony Brook student rep-
resentative on the Watson School Executive
Committee
Two-tier Mentoring
Another innovative feature of the Watson School that is proving successful is its two-tier mentoring pro-
gram championed by William Tansey. This program promotes a high level of student achievement by
having faculty and administration take an active role in mentoring and supervising the students. The
two-tier mentoring program involves an academic and research mentor for each student. At matricu-
lation, each student selects a faculty member as an academic mentor. The main roles of the academ-
ic mentor are
to aid and enrich the student's academic progress during the fall course term and beyond,
to provide advice about laboratory selection,
to serve on the thesis committee, and
to provide informed letters of recommendation for postdoctoral pursuits.
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The academic mentor follows the student's academic and research progress and provides advice
for the duration of the student's tenure in the graduate program. The academic mentors have been
invaluable in providing students with advice on (1) course instruction (sometimes leading to additional
instruction at other academic institutions), (2) interactions with research mentors, (3) involvement in
extracurricular educational activities such as at the Dolan DNA Learning Center, and (4) personal con-
cerns. After the laboratory rotations, each student chooses a research mentor. The research mentor is
the doctoral thesis research advisor, who supervises the student's independent laboratory research. By
providing both academic and research mentors, the Watson School provides each student with advice
from faculty who hold different views and can then offer unique and in-depth evaluations of the student.
In particular, the academic mentors can provide advice that is not influenced by their own research
goals. The following are the academic mentors for the entering class of 2001:
Catherine Cormier David Stewart
Claudia Feiersten Linda Van Aelst
Tomas Hromadka William Tansey
Charles Kopec Anthony Zador
Ji-Joon Song Scott Lowe
Gowan Tervo Carlos Brody
Research Progress: Can a Ph.D. Degree Be Done in Four Years?
One of the key challenges that the Watson School faces is demonstrating that, in today's scientific envi-
ronment, it is possible for a graduate student to perform sufficient research in a four-year program to
be competitive with graduates of other, longer graduate programs. The third-year students who
entered the School in the fall of 1999 have now been in the program for two and a quarter years, and
therefore, it is possible to begin determining whether students will have time to obtain publications from
their accelerated research program.
I was therefore very pleased when the beginning of this year saw a milestone in the School's histo-
ry: the publication of the first article with a Watson School student as one of its authors. In the January
18, 2001 issue of Nature, Amy Caudy is a co-author of an article on the discovery of an enzyme, called
"Dicer," that is involved in a recently uncovered form of gene silencing called "RNA interference" or
RNAi. Amy, a member of the Fall 1999 class, is performing her studies with Gregory Hannon, who stud-
ies both RNAi and the oncogenic transformation of human cells (see box on next page). This first pub-
lication listing the Watson School was particularly pleasing to me because it represents a collaboration
between two graduate students, one of whom, Emily Bernstein, is now a fourth-year student with the
Graduate Program in Genetics at SUNY Stony Brook. Emily is the lead author of this article. I hope we
see much more of such inter-programmatic synergy in the future.
By the end of this year, our students had first-author publications in press. Masafumi Muratani from
the entering class of 2000 had a manuscript accepted for publication in the journal Nature Cell Biology,
and Patrick Paddison, also from the entering class of 2000, and Amy Caudy were co-first authors on
a manuscript in press in the Proceedings of the National Academy of Sciences.
These early successes bode well for the School. I believe one of the main reasons that the School
will be successful in its four-year degree program is the attention to mentoring that our program pro-
vides. Thus, as I described in last year's report, the School has developed a detailed thesis proposal
process that gets the students and research advisors to focus on a research direction before the stu-
dent is a year and a half into the program. All members of the first entering class passed their thesis
proposal defense with flying colors last year, and in the fall already had a second meeting with their
respective thesis committees to go over their research progress. These meetings, organized by Lilian
Gann and the Watson School administration, are thus a very important element of the student's
research progress. I am very grateful to the Lita Annenberg Hazen Chair for endowing the support of
the Watson School administration that makes this organization and mentoring possible.
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Student
ENTERING CLASS OF 1999
DOCTORAL THESIS RESEARCH
Academic Research
Mentor Mentor Thesis Research
Amy Anne Gaudy Hollis Cline Gregory Hannon The biological function of
George A. and Marjorie H. RNA interference
Anderson Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Michelle Lynn Cilia Nouria Hernandez David Jackson Mechanisms of intercellular
William R. Miller Fellow trafficking via plasmodesmata
Beckman Graduate Student
Ahmet M. Den li
David Koch Fellow
Emiliano M. Rial Verde
David and Fanny Luke Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Elizabeth Ellen Thomas
Farish-Gerry Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Niraj H. To lia
Leslie C. Quick, Jr Fellow
Adrian R. Krainer Gregory Hannon Biochemical analysis of RNA-
induced gene silencing
Jan Witkowski Hollis Cline Arc role in synaptic function
William Tansey Michael Wigler A de novo approach to iden-
tifying repetitive elements in
genomic sequences
David Helfman Leemor Joshua-Tor Structural framework and
molecular mechanism of
caspase-9 activation
A Third Entering Class
On August 27, 2001, the Watson School opened its doors for the third time to welcome a new class
of students. Six students-Catherine Cormier, Claudia Feierstein, Tomas Hromadka, Charles Kopec,
Ji-Joon Song, and Gowan Tervo-all began their adventure of a graduate education in the biological
sciences. James Watson welcomed them by sharing his view of what is important about a graduate
education. His comments can be distilled to one main aim: learn what the important problems of the
day are so that each student can go off to perform postdoctoral studies on his or her chosen topic.
While Jim spoke, I wondered whether any would identify a problem as important as the one Jim came
up with for his doctoral studies: to understand the structure of the gene-DNA.
A new Admissions Committee selected this class. I stepped down from the Committee this year. My
position as chair was ably taken over by Nouria Hernandez and Adrian Krainer joined the Committee. I
stepped down none too soon, because the School had a surprising 67% increase in the number of
applications (a total of 250). With traditional excellence, Janet Duffy organized all of the applications both
for the Admissions Committee and for our co-application program with four departments and graduate
programs with the State University of New York (SUNY) at Stony Brook. Additionally, she greatly aided
Nouria Hernandez and the remainder of the Admissions Committee in reviewing the applications.
The Watson School has developed the tradition of interviewing all candidates before making deci-
sions on acceptance into its doctoral program. The Committee decided to invite 25 candidates for
interviews. With heroic effort, Janet Duffy made all of the travel arrangements and Lilian Gann orga-
nized more than 300 individual meetings with faculty members as part of the interview process! Jim
Watson and Bruce Stillman met with almost all of the candidates, which was greatly appreciated by
candidates and faculty. The Admissions Committee assessed the candidates and placed them in rank
206
ENTERING CLASS OF 2001
Catherine Y. Cormier, Boston University, Boston,
Massachusetts
Beckman Graduate Student
Claudia E. Feierstein University of Buenos Aires,
Argentina
George A. and Marjorie H. Anderson Fellow
Tomas Hromadka, Charles University in Prague,
Czech Republic
Engelhorn Scholar
Ji-Joon Song, Kwangju Institute of Science &
Technology, Kwangju, Republic of Korea
Bristol-Myers Squibb Fellow
Dougal G.R. (Gowan) Tervo, Oxford University,
United Kingdom
George A. and Marjorie H. Anderson Fellow
Howard Hughes Medical Institute Predoctoral
Fellow
Charles D. Kopec, Rutgers University, New Jersey
Lindsay-Goldberg Fellow
(Left to right) Charles Kopec, Ji-Joon Song, Catherine Cormier, Gowan Tervo, Claudia Feierstein, and Tomas Hromadka.
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order. Offers of acceptance were extended to 15 candidates, 7 of whom accepted (although we lost
one of those students for personal reasons over the summer); we lost students to the University of
California at Berkeley and San Francisco, The Rockefeller University, and elsewhere.
As in the two previous years, the entering students hail from around the globe and have provided
cultural diversity and academic excellence to the Watson School. Two of the entering students, Charles
Kopec and Dougal (Gowan) Tervo, are former participants in the Undergraduate Research Program,
continuing the developing tradition of recruiting students to the Watson School from this outstanding
program. Indeed, Gowan was successful in obtaining a Howard Hughes Medical Institute (HHMI)
Predoctoral Fellowship. This is the third year in a row that one or more Watson School students have
been awarded HHMI predoctoral fellowships. This means that 4 of the 20 (or 20%) Watson School stu-
dents are HHMI fellows! We are also very pleased that Gowan was awarded the prestigious Gibbs prize
for his studies at Oxford University.
Tomas Hromadka, who hails from Slovakia, became our third Engelhorn Scholar, joining Rebecca
Ewald and Elena Ejkova. The Engelhorn Scholars Program is dedicated to supporting European nationals
in the Watson School. This program enriches the School student body by supporting student diversity.
Holiday Party. (Left to right) Ashish Saxena, Farida Emran, Laureen Connell, Anitra
Auster, Michelle Cilia
This year also saw the arrival of two families: Soon after his arrival, TorriaS was joined by his wife
Eva and their two children Samo and Timo, while Ji-Joon was joined by his wife Ah Ran and his new-
born daughter Yeonvee. The two families each moved into the De Forrest Stable apartments, appro-
priately situated over the Mary D. Lindsay Child Care Center.
Perhaps spurred on by Jim's discussion, the six first-year students all finished the intensive fall term
in good standing. After the term was over, they and the rest of Cold Spring Harbor Laboratory could
partake in the second annual Graduate Student Holiday Party!
The Watson School Is Reviewed-Twice!
This year, the Watson School was reviewed twice-once on October 24 inconjunction with our request
for a training grant from the National Institutes of Health (NIH) and again in November 5 for renewal of
our accreditation.
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Watson School Is Awarded an NIH Training Grant
The Watson School has been fortunate to have many private benefactors who have established an
endowment to support the students, faculty, and administration. It was important, however, to seek
additional support from other sources, particularly the NIH. Such support would serve not only to
increase financial support for the School, but also, through the review process, to provide an outside
measure of how the School is progressing. Thus, in May, the Watson School applied for a training grant
from the NIH to support two new students each year in the doctoral program. We had a site visit on
October 24 by a team of dedicated educators in the biological sciences to review our proposal. The
site visit team comprised:
Susan K. Dutcher, Chair (Washington University)
Victor G. Corces (Johns Hopkins University)
Emilie F. Rissman (University of Virginia)
Rebecca H. Johnson (National Institutes of Health)
Marion Zatz (National Institutes of Health)
They met with many of the faculty and with all of the Watson School students. I was very impressed
with how the faculty and students alike dedicated themselves to presenting our innovative curriculum.
The site visitors must have enjoyed what they saw, because the proposal received a score of 132. (The
NIH has an unusual scoring system with a range from 100 to 500 in which a score of 100 is the best!)
I was told that training grant scores do not get any better. Of course, now the pressure is on to ensure
that our innovative curriculum is a long-term success.
Watson School Accreditation Is Renewed
This year, following our initial accreditation as a degree-granting institution in September 1998, the
School and Laboratory underwent a second accreditation process. Lilian Gann worked closely with the
State Education Department to prepare a "self study," which served as the basis for the review. The
self study touched on many elements of the Laboratory's organization and administration. Lilian did a
spectacular job getting all the materials together.
On November 4 and 5, a New York State accreditation team visited for a comprehensive review of
the Laboratory's application for renewal of its accreditation. The team comprised:
Jacqueline Joseph-Silverstein, Chair (University of Connecticut at Stamford)
Maurice S. Fox (Massachusetts Institute of Technology)
Elizabeth R. Gavis (Princeton University)
Phillip A. Sharp (Massachusetts Institute of Technology)
Byron P. Connell (NY State Education Department)
We were very pleased to be reviewed by such an august group that included a Nobel Laureate in
the person of Phillip Sharp! The team gave unanimous and enthusiastic support for renewal of our
accreditation without conditions. During the site visit and in the report itself, the site visit team offered
many helpful suggestions for improving our graduate program and the Laboratory, particularly in how
to transform the Laboratory into an academic institution. On December 6, I attended a meeting of the
Regents Advisory Council on Institutional Accreditation where our case for accreditation renewal was
presented. There was overwhelming support for Cold Spring Harbor Laboratory and the Watson
School, resulting in renewal of our accreditation by the Board of Regents of the State of New York for
a ten-year period.
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NEW STUDENTS FROM SHARED GRADUATE PROGRAMS
Student CSHL Research Mentor Affiliation
Elvin Garcia Alea A. Mills SUNY Stony Brook, Genetics
Ivan Ho Yi Zhong SUNY Stony Brook, Genetics
Asra Malikzay Shiv Grewal SUNY Stony Brook, Molecular and
Cell Biology
Anagha Matapurkar Yuri Lazebnik SUNY Stony Brook, Molecular and
Cell Biology
Sabrina Nunez Scott Lowe SUNY Stony Brook, Genetics
Sachin Ranade Zachary Mainen SUNY Stony Brook, Neurobiology
Khalid Siddiqui Bruce Stillman SUNY Stony Brook, Genetics
Hongjae Sunwoo David L. Spector SUNY Stony Brook, Molecular and
Cell Biology
Lung-Hao Tai Anthony Zador SUNY Stony Brook, Neurobiology
Xioarong Wang David Helfman SUNY Stony Brook, Molecular and
Cell Biology
Min Yu W. Richard McCombie SUNY Stony Brook, Genetics
Chih-Chi Yuan Nouria Hernandez SUNY Stony Brook, Molecular and
Cell Biology
Zhengwei Zhu Michael Q. Zhang SUNY Stony Brook, Biomedical
Engineering
Graduate Education in the Biological Sciences on Long Island:
The Shared Genetics Program Is Honored
Cold Spring Harbor Laboratory has been involved in graduate education for more than 25 years, large-
ly through shared programs with SUNY Stony Brook. This year, the long-standing Genetics Program
was honored by the award of the 2001 Amersham Biosciences & Science Grand Prize to Song-Hai
Shi. Song-Hai was a Genetics Program graduate student who performed
his doctoral studies with Roberto Malinow on mechanisms of long-term
potentiation in synaptic transmission. Following a world-wide search, the
Amersham Biosciences & Science Grand Prize is awarded each year for
the most outstanding Ph.D. thesis among graduate students in molecular
biology. This award re-emphasizes the high quality of students who par-
ticipate in our shared programs with SUNY Stony Brook.
Among the shared graduate programs with SUNY Stony Brook, the
Genetics Program is unique. It is the only program that was established
specifically to integrate the three academic biological research institutions
on Long Island. The Genetics Program at Stony Brook was created in
1980 as an inter-institutional program to focus and combine the existing
strengths in genetics at SUNY Stony Brook, Brookhaven National
Laboratory, and Cold Spring Harbor Laboratory. In so doing, it brought
together three very complementary institutions: a premiere university and
medical center, a government laboratory with outstanding instrumentation,
and the Laboratory which now has a century of experience in genetics.
The Genetics Program, currently led by Peter Gergen, a Drosophila geneti-
cist at SUNY Stony Brook, has been a major force on Long Island in integrating these three institutions,
and students flourish in the environment it creates, as evidenced by Song-Hai's success. This year, we
welcomed 13 new students to Cold Spring Harbor Laboratory (see box)-one more than last year.
SUNY Stony Brook Genetics stu-
dent Michelle Juarez
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Graduate Student and Postdoctoral Fellow Departures
With new arrivals come departures. This year, we saw the following graduate students and postdocs
depart:
Postdocs
Harsh Bal
Joseph Donovan
Gerardo Ferbeyre
Francisco Ferrezuelo
Lisa Foa
Michael Greenberg
Hiroyuki Higashiyama
Sangeet Honey
Jianping Jin
Wen-Chuan Lin
Graduate Students
David Mac Callum
Stephen Macknik
Olaf Merkel
Jun-ichi Nakayama
Takashi Odawara
Shannon Pendergrast
Bernardo Sabatini
Noriko Saitoh
Cyril Sanders
Andrea Calixto Zheng Li
Jeffrey Christensen Stuart Milstein
Lavine Faleiro Irina Pugach
Jennia Hizver Songhai Shi
Jason Kinchen Michael Stebbins
Ying Ying Koh Josema Torres
Soyoung Lee Jun Zhu
Career Opportunities in the Biological Sciences
Clemens Schmitt
Arndt Schmitz
Lidia Serina
Wun Chey Sin
Tatjana Singer
Yu Shen
Guanming Wu
Tong Tong Zhang
Jun Julius Zhu
The profusion of genetic sequence and other information currently being uncovered is leading to a
wealth of career opportunities for graduate students and postdoctoral fellows in the biological sciences.
No longer is it the norm to become a professor in academia. This year, we have again been very for-
tunate in being able to take advantage of the excellent series of seminars on "Alternative Careers in the
Bioscience Industry" arranged by Angeline Judex of the Center for Biotechnology at SUNY Stony
Brook. In addition, we were able to attend the first Annual Bioscience Careers Conference: Visions for
the Future, arranged by the Center for Biotechnology in partnership with the CUNY Office of Academic
Affairs. The conference was specifically designed to help graduate students and postdoctoral fellows
explore career opportunities in the commercial sector in New York State. The event was very well
attended and provided much useful information-we look forward to the next one!
Lilian Gann to Become Associate Dean
With the beginning of the new year, Lilian Gann will become associate dean
of the Watson School. Lilian joined the Laboratory in March 1999 as assistant
dean of the School. She received the Ph.D. degree in molecular virology from
the University of St. Andrews, Scotland, in 1988 for studies on transcriptional
regulation using animal viruses as models. After her postdoctoral studies,
Lilian became interested in scientific administration at the Imperial Cancer
Research Fund in London and earned an M.B.A. degree in 1996 from the
University of Westminster, London. Her dual training has made Lilian unusual-
ly well-qualified to help direct a school administration.
Since her arrival at the Laboratory, Lilian has played a crucial role in the
development of the School's innovative Ph.D. program, while also enhancing Lilian Gann
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the educational and training environment of the Laboratory for students and postdoctoral fellows gen-
erally. She is the secretary for the Executive and Qualifying Exam Committees. She also co-organizes
the Research Topics core course and the Topics in Biology Banbury course, participates in the direc-
tion of the Scientific Reasoning and Logic core course, and is a member of the C3WG. Last but not
least, she is the chair of the postdoctoral fellow working group. The position of associate dean will more
properly reflect Lilian's critical role in the development of the Watson School.
External Advisory Committee
The Watson School has been blessed with an outstanding External Advisory Committee composed of
individuals-Keith Yamamoto, the chair of the committee, Gail Mandel, Marguerite Mangin, Barbara
Meyer, Frank Solomon, and Shirley Tilghman-who have thought deeply about graduate education.
Although we may have occasional healthy differences of opinion, their advice is always extremely
thoughtful and has had a profound influence on the development of the School's curriculum. Thus, it
was a great pleasure to learn that two of its members were elevated to new positions of considerable
influence. Keith Yamamoto became Vice Dean of Research at the University of California San Francisco
School of Medicine, and Shirley Tilghman was appointed President of Princeton University. We are for-
tunate that Keith will remain on our Advisory Committee; unfortunately, Shirley had to curtail the scope
of her outside activities and therefore resigned from the Committee. We regret losing her, but we con-
gratulate her on her success and take solace in the fact that her promotion only emphasizes how truly
outstanding our Advisory Committee is.
The Watson School Grows: Urey and Janet Silver
In March, the School administration relocated from its two-bedroom suite in Dolan Hall to an apartment
in Williams. This enabled the School's staff to all be accommodated in a single location, greatly increas-
ing communication and workflow-in other words, the Dean now had an official School office! A fur-
ther move took place in November to a completely renovated Urey Cottage. This move brought first-
year students and the School administration together, where they all have office space and can share
a conference room. We are indebted to Art Brings and his staff for working so hard on this new home
for the School.
In November, the School staff also welcomed a new member. Janet Silver-called Jan in the office
to distinguish her from Janet Duffy-hails from California. Very quickly she has added to the School's
welcoming face with her charm and good nature. The School's dedicated, friendly staff and elegant
new home make students, postdocs, faculty, and visitors alike feel welcome.
The Watson School Honors David Luke Ill
A very special element of the Watson School is the support private donors have provided so that stu-
dents can be supported from a dedicated School endowment. The School is indebted to David Luke
III for making the endowment possible. Indeed, as the year came to a close, David was close to achiev-
ing his goal of $32 million to support 20 students, the faculty, and the administration. David had much
support from numerous friends of the Laboratory and Jim Watson in raising this endowment. I have
learned a great deal from working with David during this campaign, particularly that his success comes
largely from his exquisite attention to detail. I always knew with David what he expected of me and what
I could expect from him.
It was therefore a deep honor for me to be selected to read David's citation at the School's convo-
cation on November 2 when he was bestowed an honorary degree for his outstanding service to sci-
ence. I am thrilled that the School could bestow such a well-deserved award on someone without
whom the School would not exist.
April, 2002 Winship Herr
212
SPRING CURRICULUM
Topics in Biology: Evolution
ARRANGED BY
FUNDED IN PART BY
INSTRUCTOR
GUEST LECTURERS
TEACHING FELLOWS
Lilian Gann
Jan Witkowski
The Daniel E. Koshland, Jr. Visiting Lectureship
The Fairchild Martindale Visiting Lectureship
The Lucy and Mark Ptashne Visiting Lectureship
The Michel David-Weill Visiting Lectureship
Nipam H. Patel, University of Chicago
Rob De Salle, American Museum of Natural History
Neil Shubin, University of Chicago
Michael Palopoli, Bowdoin College
Greg Davis, University of Chicago
Casey Bergman, University of Chicago
Allison Beck, University of Chicago
Each year, one or a team of invited instructors offer a 7-day course at the Banbury Conference Center
to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory faculty. The
course includes morning or evening lectures as well as afternoon sessions during which students read
assigned papers. For Spring 2001, the topic was evolution. This course discussed our understanding
of the mechanisms of evolution and explored how evolutionary data can be used to further our under-
standing of various biological problems. The course ran from Sunday to Saturday, March 25-31, and
was organized and largely taught by Nipam Patel. Three guests-Rob De Salle, Neil Shubin, and
Michael Palopoli-also lectured in the course and three teaching fellows participated in all aspects of
the course. The course was highly rated by all of the student participants, including course auditors.
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Teaching Experience at the DNA Learning Center
DIRECTOR David A. Mick los
INSTRUCTORS Scott Bronson
Veronique Bourdeau
Tricia Maskiell
Amanda Mc Brien
Danielle Sixsmith
As science plays an increasing role in society, there is an increasing need for biologists to educate non-
scientists of all ages about biology. The Watson School of Biological Sciences doctoral program offers
its students unique teaching experiences through the Laboratory's Dolan DNA Learning Center, where
students teach laboratory courses. From these teaching experiences, they learn how to communicate
with nonbiologists and to inspire and educate creative young minds. The teaching module entailed
pairs of students teaching one morning a week for 12 weeks. During this time the students had the
opportunity to teach both high school and middle school students. In the initial weeks the course
instructors taught the students the didactic process-it was not until the fifth week that the students
taught on their own. At the end of the 12 weeks, the students were very excited about their teaching
experience.
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research that
leads to a unique contribution to human knowledge. After the fall course term, students participate in
laboratory rotations. These rotations provide students and faculty with the opportunity to get to know
each other and to explore possibilities for doctoral thesis research. At the end of each rotation, stu-
dents make short presentations of their studies to the other students and their rotation advisors. These
talks give students an opportunity to share their laboratory experiences and to learn how to give a sci-
entific presentation. With this latter goal in mind, the instructors of the Scientific Exposition and Ethics
core course attend the talks and give individual feedback to students on their presentations. This year,
21 faculty members served as rotation mentors.
ROTATION MENTORS
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Hollis Cline
Grigori Enikolopov
Shiv Grewal
Masaaki Hamaguchi
Gregory Hannon
Winship Herr
Z. Josh Huang
David Jackson
Yuri Lazebnik
Scott Lowe
Roberto Malinow
Robert Martienssen
Alea A. Mills
David L. Spector
Arne Stenlund
Bruce Stillman
Karel Svoboda
William Tansey
Marja Timmermans
Linda Van Aelst
Anthony Zador
FALL COURSE CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on
Scientific Reasoning and Logic
FUNDED IN PART BY The David Pall Visiting Lectureship
INSTRUCTORS Scott Lowe (Lead)
Grigori Enikolopov
Gregory Hannon
Winship Herr
Leemor Joshua-Tor
Arne Stenlund
GUEST LECTURERS Alexander A.F. Gann
Shiv Grewal
Nouria Hernandez
David Jackson
Adrian R. Krainer
Robert Martienssen
Alea A. Mills
Jacek Skowronski
Bruce Stillman
William Tansey
Maria Timmermans
Linda Van Aelst
VISITING LECTURERS Bruce Futcher, SUNY Stony Brook
Michael Hengartner, University of Zurich
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the Fall Course curriculum, students (1) acquired a broad base of knowledge
in the biological sciences, (2) learned the scientific method, and (3) learned how to think critically. This
course consisted of 12 weekly segments, each of which had a different theme. Each week, students
read an assigned set of research articles (generally four articles) and provided written answers to a
problem set that guided them through two (or, on occasion, one) of the articles. Twice weekly, students
attended lectures related to the week's topic, which included concepts and experimental methods.
During the week, the students met to discuss among themselves the assigned papers not covered by
the problem set. At the end of each weekly segment, the students submitted their problem sets and
spent the evening discussing with faculty the articles not covered by the problem set. The course cul-
minated in the 13th week with a final exam. Studying for the final exam gave the students the oppor-
tunity to synthesize and integrate what they had learned over the course of the fall term. The weekly
topics were:
Week 1 Macromolecular Structure Week 7 Apoptosis
Week 2 DNA Replication Week 8 Cell Cycle
Week 3 Transcriptional Regulation Week 9 Virus-Host Cell Interactions
Week 4 Chromosome Structure and Week 10 Cancer Genes
Function Week 11 Mobile Genetic Elements
Week 5 mRNA Processing Week 12 Development
Week 6 Signal Transduction Week 13 Final Exam
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The Norris and Henriette Darrell Core Course
on Scientific Exposition and Ethics
FUNDED IN PART BY The Edward H. Gerry Visiting Lectureship
The John P. and Rita M. Cleary Visiting Lectureship
The Martha F. Gerry Visiting Lectureship
The Seraph Foundation Visiting Lectureship
The Susan T. and Charles E. Harris Visiting Lectureship
INSTRUCTORS William Tansey (Lead)
Adrian R. Krainer
Jan Witkowski
GUEST LECTURERS Terri Grodzicker
Winship Herr
VISITING LECTURERS Robert P. Charrow, Esq., Crowell & Moring LLP
David Kremers, Distinguished Conceptual Artist, Caltech
Steve Ferguson, Office of Technology Transfer, NIH
Nicholas Wade, New York Times
Philip Reilly, J.D., M.D., C.E.O. of Interleukin Genetics
This core course offered instruction about the fundamental elements of scientific exposition-writing
skills and public speaking-and ethics. The ability to communicate effectively and to appreciate the
intricacies of ethical issues are essential skills for biologists; both subjects were taught in a series of
example-based lectures and discussion groups. This year, the course continued a novel format estab-
lished in 2000 in which the course was organized around the scientific process starting with how the
ideas for an experiment develop and covering execution of the experiment, presentation of the results
at seminars and in publication, funding, and the implications of the experimental results on scientists
and society. As a part of learning how to make oral presentations, together with the instructors, the
students also critiqued formal seminar presentations at the Laboratory. A primary objective of the
course was for students to consider exposition and ethics as an integral part of scientific research.
Research Topics
ARRANGED BY Lilian Gann
David Helfman
This core course provided students with an in-depth introduction to the fields of research that the
Laboratory scientists investigate. Students and faculty attended a weekly seminar at which faculty
members presented their current research topics and methods of investigation each Wednesday
evening. The students learned how to approach important problems in biology. These seminars,
together with the annual fall in-house symposium, provide students with a basis for selecting labora-
tories in which to do rotations. The weekly speakers were:
Week 1
Week 2
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Eli Hatchwell, Rui-Ming Xu, Marja Timmermans
Nouria Hernandez, Jacek Skowronski, Arne Stenlund
Week 3 Winship Herr, Bruce Stillman, William Tansey
Week 4 Shiv Grewal, Tatsuya Hirano, Michael P. Myers
Week 5 Andrew Neuwald, David L. Spector, Michael Q. Zhang
Week 6 Adrian R. Krainer, Alea A. Mills, Tim Tully
Week 7 Leemor Joshua-Tor, Yi Zhong, Jerry Yin
Week 8 Hollis Cline, Yuri Lazebnik, Nicholas Tonks
Week 9 Masaaki Hamaguchi, Gregory Hannon, Linda Van Aelst
Week 10 Robert Lucito, Vivek Mittal, Senthil K. Muthuswamy
Week 11 Scott Lowe, Robert Martienssen, Michael Wig ler
Week 12 Dmitri Chklovskii, David Jackson, Lincoln Stein
Week 13 Carlos D. Brody, Z. Josh Huang, W. Richard McCombie
Week 14 Grigori Enikolopov, David Helfman, Roberto Malinow
SPECIALIZED DISCIPLINES COURSES
The Genome
FUNDED BY
INSTRUCTORS
The Edward H. and Martha F. Gerry Lectureship
The Pfizer Lectureship
The George B. Rathmann Lectureship
Robert Martienssen
W. Richard McCombie
Lincoln Stein
GUEST LECTURERS Andrew Neuwald
Jan Witkowski
Michael Q. Zhang
The first draft of the human genome sequence was completed in 2000, and the new science of
genomics promises to revolutionize biological concepts and approaches. With computers, scientists
can digest the enormous amount of genetic information produced by the genome project and answer
questions about evolution, model complex processes such as signal transduction and gene regulation,
and manage and organize experiments. This course provided essential background as to how
sequence and mapping information is generated and interpreted, including the principles of genetics,
the principles of microarray and other functional strategies, and the history of the genome project.
Topics covered included genetic and physical mapping, DNA sequence acquisition and interpretation,
Web-based resources for genome data, gene modeling and protein and DNA sequence analysis, phy-
logenetic analysis, and functional genomics.
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Cellular Structure and Function
FUNDED BY The Mary D. Lindsay Lectureship
The Sigi Ziering Lectureship
INSTRUCTORS David Helfman
David L. Spector
GUEST LECTURERS Tatsuya Hirano
With the complete set of instructions available for many organisms, i.e., their genome sequence, there
is now much emphasis on understanding the function of the gene products. This understanding will
require an increasing appreciation of the structure and function of the cell. This course provided a basic
overview of the structural and functional organization of cells with particular emphasis on cellular com-
partmentalization and communication. In addition, it provided insight into the basic toolbox of the cell
biologist of the 21st century.
Systems Neuroscience
FUNDED IN PART BY The George W. Cutting Lectureship
The Klingenstein Lectureship
INSTRUCTORS Carlos D. Brody
Zachary Mainen
Anthony Zador
Cognition and behavior arise from complex interactions between billions of neurons. "Systems
Neuroscience" examined the fundamental properties of neurons (including synaptic transmission and
plasticity) and how they gave rise to higher-level (systems) brain functions such as visual perception.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
2001 CONVOCATION
On November 2 of this year, the Watson School held its second convocation. Gail Mandel, a
member of the Watson School External Advisory Committee, was the keynote speaker and
spoke of individuals who give of themselves to serve science. At the occasion, the Watson
School honored three individuals-William Maxwell Cowan, Robert J. Glaser, and David L. Luke
III-for their service to science by awarding them honorary doctoral degrees. Below are repro-
duced the citations that were read at the convocation for each of these great benefactors to sci-
ence.
William Maxwell Cowan
William Maxwell Cowan was born in Johannesburg, South Africa on September 27, 1931. He
received Bachelor's degrees from the University of Witwatersrand and both medical and doctor-
al degrees from Oxford University. Dr. Cowan's first neurobiology studies mapped an unusual
group of connections in the brain between the thalamus and the corpus striatum. This work
explained a long-standing mystery in the field and would lay the foundation for a career that
includes more than 200 published articles. Later, Dr. Cowan established principles that control
the number of cells in the brain, and he uncovered an "activity-dependent" mechanism that
prunes erroneous connections between brain cells. Dr. Cowan's association with Cold Spring
Harbor Laboratory began in 1971, when he was invited to lecture in the Laboratory's newly cre-
ated summer neurobiology course, "Basic Principles of Neurobiology." He returned for the next
ten summers to lend his expertise to neurobiology edu-
cation at the Laboratory. Dr. Cowan is a member of the
U.S. National Academy of Sciences and a Fellow of the
Royal Society. As Vice President and Chief Scientific
Officer of the Howard Hughes Medical Institute, Dr.
Cowan helped establish the Institute as a premier sup-
porter of biomedical research and education in the
United States and throughout the world.
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Robert J. Glaser
Robert J. Glaser was born in St. Louis, Missouri, on September 11, 1918. He received a
Bachelor's degree from Harvard University and an M.D. from Harvard University Medical School.
After completing clinical training in internal medicine, Dr. Glaser was appointed a National
Research Council Fellow in the Medical Sciences at Washington
University. Dr. Glaser's medical research explored the relationship
between Group A streptococcal infections and rheumatic fever and
led him to develop an animal model for the study of rheumatic fever.
He served as Vice President for Medical Affairs, Dean of the Medical
School, and Professor of Medicine, first at the University of Colorado
and later at Stanford University. Dr. Glaser is a member of the
American Academy of Arts and Sciences, the American Philosophical
Society, and the Institute of Medicine of the U.S. National Academy
of Sciences. As Director for Medical Science of the Lucille P. Markey
Charitable Trust, Dr. Glaser recommended that the Trust support
structural biology research at several institutions, including Cold
Spring Harbor Laboratory. This support helped launch the structural
biology program here, which continues to flourish today. With Dr.
Glaser's leadership, the Markey Charitable Trust also supported major
new initiatives in neuroscience research at Cold Spring Harbor
Laboratory and elsewhere. 111111.6,
David L. Luke III
David L. Luke III was born in Tyrone, Pennsylvania, on July 25, 1923. He is the great-grandson of
William Luke, founder of Westvaco Corporation, an industry leader in paper and packaging prod-
ucts and in the development of tree breeding and sustainable forestry technologies. After serving
in the United States Marine Corps during World War II, Mr. Luke received a Bachelor's degree from
Yale University in 1948. Mr. Luke's career as CEO of Westvaco sparked his interest in plant mole-
cular biology and genetics. As a result, he joined the Cold Spring Harbor Laboratory Board of
Trustees in 1985. As co-creator of the Laboratory's Infrastructure Fund
and as chair of its Second Century Fund, Mr. Luke helped expand and
improve Laboratory facilities, endow chaired professorships, and
launch a major new initiative in neuroscience research. To support plant
biology research, Mr. Luke provided seed money for the international
Arabidopsis genome sequencing project. The project generated the
first complete DNA sequence of plant genome. As Chairman of the
Board of Trustees, Mr. Luke spearheaded the establishment of the
Watson School of Biological Sciences and initiated an endowment
entirely devoted to the Watson School. Mr. and Mrs. Luke have estab-
lished a graduate student fellowship that provides, in perpetuity, full
support for one Watson School student. Mr. Luke continues today to
head the successful endowment campaign as Chairman of the Watson
School of Biological Sciences Campaign Committee. Mr. Luke is also
Director of the Josiah Macy, Jr. Foundation's "Ventures in Education"
program which links academically promising high school students with
participating medical schools. In 1998, Mr. Luke retired as Chairman of
the Board of Cold Spring Harbor Laboratory, and he was elected a life-
time Honorary Trustee.
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UNDERGRADUATE RESEARCH PROGRAM
Program Director: Leemor Joshua-Tor
Associate Program Director: Gregory Hannon
Program Administrator: Jane Reader
An important aspect of the summer program at the Laboratory is the participation of college under-
graduate students in active research projects under the supervision of full-time Laboratory staff mem-
bers. The program was initiated in 1959. Since that year, 586 students have participated in the pro-
gram, and many have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental princi-
ples of biology; (2) an increased awareness of experimental approaches to science; (3) a deeper under-
standing of the major issues in the fields of biochemistry, genetics, and molecular and cellular biology;
and (4) a personal acquaintance with research, research workers, and centers for study. The following
students, selected from 640 applicants, took part in the program:
Brian J. Adkins, Tuskegee University
Advisor: Dr. Masaaki Hamaguchi
Sponsor: National Science Foundation
A study of the DBC2 gene: Tumor suppressor candidate in
breast cancer.
Gautam Agarwal, University of Texas, Austin
Advisor: Dr. Zachary Mainen
Sponsor: Jephson Educational Trust
Discriminability and coding of odors in the olfactory bulb.
\
Sitting: Elizabeth Head, Lakshmi Swamy, Yao Chen, Allison Carey, Lindsay Hufton, Carolyn Dong
Left to right: Kelly Biddle, Raymond Chen, Benjamin de Bivort, Jovana Drinjakovic, Alicia Berger,
Timothy Sonbuchner, Lindzy Friend, Joe Markson, Michael Hoffman, Shantanu Jadhav, Seth Bechis,
Christopher Wilson, Lauri Friesenhahn, Laura Burrack, Meelis Kadaja, Elizabeth Fingar, Gautam Agarwal,
Julie Plocher
Not pictured: Brian Adkins
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Seth Kenneth Bechis, Harvard University
Advisor: Dr. Leemor Joshua-Tor
Sponsor: The Read Fund
Purification and crystallization of the replication initiation pro-
tein of the human papillomavirus high-risk strains.
Alicia Berger, University of Colorado
Advisor: Dr. Gregory Hannon
Sponsor: National Science Foundation
Creation of a phenotype array using RNA interference in
Drosophila S2 cells.
Kelly Biddle, Rice University
Advisor: Dr. David Jackson
Sponsor: National Science Foundation
Intercellular trafficking of transcription factors in Arabidopsis.
Laura Burrack, Macalester College
Advisor: Dr. Bruce Stillman
Sponsor: Libby Fund
Complex formation and function of scMCM proteins in initia-
tion of DNA replication.
Allison Carey, Pennsylvania State University
Advisor: Dr. Jerry Yin
Sponsor: National Science Foundation
Identification of molecular partners for the memory protein
DaPKC.
Raymond Chen, Harvard University
Advisor: Dr. William Tansey
Sponsor: Burroughs Wellcome
Myc: The unphosphorylated, the phosphorylated, and the
imposters.
Yao Chen, Cambridge University
Advisors: Dr. Karel Svoboda
Sponsors: The Olney Fund and Howard Hughes Medical
Institute
Visualizing mRNA trafficking in living neurons.
Benjamin de Bivort, Duke University
Advisor: Dr. Yi Zhong
Sponsor: Burroughs Wellcome
Roles of Notch and NF1 proteins in activity-dependent synap-
tic plasticity.
Carolyn Dong, University of Massachusetts, Amherst
Advisor: Dr. David L. Spector
Sponsor: National Science Foundation
Modification of transcriptional activity by nuclear positioning.
Jovana Drinjakovic, Oxford University
Advisor: Dr. Yuri Lazebnik
Sponsor: The Emanuel Ax Fund
Oncogenes induce cell fusion.
Elizabeth Fingar, Ohio University
Advisor: Dr. Hollis Cline
Sponsor: Burroughs Wellcome
Homer constructs in the Xenopus visual system.
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Lindzy Friend, University of Evansville
Advisor: Dr. Adrian R. Krainer
Sponsor: Jephson Educational Trust
Investigating the relationship between UP1 and telomeric DNA
using footprinting techniques.
Laurie B. Friesenhahn, Texas A&M University
Advisor: Dr. Shiv Grewal
Sponsor: National Science Foundation
Histone H3 Lys9 methylation and epigenetic silencing in S. pombe.
Elizabeth Head, University of Minnesota
Advisor: Dr. Robert Martienssen
Sponsor: National Science Foundation
Characterizing three putative RNAi genes in S. pombe.
Michael Hoffman, University of Texas, Austin
Advisor: Dr. Michael Q. Zhang
Sponsor: Garfield Trust
AtProbe: Arabidopsis thaliana promoter binding element data-
base.
Lindsay Hutton, Cambridge University
Advisor: Dr. Linda Van Aelst
Sponsor: Burroughs Wellcome
Identification of oligophrenin-1 binding partners in brain.
Shantanu P. Jadhav, Indian Institute of Technology, Bombay
Advisor: Dr. Anthony Zador
Sponsor: Glass Fund
A psychophysical investigation of the effect of attention on audi-
tory stream segregation, and a statistical analysis of sounds.
Meelis Kadaja, University Tartu
Advisor: Dr. Arne Stenlund
Sponsor: Shakespear Fund
The effect of tumor suppressor protein p53 on Bev-1 replica-
tion in vitro.
Joseph Markson, Harvard University
Advisor: Dr. Z. Josh Huang
Sponsor: Burroughs Wellcome
Bioinformatic approach to mechanisms of GABAergic cell-
type-specific gene expression.
Julie Plocher, University of Illinois, Urbana-Champaign
Advisor: Dr. Marja Timmermans
Sponsor: Burroughs Wellcome
Rough sheath2: How to keep hormones under control.
Timothy Sonbuchner, Gustavus Adolphus College
Advisor: Dr. Grigori Enikolopov
Sponsor: Frederica von Stade Fund
Expression of nitric oxide isoforms in hematopoietic stem cells.
La kshmi Swamy, University of Georgia
Advisor: Dr. Lincoln Stein
Sponsor: Bliss Fund
The mining of miniature inverted-repeat transposable elements
in rice.
Christopher G. Wilson, Kalamazoo College
Advisor: Dr. Robert Malinow
Sponsor: National Science Foundation
Involvement of spontaneous activity in the phosphorylation of
GIuR1 /4 by PKA.
NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to acquire a greater
knowledge and understanding of their environment. Through a series of specialized field courses, younger students
can engage in introductory programs such as Nature Bugs, Nature Detectives, and Nature Discovery, and older
students can enroll in more advanced programs such as Marine Biology and Nature Photography.
During the summer of 2001, a total of 383 students participated in 28 courses within the program. The classes
were held outdoors, weather permitting, at the West Side School. The Laboratory has equipped and maintains
classroom and laboratory facilities as well as a darkroom at West Side School. This facility is used as a base for the
students' exploration of the local environment. Field classes are held on Laboratory grounds, St. John's Preserve,
Fire Island National Seashore, the Nature Conservancy, the Cold Spring Harbor Fish Hatchery and Aquarium, and
other local preserves and sanctuaries.
In addition to the three 2-week sessions, the Adventure Education course met on Friday July 27, 2001 for a E-
mile canoe trip on the Nissequogue River in Smithtown to navigate and explore the waters of Long Island. The
course emphasizes the plant and animal life indigenous to the area as well as historic points of interest.
PROGRAM DIRECTOR: William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR: Sharon Bense, Cold Spring Harbor Laboratory
INSTRUCTORS: Alison Smith, B.S., Marine Science, University of Rhode Island
Michael Zarzicki, B.A., English, Ade 1phi University
Margot Gallowitsch, B.S., Biology, Fairfield University
Amy Friedank, B.S., Marine Science, Long Island University/Southampton College
Marlene Emmons, M.S., Art Education, Long Island University/C.W. Post Campus;
BFA, Photography, SUNY New Peitz
Patricia Grimaldi, B.S., Biology, SUNY at Stony Brook
COURSES
Nature Bugs (Kindergarten): Exploration, games, stories, and dramatics are used to introduce
the young child to a variety of natural habitats.
Nature Detectives (Grades 1-2): An introductory course in nature study, stressing interrelation-
ships between plants and animals. A variety of habitats are thoroughly explored.
Nature Discovery (Grades 1-2): Students continue their discovery of nature through activities and
concepts.
Ecology Explorers (Grades 3-4): Natural communities, food webs, and the succession of com-
munities are studied in this course. Students study the diversity of plant and animal forms native
to the Cold Spring Harbor Laboratory area.
Frogs, Flippers, and Fins (Grades 3-4): Designed for younger students as an introduction to
aquatic ecosystems. Fresh water and marine habitats are explored.
Pebble Pups (Grades 3-4): Elementary geology for students interested in making a basic study of
rocks and minerals available on Long Island. Each student completes a rock and mineral collection.
Dinosaurs and fossils are featured themes. Some of the highlights of this course include field trips
to local museums.
Freshwater Life (Grades 5-7): Students study the vertebrate, invertebrate, and plant life found in
area bogs, ponds, lakes, and streams.
Seashore Life (Grades 5-7): Children examine plant and animal life found below the tidemark.
Fish, marine worms, algae, shellfish, beach plants, and shore birds are studied.
Adventure Education (Grades 6-10): This course is a 6-mile canoe trip up and down the
Nissequogue River, exploring the flora and fauna of the waterway.
Marine Biology (Grades 8-10): This course offers a more sophisticated study of plants and ani-
mals native to the inner and outer harbors. This course provides field trips, dissection, use of the
microscope, and laboratory experiments.
Nature Photography (Grades 8-10): Students take pictures and use the darkroom to learn tech-
niques of printing and developing. Photographic techniques relating to nature photography are
emphasized. Students supply their own camera and film. Darkroom supplies are provided.
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COLD SPRING HARBOR LABORATORY
MEETINGS AND COURSES

ACADEMIC AFFAIRS
The rapid pace of advances in cell and molecular biology as well as neurobiology has made the com-
munication and dissemination of new information and technologies critical. The academic program at
Cold Spring Harbor Laboratory is designed to address the needs of the broader scientific community.
The program comprises a wide-ranging series of postgraduate laboratory and lecture courses, work-
shops, and large meetings. The program extends from early in March through mid-December, starting
with a short program of winter biotechnology conferences; followed by spring courses and meetings,
summer courses, fall meetings and courses; and ending with several late fall biotechnology confer-
ences. This year, scientists ranging from graduate students to senior faculty participated in the cours-
es and meetings. These scientists represent an international group who come from universities, med-
ical schools, research institutes, and industry.
The academic program includes a series of 3-week laboratory courses that are held in the summer,
as well as 1- and 2-week laboratory courses that are given in the spring and fall. They are held in the
Howard Hughes Medical Institute (HHMI) teaching laboratories in the Beckman Neuroscience Center,
the Marks Imaging Laboratory, and in Deb-Lick Laboratory. The bioinformatics courses take place in
the Bush Auditorium, which is adapted for the needed technology, and the neurobiology lecture cours-
es are held at the Laboratory's Banbury Center. In total, 26 courses were held this year, including two
new neurobiology lecture courses: Cellular Biology of Addiction and Biology of Developmental
Disabilities. All of the courses had more applicants than could be accommodated, which is a reflection
of their timeliness and the expertise of the instructors.
The instructors included a few Cold Spring Harbor faculty, but most came from universities and
research institutes from around the world. Their energy, enthusiasm, and very hard work were the key
to the success of the program. Many of them return for several years to teach at the Laboratory, for
which we continue to be very grateful. Course instructors, assistants, lecturers, and students are list-
ed in the pages following Meetings. We must make note this year of several heroic instructors who have
been teaching courses for at least 10 years. These include Dick Burgess, an instructor in the Protein
Purification and Characterization course; Carlos Barbas, who teaches in the Phage Display of
Combinatorial Antibody Libraries course; and the entire teaching faculty of the Macromolecular
Crystallography course: Bill Furey, Gary Gilliland, Alex McPherson, and Jim Pflugrath. Jim Boulter, who
started as an instructor in the Molecular Cloning of Neural Genes course, is retiring with honor after this
year. All of the course instructors, assistants, and lecturers are listed in the pages that follow.
The courses are supported by, and would not be possible without, a series of grants from federal
and private sources. The summer molecular genetics courses have been supported for many years by
grants from the National Institutes of Health and the National Science Foundation. A grant from the
National Institute of Mental Health supports several of the neurobiology courses. A large education
grant from HHMI has provided stable support for the neurobiology program and has allowed the
Laboratory to begin and to expand its series of spring and fall courses. The Laboratory also had a grant
from the John Merck Fund to support the Biology of Developmental Disabilities course.
A series of 19 meetings and biotechnology workshops were held this year, including the Annual
Symposium on Quantitative Biology. This year's exciting and timely symposium on the ribosome was
organized by Bruce Stillman and David Stewart and is discussed on the following pages. The other
meetings, which are often held in alternate years, covered topics ranging from Telomeres and
Telomerase to Eukaryotic mRNA Processing. Many meetings filled Grace Auditorium to capacity,
including those on Genome Mapping, Sequence, and Biology; Retroviruses; and Mechanisms of
Eukaryotic Transcription. Two meetings-Programmed Cell Death and Microbial Pathogenesis and
Host Response-had to be postponed after the tragic events of September 11. However, due to much
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work and resourcefulness on the part of the organizers and Meetings office staff, the meetings were
rescheduled and held several weeks later. The organizers and session chairs are listed in the pages
that follow.
The success of the very large program of courses and meetings is also due to the skilled efforts of
many people at Cold Spring Harbor Laboratory. They include Andrea Stephenson, the Course
Registrar; Ed Campodonico, Manager of Audiovisual Services; and Barbara Zane, the Course
Coordinator. Staff of the Meetings and Courses office handle an ever-increasing and complex workload
with skill and good humor. They include those listed above, as well as Michael Glaessgen, Drew
Mendelsohn, Mary Smith, Marge Stellabotte, and Jenna Williams. Housing and front-desk services are
provided by Nancy Weeks, Operations Supervisor, Andrea Newell and Donna Dykeman (to whom we
say goodbye this year). Audiovisual services are ably provided by Ed Campodonico, William Dickerson,
John Parsons, and the part-time audiovisual staff. Staff from several other departments also do crucial
work for the courses and meetings, including Wendy Crowley, the Senior Education Grants
Administrator; Cliff Sutkevich and his staff, who set up and maintain course equipment; and Leigh
Johnson in the Library, who handles the book and journal needs of the courses. The Information
Services department, headed by Jerry Latter for much of 2001 and subsequently by Mark Kilarjian,
provides ever-increasing computer support for all of the courses and meetings. We are grateful to them
all.
Terri Grodzicker
Assistant Director for Academic Affairs
David Stewart
Director of Meetings and Courses
T. Grodzicker, H. Geste land, R. Geste land
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66TH COLD SPRING HARBOR SYMPOSIUM ON
QUANTITATIVE BIOLOGY
The Ribosome
May 31-June 5 295 participants
ARRANGED BY Bruce Stillman, Cold Spring Harbor Laboratory
David Stewart, Cold Spring Harbor Laboratory
How proteins are made became a major focus following the discovery of the double-helical structure
of DNA in 1953. Once it was realized that the genetic code existed within the order of base pairs of
DNA, it became of immediate importance to understand how that information was converted into the
sequences of amino acids that defined individual proteins. The solution of this problem, which includes
deciphering the genetic code, is one of the great achievements in the science that is now known as
molecular biology. Many of these achievements have been recorded and celebrated at previous
Symposia in this series.
Protein synthesis occurs within the ribosome, a molecular machine comprising both protein and
RNA that in eukaryotes is first assembled in the nucleus of a cell. RNA also functions as the adaptor in
the form of tRNA that brings the individual amino acids to the ribosome. Ribosomes themselves asso-
ciate with other molecular machineries, such as the machinery that directs proteins to the cell surface.
It was once thought that figuring out the molecular details of how protein synthesis occurs would be
an insurmountable problem. But dramatic events in structural biology in recent years have changed this
view, and underscored the decision to select the ribosome as the topic for this year's Symposium.
High-resolution images of the structure of a ribosome not only tell
us how beautiful this machine is, but also reveal the surprising find-
ing that peptide bond formation is directed by RNA. Although this
has been hinted at for some time, it was difficult to envision without
seeing the ribosome structure. The structure of the ribosome, either
as its individual parts or as a whole, has also allowed views of how
the newly minted peptide chain emerges and, in the case of some
proteins, how it interacts with other molecular machinery that exports
proteins to the cell surface.
The meeting started with a talk from Jim Watson about his early
and important role in the ribosome field while at Harvard. Later fol-
lowed outstanding introductory presentations by Tom Steitz, Venki
Ramakrishnan, Nahum Sonenberg, and Roland Beckmann. The
Friday evening Reginald Harris Lecture was masterfully presented by
Harry Noller, and the Dorcas Cummings Memorial Lecture to our
friends and neighbors was beautifully presented by Venki
Ramakrishnan. There were 60 oral presentations and 136 poster
presentations over the course of the meeting, which was this year
held from May 31 to June 5. On the final day, Peter Moore presented us with a very thoughtful and
thought-provoking summary of the Symposium.
Particularly pleasing at this meeting was the return to Cold Spring Harbor Laboratory of many of the
principal contributors to the early days of ribosome research who reminisced about experiments that
contributed to understanding, at a most fundamental level, the central dogma of biology. They includ-
ed Alfred Tissieres, Donald Caspar, and Alex Rich.
Essential funds to run this meeting were obtained from the National Cancer Institute, a branch of
the National Institutes of Health. In addition, financial help from the corporate benefactors, sponsors,
A. Tissieres
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affiliates, and contributors of our meetings program is essential for these Symposia to remain a suc-
cess, and we are most grateful for their continued support. Corporate Benefactor.' Pfizer, Inc. Corporate
Sponsors: Abbott Bioresearch Center, Inc.; Amgen Inc.; Aventis Pharma AG; BioVentures, Inc.; Bristol-
Myers Squibb Corporation; Chiron Corporation; Chugai Research Institute for Molecular Medicine, Inc.;
Cogene BioTech Ventures, Ltd.; Diagnostic Products Corporation; DuPont Pharmaceuticals Company;
Forest Laboratories; Genentech, Inc.; Genetics Institute; GlaxoSmithKline; Hoffmann-LaRoche Inc.;
Johnson & Johnson; Kyowa Hakko Kogyo Co., Ltd; Eli Lilly and Company; Merck Research
Laboratories; New England BioLabs, Inc.; Novartis Pharma Research; OSI Pharmaceuticals, Inc.; Pall
Corporation; Pharmacia & Upjohn, Inc.; Research Genetics, Inc.; Schering-Plough Corporation. Plant
Corporate Associates: Monsanto Company; Pioneer Hi-Bred International, Inc.; Torrey Mesa Research
Institute; Westvaco Corporation. Corporate Affiliates: Affymetrix, Inc.; Ceptyr, Inc. Corporate
Contributors: Alexis Corporation; Biogen, Inc.; Digital Gene Technologies, Inc.; Double Twist, Inc.;
Epicentre Technology; Genomica Corporation; Incyte Genomics; InforMax; Key Gene; Lab Book, Inc.;
Lexicon Genetics, Inc.; Proteome, Inc.; Pyrosequencing; Qiagen; Silicon Genetics; Transgenomics, Inc.;
ZymoGenetics, Inc. Foundations: Albert B. Sabin Vaccine Institute, Inc.
P. Moore, V. Ramakrishnan, A Dahlberg
M. Mathews, T. Pe'ery, B. Stillman
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J. Frank, D. Stewart, J. Warner, A. Hinnebusch
Introduction
B. Stillman, Cold Spring Harbor Laboratory
James D. Watson: Introductory Comments on the Ribosome
Ribosome Structure
Chairperson: D. Caspar, Florida State University Tallahassee
Reginald G. Harris Lecture
Speaker: H.F. Noller, University of California, Santa Cruz
The Ribosome Enzyme
Chairperson: A. Rich, Cold Spring Harbor Laboratory
Initiation
Chairperson: M. Mathews, UMDNJ-New Jersey Medical
School, Newark
Alternative Initiation
Chairperson: S. Gerbi, Brown University Providence, Rhode Island
Elongation and Termination
Chairperson: R. Gesteland, Howard Hughes Medical Institute,
University of Utah, Salt Lake City
Evolution of the Code/aatRNA Synthetases
Chairperson: A. Yonath, Weizmann Institute of Science,
Rehovot, Israel
Dorcas Cummings Lecture: Protein Factories and
Antibiotics
Speaker: V. Ramakrishnan, Medical Research Council, United
Kingdom
Regulation of mRNA
Chairperson: J. Doudna, HHMI, Yale University New Haven,
Connecticut
Regulation of Protein Synthesis
Chairperson: T. Kinzy, UMDNJ-Robert Wood Johnson Medical
School, Piscataway
Ribosome Biogenesis
Chairperson: L Maquat, University of Rochester Medical
School, New York
Summary: Peter Moore, Yale University
Noller, L. Maquat, A. Yonath, D. Ayres, R. Miller, Mrs. Miller
Rich, H. Noller, A. Spirin, D. Caspar
T. Steitz, 0. Uhlenbeck, J.D. Watson
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MEETINGS
Genetic Basis of Neurological and Behavioral Disorders
March 7-11 92 participants
ARRANGED BY Charles Gilbert, The Rockefeller University
Eric R. Kandel, Columbia University/HHMI
A private meeting on the topic of the Genetic Basis of Neurological and Behavioral Disorders was held
here in the spring on behalf of three funds: The Esther A. & Joseph Klingenstein Fund, The Ruth &
Milton Steinbach Fund, and The Klingenstein Third Generation Fund. For 18 years, the Klingenstein
Fund has awarded fellowships in neuroscience related to epilepsy, and for 8 years, The Steinbach Fund
has awarded research grants for the study of macular degeneration. The Third Generation Fund sup-
ports research on childhood and adolescent depression and attention deficit hyperactive disorder. In
addition to an eminent list of invited speakers, the meeting brought together current and former fellows
and investigators supported by the foundations, as well as members of the foundation advisory boards.
The meeting included a busy schedule of talks on the Human Genome Project, genomic studies in var-
ious animal models, analytic techniques for studying gene expression, and tools for manipulating gene
expression. Speakers included Cori Bargmann, James Battey, Jr., Thomas Bouchard, Aravinda
Chakravarti, Dennis Drayna, Gerald Fischbach, Wayne Frankel, Nelson Freimer, Fred (Rusty) Gage,
Barry Ganetzky, Elliot Gershon, Eric Green, Steven Hyman, Maria Karayiorgou, Kathleen Merikangas,
Emmanuel Mignot, Jeremy Nathans, Joseph Takahashi, Stephen Warren, Huda Zoghbi, and Charles
Zuker. The meeting was open to all interested Cold Spring Harbor scientists.
E. Kandel, C. Gilbert J. Battey, W. Frankel, D. Vollrath
A. Ribero, E. Levitan
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P. Klingenstein, J.D. Watson, J. Klingenstein
BIOTECHNOLOGY CONFERENCE
Vector Targeting Strategies for Therapeutic Gene Delivery
March 15-18 114 participants
ARRANGED BY David Curiel, University of Alabama, Birmingham
Wayne Marasco, Dana Farber Cancer Institute
Stephen Russell, Mayo Foundation
The paramount requirement for advancement of gene therapy is the development of vector systems
possessing the capacities for efficient and cell-specific gene delivery. The achievement of these goals
requires that the vector system recognize specific cell signatures. In the first regard, both nonviral and
viral vectors have been engineered to address this goal. In addition, a variety of high-throughput meth-
ods have been advanced for identification of cell-specific markers. Investigators at this meeting pro-
vided an update of key technologies relevant to these goals. Since the last conference in 1999, signif-
icant progress has been noted in this field. Especially noteworthy was the progress achieved in the con-
tent of viral vector tropism modifications. This progress included the translation of novel, advanced gen-
eration vectors into the human clinical context. Future work will be required to define the range of cell-
specific signatures of relevance in the clinical context. Nevertheless, the linkage of these two tech-
nologies-target definition and vector targeting-is already yielding important advances in outcomes
achievable via gene therapy methods.
This meeting was funded in part by Amersham Pharmacia Biotech; Berlex Biosciences; Canji, Inc.;
Merck & Co., Inc., and Vector Logics, Inc. Contributions from our Corporate Sponsors, Plant Corporate
Associates, Corporate Affiliates, Corporate Contributors, and Foundations also provided core support
for this meeting.
D. Curiel, D. Larocca
S. Oqueta, W. Marasco
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PROGRAM
Target Definition I
Chairperson: D.T. Curie!, University of Alabama, Birmingham
Target Definition II
Chairperson: R. Pasqualini, University of Texas M.D. Anderson
Cancer Center Houston
Target Definition Ill
Chairperson: S. Hoffman, Cetera Genomics, Rockville,
Maryland
Transcriptional Targeting
Chairperson: R. Vile, Mayo Foundation, Rochester Minnesota
RNA Viruses
Chairperson: W. Marasco, Dana-Farber Cancer Institute,
Boston, Massachusetts
DNA Viruses
Chairperson: P.W. Roelvink, GenVec, Inc., Gaithersburg,
Maryland
New Technology
Chairperson: R. Cattaneo, Mayo Foundation, Rochester
Minnesota
V. Khuvana, S. Russell, J. Bartlett
M. Yamamoto, A. Hemminki, A. Kanerva
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BIOTECHNOLOGY CONFERENCE
Stem and Progenitor Cells: Biology and Applications
March 22-25 195 participants
ARRANGED BY David Anderson, California Institute of Technology/HHMI
Richard Gardner, University of Oxford, United Kingdom
Daniel Marshak, Cambrex Corporation/Johns Hopkins University
Cells that give rise to the differentiated tissues of an organism are referred to as stem and progenitor
cells. Our understanding of the biology of development has focused recently on stem cells derived from
early embryos, although there is now evidence that pluripotent stem cells exist in postnatal organisms.
Isolated stem and progenitor cells are being developed as therapeutic agents in cell-based therapies.
In addition, genomic and proteomic information derived from the differentiation of stem cells in vitro can
add to our ability to select targets for pharmaceutical development. Investigators at this conference
provided overview discussions as well as new findings in the field of stem cells. Explosive progress had
been noted in this field during the last 4 years, and this conference was timely. Especially noteworthy
were new discoveries in understanding how stem cell nuclei might be programmed for development.
This reaches to the heart of biological diversity: How the regulation of gene expression in somatic cells
and germ cells differs at a molecular level. Applications of stem cells derived from postnatal tissues
were discussed at length. It appears that many adult tissues have multipotent, and perhaps pluripo-
tent, stem cells available for the maintenance of tissue integrity, normal cellular turnover, and wound
repair. The molecular mechanisms controlling differentiation were discussed, and the applications of
stem cells to gene discovery and gene therapy were presented. The conference paved the way for new
development in one of the most dynamic fields of this year.
This meeting was funded in part by Osiris Therapeutics, Inc. Contributions from our Corporate
Sponsors, Plant Corporate Associates, Corporate Affiliates, Corporate Contributors, and Foundations
also provided core support for this meeting.
R. Gardner and meeting participant
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PROGRAM
Historical Perspectives and Overview Topics
Chairperson: J. Witkowski, Cold Spring Harbor Laboratory
Early Stem Cells
Chairperson: R. Gardner, University of Oxford, United Kingdom
BBC Reith Lecture: The End of Age
Speaker: Tom Kirkwood, University of Newcastle, United Kingdom
Moderator: Sue Lawley, British Broadcasting Corporation,
United Kingdom
Mesenchymal Tissues
Chairperson: D. Marshak, Cambrex Corporation and Johns
Hopkins University School of Medicine, Baltimore, Maryland
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Neural Tissues
Chairperson: D. Gottlieb, Washington University, St. Louis,
Missouri
Signal Transduction
Chairperson: D. Anderson, California Institute of Technology,
Pasadena
Hematopoiesis
Chairperson: G. Keller, Mount Sinai School of Medicine, New
York
S. Hall, G. Keller, D. Marshak
Tom Kirkwood answering questions after delivering the BBC Reith Lecture.
Telomeres and Telomerase
March 28-April 1 305 participants
ARRANGED BY Elizabeth Blackburn, University of California, San Francisco
Titia deLange, The Rockefeller University
Carol Greider, Johns Hopkins University School of Medicine
The conference consisted of seven sessions of talks and three poster sessions. As in 1999, the format
chosen was to invite two investigators to chair each session. These scientists are established in the
field, and they not only chaired the session (one chair for each half-session), but also gave a scientific
presentation. The rest of the presentations were chosen from openly submitted abstracts, allowing as
many younger scientists to present as possible, including graduate students and postdoctoral fellows.
Attendance exceeded 300 participants, a large fraction of whom presented in the total of 118 posters
and 73 talks.
The topics covered by the talk sessions and posters were all aspects of telomere and telomerase
biology, in the following groupings based on talk session: telomere length regulation and replication;
telomere structure and function; end-binding proteins; telomere-associated proteins; DNA-damage
response factors; consequences of telomere dysfunction; and telomerase-independent telomere main-
tenance.
The quality of the scientific content was very high throughout the conference in both the talks and
the posters, with significant amounts of new unpublished data being presented and extensively dis-
cussed. Discussion after each talk was lively and informative. The conference was verbally judged to
be highly successful by all who attended. There was generally strong enthusiasm for another meeting
on the same topic in 2003.
This meeting was funded in part by the National Institutes of Health. Contributions from our
Corporate Sponsors, Plant Corporate Associates, Corporate Affiliates, Corporate Contributors, and
Foundations also provided core support for this meeting.
C. Greider, T. deLange, E. Blackburn
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PROGRAM
Telomere Length Regulation and Replication
Chairpersons: C. Price, University of Cincinnati College of
Medicine, Ohio; R. Wellinger, University of Sherbrooke,
Canada
Telomerase Structure and Function
Chairpersons: J. Lingner, Swiss Institute for Experimental
Cancer Research, Epalinges; C. Autexier, McGill University
Montreal, Canada
End-binding Proteins
Chairpersons: M. McEachern, University of Georgia, Athens;
J. Cooper, University of Colorado Health Sciences Center,
Denver
Telomere-associated Proteins
Chairpersons: S. Gasser, ISREC, Epalinges, Switzerland; K.
Runge, Cleveland Clinic Foundation Research Institute, Ohio
DNA Damage Response Factors
Chairpersons: M. Blasco, National Centre of Biotechnology
Madrid, Spain; L. Harrington, University of Toronto, Canada
Consequences of Telomere Dysfunction
Chairpersons: D. Shippen, Texas A&M University College
Station; K. Collins, University of California, Berkeley
Telomerase-independent Telomere Maintenance
Chairpersons: V Lundblad, Baylor College of Medicine,
Houston; F. Ishikawa, Tokyo Institute of Technology Japan
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P. Baumann, A. Eggleston
M. Deault-Bonin, J. Parenteau
FIRST LEHRMAN-WATSON ANNUAL BIOMEDICAL CONFERENCE
Pathways to Alzheimer's Disease
April 19 107 participants
ARRANGED BY David Stewart, Cold Spring Harbor Laboratory
The Lehrman-Watson Annual Biomedical Conference Series is targeted at a professional lay audience
primarily drawn from the financial and analyst sectors. The first one-day conference focused on
Pathways to Alzheimer's Disease, a disease that afflicts approximately 4 million Americans. Recent
advances have brought us closer to an understanding of the biological basis of the disease, and a vari-
ety of treatments and therapeutic approaches are currently being tested in the clinic or developed in
the laboratory. Furthermore, the promise of genomics can be assessed against the backdrop of this
major disease, in which people with differing genetic makeup may be more or less likely to develop
Alzheimer's disease. These developments in turn drive the design of clinical trials and the evaluation of
novel drugs.
The conference opened with a Keynote Address by Marcel le Morrison-Bogorad, deputy director of
the National Institute of Aging, and then featured four panel sessions devoted to Understanding,
Probing, Treating, and Conquering Alzheimer's Disease. Each panel was moderated by leading scien-
tists, including Peter St. George-Hyslop, John Hardy, Rachel le Doody, and Dennis Selkoe; featured
talks by three experts in the field; and was followed by extensive discussion. James D. Watson pre-
sented a fascinating lunchtime talk to more than 100 meeting attendees. This conference brought
together leading investigators from academia and industry with leading life science investors, health
care and biotech venture capitalists, analysts, and business development executives.
The conference was made possible through the generous support of the Lehrman Institute, which
underwrote the entire cost of the meeting.
D. Stewart, M. Hargraves Meeting participant, T. Lehrman, L. Lehrman
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PROGRAM
Opening Keynote Address: Marcel le Morrison-Bogorad,
National Institute of Aging
PANEL I Understanding Alzheimer's Disease: Current Status
and Therapeutic Opportunities
Moderator
Peter St. George-Hyslop, University of Toronto
Panelists
Peter Davies, Albert Einstein College of Medicine
Rich Mayeux, Columbia University
Dennis Selkoe, Harvard Medical School
PANEL II Probing Alzheimer's Disease: Impact of Genomics,
Bioinformatics, and Enabling Technologies
Moderator
John Hardy, The Mayo Clinic, Jacksonville
Panelists
Mark Adams, Cetera Genomics
Karen Duff, Nathan Kline Institute
Jeanne Loring, lncyte Pharmaceuticals
PANEL III Treating Alzheimer's Disease: Advances in Clinical
Trial Design
Moderator
Rachelle Doody, Baylor College of Medicine
Panelists
Steve Dekosky, University of Pittsburgh
Mary Sano, Columbia University
PANEL IV Conquering Alzheimer's Disease: Novel Therapies in
Clinical Development
Moderator
Dennis Selkoe, Harvard Medical School
Panelists
Martin Citron, Amgen
Perry Molinoff, Bristol-Myers Squibb
Dale Schenk, Ban Pharmaceuticals
S. Chan, J. Britton
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D. Selkoe, J.D. Watson
Learning and Memory
April 25-29 122 participants
ARRANGED BY John Byrne, University of Texas-Houston Medical School
Joseph LeDoux, New York University
Leslie Ungerleider, National Institute of Mental Health
The fifth biennial meeting on Learning and Memory consisted of platform and poster presentations and
discussions of current research and concepts in the biological basis of memory. Study of the biologi-
cal bases of learning and memory is a most exciting field in neuroscience. Progress is currently very
rapid, particularly at molecular, cellular, neural system, and computational levels. Commonalities of
mechanisms appear to be emerging from studies of gene expression, synaptic plasticity (LTP and LTD),
and processes of memory storage in invertebrate systems; in particular, similar changes in the proper-
ties of membrane channels and intracellular messenger systems were identified in a number of differ-
ent neural systems in both vertebrate and invertebrate preparations. Discussions ranged from brain
systems of memory in humans through brain circuits and systems of memory, to brain plasticity and
development, basic processes of learning and memory, mechanisms of synaptic plasticity, e.g., long-
term potentiation (LTP) and long-term depression (LTD), biophysical and molecular substrates of synap-
tic plasticity, to genetic approaches to mechanisms of memory.
The meeting focused on several areas of learning and memory. One was a strong representation of
the neural systems underlying memory. In the areas of human memory, world leaders reported on their
recent findings which show that rapid advances have been made in using imaging techniques such as
PET and fMRI to probe the formation and retrieval of human memories in real time. Furthermore, sys-
tems level research in a variety of animal models revealed new insights into memory, including the new
and exciting phenomenon of reconsolidation. A second focus of the meeting was on the use of mutant
and transgenic mice to identify the roles of gene expression of particular enzyme systems in synaptic
plasticity and memory. The "gene knockout" approach is new and very promising. There was much dis-
cussion about the possibility of developing localized, inducible, reverse knockout preparations.
The meeting was funded in part by the National Institute of Neurological Disorders and Stroke and
the National Institute on Aging, branches of the National Institutes of Health; and the National Science
Foundation. Contributions from our Corporate Sponsors, Plant Corporate Associates, Corporate
Affiliates, Corporate Contributors, and Foundations also provided core support for this meeting.
J. Byrne, L. Ungerleider, J. LeDoux
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PROGRAM
Human Memory
Chairperson: M. Mishkin, NIMH, National Institutes of Health,
Bethesda, Maryland
Spines and Dendritic Processing
Chairperson: E. Schuman, California Institute of Technology,
Pasadena
Encoding
Chairperson: H. Eichenbaum, Boston University Massachusetts
Consolidation
Chairperson: Y. Dudai, Weizmann Institute of Science, Rehovot,
Israel
Pre- and Postsynaptic Plasticity
Chairperson: J. Byrne, University of Texas-Houston Medical
School
Kinases and Second Messengers
Chairperson: D. Sweatt, Baylor College of Medicine, Houston,
Texas
Reward
Chairperson: R. Wise, NIDA, National Institutes of Health,
Baltimore, Maryland
Genes and Proteins
Chairperson: T. Tully, Cold Spring Harbor Laboratory
0. Svarnik, S. Tousey
J. Yin, S. Grant
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R. Morris, M. Mishkin
PROGRAM
Signal Transduction
Chairperson: S. Coughlin, University of California, San
Francisco
Cell Cycle/Cell Death
Chairpersons: G. Salvesen, Burnham Institute, San Diego,
California; M. Hochstrasser, Yale University, New Haven,
Connecticut
Development
Chairpersons: C. Hashimoto, Yale University School of
Medicine, New Haven, Connecticut; J.M. White, University of
Virginia, Charlottesville
Neurodegeneration
Chairpersons: D.J. Selkoe, Harvard Medical School,
Brigham and Women's Hospital, Boston, Massachusetts;
S. Sinha, Elan Pharmaceuticals, South San Francisco,
California
Neoplasia/Angiogenesis
Chairpersons: W. Bode, Max-Planck Institute for Biochemistry
Martinsried, Germany; D. Hanahan, University of California,
San Francisco
Immunology/Inflammation
Chairpersons: H. Ploegh, Harvard Medical School, Boston,
Massachusetts; A. Rosen, Johns Hopkins University School
of Medicine, Baltimore, Maryland
Bone and Cartilage Metabolism
Chairpersons: D. Prockop, Tulane University School of
Medicine, New Orleans, Louisiana; D. BrOmme, Mt. Sinai
School of Medicine, New York
Infectious Diseases
Chairpersons: J.M. Musser, Rocky Mountain Laboratories,
National Institutes of Health, Hamilton, Montana; J. Kay,
Cardiff University United Kingdom
L. Dick, B. Dunn
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S. Waugh, D. Dauber
C. Craik, W. Bode
Proteolysis and Biological Control
May 2-6 203 participants
ARRANGED BY Roy Black, Immunex Corporation
Charles S. Craik, University of California, San Francisco
Ben Dunn, University of Florida
Nancy Thornberry, Merck Research Laboratories
Proteases are key regulators in a wide range of biological processes, from cell cycle and development
to cell death. This biennial meeting provides a forum that fertilizes cross-talk between experts on these
processes and experts on the proteases as enzymes.
This third meeting attracted more than 200 scientists who discussed the role of proteolysis in sig-
nal transduction, development, cell cycle, neoplasia, immune control, cell death, angiogenesis, inflam-
mation, and bone and cartilage metabolism. The reported experimental systems ranged from prokary-
otes to humans, whereas the interests of the speakers varied from dissection of protease structure to
human neurodegenerative diseases. Despite such a diversity, the participants commented that the
meeting was focused, informative, and very exciting. The cross-talk was made possible in large part
by the chairs who presented extensive overviews at the beginning of each session. In summary, the
Proteolysis and Biological Control meeting was a unifying forum that is helping us to understand how
proteases control life and death.
This meeting was funded in part by the National Institutes of Health and the National Science
Foundation. The organizers are indebted to W. Clarke Swanson, Jr. and the staff of Swanson Vineyards
for generously providing a wonderful venue for planning this meeting. Contributions from our Corporate
Sponsors, Plant Corporate Associates, Corporate Affiliates, Corporate Contributors, and Foundations
also provided core support for this meeting.
H. Ploegh, N. Thornberry
R Dempsey, S. Higashiyama
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Genome Sequencing and Biology
May 9-13 525 participants
ARRANGED BY Pui-Yan Kwok, Washington University
Jane Rogers, The Sanger Centre
Edward Rubin, Lawrence Berkeley National Laboratoy
The annual Genome Sequencing and Biology meeting marked the 14th gathering of genome scientists
in this setting. The past decade has seen remarkable progress in the mapping and sequencing of the
genomes of many "model organisms" and the publication of a "working draft" of the human genome
sequence in February 2001. Phrases such as "functional genomics" and "postgenome biology" have
become common terms. More than 500 people from around the world attended the meeting, with 298
abstracts presented describing a broad array of topics relating to the analysis of genomes from a num-
ber of different organisms.
The session topics included areas such as biological insights from phylo-genomics, mapping meth-
ods and technologies, functional genomics, computational genomics, and 21st century genetics. This
year's poster symposium featured the complete sequencing of human chromosomes 21 and 22, in
addition to the announcement by the public Human Genome Project that 80% of the human genome
had been sequenced. Once again, projection-style, interactive computer demonstrations in Grace
Auditorium effectively highlighted the critical new bioinformatics tools being developed for storing,
organizing, and analyzing genomic maps and sequences. There was also an ELSI (Ethical, Legal, and
Social Implications) panel discussion, chaired by Charmaine Royal of Howard University, which focused
on issues surrounding genetic enhancement.
The major themes of the meeting included the analysis of the draft human genome sequence and
the smallest human chromosomes, including the Y chromosome, with the surprising observation that
the number of genes in the human might be as small as 30,000. Specific presentations continued to
report major achievements in the sequencing of model organisms and the human being, the develop-
ment of new technologies for genetic analysis, and the use of microarrays for performing genome
analysis. The now traditional Saturday afternoon keynote talks were delivered by Eric Lander, Director
of the Whitehead Institute/MIT Center for Genome Research, and Paul Nurse, Head of the Imperial
Cancer Research Fund and winner of this year's Nobel Prize for Physiology or Medicine.
This meeting was funded in part by the National Human Genome Research Institute, a branch of the
National Institutes of Health. Contributions from our Corporate Sponsors, Plant Corporate Associates,
Corporate Affiliates, Corporate Contributors, and Foundations also provided core support for this meeting.
Computer demo under canvas.
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PROGRAM
Large-Scale Sequencing and Analysis
Chairpersons: S. Beck, Sanger Centre, Cambridge, United
Kingdom; J. Bouck, Baylor College of Medicine, Houston,
Texas
Polymorphisms I: Discovery and Technology
Chairpersons: D. Altshuler, Whitehead Center for Genome
Research, Cambridge, Massachusetts; S. Tyagi, Public Health
Research Institute, New York
Comparative Genomics I: Model Organisms
Chairpersons: J. Ecker, Salk Institute for Biological Studies,
La Jolla, California; S. Johnson, Washington University
School of Medicine, St. Louis, Missouri
Functional Genomics
Chairpersons: M. Eisen, Lawrence Berkeley National
Laboratory, California; Y. Hayashizaki, RIKEN, Tsukuba, Japan
ELSI Panel Discussion: Through the Past Darkly: A Window
on the American Eugenics Movement
Bioinformatics
Chairpersons: E. Birney, European Bioinformatics Institute,
Hinxton, United Kingdom; S. Eddy, Washington University
School of Medicine, St. Louis, Missouri
Polymorphisms II: Mapping and Analysis
Chairpersons: T. Long, University of California, Irvine; M.
Shriver, Pennsylvania State University University Park
Keynote Speakers
Eric Lander, Whitehead Institute/MIT Center for Genome
Research; Paul Nurse, Imperial Cancer Research Fund
Comparative Genomics II: Mammalian Genetics
Chairpersons: S. Scherer, Hospital for Sick Children, Toronto,
Canada; H.A. Lewin, University of Illinois, Urbana
F Collins, E. Lander, D. Bentley P. Kitts, J. Kent
M. Stoll, A. Kwitek-Black
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P. -Y. Kwok, E. Rubin, J. Rogers
Tyrosine Phosphorylation and Cell Signaling
May 16-20 243 participants
ARRANGED BY Nick Tonks, Cold Spring Harbor Laboratory
Sara Courtneidge, Van And le Research Institute, Grand Rapids, Michigan
Ben Neel, Beth Israel Hospital, Harvard Medical School
This fourth meeting on Tyrosine Phosphorylation and Cell Signaling opened with Keynote Addresses by
Jossie Schlessinger and Jack Dixon. Jossie Schlessinger introduced the field of tyrosine-phosphoryla-
tion-dependent signal transduction from the perspective of the protein tyrosine kinases, focusing on
signaling through the FGF receptor. Jack Dixon discussed the complementary perpective and the sig-
naling function of protein tyrosine phosphatases and highlighted the potential RNA interference as a tool
to delineate signaling pathways. The format of the meeting provided a combined emphasis on the
physiological roles of protein tyrosine kinases and phosphatases and how their actions are integrated
to modulate signaling events in vivo. The sessions were largely based around physiological processes
and cellular functions so as to try to provide biological context to the data. A variety of systems were
described, with great progress reported in genetic and biochemical approaches to the characterization
of physiological functions for tyrosine phosphorylation. In particular, exciting insights were provided into
how signaling pathways may be abrogated in a variety of human disease states and to the identity of
novel targets for therapeutic intervention. The meeting continues to be successful and alternates with
a conference with the same format at The Salk Institute, with the result that there is an annual meeting
on tyrosine phosphorylation.
The meeting was supported by grants from the National Institutes of Health and the National
Science Foundation. Contributions from our Corporate Sponsors, Plant Corporate Associates,
Corporate Affiliates, Corporate Contributors, and Foundations also provided core support for this
meeting.
N. Tonks, S. Courtneidge, B. Neel
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PROGRAM
Keynote Speakers
Chairpersons: J.E. Dixon, University of Michigan Medical
School, Ann Arbor; J. Schlessinger, New York University
School of Medicine
Metabolism and Growth Control
Chairperson: M. White, Harvard Medical School, Boston,
Massachusetts
Hematopoietic Cell Signaling
Chairperson: D. Cantrell, Imperial Cancer Research Fund,
London, United Kingdom
Cytoskeleton and Cell Adhesion
Chairperson: L. Van Aelst, Cold Spring Harbor Laboratory
Development
Chairperson: R. Klein, European Molecular Biology Laboratory
Heidelberg, Germany
Growth Control
Chairperson: J. Wang, University of California, San Diego
Signaling Abnormalities and Disease
Chairperson: B. Druker, Oregon Health Sciences University,
Portland
Immune Cell Signaling
Chairperson: G. Koretzky, University of Pennsylvania School of
Medicine, Philadelphia
I. Sansal, S. Ramaswamy, P. Vazquez
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Retroviruses
May 22-27 464 participants
ARRANGED BY Monica Roth, UMDNJ-Robert Wood Johnson Medical School
Ronald Swanstrom, University of North Carolina Center of AIDS Research
The 2001 meeting represented the 26th offering of the annual Cold Spring Harbor meeting, which
began life in 1975 as a meeting on RNA Tumor Viruses and evolved into its current focus on
Retroviruses in 1993. In addition to the abstracts presentation of the subscribed attendees, the 26th
meeting highlighted current approaches to HIV treatment.
The two keynote speakers addressed different aspects of retroviral therapy: Harriet Robinson
(Emory University) spoke on "Shots in the Light: Working toward an AIDS Vaccine" and David Ho (Aaron
Diamond AIDS Research Center) spoke on "Virus and Lymphocyte Dynamics in HIV Infection." In addi-
tion, Maxine Linial presented the new nomenclature for retroviruses, which was included within the
abstract book. The sessions followed the general life cycle of the retrovirus. The opening and closing
sessions focused on the retroviral assembly process, where linkages with the host ubiquitination sys-
tem have been identified.
Contributions from our Corporate Sponsors, Plant Corporate Associates, Corporate Affiliates,
Corporate Contributors, and Foundations provided core support for this meeting.
M. Roth F. Yoshimura, S. Chattopadhqay
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PROGRAM
Assembly
Chairpersons: E. Freed, NIAID, National Institutes of Health,
Bethesda, Maryland; L. Parent, Pennsylvania State University
College of Medicine, Hershey
Entry
Chairpersons: P. Cannon, University of Southern California, Los
Angeles; J. Cunningham, Harvard Medical School, Boston,
Massachusetts
Pathogenesis/Evolution/Endogenous Viruses
Chairpersons: P Bates, University of Pennsylvania,
Philadelphia; J. Young, University of Wisconsin, Madison
RT
Chairpersons: A. Telesnitsky, University of Michigan, Ann Arbor;
M. Georgiadis, Rutgers University Piscataway, New Jersey
Preintegration/Integration
Chairpersons: A. Engelman, Dana-Farber Cancer Institute,
Boston, Massachusetts; J. Leis, Northwestern University
School of Medicine, Chicago, Illinois
Keynote Speaker
Harriet Robinson, Emory University
Shots in the Light: Working toward an AIDS Vaccine
Transcription/Tax/Tat
Chairpersons: H. Fan, University of California, Irvine;
J. Coffin, Tufts University School of Medicine, Boston,
Massachusetts
Keynote Speaker
David Ho, Aaron Diamond AIDS Research Center, New York:
Virus and Lymphocyte Dynamics in HIV Infection
HIV Biology/Entry
Chairpersons: D. Ho, Aaron Diamond AIDS Research Center,
New York; B. Berkhout, University of Amsterdam, The
Netherlands
Assorted Accessory Proteins
Chairpersons: D. Trono, University of Geneva, Switzerland; V
Garcia, University of Texas Southwestern Medical Center,
Dallas
Processing: RNA/Protease
Chairpersons: W. Sundquist, University of Utah, Salt Lake City;
K. Beemon, Johns Hopkins University Baltimore, Maryland
NC/Packaging
Chairpersons: J. Luban, Columbia University New York; A.
Rein, National Cancer Institute, Bethesda, Maryland
M. Federspiel, J. Young
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K.-T. Jeang, P. Jolicoeur
New York Structural Biology Group
August 8 261 participants
ARRANGED BY Larry Shapiro, Mount Sinai School of Medicine
Leemor Joshua-Tor, Cold Spring Harbor Laboratory
The summer meeting of the New York Structural Biology Discussion Group was the fourth in day-long
meetings allowing structural biologists from all over the region to meet and discuss their latest results.
The meeting was open to structural biologists from different disciplines, including crystallographers,
spectroscopists, computational biologists, and biochemists, with more than 261 participants from
academia and industry from the tri-state area. The program featured nine talks and a poster session
and concluded with a beach barbecue allowing a wonderful opportunity for informal interactions. This
meeting complements the bimonthly evening meetings of the group held at The Rockefeller University.
No registration was required and participants were encouraged to set up posters.
Financial support was provided by Hampton Research Inc., Molecular Structure Corporation, Bruker
AXS Inc., Gilson Inc., and Hoffmann-La Roche Inc.
SESSION I
Chairperson: Steve Almo, Mount Sinai School of Medicine
Larry Shapiro, Mount Sinai School of Medicine: Signal trans-
duction by Tubby proteins.
David Cowburn, The Rockefeller University: Probing multi-
domain interactions with NMR.
Rui-Ming Xu, Cold Spring Harbor Laboratory: Crystal structure
of a SIR2 homolog-NAD complex.
SESSION II
Chairperson: Hao Wu, Cornell Medical School
Aneel Aggarwal, Mount Sinai School of Medicine: Crystal struc-
ture of DNA polymerase r.
Brian Chait, The Rockefeller University: Proteomic tools for dis-
secting cellular function.
Peter Moore, Yale University: Structure and function in the large
ribosomal subunit.
SESSION III
Chairperson: Barry Honig, Columbia University
Chris Jacobsen, SUNY Stony Brook: X-ray imaging, with and
without optics.
Helen Berman, Rutgers University: The Protein Data Bank and
the challenges of structural genomics.
John Kuriyan, The Rockefeller University: Structural analysis of
DNA polymerase clamp loading.
C. Lima, C. Kisker, L. Joshua-Tor, A. Aggarwal
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FIRST CSHL/WELLCOME TRUST CONFERENCE
Genome Informatics
August 8-12 256 participants
ARRANGED BY Ewan Birney, European Bioinformatics Institute
Suzanna Lewis, University of California, Berkeley
Lincoln Stein, Cold Spring Harbor Laboratory
The first Cold Spring Harbor Laboratory/Wellcome Trust conference on Genome Informatics focused on
large-scale genome annotation and utilization. The rationale behind organizing a trial joint conference in
Europe derives from the increasingly competitive academic conference market, with many institutions in
the United States and Europe openly planning to emulate the success of the Cold Spring Harbor meet-
ings' model. The conference was held at the Hinxton Hall Conference Centre, located several miles south
of Cambridge in the United Kingdom, which forms part of the Wellcome Trust Genome Campus, togeth-
er with the Sanger Centre, the European Bioinformatics Institute, and the HGMP-MRC Resource Centre.
The conference followed a format similar to that of traditional Cold Spring Harbor meetings, in that the
majority of oral presentations were drawn from openly submitted abstracts.
The explosion of biological data requires a concomitant increase in the scale and sophistication of infor-
mation technology, ranging from the storage of data and their associated data models, to the design of
effective algorithms to uncover nonobvious aspects of these data sets, to ontologies to concisely describe
biological information, and finally to software systems to support curation, visualization, and exploration.
The conference brought together some of the leading scientists in this growing field, and researchers from
other large-scale information-handling disciplines were also invited to attend. In all, 256 participants
attended, with more than 50% of delegates coming from North America, a highly unusual statistic for a
European meeting, and the meeting hosted 108 scientific presentations in talks and posters.
PROGRAM
Annotation Pipelines
Chairpersons: J. Richardson, Jackson Laboratory, Bar Harbor,
Maine; C. Mungall, Lawrence Berkeley National Laboratory
California; J. Quackenbush, The Institute for Genome
Research, Rockville, Maryland
Genome Assembly
Chairpersons: J. Kent, University of California, Santa Cruz; J.
Mullikin, Sanger Centre, Wellcome Trust Genome Campus,
Hinxton, United Kingdom
Gene Prediction
Chairpersons: R. Durbin, Sanger Centre, Wellcome Trust
Genome Campus, Hinxton, United Kingdom; A. Krogh,
Technical University of Denmark, Lyngby
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Functional Genomics
Chairperson: A. Bateman, Sanger Centre, Wellcome Trust
Genome Campus, Hinxton, United Kingdom
Curation and Ontologies
Chairperson: M. Ashburner, EMBL-EBI, Wellcome Trust
Genome Campus, Hinxton, United Kingdom
Genome Visualization
Chairpersons: M. Clamp, Sanger Centre, Welcome
Trust Genome Campus, Hinxton, United Kingdom;
J. Richter, Lawrence Berkeley National Laboratory
California
The Hinxton Hall
Conference Center
Yeast Cell Biology
AUGUST 14-19 393 participants
ARRANGED BY Brenda Andrews, University of Toronto, Canada
Chris Kaiser, Massachusetts Institute of Technology
Mark Winey, University of Colorado, Boulder
The conference on Yeast Cell Biology was the eighth biannual international meeting devoted to major
aspects of cell biology in yeast. This conference is unusual in that the study of all major areas of cell
biology are represented at a single meeting organized around a simple eukaryotic organism, the bud-
ding yeast Saccharomyces cerevisiae.
A common interest in one organism, instead of one topic in cell biology, encourages extensive
cross-fertilization of ideas, insights, and methodologies, ultimately leading to a more integrated view of
eukaryotic cell structure and function. Important insights were further gained by studies in the fission
yeast Schizosaccharomyces pombe as well as other yeasts. The meeting included a session on
genome-wide expression analysis in yeast during critical cellular processes and at different stages of
the life cycle. Major areas of interest included the functions of the actin and microtubule cytoskeleton,
and the targeting and sorting of proteins in the secretory, endocytotic, and nuclear localization path-
ways. The coordination of several cellular processes was discussed in the context of the response to
mating pheromone, meiosis, and the cell cycle, with the exit from mitosis being particularly important.
All told, it was a very rich and exciting meeting with more than 390 scientists in attendance presenting
some 277 scientific reports in 111 talks and 166 posters.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Affiliates, Corporate Contributors, and Foundations provided core support for this meet-
ing.
C. Kaiser, B. Andrews. M. Winey
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PROGRAM
Actin and Budding
Chairperson: J. Thorner, University of California, Berkeley
Cell Cycle and Checkpoints
Chairperson: P. Meluh, Memorial Sloan-Kettering Cancer
Center, New York
Endocytosis and Vacuolar Turnover
Chairperson: M. Cyert, Stanford University, California
Microtubules and Chromosomes
Chairperson: 0. Cohen-Fix, NIDDK, National Institutes of
Health, Bethesda, Maryland
Functional Genomics and Proteomics
Chairperson: M. Tyers, Samuel Lunenfeld Research Institute,
Toronto, Canada
ER and Organelle Biogenesis
Chairperson: R. Hampton, University of California, San Diego
Meiosis
Chairperson: R. Rothstein, Columbia University College of
Physicians & Surgeons, New York
Signaling and Cell Regulation
Chairperson: M. Solomon, Yale University New Haven,
Connecticut
Vesicular Traffic
Chairperson: L. Weisman, University of Iowa, Iowa City
Septins and Metabolism
Chairperson: T. Fox, Cornell University Ithaca, New York
E. Swain, H. Watson, J. Baggett T. Fox, P. Meluh, M. Rose, D. Botstein
J. Blanchette, C. Reinke, P. Connerly, J. Soderholm, B. Bevis
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M. Yaffe, G. Sprague
Eukaryotic mRNA Processing
August 22-26 299 participants
ARRANGED BY Christine Guthrie, University of California, San Francisco
Timothy Nilsen, Case Western Reserve University
The third Eukaryotic mRNA Processing Meeting was held this year, and it focused on the mechanism
and regulation of pre-mRNA splicing, 3'-end formation, transport, editing, and turnover in both yeast and
multicellular eukaryotes. Catalysis of a reaction similar to splicing by protein-free snRNAs was demon-
strated. These results provide the strongest evidence to date that the spliceosome is a ribozyme. In addi-
tion, structural characterization of the spliceosome has progressed beyond individual components; the
first cryo-electron micrographs of intact spliceosomes and subcomplexes were presented. There was
continued interest in RNA interference from both a mechanistic standpoint and its link to the production
of developmentally regulated micro-RNAs. RNA interference has also been used successfully to dissect
nuclear transport pathways as well as the mechanisms that control alternative processing.
The functional links between transcription and posttranscriptional events continue to be explored,
as are links between processing steps and transport. A major theme was the integration of all steps in
gene expression. Nuclear surveillance of mRNAs appears to occur at several steps, but the mecha-
nisms remain largely obscure. Several different mRNA decay pathways were described, many of which
target aberrant mRNAs.
Completion of various genome projects has led to an increase in array-based methodologies to
detect alternative splicing. It now appears than a substantial majority of genes generate multiple proteins
via alternative processing, and the mechanism of regulation of these pathways is beginning to be under-
stood. Other presentations at the meeting described genetic, biochemical, and cell biological approach-
es applied to the study of diverse aspects of mRNA metabolism, including 3'-end processing mecha-
nisms and regulation, splicing, editing, turnover, and transport in yeast, metazoans, plants, and viruses.
This meeting was funded in part by the National Cancer Institute and the National Institute of Child
Health and Human Development, branches of the National Institutes of Health, and by the National
Science Foundation. The Laboratory would in addition like to thank the RNA Society for its support of
this meeting. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate
Associates, Corporate Affiliates, Corporate Contributors, and Foundations also provided core support
for this meeting.
T. Nilsen, C. Guthrie
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PROGRAM
RNA Trafficking and Localization
Chairperson: I. Mattaj, European Molecular Biology Laboratory
Heidelberg, Germany
Splicing Mechanisms
Chairperson: M. Green, Howard Hughes Medical Institute/
University of Massachusetts Medical School, Worcester
3' Ends
Chairperson: M. Wickens, University of Wisconsin, Madison
Spliceosome Assembly
Chairperson: M. Ares, University of California, Santa Cruz
RNA Turnover
Chairperson: L. Maquat, University of Rochester School of
Medicine, New York
snRNP Biogenesis and Function
Chairperson: J. Steitz, Yale University School of Medicine, New
Haven, Connecticut
Regulation
Chairperson: S. Berget, Baylor College of Medicine, Houston,
Texas
D. Black, B. Chabot, N. Hernandez
N. Villegas, M. De LaRosa, J. Valdes
L. Penalva, J. Xie
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J. Steitz, M. Green, J. Manley
Mechanisms of Eukaryotic Transcription
August 29-September 2 467 participants
ARRANGED BY Nouria Hernandez, Cold Spring Harbor Laboratory
Robert Kingston, Massachusetts General Hospital
Richard Treisman, Imperial Cancer Research Fund, London
A large proportion of the regulation occurring in biological systems is at the level of gene transcription.
Accordingly, the transcription field is rapidly evolving and continuously expanding. Mechanisms of
Eukaryotic Transcription was the seventh biennial Cold Spring Harbor meeting devoted to mechanisms
of transcriptional regulation in eukaryotes, and it allowed scientists working in different areas of this field
to hear, discuss, and critically evaluate the latest results, and to incorporate them into a global picture.
The conference consisted of eight plenary sessions and two poster sessions. The sessions focused on
the structure and function of RNA polymerase, on the role of the TATA-box-binding protein TBP, TBP-
related factors and TBP-associated factors, and on advances in our understanding of initiation and
elongation mechanisms. They also addressed the structure and function of acetylases, methylases,
and their role in epigenetic regulation, interactions between transcription factors, chromatin remodeling
mechanisms, regulatory circuits, and mechanisms of activation.
This meeting was funded in part by the National Cancer Institute and National Institute of Child
Health and Human Development, branches of the National Institutes of Health. Contributions from our
Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Affiliates,
Corporate Contributors, and Foundations also provided core support for this meeting.
N. Hernandez, R. Kingston, R. Treisman
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PROGRAM
RNA Polymerase
Chairperson: P.A. Weil, Vanderbilt University, Nashville,
Tennessee
TBP and Friends
Chairperson: S. Buratowski, Harvard Medical School, Boston,
Massachusetts
Initiation and Elongation Mechanisms
Chairperson: K.M. Arndt, University of Pittsburgh,
Pennsylvania
Acetylases, Methylases, and Epigenetics
Chairperson: C.L. Peterson, University of Massachusetts
Medical Center, Worcester
Transcription Factor Interactions
Chairperson: W.P. Tansey, Cold Spring Harbor Laboratory
Chromatin Remodeling
Chairperson: J.L. Workman, Pennsylvania State University
University Park
Regulatory Circuits and Activation I
Chairperson: B.J. Graves, Huntsman Cancer Institute,
University of Utah, Salt Lake City
Activation II
Chairperson: K.A. Jones, SAIC, NCI-Frederick, Maryland
Watching the meeting on TV.
R. Chapman, D. Gregory
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M. Garey, K. Yamamoto
Eukaryotic DNA Replication
September 5-9 408 participants
ARRANGED BY Thomas Kelly, Johns Hopkins University School of Medicine
Bruce Stillman, Cold Spring Harbor Laboratory
This was the eighth biannual meeting on Eukaryotic DNA Replication held at Cold Spring Harbor.
Studies of eukaryotic DNA replication are advancing rapidly on many fronts, and this meeting is now
established as the most important in the field. More than 400 investigators participated in the 10 sci-
entific sessions, and there were nearly 275 platform and poster presentations. Thus, interest in the
mechanisms and regulation of DNA replication in eukaryotic cells remains extremely high, and the
meeting is playing a key role in fostering the exchange of new ideas and experimental approaches. The
meeting included eight scientific presentation sessions and two poster sessions.
Essential funding for the meeting was provided by the National Cancer Institute and the National
Institute of Environmental Health Sciences, branches of National Institutes of Health, and the National
Science Foundation. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant
Corporate Associates, Corporate Affiliates, Corporate Contributors, and Foundations also provided
core support for this meeting.
B. Stillman, T. Kelly L. Frappier, T. Melendy, K. Fien, D. Jeruzalmi
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PROGRAM
Replication Fork Proteins
Chairperson: L. Frappier, University of Toronto, Canada
Formation and Control of Initiation Complexes
Chairperson: T. Kelly, Johns Hopkins University, Baltimore,
Maryland
Control of DNA Replication
Chairperson: 0. Aparicio, University of Southern California, Los
Angeles
Replication and the DNA Damage Response
Chairperson: E. Fanning, Vanderbilt University Nashville,
Tennessee
Aspects of Chromosome Replication
Chairperson: J. Li, University of California, San Francisco
Origin-binding Proteins
Chairperson: E. Boye, Institute for Cancer Research, Oslo,
Norway
Initiation
Chairperson: S. Gerbi, Brown University Providence, Rhode
Island
Defining Origins
Chairperson: R. Bambara, University of Rochester, New
York
R. Laskey, Y. Ishimi
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S. Weller, D. Wigley
J. Diffley
SECOND CSHL WORKSHOP ON COMPUTATIONAL BIOLOGY
Integrating Genome Sequence, Sequence Variation,
and Gene Expression
September 28-30 176 participants
ARRANGED BY Michael Q. Zhang, Cold Spring Harbor Laboratory
Aravinda Chakravarti, Johns Hopkins Hospital
Michael B. Eisen, Lawrence Berkeley National Laboratories and University of
California, Berkeley
This second workshop on Computational Biology focused primarily on Integrating Genome Sequence,
Sequence Variation, and Gene Expression. As the Human Genome Project picks up speed to deliver
the finished human genome, functional genomics has started to bear fruit in many areas of biology and
medicine. Vast DNA sequence information enables investigators to simultaneously monitor the expres-
sion of large numbers of genes in vivo or to closely examine genome variation at the nucleotide reso-
lution. Computational biology and bioinformatics have increasingly significant roles in these large-scale
investigations. To further promote interaction between computational and experimental researchers,
the 2001 meeting has addressed the following
questions:
What have we already learned from studies of
large-scale gene expression, sequence struc-
ture, and variation?
At
al methods be introduced into the overall
experimental design, beyond their practical
application in data analysis?
What limitations do we have to overcome in
order to obtain real and reliable functional
interpretations from large amounts of com-
plex and noisy data?
M. Zhang, A. Chakravarti
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The workshop concentrated primarily on biological and biomedical principles, rather than algorith-
mic aspects of computational biology. The topics covered a wide range of structural and functional
issues in genomics/proteomics. Despite its brevity, the workshop attracted substantial international
participation from laboratories in Japan, as well as from Europe and Canada (originally 230 registrants
planned to attend). Due to the terrorist attack on September 11, several international and west-coast
people were not able to attend. Among many distinguished session chairs and speakers, two very pop-
ular lectures were given by Ron Davis (Stanford University) and Partha Mitra (Bell Laboratories).
Attendants praised this workshop for its quality and unique setting and expressed strong interest in
continuing this format in the future.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Affiliates, Corporate Contributors, and Foundations provided core support for this meeting.
PROGRAM
State of the Art in Analysis of Sequence Variation and Gene
Expression
Chairpersons: A. Chakravarti, Johns Hopkins University School
of Medicine, Baltimore, Maryland; L. Stein, Cold Spring
Harbor Laboratory
Modeling Global Gene Expression
Chairpersons: M. Eisen, Lawrence Berkeley National Labora-
tory California; E. Siggia, The Rockefeller University, New York
Modeling Whole-genome Variation
Chairpersons: R. Davis, Stanford DNA Sequencing &
Technology Center Palo Alto, California; E. Eichler, Case
Western Reserve University, Cleveland, Ohio
Integrating Genomics and Biological Function
Chairpersons: M. Zhang, Cold Spring Harbor Laboratory;
G. Rubin, Howard Hughes Medical Institute, University of
California, Berkeley
R. McCombie, J. McPherson
N. Pavy, N. Banerjee
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M. McAlear, M. Liu
Neurobiology of Drosophila
October 3-7 307 participants
ARRANGED BY Hugo Bellen, HHMI/Baylor College of Medicine
Barbara Taylor, Oregon State University
The goal of the 2001 Neurobiology of Drosophila meeting, as it has been since its inception, was to
foster communication of ideas, techniques, and new discoveries within the field of Drosophila neurobi-
ology. The meeting was structured with platform and poster presentations by a variety of researchers,
including graduate students, postdoctoral fellows, and junior and senior faculty. The topics for the plat-
form sessions were chosen from areas where exciting advances are being made in the molecular and
cellular mechanisms underlying neurophysiology, axon guidance and synaptic plasticity, sensory sys-
tems, embryonic and adult nervous system development and organization, behavior, neuronal and glial
determination and differentiation. The research reported relies on a wide range of techniques, includ-
ing genetic, molecular, cellular, neurophysiological, and behavioral and genomic approaches to basic
questions of nervous system development and function. The highlights of the meeting included pre-
sentations of new and exciting developments, including identification of new growth factors involved in
synaptic plasticity, a new noncircadian role for clock genes in sleep and rest behavior, and identifica-
tion of topographic olfactory maps in higher brain centers. At the Elkins plenary lecture, which is pre-
sented by a recent Ph.D. graduate, exciting work was introduced on how receptors mediate a repul-
sive signal act in concert to channel growing axons into separate pathways. The environment of the
B. Taylor, H. Bellen R. Kraut, U. Thomas, U. Kuchinke
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meeting allowed many opportunities for informal discussions among all participants. The high quality of
the presentations, novel findings, and new techniques discussed at the meeting demonstrated the
vitality of Drosophila research. The character of the discussions leads to the cross-fostering of ideas
that is valuable to everyone in the field.
This meeting was funded in part by the National Institute of Child Health and Human Development
and the National Institute of Neurological Disorders and Stroke, branches of the National Institutes of
Health, and the National Science Foundation. Contributions from our Corporate Benefactors,
Corporate Sponsors, Plant Corporate Associates, Corporate Affiliates, Corporate Contributors, and
Foundations also provided core support for this meeting.
PROGRAM
Sensory Systems and Eye Development
Chairperson: J. Treisman, New York University School of
Medicine, New York
Neuronal and Glial Determination
Chairperson: J. Skeath, Washington University School of
Medicine, St. Louis, Missouri
Genome and Techniques
Chairperson: E. Bier, University of California, San Diego
Elkins Memorial Lecture
Axon Guidance Synapse Formation and Synapse Plasticity
Chairperson: V. Budnik, University of Massachusetts, Amherst
Adult CNS Development and Neuronal Degeneration
Chairperson: K. Ito, National Institute of Basic Biology, Okazaki,
Japan
Behavior
Chairperson: J. Ewer, Cornell University Ithaca, New York
Neurophysiology
Chairperson: J.T. Littleton, Massachusetts Institute of
Technology, Cambridge
U. Heberlein, G. Marden
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B. Ganetzky, S. Singh, D. Ebert, N. Atkinson
Microbial Pathogenesis and Host Response
October 10-14 170 participants
ARRANGED BY Stanley Maloy, University of Illinois
Paula Sundstrom, Ohio State University
Ronald Taylor, Dartmouth Medical School
Throughout recorded history, microbial pathogens have been a major cause of human disease and
mortality. However, with the advent of effective antibiotics, it seemed like the war on microbes had been
won. Hence, for several decades, health-related research shifted to topics such as cancer, heart dis-
ease, and genetic diseases. Although research in microbial pathogenesis slowed, the microbes con-
tinued to evolve. Microbial resistance to antibiotics developed faster than new antibi-
otics could be made available, and the resistance spread throughout the microbial
world. The global expansion of food distribution networks increased the rapid dis-
semination of microbial pathogens. Simultaneously, emerging microbial pathogens
filled new ecological niches, such as indwelling medical devices that provide a surface
for biofilms and the growing population of patients who are immunocompromised due
to primary infections such as HIV or due to therapies for chronic diseases.
Furthermore, recent discoveries have demonstrated that some diseases (e.g., ulcers
and coronary heart disease), previously believed to be caused by a genetic predis-
position or environmental conditions, are actually caused by or are strongly associat-
ed with microbes. Finally, humans have facilitated the development of microbial
pathogens as agents of bioterrorism.
This microbial offensive has summoned a renewed counterattack on microbial
pathogens that has intensified during the last several years. A variety of new tools
have become available that make it possible to dissect the molecular basis of patho-
genesis from both the microbial and host perspectives. This has yielded exciting rapid advances in
understanding the basis of pathogenesis for several important infectious diseases. Insight into the mo-
lecular mechanisms of pathogenesis has predicted new ways to control infection, including the identi-
fication of novel targets for antimicrobials and novel approaches for vaccine develop-
ment. Nevertheless, many more questions remain unanswered and many pathogens
are still poorly understood. Understanding microbial pathogenesis demands a
detailed knowledge of the host response as well as the pathogen itself. Both of these
perspectives provide potential strategies for solving important clinical problems.
To elucidate these distinct aspects of microbial pathogenesis requires an interdis-
ciplinary approach, integrating the fields of microbiology, eukaryotic cell biology, and
immunology. To facilitate such interactions, the third meeting on Microbial
Pathogenesis and Host Response was planned to begin on September 12-16,2001.
Due to the events of September 11, the meeting was rescheduled for October 10-14.
Rescheduling the meeting on such short notice had a major impact on the meeting.
Many of the speakers and participants who had planned to attend in September were
unable to attend the meeting in October. Nevertheless, a revised program was rapid-
ly prepared and the rescheduled meeting was well attended. The revised program
included a Keynote Address by Ron Atlas, an international expert on bioterrorism, presented to an
overflow audience that included news media. The timeliness of the Keynote Address and the need for
new approaches to combat microbial pathogens was sadly highlighted by the distribution of anthrax
spores in the U.S. mail.
The meeting attracted a diverse group of international scientists who approach the study of bacte-
rial and fungal pathogens from a broad range of perspectives. Sessions focused on how genomic DNA
sequences and functional genomic approaches can be used to identify gene products involved in
pathogenesis; how environmental reservoirs of pathogens, genetic exchange between pathogens, and
P. Sundstrom
M. Neely
mutation allow pathogens to rapidly evolve new traits; how pathogens enter eukaryotic hosts; how
pathogens manipulate the host response; how the host responds to ward off infections (or sometimes
to inadvertently promote infections); and how recent insights into pathogenesis are being used to facil-
itate the development of novel antibiotics and vaccines. The talks and poster sessions generated live-
ly, interactive discussions. Many presentations describing the use of a new method to solve a complex
problem led to animated discourse about how the approach could be applied to answer recalcitrant
questions about other host-pathogen interactions. Some of these interactions have already produced
fruitful scientific collaborations. Despite the active scientific research on microbial pathogenesis and the
impressive progress in this field, it is clear that as one problem is solved, another microbial pathogen
will rapidly take its place. Hence, there will be a continual need for the free, interactive exchange of
ideas like that stimulated by this meeting.
This meeting was partially supported by funds from the National Institute of Allergy and Infectious
Diseases, the National Institute of Dental Research, branches of the National Institutes of Health, and
the U.S. Army. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate
Associates, Corporate Affiliates, Corporate Contributors, and Foundations also provided core support
for this meeting.
PROGRAM
Genomic Analysis of Pathogens
Chairperson: S. Maloy, University of Illinois, Urbana
Evolution of Pathogens
Chairperson: M. Neely, Wayne State University School of
Medicine, Detroit, Michigan
Adhesion and Entry
Chairperson: J. Puente, Universidad Nacional Autonoma de
Mexico
Export
Chairperson: R. DeVinney, University of Calgary Health Science
Center, Canada
Host Responses
Chairperson: B. Cookson, University of Washington, Seattle
Toxins
Chairperson: N. Freitag, Seattle Biomedical Research Institute,
Washington
Antibiotics and Vaccines
Chairperson: L. Miesel, Schering Plough Research Institute,
Kenilworth, New Jersey
Keynote Speaker
J.W. Murphy, University of Oklahoma Health Science Center,
Oklahoma City
Reservoirs of Pathogens in the Environment
Chairperson: P. Small, University of Tennessee, Knoxville
S. Maloy, J. Gogren, R. Taylor
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D. Lee, H. Winther-Larsen, J. Vogel
Programmed Cell Death
November 9-13 312 participants
ARRANGED BY Hermann Steller, HHMI/Massachusetts Institute of Technology
Craig Thompson, HHMI/University of Chicago
Eileen White, HHMI/Rutgers University
This fourth meeting on Programmed Cell Death, originally scheduled for September 19-23, was after
much discussion rescheduled for mid-November. As a result, a large proportion of senior session chairs
had to cancel, but the majority of presenters rearranged their schedules to attend, a testament to the
vitality of this meeting. The meeting included eight oral sessions and two poster sessions. The open-
ing Keynote Address was delivered by Gerry Adams of the Walter & Eliza Hall Institute of Medical
Research, Australia. In all, 312 international participants attended this fascinating forum on the current
state of apoptosis research, with much heated debate at posters, over meals, and in the bar.
This meeting was funded in part by the National Institute on Aging, the National Cancer Institute,
and the National Institute of Child Health and Human Development, branches of the National Institutes
of Health, and the National Science Foundation. Contributions from our Corporate Benefactors,
Corporate Sponsors, Plant Corporate Associates, Corporate Affiliates, Corporate Contributors, and
Foundations also provided core support for this meeting.
H. Steller, Y. Lazebnik, S. Larisch
C. Thompson, E. White, K. Tomaselli
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PROGRAM
Developmental Apoptosis
Chairpersons: H.R. Horvitz, Massachusetts Institute of
Technology Cambridge; B. Hay, California Institute of
Technology Pasadena
Keynote Speaker
S. Cory, Walter and Eliza Hall Institute of Medical Research,
Melboume, Australia
Animal Models
Chairpersons: J.M. Hardwick, Johns Hopkins University
Baltimore, Maryland; M. Lenardo, NIAID, National Institutes of
Health, Bethesda, Maryland
Mitochondria! Involvement in Apoptosis
Chairpersons: Y. Tsujimoto, Osaka University Graduate School
of Medicine, Japan; J. Reed, Burnham Institute, La Jolla,
California
BCL-2 Regulation
Chairpersons: S. Korsmeyer, Dana Farber Cancer Institute,
Harvard Medical School, Boston, Massachusetts; S.
Kornbluth, Duke University Medical Center, Durham, North
Carolina
Oncogenes/Tumor Suppressor Regulation of Apoptosis
Chairpersons: S. Lowe, Cold Spring Harbor Laboratory,
G. Evan, University of California Comprehensive Cancer
Center, San Francisco
Signal Transduction I
Chairperson: M. Greenberg, Children's Hospital, Harvard
Medical School, Boston, Massachusetts
Signal Transduction II
Chairperson: J. Yuan, Harvard Medical School, Boston,
Massachusetts
Caspase Activation/Inactivation
Chairpersons: X. Wang, University of Texas Southwestern
Medical Center, Dallas; D. Vaux, University of Oxford, United
Kingdom
M. Poukkula, S. Tran, P Peri
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. MacGregor, B. McConnell
BIOTECHNOLOGY CONFERENCE
Molecular Approaches to Vaccine Design
Nov. 29-Dec. 2 196 participants
ARRANGED BY Rafi Ahmed, Emory University School of Medicine
Dennis Burton, Scripps Institute
Emilio Emini, Merck Research Laboratories
This second winter biotechnology conference on Molecular Approaches to Vaccine Design emphasized
an understanding of the basic concepts underlying immune responses to infectious agents and how
this knowledge could be applied to design new and more effective vaccines. The meeting opened with
a fascinating introductory session entitled Perspectives in Vaccine Development, which included talks
by Gary Nabel (government), Alan Shaw (industry), Margaret Liu (private foundation), and Michael
Parker (vaccines and bioterrorism). Five platform sessions focused on HIV vaccine design; malaria vac-
cine design; viral immunity and vaccines; bacterial immunity and vaccines; and immunological memo-
ry. Despite the events of September 11, the meeting featured 56 scientific presentations in all, and
attracted more than 100 participants. The meeting proved to be a unique forum in which to discuss
how modern molecular and structural biology and immunology are beginning to contribute to an under-
standing of how vaccines work and how new vaccines can be designed.
This meeting was funded in part by the Chiron Corporation. Contributions from our Corporate
Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Affiliates, Corporate Contribu-
tors, and Foundations also provided core support for this meeting.
PROGRAM
Perspectives on Vaccine Development
USDA/Plum Island Animal Disease
Center, Greenport, New York
HIV Vaccine Design
Chairperson: J. Moore, Cornell University Weill Medical College,
New York
Malaria Vaccine Design
Chairperson: L. Miller, NIAID, National Institutes of Health,
Bethesda, Maryland
Viral Immunity and Vaccines
Chairperson: E. Emini, Merck Research Laboratories, West
Point, Pennsylvania
Bacterial Immunity and Vaccines
Chairperson: D. Burton, Scripps Research Institute, La Jolla,
California
Immunological Memory
Chairperson: R. Ahmed, Emory University School of Medicine,
Atlanta, Georgia
E. Emini, R. Ahmed, D. Burton
P. Colman, L. Miller
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BIOTECHNOLOGY CONFERENCE
Physiological Genomics and Rat Models
December 5-8 125 participants
ARRANGED BY Howard Jacob, Medical College of Wisconsin
Douglas Vollrath, Stanford University School of Medicine
This second winter biotechnology conference on Physiological Genomics and Rat Models followed
from the successful inaugural meeting in December 1999. This conference series is the first to focus
exclusively on the rat as a model organism for biological research, and seeks to bring together the vast
body of research that continues to be generated in the area of rat physiology, pathophysiology, toxi-
cology, neuroscience, etc., with new genetic resources and genomic tools now being developed for
the rat. Topics at the meeting included Genomics: Rat Genome Project; Bioinformatics: Rat Genome
Database and Rat Map; Expression Profiling; Comparative Mapping: Radiation Hybrid Mapping;
Complex Trait Analysis: Statistical Analysis and High Throughput Phenotyping; Model Systems:
Autoimmunity, Behavior, Diabetes, Retinal Degeneration/Gene Therapy, Cancer, Obesity, Heart
Disease; Transgenics: Cardiovascular Models, Cancer Models, Rat Transgenic Model for AIDS, Nuclear
Transfer, Embryonic Stem Cells; Pharmacogenomics/Risk Assessment: Drugs of Addiction, Ethanol,
and Obesity. The meeting also included a special workshop on DNA microarrays and a special pre-
meeting on Physiological Genomics: From Phenotype to Genotype and Back Again. Invited speakers
included John Critzer, Richard Gibbs, Michael Gould, Goran Levan, Norman Lee, Barry Levin, Mike
Menaker, Alan Pack, Eddy Rubin, Jacqueline Schien, and Peter Tonellato. In all, the meeting featured
91 scientific presentations and attracted 125 participants from around the world.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Affiliates, Corporate Contributors, and Foundations provided core support for this meeting.
D. Vollrath, H. Jacob
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PROGRAM
Functional Genomics
Chairpersons: H. Jacob, Medical College of Wisconsin,
Milwaukee; D. Vollrath, Stanford University School of
Medicine, California
Bioinformatics
Chairpersons: F. Stahl, Goteborg University Germany; M.
Lundberg, NHBLI, National Institutes of Health, Bethesda,
Maryland
Models I
Chairpersons: E. Blankenhorn, MCP Hahnemann University,
Philadelphia, Pennsylvania; M. Menaker, University of Virginia,
Charlottesville
Models II
Chairpersons: L. Carr, Indiana University School of Medicine,
Indianapolis; M. Gould, University of Wisconsin, Madison
Genomic Resources and Tools
Chairperson: B. Rail, National Institutes of Health, Bethesda,
Maryland
Models III
Chairpersons: J. Rapp, Medical College of Ohio, Toledo; S.
Mockrin, NHLBI, National Institutes of Health, Bethesda,
Maryland
Microarray Minicourse and Expression Study Examples
Chairpersons: N. Lee, The Institute for Genomic Research,
Rockville, Maryland; P. Tonellato, Medical College of
Wisconsin, Milwaukee
Sequencing
Chairpersons: J. Peterson, NHGRI, National Institutes of Health,
Bethesda, Maryland; R. Gibbs, Baylor College of Medicine,
Houston, Texas
Models IV
Chairpersons: A. Pack, University of Pennsylvania, Philadelphia;
H. Markholst, Hagedorn Research Institute, Gentofte,
Denmark
D. Vollrath, M. Menaker, D. Stewart
A. Provoost, D. Brown
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that they are not
adequately treated by universities. Our aim is to provide intensive study in the most recent develop-
ments and techniques in these subjects and to prepare students to enter directly into research in a par-
ticular area. To ensure up-to-date coverage of current research work, we bring together course faculty
from many laboratories around the world and supplement this staff with a series of seminar speakers.
Advanced Genome Sequence Analysis
March 14-27
INSTRUCTORS E. Mardis, Washington University School of Medicine, St. Louis, Missouri
W.R. McCombie, Cold Spring Harbor Laboratory
J. McPherson, Washington University School of Medicine, St. Louis, Missouri
T. Wood, Bryan College, Dayton, Tennessee
ASSISTANTS
A. Bahret, Cold Spring Harbor Laboratory
V. Balija, Cold Spring Harbor Laboratory
M. De la Bastide, Cold Spring Harbor Laboratory
L. Gnoj, Cold Spring Harbor Laboratory
L. King, Cold Spring Harbor Laboratory
K. Kirchoff, Cold Spring Harbor Laboratory
B. Miller, Cold Spring Harbor Laboratory
C. Nusbaum, Whitehead Institute/MIT, Cambridge,
Massachusetts
A. O'Shaughnessy, Cold Spring Harbor Laboratory
L. Palmer, Cold Spring Harbor Laboratory
T. Rohlfing, Washington University School of Medicine,
St. Louis, Missouri
L. Spiegel, Cold Spring Harbor Laboratory
T. Zutavern, Cold Spring Harbor Laboratory
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This course focused on obtaining and analyzing genomic DNA sequence data and on large-scale
sequencing, presenting students with important information on the technical and project management
aspects of genomic DNA sequencing projects as well as the computational analysis of the sequence.
This was achieved by carrying out a large-scale sequencing project during the class, with a special
emphasis on the technical nuances of large-scale sequencing. Increases in sequencing efficiency now
permit us to carry out the production phase of the student's sequencing project in less time. As a result,
the course increased its emphasis on two areas: the finishing process and the analysis of DNA
sequence (both computational and experimental). Last year's course included a module on sequence-
based polymorphism analysis. This year, the course expanded the polymorphism analysis to include
sequencing of regions from multiple individuals and additional SNP analysis. This curriculum allowed
students to learn advanced techniques and principles of genomic DNA sequence analysis, from data
generation to analysis of sequence variations in populations.
PARTICIPANTS
Bacanamwo, M., B.S., Ph.D., University of Missouri, Columbia
Chen, E., M.D., Ph.D., Morehouse School of Medicine, Atlanta,
Georgia
Dudley, P., B.S., Ph.D., National Eye Institute, NIH, Bethesda,
Maryland
Glazier, A., B.Sc., Ph.D., MRC Clinical Sciences Centre,
London, United Kingdom
Grimsley, C., M.S., Ph.D., University of Chicago, Illinois
Kim, H.R., B.S., M.S., Clemson University Genomics Institute,
Clemson, South Carolina
Lee, K., M.S., Ph.D., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Liu, T.-T., B.S., Ph.D., National Yang Ming University, Taipei,
Taiwan
SEMINARS
Altschuler, D., Whitehead/MGH/Harvard, Cambridge,
Massachusetts: SNPs: Associative.
Birney, E., Europe Bioinformatics Institute, Hinxton, United
Kingdom: Gene prediction.
Eichler, E., Case Western Reserve University, Cleveland, Ohio:
Segmental duplication of the human genome.
Lai, E., Glaxo-Wellcome, Reseach Triangle Park, North
Carolina: SNPs: Pharmacogenetics.
Martienssen, R., Cold Spring Harbor Laboratory: Functional
genomics in Arabidopsis thaliana.
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Munro, M., B.Sc., Ph.D., University of Leicester, United Kingdom
Parimoo, S., B.S., M.S., Ph.D., Johnson & Johnson, Skillman,
New Jersey
Riba, L., B.S., M.S., Biomedical Institute National University of
Mexico, Mexico City
Song, Q., Ph.D., Morehouse School of Medicine, Atlanta,
Georgia
Stankiewicz, R., B.S., Ph.D., United States Department of
Agriculture, Stoneville, Mississippi
Walsh, E., B.S., Ph.D., University of Texas, El Paso, Texas
Wil lour, V., B.S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Xu, P., B.S., Ph.D., Virginia Commonwealth University,
Richmond, Virginia
McKernan, K., Whitehead Institute/MIT Center for Genome
Research, Cambridge, Massachusetts: High-throughout
automation for genome sequencing.
Metzker, M., Baylor College of Medicine, Houston, Texas:
Sequencing technologies.
Stein, L., Cold Spring Harbor Laboratory: Worm Base.
Watson, J., Cold Spring Harbor Laboratory: Overview and his-
tory.
Wilson, R., Washington University, St. Lobs, Missouri: Human
Genome Project.
Protein Purification and Characterization
April 18-May 1
INSTRUCTORS R. Burgess, University of Wisconsin, Madison
A. County, University of California, Los Angeles
S.-H. Lin, University of Texas, Houston
K. Severinov, Waksman Institute, Rutgers University, Piscataway, New Jersey
ASSISTANTS L Anthony, University of Wisconsin, Madison
V. Bhaskar, University of California, Los Angeles
K. Earley, M.D. Anderson Cancer Center/University of Texas, Houston
F. Gharandaghi, Boehringer Ingelheim, Ridgefield, Connecticut
S. Jia, University of California, Los Angeles
A. Manogaran, Marquette University, Milwaukee, Wisconsin
D. Markov, Waksman Institute of Microbiology, Piscataway, New Jersey
S. Nechaev, Rutgers State University, Waksman Institute, Piscataway, New Jersey
N. Thompson, University of Wisconsin, Madison
This course was intended for scientists who are not familiar with techniques of protein isolation and
characterization. It was a rigorous program that included laboratory work all day and a lecture with a
discussion session every evening. Each student became familiar with each of the major techniques in
protein purification by actually performing four separate isolations including (1) a regulatory protein from
muscle tissue; (1) a sequence-specific, DNA-binding protein; (3) a recombinant protein overexpressed
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in E. coli; and (4) a membrane-bound receptor. A variety of bulk fractionation, electrophoretic, and
chromatographic techniques were employed including precipitation by salts, pH, and ionic polymers;
ion exchange, gel filtration, hydrophobic interaction, and reversed-phase chromatography; lectin affin-
ity, ligand affinity, oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel elec-
trophoresis, and electroblotting; and high-performance liquid chromatography. Procedures were pre-
sented for solubilizing proteins from inclusion bodies and refolding them into active monomeric forms.
Methods of protein characterization were utilized, including immunological and biochemical assays,
protein-protein interaction studies by far-western analysis, peptide mapping, amino acid analysis, pro-
tein sequencing, and mass spectrometry. Emphasis was placed on strategies of protein purification
and characterization. Guest lecturers discussed protein structure, modification of proteins, methodolo-
gies for protein purification and characterization, and applications of protein biochemistry to cell and
molecular biology.
PARTICIPANTS
Barker, M., B.S., Ph.D., University of Wisconsin, Madison
Bertwistle, D., B.Sc., Ph.D., St. Jude Children's Research
Hospital, Memphis, Tennessee
Brodhagen, M., B.S., M.S., Oregon State University, Corvallis
Camacho Carvajal, M., B.S., Ph.D., Max-Planck Institute for
Immunology, Freiburg, Germany
Cuajungco, M., B.S., Ph.D., Harvard Medical School/MGH,
Boston, Massachusetts
Di Tullio, G., B.S., Ph.D., University of South Carolina, Charleston
Godoy, V, Ph.D., Massachusetts Institute of Technology,
Cambridge
SEMINARS
Burgess, R., University of Wisconsin, Madison: Overview of pro-
tein purification, immunoaffinity purification.
Burgess, R., University of Wisconsin, Madison: Biochemical
studies of RNA polymerase /o factor interactions.
Courey, A., University of California, Los Angeles: Mechanisms of
activation and repression by the dorsal morphogen.
Fenyo, D., President, ProteoMetrics, New York: Mass spec-
trometry and the proteome/automatic analysis of proteomic
information.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Proteins in 3-D.
Lesley, S., Genomics Institute of the Novartis Foundation, La
Jolla, California: High through-put protein expression, purifica-
tion, and crystallization.
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Karpf, A., B.S., Ph.D., University of Utah, Salt Lake City
Naested, H., B.S., M.S., Copenhagen University, Denmark
Preiss, J., B.A., Ph.D., Fred Hutchinson Cancer Research
Center, Seattle, Washington
Saito, M., B.A., Ph.D., Princeton University, New Jersey
Stefani, G., M.D., The Rockefeller University, New York
Tachedjian, G., B.S., Ph.D., Columbia University, New York
Verlade, J., B.S., Ph.D., University of Maryland, Baltimore
Wang, X., B.S., Ph.D., National Institute of Environmental
Health Sciences, Research Triangle Park, North Carolina
Wilson, B., B.S., Ph.D., Jackson State University, Mississippi
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas:
Regulation of angiogenesis by C-CAM tumor suppressor/
isolation of bone-response factors in advanced prostrate
cancer.
Segal, D., Scripps Research Institute, La Jolla, California: Novel
zinc finger proteins for the therapeutic regulation and modifi-
cation of genomes.
Severinov, K., Waksman Institute, Rutgers, Piscataway, New
Jersey: Viral proteins that inhibit host RNA polymerase func-
tion.
Stillman, B., Director, Cold Spring Harbor Laboratory: Biochem-
ical approach for understanding chromosome inheritance.
Cell and Developmental Biology of Xenopus
April 21-May 1
INSTRUCTORS K. Cho, University of California, Irvine
J. Christian, Oregon Health Sciences, Portland
ASSISTANTS I. Blitz, University of California, Irvine
N. Hirsh, University of Virginia, Charlottesville
M. Yuge, Fukuoka Women's University, Fukuoka, Japan
The frog Xenopus is an important vertebrate model for studies of maternal factors, regulation and mol-
ecular mechanisms of tissue inductions, and regulation of cell fate decisions. In addition, Xenopus
oocytes and embryos provide a powerful system in which to conduct a number of cell biological and
gene regulation assays. This course provided extensive laboratory exposure to the biology, manipula-
tion, and use of oocytes and embryos of Xenopus. The course consisted of intensive laboratoryses-
sions, supplemented by daily lectures and demonstrations from experts in cellular, experimental, and
molecular development. Areas covered included (1) care of adults; (2) oocyte isolation and embryopro-
duction; (3) stages of embryonic development and anatomy; (4) whole-mount in situ hybridization and
immunocytochemistry; (5) microinjection of eggs and oocytes with lineage tracers, DNA constructs,
mRNA, and antisense oligonucleotides; (6) micromanipulation of embryos, including explant and trans-
plantation assays; (7) preparation of transgenic embryos; and (8) use of Xenopus tropicalis for genetic
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analyses. This course was suited both for investigators who had no experience with Xenopus and for
those who work with Xenopus and wish to learn new and cutting edge techniques. All applicants had
current training in molecular biology and some knowledge of developmental biology. The 2001 course
guest lecturers were Robert Grainger (University of Virginia, Charlottesville), Janet Heasman (Children's
Hospital Medical Center, Cincinnati, Ohio), Raymond Keller (University of Virginia, Charlottesville),
Kristen Kroll (Washington University School of Medicine, St. Louis, Missouri), Sally Moody (George
Washington University Medical Center, Washington, D.C.), Randall Moon (University of Washington,
Seattle), Jonathan Slack (University of Bath, Bath, United Kingdom).
PARTICIPANTS
Brugmann, S., B.S., Ph.D., The George Washington University,
Washington, D.C.
Coleman, T., B.A., Ph.D., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Costa, R., Ph.D., Wellcome/CRC Institute, Cambridge, United
Kingdom
Deignan, K., B.Sc., Ph.D., University College Dublin, Ireland
Deroo, T., B.S., Ph.D., University of Ghent, Belgium
Kaelin, R., B.S., Swiss Federal Institute of Technology, Zurich,
Switzerland
Larrain, J., B.S., Ph.D., University of California, Los Angeles
Lee, M., B.S., Hong Kong University of Science and Technology,
Clearwater Bay, Hong Kong
SEMINARS
Cho, K., University of California, Irvine: DNA microarray analy-
ses in Xenopus.
Christian, J., Oregon Health Sciences University, Portland:
Cross-talk between CaM KIV and BMP pathways regulates
survival and lineage commitment of hematopoietic progeni-
tors.
Grainger, R., University of Virginia, Charlottesville: Xenopus tropi-
calis: A new model for vertebrate developmental genetics.
Heasman, J., Children's Hospital Medical Center, Cincinnati,
Ohio: Maternal control of embryonic patterning: loss of func-
tion approaches.
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Lindsay, H., B.Sc., University of Sussex, Brighton, United
Kingdom
Novo, D., B.S., Ph.D., University of California, Los Angeles
Psychoyos, D., B.Sc., Ph.D., The Salk Institute, La Jolla,
California
Ruzov, A., Ph.D., Institute of Gene Biology, Moscow, Russia
Schweickert, A., B.S., Ph.D., Institute of Toxicology and
Genetics, Karlsruhe, Germany
Simon, K., M.S., Universitatsklinikum Essen, Germany
Tseng, H.-T, B.S., Ph.D., Baylor College of Medicine, Houston,
Texas
Wong, L., B.S., Ph.D., University of California, San Diego
Wu, C., B.S., Washington University, St. Louis, Missouri
Keller, R., University of Virginia, Charlottesville: Early Xenopus
morphogenic movements.
Kroll, K., Washington University School of Medicine, St. Louis,
Missouri: Formation of the vertebrate neural plate.
Moody, S., George Washington University Medical Center,
Washington, D.C.: Building the retina from scratch.
Moon, R., University of Washington, Seattle: How the
dorsoventral axis is specified by two distinct Wnt signaling
pathways.
Slack, J., University of Bath, United Kingdom: Studies on tail
development and limb regeneration.
Developmental Neurobiology
June 6-19
INSTRUCTORS B. Barres, Stanford Medical School, Stanford, California
S. Burden, New York University Medical Center, New York
H. Cline, Cold Spring Harbor Laboratory
The aim of this lecture course was to discuss principles and recent advances in developmental neuro-
biology. Major topics considered included determination, proliferation, and differentiation of neural cells;
trophic interactions in neural development; gradients and compartments; guidance of axons to targets;
and the formation of synapses. These topics were considered within the context of the development
of both invertebrate and vertebrate neural systems. Prospective students had a background in neuro-
biology or molecular biology.
PARTICIPANTS
Cayouette, M., B.S., Ph.D., University College London, United
Kingdom
Chrast, R., M.S., Ph.D., The Salk Institute, San Diego, California
De Silva, T, B.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Dino, M., B.S., Ph.D., Yale University, New Haven, Connecticut
Dugas, J., B.S., Ph.D., Stanford University, California
Freitas, A., B.S., Ph.D., Ludwig Institute for Cancer Research,
Sao Paulo, Mexico
Hammond, R., BA., Ph.D., King's College London,United
Kingdom
Hermanson, E., B.S., M.S., Ludwig Institute for Cancer
Research, Stockholm, Sweden
Hughes, C., BA., Ph.D., Indiana University, Bloomington
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Ireland, J., B.Sc., Ph.D., University of Cambridge, United
Kingdom
Jensen, J., B.A., Yale University, New Haven, Connecticut
Kaneshiro, K., B.S., University of Tokyo, Japan
Liu, L., B.S., Ph.D., Genomics Institute of the Novartis Research
Foundation, San Diego, California
Mc Ewen, a, B.A., University of Michigan, Ann Arbor
Page, D., B.S., MRC Laboratory of Molecular Biology, Cambridge,
United Kingdom
SEMINARS
Bargmann, C., Howard Hughes Medical Institute/University of
California, San Francisco: Neuronal diversification and neu-
ronal function in C. elegans.
Berg, D., University of California, San Diego, La Jolla: Synapse
formation on central and peripheral neurons. Calcium trans-
ients and gene regulation by nictinic receptors on somatic
spines.
Burden, S., New York University Medical Center, New York:
Neuromuscular synapse formation.
Dickson, B., IMP, Vienna, Austria: Wiring up the fly: Molecular
mechanisms of axon guidance in Drosophila.
Huang, J., Cold Spring Harbor Laboratory: GABAergic inhibito-
ry circuits and experience-dependent plasticity.
Jan, Y.N., HHMI/University of California, San Francisco:
Neuronal cell fate specification.
Jessell, T, Columbia University, New York: Spinal cord develop-
ment.
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Parmar, M., B.Sc., Lund University, Sweden
Shao, Y., B.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
VanSaun, M., B.S., Ph.D., University of Kansas Medical Center,
Kansas City
Vasconcelos, M.L., B.S., Ph.D., HHMI/University of California,
Los Angeles
Wilson, P., B.S., Ph.D., The Rockefeller University, New York
Kinter, C., The Salk Institute, La Jolla, California: Early steps
in vertebrate neural development.
Krumlauf, R., Stowers Institute for Medical Research, Kansas
City, Missouri: Patterning the hindbrain.
O'Leary, D., The Salk Institute, La Jolla, California
Scheiffele, P., University of California, Berkeley: Target
recognition and synapse formation in the cerebellar
system.
Shatz, C., Harvard Medical School, Boston, Massachusetts:
Role of neural activity in brain wiring during visual system
development.
Smith, S., Stanford University, California: Synaptogenic
contact events.
Stern, C., University College London, United Kingdom:
Molecular dissection of neural induction in the chick
embryo.
Advanced Bacterial Genetics
June 6-26
INSTRUCTORS K. Hughes, University of Washington, Seattle
H. Kaplan, University of Texas Medical School, Houston
K. Pogliano, University of California, San Diego, La Jolla
ASSISTANTS H. Bonifield, University of Washington, Seattle
A. Perez, University of California, San Diego, La Jolla
J. Rivera, University of Texas Medical School, Houston
This laboratory course presented logic and methods used in the genetic dissection of complex biolog-
ical processes in bacteria. The methods presented include mutagenesis using transposons, mutator
strains, and chemical and physical mutagens; mapping mutations using genetic and physical tech-
niques; generation and analysis of gene fusions; molecular cloning; polymerase chain reaction;
Southern blot analysis; epitope insertion mutagenesis; and site-directed mutagenesis. A key compo-
nent of the course was the use of sophisticated genetic methods in the analaysis of pathogenic and
"undomesticated" bacteria. Invited lecturers described the use of genetic aproaches to study biologi-
cal processes in a variety of bacteria.
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PARTICIPANTS
Berg, A.A., M.S., Stockholm University, Sweden
Ammendola, S., B.S., M.A., University of Rome, Italy
Carlsson, F., B.S., Ph.D., Lund University, Sweden
Deng, S., B.A., Ph.D., University of Alabama, Birmingham
El Amin, N., M.D., Karolinska Institute, Huddinge, Sweden
Fleckenstein, J., B.S., M.D., University of Tennessee, Memphis
Illingworth, R., B.Sc., Ph.D., AstraZeneca R&D Boston,
Waltham, Massachusetts
Karlsson, A., B.S., M.S., Karolinska Institutet, Stockholm,
Sweden
Karlsson, S., M.Sc., Karolinska Institutet, Stockholm, Sweden
SEMINARS
Beckwith, J., Harvard University, Cambridge, Massachusetts:
Casacades of thiol/disulfide exchange reactions in E. coli
redox pathways.
Botstein, D., Stanford University School of Medicine, California:
Microarray analysis of the yeast genome.
Hatzell, P., University of Idaho, Moscow: Control of differentia-
tion and cell cycle progression in Caulobacter crescentus.
Hofmeister, A., University of California, Berkeley: Chromosomal
position-dependent temporal control of a sporulation tran-
scription factor.
Jacobs, C., Yale University, New Haven, Connecticut: Control
of differentiation and cell cycle progression in Caulobacter
crescentus.
Kaiser, D., Stanford University School of Medicine, California:
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Komarova, A., B.S., Ph.D., Russian Academy of Science,
Moscow, Russia
Magnusson, L., M.S., Goteborg University, Sweden
Mathew, S., B.S., Ph.D., Novartis Pharmaceutical Corporation,
Summit, New Jersey
Mattison, K., B.S., Oregon Health Sciences University,
Portland
Mylonakis, E., Ph.D., Massachusetts General Hospital, Boston
Pena, J.R., B.S., M.S., Massachusetts General Hospital,
Boston
Stefan, A., B.S., Ph.D., University of Bologna, Italy
The social intelligence of Myxobacteria.
Losick, R., Harvard University, Cambridge, Massachusetts:
Asymmetric division and cell fate.
Maloy, S., University of Illinois, Urbana: Genetic barriers that
limit exchange between closely related bacteria.
Roth, J., University of Utah, Salt Lake City: Adaptive mutagene-
sis: Growth under selection explains the miracles of adapative
mutation and temporary hypermutability.
Silhavy, T, Princeton University, New Jersey: Coping with enve-
lope stress.
Willey, J., Hofstra University, Hempstead, New York: Morpho-
logical differentiation in the filamentous bacterium Strepto-
myces coelicolor.
Molecular Embryology of the Mouse
June 6-26
INSTRUCTORS S.-L. Ang, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Strasbourg, France
A. Goss ler, Institut fur Molekularbiologie, Hannover, Germany
CO-INSTRUCTORS T. Lufkin, Mount Sinai School of Medicine, New York
C. Stewart, National Cancer Institute/FCRDC, Frederick, Maryland
ASSISTANTS G. Mellitzer, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Strasbourg, France
K. Schuster-Gossler, Institut fur Molekularbiologie, Hannover, Germany
This intensive laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse embryonic development. Laboratory components provided an intro-
duction into the technical aspects of working with and analyzing mouse embryos, and lectures provid-
ed the conceptual basis for contemporary research in mouse development. Experimental techniques
that were covered in the practicals included in vitro culture and manipulation of pre- and postimplan-
tation embryos, transgenesis by DNA microinjection, embryo transfer, establishment, culture, and
genetic manipulation of embryonic stem cells, production of chimeras by aggregation with and injec-
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tion of embryonic stem cells, and the analysis of development by whole-mount in situ hybridization,
skeletal preparation, and transgene expression. Last year's speakers were Arturo Alvarez-Buylia, Ang
Siew-Lan, Marisa Bartholomei, Richard Behringer, Charles Emerson, Richard Gardner, Achim Goss ler,
Tom Gridley, Francois Guillemot, Brigid Hogan, Tom Jessell, Alex Joyner, Robin Lovell-Badge, Tom
Lufkin, Gail Martin, Anne McLaren, Andras Nagy, Janet Rossant, John Schimenti, Michael Shen, Austin
Smith, Davor Solter, Colin Stewart, and Patrick Tam.
PARTICIPANTS
Basson, M., Ph.D., Mount Sinai School of Medicine, New York
Billon, N., Ph.D., MRC/MCB, London, United Kingdom
Branda, C., B.A., Ph.D., Harvard Medical School, Boston,
Massachusetts
Dawson, K., B.Sc., Ottawa Hospital Research Institute, Canada
Dodge, J., BA., M.S., University of Vermont, Burlington
Gidekel, S., M.S., Ph.D., The Hebrew University-Hadassah
Medical School, Jerusalem, Israel
Harboe, T., B.Sc., M.Sc., University of Copenhagen, Denmark
Huh, G., B.Sc., Ph.D., Harvard Medical School, Boston,
SEMINARS
Alvarez-Buylia, A., University of California, San Francisco:
Unified hypothesis of neural stem cell origin.
Ang, S.-L., IGBMC, Strasbourg, France: Anterior-posterior pat-
terning of the mouse embryo.
Bartholomei, M., University of Pennsylvania School of Medicine,
Philadelphia: Regulation of genomic imprinting.
Behringer, R., University of Texas/M.D. Anderson Cancer
Center, Houston: Transgenesis.
Emerson, C., University of Pennsylvania, Philadelphia: Signaling
and transcriptional mechanisms controlling skeletal myogenesis.
Gardner, R., University of Oxford, United Kingdom: Analysis of
cell lineage and pattern formation in early mouse develop-
ment.
Goss ler, A., Institut fur Molekularbiologie, Hannover, Germany:
Somitogenesis.
Gridley, T, The Jackson Laboratory, Bar Harbor, Maine: Notch
signaling in development and disease.
Guillemot, F., IGBMC, France: Proneural genes and the regula-
tion of neurogenesis.
Hogan, B., Vanderbilt University Medical Center/HHMI,
Nashville, Tennessee: BMP signaling, Forkhead genes, and
morphogenesis.
Jesse II, T., Columbia University, New York: Regionalization and
neuronal specification in the spinal cord.
Joyner, A., New York Medical Center/Skirball Institute of
Biology, New York: Organizing regions play critical roles in
patterning of the neural tube.
Lovell-Badge, R., MRC National Institute for Medical Research,
London, United Kingdom: Sox genes and cell fate decision.
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Massachusetts
Jacquemin, P., B.Sc., Ph.D., Universite Catholique de Louvain,
Brussels, Belgium
Kim, S., B.S., M.S., University of Minnesota, Minneapolis
Meletis, K., M.Sc., Karolinska Institutet, Stockholm, Sweden
Reddy, S., B.S., Ph.D., University of Pennsylvania, Philadelphia
Rodrigo-Blomqvist, S., M.Sc., Ph.D., Goteborg University,
Sweden
Zhang, M., B.S., Ph.D., Baylor College of Medicine, Houston,
Texas
Sex determination.
Lufkin, T., Mount Sinai School of Medicine, New York:
Homeobox genes and embryonic patterning.
Martin, G., University of California, San Francisco: Genetic
approaches to studying the function of FGF signaling in
embryonic development.
McLaren, A., Wellcome/CRC Institute, Cambridge, United
Kingdom: Germ cells.
Nagy, A., Mount Sinai Hospital, Toronto, Canada: Chimeras
and mosaics for dissecting complex phenotypes of induced
mutations.
Rossant, J., Samuel Lunenfeld Research Institute, Toronto,
Canada: Development of extraembryonic lineages.
Schimenti, J., The Jackson Laboratory, Bar Harbor, Maine:
Mouse genetics (Part 1). Mouse genetics (Part II).
Shen, M., UMNDJ-Robert Wood Johns Medical School,
Piscataway, New Jersey: Molecular pathway for left-right
axis specification.
Smith, A., University of Edinburgh, United Kingdom: Embryonic
stem cells: Pluripotency and differentiation.
Solter, D., Max-Planck Institut fOr Immunobiologie, Freiburg,
Germany: Control of gene expression during oocyte to
embryo transition: Reprogramming and cloning.
Stewart, C., NCI-FCRDC, Frederick, Maryland: Signaling during
embryo implantation and early postimplantation development.
Genome engineering using site-specific and homologous
recombination.
Tam, P., Childen's Medical Research Institute, Australia:
Establishment of tissue patterns during embryogenesis.
Phyiological Approaches to Ion Channel Biology
June 6-26
INSTRUCTORS R. Heidelberger, University of Texas Houston Medical School, Houston
T. Otis, University of California, Los Angeles
N. Spruston, Northwestern University, Evanston, Illinois
L. Trussell, Oregon Health Sciences University, Portland
ASSISTANTS J. Dzubay, Oregon Health Sciences University, Portland
A. Klug, Oregon Health Sciences University, Portland
This intensive laboratory/lecture course introduced students to electrophysiological approaches for the
study of ion channels in their native environments. Hands-on exercises included patch-clamp record-
ing of ion channel activity in acutely isolated or cultured cells or neurons in brain slice preparations.
Different recording configurations (e.g., extracellular, whole-cell, cell-free patches, and single channel)
were used. The advantages and disadvantages of each method and preparation were considered in
order to match experimental approaches to scientific questions. Similarly, various methods for lig-
and/drug application were demonstrated. A primary goal was to identify properties of ion channels that
allow neurons to carry out their unique physiological or systems-level roles. These properties were relat-
ed to information previously gained from molecular cloning and heterologous expression of ion chan-
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nel genes. Areas of particular interest included channels that (1) were activated by the neurotransmit-
ter at central and peripheral synapses, (2) interacted with other channels to shape the response prop-
erties of neurons, (3) respond to neuromodulators with changes in functional properties, or (4) were
developmentally required and regulated. The research interests of guest lecturers complemented and
expanded this list. This course was intended for students with specific plans in applying these tech-
niques to a defined problem. Guest speakers included Chinfei Chen, Steve De Vries, Paul Fuchs,
Michael Hausser, Ruth Heidelberger, Dick Horn, John Huguenard, Lori Isom, Wu Ling-Gang, Roberto
Malinow, Tom Otis, Indira Raman, Angie Ribera, Nelson Spruston, and Larry Trussell.
PARTICIPANTS
Al-Hallaq, R., B.A., Ph.D., Georgetown University Medical
Center, Washington, D.C.
Asamoah, 0., B.A., University of California School of Medicine,
Los Angeles
Burger, R.M., B.A., Ph.D., University of Washington, Seattle
Calakos, N., B.S., Ph.D., Stanford University, Palo Alto,
California
Davis, T., B.S., University of Michigan, Ann Arbor
Dean, C., B.S., University of California, Berkeley
SEMINARS
Chen, C., Harvard Medical School, Boston, Massachusetts:
Synaptic transmission at retinogeniculate synapses.
De Vries, S., University of Texas, Houston Health Science
Center: Synaptic transmission in the retina.
Fuchs, P., Johns Hopkins University Medical School, Baltimore,
Maryland: Auditory hair cells.
Hausser, M., University College London, United Kingdom:
Dendritic coincidence detection.
Heidelberger, R., University of Texas, Houston Medical School:
Synaptic transmission in the retina.
Horn, D., Jefferson Medical College, Philadelphia, Pennsylvania:
Ion channel gating.
Huguenard, J., Stanford University Medical School, California:
Differential ion channel expression: Cellular and circuit conse-
quences.
Isom, L., University of Michigan School of Medicine, Ann Arbor:
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Fall, C., B.S., Ph.D., New York University, New York
Gael, H., B.S., M.S., Swiss Federal Institute of Technology,
Zurich, Switzerland
Ji, Q., M.D., Wyeth-Ayerst Research, Monmouth Jct., New
Jersey
Kelliher, K., B.S., Ph.D., University of Maryland, Baltimore
Muschol, M., B.A., Ph.D., University of Pennsylvania,
Philadelphia
Palfreyman, M., B.S., B.A., University of Utah, Salt Lake City
Accessory subunits and Na' channel function.
Ling-Gang, W., Washington University, St. Louis, Missouri:
Presynaptic terminal physiology.
Malinow, R., Cold Spring Harbor Laboratory: LTP.
Otis, T., University of California, Los Angeles: Glutamate trans-
port and excitatory synaptic signaling.
Raman, I., Northwestern University, Evanston, Illinois: Ionic
mechanisms of spontaneous activity of central neurons.
Ribera, A., University of Colorado, Denver: Ion channel function
in zebrafish behavioral mutants.
Spruston, N., Northwestern University, Evanston, Illinois:
Dendritic excitability in CA1 pyramidal neurons. Action poten-
tial bursting in hippocampal pyramidal neurons.
Trussell, L., Oregon Health Sciences University, Portland:
Presynaptic modulation by ionotropic receptors.
DNA Microarrays
June 19-26
INSTRUCTORS J. DeRisi, University of California, San Francisco
V. lyer, University of Texas, Austin
ASSISTANTS T. Basarsky, Axon Instruments, Union City, California
A. Carroll, University of California, San Francisco
M. Diehn, Stanford University School of Medicine, California
J. Gerton, University of California, San Francisco
M. Llinas, University of California, San Francisco
B. Pulliam, University of California, San Francisco
C. Seidel, University of California, Berkeley
D. Wang, University of California, San Francisco
A DNA microarray is a simple, inexpensive and versatile tool for experimental explorations of genome
structure, gene expression programs, gene function, and cell and organismal biology. In this hands-on
course, students were guided through the process of building a robot for printing DNA microarrays,
preparing DNA samples and slides to be used for printing microarrays, printing DNA microarrays,
designing and conducting experiments for analysis by DNA microarray hybridization, data analysis, dis-
play, and interpretation. Experimental applications covered in the course included systematic studies
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of global gene expression programs, inferring gene function using microarrays, genotyping, and mea-
suring changes in gene copy number. Students who completed this course were able to set up their
own independent facility for printing and experimental use of DNA microarrays. Guest lecturers pre-
sented the state of the art in new technology, experimental applications, and interpretation of large
genomic data sets.
PARTICIPANTS
Bonds, W., B.S., Ph.D., Yale University School of Medicine,
New Haven, Connecticut
Burchett, S., B.S., Ph.D., Yale University School of Medicine,
New Haven, Connecticut
Chowdhary, B., Ph.D., Texas A&M University, College
Station
Gopas, J., B.Sc., Ph.D., Ben Gurion University, Beer-Sheva,
Israel
Lear, T., B.A., Ph.D., University of Kentucky, Lexington
Legare, D., B.S., Ph.D., Centre de Recherche en Infect° 'ogle,
Quebec, Canada
Lopes, U., B.S., Ph.D., Universidade Federal do Rio de Janeiro,
Rio de Janeiro, Brazil
Manduchi, E., B.S., Ph.D., Penn Center for Bioinformatics,
Philadelphia, Pennsylvania
Melake-Berhan, A., B.S., Ph.D., International Institute of
Tropical Agriculture, Croydon, United Kingdom
SEMINARS
Basarsky, T., Axon Instruments, Union City, California: Practical
and technical considerations when scanning microarrays.
Berka, R., Novozymes Biotech, Inc., Davis, California:
Microarray analysis of the Bacillus subtilis competence
regulation.
Botstein, D., Stanford University School of Medicine, California:
Genome-wide gene expression in cancer.
Brown, P., Stanford University, California: Using microarrays to
explore human physiology and disease.
DeRisi, J., University of California, San Francisco: Progress
update.
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Melville, K., B.S., National Research Council of Canada, Nova
Scotia
Ott, I., B.S., M.D., Deutsches Herzzentrum Munchen,
Germany
Rabinowicz, P., B.S., M.S., Ph.D., Cold Spring Harbor Laboratory
Robinson, K., B.S., Ph.D., North Carolina State University,
Raleigh
Rogers, A., B.Sc., Ph.D., University of Southampton, United
Kingdom
Sims, T., B.S., Ph.D., Northern Illinois University, De Kalb
Smith, E., B.S., M.S., Virginia Tech., Blacksburg
Teng Teng, L., M.S., Ph.D., University of Alabama, Birmingham
Wagner, F., Ph.D., Free University Berlin, Germany
Wilson, R., Ph.D., Washington University School of Medicine,
St. Louis, Missouri
Zack, D., Ph.D., Johns Hopkins University School of Medicine,
Baltimore, Maryland
Diaz, E., University of California, Berkeley: Spatial and temporal
maps of gene expression in the developing nervous system.
Fero, M., Stanford University, California: Low-cost cDNA
microarrays: The core facility approach.
Li, H., University of California, San Francisco: Building a
dictionary for DNA: Decoding the regulatory regions of a
genome.
O'Shea, E., University of California, San Francisco: Signaling
phosphate starvation.
Pulliam, B., University of California, San Francisco: NOMAD-A
microarray database.
Structure, Function, and Development of the Visual System
June 22-July 5
INSTRUCTORS K. McAllister, University of California, Davis
W.M. Usrey, University of California, Davis
This lecture/discussion course explored the functional organization and development of the visual sys-
tem as revealed by the use of a variety of anatomical, physiological, and behavioral methods. It was
designed for graduate students and more advanced researchers who wished to gain a basic under-
standing of the biological basis for vision and to share in the excitement of the latest developments in
this field. Topics included phototransduction and neural processing in the retina; functional architecture
of striate cortex; cellular basis of cortical receptive field properties; the anatomy, physiology, and per-
ceptual significance of parallel pathways; functional parcellation of extrastriate cortex; the role of pat-
terned neuronal activity in the development of central visual pathways; and molecular mechanisms of
development and plasticity in the visual system.
PARTICIPANTS
Alitto, H., B.S., University of California, Davis
Basole, A, B.Sc., M.Sc., Duke University Medical Center,
Durham, North Carolina
Biederlack, J., Diplom., Max-Planck Institute for Brain,
Frankfurt, Germany
Cancedda, L., B.S., Scuola Norma le Superiore, Pisa, Italy
Carroll, J., B.S., Medical College of Wisconsin, Milwaukee
Chien, S.H.-L., B.S., M.S., Ph.D., University of Washington,
Seattle
Firth, S., B. Pharm, B.Sc., University of Texas, Houston
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Harness, P., B.S., University of California, Davis
Hosoya, T., Ph.D., Harvard University, Cambridge,
Massachusetts
Huberman, A., B.A., M.S., University of California, Davis
Hunter, C., Ph.D., National Institutes of Health, Bethesda,
Maryland
Kaldy, Z., M.A., M.S., Rutgers University, Piscataway, New
Jersey
Liu, C.-H., B.S., M.S., Brown University, Providence, Rhode
Island
SEMINARS
Bonhoeffer, T., Max-Planck Institute of Neurobiology, Muenchen-
Martinsried, Germany: Spatial relationships among three
columnar systems in cat area 17.
Britten, K., University of California, Davis: Neural mechanisms
for processing of optic flow.
Chapman, B., University of California, Davis: How the visual
system got its stripes.
Cline, H., Cold Spring Harbor Laboratory: Cellular mechanisms
of visual system development II.
Constantine-Paton, M., Yale University, New Haven, Connecticut:
Cellular mechanisms of visual system development I.
Dacey, D., University of Washington, Seattle: Parallel pathways
for spectral coding in primate retina.
Feller, M., University of California, San Diego: Retinal waves and
neural development.
Fitzpatrick, D., Duke University, Durham, North Carolina:
Functional properties of neural circuits in the visual system.
Hubei, D., Harvard Medical School, Boston, Massachusetts:
Functional architecture of macaque monkey visual cortex.
Katz, L., Duke University Medical Center/HHMI, Durham, North
Carolina: What's critical for the critical period in visual cortex?
Martin, K., University ETH Zurich, Switzerland: From single cells
to simple circuits in the cerebral cortex.
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McKay, S., B.Sc., M.Sc., University of Oxford, United
Kingdom
Montoro, R., B.S., Ph.D., Columbia University, New York
Saunoriute Kerbeliene, S., B.S., M.S., Vilnius University,
Lithuania
Schmid, A., Diplom., ETH Zurich, Switzerland
Sigala, N., B.S., M.S., Max-Planck Institute for Biological
Cybernetics, Tuebingen, Germany
Slutsky, D., B.S., University of California, Davis
Wong, E., B.S., University of Houston, Texas
Masland, D., Harvard University/MGH, Boston, Massachusetts:
Neuronal diversity in the retina.
McAllister, K., University of California, Davis: Neurotrophins
and visual cortex development.
Movshon, T., New York University, New York: Behavioral
choice and the visual responses of neurons in macaque
MT.
Paradiso, M., Brown University, Providence, Rhode Island:
Neural correlates of brightness perception.
Reynolds, J., The Salk Institute, San Diego, California: The
effects of attention on visual processing.
Roelfsema, P., University of Amsterdam, The Netherlands:
Object-based attention in the primary visual cortex of the
macaque monkey.
Schnapf, J., University of California, San Francisco: Functional
properties of vertebrate photoreceptors.
Shad len, M., University of Washington, Seattle: Neural
mechanisms that underlie decisions about sensory
stimuli.
Sherman, M., University of Oxford, United Kingdom: The func-
tional organization of thalamocortical relays.
Usrey, M., University of California, Davis: Functional properties
of neural circuits in the visual system.
Arabidopsis Molecular Genetics
June 29-July 19
INSTRUCTORS J. Bowman, University of California, Davis
U. Grossniklaus, University of Zurich, Switzerland
R. Puritt, Purdue University, West Lafayette, Indiana
ASSISTANTS S. Floyd, University of California, Davis
D. Schurmann, Friedrich Miescher Institute, Basel, Switzerland
This course provided an intensive overview of topics in plant growth, physiology, and development,
focusing on molecular genetic approaches to understanding plant biology. It emphasized recent results
from Arabidopsis thaliana and other model plants and provided an introduction to current methods
used in Arabidopsis research. It was designed for scientists with experience in molecular techniques or
in plant biology who wish to work with Arabidopsis. The course consisted of a vigorous lecture series,
a hands-on laboratory, and informal discussions. Discussions of important topics in plant research was
presented by the instructors and by invited speakers. These seminars included plant morphology and
anatomy; gene dosage effects and epigenetic phenomena; cell biology (including calcium signaling, cell
polarity, and centromere behavior); plant development (including development of flowers, roots, meris-
terns, and leaves, male and female gametophytes, and embryos); floral induction; synthesis, function,
and perception of hormones; bioinformatics tools available to the Arabidopsis community; and the
potential of the Arabidopsis genome project for accelerating Arabidopsis research. Speakers provided
overviews of their fields, followed by in-depth discussions of their own work. The laboratory sessions
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provided an introduction to important techniques currently used in Arabidopsis research. These includ-
ed studies of Arabidopsis development, mutant analysis, methods in plant pathology and phylogenet-
ic analysis, histochemical staining, transient gene expression, applications of green fluorescent protein
fusions, protein isolation and detection; mass spectrometry, gene chip technology, QTL analysis and
techniques commonly used in genetic and physical mapping, and map-based cloning. The course also
included several short workshops on important themes in genetics. This year's speakers included
Gethyn Allen, Roger Beachy, Andrew Bent, John Bowman, Winslow Briggs, Clint Chapple, Nancy
Dengler, Liam Dolan, Hugo Dooner, Dick Flavell, Ueli Grossniklaus, David Jackson, Toby Kellogg, Rob
Martienssen, Peter McCourt, Tom Mitchell-Olds, June Nasrallah, Scott Peck, Craig, Pikaard, Bob
Pruitt, Ralph Quatrano, Eric Richards, Eric Schaller, Dave Spector, Ian Sussex, Sakis Theologis, and
Tong Zhu.
PARTICIPANTS
Alvarez-Venega, R B.S., Ph.D., Purdue University, West
Lafayette, Indiana
Boavida, L., LIC., Gulbenkian Institute of Science, Oeiras,
Portugal
Carmona Dominguez, E., B.S., Ph.D., Purdue University, West
Lafayette, Indiana
Deshpande, A., B.Sc., Ph.D., Purdue University, West Lafayette,
Indiana
Hoedemaekers, K., B.S., University of Nijmegen, The
Netherlands
Krishnaswamy, L., B.Sc., M.Sc., Iowa State University, Ames
SEMINARS
Allen, G., University of California, San Diego: Cellular physiology.
Beachy, R., Donald Danforth Plant Science Center, St. Louis,
Missouri: Plant viruses.
Bent, A., University of Wisconsin, Madison: Plant pathogen.
Bowman, J., University of California, Davis: Flowers. Genetics
workshop II: Mutagenesis.
Briggs, W., Carnegie Institution of Washington, Stanford,
California: Light responses.
Chapple, C., Purdue University, West Lafayette, Indiana:
Secondary metabolism.
Dengler, N., University of Toronto, Ontario, Canada: Plant
anatomy.
Dolan, L., John Innes Centre, Norfolk, United Kingdom: Roots.
Dooner, H., Rutgers University, Piscataway, New Jersey:
Transposons.
Flavell, D., Ceres, Inc, Malibu, California: Past and future of
plant molecular biology.
Grossniklaus, U., University of Zurich, Switzerland: Female
gametophyte. Genomic imprinting. Genetics workshop III:
Epiztasis.
Jackson, D., Cold Spring Harbor Laboratory: Meristem and
leaf.
Kellogg, T, University of Missouri, St. Louis: Evolution.
Martienssen, R., Cold Spring Harbor Laboratory: Enhancer
traps.
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Lall, S., B.Sc., Ph.D., Iowa State University, Ames
Lin, B.-L., B.S., Ph.D., Academia Sinica, Taiwan, Republic of
China
Maizel, A., B.S., Ph.D., CNRS, Paris, France
Nakanishi, S., B.E., M.S., Washington State University, Pullman
Raizada, M., B.Sc., Ph.D., University of Guelph, Canada
Royackers, K, B.S., M.S., Catholic University, Leuven, Belgium
Shippen, D., B.S., Ph.D., Texas A&M University, College Station
Suarez, M.-C., B.S., M.S., California State University, Fresno
Ueda, M., B.S., M.S., Kyoto University, Japan
Wrzaczek, M., M.S., University of Vienna, Austria
McCourt, P., University of Toronto, Canada: Humane
networks.
Mitchell-Olds, T, Max-Planck Institute of Chemical Ecology,
Jena, Germany: Natural variation.
Nasrallah, J., Cornell University, Ithaca, New York: Self incom-
patibility.
Peck, S., John lanes Centre, Norwich, United Kingdom:
Proteomics.
Pikaard, C., Washington University, St. Louis, Missouri:
Epigenetics I.
Pruitt, B., Purdue University, West Lafayette, Indiana: Male
gametophyte and signaling. Genetics workshop I: Mapping.
Quatrano, R., Washington University, St. Louis, Missouri: Cell
biology.
Richards, E., Washington University, St. Louis, Missouri:
Epigenetics II.
Schaller, E., University of New Hampshire, Durham: Ethylene.
Spector, D., Cold Spring Harbor Laboratory: Microscopy.
Sussex, I., Yale University, New Haven, Connecticut: Plant
morphology.
Theologis, S., Plant Gene Expression Center, Albany, California:
Auxin and genomics.
Zhu, T., Torrey Mesa Research Institute, San Diego, California:
Affimetrix chips.
Molecular Cloning of Neural Genes
June 29-July 19
INSTRUCTORS J. Boulter, University of California, Los Angeles
K. Jensen, The Rockefeller University, New York
D. Lavery, Glaxo Wellcome Experimental Research, Lausanne, Switzerland
C. Lai, Scripps Research Institute, La Jolla, California
CO-INSTRUCTOR W. Welwyn, University of California, Los Angeles
ASSISTANTS J. Arjomand, University of California Neuropsychiatric Institute, Los Angeles
C. Cottiny, GlaxoSmithKline, S.A., Lausanne, Switzerland
A. Klaassen, University of California, Los Angeles
J. LeMieux, Harvard Medical School, Boston, Massachusetts
E. Ruchti, GlaxoSmithKline, S.A., Lausanne, Switzerland
M. Samson, Harvard Medical School, Boston, Massachusetts
This intensive laboratory and lecture course taught neuroscientists current approaches to molecular
neurobiology. The course consisted of daily lectures and laboratory exercises on the practice of mole-
cular neurobiology, with an emphasis on modern approaches to cloning and analyzing the expression
of neural genes. A series of evening research seminars by invited speakers focused on the ways in
which these molecular techniques have been successfully applied. In the past, evening seminar topics
have included expression cloning, single cell cloning, subtractive cDNA cloning strategies, and genet-
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is and mechanistic studies of neurologic disease, aquisition of cell identity, and axon guidance in the
developing nervous system. The laboratory portion of the course began with instruction in a series of
basic molecular biological techniques and rapidly advanced to more sophisticated methodologies.
Students learned to prepare genomic, phage, and plasmid DNAs and total and poly(A)' RNA and to
generate and screen cDNA libraries. Additional topics and methods covered included restriction map-
ping, agarose and polyacrylamide gel electrophoresis, northern and Southern blotting, subcloning,
oligonucleotide primer design, a selection of PCR-based techniques, and the use of nucleotide and
protein sequence databases. Gene expression studies included the production of fusion proteins in
bacteria and mammalian cell transfection. An introduction to gene profiling was presented through the
use of cDNA arrays and Affymetrix gene chips. The advanced techniques featured the construction of
cDNA libraries from single cells and the use of subtractive cDNA methods to clone genes expressed
in limited populations of cells.
PARTICIPANTS
Allen, N., B.Sc, Ph.D., University College London, United
Kingdom
Berman, D., B.S., Ph.D., The Weizmann Institute of Science,
Rehovot, Israel
Bhandawat, V., M.Sc., Ph.D., Johns Hopkins School of
Medicine, Baltimore, Maryland
Bolotina, V., B.S., Ph.D., Boston University School of Medicine,
Massachusetts
Caric, D., M.D., Ph.D., Pittsburgh University, Pennsylvania
Drew, L, B.Sc., Ph.D., University College London, United
Kingdom
Golovina, V., M.S., Ph.D., University of Maryland School of
Medicine, Baltimore
SEMINARS
Barres, B., Stanford University School of Medicine, California:
Neuron-glial interactions in the developing brain.
Bettler, B., Novartis Pharma A/G, Basel, Switzerland: Molecular
insights into GABA receptor physiology.
Cline, H., Cold Spring Harbor Laboratory: Functional analysis
of activity-regulated genes in visual system development.
Lemke, G., The Salk Institute for Biological Studies, La Jolla,
California: Axial polarization of the eye and retino-collicular
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Kano Id, P., M.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Kaplan, M., B.A., Ph.D., University of California, San
Francisco
Lamprecht, R., B.S., Ph.D., New York University, New York
Unkenhoker, B., B.A., Ph.D., Stanford University, California
Morcos, Y., B.Sc., Ph.D., University of Tennessee, Memphis
Polleux, F., B.S., Ph.D., INSERM, Bron, France
Robert, A., M.D., Ph.D., Yale University, New Haven,
Connecticut
Robles, E., B.S., University of Wisconsin, Madison
Xu, J., B.S., Ph.D., University of California, Los Angeles
mapping.
Mayford, M., Scripps Research Institute, La Jolla, California:
Genetic approaches to memory in the mouse.
Walsh, C., Harvard Medical School, Boston, Massachusetts:
Positional cloning of genes required for cerebral cortical
development in mice and humans.
Weinmaster, G., University of California School of Medicine, Los
Angeles: Notch signal transduction in mammalian cells.
Neurobiology of Drosophila
June 29-July 19
INSTRUCTORS K. Broadie, University of Utah, Salt Lake City
S. deBelle, University of Nevada, Las Vegas
G. Tear, King's College, London, United Kingdom
ASSISTANTS L. Flintoft, King's College, London, United Kingdom
R. Renden, University of Utah, Salt Lake City
C. Riedl, University of Toronto, Mississauga, Ontario, Canada
This laboratory/lecture course was intended for researchers at all levels from beginning graduate stu-
dents through established primary investigators who want to use Drosophila as an experimental sys-
tem for nervous system investigation. The 3-week course was divided into the study of development,
physiology/function, and behavior. Daily seminars introduced the students to a variety of research top-
ics and developed those topics by including recent experimental contributions and outstanding ques-
tions in the field. Guest lecturers brought original preparations for viewing and discussion and direct
laboratory exercises and experiments in their area of interest. The course provided students with
hands-on experience using a variety of experimental preparations that are utilized in the investigation
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of current neurobiological questions. The lectures and laboratories focused on both the development
of the nervous system and its role in controlling larval and adult behaviors. In addition to an exposure
to the molecular genetic approaches available in Drosophila, students learned a variety of techniques
including labeling of identified neurons, electrophysiological recording from nerves and muscles, and
the analysis of larval and adult behavior. Collectively, the course provided a comprehensive and prac-
tical introduction to modern experimental methods for studying the Drosophila nervous system. The
specific topics from this year's course included neurogenesis, axon pathfinding, synaptogenesis, mem-
brane excitability, synaptic function and plasticity, photoreception, mechanoreception, neural circuits,
biological rhythms, courtship, learning and memory, and locomotory and flight behaviors. This year's
lecturers included Justin Blau, Kendal Broadie, Steven deBelle, Aaron Di Antonio, Alicia Hidaglo,
Matthias Landgraff, Maurice Kernan, Rod Murphey, Kevin O'Dell, Diane O'Dowd, William Pak, David
Shepherd, Jim Skeath, Roland Strauss, Guy Tear, Jessica Treisman, Tim Tully, and David Van Vector.
PARTICIPANTS
Ben-Shahar, Y., B.Sc., M.S., University of Illinois, Urbana
Collins, C., BA., Ph.D., University of California, Berkeley
Dickman, D., B.A., Harvard Medical School, Boston,
Massachusetts
Dunkelberger, B., B.S., University of Nevada, Las Vegas
Forni, J., B.Sc., Ph.D., King's College London, United
Kingdom
Jafar-Nejad, H., M.D., Baylor College of Medicine, Houston,
Texas
SEMINARS
Blau, J., New York University, New York: Circadian rhythms.
Broadie, K., University of Utah, Salt Lake City: Introduction to
Drosophila physiology: Synaptogenesis and synaptic struc-
ture-function.
De Belle, S., University of Nevada, Las Vegas: Introduction to
behavior. Foraging behavior.
Tully, T., Cold Spring Harbor Laboratory: Learning and memory.
Di Antonio, A., Washington University School of Medicine, St.
Louis, Missouri: Synaptic plasicity and synaptic modulation.
Hidalgo, A., University of Cambridge, United Kingdom: The
role of glia in the nervous system.
Kernan, M., SUNY, Stony Brook, New York: Mechanoreception.
Landgraff, M., University of Cambridge, United Kingdom: Acquisi-
tion of neuronal identity in the embryo.
Murphey, R., University of Massachusetts, Amherst: Neural cir-
cuits in Drosophila.
O'Dell, K., University of Glasgow, United Kingdom: Courtship
behavior.
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Loren, C, BA., M.A., Umea Universitet, Sweden
Palanker, L., B.S., University of Utah, Salt Lake City
Rikhy, R., B.Sc., M.Sc., Tata Institute of Fundamental
Research, Colaba, Mumbai, India
Rollmann, S., B.S., Ph.D., North Carolina State University,
Raleigh
Wick line, L., B.A., Washington University, St. Louis,
Missouri
Ye, B., B.S., Ph.D., University of California, San Francisco
O'Dowd, D., University of California, Irvine: Ion channels and
neuronal culture.
Pak, W., Purdue University, West Lafayette, Indiana:
Phototransduction.
Shepherd, D., University of Southampton, United Kingdom:
Development of the adult CNS.
Skeath, J., Washington University School of Medicine,
St. Louis, Missouri: Early events of neurogenesis in the
embryo.
Strauss, R., Theodor-Boveri Institut fuer Biowissenschaften,
Wuerzberg, Germany: Motor/visual behavior.
Tear, G., Kings College, London, United Kingdom: Introduction
to Drosophila development and experimental techniques.
Treisman, J., New York University School of Medicine, New
York: Development of the visual system in the larva and
adult.
Van Vactor, D., Harvard Medical School, Boston, Massachu-
setts: Axon guidance mechanisms in the embryo.
Mouse Behavioral Analysis
July 6-19
INSTRUCTORS M. Fanselow, University of California, Los Angeles
M. Mayford, The Scripps Research Institute, La Jolla, California
ASSISTANTS B. Godsil, University of California, Los Angeles
A. Matynia, University of California, Los Angeles
L. Reijmers, The Scripps Research Institute, La Jolla, California
B. Wiltgen, University of California, Los Angeles
This course provided a theoretical and experimental introduction to behavioral analysis in the mouse,
with a focus on learning and memory. It is specially designed for geneticists, molecular biologists, phar-
macologists, and electrophysiologists with a need for a hands-on introduction to behavioral analysis of
the mouse. Additionally, the course covered the principles of using mutant mice in behavioral studies,
as well as the issues involved in integrating behavioral, neuroanatomical, neurophysiological, and mol-
ecular findings. Among the methods presented were the water maze, cued and contextual fear condi-
tioning, natural/ethologically relevant learning, open field behavior, the rotor-rod, and other activity tests.
In addition, there were demonstrations of several aspects of in vitro electrophysiology (fields and whole-
cell recordings of synaptic plasticity).
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PARTICIPANTS
Berghard, A., B.S., Ph.D., Umea University, Switzerland
Delorey, T., B.S., Ph.D., Molecular Research Institute,
Mountain View, California
Garcia, A.D., B.S., University of California, Los Angeles
Lerchner, W., M.Sc., Ph.D., Caltech/Human Frontiers
Science Program, Organization, Pasadena, California
Lo, L. -T., B.M., Washington University School of Medicine, St.
Louis, Missouri
Offenhaeuser, N., B.S., Ph.D., FIRG Institute of Molecular
SEMINARS
Balleine, B., University of California, Los Angeles; Holland, PM.,
Duke University, Durham, North Carolina; Fanselow, M., Univer-
sity of California, Los Angeles: What are the essentials of learn-
ing and behavior?" Introduction to behavioral psychology II.
Blanchard, C., John A. Burns School of Medicine, Honolulu,
Hawaii: Crosspieces. Generality of aggression and defense.
Blanchard, R., University of Hawaii: Aggressive and defensive
behavior in the rat and mouse.
Fanselow, M., University of California, Los Angeles: Introduction
to behavioral psychology I. Functional basis of Pavlovian con-
ditioning. Stats for molecular biologists. What can mouse
genetics offer to psychology?
Hen, R., Columbia University, New York: Roundtable:
Psychiatric genetics in the mouse? Genetics of anxiety.
Holland, P., Duke University, Durham, North Carolina: Introduc-
tion to learning theory II. Introduction to learning theory II.
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Oncology, Milan, Italy
Panda, S., M.S., Ph.D., The Scripps Research Institute, La
Jolla, California
Till, S., B.S., M.S., Columbia University, New York
Wada, Y., B.A., Ph.D., RIKEN Genomic Sciences Center,
Yokohama, Japan
Wilquet, V., B.S., Ph.D., University of Leuven, Belgium
Wood, M., B.S., Ph.D., University of Pennsylvania, Philadelphia
Knowlton, B., University of California, Los Angeles:
Neural systems. Neural systems of behavior.
Mayford, M., The Scripps Research Institute, La Jolla,
California: Genetic approaches to memory. Genetic
background issues. What can mouse genetics offer to
psychology? How to combine ethological and genetic
approaches.
Takahashi, J., Northwestern University, Evanston, Illinois:
ENU, QTLs, transgenics, knockouts, utility of each and
future directions. Molecular understanding of a complex
behavior through forward genetics.
Thompson, R., University of Southern California, Los Angeles:
Classical conditioning of discrete behavioral resposes.
Roundtable: Cerebellar learning.
Wilson, M., Massachusetts Institute of Technology, Cambridge:
Systems neurophysiology.
Biology of Memory: From Molecules to Behavior
July 7-20
INSTRUCTORS J. Byrne, University of Texas, Houston
H. Eichenbaum, Boston University, Massachusetts
K. Martin, University of California, Los Angeles
L. Squire, University of California, San Diego
This lecture course provided an introduction to cell, molecular, and systems approaches to learning and
memory. It was suited for graduate students in molecular biology, neurobiology, and psychology as well
as research workers who are interested in an introduction to this field. The course covered topics rang-
ing from behavioral considerations of learning and memory to gene regulation in the nervous system.
The lectures provided an intensive coverage of six selected areas: (1) an introduction to modern behav-
ioral studies of learning and memory; (2) an overview of the cell biology of neuronal plasticity and sec-
ond messenger systems; (3) regulation of gene expression; (4) cellular and molecular mechanisms of
simple forms of learning and memory in invertebrates and vertebrates; (5) cellular and molecular mech-
anisms of long-term potentiation and depression in various regions of the mammalian brain; and (6)
systems approaches to learning in vertebrates and humans.
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PARTICIPANTS
Antzoulatos, E., B.A., University of Texas, Houston
Baldassa, S., B.S., Ph.D., University of Milan, Italy
Bengtsson, F., M.S., Ph.D., University of Lund, Sweden
Boyden, E., B.S., M.S., Stanford University, California
Colombo, J., B.S., M.S., University of Fribourg, Switzerland
Fioravante, D., B.A., Ph.D., University of Texas, Houston
Fraidakis, M., M.D., M.S., Karolinska Institute, Stockholm,
Sweden
Frenkel, D., M.S., Ph.D., Tel Aviv University, Israel
Galvez, R., B.A., University of Illinois, Urbana-Champaign
Johnson, A., B.S., University of Texas-Houston HSC Medical
School
Jones, S., B.S., East Carolina University, Greenville, North
Carolina
SEMINARS
Ball, G., Johns Hopkins University School of Medicine,
Baltimore, Maryland: Ethological approaches to learning.
Bear, M., Brown University/HHMI, Providence, Rhode Island:
Long-term depression.
Byrne, J., University of Texas-Houston Medical School:
Nonassociative learning in Aplysia. Introduction to the cellular
study of learning. Associative learning in Aplysia. Overview of
membranes and synaptic transmission.
Eichenbaum, H., Boston University, Massachusetts: Role of
LTP and LTP in learning. Memory systems in rodents.
Gilbert, C., The Rockefeller University, New York: Dynamics of
adult visual cortex.
Greenough, W., University of Illinois, Urbana: Morphological
correlates of learning and experience.
Holland, P., Duke University, Durham, North Carolina: Introduc-
tion to learning theory I. Introduction to learning theory II.
LeDoux, J., New York University, New York: Fear conditioning.
Malinow, R., Cold Spring Harbor Laboratory: Long-term poten-
tiation I.
Martin, K., University of California, Los Angeles: Mechanisms of
site-specific synaptic facilitation I. Mechanisms of site-specific
Ke, M., B.S., M.D., Stanford University Medical School,
California
McGaughy, J., B.A., Ph.D., Boston University, Massachusetts
Nary, S., B.S., New York University Medical Center, New
York
Robitsek, J., B.A., Boston University, Massachusetts
Spors, H., M.D., Max-Planck Institute for Medical Research,
Heidelberg, Germany
Vale-Martinez, A., B.A., Ph.D., Boston University, Massachu-
setts
Waldenstrom, A., M.Sc., Ph.D., Lund University, Sweden
Zhang, Z., B.S., M.S., Max-Planck Institute of Psychiatry,
Munich, Germany
synaptic facilitation 2.
Mayford, M., University of California, San Diego: Gene-knock-
out/transgenic approaches to study learning.
McGaugh, J., University of California, Irvine: Modulation of
memory.
Miller, E., Massachusetts Institute of Technology, Cambridge:
Role of prefrontal cortex in memory.
Raymond, J., Stanford University, California: Adaptive modifica-
tions of the VOR.
Schulman, H., Stanford University School of Medicine, Califor-
nia: Overview and their role in
learning and memory I. Overview of second-messenger sys-
tems and their role in learning and memory II.
Squire, L., University of California, San Diego: Memory systems
in nonhuman primates. Human memory and disorders of
memory.
Thompson, R., University of Southern California, Los Angeles:
Classical conditioning of discrete behavioral responses.
Tully, T., Cold Spring Harbor Laboratory: Genetic approaches
to study learning in Drosophila.
Molecular Mechanisms of Human Neurological Diseases
July 23-29
INSTRUCTORS A. Aguzzi, University Hospital of Zurich, Switzerland
S. Gandy, New York University and Nathan S. Kline Institute of
Psychiatric Research, Orangeburg, New York
J. Hardy, Mayo Clinic, Jacksonville, Florida
ASSISTANT V. Lingappa, University of California, San Francisco
How and why do neurons die in specific human neurological disorders? What are the molecular and
biochemical manifestations of specific genetic lesions in neurodegenerative disorders? Do different
pathological deaths share common mechanisms? What practical treatments are contemplated? This
lecture course explored possible answers to these important questions. Recent advances in neuroge-
netics and in molecular and cell biology have begun to shed light on the mechanisms that underlie ner-
vous system injury in disease states such as Alzheimer's disease, Parkinson's disease, frontotemporal
dementia, stroke, tauopathies, synucleinopathies, prion diseases, and polyglutamine repeat disorders.
Taking advantage of small class size and extensive discussion, invited faculty lecturers examined criti-
cal issues in their areas of expertise. Overviews were provided and course participants did not have to
be familiar with neurological diseases. The course focused principally on the specific hypotheses and
approaches driving current research. Emphasis was placed on the highly dynamic interface between
basic and clinical investigation, including the interdependence of clinical research and disease model
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development, and the value of disease research in understanding the function of the normal nervous
system. This year's lecturers were Adriano Aguzzi, Richard Frackowiak, Paul Fraser, Sam Gandy, Tim
Greenamyre, John Hardy, David Holtzman, Peter St. George-Hyslop, Virginia Lee, Vishu Lingappa,
James Meschia, Diane Murphy, Bob Vassar, John Trojanowski, Mike Hutton, MarcyMacDonald, Parsa
Kazemi-Esfarjani, and David Westaway.
PARTICIPANTS
Alonso, A., B.S., M.S., Ph.D., NYS Institute for Basic Research,
Staten Island, New York
Bernacchia, A., B.S., Ph.D., University of Bologna, Italy
Ching, Y.P., B.Sc., Ph.D., Hong Kong University, Hong
Kong
Chou, T., B.S., Ph.D., University of Pennsylvania, Philadelphia
Cole, N., B.S., Ph.D., National Institutes of Health, Bethesda,
Maryland
Corvetti, L, M.D., International School for Advanced Studies,
Trieste, Italy
Deitz, W., Yale University, New Canaan, Connecticut
Fraidakis, M., M.D., MS., Karolinska Institute, Stockholm,
Sweden
Frenkel, D., M.S., Tel Aviv University, Israel
Heppner, F., M.D., University Hospital Zurich, Switzerland
SEMINARS
Aguzzi, A., University Hospital of Zurich, Switzerland: Molecular
biology of prion diseases.
Frackowiak, R., Wellcome Trust, London, United Kingdom:
Structural and function basis of neurodegenerative illness.
Fraser, A, University of Toronto, Canada: Biophysics of amy-
loidogenesis.
Gandy, S., New York University and Nathan S. Kline Institute of
Psychiatric Research, Orangeburg, New York: Regulation of
amyloidosis by gonadal hormones.
Greenamyre, T., Emory University, Atlanta, Georgia: Clinical fea-
tures of Parkinson's. A model for Parkinson's based on an
environmental toxin.
George-Hyslop St., P., University of Toronto, Canada: Genetics
and molecular biology of Alzheimer's disease.
Hardy, J., Mayo Clinic Jacksonville, Florida: An overview of
neurogenetics.
Holtzman, D., Washington School of Medicine, St. Louis,
Missouri: Molecular biology of stroke. Genetics and trans-
genes of apolipoprotein E. Depletion of peripheral abeta
as a strategy to lower brain amyloid load.
Hutton, M., Mayo Clinic Jacksonville, Florida: Genetics and
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Kohler, R., Ph.D., Lion Bioscience Research, Inc., Cambridge,
Massachusetts
Kroening, A.-K., Dipl., Institute of Clinical Neurobiology,
Wuerzburg, Germany
Lynch-Ballard, E., M.D., University of Texas, Houston
Maggi, L, Ph.D., SISSA-ISAS, Trieste, Italy
Majumder, S., B.Sc., Ph.D., University of Texas, M.D. Anderson
Cancer Center, Houston
Mattiazzi, M., B.S., Ph.D., University of Bari, Italy
Sigurdson, C., B.S., Colorado State University, Fort Collins
Ritz, B., M.D., Ph.D., University of California, Los Angeles
Roy, M., B.A., Ph.D., Stanford University, California
Sharmeen, L., M.Sc., Ph.D., Pfizer Global R&D, Ann Arbor,
Michigan
transgenesis of tauopathies.
Kazemi-Esfarjani, P., Califorina Institute of Technology,
Pasadena: Modeling triple repeat diseases in Drosophila.
Lee, V., University of Pennsylvania School of Medicine,
Philadelphia: Biochemistry of tauopathies.
MacDonald, M., Massachusetts General Hospital, Charlestown:
Trinucleotide repeat diseases.
Lingappa, V., University of California, San Francisco: Cell
biology of prion proteins biogenesis.
Meschia, J., Mayo Clinic, Jacksonville, Florida: Clinical features
of stroke syndromes.
Murphy, D., NINDS, National Institutes of Health, Rockville,
Maryland: Introduction to NIH.
Trojanowski, J., University of Pennsylvania, Philadelphia:
Synucleinopathies.
Vassar, B., Northwestern University Medical School, Chicago,
Illinois: Molecular biology and transgenesis of BACE, a/k/a
beta secretase.
Westaway, D., University of Toronto, Canada: Transgenic
modeling of Alzheimer disease. Immunotherapy of
Alzheimer's disease.
C. elegans
July 24-August 13
INSTRUCTORS A. Chisholm, University of California, Santa Cruz
M. Hengartner, University of Zurich, Switzerland
E. Jorgensen, University of Utah, Salt Lake City
R. Korswagen, University Hospital Utrecht, The Netherlands
ASSISTANTS T. Harris, Cold Spring Harbor Laboratory
M. Hammarlund, University of Utah, Salt Lake City
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans genome pro-
ject. The course was suited both for those who have current training in molecular biology and some
knowledge of genetics, but have no experience with C. elegans, and for students with some prior worm
experience who wished to expand their repertoire of expertise. The following topics were covered both
in the laboratory and by lectures from experts in the field: worm pushing, C. elegans databases and
worm bioinformatics, anatomy and development, forward genetics, chemical and transposon mutage-
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nesis, generation of transgenic animals, expression pattern analysis, reverse genetics, construction and
screening of deletion libraries, and RNA inactivation. The course was designed to impart sufficient train-
ing to the students in the most important attributes of the C. elegans system to enable them to embark
on their own research projects after returning to their home institutions.
PARTICIPANTS
Aikawa, J.-I., B.A., Ph.D., RIKEN, Saitama, Japan
Bazzoni, G., BA., M.D., Mario Negri Institute for Pharmacolog-
ical Research, Milan, Italy
Carlow, C., B.S., Ph.D., New England Biolabs, Beverly,
Massachusetts
Degtyareva, N., B.S., Ph.D., University of North Carolina,
Chapel Hill
Hansen, M., B.S., M.S., Copenhagen University, Denmark
Holmberg, C., M.S., Ph.D., Turku Centre for Biotechnology,
Finland
Kirk, K., B.S., Ph.D., New Mexico Technology, Socorro
Kiyokawa, E., M.D., Ph.D., RIKEN, Saitama, Japan
Larsen, M., M.D., Ph.D., University of Southern Denmark,
SEMINARS
Aroian, R., University of California, San Francisco: Pathogene-
sis, toxicity assays.
Bowerman, B., University of Oregon, Eugene: Early embryoge-
nesis, is screens, and movies.
Chisholm, A., University of California, Santa Cruz: Eph signal-
ing; microscopy.
Garriga, G., University of California, Berkeley: Neuronal devel-
opment, screening RNAi phenotypes.
Hengartner, M., University of Zurich, Switzerland: Cell death;
suppressor genetics.
Jin, Y., University of California, Santa Cruz: Synapse develop-
ment, transformation + a little GFP.
Jorgensen, E., University of Utah, Salt Lake City: Synaptic
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Odense, Denmark
Lech leiter, J., BA., Ph.D.. University of Texas Health Sciences
Center, San Antonio
Pintard, L., Ph.D., Swiss Institute of Cancer Research,
Lausanne, Switzerland
Porter, M., B.Sc., Ph.D., University College London, United
Kingdom
Riedl J., B.S., Ph.D., University of Utrecht, The Netherlands
Seitz, S., M.S., Max-Planck Institute of Molecular Genetics,
Berlin, Germany
Strauss, K., Max-Planck Society, TUebingen, Germany
Tewari M., BA., Ph.D., Harvard Medical School, Boston,
Massachusetts
function, forward genetics.
Kenyon, C., University of California, San Francisco: Aging,
aging assay, laser ablation.
Korswagen, R., University Hospital Utrecht, The Netherlands:
Wnt signaling, suppressor screens.
Stein, L., Cold Spring Harbor Laboratory: C. elegans genome
Wormbase.
Plasterk, R., Hubrecht Laboratory, Utrecht, The Netherlands:
RNAi, mechanisms, RNAi.
Vidal, M., Dana-Farber Cancer Institute, Boston, Massachu-
setts: Vulva! signaling, proteomics.
Villeneuve, A., Stanford University School of Medicine, Califor-
nia: Meiosis, recombination, and balancers.
Biology of Developmental Disabilities in Children
July 30-August 3
INSTRUCTORS B.J. Casey, Weill Medical College of Cornell University, New York
Y. Munakata, University of Denver, Colorado
This course explored basic developmental principles of the brain and behavior and their application to
understanding the biology of developmental disabilities. Leading authorities in areas of higher cognitive
functions, including language and cognitive control, presented models of typical and atypical brain
development. Students were exposed to a wide spectrum of methods currently being used in devel-
opmental science, including neuroimaging, computational modeling, human genetics, and animal mod-
els. Emphasis was placed on a converging methods approach, and these methods were discussed in
both lectures and workshops throughout the course in the context of models of developmental dis-
abilities. This year's lecturers were Annette Karmiloff-Smith, Isabel Gautier, Michelle de Haan, Kathleen
Thomas, Helen Neville, April Benasich, Bruce McCandliss, Adele Diamond, John Fosse Ila, and William
Greenough.
PARTICIPANTS
Berger, Sarah, BA., Ph.D., New York University, New York
Brunssen, S., B.S., M.S., University of North Carolina, Chapel
Hill
Choudhury, N., BA., Ph.D., Rutgers University, Newark, New
Jersey
Cleary, M., B.A., Ph.D., Indiana University, Bloomington
Eigsti, I.-M., B.A., Ph.D., The University of Rochester, New York
Fan, J., B.S., Ph.D., The Sack ler Institute, Cornell University,
New York
Hay, D., B.A., Ph.D., University of Saskatchewan, Canada
Herbert, M., Ph.D., M.D., Massachusetts General Hospital,
Charlestown
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Liu, D., B.S., Ph.D., University of Michigan, Ann Arbor
MacKenzie, M., B.Sc., M.Sc., University of Michigan, Ann Arbor
McDuffie, A., B.A., M.A., Vanderbilt University, Nashville,
Tennessee
Morton, B., Ph.D., University of Denver, Colorado
Raz, A., M.S., Ph.D., Cornell University, New York
Raz, S., B.A., Ph.D., University of Memphis, Tennessee
SEMINARS
Benasich, A., Rutgers University, Newark, New Jersey: Typical
and atypical development of language and speech.
Casey, B.J., Sack ler Institute, New York; Munakata, Y., Denver
University, Colorado: Overview of upcoming week.
Casey, B.J., Sack ler Institute, New York: Impact of disruption of
frontostriatal circuitry on development.
De Haan, M., University College London, United Kingdom:
Developmental principles of facing processing.
Diamond, A., Eunice Kennedy Shriver Center, Waltham,
Massachusetts: Development of prefrontal cortex and related
disorders.
Fosse Ila, J., The Rockefeller University, New York: Human
genetics workshop.
Gauthier, I., Vanderbilt University, Nashville, Tennessee:
Organization of face and object processing.
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Ruz, M., B.S., M.S., University of Granada, Spain
Sheridan, M., B.S., Washington University, St. Louis, Missouri
Thomas, Jennifer, BA, M.S., Rutgers University, Newark, NewJersey
Tottenham, N., B.A., Ph.D., University of Minnesota, Minne-
apolis
Wang, A., B.A., Ph.D., University of California, Los Angeles
Greenough, W., University of Illinois, Urbana: Environmental and
genetic factors in atypical and typical development.
Karmiloff-Smith, A., Institute of Child Health, London, United
Kingdom: Different approaches to relating genes to develop-
mental disorders.
Manakata, Y., Denver University, Colorado: Workshop on com-
putational modeling of prefrontal function.
McCandliss, B., Sack ler Institute, New York: Workshop on
speech and language interventions.
Neville, H., University of Oregon, Eugene: Plasticity and organi-
zation of language development.
Posner, M., Sack ler Institute, New York: Putting the course in
perspective?
Thomas, K., Sack ler Institute, New York: Workshop on pedi-
atric neuroimaging: ERP, MRI, fMRI.
Eukaryotic Gene Expression
July 24-August 13
INSTRUCTORS B. Dynlacht, Harvard University, Cambridge, Massachusetts
J. Goodrich, University of Colorado, Boulder
J. Lees, Massachusetts Institute of Technology, Cambridge
M. Timmers, University Medical Centre Utrecht, The Netherlands
ASSISTANTS P. Danielian, Massachusetts Institute of Technology, Cambridge
M. Kleiman, University Medical Centre Utrecht, The Netherlands
J. Rayman, Harvard University, Cambridge, Massachusetts
This course was designed for students, postdocs, and principal investigators who have recently ven-
tured into the dynamic area of gene regulation. The course focused on state-of-the-art strategies and
techniques employed in the field. Students made nuclear extracts, performed in vitro transcription, and
measured RNA levels using primer extension. Emphasis was placed on biochemical studies of protein-
DNA and protein-protein interactions. Detailed characterizations of the DNA-binding properties of site-
specific transcription factors were carried out using electrophoretic mobility shift and DNase I foot-
printing assays. These assays were used to study protein-DNA interactions in crude extracts and using
recombinant proteins. Coimmunoprecipitation and binding assays were employed to investigate pro-
tein-protein interactions with the general transcription machinery. During the past few years, the gene
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regulation field has begun to emphasize the importance of in vivo approaches to studying protein-DNA
and protein-protein interactions. Students were therefore exposed to the chromatin immunoprecipita-
tion technique. Experience with basic recombinant DNA techniques was a prerequisite for admission
to this course. Lectures by the instructors covered the current status of the gene expression field, the-
oretical aspects of the methodology, and broader issues regarding strategies for investigating the reg-
ulation of gene expression in eukaryotes. Guest lecturers discussed contemporary problems in eukary-
otic gene regulation and technical approaches to their solution. The speakers this year included Laura
Attardi, Marisa Bartolomei, Steve Buratowski, Ken Burtis, Mike Carey, Brian Dynlacht, Jim Goodrich,
Shiv Grewal, Leemor Joshua-Tor, Bob Kingston, Jackie Lees, Lorenz Poellinger, Bob Roeder, Marc
Timmers, Laszlo Tora, and Toshi Tsukiyama.
PARTICIPANTS
Agostinho, M., University of Libson, Portugal
Bahadur, U., B.Sc., M.S., Indian University of Science,
Bangalore, India
Bubier, J., B.A., Marquette University, Milwaukee, Wisconsin
Corrigan, A., B.S., Aeomica Disease Profiling Nycomed,
Amersham, Sunnyvale, California
Gartel, A., B.S., Ph.D., University of Illinois, Chicago
Giraldo, P., M.Sc., Centro Nacional de Biotechnologia, Madrid,
Spain
Glisovic T., B.S., M.S., Pharmaceutical Biosciences, Uppsala,
Sweden
Koss ler, H., Dipl., Institut fur Biochemie, Gottingen, Germany
SEMINARS
Attardi, L., Stanford University, California: Identification of apop-
tosis-specific p53 target genes.
Bartolomei, M., University of Pennsylvania, Philadelphia: Mecha-
nism of genomic imprinting.
Buratowski, S., Harvard Medical School, Boston, Massachu-
setts: Connecting transcription to chromatin and mRNA pro-
cessing.
Burtis, K., University of California, Davis: Production and use of
cDNA microarrays for analysis of gene expression in Drosoph-
ila.
Carey, M., University of California School of Medicine, Los
Angeles: Enhanceosome assembly and function.
Dynlacht, B., Harvard University, Cambridge, Massachusetts:
Transcriptional regulation during the mammalian cell cycle.
Goodrich, J., University of Colorado, Boulder: Mechanisms of
human RNA ploymerase II transcription.
Grewal, S., Cold Spring Harbor Laboratory: Linking histone
modifications to gene activity and more.
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Lieto, L., B.S., Ph.D., NIAID, National Institutes of Health,
Rockville, Maryland
Melnick, A., M.D., Mt. Sinai Medical Center, New York
Nykanen, P., M.S., Turku Centre for Biotechnology, Finland
Richter, H., B.S., M.Sc., University of Copenhagen, Bagsvaerd,
Denmark
Shureiqi, I., B.S., M.D., University of Texas, Houston
Skowronska-Krawczyk, D., M.S., Ph.D., University of Geneva,
Switzerland
Stanhill, A., B.Sc., M.Sc., Hebrew University, Jerusalem, Israel
Upreti, M., M.S., Ph.D., Jawaharlal Nehru University, New Delhi,
India
Joshua-Tor, L., Cold Spring Harbor Laboratory: Transcription
factors in 3D in Drosophila.
Kingston, B., Harvard University, Boston, Massachusetts: A bio-
chemical approach to epigenetic regulation: SWI/SNF and
polycomb.
Lees, J., Massachusetts Institute of Technology, Cambridge:
The in vivo roles of the E2F transcription factors.
Poellinger, L., Karolinska Institute, Stockholm, Sweden: Mecha-
nism of action of stress-inducible transcription factors.
Roeder, B., The Rockefeller University, New York: Role of gen-
eral and gene-specific coactivators in transcription.
Timmers, M., Utrecht University, The Netherlands: Analysis of
basal transcription faction B-TFIID: Putting the heat on TBP.
Tora, L., IGBMC, Illkirch, France: The role of TAFs in regulation
of RNA polymerase II transcription.
Tsukiyama, T, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Function of yeast ISWI chromatin
remodeling complexes in transcription.
Imaging Structure and Function in the Nervous System
July 24-August 13
INSTRUCTORS K. Delaney, Simon Fraser University, Burnaby, BC, Canada
V. Murthy, Harvard University, Cambridge, Massachusetts
K. Svoboda, Cold Spring Harbor Laboratory
ASSISTANTS J. Burrone, Harvard University, Cambridge, Massachusetts
J. Bollmann, Max-Planck Institute for Medical Research, Heidelberg, Germany
I. Davison, Simon Fraser University, Burnaby, BC, Canada
S. Levi, Washington University, St. Louis, Missouri
S. Shi, University of California, San Francisco
Advances in light microscopy, digital image processing, and the development of a variety of powerful
fluorescent probes present expanding opportunities for investigating the nervous system, from synap-
tic spines to networks in the brain. This intensive laboratory and lecture course provided participants
with the theoretical and practical knowledge to utilize emerging imaging technologies. The primary
emphasis of the course was vital light microscopy. Students learned the principles of light microscopy,
as well as use of different types of electronic cameras, laser scanning systems, functional fluorophores,
delivery techniques, and digital image-processing software. In addition to transmitted light microscopy
for viewing cellular motility, the course examined a variety of molecular probes of cell function, includ-
ing calcium-sensitive dyes, voltage-sensitive dyes, photo-activated ("caged") compounds, and exocy-
tosis tracers. Issues arising in the combination of imaging with electrophysiological methods were cov-
ered. Particular weight was given to multiphoton laser scanning microscopy and to newly available bio-
logical fluorophores, especially green fluorescent protein (GFP) and its variants. A spectrum of neural
10'
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and cell biological systems, including living animals, brain slices, and cultured cells were used.
Applicants had a strong background in the neurosciences and in cell biology. Lecturers in the 2001
course included Kerry Delaney, William Betz, Holly Cline, Ann Marie Craig, Richard Day, Winfried Denk,
Joseph Fetcho, Paul Forscher, Laurence Katz, David Kleinfeld, Fred Lanni, Richard Lewis, Jeff
Lichtman, Jerome Mertz, Venkatesh Murthy, Karel Svoboda, Roger Tsien, and Samuel Wang.
PARTICIPANTS
Brenowitz, S., B.A., Oregon Health Sciences University,
Portland
Chang, S., B.S., Ph.D., Yale University-HHMI, New Haven,
Connecticut
Franks, K., B.S., Ph.D., The Salk Institute, La Jolla, California
Guatimosim, C., B.S., Ph.D., Univeresidade Federal de Minas
Gerais, Brazil
Hess, D., B.S., University of Pennsylvania School of Medicine,
Philadelphia
Iwanaga, y , B.S., Ph.D., Max-Planck Institute for Brain
Research, Frankfurt, Germany
SEMINARS
Betz, W., University of Colorado, Denver: Imaging secretion,
FM-1-43.
Bollman, J., Max-Planck Institute for Medical Research, Heidel-
berg, Germany: Ca. uncaging.
Cline, H., Cold Spring Harbor Laboratory: In vivo imaging in
tadpoles.
Craig, A.M., Washington University School of Medicine, St.
Louis, Missouri: Immunofluorescence. Imaging synaptic pro-
teins.
Day, R., University of Virginia, Charlottesville: GFP basics. Fret
basic and applications.
Delaney, K., Simon Fraser University, Burnaby, Canada: Intro-
duction to calcium imaging.
Denk, W., Max-Planck Institute for Medical Research, Heide-
lberg, Germany: 2-photon microscopy.
Fetcho, J., SUNY Stony Brook, New York: In vivo imaging in
zebrafish.
Forscher, P., Yale University, New Haven, Connecticut: DIC
microscopy.
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Portera-Cailliau, C., B.A., Ph.D., Columbia University, New York
Stocca, G., M.S., Ph.D., Vanderbilt University, Nashville,
Tennessee
Tashiro, Y., B.A., M.A., Osaka University, Japan
Tsao, D., B.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Wyart, C., B.S., Ph.D., Laboratoire des Fluides Complex-es,
Strasbourg, France
Zakharenko, S., M.D., Ph.D., HHMI, Columbia University, New
York
Katz, L., Duke University Medical Center, Durham, North
Carolina: Imaging, past and future.
Kleinfeld, D., University of California, La Jolla: In vivo imaging of
blood flow.
Lanni, F, Carnegie-Mellon University, Pittsburgh, Pennsylvania:
Fluorescence microscopy.
Lewis, R., Stanford University School of Medicine, California:
Imaging, past and future.
Lichtman, J., Washington University, St. Louis, Missouri: Con-
focal microscopy.
Mertz, J., Ecole Superieure de Physique et de Chimie
Industrielles, France: Nonlinear microscopies
Murthy, V., Harvard University, Cambridge, Massachusetts:
Imaging secretion, FM-1-43. GFP probes to image secretion.
Svoboda, K., Cold Spring Harbor Laboratory: Basic optics.
Applications of 2-photon.
Tsien, R., University of California, San Diego: GFP-based
probes.
Wang, S., Princeton University, New Jersey: Uncaging.
Yeast Genetics
July 24-August 13
INSTRUCTORS D. Amberg, SUNY Syracuse, New York
D. Burke, University of Virginia, Charlottesville
0. Cohen-Fix, NIDDK, National Institutes of Health, Bethesda, Maryland
ASSISTANTS Y. Green, NIDDK, National Institutes of Health, Bethesda, Maryland
L. Grulich, SUNY, Syracuse, New York
K. Ross, NIDDK, National Institutes of Health, Bethesda, Maryland
L. Topper, University of North Carolina, Chapel Hill
This course is a modern, state-of-the-art laboratory course designed to teach the students the full
repertoire of genetic approaches needed to dissect complex problems in the yeast Saccharomyces
cerevisiae. Combinations of classical genetic approaches are emphasized, including the isolation and
characterization of mutants, tetrad analysis, complementation, and mitotic recombination. Molecular
genetic techniques, including various types of yeast transformation, gene replacement with plasmids
and PCR, construction and analysis of gene fusions, and generation of mutations in cloned genes,
were also emphasized. Students used the classical and molecular approaches to gain experience in
identifying and interpreting various kinds of genetic interactions including suppression and synthetic
lethality. Students were immersed in yeast genomics and performed and interpret experiments with
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DNA arrays. Students gained first-hand experience in modern cytological approaches such as epitope
tagging and imaging yeast cells using indirect immunofluorescence, GFP-protein fusions, and a variety
of fluorescent indicators for various subcellular organelles. Lectures on fundamental aspects of yeast
genetics were presented along with seminars given by outside speakers on topics of current interest.
This years speakers included Joaquin Arino, Kerry Bloom, Charlie Boone, Fred Cross, Dean Dawson,
David Levin, Susan Michaelis, Jodi Nunnari, Mark Rose, Rodney Rothstein, Jeremy Thorner, and Mark
Tyers.
PARTICIPANTS
Aulds, J., B.S., Ph.D., Upstate Medical University, Syracuse,
New York
Baehr, A., M.S., Ph.D., University of Heidelberg, Germany
Bagnat, M., Ph.D., MPI-GBG, Dresden, Germany
Balcer, H., B.S., Ph.D., Brandeis University, Waltham, Massa-
chusetts
Giota, F., M.Sc., Ph.D., Botanical Institute, Hever lee-Leuven,
Belgium
Gottlieb, T., BA., Ph.D., Fred Hutchison Cancer Research
Center, Seattle, Washington
Hogan, S., B.S., M.S., Genome Therapeutics Corporation,
Waltham, Massachusetts
Kumamoto, C., B.A., Ph.D.,Tufts University, Boston, Massa-
chusetts
SEMINARS
Arino, J., Universidad Autonoma de Barcelona, Spain: Ppz
phosphatases: Looking for a job.
Bloom, K., University of North Carolina, Chapel Hill: Chromo-
some and nuclear dynamics in yeast.
Boone, C., University of Toronto, Canada: SGA and functional
genomics in yeast.
Tyers, M., Washington University, St. Louis, Missouri: Genome-
wide synthetic lethal arrays for discovery of gene function
and pathway mapping. More genome-wide synthetic lethal
arrays for discovery of gene function and pathway mapping.
Cross, F., The Rockefeller University, New York: Strange arith-
metic in genetic analysis of mitotic exit.
Dawson, D., Tufts University, Boston, Massachusetts: Finding
your partner without loosing your sister; challenges for meiot-
ic chromosomes.
Levin, D., Johns Hopkins University, Baltimore, Maryland: Cell
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Lehtinen, S., M.Sc., Ph.D., University of Tampere, Finland
Li, L., B.S., M.S., St. John's University, Jamaica, New
York
Santos, J., B.S., Ph.D., National Institutes of Environmental
Health Sciences, Durham, North Carolina
Schneider, K., B.S., Ph.D., Massachusetts Institute of Tech-
nolgy, Cambridge
Schrift, G., B.S., University of Iowa, Iowa City
Van Berkum, N., B.S., M.S., University Medical Center Utrecht,
The Netherlands
Wiedemann, N., Dipl., University of Freiburg, Germany
Witt, S., B.S., Ph.D., Louisiana State University Health
Sciences Center, Shreveport
wall integrity signaling.
Michaelis, S., Johns Hopkins Medical School, Baltimore,
Maryland: Nonclassical biogenesis of yeast a-factor: CaaX
processing and export via an ABC transporter.
Nunari, J., University of California, Davis: Regulation of mito-
chondrial behavior.
Rose, M., Princeton University, New Jersey: Nuclear (con)fusion
during mating-Kar54 where you are?
Rothstein, R., Columbia University, New York: Genome gym-
nastics: Using recombination as a tool (and some biology,
too!)
Stearns, T., Stanford University, California: The DNA damage
checkpoint is nuclear limited in yeast.
Thorner, J., University of California, Berkeley: Septins, septin fil-
ament assembly, and a novel cell cycle checkpoint.
Cellular Biology of Addiction
August 7-13
INSTRUCTORS R. Blakely, Vanderbilt University School of Medicine, Nashville, Tennessee
B. Madras, Harvard Medical School, Southborough, Massachusetts
N. Volkow, Brookhaven National Laboratory, Upton, New York
ASSISTANT G. Miller, Harvard Medical School, Boston, Massachusetts
Drug addiction is the most costly neuropsychiatric disorder faced by our nation. The primary objectives
of this workshop were to provide an intense dialogue of the fundamentals, state-of-the-art advances,
and major gaps in the cell and molecular biology of drug addiction. Targeted to new or experienced
investigators, the course combined formal presentations and informal discussions to convey the mer-
its and excitement of cellular and molecular approaches to drug addiction research. With the advent of
genomics and proteomics, an extraordinary opportunity now exists to develop comprehensive models
of neuroadaptative processes fundamental to addiction, craving, and relapse to drug use and to brain
function, in general. A range of disciplines and concepts were represented, including (1) current views
on addiction; (2) the contribution of noninvasive brain imaging to identify drug targets and adaptive
processes; (3) the association between neuroadaptative processes to drugs and behavioral manifes-
tations; (4) linkage of genotype to drug response; (5) tolerance, sensitization, and adaptation at the cel-
lular level; and (6) regulation of receptor, enzyme function, and associated neural activity. This work-
shop course provided an integrated view of current and novel research on neuroadaptive responses to
addiction, fostered discussion on collaboration and integration, provided critical information needed to
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construct a model of addiction as a disease, and molecular targets for biological treatments. Beyond
the plane of scientific endeavor, the information from these approaches are vital for formulating public
policy and for enlightening the public on the neurobiologicalconsequences of drug use and addiction.
This workshop course was designed to generate interest in cell and molecular biology, open conduits
for collaborations and novel routes to investigating the neurobiology of addiction.
PARTICIPANTS
Benveniste, H., M.D., Ph.D., Brookhaven National Laboratory/
SUNY Upton, New York
Brown, J., B.S., Ph.D., New England Regional Primate
Research Center, Southborough, Massachusetts
Caine, S.B., B.A., Ph.D., Harvard Medical School, Belmont,
Massachusetts
Carey, R., B.A., Ph.D., VA Medical Center, Syracuse, New York
Corti, C., B.Sc., Ph.D., GlaxoSmithKline, Verona, Italy
Dawes, M., BA., M.D., University of Texas Health Science
Center, San Antonio
Falerio, L., Ph.D., Brown University, Providence, Rhode Island
Gulley, J., B.S., Ph.D., University of Colorado Health Sciences
Center, Denver
Keefe, K., B.A., Ph.D., University of Utah, Salt Lake City
Lindsey, K., B.A., Ph.D., Emory University, Atlanta, Georgia
Lloyd, S., B.A., M.S., St. Jude Children's Research Hospital,
Memphis, Tennessee
Maldonaldo-Vlaar, C., B.S., Ph.D., University of Puerto Rico,
San Juan
Allen, R., Oregan Health Sciences University, Portland: Opioid
regulation of cell responses.
Blakely, R., Vanderbilt University School of Medicine, Nashville
Tennessee: The serotonin transporter: Structure, trafficking,
and in vivo imaging.
Collins, A., University of Colorado, Boulder: A primer for using
genetic strategies to study nicotine abuse.
Crabbe, J., Oregon Health Sciences University, Portland: Genes
and their evironment.
Devi, L., New York University School of Medicine, NewYork:
Receptor dimerization and functional consequences.
Edwards, R., University of California, San Francisco: Vesicular
and membrane transporters: Modulators of transportersand
synaptic activity.
Evans, C., Regents University of California, Los Angeles:
Endogenous opiates in reward and adaptive responses to
opiates.
Kreek, M.J., The Rockefeller University, New York: Peptide
gene polymorphisms and potential implications for addiction
to opiates.
Lester, H., California Institute of Technology, Pasadena: Ion
channel receptors and transporters: Role in brain function.
Madras, B., Harvard Medical School, Southborough, Massa-
chusetts: Brain imaging of psychostimulant targets: Rele-
vance to cocaine addiction and medicationsdevelopment.
Pollack, J., National Institute of Drug Addiction, Baltimore,
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Maraganore, D., B.S., M.D., Mayo Clinic, Rochester,
Minnesota
Mayne, L., B.Sc., University of Sussex, Brighton, United
Kingdom
Morrell, J., B.S., Ph.D., Rutgers University, Newark, New Jersey
Rahim, R., B.S., Ph.D., Temple University, Philadelphia,
Pennsylvania
Rubakhin, S., M.Sc., Ph.D., University of Illinois, Urbana-
Champaign
Schramm, N., B.S., Ph.D., Vanderbilt University, Nashville,
Tennessee
Silveri, M., B.S., Ph.D., McLean Hospital, Belmont, Massa-
chusetts
Taha, S., B.S., Ph.D., University of California, San Francisco
Thomas, M., B.A., Ph.D., University of Michigan, Ann
Arbor
Whittington, R., BA., M.D., Columbia University, New York
Xu, M., B.S., Ph.D., University of Cincinnati, Ohio
Yun, I., BA., M.S., University of California, San Francisco
Maryland: NIDA support for genetic and molecular approach-
es to drug abuse.
Robinson, T., University of Michigan, Ann Arbor: Drug-induced
neuroplasticity: Implications for motivational and emotional
processes in addiction.
Rudnick, G., Yale University School of Medicine, New Haven,
Connecticut: Transporter structure and function.
Self, D., University of Texas Southwestern Medical Center: Drug
craving and relapse in drug addiction.
Tsien, R., University of California, San Diego: Monitoring and
manipulating cell signals and proteins.
Volkow, N., Life Sciences, Brookhaven National Laboratory,
Upton, New York: Imaging the effects of chronic drug use in
human brain.
Von Zastrow, M., University of California, San Francisco:
Differences in cellular response to opiates in vitro: A modelfor
cellular tolerance?
Vrana, K., Wake Forest University Medical School, Winston-
Salem, North Carolina: Functional genomics of substance
abuse.
Wong, D., Johns Hopkins University, Baltimore, Maryland: Neuro-
toxic effects of drugs of abuse: Imaging, mechanisms, and cor-
relation with neuropsychological tests.
Worley, P., Johns Hopkins University School of Medicine,
Baltimore, Maryland: Immediate early genes and synaptic
plasticity.
Macromolecular Crystallography
October 15
INSTRUCTORS W. Furey, VA Medical Center, Pittsburgh, Pennsylvania
G. Gilliland, National Institute of Standards and Technology, Gaithersburg, Maryland
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku/MSC, Inc., The Woodlands, Texas
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This intensive laboratory/computational course focused on the major techniques used to
determine the three-dimensional structures of macromolecules. It was designed for scientists with a
working knowledge of protein structure and function, but who are new to macromolecular crystallog-
raphy. Topics covered included crystallization (proteins, nucleic acids, and complexes), crystal charac-
terization, X-ray sources and optics, synchrotrons, crystal freezing, data collection, data reduction, mul-
tiple isomorphous replacement, multiwavelength anomalous diffraction phase determination, solvent
flattening, molecular replacement and averaging, electron density interpretation, structure refinement,
molecular graphics, noncrystallographic summary, simulated annealing, and coordinate desposition.
Participants learned through extensive hands-on experiments. They crystallized and determined a pro-
tein structure, along with lectures on the theory and informal discussions behind the techniques.
Applicants were familiar with the creation and editing of simple text files on UNIX workstations, using a
screen-based editor such as vi, emacs, or jot.
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PARTICIPANTS
Adams, E., B.S., Ph.D., Stanford University School of Medicine,
California
Bertero, M., Ph.D., University of British Columbia, Canada
Bohle, S., B.A., Ph.D., University of Wyoming, Laramie
Bredt, D., M.D., Ph.D., University of California, San Francisco
Celie, P., Ph.D., Netherlands Cancer Institute, Amsterdam
Edayathumangalam, R., B.Sc., M.Sc., Colorado State
University, Fort Collins
Gibson, T., B.A., Ph.D., University of Wisconsin, Madison
Hubbard, J., B.Sc., Ph.D., GlaxoSmithKline, Stevenage, United
Kingdom
Kosinski-Collins, M., B.S., Ph.D., Massachusetts Institute
of Technology, Cambridge
SEMINARS
Adams, P., Lawrence Berkeley Laboratory, Berkeley, California:
Simulated annealing refinement. Introduction to CNS.
Brodersen, D., MRC Laboratory of Molecular Biology, United
Kingdom: Crystallographic methods for macromolecular
assemblies. Insights from the atomic resolution structure of
the 30S ribosomal subunit.
Dodson, E., University of York, United Kingdom: CCP4:
System and tutorial.
Furey, W., VA Medical Center, Pittsburgh, Pennsylvania:
Isomorphous replacement and anomalous scattering I.
Isomorphous replacement and anamalous scattering II.
Symmetry operators. Phase improvement by solvent flatten-
ing/negative density transaction. Crystallographic symmetry
operations and their application. Noncrystallographic
symmetry averaging. Structure determination and
analysis of the pyruvate dehydrogenase. Multienzyme
El complex.
Hendrickson, W., Columbia University, New York: MAD phas-
ing: Theory and practice.
Hung, L.-W., Brookhaven National Laboratory, Upton, New
York: Practical aspects of MAD methods. Solve tutorial.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Crystal struc-
tures of two intermediates in the assembly of the papillo-
mavirus replication and initiation complex. Structure
presentation.
Kjeldgaard, M., Aarhus University, Denmark: Electron density
fitting from A to 0.
McPherson, A., University of California, Irvine: Crystallization of
macromolecules I. Crystallization of macromolecules II.
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Nielsen, R., B.A., University of Aarhus, Denmark
Ohren, J., B.A., M.S., Pfizer Global Research and Develop-
ment, Ann Arbor, Michigan
Petros, A., B.S., Ph.D., Abbott Laboratories, Abbott Park,
Illinois
Ramirez, U., B.S., Ph.D., Northwestern University, Chicago,
Illinois
Shuman, S., B.A., Ph.D., Memorial Sloan-Kettering Cancer
Institute, New York
Sironi, L., B.S., Ph.D., European Institute of Oncology, Milano,
Italy
Vannini, A., B.S., M.S., Institute di Richerche di Biologia
Molecolare, Angeletti, Rome, Italy
Vectors, waves, symmetry, and planes. Preliminary crystal
characterization, crystallographic symmetry, and unit cells.
Fundamental diffraction relationships I. Fundamental diffrac-
tion relationships II. Fourier transforms and the electron densi-
ty equations. Patterson techniques. Heavy atoms and anom-
alous scatterers.
Navaza, J., CNRS-GIF, Gif-sur-Yvette, Switzerland: Molecular
replacement.
Perrakis, A., NKI, Netherlands Cancer Institute, Amsterdam:
ARP/wARP: The underlying concepts and algorithms for
automated procedures for phase improvement, extension,
and model building ARP/wARP: Implementation and exam-
ples of applications.
Pflugrath, J., Rigaku/MSC, Inc., The Woodlands, Texas: Data
collection: Design and setup. Cryocrystallography. Data col-
lection: Integration and post processing. Application of anom-
alous scattering from sulfur atoms.
Richardson, J., Duke University Medical Center, Durham, North
Carolina; Richardson, D., Duke University Medical Center,
Durham, North Carolina: Contact dots.
Sweet, R., Brookhaven National Laboratory, Upton, New York:
Introduction to X-ray crystallography. X-ray sources and
optics.
Tronrud, D., University of Oregon, Eugene: Macromolecular refi-
inement I. Macromolecular refinement II. TNT tutorial.
Westbrook, J., Rutgers University, Piscataway, New Jersey:
The protein data bank.
Xu, R.-M., Cold Spring Harbor Laboratory: Structural basis of
NAD+-dependent protein deacetylation.
Bioinformatics: Writing Software for Genome Research
October 17
INSTRUCTORS S. Rozen, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
L. Stein, Cold Spring Harbor Laboratory
ASSISTANTS A. Day, University of California, Los Angeles
E. Birney, EMBL-EBI, Hinxton, United Kingdom
J. Barnett, Massachusetts Institute of Technology, Cambridge
R. Halgren, Michigan State University, East Lansing
J. Kissinger, University of Pennsylvania, Philadelphia
V. Mootha, Whitehead Institute, Cambridge, Massachusetts
C. Mungal, University of California, Berkeley
L. Palmer, Cold Spring Harbor Laboratory
The desktop computer is rapidly becoming an indispensable tool in the biologist's toolchest. The suc-
cess of the human genome project has created an explosion of information: billions of bits of biologi-
cal information stashed electronically in databases around the globe just waiting for the right key to
unlock them. New technologies such as DNA microarrays and high-throughput genotyping create an
information overload that the traditional laboratory notebook cannot handle. To exploit the information
revolution in biology, biologists must move beyond canned Web interfaces and Excel spreadsheets.
They can take charge of the data by creating their own software to fetch, manage, and integrate it.
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The goal of this course was to provide biologists with the tools needed to deal with this changing
landscape. Designed for students and researchers with little prior knowledge of programming, this 2-
week course taught the fundamentals of the Unix operating system, Perl scripting, dynamic Web page
development with the CGI protocol, and database design. The course was combined with formal lec-
tures with hands-on experience in which students work to solve a series of problem sets drawn from
common scenarios in biological data acquisition, integration, and laboratory workflow management.
For their final projects, students posed problems using their own data and worked with each other and
the faculty to solve them.
PARTICIPANTS
Alcazar, R., B.S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Brown, C., B.S., Ph.D., Washington State University, Pullman
But land, S., B.Sc., M.Sc., University of British Columbia,
Vancouver, Canada
Gaudy, M., B.S., Ph.D., Burke Medical Research Institute of
Cornell Medical College, White Plains, New York
Chang, J., B.S., Ph.D., Whitehead Institute/Massachusetts
Institute of Technology, Cambridge
Futcher, B., B.Sc., SUNY Stony Brook, New York
Hong, N., B.S., Ph.D., University of California, San Francisco
Huang, S., B.S., Ph.D., Memorial Sloan-Kettering Cancer
Center, New York
Johnston, D., B.Sc., Ph.D., The Natural History of Museum,
London, United Kingdom
Jordan, B., BA., Massachusetts Institute of Technology, Center
for Cancer Research, Cambridge
Lamb, J., B.Sc., Ph.D., Dana-Farber Cancer Institute, Boston,
Massachusetts
Miska, E., BA., Ph.D., Massachusetts Institute of Technology,
Cambridge
SEMINARS
Daly, M., Whitehead Institute/Massachusetts Institute of
Technology, Cambridge: LD.
Gaasterland, T., The Rockefeller University, New York: Genomic
analysis.
Hughey, R., University of California, Santa Cruz: HMMS.
Jamison, C., George Mason University, Manassas, Virginia:
Object-oriented Pen.
Lewis, S., Lawrence Berkeley Laboratory, Berkeley, California:
Gene ontologies.
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Moreno, C., B.S., Ph.D., Emory University, Atlanta, Georgia
Murphy, C., B.S., Ph.D., University of California, San Francisco
Nash, J., B.Sc., Ph.D., National Research Council of Canada,
Ontario
Nelson, R., B.S., Ph.D., St. Louis University, Missouri
Palomino Mondragon, M., B.S., University of California, Irvine
Rathore, D., B.S., Ph.D., National Institutes of Health,
Bethesda, Maryland
Reiter, L, B.S., Ph.D., University of California, San Diego
Schoepfer, R., M.D., University College London, United
Kingdom
Singer, T., M.S., Ph.D., Cold Spring Harbor Laboratory
Tanurdzic, M., B.Sc., Ph.D., Purdue University, West Lafayette,
Indiana
Taylor, K., B.S., Ph.D., Cedars Sinai Medical Center, Los
Angeles, California
Wei, Y., B.S., Ph.D., Blackstone Technology Group, West
Caldwell, New Jersey
Zhao, X., B.S., Ph.D., Cold Spring Harbor Laboratory
Zito, K., B.S., Ph.D., Cold Spring Harbor Laboratory
Marth, G., National Institutes of Health/National Center for
Biotechnolgy Information, Bethesda, Maryland: Sequence
pipeline.
Pearson, W., University of Virginia, Charlottesville: Sequence
alignment.
Pietzsch, R., Pfizer Global Research and Development, Groton,
Connecticut: Practical and flexible database.
Slonim, D., Genetics Institute, Wyeth-Ayerst Research, Cam-
bridge, Massachusetts: Expression topic.
Immunocytochemistry, In Situ Hybridization, and Live Cell Imaging
October 20-November 2
INSTRUCTORS G. Matera, Case Western Reserve University, Cleveland, Ohio
J. Murray, University of Pennsylvania School of Medicine, Philadelphia
J. Swedlow, University of Dundee, United Kingdom
ASSISTANTS A. Binnie, Oxford University, United Kingdom
M. Difilippantonio, National Cancer Institute/NIH, Bethesda, Maryland
T. Howard, University of New Mexico, Albuquerque
K. Hu, University of Pennsylvania, Philadelphia
M. Platani, University of Dundee, United Kingdom
This course focused on specialized techniques in microscopy, in situ hybridization, immunocytochem-
istry, and live cell imaging related to localizing DNA, RNA, and proteins in fixed cells as well as protein
and RNA dynamics in living cells. The course emphasized the use of the latest equipment and tech-
niques in fluorescence microscopy, including confocal laser scanning microscopy, deconvolution meth-
ods, digital image processing, and time-lapse imaging of living specimens. The course was designed
to present students with state-of-the-art technology and scientific expertise in the use of light
microscopy to address basic questions in cellular and molecular biology. The course was designed for
the molecular biologist who is in need of microscopic approaches and for the cell biologist who is not
familiar with the practical application of the advanced techniques presented in the course. Among the
methods presented were the preparation of tagged nucleic acid probes, fixation methods, detection of
multiple DNA sequences in single nuclei or chromosome spreads, comparative genomic hybridization,
cellular localization of RNA, localization of nucleic acids and proteins in the same cells, use of a variety
of reporter molecules and nonantibody fluorescent tags, indirect antibody labeling, detection of multi-
ple proteins in a single cell, and the use of GFP variants to study protein expression, localization, and
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dynamics. In each method, several experimental protocols were presented allowing the students to
assess the relative merits of each and to relate them to their own research. Students were encouraged
to bring their own nucleic acid, protein, or antibody probes to the course, which were used in addition
to those provided by the instructors. The laboratory exercises were supplemented with lectures given
by invited distinguished scientists, who presented up-to-the-minute reports on current methods and
research using the techniques being presented.
PARTICIPANTS
Ben T., H., B.S., M.S., Biozentrum, Basel, Switzerland
Brodin, G., B.S., Ludwig Institute for Cancer Research,
Uppsala, Sweden
Brown, N., B.S., Ph.D., Northwestern University, Evanston,
Illinois
Eriksson, S., B.S., M.S., Karolinska Institute, Stockholm,
Sweden
Groth, A., B.S., M.S., Danish Cancer Society, Copenhagen,
Denmark
Henel, G., B.S., Mayo Graduate School, Rochester,
Minnesota
Houston, A., B.S., Ph.D., University College Cork, Ireland
Jahnel, R., B.S., M.S., Freie Universtat Berlin, Germany
Kim, S., B.S., M.S., Korea Advanced Institute of Science and
SEMINARS
Dernburg, A., Lawrence Berkeley National Laboratory, Berkeley,
California: Chromosome FISH.
Fraser, S., California Institute of Technology, Pasadena: Imaging
the cell movements and lineages of vertebrate embryos with
light and MRI microscopy.
Matera, G., Case Western Reserve University, Cleveland, Ohio:
RNA FISH.
Murray, J., University of Pennsylvania School of Medicine, Phila-
delphia: Basic Introduction to light and fluorescence micros-
copy. Immunocytochemistry.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia; Swedlow, J., National Cancer Institute/NIH,
Dundee, United Kingdom: Principles of confocal microscopy
and deconvolution techniques.
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Technology, Taejon, Republic of Korea
Lurio, K., M.D., Ph.D., National Public Health Institute, Helsinki,
Finland
Lyles, V., B.A., University of California, Los Angeles
Rashkova, S., B.S., Ph.D., Massachusetts Institute of
Technology, Cambridge
Rubtsov, A., B.S., M.S., University of Colorado Health Science
Center, Denver
Vorwerk, S., B.S., M.S., Max-Planck Institute for Plant Breeding
Research, Cologne, Germany
Voss, T, B.S., Ph.D., University of Virginia Health Sciences,
Charlottesville
Wei, C., B.S., Ph.D., University of Texas, M.D. Anderson
Cancer Center, Houston
Pederson, T., University of Massachusetts Medical School,
Worcester: Tracking RNA molecules in the nucleus.
Ried, T, National Cancer Institute/NIH, Bethesda, Maryland:
Mechanisms and consequences of chromosomal aberrations
in cancer cells.
Singer, R., Albert Einstein Co lige of Medicine, Bronx, New York:
Cytoplasmic organization of mRNA.
Spring, K., National Heart, Lung, and Blood Institute/NIH,
Bethesda, Maryland: Cameras and light sources.
Straight, A., Harvard Medical School, Boston, Massachusetts:
Applications of green fluorescent protein in microscopy.
Swedlow, J., University of Dundee, United Kingdom: Live-cell
imaging.
Computational Genomics
October 31-November 5
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
R. Smith, GlaxoSmithKline, King of Prussia, Pennsylvania
ASSISTANT A.J. Mackey, University of Virginia, Charlottesville
Beyond BLAST and FASTA: This course presented a comprehensive overview of the theory and prac-
tice of computational methods for gene identification and characterization from DNA sequence data.
The course focused on approaches for extracting the maximum amount of information from protein
and DNA sequence similarity through sequence database searches, statistical analysis, and multiple
sequence alignment. Additional topics included gene recognition (exon/intron prediction), identifying
signals in unaligned sequences, and integration of genetic and sequence information in biological data-
bases. The course combined lectures with hands-on exercises; students were encouraged to pose
challenging sequence analysis problems using their own data. The course maked extensive use of local
VVWVV pages to present problem sets and the computing tools to solve them. Students used Windows
and Mac workstations attached to a Unix server; participants had to be comfortable using the Unix
operating system and a Unix text editor. The course was designed for biologists seeking advanced
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training in biological sequence analysis, computational biology core resource directors and staff, and
scientists in other disciplines, such as computer science, who wish to survey current research prob-
lems in biological sequence analysis.
PARTICIPANTS
Brigido, M., BA., Ph.D., Universidade de Brasilia, Asa forte,
Brasilia
Chen, H.-C., B.S., M.S., National Center for Biotechnology
Information, Bethesda, Maryland
Clark, T., B.S., Ph.D., The University of Chicago, Illinois
Czabarka, E., B.S., M.S., Ph.D., NLM, NCBI, National Institutes
of Health, Bethesda, Maryland
DeCamilli, P., B.S., M.D., Yale University School of Medicine,
New Haven, Connecticut
Fauron, C., B.A., M.S., Ph.D., University of Utah, Salt Lake
City
Good, P. B.S., Ph.D., National Human Genome Research
Institute, Bethesda, Maryland
Guo, D., B.S., Ph.D., Virginia Bioinformatics InstituteNirginia
Technology, Blacksburg
Hoffmann, H., B.S., Ph.D., Alpha Gene, Lunenburg, Massachu-
setts
Huang, S., B.S., Ph.D., Memorial Sloan-Kettering Cancer
Center, New York
Lovato, M., B.A., The Scripps Research Institute, La Jolla,
California
Matise, T, B.S., Ph.D., Rutgers University, Piscataway, New
Jersey
SEMINARS
Altschul, S., National Library of Medicine, Bethesda, Maryland:
Statistics of sequence similarity scores. Iterated protein data-
base searches with PSI -BLAST.
Ashburner, M., EMBL-EBI, Cambridge, United Kingdom:
Gene ontologies-From structure to function. The
Drosophila Genome Project-What have we learned.
Bateman, A., The Sanger Centre, Hinxton, United Kingdom:
Introduction to protein family databases. Multiple sequence
alignment with hidden Markov models.
Cooper, F, National Center for Biotechnology Information,
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Miller III, H., B.S., Ph.D., E. Tennessee State University,
Johnson City
Moloshok, T, B.S., Ph.D., Fox Chase Cancer Center,
Philadelphia, Pennsylvania
Olofeson, P., M.S., Ph.D., Inflammation Research, Lund,
Sweden
Park, Y., B.S., Ph.D., NCBI, National Institutes of Health,
Bethesda, Maryland
Pear, W., BA., Ph.D., University of Pennsylvania,
Philadelphia
Strand, M., BA., Ph.D., ARO/NIEHS, Research Triangle Park,
North Carolina
Vincent, B., B.S., Louisana State University, New Orleans
Welsh, J., B.Sc., M.S., National Research Council, Halifax,
Canada
Westerman, R., B.S., Purdue University, West Lafayette,
Indiana
Xie, Q., B.S., Ph.D., GlaxoSmithKline, King of Prussia,
Pennsylvania
Zhao, C., B.S., Ph.D., Marshfield Medical Research
Foundation, Marshfield, Wisconsin
Zhao, Y., B.S., M.D, University of Southern California, Los
Angeles
Bethesda, Maryland: NCBI Databases. NCBI tools for
genome analysis.
Pearson, W., University of Virginia, Charlottesville: Protein
evolution-biology. Algorithms for pairwise sequence
comparison. Motifs in protein and DNA sequences.
Smith, R., GlaxoSmithKline, King of Prussia, Pennsylvania:
Introduction to multiple sequence alignment.
Yandell, M., Celera Genomics, Rockville, Maryland: Eukaryotic
gene identification. Bioinformatics on a genome scale.
Phage Display of Combinatorial Antibody Libraries
November 6-19
INSTRUCTORS C. Barbas, The Scripps Research Institute, La Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, San Diego
ASSISTANTS R. Fuller, Scripps Research Institute, La Jolla, California
C. Goodyear, University of California, San Diego
K. Noren, New England Biolabs, Beverly, Massachusetts
C. Tuckey, New England Bio labs, Beverly, Massachusetts
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This intensive laboratory/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and selection of desired antibodies from the library. Students learned the theoretical and prac-
tical aspects of constructing combinatorial libraries from immune and nonimmune sources as well as
the construction of synthetic antibody libraries. Antibodies were selected from the library by panning.
Production, purification, and characterization of Fab fragments expressed in E. coli were also covered.
Studies resulting in specific peptide-bearing phage were also performed.
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The lecture series, presented by a number of invited speakers, emphasized the PCR of immuno-
globulin genes, the biology of filamentous phage and the utility of surface expression libraries, expres-
sion of antibodies in E. coli and mammalian cells, antibody structure and function, catalytic antibodies,
directed protein evolution, retroviral and cell display libraries, the immunobiology of antibody activity,
and recent results on the use of antibodies in therapy. The theory and practical implications for selec-
tion from phage displayed libraries of random peptides, cDNA products, and semisynthetic proteins
were also explored.
PARTICIPANTS
An, Z., B.S., Ph.D., Merck Reseach Laboratories, Rahway, New
Jersey
Banedee, C., B.Sc., Ph.D., Dyax Corp, Cambridge, Massachu-
setts
Boffey, J., B.Sc., Ph.D., Glasgow University, Scotland
Brown, E., B.Sc., Glasgow Caledonian University, Scotland
Eckert, D., B.S., Ph.D., Merck Research Labs, Rahway, New Jersey
Gerena, R., B.S., Ph.D., Immunicon Corporation, Huntingdon
Valley, Pennsylvania
Handali, S., M.D., Tulane University, New Orleans, Louisiana
Huebner, J., M.D., Brigham & Women's Hospital, Boston,
Massachusetts
Jeong, Y., Ph.D., Weill Medical College of Cornell University,
New York
SEMINARS
Barbos, C., The Scripps Research Institute, La Jolla, California:
Software and hardware for genomes: Polydactyl zinc finger
proteins and the control of endogenous genes.
McHeyzer-William, M., Duke University Medical Center,
Durham, North Carolina: Regulation and development of
antibody responses in vitro.
Model, P, The Rockefeller University, New York: Biology of
the filamentous phage.
Noren, C., New England Biolabs, Beverly, Massachusetts:
Phage peptide libraries: The Ph.D. for peptides.
Pasqualini, R., University of Texas M.D. Anderson Cancer
The Laboratory would like to acknowledge the generosity
reagents to the various courses:
ALA Scientific Instruments, Inc.
A-M Systems Inc.
Affymetrix Inc.
Ambion Inc.
Amersham Biosciences
AM.RI.
Applied Biosystems
Applied Precision Inc.
Applied Scientific Instrumentation, Inc.
Astro-Med Inc.
Axon Instruments
Becton Dickinson Labware
Bellco Glass Inc.
Berthold Technologies USA, LLC
Biocrest Manufacturing
Bio-Rad Laboratories
Bioptechs Inc.
BioVision Technologies
Bio Whittaker Molecular Applications
Brinkmann Instruments
Burleigh Instruments, Inc.
Carl Zeiss, Inc.
Cell and Molecular Technologies, Inc.
Cell Signalling Technology Inc.
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Chemicon Inc.
Chrome Technology Corporation
Clontech Laboratories, Inc.
Codonics Inc.
Coherent Laser
Dugan Corporation
David Kopf Instruments
Delaware Diamond Knives
Diagnostic Instruments, Inc.
Drummond Scientific Company
Dynal
EY Laboratories Inc.
Eastman Kodak Company
Fisher Scientific
Fotodyne Inc.
Galil Motion Control
Genetronics Inc.
HVS Image Ltd.
Hamamatsu Photonic Systems
Hampton Research
Harvard Apparatus, Inc.
Instrutech Corp.
Intelligent Imaging Innovations Inc.
Invitrogen Corporation
Knapp, B., M.S., Ph.D., Max-Planck Institute, Freiburg,
Germany
Krah, R., BA., Ph.D., IDEK< Laboratories Inc., Westbrook,
Maine
Lovett, M., BA., Howard Hughes Medical Institute and
University of California, San Francisco
Mori, T., B.S., Ph.D., National Cancer Institute, Frederick,
Maryland
Schmechel, D., Ph.D., National Institute for Occupational Safety
and Health, Morgantown, West Virginia
Schmucker, D., B.S., Ph.D., Harvard Medical School and
Dana-Farber Cancer Institute, Boston, Massachusetts
Wayner, E., B.S., Ph.D., Fred Hutchinson Cancer Research
Center, Seattle, Washington
Center, Houston: In vivo panning.
Sidhu, S., Genetech, Inc., S. San Francisco, California:
Mapping protein and cellular function with phage display.
Siegel, D., University of Pennsylvania School of Medicine,
Philadelphia: Cell surface selection of combinatorial Fab
libraries.
Silverman, G., University of California, San Diego: Repertoire
cloning of SLE autoantibodies.
Wilson, I., The Scripps Research Institiute, La Jolla, California:
Structural biology of the immune system.
of the following companies who loaned equipment and
Jackson Immunoresearch
Laboratories
Jouan, Inc.
Leica Microsystems Inc.
Mcmaster Carr Supply Company
Majer Precision Engineering Inc.
Med Associates Inc.
Micro Video Instruments
MJ Geneworks
MJ Research Inc.
Modulation Optics, Inc.
Molecular Devices Corporation
Molecular Dynamics
Molecular Probes Inc.
Nalge Nunc International
Narishige International USA, Inc.
Newark Electronics
New England Biolabs, Inc.
Newport Corp.
Nikon Inc.
Novagen Inc.
Olympus America Inc.
Operon Technologies Inc.
Optronics
Parker Hannifin Corporation
Perkin Elmer Life Sciences
Pierce Chemical Co.
Promega Corp.
Qiagen Inc.
Robbins Scientific Corporation
Roche Diagnostics
SD Instruments Inc.
Santa Cruz Biotechnology Inc.
Savant Instruments
Schleicher & Schuell Inc.
Sigma-Aldrich
Sony Medical Systems
Specialty Media
Sutter Instruments
TI.L.L. Photonics Gmbh
Technical Manufacturing Corp.
Teco Pneumatic Inc.
Universal Imaging Corporation
WVR Scientific Products
Vector Laboratories
Vincent Associates
Waters Corp.
Western Technology Marketing, Inc.
SEMINARS
Invited Speaker Program
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
latest findings on a weekly basis. These seminars keep the CSHL staff current on the latest develop-
ments and broaden their perspectives. Graduate students and postdoctoral fellows meet with the sem-
inar speakers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas
in an informal setting.
January
Dr. Michael Dustin, Washington University School of Medicine.
The immunological synapse. (Host: Leemor Joshua-Tor)
Dr. Nat Heintz, The Rockefeller University. Molecular mecha-
nisms of cerebellar development. (Host: Josh Huang)
Dr. William Newsome, HHMI/Stanford University School of
Medicine. Making decisions: The brain's link between per-
ception and action. (Host: Tony Zador)
February
Dr. Steven Henikoff, Fred Hutchinson Cancer Research Center.
Targeted screening for induced mutations. (Host: Rob
Martienssen)
Dr. Yi Xian Zheng, Carnegie Institution of Washington. The
nucleation and organization of the microtubule cytoskeleton.
(Host: Greg Hannon)
Dr. Joseph Nevins, Duke University Medical Center. Synergy in
pathways that regulate G1 cell cycle progression. (Host:
Michael Zhang)
Dr. David Allis, University of Virginia. Deciphering the histone
code: A growing "tale" about four "tails." (Host: David Spector)
March
Dr. Timothy Nilsen, Case Western Reserve University. Trans-
splicing: Novel SL RNP-specific factors and the splice site
recognition problem. (Host: Greg Hannon)
Dr. Derek Van Der Kooy, University of Toronto. How to make a
mammalian brain. (Host: Ed Stern)
Dr. Robert Benezra, Memorial Sloan-Kettering Cancer Center.
Id proteins are required for tumor angiogenesis. (Host: Rob
Lucito)
Dr. Nick Dyson, Massachusetts General Hospital Cancer
Center. Control of cell proliferation by the E2F transcription
factor. (Host: Scott Lowe)
April
Dr. Donald Ingber, Children's Hospital, Harvard Medical
School. The mechanics of cell and tissue regulation. (Host:
David Helfman)
Dr. Kevan Shokat, University of California, San Francisco.
Unnatural ligands for engineered receptors: New tools for
chemical genetics. (Host: Tatsuya Hirano)
Dr. Doug Hanahan, University of California, San Francisco.
Acquired cells and capabilities mediating tumorigenesis in
mice. (Host: Winship Herr)
October
Dr. Robert Desimone, NIMH, National Institutes of Health. How
the brain pays attention. (Host: Tony Zador)
Dr. Sangram Sisodia, University of Chicago. Molecular neuro-
biology of Alzheimer's disease. (Host: Yi Zhong)
November
Dr. Lorraine Pi Ilus, University of California, San Diego.
Modifying chromatin to modulate chromosomes and gene
expression. (Host: Shiv Grewal)
December
Dr. Gary Felsenfeld, NIDDK, National Institutes of Health.
Establishment and maintenance of chromatin boundaries.
(Host: Nouria Hernandez)
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In-House Seminar Program
Cold Spring Harbor In-House Seminars were initiated to providea semiformal avenue for communica-
tion between the various research groups at the Laboratory. The seminars also afford a necessary
opportunity for the graduate students and postgraduate staff to developtheir skills in organizing, pre-
senting, and defending their research.
January
Wun Chey Sin (Cline Lab): Rho in light-induced development.
Eric Drier (Yin Lab): Memory enhancement by a mammalian
atypical PKC isoform, PKM-Zeta in Drosophila melanogaster.
Rui-Ming Xu: Structural basis of NAD-dependent protein
deaceylation.
Marja Timmermans: Do plants get cancer?: Repression of
stem cell fate during leaf development.
February
Maria Soengas (Lowe Lab): Struggling between life and death:
Oncogenes, tumor suppressors and apoptosis.
Joanna Wysocka (Herr Lab): HCF-1 is targeted to chromatin
by its VP16 interaction domain to promote dell proliferation.
Bill Tansey: Transcriptional regulation and the ubiquitin-protea-
some pathway-or-do transcription factors have to die?
Ub the Judge.
March
Bruce Stillman: Inheritance of the genome.
Scott Powers, Tularik Genomics/CSHL: Discovery of ampli-
cons and candidate oncogenes.
Andrew Neuwald: Identifying determinants of protein structure
and function through sequence CHAIN analysis.
April
Dmitri Chklovskii: Maps in your brain: What can we learn from
them?
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David Jackson: Outside control: Communication and prolifera-
tion in plant stem cells.
Arne Stenlund: Initiation of papillomavirus DNA replication pro-
ceeds through an ordered assembly pathway.
October
Shiv Grewal: Epigenetic control of higher-order chromatin
assembly.
Michael Zhang: Computational molecular biology of gene
expression and regulation.
T.C. Meng (Tonks Lab): Redox-dependent signal transduction:
Signaling through reversible oxidation and inactivation of pro-
tein tyrosine phosphatases.
November
(Malinow Lab): Receptor trafficking in the devel-
oping brain: A story of forced retention and conditional
release.
Geraldine Pawlak (Helfman Lab): Interactions between cell sig-
naling and the cytoskeleton during oncogenic transforma-
tion.
December
Mary Byrne (Martienssen Lab): Stem cell fate and organogen-
esis in Arabidopsis.
Eli Hatchwell (Spector Lab): Histone tail modifications during
the initiation of X-chromosome inactivation.
2,;;'

BANBURY CENTER
DIRECTOR'S REPORT
The Banbury Center continues to be used almost year-round. There were 26 meetings in the Banbury
meetings program, and Laboratory staff came to the Center for seven internal meetings. The graduate
students of The Watson School of Biological Sciences held in March a week-long course on evolution,
and local community groups used our facilities on five occasions. Of the more than 650 participants in
the meetings in 2001,104 (14%) came from abroad. American participants came from 40 states, with
3 states-New York, California, and Maryland-providing one third of the visitors. The program of
meetings was, as usual, catholic in its range of topics.
Science Policy
Napster is a good example of how the Internet is making, and provoking, extraordinary changes in the
dissemination of anything that can be digitized. The world of scientific publishing is not immune from
these changes and Electronic Access to Scientific Literature (John Inglis and Jan Witkowski, April
16-18) was held to examine ideas and initiatives intended to lower the barriers to electronic access to
the scientific literature. Stimulated by the Pub Med Central Initiative, the participants examined this and
its implications for commercial publishers.
Great hope is being held for the applications of genomics to health care. This depends on having
not only the sequence of the human genome, but also appropriate technologies for using that infor-
mation and, just as importantly but often neglected, the appropriate health care and regulatory poli-
cies. The purpose of Integrating Genomics Technologies in Health Care: Practice and Policy
Challenges (Finley Austin and Thame Kreiner, February 25-28) was to assess where the technology is
heading; to educate participants in what is happening in fields other than their own; and to consider
broader issues such as social impact, safety, and oversight.
Another health care area where practical applications are heavily dependent on policy is in vaccine
development. Making Vaccines for the Developing World: Access to and Deployment of New
Technologies (Melinda Moree and Philip K. Russell, October 9-11) examined the ways in which early
access to enabling technologies is important for efficient and cost-effective vaccine development.
There may be difficulty in gaining such access except in cases where the price of the vaccine can be
set to pay for royalties on enabling technologies. There was discussion of what can be done to pro-
mote partnerships between public sector vaccine developers and the technology companies.
Genomics
The availability of complete genome sequences has spurred a tremendous increase in sequence analy-
sis, but this is being done largely on an ad hoc basis, with Web Sites using different sets of nomen-
clature rules, query systems, and user interfaces. The information becomes fragmented, and it is diffi-
cult for biologists to know what is available. The Genomic Annotation Workshop: DNA Replication
(Lincoln Stein and Ewan Birney, March 17-22) was the first in a series of workshops that will take a
well-circumscribed topic-in this case DNA replication-and bring biologists expert in the topic togeth-
er with informaticists. Together, they will create curated annotations of the genome that summarize the
current state of knowledge in the field. The workshop was very successful and the results were pre-
sented at the DNA Replication meeting.
Cancer
Three meetings on cancer were held at Banbury in 2001, all dealing with important issues in cancer
treatment. Two - Interferon: Biological Mechanisms and Disease Treatments I and //-dealt with the
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Meier House provides accommodations for meeting participants at Banbury Center.
clinical uses of interferon. Organized by Josh Fidler, and by Ernest Borden and Judah Folkman, respec-
tively, the meetings were particularly interesting in that they were not restricted to interferon and can-
cer, but reviewed the actions of interferon in virus infections as well as in multiple sclerosis. The meet-
ings also discussed the clinical trials of interferon and whether extending the findings to multi-institu-
tional Phase II trials will yield insights into the biology, pathology, and mechanisms of antitumor actions
of interferons.
New Concepts for Clinical Cancer Trials (Douglas Hanahan, Jan Witkowski, Judah Folkman, Robert
Kerbel, and Jim Pluda, November 4-7) discussed new findings indicating that the manner in which can-
cer treatments are given is important. It seems that different dosing schedules combined with lower
doses could increase the efficacy and reduce the toxicity and side effects of traditional cytotoxic drugs,
and perhaps also of radiotherapy and some investigational drugs. However, whereas a maximum tol-
erated dose is relatively easy to establish, it is not as clear how to determine optimal dosing at the low-
est possible levels while maintaining maximal efficacy in these kinds of schedules. The possible bene-
fits for patients are so great that these problems must be overcome.
The J.P. Morgan H&Q Executives Conference
David Deming and J.P. Morgan H&Q continue to support what is one of the highlights of the Banbury
Center year. This year's meeting-Controlling Cancer-tackled the controversial idea that an all-out war
on a patient's cancer by chemotherapy, radiation, and surgery-all of which cause considerable suf-
fering to the patient-may not be the best strategy. Instead, it may be possible to contain cancer, treat-
ing it as a chronic disease. We had a marvelous set of speakers including Doug Hanahan, Scott Lowe,
Bob Kerbel, Kari Alitalo, Raghu Kalluri, Brian Sawyers, and Joseph Schlessinger.
Neuroscience
The two Banbury Center meetings on neuroscience dealt with contrasting aspects of brain function.
One-Cortical Maps (Dmitri Chklovskii and Alexei Koulakov, October 13-16)-was primarily experi-
mental. The goal of the meeting was to stimulate discussion between neuroscientists working on dif-
ferent aspects of cortical maps: theoretical and experimental, physiological and anatomical, and devel-
opmental and functional.
In contrast, Can a Machine Be Conscious? (David Chalmers, Rod Goodman, Owen Holland,
Christof Koch, and Jerome Swartz, May 13-16) dealt with a topic with strong psychological and philo-
sophical underpinnings. A wealth of new experimental information about the brain has been gathered
by neuroscientists, and the organizers felt that the time was ripe for a meeting to discuss how these
data inform classic thinking on consciousness. The topic was focused by considering the design and
construction of a conscious machine. Could a machine ever be said to be conscious? Or is con-
sciousness something only biologically evolved animals and humans can ever possess?
Biology
Meetings on basic research in biology are the foundation of the Banbury Center program, and there
were some especially interesting meetings in this category in 2001.
Discovered 10 years ago, various families of seven-transmembrane receptor genes have been iden-
tified that encode chemosensory receptors, for example, nematode and fruit fly odorant receptors,
vomeronasal receptors, and taste receptors. With recent advances in genome sequencing projects,
genome-wide studies of these families have become feasible. However, no meetings have been dedi-
cated to the molecular biology of chemosensory receptor genes, which form the largest known gene
families in animal genomes. Molecular Biology of Chemosensory Receptors: The First Decade (Peter
Mombaerts and Stuart Firestein, March 11-14) was devoted to a review of all that is known of these
molecules. In conjunction with this meeting, Chemosensory Receptor Classification (Peter Mombaerts,
Stuart Firestein, and Randall Reed, March 15) was a workshop on possible approaches for classifica-
tion of receptors and their families.
A meeting on Mammalian Cloning: Biology and Practice held at the Center in 2000 discussed tech-
nical aspects of the high failure rate of cloning. Stability and Reversal of the Differentiated State (Robin
Lovell-Badge, David Stocum, and Jan Witkowski, October 28-31) concentrated on the biology that
might underlie these failures, examining the fundamental biology of differentiation and its reversal.
Participants worked on imprinting, X-inactivation, methylation, stem cells, germ cells, regeneration, and
cloning in organisms as diverse as amphibia, mammals, and plants.
Epithelial and endothelial tubes are a fundamental structural unit of organ design, but very little is
known about how epithelial and endothelial tubes form, how their sizes and shapes are regulated, and
how tubular structures are maintained. Epithelial and Endothelial Tube Morphogenesis (Mark Krasnow
and W. James Nelson, November 11-14) reviewed what is known from basic cell biological studies and
genetic analysis of tube formation and maintenance in organisms as diverse as C. elegans, Drosophila,
zebrafish, and mice, and the identification of genes involved in human tubulogenesis disorders.
The History and Mechanisms of Animal and Plant Evolution (John Doebley, Charles Marshall, and
Nipam Patel, October 21-24) took on a big topic-how it is that plants and animals have come to be
the way they are today. Participants included paleontologists, developmental biologists, geneticists,
and morphologists. All were expected to contribute their own special knowledge to discussions of the
relationship between micro- and macro-evolution, the early diversification of phyla, the genetic basis of
evolutionary changes in morphology and development, and the adaptive forces underlying evolution-
ary change.
The theme of including animal and plant studies was continued in Common and Contrasting
Mechanisms of Pathogen Virulence and Host Resistance in Plant and Animal Diseases (Jorge Galan and
Brian Staskawicz, April 8-11). This discussion meeting brought together researchers working on micro-
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bial pathogenesis and host resistance mechanisms in both plant and animal systems. Researchers
working on animal cells have advantages in cell biology and biochemistry, whereas the plant communi-
ty has led in the genetic dissection of host response to pathogen infection. Key questions discussed
included whether plant and animal pathogens share common mechanisms of pathogenesis and
whether the signaling mechanisms involved are conserved between plant and animal hosts.
Neurological Disorders
The Fragile X syndrome is one of the best-characterized developmental genetic disorders, and rapid
advances are being made in understanding the biological processes involved. Understanding the
Neural Basis of Fragile X (William Greenough, David Nelson, and Don Bailey, March 4-7) reviewed the
data coming from the wide range of studies on various aspects of basic and clinical research relating
to the neural basis of Fragile X, including the nervous system phenotype in Fragile X syndrome and ani-
mal models, and FMRP synthesis, regulation, and the mRNAs to which it binds.
The other two meetings in this category discussed neurological disorders that are poorly charac-
terized. Autism is a particularly controversial subject, especially in relation to its possible environmental
causes. Microbiology Immunology, and Toxicology of Autism and Other Neurodevelopmental
Disorders (Ian Lipkin, February 11-14) tackled a broad range of topics relating to autism, including the
genetics and neurobiology of autism, the general issue of the toxicology of neurodevelopmental disor-
ders, and the possible role of vaccines as a cause of autism.
Another major neurological disorder that remains intractable is depression, and one area that has
been especially neglected is childhood depression. Banbury took a small step to rectify this by holding
a meeting on Childhood Depression: A Critical Review (Boris Birmaher and Ian Goodyer, February
20-23). First-episode depression occurs in the 8- to 18-year age group, and therefore this is an impor-
Robertson House provides housing accommodations at Banbury Center.
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tant group to study from an etiological as well as clinical perspective. The meeting examined features
such as why it is that depressions are uncommon in prepubertal children compared to postpubertal
adolescents, and why childhood depressives do not respond to antidepressants, whereas adolescent
depressives do.
Workshop for Judges
Banbury Center has always had a strong interest in the public understanding of science, having had
workshops for science journalists and congressional staff for many years. These have continued in the
Basic Issues of Science workshops, held in conjunction with the Federal Judicial Center in Washington.
The workshops do not deal with the role of science in the courtroom but rather introduce the concepts
and styles of science to the judges. This was, as always, a delightful meeting, and one highlight was
the presentation and discussion by Peter Neufeld, who established the Innocence Project with Barry
Scheck. (Peter Neufeld first came to Banbury for the 1989 meeting on DNA and Forensic Science, a
historic meeting that had an important role in the early debates about DNA fingerprinting.)
The American Eugenics Image Archive Project
This project, a collaborative effort with the Dolan DNA Learning Center, is proving to be a great suc-
cess. In 2001, Dave Micklos and I implemented a further step in the project with a meeting American
Eugenics and the New Biology: Perspectives and Parallels (David Micklos and Jan Witkowski, May
6-8). The meeting provided an opportunity for opinion leaders and policymakers from government, sci-
ence, health care, education, and the mass media to learn about America's past involvement in eugen-
ics from leading experts. As we had hoped, the eclectic mix of high-level participants and presenters
created lively exchanges.
We also held a meeting of the Project's Eugenics Advisory Board (David Micklos and Jan Witkowski,
September 30October 1). This was a most important meeting in that the Board recommended to the
National Institutes of Health that the site be made public in its entirety.
The Watson School of Biological Sciences-Topics in Biology
Banbury Center again held the week-long Topics in Biology course for students of The Watson School
of Biological Sciences. This year the topic was evolution, and the lead instructor was Nipam Patel. The
breadth of the course was great, running from reviewing the immense variety of life to the details of
molecular evolution. A highlight of the week was a visit to the American Museum of Natural History.
Other Meetings
Several Laboratory groups came to Banbury for review and planning meetings, as did the Dolan DNA
Learning Center and the Cold Spring Harbor Laboratory Press. As usual, we made the Center avail-
able to a small number of local community groups, notably Lloyd Harbor Village, The Cold Spring
Harbor School District, and Holiday House.
Meier House
The Meier House was purchased by the Laboratory in 1999 to provide additional accommodation for
Banbury Center meetings and to serve as a place where writers could come for periods of time to work
in peace on their books. It has been an invaluable addition to the Banbury estate, and there is no doubt
that participants in our meetings have enjoyed using it.
333
Funding
The sources of support for Banbury Center meetings are given for each meeting in the following list of
programs. The Center and the scientists who participated in our meetings are very grateful for the gen-
erosity of all those institutions that provided this support.
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Jan Witkowski
MEETINGS
Microbiology, Immunology, and Toxicology of Autism and Other
Neurodevelopmental Disorders
February 11-14
FUNDED BY Cure Autism Now Foundation, McNeil Consumer Healthcare, National Alliance for
Autism Research (NAAR), and the University of California, Davis M.I.N.D. Institute
ARRANGED BY W.I. Lipkin, University of California, Irvine
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
W.I. Lipkin, University of California, Irvine
SESSION 1: Scope of the Problem: Epidemiology of Autism and Neurodevelopmental Disorders
Co-Chairpersons: G. Dawson, University of Washington, Seattle and J. Cordero, Centers for Disease
Control and Prevention, Atlanta, Georgia
E. Susser, HIV Center for Clinical and Behavioral Studies, New autism spectrum disorders.
York, New York: Epidemiological approaches to neurodevel- M. Yeargin-Allsopp, Centers for Disease Control and
opmental disorders. Prevention, Atlanta, Georgia: Past and future perspectives in
E. Fombonne, Institute of Psychiatry, King's College London, autism epidemiology.
United Kingdom: Epidemiology of autism. J. Cordero, Centers for Disease Control and Prevention,
B. Taylor, Royal Free & University College Medical School, Atlanta, Georgia: Review of epidemiology presentations.
London,United Kingdom: MMR in the UK and prevalence of
SESSION 2: Host Factors: Genetics of Autism
Chairperson: E. London, National Alliance for Autism Research, Princeton, New Jersey
C. Gilliam, Columbia Genome Center, New York, New York: K.G. Becker, National Institute on Aging, Baltimore,
Genetics of autism (AGRE Project). Maryland: Comparative genomics of autism, Tourette's
M.A. Pericak-Vance, Duke University Medical Center, Durham, Syndrome, dyslexia, and immune disorders.
North Carolina: Genetics.
E. Fombonne, E. Susser
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SESSION 3: Anatomy and Neurobiology of Autism
Chairperson: D.G. Amaral, University of California, Davis, Sacramento
T.L. Kemper, Boston University School of Medicine,
Massachusetts: Neuropathology of autism.
N. Minshew, University of Pittsburgh Medical Center, Pennsyl-
vania: Cortical dysfunction in autism.
D.C. Chugani, Children's Hospital of Michigan, Detroit: Neuro-
SESSION 4: Immunology of Neurodevelopmental Disorders
Chairperson: W.I. Lipkin, University of California, Irvine
chemical pathways in autism.
G. Dawson, University of Washington, Seattle: Early indices of
brain dysfunction in autism.
E. Courchesne, University of California, San Diego, La Jolla:
Functional and structural imaging studies in autism.
S.E. Swedo, National Institute of Mental Health, Bethesda, S. Jacobson, National Institute of Neurological Disorders &
Maryland: PANDAS in OCD spectrum disorders. Stroke, Bethesda, Maryland: Viral paradigms for chronic
W.I. Lipkin, University of California, Irvine: A murine PANDAS CNS diseases.
model. K.B. Nelson, National Institute of Neurological Disorders &
E. Hollander, Mount Sinai School of Medicine, New York, New Stroke, Bethesda, Maryland: Neonatal predictors of neu-
York: D8/17 and autism. rodevelopmental disorders.
SESSION 5: Animal Models
Chairperson: S. Jacobson, National Institute of Neurological Disorders & Stroke,
Bethesda, Maryland
M. Hornig, University of California, Irvine: Infectious and D.G. Amaral, University of California, Davis, Sacramento: The role
immune factors in neurodevelopmental damage. of the amygdala in social behavior: Implications for autism.
K.M. Carbone, Food and Drug Administration, Bethesda, L.R. Young, Emory University, Atlanta, Georgia: Social interac-
Maryland: Viral immune models of autism. tions in prairie voles.
SESSION 6: Toxicology of Neurodevelopmental Disorders
Chairperson: N. Minshew, University of Pittsburgh Medical Center, Pennsylvania
M. Aschner, Wake Forest University School of Medicine,
Winston-Salem, North Carolina: Neuropathogenesis of mer-
cury intoxication.
S. Barone, Environmental Protection Agency, Research
Triangle Park, North Carolina: Effects of gestational mercury
exposure on neurotrophic factor signaling and altered devel-
opment of the nervous system.
S. Bernard, ARC Research, Cranford, New Jersey: Mercury
and autism pathogenesis.
SESSION 7
Co-Chairpersons: W.I. Lipkin, University of California, Irvine and E. Susser,
HIV Center for Clinical and Behavioral Studies, New York, New York
A.J. Wakefield, Royal Free & University College Medical
School, London, United Kingdom: MMR, the gut, and autism.
J. O'Leary, Coombe Women's Hospital, Dublin, Ireland:
Molecular detection of measles virus sequences in white cells
and gastrointestinal tissues of children with neurodevelop-
mental disorders.
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M.A. Afzal, National Institute for Biological Standards & Control,
Hats, United Kingdom: Vaccines, Crohns disease, and autism.
F. De Stefano, Centers for Disease Control & Prevention,
Atlanta, Georgia: Review of vaccines and autism epidemiolo-
gy.
W.I. Lipkin, University of California, Irvine: Closing summary.
E. Hollander, S. Swedo, B. Taylor
Childhood Depression: A Critical Review
February 20-23
FUNDED BY Cold Spring Harbor Laboratory
ARRANGED BY B. Birmaher, University of Pittsburgh Medical Center, Pennsylvania
I.M. Goodyer, University of Cambridge, United Kingdom
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Conceptual Aspects
Chairperson: I.M. Goodyer, University of Cambridge, United Kingdom
S.J. Suomi, National Institute of Child Health and Human evolutionary psychology of depression.
Development, Bethesda, Maryland: Childhood depression: A R. Hornsby, Sir Robert Mond Memorial Trust, London,
critical review. United Kingdom: A personal perspective (on adolescent
L Wolpert, University College London, United Kingdom: The despair).
SESSION 2: Clinical Aspects
Co-Chairpersons: I.M. Goodyer, University of Cambridge, United Kingdom and
L. Wolpert, University College London, United Kingdom
J. Kaufman, Yale University, New Haven, Connecticut: Are
child-, adolescent-, and adult-onset depression one and the
same disorder?
P.J. Ambrosini, MCP-Hahnemann University, Philadelphia,
Pennsylvania: Irritability in adolescent affective disorders.
E. Fombonne, King's College London, United Kingdom: Long-
term outcomes of child and adolescent depression: The
Maudsley study.
I. Goodyer, L. Wolpert, J. Costello
337
SESSION 3: Biological Studies
Chairperson: L. Wolpert, University College London, United Kingdom
A.C. Angold, Duke University Medical Center, Durham, North social predictors of depression in adolescents.
Carolina: The roles of various types of stressor, parental B. Birmaher, University of Pittsburgh Medical Center,
depression, testosterone, and estradiol in relation to chang- Pennsylvania: Biological studies in never depressed children
ing rates of depression. at high risk to develop MDD.
J.A. Graber, Columbia University, New York, New York: Psycho-
SESSION 4: Social Environment Influences
Chairperson: B. Birmaher, University of Pittsburgh Medical Center, Pennsylvania
J. Costello, Duke University, Durham, North Carolina: Child and ences on early (prepubertal) versus later (postpubertal) first
adolescent depression: Prodromal signs and symptoms. onset of MDE.
J. Garber, Vanderbilt University, Nashville, Tennessee: D. Williamson, University of Pittsburgh Medical Center,
Psychosocial predictors of depression in adolescents. Pennsylvania: Environmental risk factors for depression in
M.A. Rueter, University of Minnesota, St. Paul: Familial influ- children and adolescents.
SESSION 5: Affective-Cognitive Processes
Co-Chairpersons: B. Birmaher, University of Pittsburgh Medical Center, Pennsylvania
and E. Fombonne, King's College London, United Kingdom
L. Murray, University of Reading, United Kingdom: Identifying
cognitive vulnerability to depression in five-year-olds.
I. M. Goodyer, University of Cambridge, United Kingdom: Are
sensitive minds bad for the brain? Mood-linked cognitions as
psychoendocrine insults.
L. Mufson, New York State Psychiatric Institute, New York:
IPT-A: Translating efficacy into effectiveness research.
SESSION 6: Pharmacological Treatment
Chairperson: E. Fombonne, King's College London, United Kingdom
N. Ryan, University of Pittsburgh Medical Center, Pennsylvania: artifact of available studies?
SSRIs treat child and adolescent major depression while R.A. Kowatch, University of Cincinnati Medical Center, Ohio:
TCAs are ineffective: Is this a real difference in noradrenergic Pharmacological trials in pediatric bipolars: Is placebo nec-
versus serotonergic therapeutic strategies or is it merely an essary?
SESSION 7: Family/Genetic Approaches
Chairperson: S.J. Suomi, National Institute of Child Health and Human
Development, Bethesda, Maryland
R.D. Todd, Washington University School of Medicine, St.
Louis, Missouri: Gene-environment interactions in the devel-
opment of early-onset depression: Results from an epidemi-
ologically based twin study of brain morphometry.
M.M. Weissman, Columbia University, New York, New York:
Children and depression: Results from top-down and bot-
tom-up studies.
SESSION 8: Neuroimaging
Chairperson: S.J. Suomi, National Institute of Child Health and Human
Development, Bethesda, Maryland
H. Blumberg, Yale University, New Haven, Connecticut:
Structural and functional MRI studies of bipolar disorder
in adolescents and adults.
K.N. Botteron, Washington University School of Medicine,
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St. Louis, Missouri: Structural brain differences in early-onset
depression: Neurodevelopmental or neurodegenerative
mechanisms.
Integrating Genomics Technologies in Health Care:
Practice and Policy Challenges
February 25-28
FUNDED BY Burroughs Wellcome Fund, Hoffmann-La Roche Inc., and Affymetrix, Inc.
ARRANGED BY M.J.F. Austin, Hoffmann-La Roche Inc., Nutley, New Jersey
T. Kreiner, Affymetrix, Inc., Santa Clara, California
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
M.J.F. Austin, Hoffmann-La Roche Inc., Nutley, New Jersey
SESSION 1: Technologies and Analysis
Chairperson: L. Babiss, Hoffmann-La Roche Inc., Nutley, New
J. Warrington, Affymetrix, Inc., Santa Clara, California:
Microarray applications in diagnostics.
W.H. Koch, Roche Molecular Systems, Alameda, California:
Microarray-based genotyping of polymorphic drug metabo-
lism: Pharmacogenetics lessons galore.
E. Lai, Glaxo Wellcome Inc., Research Triangle Park, North
Carolina: Application of SNP technologies in health care:
What have we learned and what are the challenges?
Jersey
E.S. Winn-Deen, Celera Genomics, Rockville, Maryland: Diag-
nostics in the postgenomic era.
J. Hoh, Rockefeller University, New York, New York: Problems
in the analysis of microarray data from first principles.
J.D. Terwilliger, Columbia University, New York, New York: Why
the HGP will likely have minimal if any effect on public health
and medicine in the foreseeable future.
SESSION 2: Applications I
Chairperson: U. Francke, HHMI, Stanford University Medical Center, California
N.C. Dracopoli, Bristol-Myers Squibb, Princeton, New Jersey:
Application of pharmacogenomics in clinical drug develop-
ment.
C. Dykes, Variagenics, Inc., Cambridge, Massachusetts:
Candidate gene studies within clinical development.
N.A. Holtzman, The Johns Hopkins Medical Institutions,
Baltimore, Maryland: Separating genotype from geno-
hype: Will we be able to predict and prevent common com-
plex diseases?
B.R. Korf, Partners Center for Human Genetics and Harvard
Medical School, Boston, Massachusetts: Integration of
genetics into medical practice.
D.K. Burns, Glaxo Wellcome Inc., Research Triangle Park,
North Carolina: Moving genetics from research to impacting
clinical practice: The GlaxoSmithKline perspective.
M. Austin, D. Burns, E. Winn-Deen
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SESSION 3: Applications II
Chairperson: U. Francke, HHMI, Stanford University Medical
A. Guttmacher, National Human Genome Research Institute,
Bethesda, Maryland: From research laboratory to neighbor-
hood health center: The NHGRI's efforts to translate DNA into
health care.
C.C. Morton, Brigham & Women's Hospital, Boston,
Massachusetts: Genomic resources applied in the clinical
cytogenetics laboratory.
Center, California
W. Uhlmann, University of Michigan, Ann Arbor: Genetic coun-
seling in our current health care system.
G. Wiesner, Case Western Reserve University, Cleveland, Ohio:
The GREAT system: Linking genomics to primary care.
R.L. White, DNA Sciences, Inc., Fremont, California: DNA
Sciences' Gene Trust Project.
SESSION 4: Regulatory and Policy Issues
Chairperson: L. Knowles, The Hastings Center, Garrison, New York
G. Koski, National Institutes of Health, Rockville, Maryland: Identifying "Race": Looking through a genomics prism.
Realism and regulation of research in the genomics era. J. Doll, U.S. Patent and Trademark Office, Arlington, Virginia:
P.F. Terry, Genetic Alliance, Washington, D.C.: Policy issues: A The ground rules for genomic patenting.
consumer perspective. H.T. Greely, Stanford University Law School, California:
B. Koenig, Stanford University, California: Update on the Regulatory and health financing constraints on clinical
Secretary's Advisory Committee on Genetic Testing (SACGT); genomics.
SESSION 5: Closing Discussion: Managing the Future-A Group Discussion to
Identify Key Needs and Next Steps
Interlocutors: T. Kreiner, Affymetrix, Inc., Santa Clara, California and
M.J.F. Austin, Hoffmann-La Roche Inc.
L Babiss, Hoffmann-La Roche Inc., Nutley, New Jersey:
Technology and analysis key trends.
U. Francke, HHMI, Stanford University
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California: Applications and clinical applications key trends.
L. Knowles, The Hastings Center, Garrison, New York:
and policy issues.
Meeting in session.
Understanding the Neural Basis of Fragile X
March 4-7
FUNDED BY
ARRANGED BY
National Institute of Mental Health (NIMH), with additional support from
National Institute of Child Health and Human Development (NICHD)
(through a grant to the University of Illinois, Urbana)
W. Greenough, University of Illinois, Urbana
D.L. Nelson, Baylor College of Medicine, Houston, Texas
D. Bailey, University of North Carolina at Chapel Hill
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
K. Clapp, FRAM Research Foundation, Newburyport, Massachusetts
SESSION 1: Human Phenotype
Chairperson: L. Crnic, University of Colorado Health Sciences Center, Denver
R.J. Hagerman, MIND Institute, University of California, X syndrome.
Davis Medical Center, Sacramento: Spectrum of involvement E. Berry-Kravis, Rush Children's Hospital, Chicago, Illinois:
in Fragile X syndrome and in permutation area. Pharmacological approaches to seizures, behavior, and cog-
D. Bailey, University of North Carolina, Chapel Hill: nition in Fragile X syndrome: Present and future.
Opportunities for integrative biobehavioral research in Fragile
SESSION 2: Animal Phenotype
Chairperson: D. Bailey, University of North Carolina, Chapel Hill
W.T. Greenough, University of Illinois, Urbana: FMRP expres-
sion and neural morphology.
W.T. Brown, New York State Institute for Basic Research,
Staten Island: Toward an improved mouse model of
Fragile X.
B. Oostra, Erasmus Universiteit Rotterdam, The Netherlands:
Mouse models for Fragile X syndrome.
L. Crnic, University of Colorado Health Sciences Center,
Denver: Abnormalities in the auditory startle response in
FMR1-targeted mutants on several genetic backgrounds.
R.E. Paylor, Baylor College of Medicine, Houston,
Texas: More behavioral phenotyping of mouse models of
Fragile X.
H. Siomi, University of Tokushima, Japan: Cell culture and
whole animal approaches to understanding the function of
the FMR1 protein in Drosophila.
J.R. Larson, University of Illinois, Chicago: Olfactory learning
and memory in mice.
K. Clapp, W. Greenough
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SESSION 3: FMR1 mRNA Transport, Regulation of FMRP Synthesis, and
Interacting Proteins
Chairperson: W.T. Greenough, University of Illinois, Urbana
D.L. Nelson, Baylor College of Medicine, Houston, Texas:
Consequences of mutation of the FMR1/FXR genes in
mouse and fly.
G.J. Bassell, Albert Einstein University, Bronx, New York:
FMRP trafficking in cultured hippocampal neurons.
G. Neri, Universita Cattolica, Rome, Italy: Pharmacological
reactivation of the fully mutated FMR1 gene.
P. Chiurazzi, Universita Cattolica, Rome, Italy: Methylation
analysis of the promoter of the inactive and reactivated fully
mutated FMR1 gene.
P.J. Hagerman, University of California, Davis: Expression of
the Fragile X gene.
K.M. Huber, Brown University, Providence, Rhode Island: Role
for dendritic protein synthesis in hippocampal long-term
depression.
K.J. Mack, University of Wisconsin, Madison: Sensory experi-
ence increases, and seizures reduce, expression of the
Fragile X mental retardation protein.
R.P. Bauchwitz, St. Luke's-Roosevelt Institute of Health
Sciences, New York: Further analysis of Fmr1 transgenic and
knockout mice.
R.F. Kooy, University of Antwerp, Belgium: Differentially
expressed sequences in the Fragile X knockout mouse.
S.T. Warren, Emory University School of Medicine, Atlanta,
Georgia: DNA chip analysis of FMRP function and the con-
sequence of its absence.
SESSION 4: Cellular Functions of FMRP
Chairperson: D.L. Nelson, Baylor College of Medicine, Houston,Texas
I.J. Weiler, University of Illinois, Urbana-Champaign: Some
translational deficits in Fmr-1 knockout.
SESSION 5: Interacting RNAs and Proteins
Chairperson: P.J. Hagerman, University of California, Davis
B. Bardoni, CNRS, Illkirch, France: Search for FMRP function
through the characterization of four novel FMRP-interacting
proteins.
H. Moine, CNRS, Strasbourg, France: Characterization of a
specific binding target for FMRP on its own mRNA.
J. Darnell, Rockefeller University, New York, New York:
Identification of sequence-specific RNA targets for KH2 and
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M.G. Rattazzi, New York State Institute for Basic Research,
Staten Island: Toward gene therapy of Fragile X syndrome.
newly characterized high-affinity RNA-binding domains of
FMRP.
A.T. Hoogeveen, Erasmus University Medical School,
Rotterdam, The Netherlands: FMRP and its related proteins.
E.W. Khandjian, Hop. St. Francois d'Assise, Quebec, Canada:
The expanding Fragile X protein family: RNA-binding proteins
and more?
Coffee break on back porch of Banbury Conference Center.
Molecular Biology of Chemosensory Receptors: The First Decade
March 11-14
FUNDED BY
ARRANGED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program,
with additional support from Senomyx, Inc.
P. Mombaerts, The Rockefeller University, New York, New York
S. Firestein, Columbia University, New York, New York
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Opening Lecture:
L.B. Buck, Harvard Medical School, Boston, Massachusetts
SESSION 1: Mammalian Odorant Receptors: Genomics
Chairperson: P. Mombaerts, The Rockefeller University, New York, New York
D. Lancet, Weizmann Institute of Science, Rehovot, Israel: Washington: Comparative OR genomics: Large-scale
Mining the genome: The complete human olfactory receptor change and polymorphism.
repertoire. J. Strotmann, University of Hohenheim, Stuttgart, Germany:
S. Zozulya, Senomyx, Inc., La Jolla, California: The repertoire Olfactory receptors with atypical features.
of human functional odorant receptor candidates. S. Firestein, Columbia University, New York, New York:
B.J. Trask, Fred Hutchinson Cancer Research Center, Seattle, Molecular pharmacology of odor receptors.
SESSION 2: Other Chemosensory Receptors
Chairperson: R. Axel, HHMI, Columbia University, New York, New York
R. Tirindelli, Universita di Parma, Italy: The coexpression of Drosophila taste receptor genes.
putative pheromone receptors suggests another mode of C.I. Bargmann, University of California, San Francisco:
information processing in the olfactory systems. Odor discrimination and olfactory receptor expression
L. Vosshall, The Rockefeller University, New York, New York: in C. elegans.
Determinants of spatial convergence in the Drosophila olfac- H. Robertson, University of Illinois at Urbana-Champaign:
tory system. Molecular evolution of the nematode and insect chemore-
H. Amrein, Duke University Medical Center, Durham, North ceptor superfamilies.
Carolina: Identification and expression of a large family of
L. Buck, R. Axel, N. Ryba
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SESSION 3: Taste Receptors
Chairperson: M. Zoller, Senomyx, Inc., La Jolla, California
J.F. Battey, National Institute on Deafness and Other Research, Bethesda, Maryland: Bitter taste receptors.
Communication Disorders, Bethesda, Maryland: Discovery of N. Chaudhari, University of Miami School of Medicine, Florida:
genes selectively expressed in taste receptor cells. Comparing umami taste with the properties of a cloned tasteN. Ryba, National Institute of Dental and Craniofacial receptor.
SESSION 4: Odorant Receptors: Molecular Biology
Chairperson: R.F. Margolskee, HHMI, Mount Sinai School of Medicine,
New York, New York
A. Chess, Whitehead Institute, Cambridge, Massachusetts: B. Davis, National Institute on Deafness and Other
Genome-wide coordination of olfactory receptor genes. Communication Disorders, Rockville, Maryland: TheT. McClintock, University of Kentucky, Lexington: Intracellular growth and the taste and smell programs at the NIDCD,
trafficking of olfactory receptors. 1990-2000.
SESSION 5: Odorant Receptors: Development
Chairperson: L.B. Buck, Harvard Medical School, Boston, Massachusetts
B. Key, University of Queensland, Brisbane, Australia:
Changing the cell surface glycocode on olfactory axons via
transgenesis: The combined role of odorant receptors and
cell surface.
C.A. Greer, Yale University School of Medicine, New Haven,
Connecticut: Axonal targeting and organization of the olfac-
tory bulb glomerulus.
R.R. Reed, HHMI, The Johns Hopkins University, Bethesda,
Maryland: Engineering altered activity in the mammalian
olfactory system.
H. Sakano, University of Tokyo, Japan: Mutually exclusive
expression of odorant receptor transgenes.
SESSION 6: Odorant Receptors: Function
Chairperson: S. Firestein, Columbia University, New York, New York
G.M. Shepherd, Yale University Medical School, New Haven,
Connecticut: Odor determinants, receptor-binding pockets,
and odor images: Convergence of experiment and theory.
C. Wetzel, Ruhr-University-Bochum, Germany: Functional
expression and characterization of olfactory receptors of ver-
tebrates and invertebrates.
D. Giorgi, Institut de Genetique Humaine, Montpellier, France:
Closing Lecture:
R. Axel, HHMI, Columbia University, New York, New York
Identification of specific ligands of mouse OR912-93.
S. Korsching, University of Cologne, Germany: Concentration
and structure-dependent odor space in the mouse olfactory
bulb.
K. Touhara, University of Tokyo, Japan: Reconstitution of
mouse olfactory receptors that recognize an overlapping set
of odorants.
Genomic Annotation Workshop: DNA Replication
March 17-22
FUNDED BY National Institutes of Health
ARRANGED BY L.D. Stein, Cold Spring Harbor Laboratory
E. Birney, European Bioinformatics Institute, Cambridge,United Kingdom
WORKSHOP MEMBERS:
L.I. Aravind, National Center for Biotechnology Information, National Library of Medicine (NLM), Bethesda, Maryland
J. Ashurst, Sanger Centre, Cambridge, United Kingdom
A.G. Bateman, Sanger Centre, Cambridge, United Kingdom
E. Birney, European Bioinformatics Institute, Cambridge, United Kingdom
M. Clamp, Sanger Centre, Cambridge, United Kingdom
R. Copley, EMBL Heidelberg, Germany
E.E. Eichler, Case Western Reserve University, Cleveland, Ohio
J. Gilbert, Sanger Centre, Cambridge, United Kingdom
A. Kanapin, European Bioinformatics Institute, Cambridge, United Kingdom
A. Neuwald, Cold Spring Harbor Laboratory
K. Pruitt, National Library of Medicine (NLM), Bethesda, Maryland
J. Stalker, Sanger Centre, Cambridge, United Kingdom
L.D. Stein, Cold Spring Harbor Laboratory
B. Stillman, Cold Spring Harbor Laboratory
E. Stupka, European Bioinformatics Institute, Cambridge, United Kingdom
Bioinformaticists at work.
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The Basic Issues of Science
April 1-4
FUNDED BY The Federal Judicial Center
ARRANGED BY J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
J.A. Witkowski, Banbury Center, Cold Spring Harbor Labora-
tory and F.M. Smith, Federal Judicial Center, Washington,
D.C.: Welcoming remarks.
G.E. Allen, Washington University, St. Louis, Missouri: Eugenics:
Past, present, and future.
SESSION 2
J. Maienschein, Arizona State University, Tempe: From Darwin
to Dolly: Developments in the biological sciences in the 20th
century.
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: Fundamentals of genetics.
SESSION 3
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory, The Human Genome Project: Origins and future.
D. Blacker, Massachusetts General Hospital, Boston,
Massachusetts: Using molecular human genetics: Alzheimer's
disease.
SESSION 4
R Reilly, Interleukin Genetics, Inc., Waltham, Massachusetts:
Social implications of genetic research.
SESSION 5
P. Neufeld, Innocence Project, New York, New York: Using
DNA forensics.
SESSION 6
I. Pepperberg, Massachusetts Institute of Technology,
Cambridge, Massachusetts: What Alex the Grey Parrot tells
us about human cognition and language.
R. Park, University of Maryland, College Park, Maryland:
Science and pseudoscience and the courtroom.
Federal Judicial Conference attendees.
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Common and Contrasting Mechanisms of Pathogen Virulence and
Host Resistance in Plant and Animal Diseases
April 8-11
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J. Galan, Yale University School of Medicine, New Haven, Connecticut
B.J. Staskawicz, University of California, Berkeley
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Innate Immunity and Host Defense Responses
Chairperson: B.J. Staskawicz, University of California, Berkeley
K. Anderson, Memorial Sloan-Kettering Institute, New York,
New York: Genetic analysis of the response to infection in
Drosophila.
G. Nunez, University of Michigan Medical School, Ann Arbor:
Regulation of apoptosis and NE-xB activation by Nod pro-
teins.
S. Miller, University of Washington, Seattle: Lipid A modifications
and the resistance of gram-negative bacteria to innate immunity.
B.J. Staskawicz, University of California, Berkeley: NDR1,
a putative GPI-anchored protein specifying bacterial
disease resistance in Arabidopsis thaliana.
J. Parker, The Sainsbury Laboratory, Norwich, United
Kingdom: Connecting local and systemic plant
resistance pathways.
X. Dong, Duke University, Durham, North Carolina: Signal
transduction in systemic acquired resistance.
SESSION 2: Bacterial Modulators of Host Responses
Chairperson: J. Galan, Yale University School of Medicine, New Haven,
Connecticut
J. Galan, Yale University School of Medicine, New Haven,
Connecticut: Mimicry of cellular proteins as a strategy for the
modulation of cellular responses by bacterial pathogens.
H. Wolf-Watz, University of Umea, Sweden: Modulation of
expression and translocation of Yersinia virulence effectors
after target cell contact.
D. Philpott, Institut Pasteur, Paris, France: How Shigella plants
the seeds of inflammation into intestinal cells.
K. Orth, University of Michigan Medical Center, Ann Arbor:
Black death, Black spot: Yersinia effector is a ubiquitin-like
protein protease.
A. Collmer, Cornell University, Ithaca, New York: The Hrp (type
III secretion system) effector proteins of Pseudomonas
syringae pv. tomato DC3000.
U. Bonas, Martin-Luther University, Halle, Germany: Type III
effector proteins and their role in the Xanthomonas-plant
interaction: Recognition or disease?
U. Bonas, J. Dangl, B. Staskawicz, P. Schulze-Lefert
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SESSION 3: Mechanisms of Microbial/Host Interactions I
Chairperson: D. Portnoy, University of California, Berkeley
G.B. Martin, Cornell University, Ithaca, New York: Pseudo-
monas effector proteins that interact with the tomato Pto
kinase.
J. Dangl, University of North Carolina, Chapel Hill: Type Ill effec-
tors in the P syringae interaction with Arabidopsis.
R. Innes, Indiana University, Bloomington: Recognition of the
Pseudomonas virulence protein AvrPphB by Arabidopsis.
D. Portnoy, University of California, Berkeley: A PEST-like se-
SESSION 4: Mechanisms of Microbial/Host Interactions II
Chairperson: J.D.G. Jones, The Sainsbury Laboratory, Norwich
J.D.G. Jones, The Sainsbury Laboratory, Norwich, United
Kingdom: Mode of action of tomato Cf- genes that confer
resistance to Cladosporium fu/vum.
J. Ellis, CSIRO, Canberra, Australia: Specificity, repression, and
activation of rust resistance proteins.
S. Hulbert, Kansas State University, Manhattan: NBS genes in
cereals.
K. Shirasu, The Sainsbury Laboratory, Norwich, United King-
SESSION 5: Plant Defense Responses
Chairperson: F.M. Ausubel, Massachusetts General Hospital,
P Schulze-Lefert, M.-Planck-Institut fCir Zuchtungsforschtung,
Koln, Germany: Activation of and rescue from cell death in
plant disease resistance.
SESSION 6: Model Systems and Genomics
quence in listeriolysin 0 essential for Listeria monocytogenes
pathogenicity.
J.F. Miller, University of California, Los Angeles: Parasite adap-
tation to a dynamic host: Bordetella -phage interactions.
S. Hultgren, Washington University, St. Louis, Missouri:
Pathogenic fiber formation in bacteria: Structure, function,
and role in diseases of the urinary tract.
, United Kingdom
dom: RAR1: A link from R genes to ubiquitination machinery.
C. Roy, Yale School of Medicine, New Haven, Connecticut:
Implications for pathogen evolution: Hijacking of a eukaryot-
ic host gene by Legionella pneumophila.
E. Groisman, Washington University School of Medicine,
St. Louis, Missouri: The SPI-2 pathogenicity island of
Salmonella enteric.
Boston
Chairperson: F.M. Ausubel, Massachusetts General Hospital, B
F.M. Ausubel, Massachusetts General Hospital, Boston:
Modeling human pathogenesis in nonvertebrate model hosts.
P.F. Predki, DOE Genome Institute, Walnut Creek, California:
Rapid characterization of pathogen genomes via high-
348
B. Baker, University of California, Berkeley: Molecular-genetic
characterization of the N-mediated TMV disease resistance
pathway.
oston
throughput draft sequencing.
S. Lory, Harvard Medical School, Boston, Massachusetts:
Eavesdropping on communications between pathogens and
their host using DNA microarrays.
J. Galan, E. Groisman, C. Roy
Electronic Access to Scientific Literature
April 16-18
FUNDED BY Cold Spring Harbor Laboratory
ARRANGED BY J. Inglis, Cold Spring Harbor Laboratory Press
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory
J. Inglis, Cold Spring Harbor Laboratory Press
SESSION 1: Users' Wants and Needs
Chairperson: B. Alberts, National Academy of Sciences,
Washington, D.C.
B. Stillman, Cold Spring Harbor Laboratory: What do scientists
want? (followed by additional comments, participating scien-
tists)
A. Okerson, Yale University, New Haven, Connecticut: What do
libraries want?
Additional comments, participating librarians.
SESSION 2: Cross-Publisher Initiatives
Co-Chairpersons: B. Alberts, National Academy of
Sciences, Washington, D.C. and N. Cozzarelli, PNAS-
University of California, Berkeley
D. Lipman, National Center for Biotechnology Information,
NIH, Bethesda, Maryland: Pub Med Central
Discussion of Pub Med Central
K. Hunter, Elsevier Science, New York, New York: Cross Ref
SESSION 3: What Are Individual Publishers Doing?
Chairperson: P. Campbell, Nature Publishing Group,
London, United Kingdom
Brief presentations and discussions by publishers.
SESSION 4: What Next?
Co-Chairpersons: J. Inglis, Cold Spring Harbor Laboratory
Press and J.A. Witkowski, Banbury Center, Cold Spring
Harbor Laboratory
B. Alberts, J. Sack, J. Fox, N. Cozzarelli
M. Eisen R. Bovenshulte, K. Hunter
349
Interferons: Biological Mechanisms and Disease Treatments I
April 29-May 1
FUNDED BY Herbert J. Siegel Fund for Cancer Pharmacogenomics
ARRANGED BY I.J. Fidler, M.D. Anderson Cancer Center, Houston, Texas
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring
Harbor Laboratory
I.J. Fidler, M.D. Anderson Cancer Center, Houston, Texas:
Introduction and antiangiogenic properties of interferon al,
J.E. Darnell, The Rockefeller University, New York, New York:
The stats in cancer.
B.B. Aggarwal, M.D. Anderson Cancer Center, Houston,
Texas: Molecular basis for the antiproliferative and anti-
inflammatory effects of interferon.
J.M. Folkman, Children's Hospital, Boston, Massachusetts:
Antiangiogenic therapy with low-dose interferon a,.
SESSION 2
Chairperson: E.G. Borden, Cleveland Clinic Foundation,
Taussig Cancer Center, Ohio
C.P.N. Dinney, M.D. Anderson Cancer Center, Houston,
Texas: Interferon gene therapy for superficial bladder can-
cer.
J.M. Kirkwood, University of Pittsburgh Cancer Institute,
Pennsylvania: Adjuvant therapy.
A.M.M. Eggermont, University Hospital Rotterdam, The
Netherlands: Adjuvant therapy with intermediate doses of
IFN and the rationale of the Peg- Intron Eortc 18991 trial.
B. Clarkson, Memorial Sloan-Kettering Cancer Center, New
York, New York: New inhibitors of abl tyrosine kinase and
other targets for specific therapies of CML.
S. Rich, Rush-Presbyterian-St. Luke's Medical Center,
Chicago, Illinois: The role of growth factors and inhibitors in
the pathobiology of primary pulmonary hypertension.
SESSION 3
Chairperson: I.J. Fidler, M.D. Anderson Cancer Center,
Houston, Texas
E.G. Borden, Cleveland Clinic Foundation, Taussig Cancer
Center, Ohio: Genes, apoptosis, and angiogenesis.
P.B. Chapman, Memorial Sloan-Kettering Cancer Center, New
York, New York: Utility of high-dose IFNia in melanoma.
F. Randazzo, Chiron Corporation, Emeryville, California:
Analyzing pathways in cancer by combining functional analysis
with gene expression profiling of small tumor biopsy samples.
S. Lowe, Cold Spring Harbor Laboratory: Cellular senescence
induced by oncogenic ras.
S.E. Krown, Memorial Sloan-Kettering Cancer Center, New
York: Interferon therapy for Kaposi's sarcoma: Evidence for
activity of low-dose daily interferon.
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P Chapman, E. Bergs land
I.J. Fidler, J. Folkman
American Eugenics and the New Biology:
Perspectives and Parallels
May 6-8
FUNDED BY
ARRANGED BY
SESSION 1: History
National Human Genome Research Institute,
National Institutes of Health
D. Mick los, DNA Learning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
G.E. Allen, Washington University, St. Louis, Missouri:
Progressive origins of eugenics and the Eugenics Record
Office.
E.A. Carlson, State University of New York, Stony Brook: Bad
seed, corrupted germ plasm, prized pedigrees, and eugenic
worth.
SESSION 2: Impacts
S. Selden, University of Maryland, College Park: Fitter families
for future firesides: State fairs and the construction of merit
and race in America, 1913-1930.
P.A. Lombardo, University of Virginia, Charlottesville:
Immigration and sterilization in the United States.
N.A. Holtzman, The John Hopkins Medical Institutions,
Baltimore, Maryland: Is eugenics dead and buried?
SESSION 3: Resources
D. Mick los, DNA Learning Center, Cold Spring Harbor and J.A.
Witkowski, Banbury Center, Cold Spring Harbor Laboratory:
Introduction to the image archive on the American eugenics
movement.
SESSION 4: Lessons
D. Paul, Brandeis University, Waltham, Massachusetts:
Comparative eugenics.
D. Hamer, National Cancer Institute, Bethesda, Maryland:
Genetics of human behavior.
Session 5: General Discussion
G. Allen, N. Holtzman, P. Woolf
J. Apple, P. Seawell
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Can a Machine Be Conscious?
May 13-16
FUNDED BY The Swartz Foundation
ARRANGED BY C. Koch, California Institute of Technology, Pasadena
D. Chalmers, University of Arizona
R. Goodman, California Institute of Technology, Pasadena
0. Holland, Clinton House, Stroud, United Kingdom
J. Swartz, The Swartz Foundation, East Setauket, New York
Introduction and Welcome:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
J. Swartz, The Swartz Foundation, East Setauket, New York
SESSION 1
Chairperson: C. Koch, California Institute of Technology, Pasadena
D.J. Chalmers, University of Arizona, Tucson: Machine con- G. Tononi, University of Wisconsin, Madison: Recipes for con-
sciousness: Problems and prospects. sciousness.
C. Koch, California Institute of Technology, Pasadena: From E. Rolls, University of Oxford, United Kingdom: Consciousness
biological to machine consciousness. and dual routes to action in neural network machines.
SESSION 2
Chairperson: R.M. Goodman, California Institute of Technology,
M.A. Goodale, University of Western Ontario, Canada: Why we
need two cortical visual systems: A teleassistance model.
C.D. Frith, University College London, United Kingdom: The
importance of other minds.
L. Steels, Free University of Brussels, Belgium: The role of lan-
guage in the emergence of consciousness.
352
Pasadena
J.C. Hawkins, Handspring Inc., Mountain View, California:
What neuroanatomy and the physiology of our senses tell us
about consciousness and intelligence.
S. Blackmore, University of the West of England, Bristol, United
Kingdom: Consciousness in meme machines.
C. Koch, A. Zador, J. Hawkins
SESSION 3
Chairperson: D.J. Chalmers, University of Arizona, Tucson
N. Block, New York University Faculty of Arts & Sciences, New Robot usable models of visual consciousness.
York: What are experiments about consciousness really R.M. Goodman, California Institute of Technology, Pasadena
about? and 0. Holland, Clinton House, Stroud, United Kingdom:
E. Dietrich, Virginia Institute of Technology, Blacksburg: Can a Autonomous robots + dynamic environment + intelligent
machine be conscious? Sure, but it won't help. control = consciousness?
I. Aleksander, Imperial College, London, United Kingdom:
SESSION 4
Chairperson: 0. Holland, Clinton House, Stroud, United Kingdom
B. Baars, The Neurosciences Institute, San Diego, California: Cerebral processing of conscious and unconscious stimuli: A
Self systems in the brain constrain conscious contents: A neural workspace hypothesis.
global workspace perspective. A.J. Clark, University of Sussex, Brighton, United Kingdom:
S. Franklin, University of Memphis, Tennessee: Conscious soft- Consciousness and perceptual knowledge.
ware agents. We've got one running. How conscious is it? I A. Cleeremans, Free University of Brussels, Belgium: Being
don't know. virtual: Consciousness and self as graded, adaptive phe-
S. Dehaene, Service Hospitalier Frederic Joliot, Orsay, France: nomena.
SESSION 5
Chairperson: C. Koch, California Institute of Technology, Pasadena
D. Psaltis, California Institute of Technology, Pasadena:
Awareness-based computing.
I. Aleksander, J. Witkowski
Interferons: Biological Mechanisms and Disease Treatments II
September 9-11
FUNDED BY Herbert J. Siegel Fund for Cancer Pharmacogenomics
ARRANGED BY E.C. Borden, Cleveland Clinic Foundation, Ohio
J. Folkman, Children's Hospital, Boston, Massachusetts
Introductions:
J.D. Watson, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: OFMs: Mechanisms and Antiangiogenic Effects
Chairperson: I.J. Fidler, M.D. Anderson Cancer Center, Houston,
J. Folkman, Children's Hospital, Boston, Massachusetts:
Introduction: IFNs overview of antiangiogenesis results.
E.C. Borden, Cleveland Clinic Foundation, Ohio: Objective and
the interferon system.
I.J. Fidler, M.D. Anderson Cancer Center, Houston, Texas:
INFNs: Preclinical antiangiogenesis mechanisms.
SESSION 2: Considerations in Clinical Study Designs
Chairperson: E.C. Borden, Cleveland Clinic Foundation, Ohio
S. Weiss, Emory University Hospital, Atlanta, Georgia: Pathol-
ogy of angiogenic neoplasms.
D. Lindner, Cleveland Clinic Foundation, Ohio: IFNs in preclini-
cal tumor models.
S.E. Krown, Memorial Sloan-Kettering Cancer Center, New
York, New York: Effective dose and schedule for Kaposi's
sarcoma.
A.M.M. Eggermont, University Hospital Rotterdam, The
Netherlands: Doses and schedules in melanoma-European
experience.
B.R.G. Williams, Cleveland Clinic Foundation, Ohio: Assess-
ment of mechanisms by gene array.
R. Kalluri, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Tumstatin and INFN-a gene expression.
J.M. Pluda, CTEP National Cancer Institute, Rockville,
Maryland: Potential for combination with other antiangiogenic
agents.
SESSION 3: Discussion and Presentation of Preclinical and
Phase II/III Cooperative Group Clinical Study Designs
Discussion Groups:
A. Ezekowitz, Massachusetts General Hospital, Boston:
Hemangiomas.
A.W. Bleyer, University of Texas, M.D. Anderson Cancer
Center, Houston: Giant cell tumors of bone.
G. Thomas Budd, Cleveland Clinic Foundation, Ohio: Angio-
sarcomas.
J.E. Darnell, The Rockefeller University, New York, New York:
Critical preclinical questions.
Recommendations for Future Studies:
Co-Chairpersons: E.C. Borden, Cleveland Clinic
Foundation, Ohio and J. Folkman, Children's Hospital,
Boston, Massachusetts: Next steps and summary.
Texas
J.E. Darnell, The Rockefeller University, New York, New York:
IFN-induced signaling.
A. Ezekowitz, Massachusetts General Hospital, Boston: Life-
threatening hemangiomas.
A.W. Yasko, M.D. Anderson Cancer Center, Houston, Texas:
Giant cell tumors of bone.
J. Darnell, B. Williams
Meeting of the Editorial Advisory Panel: Digital Image Archive on
the American Eugenics Movement
September 30-October 1
FUNDED BY National Human Genome Research Institute, National Institutes of Health
ARRANGED BY D. Mick los, Dolan DNA Learning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Welcome and Review
Overview of Image Archive
Full-text Searching
Bulletin Board
New Collections: Ellis Island, CSHL, Estabrook Archives
Banbury Center Meeting
SESSION 2: Discussion of NIH Restrictions and Conditions for
Lifting "People under Scrutiny," Potential for Abuse, and
Concern about Re-exploration of Disabled People
Conditions fulfilled:
Additional EAP member
Posting of editorial policy
Use agreement
Conditions remaining:
EAP discussion of separating site into educational and
archival components
Report of previous Working Group discussion
Site use and relevant site feedback
Resolution
SESSION 3: Tour of Dolan DNA Learning Center
SESSION 4: Independent Exploration of Eugenics Site, Bioin-
formatics Lab
Assignment of new images to topic areas
SESSION 5: Discussion of Future Plans
Collection trip to Eugenics Society and University College Ar-
chives, London
Future collection trips
S. Selden, P. Lombardo, and R Ryan at the Dolan DNA Learning Center.
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Making Vaccines for the Developing World: Access to and
Deployment of New Technologies
October 9-11
FUNDED BY Albert B. Sabin Vaccine Institute, Inc.
ARRANGED BY M. Moree, PATH/Malaria Vaccine Initiative, Seattle, Washington
P.K. Russell, Albert B. Sabin Vaccine Institute, Potomac, Maryland
Co-Chairpersons:
L.K. Gordon, VaxGen, Inc., Brisbane, California
R. Rabinovich, PATH/Malaria Vaccine Initiative, Rockville, Maryland
Welcome and Introductions:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D.L. Douglas, Albert B. Sabin Vaccine Institute, New Canaan, Connecticut
P.K. Russell, Albert B. Sabin Vaccine Institute, Potomac, Maryland
R. Rabinovich, PATH/Malaria Vaccine Initiative, Rockville, Maryland and
Lance K. Gordon, VaxGen, Inc., Brisbane, California: Charge to the conference.
P.K. Russell, Albert B. Sabin Vaccine Institute, Potomac, Maryland: Recommendations
from previous meetings.
R.I. Mahoney, International Vaccine Institute, Sedona, Arizona: Management of
intellectual property.
H. Kett ler, Institute for Global Health, San Francisco, California: Development of
intellectual property: The Biotechnology Foundation.
SESSION 1: Case Studies: Access to Technologies for the
Developing World
Chairperson: M. Moree, PATH/Malaria Vaccine Initiative,
Seattle, Washington
R. Insel, University of Rochester Medical Center, New York:
Pneumococcal vaccines.
M.A. Liu, Bill & Melinda Gates Foundation, Seattle,
Washington: DNA vaccine technology.
SESSION 2: Perspectives
Chairperson: P.K. Russell, Albert B. Sabin Vaccine Institute,
Potomac, Maryland
T A. Young, Texas A&M University System, College Station:
Academic technology transfer office-Rewards, motivations,
accountability.
L Gordon, VaxGen Inc., Brisbane, California: Biotech-Strategies
for the development and partnering of platform technologies.
R. Rabinovich, PATH/Malaria Vaccine Initiative, Rockville,
Maryland: NG0s-Access to platform technologies.
SESSION 3: Small Group Sessions: Identification of Problems
How to access and compile scientific data for the evaluation of
platform technologies for products for the developing world?
Can the initial licensing step be used to gain access to platform
technologies for the developing world?
How can licensing practices for companies be modified to fur-
ther access?
What different access to technology strategies may be
necessary for products that have dual markets vs. products
that only have a developing world market?
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SESSION 4
Reporting from Small Group Discussions: Chairperson: R.
Rabinovich, PATH/Malaria Vaccine Initiative, Rockville,
Maryland
Recommendations for Action: Chairperson: L.K. Gordon,
VaxGen, Inc., Brisbane, California
Future Agenda: Chairperson: P.K. Russell, Albert B. Sabin
Vaccine Institute, Potomac, Maryland
C. Schirvel, R. Intel
Cortical Maps
October 13-16
FUNDED BY Marie H. Robertson Memorial Fund for Neurobiology
ARRANGED BY D. Chklovskii, Cold Spring Harbor Laboratory
A. Koulakov, University of Utah, Salt Lake City
Welcome and Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D. Chklovskii, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: A. Koulakov, University of Utah, Salt Lake City
N. Swindale, University of British Columbia, Vancouver: Visual
cortex polymaps.
G.G. Blasdel, Harvard University, Boston, Massachusetts:
Optical imaging in primate visual cortex.
A. Grinvald, The Weizmann Institute of Science, Rehovot,
Israel: Visualization of cortical architecture and dynamics.
A. Koulakov, University of Utah, Salt Lake City: Wiring econo-
SESSION 2
Chairperson: D. Chklovskii, Cold Spring Harbor Laboratory
Z.F. Kisvarday, Ruhr-University Bochum, Germany: Area- and
age-related changes of pinwheel center positions in relation
to ocular dominance map.
E. Kaplan, Mount Sinai School of Medicine, New York, New
York: Color, size, and all the rest: How do they all fit inside the
visual cortex?
M. Sur, Massachusetts Institute of Technology, Cambridge:
Orientation maps and local processing in visual cortex.
my and polymaps.
D. Chklovskii, Cold Spring Harbor Laboratory: Orientation pref-
erence maps: A wiring optimization approach.
D.C. Van Essen, Washington University School of Medicine, St.
Louis, Missouri: Cortical maps and mappings between mon-
keys and humans.
J.C. Horton, University of California, San Francisco: Lessons
for column formation in primate striate cortex from a precise
topographic map generated from the shadows of retinal
blood vessels.
K.D. Miller, University of California, San Francisco: Which prop-
erties should be organized into maps?-A developmental
model.
G. Blasdel, S. Lowell
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SESSION 3
Chairperson: A. Grinvald, The Weizmann Institute of Science, Rehovot, Israel
S. Lowell, Leibniz Institute for Neurobiology, Magdeburg,
Germany: Is there a genetic influence on the layout of visual
cortical maps?
U.T. Eysel, Ruhr-University of Bochum, Germany: Optical
imaging of cortical maps and the effects of visual cortex
lesions: A demonstration of general robustness and subtle
modifiability of cortical maps.
D. Fitzpatrick, Duke University, Durham, North Carolina:
Relating patterns of connectivity to functional maps in the
visual cortex.
E.M. Callaway, The Salk Institute for Biological Studies, La
Jolla, California: Relationships between afferent input, local
circuits,and functional organization of primary visual cortex.
G.J. Goodhill, Georgetown University Medical Center,
Washington, D.C.: The effect of variable elastic topologies on
the structure of ocular dominance and orientation maps.
L. Krubitzer, University of California, Davis: Cortical maps:
Genetic and epigenetic contributions to the phenotype.
SESSION 4
Chairperson: N. Swindale, University of British Columbia, Vancouver, Canada
J.S. Lund, University of Utah, Salt Lake City: Anatomical sub-
strates for local and global integration of visual information:
Intrinsic and feedback connections of macaque VI cortex.
A. Shmuel, University of Minnesota, Minneapolis: Functional
organization of the feedback connection from V2 to VI of the
primate.
A.W. Roe, Yale University School of Medicine, New Haven,
Connecticut: The ANDS, and NOTs of feature-specific inte-
gration in VI and V2 of the primate.
K. Obermayer, Berlin, Germany: Role of nonlinear intracortical
interactions in cortical map formation.
F. Wolf, Max-Planck Institute, Gottingen, Germany: Are orien-
tation preference maps optimized for visual function?
Tsodyks, The Weizmann Institute of Science, Rehovot,
Israel: Visual maps and population activity in the visual cor-
tex.
SESSION 5
Chairperson: G.G. Blasdel, Harvard University, Boston, Massachusetts
D.-S. Kim, University of Minnesota Medical School, cal architecture and its role in early vision.
Minneapolis: Functional MRI of cortical maps-Scopes, M. Rosa, Monash University, Victoria, Australia: Small brains,
future, and limitations. great maps: The visual cortex in a dwarf primate, the mar-
V. Dragoi, Massachusetts Institute of Technology, Cambridge: moset monkey.
Inhomogeneities in the structure of orientation maps and their R Ak, Mount Sinai School of Medicine, New York, New York:
consequences for cortical function. Representation of spatial frequency selectivity in the mam-
A. Das, The Rockefeller University, New York, New York: Corti- malian primary visual cortex.
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Banbury Conference Center
J.P. Morgan H&Q/Cold Spring Harbor Laboratory Executive
Conference on Controlling Cancer
October 18-20
ARRANGED BY J.D. Watson, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
J.D. Watson, Cold Spring Harbor Laboratory: Welcoming
remarks.
D. Hanahan, Hormone Research Institute, University of
California, San Francisco: Cancer as an organ.
SESSION 2
S. Lowe, Cold Spring Harbor Laboratory: Genes, cell death,
and therapies.
C. Sawyers, Jonsson Comprehensive Cancer Center, Univer-
sity of California, Los Angeles: Gleevec and other kinase in-
hibitors in cancer therapies.
R. Kerbel, Sunnybrook and Women's Health Sciences Centre,
Toronto, Canada: Anti-angiogenic drugs as a new therapeu-
tic approach for cancer.
SESSION 3
V. Mittal, Cold Spring Harbor Laboratory: DNA array technolo-
gy and cancer.
R. Lucito, Cold Spring Harbor Laboratory: Using array tech-
nology to detect genomic mutations in cancer.
SESSION 4
K. Alitalo, Finnish Academy of Sciences, University of Helsinki,
Finland: Lymphangiogenesis: A new target for cancer treat-
ment.
J. Schlessinger, Signaling pathways: Targets for drug discov-
ery.
R. Kalluri, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Regulation of angiogenesis and tumor
growth by vascular basement membranes.
Discussion: Cancer therapies-What next?
Closing Remarks:
J.D. Watson, Cold Spring Harbor Laboratory
L. Hudson, J. Watson
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The History and Mechanisms of Animal and Plant Evolution
October 21-24
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J. Doebley, University of Wisconsin, Madison
C. Marshall, Harvard University, Cambridge, Massachusetts
N.H. Patel, HHMI, University of Chicago, Illinois
SESSION 1: Investigating Microevolutionary Change
Chairperson: N.H. Patel, HHMI, University of Chicago, Illinois
F. Nijhout, Duke University, Durham, North Carolina: The micro-
evolution of developmental mechanisms.
A. Long, University of California, Irvine: Using linkage disequi-
libria to dissect complex traits.
J. Doebley, University of Wisconsin, Madison: The evolution of
plant form: Examples from maize and its relatives.
SESSION 2: Variation, Adaptation, and Speciation
Chairperson: J. Doebley, University of Wisconsin, Madison
P.M. Brakefield, University of Leiden, The Netherlands: Does
development constrain butterfly eyespot evolution?
D.W. Schemske, Michigan State University, East Lansing:
D. Stern, Princeton University, New Jersey: A developmental
genetic approach to understanding microevolutionary mor-
phological variation.
G.C. Gibson, North Carolina State University, Raleigh: Will we
ever have the power to dissect quantitative traits down to the
nucleotide level?
Ecological genetics of adaptation and speciation.
H.A. Orr, The University of Rochester, New York: Are mathe-
matical theories of adaptation possible?
SESSION 3: Evolution of Genetic Pathways
Chairperson: C. Marshall, Harvard University, Cambridge, Massachusetts
C. Queitsch, University of Chicago, Illinois: Hsp90 buffers the Drosophila sex determination pathway.
genetic variation, environmental responses and developmen- G. O'Dell, University of Washington, Seattle: The robustness of
tal stability in Arabidopsis thaliana. evolved genetic networks would be astonishing were it not
A.S. Wilkins, BioEssays, Cambridge, United Kingdom: How a essential.
complex genetic pathway (might have) evolved: The case of
A. Wilkins, J. Gerhart, M. Akam
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SESSION 4: Plant Evolution
Chairperson: M. Akam, University of Cambridge, United
Kingdom
M.J. Donoghue, Yale University, New Haven, Connecticut:
Homoplasy, heterotopy, and constraints on evolution in
plants.
J. Maloof, The Salk Institute for Biological Studies, San
Diego, California: Natural variation in Arabidopsis light signaling.
SESSION 5: Arthropod Evolution
Chairperson: M.Q. Martindale, University of Hawaii,
Honolulu
D.E.G. Briggs, University of Bristol, United Kingdom: Morpho-
logical data from Cambrian fossils: Evidence for pattern and
process?
W. Arthur, University of Sunderland, United Kingdom: How do
evolutionary differences in segment number arise? Develop-
mental and population studies of a centipede model system.
M. Akam, University of Cambridge, United Kingdom: Arthro-
pod relationships: New trees and their implications for the
evolution of development.
N.H. Patel, HHMI, University of Chicago, Illinois: Evolution of
arthropod segmentation and body patterning.
SESSION 6: Chordate and "Basal" Metazoan Evolution
Chairperson: P.W.H. Holland, University of Reading, United
Kingdom
J.C. Gerhart, University of California, Berkeley: Hemichordates
and the origin of chordates.
B.J. Swalla, University of Washington, Seattle: The role
of the innate immune system in the evolution of the
chordates.
P. Janvier, Museum National d'Histoire Naturelle, Paris, France:
From jawless to jawed vertebrates: A "blackbox" of verte-
brate evolution.
M.Q. Martindale, University of Hawaii, Honolulu: Axial pattern-
ing in "radially" symmetrical metazoans.
SESSION 7: Evolutionary Changes in Gene Regulation
Chairperson: G.C. Gibson, North Carolina State University,
Raleigh
M. Ludwig, University of Chicago, Illinois: Evolution of cis-reg-
ulatory elements.
G. Wray, Duke University, Durham, North Carolina: Evolution of
a gene regulatory system: The Endol 6 promoter of camaro-
dont sea urchins.
SESSION 8: The Origins of Animal Multicellularity
Chairperson: N. Shubin, University of Chicago, Illinois
P.W.H. Holland, University of Reading, United Kingdom:
Origins of animal multicellularity.
A. Adoutte, Centre de Genetique Moleculaire du CNRS,
France: The new animal phylogeny: Implications for under-
standing the evolution of development.
SESSION 9: The Geological Record
Chairperson: J. Gerhart, University of California, Berkeley
C. Marshall, Harvard University, Cambridge, Massachusetts:
Evolution as the filtering of development by geology.
D. Erwin, National Museum of Natural History: Evolutionary
innovation: Construction of ecospace.
SESSION 10: Discussion
Co-Moderators: J. Doebley, University of Wisconsin, Madi-
son; C. Marshall, Harvard University, Cambridge, Massa-
chusetts; and N.H. Patel, HHMI, University of Chicago, Illinois
Wine and Cheese Party
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Stability and Reversal of the Differentiated State
October 28-31
FUNDED BY Yamanouchi USA Foundation
ARRANGED BY R. Lovell-Badge, National Institute for Medical Research, London, United Kingdom
D. Stocum, Indiana University-Purdue University, Indianapolis
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction and Welcome:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Pluripotency, ES Cells, and Germ Cells
Chairperson: R. Lovell-Badge, National Institute for Medical Research, London,
United Kingdom
A. Smith, University of Edinburgh, United Kingdom: P.J. Donovan, Thomas Jefferson University, Philadelphia,
Pluripotency and lineage restriction in embryonic stem Pennsylvania: Transformation of germ cells into pluripotent
cells. stem cells.
M.A. Surani, University of Cambridge, United Kingdom: The mam- R.G. Martinho, New York University Medical School, New York:
malian germ line: Origin, pluripotency, and epigenetic repro- Transcriptional regulation in Drosophila primordial germ cells.
gramming.
SESSION 2: Nuclear Reprogramming
Chairperson: M.C. Raff, University College, London, United Kingdom
R. Jaenisch, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Nuclear cloning and the repro-
gramming of the genome.
P. Mombaerts, The Rockefeller University, New York, New
York: Derivation of ES cell lines via nuclear transfer in mouse.
B. Knowles, The Jackson Laboratory, Bar Harbor, Maine:
Molecular control of the oocyte to embryo transition.
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K.E. Latham, Temple University School of Medicine,
Philadelphia, Pennsylvania: Incomplete or progressive
reprogramming of somatic cell nuclei during cloning
in mice.
K.J. McLaughlin, University of Pennsylvania, Kennett Square:
Visualizing reprogramming of Oct4 in mouse clones.
B. Carlson, D. Stocum, J. Watson
SESSION 3: Current Status of Stem Cell Regulations
Chairperson: R. Jaenisch, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts
L. Skirboll, Office of Science Policy, NIH, Bethesda, Maryland:
The development of U.S. stem cell policy.
A. Colman, PPL Therapeutics plc, Edinburgh, United Kingdom:
Patent and regulatory issues concerning research and thera-
peutic applications of human ES cells.
J. Burley, Queen's College, Oxford, United Kingdom: Ethical
and policy issues.
SESSION 4: Regeneration and Reversal of the Differentiated State
Chairperson: P. Mombaerts, The Rockefeller University, New York, New York
D. Stocum, Indiana University-Purdue University, Indianapolis: in the regenerating salamander limbs.
Regenerative biology and medicine. B.M. Carlson, University of Michigan, Ann Arbor: Stability and
J. Brockes, University College London, United Kingdom: instability of differentiation in long-term denervated and aging
Plasticity of the differentiated state during urodele amphibian mammalian skeletal muscle.
regeneration. M.C. Raff, University College London, United Kingdom:
W.-S. Kim, Sogang University, Seoul, Korea: Dedifferentiation Reversing direction in the oligodendrocyte lineage.
SESSION 5: Cell Fate Decisions and Potential
Chairperson: D. Stocum, Indiana University-Purdue University,
S. Huang, Children's Hospital/Harvard Medical School,
Boston, Massachusetts: Switching between cell fates:
Attractors in cell regulatory networks.
D. Jackson, Cold Spring Harbor Laboratory: Control of com-
munication and proliferation in plant stem cells.
J.C. Watson, Indiana University-Purdue University, Indiana-
polis: Photoregulated protein kinases in plants.
M. Timmermans, Cold Spring Harbor Laboratory: Suppression
SESSION 6: Adult Stem Cells and Their Potential
Chairperson: A. Smith, University of Edinburgh, United
Kingdom
Diana Clarke, Curis Inc., Cambridge, Massachusetts: Under-
standing stem cells derived from the adult brain and pan-
creas.
F.M. Watt, Imperial Cancer Research Fund, London, United
Kingdom: Stem cell renewal and lineage commitment in
mammalian epidermis.
F.D. Miller, McGill University, Montreal, Canada: Isolation and
characterization of multipotent adult stem cells from mam-
malian dermis.
D. Meletis, Karolinska Institute, Stockholm, Sweden: Stem
cells and regulation of differentiation.
SESSION 7: General Discussion
Co-Chairpersons: R. Lovell-Badge, National Institute for
Medical Research, London, United Kingdom and D.
Stocum, Indiana University-Purdue University, Indianapolis
Indianapolis
of stem cell fate during lateral organ development in maize.
B. Petersen, University of Florida, Gainesville: In vitro trans-dif-
ferentiation of adult hepatic stem cells and their potential
plasticity.
R. Lovell-Badge, National Institute for Medical Research,
London, United Kingdom: Stem cell genes and cell fate deci-
sions.
B. Knowles
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New Concepts for Clinical Cancer Trials
November 4-7
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY D. Hanahan, University of California, San Francisco
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Steering Committee:
J. Folkman, Children's Hospital, Boston, Massachusetts
R.S. Kerbel, Sunnybrook & Women's Health Sciences Centre, Toronto, Canada
J.M. Pluda, CTEP National Cancer Institute, Rockville, Maryland
Introduction and Welcome:
D. Hanahan, University of California, San Francisco
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Metronomic Dosing of Chemotherapy
Chairperson: J. Folkman, Children's Hospital, Boston, Massachusetts
J. Folkman, Children's Hospital, Boston, Massachusetts: The
concept of metronomic dosing and its realization in tradition-
al mouse models.
J. Folkman, Children's Hospital, Boston, Massachusetts: Met-
ronomic chemotherapy: The impact of suppressing p53 in
tumor endothelium.
Experience(s) in the Clinic with Metronomic Chemotherapy
E. Bergs land, University of California, San Francisco:
Challenges related to putting metronomic chemotherapy into
clinical practice.
Y. Takahashi, Kanazawa University, Japan: Survival without
tumor shrinkage: Tumor dormancy therapy.
B.A. Kamen, Cancer Institute of New Jersey, New Brunswick:
Pediatric experience: Empiric validation of "metronomics."
L. Hlatky, Dana-Farber Cancer Institute, Boston, Massa-
chusetts: Optimal dosing entails balanced metronomic sup-
pression of the vascular and tumor cell compartments.
General Discussion: Issues, problems, possible actions to
expedite clinical evaluation of metronomic strategies, assess-
ing schedules and doses, biomarkers, etc.
SESSION 2: Combining Metronomic Chemotherapy with Investigational Drugs
Chairperson: R.S. Kerbel, Sunnybrook & Women's Health Sciences Centre,
Toronto, Ontario, Canada
R.S. Kerbel, Sunnybrook & Women's Health Sciences Centre,
Toronto, Ontario, Canada: Demonstrating the principle of
combining metronomic chemotherapy with investigational
anti-angiogenic drugs.
Other Preclinical Results
R. Giavazzi, Mario Negri Institute for Pharmacological Research,
Bergamo, Italy: Combination treatments with experimental
drugs and chemotherapies in preclinical models.
G. Bergers, University of California, San Francisco: Assess-
ment of metronomic chemotherapy in mouse models of multi-
stage carcinogenesis.
H.M. Pinedo, Free University Hospital, Amsterdam, The
Netherlands: Phenomena to be considered in clinical trials
aiming to achieve angiogenesis inhibition.
S.G. Eckhardt, University of Colorado Cancer Center, Denver:
Ex vivo analyses of biological activity.
J.M. Pluda, CTEP National Cancer Institute, Rockville,
Maryland: NCI experiences with new clinical trial designs and
agents.
General Discussion: Issues, problems, possibilities E. Bergs land, R. Kerbel
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SESSION 3: Combining Metronomic Dosing of Chemotherapies with Approved
Agents Being Used Offline (e.g., Celebrex and Thalidomide)
Chairperson: R.S. Kerbel, Sunnybrook & Women's Health Sciences Centre,
Toronto, Ontario, Canada
R.S. Kerbel, Sunnybrook & Women's Health Sciences Centre,
Toronto, Canada: Preclinical and clinical studies on metro-
nomic antiangiogenic therapy.
Results in Animal Models or Clinical Trials/Experiences
S. Baruchel, Hospital for Sick Children, Toronto, Canada: Low-
dose chemotherapy and Celebrex as an anti-angiogenic
approach: Results of a pediatric clinical trial.
R. Buckstein, Sunnybrook Regional Cancer Centre, Toronto,
Canada: High-dose Celebrex and low-dose cyclophos-
phamide in relapsed/refractory Hodgkin's lymphoma.
M.W. Kieran, Dana-Farber Cancer Institute, Boston, Massa-
chusetts: Combination therapies.
General Discussion of Topics 2 and 3: Issues, problems,
opportunities. Possible actions to validate metronomic dos-
ing strategies, and to assess when metronomic vs. MTD
strategies are warranted in combinatoric trials.
SESSION 4: The Case of Interferon-a
Chairperson: J. Folkman, Children's Hospital, Boston, Massachusetts
J. Folkman, Children's Hospital, Boston, Massachusetts: The
childhood hemangioma experience.
R. Kalluri, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Endogenous interferon suppresses angio-
genesis in response to the collagen IV fragment tumstatin, an
angiogenesis inhibitor.
SESSION 5: Targeting Different Stages in Cancer Progression
Chairperson: D. Hanahan, University of California, San Francisco
D. Hanahan, University of California, San Francisco: The
lessons from mouse models of multistage carcinogenesis:
Stage-specific efficacy of MMP inhibitors, and tyrosine kinase
receptor inhibitors.
Relevant Experiences from Clinical Trials and Mouse
Models (e.g., the problems and promise of MMP-1 in Phase
Ill Trials)
G. Bergers, University of California, San Francisco: Targeting
peri-endothelial support cells.
J.S. Humphrey, Bristol-Myers Squibb PRI, Wallingford,
Connecticut: Clinical trials of MMP1, then and now.
General Discussion: Issues, problems, possible actions to
address the use of metronomic, low doses of IFNa, both
alone and in combination with other agents.
R.S. Herbst, M.D. Anderson Cancer Center, Houston, Texas:
Clinical trials with RTK-1.
L. Murray, SUGEN, Inc., South San Francisco, California:
Clinical trials with RTK-1.
J. Folkman, Children's Hospital, Boston, Massachusetts: How
do you equate mouse stages to human stages, when con-
sidering the implications of stage-specific efficacy?
General Discussion: Issues and problems: The path forward
to address the concept of stage-specific efficacy in clinical
trials.
SESSION 6: Finale: The Path Forward
Chairperson: J.M. Pluda, CTEP National Cancer Institute, Rockville, Maryland
J.M. Pluda, CTEP National Cancer Institute, Rockville,
Maryland: The NCI perspective.
I.M. Chico, U.S. Food and Drug Administration, Rockville,
Maryland: The FDA perspective.
A. Barge, AstraZeneca Pharmaceuticals, Cheshire, United
Kingdom: Big pharma perspective.
L. Norton, Memorial Sloan-Kettering Cancer Center, New York,
New York: Oncologist perspective.
Wrap-up Discussion: Action items, initiatives, cooperative
opportunities (Possible topics: How can mouse models con-
tinue to help move forward the evaluation of these new con-
cepts, of stage-specific efficacy, metronomic and low dosing,
etc? Can/should stage-specific, metronomic, and low-dose
trials be expedited for radiation and chemotherapy as single
agents, so as to potentially allow broader combinatroic test-
ing with approved and experimental drugs? If yes, how best
to do so?)
A Final Question to the Participants: Should we seek to
convey some of the perspectives forthcoming from this
workshop to the wider community?
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Epithelial and Endothelial Tube Morphogenesis
November 11-14
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY M.A. Krasnow, Stanford University School of Medicine, California
W.J. Nelson, Stanford University School of Medicine, California
Welcome and Goals of Meeting:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Mechanisms of Tube Formation-In Vitro Studies
Chairperson: A.L. Hubbard, Johns Hopkins University School of Medicine,
Baltimore, Maryland
K.E. Mostov, University of California, San Francisco: Epithelial
tubulogenesis, polarity, and membrane traffic.
W.J. Nelson, Stanford University School of Medicine, Califor-
nia: Cell dynamics in epithelial morphogenesis.
G.E. Davis, Texas A&M University System Health Science
Center, College Station, Texas: Cdc42 and Racl control
SESSION 2: Mechanisms of Tube Formation-In Vivo Studies
Chairperson: H. Skaer, University of Cambridge, United Kingdom
B.M. Weinstein, National Institute of Child Health and Human
Development, Bethesda, Maryland: Studying blood vessel
formation in the developing zebrafish.
C.H. Damsky, University of California, San Francisco: Pseudo-
vasculogenesis: Formation of a hybrid fetal/maternal vascu-
lar system during development of the human placenta.
G.R. Dressler, University of Michigan, Ann Arbor: Cell migration
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endothelial cell vacuole and lumen formation in three-dimen-
sional extracellular matrices.
A.L. Hubbard, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Vesicle traffic in polarized epithelial cells.
M.E. Gerritsen, Genentech, Inc., South San Francisco, Califor-
nia: Gene expression profiling during angiogenesis in vitro.
and adhesion in the developing kidney.
H. Skaer, University of Cambridge, United Kingdom: Cell
recruitment in tubulogenesis: Parallels between Drosophila
and mammalian kidney development.
D.J. Andrew, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Genetic control of tube morphology in
the Drosophila salivary gland.
B. Weinstein, D. Li
SESSION 3: Mechanisms of Tube Formation-Signaling and Regulation
Chairperson: A.P. McMahon, Harvard University, Cambridge, Massachusetts
A.P. McMahon, Harvard University, Cambridge, Massachusetts:
Tubule branching in the lung.
E. Keshet, The Hebrew University Hadassah Medical School,
Jerusalem, Israel: Organ-specific induction of vascular net-
works in the adult.
W. Birchmeier, Max-Delbruck-Centrum, Berlin-Buch, Germany:
c-met signaling in tubulogenesis.
C. Samakovlis, Stockholm University, Sweden: Bnl (FGF) sig-
naling regulates apical cell dynamics and epithelial tube
length in the Drosophila trachea.
SESSION 4: Tubulogenesis Mutants and Diseases I
Chairperson: G.J. Beitel, Northwestern University, Evanston, Illinois
G.J. Beitel, Northwestern University, Evanston, Illinois: Mecha-
nisms of length and diameter control in the epithelial tubes of
the Drosophila tracheal system.
M. Buechner, University of Kansas, Lawrence: Regulation of
the diameter of the excretory canals, a single-celled tubular
epithelium in C. elegans.
F. Karim, Exelixis, Inc., South San Francisco, California:
Genetic dissection of pathways controlling branching mor-
phogenesis and vascular remodeling.
I. Drummond, Massachusetts General Hospital, Charlestown:
Epithelial patterning and function in the zebrafish pronephric
kidney.
G. Germino, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Role of PKD protein in establishing and
maintaining tubular structure.
SESSION 5: Tubulogenesis Mutants and Diseases II/Engineering and Evolution of
Blood Vessels
Chairperson: D. Marchuk, Duke University Medical Center, Durham, North
Carolina
D. Marchuk, Duke University Medical Center, Durham, North
Carolina: Vascular morphogenesis: What we have learned
from inherited vascular dysplasias.
D.Y. Li, University of Utah, Salt Lake City: Mouse angiogenesis
mutants: Role of matrix in morphogenesis.
D. Radisky, Lawrence Berkeley Laboratory, California: Mecha-
nisms leading to lumina! morphogenesis in the mammary
gland.
M.A. Krasnow, Stanford University School of Medicine,
California: Developmental control of blood cell migration by
the Drosophila VEGF pathway: Implications for evolution of
the vascular system.
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Searching for Meaning in the Human Genome
Albert Einstein spent a great portion of his life pondering the forces that govern the universe. His quan-
tum theory sketched out the grand rules by which elementary particles move and interact to construct
all matter. In response to the perception that quantum mechanics had reduced life to a set of mathe-
matical probabilities, Einstein famously said, "I cannot believe that God would choose to play dice with
the universe." In a similar way, the publication of the human genome sequence, in February 2001, gives
us cause to ponder the forces that have shaped our own genetic inheritance and wonder if anyone is
playing dice with our genes.
As the race to sequence the human genome heated up, the Cold Spring Harbor Laboratory
Meetings Office came up with its own game of chance to divert the attention of visiting gene experts.
Called Genesweep, it is a competition to guess the actual number of human genes. Up to within sev-
eral weeks of the initial publications of the genome sequence, most bets hovered around 100,000
genes, with some going as high as 150,000.
The announcement that two independent sequencing efforts had arrived at a number of approxi-
mately 30,000 genes therefore came as a surprise even to experts. This raised an obvious question:
How can humans get along with only about twice as many genes as a fruitfly (with 13,000 genes) or a
microscopic roundworm (with 19,099 genes)? At least part of the answer lies in the range of informed
bets in the Genesweep contest. Bets on larger numbers were in part based on experiments which
sample genes that are expressed (active) in different kinds of cells. These methods, and the higher esti-
mates they produced, were favored by the so-called "gene mining" companies-who obviously would
like more genes to sell to their clients.
There is good reason for this seeming overestimate. Prior to protein synthesis, the DNA code is tran-
scribed into a complementary RNA code. Through a process called RNA splicing, discovered inde-
pendently at Cold Spring Harbor Laboratory and the Massachusetts Institute of Technology, the RNA
code is cut and spliced to produce different kinds of directions. Thus, although most genes are repre-
sented only once in the human genome, a single gene can be alternatively spliced to produce several
different proteins. In this way, the genomes of higher organisms can get a lot of proteins out of rela-
tively few genes.
One would have thought that the two independent sequencing projects would have produced
enough information to identify every single human gene. However, several recent assessments suggest
that both genome projects may have missed as many genes as they found. In fact, it is very difficult to
compare or move between the data sets produced by the two projects. Each used different experi-
mental methods and different computer software to search out genes among the raw data. Many
genes are missing from gaps in sequence, where adjacent chromosome pieces have yet to be linked
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together. Regions containing large amounts of repetitive DNA, especially around the centromeres, will
likely never be completely sequenced and assembled-although few genes are likely to be missed
there. Thus, a year after what seemed to the general public the definitive effort to sequence the human
genome, we still can only guess at the number of genes that make us human. The Genesweep prize
has yet to be awarded.
Rightly, the general public and most scientists focus on the genes revealed by the Human Genome
Project. Of course, naming and knowing all of our genes will be a great step forward in understanding
how our cells work-and exactly what goes wrong in various diseases. Making human life healthier
and, presumably, happier are the practical outcomes of the Human Genome Project. However, just as
meaning sometimes lies between the lines of prose or verse, some of the meaning of our genome lies
between the genes. Indeed, most of the human genome is not the stuff of genes.
The road to sequencing the human genome began in the 1950s and 1960s. During this period, the
discovery of the structure of DNA and the cracking of the genetic code showed the rules that allow liv-
ing matter to be faithfully reassembled in each generation. Although reducing inheritance to a set of
chemical probabilities may have unveiled the mystery of procreation, it did not rob life of meaning. For
James Watson, Cold Spring Harbor President and co-discoverer of the DNA structure, it was enough
that DNA is "a beautiful molecule." Unfortunately, it takes a fair appreciation of chemistry to understand
what Jim Watson means by this. Whereas the DNA structure is more than most people can fathom,
the genetic code-the directions for making proteins-can be followed by any fifth grader. Therefore,
the cracking of the genetic code was comforting, because, at the very least, it makes good sense.
At the same time, other scientists were turning up evidence that protein-coding regions make up
only a fraction of the genomes of higher organisms, including humans. Much of this non-gene DNA is
found around the centromere, a knob-like swelling in each chromosome. Here, short DNA sequences
are repeated tens to thousands of times, creating a vast DNA desert virtually devoid of genes. It is
thought that these short DNA repeats arise when the enzyme involved in copying DNA "stutters," los-
ing its place among a string of repeats and adding an extra unit from time to time. Thus, the repeated
regions increase in size over the long course of evolution.
Longer DNA repeats are found outside the centromeres. Ranging from several hundred to several
thousand DNA units in length, these repeats are not due to duplication errors. Rather, they are trans-
posable elements-so-called jumping genes-that have copied themselves and moved from chromo-
some to chromosome. Although transposable elements were first discovered in corn, by Cold Spring
Harbor Laboratory scientist Barbara McClintock, they have since been identified in every organism
studied-including humans.
In the 1970s, a third type of non-gene DNA, termed an intron, was discovered. Up until that time,
most of what was known about gene structure had come from studying bacteria in which each gene
generally is a continuous stretch of DNA code, beginning with a start codon and ending with a stop
codon. The genes of higher organisms (eukaryotes) turned out to be more complex. In these genes,
the genetic code is interrupted by numerous introns, giving rise to "split genes." The average human
gene has tens of introns, and the intron sequences are almost always longer than the coding
sequences. Prior to protein synthesis, the phenomenon of RNA splicing removes the introns to pro-
duce a continuous genetic code.
By the start of the Human Genome Project, the going estimate was that these three types of non-
coding DNA weighed in at 95% of the human genetic endowment! In comparison, the entire genetic code
of all the genes needed for human life was thought to constitute only about 5% of our total complement
of DNA. The draft sequence showed that this estimate was overgenerous by a factor of three. It now
appears that as little as 1.5% of the human genome actually carries genetic code for making proteins.
Why so little gene information and why so much "junk?" What kind of way is this to run a genome?
At least some fraction of noncoding DNA is far from junk. Noncoding regions between genes contain
specific sequences-called promoters and enhancers-that regulate when, where, and how much of
a protein is produced. This coordinated activity of genes is especially important during embryonic
growth and development. Noncoding regions within genes-introns-contain information that directs
RNA splicing, which allows a diversity of proteins to be produced from a single gene. Indeed, gene reg-
372
ulation and splicing are considered the means through which an essentially identical set of mammalian
genes is elaborated into a human, a mouse, or a monkey. Thus, it is not the genes that set humans
apart, it is what we do with them.
The noncoding DNA that surrounds promoters, enhancers, and splice signals can be explained as
the necessary evolutionary "grist" from which these gene regulators emerged. Short repeated units can
be dismissed as mere mistakes in the complex machinery needed for replicating DNA. From a meta-
physical standpoint, the transposable elements are more difficult to explain. Two transposable ele-
ments, called L1 and Alu, are the most frequent gene-sized sequences in the human genome. About
1 million copies of A/u and 500,000 copies of L1 compose about 27% of human DNA by weight. Each
of these hundreds of thousands of copies arose from an individual "jump" at some point in human evo-
lution. L1 transposons came into the genome about 150 million years ago, so we share these
sequences with many vertebrates, including fish and mice. Alu is only about 65 million years old-
young enough that its jumping is confined to primates, the "monkey" branch of the tree of life. Several
thousand A/u elements are found only in humans, so they have made the jump in the past 6 million
years-after humans diverged from a common ancestor with chimps. L1 carries a gene for the enzyme
reverse transcriptase (RT), which converts L1 RNA into a mobile DNA copy. This same enzyme enables
retroviruses, such as human immunodeficiency virus (HIV), to insert into positions on the human chro-
mosome from which they cause infection. Current thinking holds that the retroviruses borrowed the RT
gene from transposons in the host genome.
Interestingly, the L1 RT enzyme has an additional function analogous to restriction enzymes, the
"scissors" that allow biologists to precisely manipulate DNA. L1 makes staggered nicks on each side
of the DNA molecule, thus providing a site into which a reverse-transcribed DNA copy can integrate
into a new chromosome position. L1 appears to search through DNA and make its first cut in a region
containing roughly the same string of DNA letters, termed a consensus sequence. But the second nick
is unpredictable. Thus, the jumping about that is mediated by L1 RT lies somewhere between pre-
dictability and randomness.
Regardless, with no functional genes at all, Alu is thought to rely on RT enzyme produced by L1.
This makes Alu a parasite of L1 in a molecular symbiosis that puts a point on the axiom:
Great fleas have little fleas
Upon their back to bite 'ern
And little fleas have lesser fleas
And so ad infinitum.
Biologists struggle to find the meaning of transposons that take so much space in the human
genome. Some believe transposons have been successful because they have enabled the genomes
they inhabited to compete more successfully on the battleground of evolution. A/u jumping peaked 40
million years ago, reaching a rate of perhaps one new jump in each newborn primate. This period
roughly coincided with the evolutionary "radiation" that led to the development of forerunners of mod-
ern branches of the primate family. A/u accumulates in gene-rich regions, and its jumping may be acti-
vated under stressful conditions. These facts have led some to speculate that Alu transposition has had
a positive role in primate evolution, creating gene variations that provided a selective advantage for
evolving primates as they adapted to changes in the earth's environment. Other biologists believe that
the success of Alu and other transposons rests entirely in their own reproductive ability. Alu, which
makes no protein, may exist solely for its own replication. This fits Richard Dawkins' moniker of "self-
ish DNA." If one continued on this line of thought, one might craft a definition of life from the viewpoint
of DNA:
Life is the perpetuation and amplification of a DNA sequence through time.
According to this view, A/u is a supremely successful life form, with a million copies of itself perpet-
uated in each of the billions of humans and primates alive today.
Of course, most people would not like to entertain the possibility that our genomes are merely ves-
sels for the reproduction of some selfish and fidgety DNA. Those so inclined might find some cheer
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knowing that (HOORAY!) some transposons have gone extinct like the dinosaurs. The A/u/L1 symbio-
sis replaced an earlier and virtually identical symbiosis between a sequence called Mer and L2.
Although they have not jumped for at least 100 million years, Mer and L2 "fossils" still litter about 5%
of the human genome.
All told, various types of transposons make up more than half of our genetic endowment. If pos-
session is nine-tenths of the law, one might ask "Who's in charge of this genome, anyway?" The truth
is, we will probably never know for certain whether transposons are part of the plan or just little fleas
playing dice with our DNA.
The Genes We Share
By year's end, we were well into production of our own tribute to the human genome project-a new
exhibit entitled The Genes We Share. The exhibit takes a global look at the incredible genetic similari-
ty of all human beings, as well as the differences that make each person unique. The 2000-square-foot
exhibit will include an array of historical items, audiovisual installations, and interactive exhibits. To make
way for the new work, we dismantled the long-standing exhibition, Story of a Gene, which focused on
the biology, medical applications, and social issues of human growth hormone. It nearly broke our
hearts to paint over the Cellarium, a room-size depiction of the interior of a human cell.
The Genes We Share celebrates the 50th anniversary of the discovery of the DNA structure, which
set the stage for the recent efforts to determine the entire DNA sequence of the human genome. As
visitors explore the exhibition, they will be encouraged to view the human genome as a record of our
shared ancestry, an instruction manual for our
bodies, and a source of information that can
foreshadow a person's future health.
Visitors will be greeted in the front hall with
photomurals of crowded "peoplescapes," illus-
trating the similarities and differences between
the people of the world. The main hall (the for-
mer Cellarium) shifts focus to the individual. An
interactive area will allow visitors to observe and
make records of their own physical features
and to compare these with the features of other
individuals. Shifting focus even closer, micro-
scopic footage and high-resolution animations
will highlight body structures and biological
processes that we all share. The endpoint of
this area will explore DNA variations in our
genomes that make each of us unique. DNA
and personality profiles of identical twins, Matt
and Danny, will explore the relationship
between nature (DNA) and nurture (environ-
ment).
Other installations in the central hall will shift
focus back to the level of human populations
and how genetic differences have evolved
between them. An interactive map of the world
will depict the migration paths of our earliest
ancestors and illustrate some of the environ-
mental factors that influenced human evolution.
An interactive table, in the shape of a cellular
component called a mitochondrion, will allow
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Designers from the London Science Museum install the
floor-to-ceiling replica of the original DNA model built by
Watson and Crick.
visitors to explore the use of DNA to study human evolution and trace our ancestry. Mini-displays high-
light unusual DNA "memorabilia"-including the hair of Anna Anderson-Manahan (who claimed to be
the Russian Duchess, Anastasia) and the mitochondrial DNA sequence of the Nobel laureate, James
D. Watson.
The smallest exhibition space, located beneath the projection room of the Multitorium, will explore
the anatomical, genetic, and behavioral changes that evolved to set humans apart from other primates.
Skeletons of a chimpanzee, a modern human, and Neanderthal (the first adult reconstruction ever dis-
played) will be set within the recreation of a cave environment. Recreations of prehistoric paintings, as
well as Neanderthal and Cro-Magnon burials, will encourage visitors to think about the earliest evidence
of human self-awareness. By comparing mitochondrial DNA sequences, visitors will see evidence of
genetic changes that accumulated through evolutionary time, since humans shared common ances-
tors with chimps and Neanderthals.
The interpretation of the human DNA sequence will be introduced by an interactive exhibit, "Stories
in Our Genes," in which Matt Ridley presents a guided tour through human chromosomes, based on
his popular book, Genome. This leads into elements dealing directly with DNA structure and sequenc-
ing. An eight-foot-tall reconstruction of the original metal DNA model made by Watson and Crick in
1953 represents the beginning of the quest to understand ourselves. A working DNA sequencer, oper-
ating daily to sequence DNA submitted by student classes from around the United States, will illustrate
the ubiquity of DNA sequencing technology. Finally, exhibits on DNA "chips" and gene therapy will
encourage the viewer to ponder how DNA will affect their future lives and health.
We Become the Dolan DNA Learning Center
On June 8, 2001, we rededicated a facility doubled in size by completion of the Biomedia Addition. The
ceremony honored the generosity of Charles and Helen Dolan, from whom our institution now takes its
name. The Dolan Family Foundation's lead gift toward the $5 million expansion was the culmination of
years of support, stretching back to when Helen was a member of the original trustee committee that
guided the founding of the DNALC. Charles is a quiet pioneer of the cable television industry, and his
company, Cablevision, was the major donor to an earlier 1993 renovation of the DNALC. This venture
created our 104-seat auditorium as a venue for Long Island Discovery, a multimedia presentation that
has been seen by more than 76,000 people visiting the DNALC.
The keynote address was given by Dr. Peter Bruns, Vice President of Grants and Special Programs
of the Howard Hughes Medical Institute, which has supported our educational programs for the past
seven years. The event also marked the unveiling of a large-scale portrait of Charles and Helen in the
formal entrance to the Biomedia Addition. The impressionist painting was created by Lewis Miller, an
Australian artist whose works at CSHL include a monumental portrait of President James Watson and
character sketches of noted scientific visitors. Mr. Miller won the 1998 Archibald Prize, Australia's most
prestigious award for portraiture.
The dedication also marked the end of a difficult renovation period, during which the multimedia
group sought temporary offices on the main lab campus and the instructional group was crammed into
makeshift offices in a former exhibit gallery. United again in our new facility, our educators and multi-
media designers can once again collaborate in the manner that has enabled us to create novel instruc-
tional materials.
Our new facility, designed by the noted architectural firm Centerbrook, is a joy to inhabit. The entire
upper level is given over to multimedia production. Enclosed offices along the length of the building pro-
vide quiet spaces for writing, and two open bays and a conference area provide open spaces for col-
laborative work. The area is home to an eclectic staff with varied backgrounds in research biology, sci-
ence communication, computer programming, exhibition development, and graphic design.
New and redeveloped spaces on the lower level accommodate our programs for student enrich-
ment and teacher training. Three teaching laboratories are organized around "island" benches of our
own design, which encourage cooperative learning. The laboratories incorporate the latest multimedia
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With all major renovations complete, the DNALC was rededicated on June 11, 2001. Clockwise, from top left:
The new west entry to the Bio Media Addition; upgraded teaching laboratory; garden border in front of the
DNALC depicting the DNA helix; terrace and shade garden adjacent to the new lunchroom; and the Lewis Miller
portrait of Charles and Helen Dolan, hanging inside the west entrance.
projection technology and stereo sound, allowing instructors to integrate digitized lab results with an
array of education resources-including live V\AAAA/ content, molecular animations, videotapes, and
DVDs. An adjacent prep lab, complete with DNA sequencer and several types of centrifuges, supports
the most advanced experiments by staff and student interns.
The striking, octagonal computer laboratory is the symbolic heart of the building, emphasizing the
increasing use of computers to "mine" the genetic information encoded in DNA molecules. Like today's
genome scientists, DNALC students now have the opportunity to move effortlessly between in vitro ("in
glass," or test tube) manipulations of DNA biochemistry to in silico (computer) manipulations of the
genetic information stored in DNA. For example, in the biochemistry lab, students can isolate their own
DNA, amplify a variable region by PCR, and analyze the results by gel electrophoresis. Then, in the
computer laboratory, student DNA types are entered into a database and the class "population" is
compared to world population using statistical measures.
Instructional staff share a communal office, and a reception/business office sets a professional tone
to our interaction with visiting teachers and administrators. In addition, updated restrooms have
replaced the antiquated (and tiny) facilities installed in 1925 for elementary children who were the build-
ing's first clientele. The original girls' lavatory found new use as a corridor to provide common access
to the three teaching laboratories. A new lunchroom allows students to have a relaxed meal looking out
on our shade garden, rather than huddling in the hallway or on a school bus.
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Instructional Programs
Despite the mayhem of operating a building under construction-including a three-month abandon-
ment of two teaching laboratories during renovation of the original building-a total of 20,868 teachers
and students, representing 102 school systems, took part in DNALC laboratory activities during 2001.
Amazingly, this number very nearly matches the level of calendar year 2000, when we hosted 21,750
workshop and lab participants. With three functional laboratories up and running by late spring, we
increased summer programs by 22%; 557 students participated in workshops at the DNALC as well
as at John F Kennedy High School (Bronx), Brooklyn Technical High School (Brooklyn), and Central
Islip High School (Central Islip).
Our DNA Sequencing Service doubled in size, processing over 2,000 samples submitted by 64 high
schools, 38 universities, and 5 community colleges. Developed several years ago with funding from the
National Science Foundation, this service offers students the unique opportunity to use their own DNA
to learn elements of modern genomic biology. The exponential growth of this program has been made
possible by the gift of a 377 DNA sequencer and ongoing donations of sequencing reagents and
instrument service by Applied Biosystems, which allows the DNALC to increase the size of our pro-
gram while continuing to provide the service for free. Technical support for the Sequencing Service is
provided by several research staff at the main CSHL campus: Joan Alexander, Spencer Teplin, Ray
Preston, and Patrick Smith.
Using a kit developed by the DNALC and distributed by Carolina Biological Supply Company, stu-
dents isolate DNA from their own hair roots or cheek cells. Their DNA is mixed with freeze-dried PCR
reagents to amplify (clone) a highly variable region of the mitochondrial genome. The amplified samples
are then mailed to the DNALC, where high school interns perform the final DNA sequencing reactions.
The student DNA sequences are then databased in an educational workspace at our WVVVV site, from
which students can launch a number of analyses, including BLAST searches and CLUSTAL sequence
alignments. A companion VVVVVV site, Genetic Origins, contains everything needed to reproduce the
experiment and use the results to explore unanswered questions in human evolution.
For the past several years, middle-school field trips had combined lab work with interpretive use of
the Story of a Gene exhibit. Thus, dismantling the exhibit required us to rethink how we could contin-
ue to provide a rich experience for middle-school students while we develop the new exhibit, The
Genes We Share. We turned this quandary into an opportunity to quickly integrate the computer lab-
oratory into the life of the DNALC.
Working directly with multimedia designer Chun-hua Yang, the middle-school staff developed a
guided multimedia module for middle-school visitors. The result was an interactive mystery based on
the true story of Anastasia Romanov. During a typical session, a DNALC instructor uses video clips
from the NOVA video, Anastasia: Dead or Alive, to introduce the Romanov family and circumstances
of their murder in 1918.
Middle-school stu-
dents participate in
the Anastasia com-
puter experience led
by educator Maureen
Cowan.
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Students then work collaboratively at their computer stations, using forensic methods to determine
the ages and sexes of skeletal remains from a common grave in Siberia. Comparing DNA from the
skeletons to living descendants of the Russian royal family confirms the identity of the five Romanovs,
but leaves open the fate of the youngest daughter, Anastasia. Following this story, students compare
the lives and physical features of Anna Anderson, a woman who many people, including some surviv-
ing Russian royalty, believed was Anastasia. A comparison ofAnna Anderson's DNA with that from the
bones in the Siberian grave recreates scientific experiments conducted in the 1990s and provides the
final word on the mystery of Anastasia. Teacher and student reaction to the Anastasia module has been
almost overwhelming. We believe the module is one of the very best examples of effective use of mul-
timedia in science education. By year's end we had begun development of a VWVW version to make
this stunning work available worldwide.
In the spring, we continued our honors seminar series for local students, Great Moments in DNA
Science. The program attracted 476 secondary science studentsto a range of topics in modern biology:
Dr. Gregory Hannon, Cold Spring Harbor Laboratory: "The Role of Cell Proliferation Control inCancer"
Robert Baumann, Suffolk County Crime Laboratory: "The Use of DNAin Criminal Investigations"
Dr. Howard Rosenbaum, American Museum of Natural History:
"Working With Whales: DNA as a
Useful Tool for Conserving the World's Largest Creatures"
Expanding the DNALC Model to the East and West
The year provided us with new opportunities to disseminate our
unique way of working. Following up on a visit in October 2000 from
the Minister of Education, RAdm Teo Chee Hean, of the Republic of
Singapore, we worked with ministry officials to explore the possibil-
ity of setting up a sister institution in the island republic noted for
student science achievement. During a week-long visit in February,
DNALC director David Mick los was given an extensive tour of all lev- Director Dave Mick los meets with
students in Singapore.els of the science education and research system, including ele-
mentary and secondary schools, junior and technical colleges, and the national university and research
institutes. In May, Dave and Scott Bronson returned to Singapore to instruct a DNA Science Workshop
for high school and junior college faculty, and four Singaporean educators visited the DNALC in July to
attend the Pfizer Leadership Institute.
In the following months, continuing discussions led to the proposal to establish two institutions in
Singapore based closely on the DNALC model. One, at the Singapore Science Centre, will focus on
student enrichment and public outreach. The other, at the National Institute of Education, will focus on
teacher training. We anticipate a high-level visit from the Ministry in 2002 and a subsequent multi-year
agreement for the substantial transfer of intellectual property to the Singaporecenters-including
teacher training, technical assistance, WWW site mirroring, and joint curriculum development. With
central control of a school system about the size of Chicago, we regard this as a unique opportunity
to experiment with the rapid and large-scale deployment of instructional methods we have developed
over the past 15 years.
Closer to home, a different opportunity presented itself when CSHL Trustee Arthur Spiro proposed
to develop a "DNALC West" in collaboration with the Research Institute of North Shore-Long Island
Jewish (NS-LIJ) Health System. In this case, it was agreed that the DNALC will operate a teaching lab
hosted at NS-LIJ, mirroring lab field trips and summer workshops conducted at the DNALC. By year's
end, plans were in hand for a teaching laboratory and student lunchroom to be located in space adja-
cent to the system's diagnostic laboratories, just off the Northern State Parkway in Lake Success. The
NS-LIJ facility will allow us to better serve school districts in western Nassau County, Brooklyn, Queens,
and Manhattan.
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Howard Hughes Vector Net Programs
With funding from the Howard Hughes Medical Institute (HHMI), we continued our longstanding effort
to introduce students and faculty to the use of modern networked computing in genomic biology.
Central to this effort is Vector Net, a stand-alone, portable computer laboratory, consisting of 12 user
laptops and a laptop server. The program is based on our earlier work with Vector mobile DNA labo-
ratories-specially designed Ford vans and reagent kits we introduced in the mid-1980s to deliver
teacher training in molecular genetics to sites around the country. Vans and DNA footlockers are now
standard methods for resource sharing between schools in many regions of the country. In a similar
way, Vector Net was designed to prove the feasibility of "backpacking" a bioinformatics computer lab-
oratory essentially anywhere.
The student component, New York City Genes is a collaborative project with the Gateway to Higher
Education Program, a major science education initiative by Mt. Sinai Medical School and NYC public
schools. In 2001, we trained 55 high school teachers from New York City to use the Vector Net
Laboratory to access the DNALC's rich Internet content, data analysis tools, and on-line bioinformat-
ics facilities. In the spring, the Vector Net system was rotated to Brooklyn Technical High School
(Brooklyn), the High School for the Humanities (Manhattan), and Stevenson High School (Bronx) where
it was used by some 250 primarily minority students in grades 9-11. The availability of a set of net-
worked computers in the biology classroom allowed students to move between lab experiments and
computer analysis of their own DNA polymorphisms.
Bioinformatics is a relatively young discipline that attempts to analyze the information content of
DNA. Since it merges biology and information technology, the field offers an interesting means to
involve computer-literate students in science. Most bioinformatics tools and data sets are freely avail-
able on the Internet. Students and teachers have the unprecedented opportunity to use the same tools
that biologists do to explore the human genome.
The Vector Bioinformatics Workshop aims to enable teaching faculty to take advantage of the trea-
sure trove of DNA data flowing from the Human Genome Project, while improving basic computer skills.
During its first summer, 78 high school and college faculty participated in workshops held at four inde-
pendent research institutions. We relished the chance to visit these wonderful institutions and renew
friendships with local organizers who were essential to our summer success:
Susan Cooper, Trudeau Institute, Saranac Lake, New York
Nancy Hutchison, Fred Hutchinson Cancer Research Center, Seattle, Washington
Ellen Potter, Salk Institute, La Jolla, California
Philip Silverman, Oklahoma Medical Research Foundation, Oklahoma City
The week-long workshop guides participants in logical steps from DNA isolation through sequence
basics to in silico gene discovery. The workshops begin with basic methods for analyzing patterns in
DNA sequences and progress to on-line algorithms that identify gene features, including open reading
frames and intron/exon boundaries. Participants then use genome browsers to find genes in on-line
databases, identify their chromosome locations, identify homologs in other organisms, and explore
their involvement in normal and disease processes. Conceptually, the week culminates in the investi-
gation of pharmacogenetics and the research efforts to identify single nucleotide polymorphisms
(SNPs) that predict disease susceptibility and drug response.
The computer work is punctuated by biochemistry labs that use the teacher's own DNA as a
starting point for on-line analysis, using the DNALC's custom Bio Servers. Simple DNA types at the
PV92 locus on chromosome 16-developed via PCR and gel electrophoresis-are the basis for
studies of human population genetics and tests of competing theories of human origins. Making use
of the DNALC's Sequencing Service (described above), sequencing the control region reveals SNPs
in each participant's own DNA and provides a foundation for sequence comparisons and database
searches.
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Pfizer Leadership Institute
Originally supported by the National Science Foundation during summers 1993 through 1995, the
Leadership Institute in Human and Molecular Genetics returned in 2001 with Pfizer Foundation fund-
ing. Affectionately known as "DNA Boot Camp," this Institute is to high school biology teachers what
the CSHL postgraduate research courses are to scientists-an intense immersion into high-level exper-
imentation and thinking. During their three-week stay in July, participants are housed on the main cam-
pus of CSHL, where they can interact with CSHL staff and visiting scientists at meals and seminars.
The 20 faculty participants in 2001 represented 14 different states, and a rigorous selection process
ensured that they were among the top 5% of high school biology teachers nationwide. As evidence of
their professionalism, 85% of the participants had advanced degrees, and they averaged 18 years'
teaching experience. The schools they represented ranged from well-financed private institutions to
large urban high schools with limited budgets; 55% of their schools have a minority population of
19-52%, and 25% of them provide lunch assistance for their student population. The intent of the
Institute is to further develop their content and leadership skills so they can function as regional experts
in advanced biology instruction.
The Institute incorporates high-level theoretical, laboratory, and computer work-including human
and plant DNA polymorphisms, DNA sequencing, bioinformatics, and computer multimedia. Seminars
presented by CSHL research scientists Richard McCombie, Rob Martienssen, Vivek Mittal, and David
Helfman extended coursework to real-life research problems. A field trip to the American Museum of
National History, in New York City, provided an opportunity to tour "The Genomic Revolution" exhibit
with curator Rob De Salle, to attend a symposium on "Teaching in the Genome Age," and to interact
with Woodrow Wilson Fellows taking part in a similar institute at Princeton.
The Institute culminated with independent time during which participants were free to follow up on
laboratory or computer work of particular interest to them, and to prepare curriculum materials for use
in their own classrooms. Projects included identification of genes/transgenes in plants, bioinformatics,
and Web page construction. One teacher brought bone material from a 1000-year-old South American
mummy to the workshop. During the independent work period, she and two colleagues extracted and
analyzed the mummy's mitochondrial DNA. Other teachers learned how to do electronic PCR or
explored parallels between modern genetics and the ill-fated eugenics movement.
DNA Interactive
Pfizer Leadership participants
and DNALC staff on the final
day of the three-week-long
workshop.
In the spring, CSHL was abuzz with news of Jim Watson's plan for a five-part PBS television series,
Genetic Journey, to celebrate the 50th anniversary of his discovery of the double helix. This will surely
be the most notable public science event of 2003. Thus, we were thrilled when, in the fall, the DNALC
was brought into the project to develop DNA Interactive (DNA°, an interactive VVVWV "portal" through
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which teachers and students can enter a rich world of on-line resources about the DNA revolution.
Development of the site, as well as supporting vidoegraphy and animations, is being funded by a $2
million grant from the Howard Hughes Medical Institute.
DNAi will be organized around five mini-courses that loosely follow the content of the TV series.
Each mini-course will draw a variety of media elements into a common window, or "player"-including
video interviews from Genetic Journey, schematic animations, high-resolution graphic animations,
interactive problems, downloadable lesson plans and student workbooks, and connections to science
education standards. DNAi's unique content will be complemented by a revolutionary site structure.
Working from the premise that teachers gain "ownership" of their curriculum by organizing knowledge
drawn from a number of sources, DNAi will allow teachers to customize information and multimedia
tools to best suit their unique instructional needs and preferences.
DNAi will employ a sophisticated content management system, which will be used by the DNALC
staff to create the content of the site and allow teachers to customize the content according to their
own needs. A user profile is stored on the DNAi server, and upon logging on, a teacher's customized
content is assembled "on the fly" from content stored in the DNAi multimedia database. The site will
be customizable on three levels. On the first level, teachers can create a custom class page, incorpo-
rating interactive page design of the sort offered on the start pages of Yahoo, MSNBC, and other on-
line companies. The class page includes a message board to alert students to current work and
assignments, a news feed of genetics articles from around the WWW, and a message board that at
once anchors class discussions within wider discussions at the DNAi site.
On a second level, teachers will be able to edit modules within the mini-courses, shortening them
or adding customized narrative. On a third level, teachers will be able to search, by keyword, all of the
multimedia content at the site, then edit the returned items for display in a custom player. Each select-
ed item can then be annotated by the teacher for class presentation or homework assignment. This
will give biology teachers the multimedia equivalent of Powerpoint-a simple presentation builder linked
to a database of thousands of searchable video clips, animations, molecular graphics, photographs,
and narrative elements.
DNAi represents a tremendous opportunity for the DNALC to make good use of the sophisticated
Internet publishing capabilities it has built over the past several years. We believe that DNAi will intro-
duce a new way for biology teachers and students to interact on the WWW, and we expect it to draw
between 500,000 and 1 million visitors per month. Upon publication of DNAi, in spring 2003, we will
be positioned for additional large-scale projects in biological multimedia.
Our WWW Domain Expands
The Gene Almanac WWW site is a portal to a number of content sites developed and managed by the
DNALC. In 2001, the sites received a combined visitation of 1.7 million, an increase of 54% over the
previous year. DNA from the Beginning is still the most popular site, but within months of its launch, the
new site Your Genes, Your Health was poised to overtake it in popularity.
In anticipation of future growth, we improved our site architecture and updated our server hardware.
We also implemented common sense-domain names, which will aid visitors in finding our sites:
Gene Almanac: http://www.genealmanac.org
DNA from the Beginning: http://www.dnaftb.org
Your Genes, Your Health: http://www.yourgenesyourhealth.org
Archive of the American Eugenics Movement: http://www.eugenicsarchive.org
Genetic Origins: http://www.geneticorigins.org
Bioservers: http://www.bioservers.org
In December 2000, we posted the final chapters of our Internet-accessible tutorial DNA from the
Beginning (DNAFTB). To make this work available to those without fast Internet connections, in
November we released a CD-ROM version for stand-alone play. Animation, video, and photographic
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resources of the 41-chapter work are so extensive that they fill three disks. The set is available at our
VVWVV site for $49.99, using PayPal to expedite credit card purchases.
With completion of DNAFTB, the Biomedia staff began developing a companion site entitled Your
Genes, Your Health (YGYH). A multimedia guide to genetic disorders, YGYH is targeted at patients and
families who are urgently looking for understandable information about specific genetic disorders. The
site deals with relatively common disorders, and focuses on how ongoing molecular genetics research
is improving diagnostics and the types of treatment that are currently available.
YGYH was launched in April with Fragile X syndrome, followed by Marian syndrome, cystic fibrosis,
hemophilia, and Duchenne/Becker muscular dystrophy. The hemophilia module was a Yahoo Web Site
pick of the week. Modules on phenylketonuria, Huntington disease, neurofibromatosis, sickle cell,
hemochromatosis, thalassemia, Tay-Sachs, Alzheimer, Down syndrome, and either asthma or diabetes
will follow in 2002. Each disorder starts with short facts for quick browsing. More in-depth information
is provided by animations on the disorder's cause, inheritance, and diagnosis. Video interviews with
patients, health-care providers, and researchers provide insiders' perspectives on having and treating
genetic disorders. Based on feedback received from this Web Site, these insiders' perspectives are
extremely helpful for the newly diagnosed. Each disorder also has links to support groups and foun-
dations, which advise us during development.
In February 2001, the Biomedia group obtained a 3-year, $850,000 grant from the National
Institutes of Health to build a multimedia Internet site called Inside Cancer. The Web Site is geared
toward the general public and will be especially useful to teachers and students. It will be a resource
for people who want authoritative information on the workings of a cancer cell. Animations and video
interviews with cancer researchers and other experts will help people understand the complex science
and issues of cancer. The Inside Cancer site will have five modules: (1) What is Cancer shows how can-
cers develop from a single cell. (2) Causes & Prevention identifies behaviors and environmental factors
that increase cancer incidence. (3) Diagnosis & Treatment explains traditional and experimental strate-
gies for identifying and fighting cancer. (4) Cancer in the Laboratory explains key experiments that have
advanced our understanding of cancer at the cellular and molecular levels. (5) Pathways to Cancer is
a three-dimensional tour showing how growth signals are relayed from the cell exterior to the nucleus
and how they are perturbed in cancer cells.
Eugenics Image Archive
The Image Archive on the American Eugenics Movement Web Site continues to be a popular resource.
In 2001, the Archive received 84,000 visitors who requested 428,000 documents. We increased the
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holdings of the Archive by nearly 50% when we photographed 700 additional objects from the CSHL
Archives and two other sites. At the International Center of Photography (ICP) in Manhattan, we were
able to gather an eclectic set of images from the exhibition Perfecting Mankind: Eugenics and
Photography. We were very excited to receive permission to access collections at the University
College, London, where we spent a frenetic two days in October in the collections of Francis Galton,
Karl Pearson, and Lionel Penrose. It was thrilling to see Galton's notebooks for Hereditary Genius, the
work that started the eugenics movement; data from his work on fingerprint analysis and composite
portraiture; and personal correspondence with his cousins Charles and Leonard Darwin.
To allow people to have the sense of working with original documents that represent the objectives
and methods of the eugenics movement, about half of the Archive consists of photographs of rare doc-
uments and correspondence. However, the content of these photographs cannot be searched. Thus,
in 2001 we began a major project to transcribe each written document in the collection. Under this sys-
tem, each image of a document has a corresponding text file, which can be searched along with titles.
Thus, a search returns both the archival photograph and a corresponding text file, which is easier to
read and from which quotations can be easily extracted.
On May 6-8, we held the first of three Banbury meetings to be sponsored under our grant from the
National Human Genome Research Institute. American Eugenics and the New Biology: Perspectives
and Parallels aims to familiarize "opinion leaders" about this dark saga in American science. The meet-
ing drew 31 participants from diverse fields, including family genetics, education, ethics, journalism,
government, industry, and philanthropy. Sessions on the history and lessons learned from the eugen-
ics movement included presentations by four members of our Advisory Panel: Gar Allen, Elof Carlson,
Paul Lombardo, and Steve Selden.
Garland Allen, Washington University, St. Louis, Missouri
Elof Carlson, SUNY, Stony Brook, New York
Katie Clapp, FRAXA Research Foundation, Newbury-
port, Massachusetts
Pat Colbert-Cormier, Lafayette High School, Louisiana
Nancy Fisher, Regence Blue Cross, Seattle, Washington
Henry Friedlander, City University of New York, New York
Daniel Kevles, California Institute of Technology,
Pasadena
Philip Kitcher, University of California, San Diego
Martin Levitt, American Philosophical Society, Philadel-
phia, Pennsylvania
Paul Lombardo, University of Virginia, Charlottesville
Nancy Press, Oregon Health Sciences University,
Portland
Philip Reilly, Shriver Center for Mental Retardation,
Waltham, Massachusetts
Pat Ryan, Carolina Biological Supply Company, Burling-
ton, North Carolina
Marsha Saxton, World Institute on Disability, San
Francisco, California
Steven Selden, University of Maryland, College Park
Terry Sharrer, National Museum of American History,
Washington, D.C.
Dean Hamer of the Nation-
al Cancer Institute dis-
cusses the genetics of
human behavior with par-
ticipants at the first Ameri-
can Eugenics and the New
Biology meeting in May.
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Staff and Interns
We were sorry to bid farewell to several staff members in 2001. Vin Torti, the Chief Development Officer
for the DNALC, left in July for a position at Long Island Institute of Technology. He is currently working
as the development officer at Winthrop Hospital. Our scientific coordinator, Veronique Bourdeau, went
on maternity leave in September and had a baby boy. The whole family then moved to Montreal, where
Vero's husband took a position at the local university. In the future, we hope to work with Vero to bring
some of the DNALC's programs to the Great White North. After contributing key writing to the DNAFTB
and YGYH VVVVVV sites, Susan Conova left in December for a position in the external relations depart-
ment of Columbia Health Science, where she is a science writer and communicator.
With the increase in physical space at the DNALC, we were able to plan for a new exhibit. Bronwyn
Terrill joined us in February to develop the new DNALC exhibit The Genes We Share, which will be open
to the public in 2002. Bronwyn, our Australian import, has a background in science communication and
museum exhibit development and has worked at several major science museums and organizations in
Australia.
The Biomedia group expanded in response to the DNALC's growing web presence. Wen-Bin (Bin)
Wu started in April as a new multimedia designer. He has a background in print design and a masters
degree in computer design from Rochester Institute of Technology. Bin's eye for simplicity and elegance
and his attention to detail have brought a new look to our Web Sites. Adrian Arva was an eagerly await-
ed addition to the Biomedia staff. Adrian responded to our on-line advertisement for a computer pro-
grammer in September of 2000. His interest in Web Site development and bioinformatics, and his med-
ical/science background, made him an ideal choice for our web programmer. It took a little longer for
the U.S. and Romanian governments to agree with our choice, but Adrian finally began working at the
DNALC in May.
The middle-school instructional group also saw changes. In September, we were thrilled to welcome
Tricia Maskiell back to the middle-school staff. Tricia had left her position at the DNALC in 2000 when
her husband's job required a move to New Hampshire. One of the first things Tricia did when they
moved back to New York in 2001 was to contact the DNALC and take on a part-time position. Danielle
Sixsmith, another middle-school teacher, went on maternity leave this summer, and returned in
November with a new addition to her family-a baby girl. Danielle is working part-time, and will head
up DNALC West, the satellite facility we are currently developing with the North ShoreLong Island
Jewish Health System.
To make full use of our enlarged teaching facilities, in the fall we recruited Jennie Aizenman and
Hong Zhou to the instructional group. In addition to teaching high school classes, Jennie will develop
new labs for the students. She received her Ph.D. in molecular microbiology and immunology from the
Johns Hopkins University School of Public Health and did postdoctoral work at Rockefeller University.
Hong helps manage our high school interns and our DNA Sequencing Service. The wife of CSHL sci-
entist Jerry Yang, Hong has a masters degree in molecular biology and has worked in science labs in
China and in the United States.
Veteran interns Yan Liang Huang (Harborfields High School) and Janice Lee (Oyster Bay High
School) assisted us throughout the year training new interns and working in our new laboratory class-
rooms and prep labs. Janice is researching RNAi in fission yeast with CSHL's Tom Volpe (Delbruck).
She also completed her research of PCR analysis of the CF1 mutation in Arabidopsis and, over the
summer, helped train the younger interns.
Other veteran interns, whom we miss tremendously, left mid-year to pursue their scientific interests.
Among them, Caroline Lau (Syosset High School) was chosen for the prestigious CSHL "Partners for
the Future" program. She has been teamed with David Jackson (Delbruck), and is studying cell-to-cell
communication in Arabidopsis thaliana. Rebecca Shoer (Syosset High School) is researching new pro-
tocols for microarray techniques with Vivek Mittal at the Woodbury Genome Center. Jordan Komisaro
(Long Beach High School) is researching Arabidopsis genetics with Rob Martienssen (Delbruck). Daniel
Goldberg (Half Hollow Hills East) has joined a researcher at NS-LIJ. Rebecca (Becca) Yee, a former high
school intern at the DNALC, used her summer break from Wellesley College to help instruct and coor-
dinate new interns. Her expertise and skill were greatly appreciated during the hectic workshop sea-
son. Visiting summer interns were Daniel De Roulet, Daniel Davison, Brendan O'Kane, and Dennis
O'Kane.
Processing and sequencing mitochondrial DNA sent from around the country has become an
important responsibility of the intern force. Sirish Kondabolu (Half Hollow Hills High School) and
Jonathan Mogen (Half Hollow Hills High School), along with senior intern Andrew Diller, have kept pace
beautifully as we continue to meet the increasing demand on the DNALC's on-site sequencing pro-
gram.
Joining the intern crew in the spring were Jared Winoker (Syosset High School), Marie Mizuno (Cold
Spring Harbor High School), Benjamin Blond (Syosset High School), and Kunal Kadakia (Syosset High
School). Jared and Kunal have been studying the allelic frequency of the A/u insertion on chromosome
16. Benjamin has been working with Jennie Aizenman on mutagenesis of enhanced GFP and BFP pro-
teins. Marie is researching apoptosis with Yuri Lazebnik (Hershey).
Fall 2001 newcomers included Eric Paniagua (Long Island School for the Gifted), Saroja Bangaru
(Long Island School for the Gifted), Michelle Louie (Kings Park High School), Ha la Mostafa (Kings Park
High School), Gerad Ryan (Kings Park High School), Jarrett Linder (Half Hollow Hills High School), Alex
Witkowski (Cold Spring Harbor High School) and Wayne Chiang (Cold Spring Harbor High School).
The Biomedia group also had talented and enthusiastic interns to help with the day-to-day opera-
tions of Web Site production. Tracy Mak (Syosset High School) and Felix Hu (Northport High School)
as returning high school interns were indispensable in taking care of all the details. Felix was extreme-
ly helpful over the summer with software and computer installations. Summer college interns Eun-Sook
Jeong (C.W. Post), Kun-Feng Chen (C.W. Post), and Matthijs Muller (Free University of Amsterdam,
Netherlands) helped with initial production of the Your Genes, Your Health Web Site. We also welcomed
Watson School graduate student Elizabeth Thomas to assist us with VVVVVV development.
2001 Workshops, Meetings, and Collaborations
January 16-18 National Institutes of Health, A Decade of ELSI Research Conference, Bethesda, Maryland
January 22-23 Your Genes, Your Health interview, Katherine Clapp, FRAXA Research Foundation,
Newburyport, Massachusetts
January 24 Your Genes, Your Health interview, Debbie Stevenson, FRAXA Research Foundation,
National Fragile X Foundation, New York, New York
January 25 Site visit by Rebecca Burkhadt, Long Island Business News
January 29 Your Genes, Your Health interview, Dr. Ted Brown, New York State Institute for Basic
Research in Developmental Disabilities, Staten Island, New York
January 30 Site visit to American Museum of Natural History and the International Center of
Photography, New York, New York
February 13 Site visit by Axel Jahns, Brinkmann Instruments
February 15-20 American Association for the Advancement of Science Annual Meeting, San Francisco,
California
February 16-25 Site visit to the National Institute of Education, Singapore
March 14 Site visit by Dr. Rod Wing, Dr. Jerry Trapnell, and Dr. Harold Cheatham, Clemson University,
South Carolina
March 18 Presentation for students and parents, Parrish Art Museum, Southampton, New York
March 20 Site visit by Dr. James Bonacum, American Museum of Natural History, New York, New
York
March 22 Howard Hughes Medical Institute, New York City Genes teacher training, York College,
Queens, New York
March 22-25 National Science Teachers Association Annual Meeting, St. Louis, Missouri
March 29 Workshop presentation for National Institute of Science Meeting, Atlanta, Georgia
March 30 National Human Genome Research Institute ELSI Project, Eugenics Image Archive, collec-
tion visit to International Center of Photography, New York, New York
Your Genes, Your Health interview, Dr. Richard Devereux, New York Presbyterian Hospital,
New York, New York
April 4 Site visit by Judy Winkler, Invention Factory Science Center, Trenton, New Jersey
National Institute of Social Sciences Board Meeting, New York, New York
Presentation for Career Day at Sayville High School, Sayville, New York
April 6 Your Genes, Your Health interview, Julie Kurnitz, New York, New York
April 13 Laboratory for Pine Creek and George Washington High Schools, Colorado Springs,
Colorado
April 20 Site visit to American Museum of Natural History, New York, New York
April 25 National Institute of Social Sciences Meeting, Harvard Club, New York, New York
April 26 Site visit by Wendy Law and David Masterman, Fred Hutchinson Cancer Research Center,
Seattle, Washington
April 28 Presentation for students and parents, Planting Fields Arboretum State Historic Park,
Oyster Bay, New York
May 1 Great Moments in DNA Science Honors Students Seminar, CSHL
May 4 Your Genes, Your Health interview, Dr. Allan Rubenstein, Mount Sinai School of Medicine,
New York, New York
May 6-8 National Institutes of Health ELSI conference, American Eugenics and the New Biology:
Perspective and Parallels, Banbury Center, CSHL
May 7 Great Moments in DNA Science Honors Students Seminar, CSHL
May 10 Site visit by Dr. Peter Bruns, Vice President for Grants and Special Programs, Howard
Hughes Medical Institute
May 11 Site visit by Jesse Raiford, Maximum Science Studio
May 14 Site visit by Christine Herbes-Sommers and Sandy Haller, Human Race project, California
Newsreel
May 15 Great Moments in DNA Science Honors Students Seminar, CSHL
Your Genes, Your Health interview, Cara Kaek and daughter Noel, Long Island, New York
May 16 Site visit by Robert M. Frehse, Jr., Vice President and Executive Director, The Hearst
Foundation, New York City
May 18-20 American Society for Microbiology Education Conference, Orlando, Florida
May 22 Site visit by Dean Madden and John Schollar, University of Reading, United Kingdom
May 28-June 1 DNA Science Workshop, National Institute of Education, Singapore
May 29 Your Genes, Your Health interview, Paul Brayshaw, Washington D.C.
May 30 Your Genes, Your Health interview, Price family, Washington D.C.
Your Genes, Your Health interview, Dr. Katherine High, Children's Hospital of Philadelphia,
Pennsylvania
June 8 Dolan DNA Learning Center Building Dedication
June 11-13 Teacher training workshop for Singapore Ministry of Education
June 12 Your Genes, Your Health interview, Dr. Catherine Manno, Children's Hospital of
Philadelphia, Pennsylvania
June 15 Site visit and interview by Scott Feldman, News 12 Long Island
June 18-22 Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Oklahoma Medical
Research Foundation, Oklahoma City, Oklahoma
June 25-29 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
July 2-20 Pfizer Leadership Institute in Human and Molecular Genetics, DNALC
July 6 Site visit by Karen Arenson, The New York Times
July 7 Howard Hughes Medical Institute, New York City Genes teacher training, American
Museum of Natural History, New York, New York
July 9-13 Green Genes Workshop, DNALC
Genomic Biology & PCR Minority Workshop, Central Islip High School, New York
July 16-20 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Minority Workshop, Brooklyn Technical High School, New York
July 18 Your Genes, Your Health interview, Dr. Clement Ren, Stony Brook University Medical
Center, New York
July 23-27 Fun With DNA Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Minority Workshop, John F. Kennedy High School, Bronx, New York
Genomic Biology & PCR Workshop, DNALC
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Salk Institute for
Biological Studies, La Jolla, California
July 25 Your Genes, Your Health interview, Dr. Jane Halperin, genetic counselor, New York, New
York
July 26 DNA from the Beginning interview, Dr. Nathaniel Comfort, Baltimore, Maryland
July 30-August 3 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
DNA Science Workshop, Brooklyn Technical High School, New York
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Fred Hutchinson
Cancer Research Center, Seattle, Washington
July 31 Your Genes, Your Health interview, Suzanne Burger, Westchester County, New York
August 6-10 Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
August 9 Your Genes, Your Health interview, Dr. Alfred Spiro, Albert Einstein College of Medicine,
Bronx, New York
DNA from the Beginning interview, Dr. Scott Gilbert, Swarthmore College, Pennsylvania
August 13-17 Fun With DNA Workshop, DNALC
Genetic Horizons Workshop, DNALC
Genomic Biology & PCR Workshop, DNALC
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Trudeau Institute,
Saranac Lake, New York
August 20-24 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
August 22 Site visit by Michael Dowling, Roy Zuckerberg, and Dan De Roulet, North Shore-Long Island
Jewish Health System
August 23 Your Genes, Your Health interview, Dr. Selma Snyderman, Mount Sinai School of Medicine,
New York, New York
August 27 Site visit by Michael Gilman and Gregory Peterson, Biogen, Cambridge, Massachusetts
Your Genes, Your Health interview, Erin Buckley, Huntington, New York
August 31 Site visit by Clare Matterson, Wellcome Trust, London, U.K., and D. Burke, Pricewater-
house Coopers
August 27-31 Fun With DNA Workshop, DNALC
DNA Science Workshop, DNALC
September 7-9 Workshop presentation for students taking part in the Human Race project, Allston,
Massachusetts
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September 18 Site visit by David Bowtell and Joe Sambrook, Peter Mac Callum Cancer Institute, East
Melbourne, Australia
September 20 Gateway Institute for Higher Education Coordinator Meeting, City College, New York, New York
September 21 Your Genes, Your Health interview, Dr. Chris Ross, Johns Hopkins University School of Medicine,
New York, New York
Your Genes, Your Health interview, Suzanne Doggett, Huntington's Disease Society of America,
New York, New York
Your Genes, Your Health interview, Nancy and Barry Goldring, Huntington's Disease Society of
America, New York, New York
September 30- National Human Genome Research Institute ELSI Project, Eugenics Image Archive,
October 1 Editorial Advisory Panel Meeting, Banbury Center, CSHL
Your Genes, Your Health interview, Pat Ryan, Carolina Biological Supply Company, Burlington,
North Carolina
October 2 Your Genes, Your Health interview, Dr. Kusum Viswanathan, Brookdale University Hospital and
Medical Center, New York
Your Genes, Your Health interview, Dr. Kenneth Rivlin, Brookdale University Hospital and Medical
Center, New York
October 3 Inter School Exchange Faculty Dinner, DNALC
October 4 Site visit by Dr. Michael Schroeder, Eppendorf AG, Hamburg, Germany
October 5 Site visit by Piero Benedetti, Padova University, Italy
October 15 Site visit by Linda Winston, American Museum of Natural History, New York, New York
October 17 Presentation for Long Island School to Career Partnership, Huntington Hilton, New York
October 18 Inside Cancer interview, Dr. Scott Lowe, CSHL
October 18-19 Exhibit interview, Dr. Matt Ridley, International Center for Life, Newcastle, United Kingdom
Inside Cancer interview, Dr. Judah Folkman, Harvard Medical School, Massachusetts
October 20 Inside Cancer interview, Dr. Doug Hanahan, University of California-San Francisco
October 22-26 National Human Genome Research Institute ELSI Project, Eugenics Image Archive, collection
visit to University College, London, United Kingdom
October 25 Your Genes, Your Health interview, Maya Priest, New York, New York
October 29-31 Howard Hughes Medical Institute Precollege Directors Meeting, Chevy Chase, Maryland
November 6 Inside Cancer interview, Dr. Mike Wig ler, CSHL
November 7-10 National Association of Biology Teachers Annual Meeting, Montreal, Quebec, Canada
November 14 Site visit to Biogen, Cambridge, Massachusetts
November 15 Site visit by Barbara Spezia le, Clemson University, South Carolina
November 16 Site visit by Kip Powers and David Tesseo, Science Center of Southeastern Connecticut, New
London
November 20 Site visit by Marcia Welsch, Elaine Sands and Gayle Ins ler, Ade 1phi University, Garden City, New
York
November 28 Site visit by Katie Barbour and Doug Crain, Flying Colors Media
December 3 Site visit by Ann McDermott, Oncogene Pharmaceuticals, Melville, New York
Site visit to New York Institute of Technology, Old Westbury, New York
December 4-5 National Human Genome Research Institute ELSI Review Panel, Bethesda, Maryland
December 7 Site visit by Dr. Sheldon Karnilow and Mike DeStio, Half Hollow Hills School District, Dix Hills,
New York
December 12 Museum exhibit interview, Syd Mandelbaum, Cedarhurst, New York
December 18 Site visit to Biogen, Cambridge, Massachusetts
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Sites of Major Faculty
Key: High School
ALABAMA
ALASKA
ARIZONA
ARKANSAS
CALIFORNIA
COLORADO
CONNECTICUT
DISTRICT OF COLUMBIA
FLORIDA
GEORGIA
HAWAII
ILLINOIS
INDIANA
IDAHO
IOWA
KANSAS
KENTUCKY
LOUISIANA
MAINE
MARYLAND
MASSACHUSETTS
MICHIGAN
MISSISSIPPI
MISSOURI
NEW HAMPSHIRE
NEVADA
NEW YORK
Workshops 1985-2001
College Middle School
University of Alabama, Tuscaloosa
University of Alaska, Fairbanks
Tuba City High School
Henderson State University, Arkadelphia
Foothill College, Los Altos Hills
University of California, Davis
San Francisco State University
University of California, Northridge
Canada College, Redwood City
Pierce College, Los Angeles
California Lutheran University, Thousand Oaks
Laney College, Oakland
California State University, Fullerton
Salk Institute for Biological Studies, La Jolla
Colorado College, Colorado Springs
United States Air Force Academy, Colorado Springs
University of Colorado, Denver
Choate Rosemary Hall, Wallingford
Howard University
North Miami Beach Senior High School
University of Western Florida, Pensacola
Armwood Senior High School, Tampa
University of Miami School of Medicine
Fernbank Science Center, Atlanta
Morehouse College, Atlanta
Morehouse College, Atlanta
Kamehameha Secondary School, Honolulu
Argonne National Laboratory
University of Chicago
Butler University, Indianapolis
University of Idaho, Moscow
Drake University, Des Moines
University of Kansas, Lawrence
Murray State University
University of Kentucky, Lexington
Western Kentucky University, Bowling Green
Jefferson Parish Public Schools, Harvey
John McDonogh High School, New Orleans
Bates College, Lewiston
Annapolis Senior High School
Frederick Cancer Research Center, Frederick
McDonogh School, Baltimore
Montgomery County Public Schools
St. John's College, Annapolis
University of Maryland, School of Medicine, Baltimore
Beverly High School
City Lab, Boston University School of Medicine
Dover-Sherborn High School, Dover
Randolph High School
Winsor School, Boston
Boston University
Athens High School, Troy
Mississippi School for Math & Science,
Columbus
Washington University, St. Louis
Washington University, St. Louis
St. Paul's School, Concord
New Hampshire Community Technical College, Portsmouth
University of Nevada, Reno
Albany High School
Bronx High School of Science
Columbia University, New York
1987-1990
1996
1988
1992
1997
1986
1991
1993
1997
1998
1999
1999
2000
2001
1994
1995
1998
1987
1992,1996
1991
1991
1991
2000
1989
1991,1996
1997
1990
1986,1987
1992,1997
1987
1994
1987
1995
1988
1992
1992
1990
1993
1995
1989
1995
1988
1990-1992
1991
1999
1986
1997
1989
1988
1987
1994,1996
1989
1990,1991
1989
1997
1986,1987
1999
1992
1987
1987
1993
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Cold Spring Harbor High School 1985,1987
DeWitt Middle School, Ithaca 1991,1993
DNA Learning Center 1988-1995, 2001
DNA Learning Center 1990,1992, 1995,2000
DNA Learning Center 1990-1992
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987-1990
Titusville Middle School, Poughkeepsie 1991,1993
Wheatley School, Old Westbury 1985
U.S. Military Academy, West Point 1996
Stuyvesant High School, New York 1998-1999
Trudeau Institute, Lake Saranac 2001
NORTH CAROLINA North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA School of Science and Mathematics, Oklahoma City 1994
Oklahoma City Community College 2000
Oklahoma Medical Research Foundation, Oklahoma City 2001
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Longhorn Creek High School, Houston 1991
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
University of Texas, Austin 1999
Austin Community College-Rio Grande Campus 2000
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998
University of Utah, Salt Lake City 2000
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
WASHINGTON University of Washington, Seattle 1993,1998
Fred Hutchinson Cancer Research Center, Seattle 1999, 2001
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986,1987
University of Wisconsin, Madison 1988,1989
Madison Area Technical College 1999
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
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2001 PUBLICATIONS
LABORATORY MANUALS "Discovering the Double Helix" (Video)
James D. Watson
Arabidopsis: A Laboratory Manual
Detlef Weigel and Jane Glazebrook
Protein-Protein Interactions: A Molecular Cloning Manual
Erica Golemis (ed.)
Lateral DNA Transfer: Mechanisms and Consequences
Frederic Bushman
Safety Sense: A Laboratory Guide
CSHL MONOGRAPH SERIES The Unfit: A History of a Bad Idea
Elof Mel Carlson
Stem Cell Biology
Daniel R. Marshak, Richard L. Gardner, and David Gottlieb
(eds.)
SYMPOSIUM
Biological Responses to DNA Damage
Cold Spring Harbor Symposia on Quantitative Biology
Volume LXV
TEXTBOOKS
Bioinformatics: Sequence and Genome Analysis
David W. Mount
Genes & Signals
Mark Ptashne and Alexander Gann
CHILDREN'S BOOKS
Enjoy Your Cells
Fran Balkwill and Mic Rolph
Germ Zappers
Fran Balkwill and Mic Rolph
JOURNALS
Genes & Development (Volume 15, 24 issues)
T. Grodzicker and D. Solter (eds.)
Genome Research (Volume 11, 12 issues)
A. Chakravarti, R. Gibbs, E. Green, R. Myers, and L. Goodman
(eds.)
OTHER TITLES Learning & Memory (Volume 8, 6 issues)
J.H. Byrne (ed.)A History of Genetics (reprint edition)
A.H. Sturtevant
An A to Z of DNA Science: What Scientists Mean When They
Talk about Genes and Genomes
Jeffre L. Witherly, Galen P. Perry, and Darryl L. Leja
A Passion for DNA: Genes, Genomes, and Society (paperback
edition)
James D. Watson
At the Helm: A Laboratory Navigator
Kathy Barker
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Protein Science (Volume 10, 12 issues)
M. Hermodson (ed.)
OTHER
CSHL Annual Report 2000
Banbury Center Annual Report 2000
Administration and Financial Annual Report 2000
COLD SPRING HARBOR LABORATORY PRESS
For this publishing house, 2001 was a year of new beginnings and satisfactory outcomes. Revenue
rose by 14% to $9,940,000, and our contribution to the economy of the Laboratory, combining over-
head allocations and operating margin, exceeded $1 million. Financial highlights of the year included
the strong first-year sales of the new edition of the manual Molecular Cloning, significant advances in
subscriptions to Genome Research and Protein Science, and robust journal advertising sales that with-
stood the sharpest industry downturn in a generation.
Books for Scientists
The book program produced a front list of unusual interest and diversity. Of the 15 new titles published,
8 were for the professional use of research investigators.
Stem Cell Biology, edited by Daniel Marshak, Richard Gardner, and David Gottlieb, acknowledged
the tidal wave of scientific and popular interest in stem cells and their clinical applications but suc-
ceeded in the editors' goal of providing a longer and more authoritative view of a field in which, despite
many advances, much remains to be learned before new treatments can be established.
Lateral DNA Transfer: Mechanisms and Consequences, by Frederic Bushman, also addressed a
topic of emerging biological interest-the fascinating consequences of the exchange of genetic infor-
mation between species. The immense scope of the topic touches on all levels of biological organiza-
tion, and the author's ability to assemble and synthesize such information was highly praised.
We were also well satisfied by the warm reception that greeted At the Helm: A Laboratory Navigator
by Kathy Barker. Newly appointed principal research investigators must recruit, motivate, and lead a
research team, manage personnel and institutional responsibilities, and compete for funding while
maintaining the outstanding scientific record that got them their position in the first place. Small won-
der, then, that many of these young scientists feel ill-prepared, especially since their training contains
no formal education in leadership roles and responsibilities. At The Helm addresses that need and
there is no other book like it. After investing several years in research and interviews, Kathy Barker has
produced a remarkable source of advice and wisdom that new and aspiring principal investigators
have greeted with enthusiasm and relief.
The year's strongest sales were achieved by the newly released third edition of the classic labora-
tory manual Molecular Cloning, by Joe Sambrook and David Russell. This extraordinary book has been
a best seller since its first publication in 1982, and in its new edition has once again become a must-
have information source for all laboratories using molecular approaches to the study of genes, cells,
and proteins. Yet, even its 2300 pages cannot encompass all aspects of current technology in ade-
quate depth, and we have begun the development of a series of advanced manuals that carry the
authoritative stamp of Molecular Cloning to new levels of detail. The first of these, ProteinProtein
Interactions, edited by Erica Golemis, was published at the end of the year and is already proving suc-
cessful. Our collection of manuals was further expanded with the valuable addition of Arabidopsis by
Detlef Weigel and Jane Glazebrook, the first techniques book in plant biology that Cold Spring Harbor
has published in several years. And the books for scientists were rounded out by Symposium 65:
Biological Responses to DNA Damage, the latest volume in the annual series of symposia at the
Laboratory that for more than 60 years has provided analysis and interpretation of the most interest-
ing problems in biology.
The backlist of professional titles showed strong sales, led by At the Bench, Using Antibodies, and
Transcriptional Regulation in Eukaryotes. With the support of an educational grant from the Office of
AIDS Research at the National Institutes of Health, we were able to bring back into print the classic
1997 volume Retrovfruses, edited by John Coffin, Stephen Hughes, and Harold Varmus, and also to
produce a CD version that can be sent free of charge to research and clinical facilities overseas where
literature resources are limited.
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Books for the Public
Our commitment to the publication of a limited number of quality titles with an audience beyond sci-
entists continued this year with the release of two books for general readers, a videotape, and the first
two of a planned series of four children's books.
The Unfit: A History of a Bad Idea, by Elof Axel Carlson, is an account of the history of social essen-
tialism or the human propensity for identifying individuals as genetically inferior on the basis, for exam-
ple, of race, social class, or behavior. This thought-provoking work was widely reviewed and uniformly
praised as a careful, balanced, and much needed contribution to the literature of eugenics. The use
and potential abuses of genetic knowledge are becoming a matter of increasing public interest and
concern, yet for citizens untrained in science, the technical terms used by experts in the field often
make the arguments hard to follow. An A to Z of DNA Science, by Jeffre Witherly, Galen Perry, and
Darryl Leja, is designed to help nonspecialists understand what scientists mean when they talk about
genes and genomes; it is a small pocket-sized book in which terms are defined and helpfully illustrat-
ed.
A decade ago, we began distributing a unique series of four children's books by Fran Balkwill and
Mic Rolph that presented information about genes, cells, and proteins in an entertaining, straightfor-
ward way, with lively colorful illustrations. The series was immensely popular among scientists, the only
market we had the rights to address with these books. Ten years is a long time in biological research
and much has changed. Now, Balkwill and Rolph have created a new series of books, entitled Enjoy
Your Cells, in which the science is entirely undated, the pictures entirely new, and the scope expand-
ed. The first books in this enjoyable series, Enjoy Your Cells and Germ Zappers, were released in the
fall, and we now have the opportunity to bring them to the attention of the broader educational market
worldwide.
Books for Students
Our textbook publishing initiative made a strong start with the appearance of Bioinformatics: Genome
and Sequence Analysis, by David Mount. Published in March, it quickly became the book of choice for
courses in this emerging discipline and, by year's end, had been adopted in more than 40 schools,
including such major research universities as Harvard, Princeton, and the University of California at
Berkeley.
The advanced textbook Genes & Signals, by CSHL Trustee Mark Ptashne and staff member Alex
Gann, was published in December, to glowing advance praise from leading scientists. Inspection
copies for seniors' courses are already in review at more than 80 schools and sales in its first few
months are very strong.
Development began on a number of other textbook titles, including a second edition of DNA
Science, which is based on courses taught at the Laboratory's Dolan DNA Learning Center, and
Discovering Genomics, Proteomics, and Bioinformatics by Malcolm Campbell, which will be co-pub-
lished with the leading textbook publisher Benjamin Cummings. Also in development with Benjamin
Cummings is a fifth edition of Jim Watson's classic text Molecular Biology of the Gene, which is being
revised by Richard Losick (Harvard), Tania Baker and Steve Bell (Massachusetts Institute of
Technology), Mike Levine (University of California at Berkeley), and Alex Gann (Cold Spring Harbor
Laboratory).
In the development of all of these projects, the writing center at the Meier House has proved to be
an extraordinary asset, and more than a dozen authors spent productive and pleasant periods in resi-
dence during the year.
On-line Publishing
In 2001, the Press Web Site was redesigned to permit easier use and more effective marketing activi-
ties, e-commerce-enabled, and relaunched for separate American and European access, with prices
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displayed in appropriate currencies. On-line purchasing grew substantially in 2001 to represent greater
than 12% of total book sales, and a steadily increasing number of scientists have registered at the Site
to receive advance information and special offers.
Three Web Sites are specifically devoted to individual books: MolecularCloning.com,
BioinformaticsOnline.org, and GenesandSignals.org. These sites require registration, and the first two
require book purchase for access. The sites offer services such as the opportunity to download and
print book content, links to other on-line resources, and downloads of graphic images for teaching pur-
poses. More than 7000 scientists have registered as users of these sites and the number continues to
grow.
Journal Publishing
Circulation of Genes & Development in 2001 reflected continued strength in institutional subscriptions,
with a decline in individual subscriptions as an ever larger number of institutions networked the elec-
tronic edition of the journal to their entire staff. Manuscript submission continued to be strong, and the
journal's impact factor rose to 19.67, maintaining its position among the top ten journals in all of exper-
imental biology. Davor Solter stepped down as European Editor in December after 4 years in the posi-
tion that required attention to a steadily increasing number of manuscripts. His wise and careful judg-
ment was a great asset to the journal, and we are most grateful for his work on the its behalf. Davor
was succeeded by Rudi Grosschedl (University of Munich), whom we are glad to welcome on board.
The circulation of Genome Research rose by a remarkable 14% in 2001, with significant growth in
both individual and institutional subscriptions. Manuscript submission increased by 10% and seems
likely to increase still more, assisted by the implementation at year's end of an entirely electronic man-
uscript submission and review system. The journal's impact factor rose to 7.61.
Learning & Memory increased in circulation by 22%. The manuscript submission rate was main-
tained and the journal's impact factor rose sharply to 4.01, an achievement in neuroscience, a field that
now offers scientists the opportunity to publish in well over 100 journals.
The first year of our contract with The Protein Society to publish its journal Protein Science had a
satisfying outcome. The journal was redesigned in print and re-launched in an electronic form that
made it readily available to subscribers for the first time. Targeted marketing resulted in a 40% increase
in institutional subscriptions and advertising income rose more than fourfold.
In a difficult year for the advertising industry, sales in our journals rose by 13.5%, an excellent result.
Encouraged by the early success of our partnership with The Protein Society, we entered into dis-
cussions with The RNA Society about its journal RNA. After responding to the Society's competitive
request for a proposal, we were delighted to reach agreement to publish the journal on the Society's
behalf beginning in January 2003.
Sales, Marketing, and Distribution
Our sales and marketing programs now reflect the more complex and international business environ-
ments in which we operate. Promotional activities in 2001 included direct mail of redesigned newslet-
ters, catalogs, and brochures, as well as meeting exhibits, advertising in print publications and on-line,
and print and broadcast media publicity. We attended 11 professional meetings, displaying new and
established books in such numbers that a double exhibit booth has now become a standard necessi-
ty. Effective use was made of the conferences at the Laboratory to draw scientists' attention to our new
publications.
Our frontlist received a gratifying number of favorable reviews in widely read publications such as
Nature, Science, Cell, and the Trends journals. Several book signings at bookstores and our exhibit
stands brought out crowds eager to meet the authors.
A first foray into the complex and competitive task of gaining textbook adoptions was highly suc-
cessful and propelled David Mount's Bioinformatics to the position of market leader in this emerging
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field of study by year's end. A children's book marketing consultant was hired to advise us on reach-
ing the trade and educational markets. As part of this exercise, a children's book flyer was mailed to
95,000 teachers, librarians, and booksellers in September to announce the arrival of the first two books
in the Enjoy Your Cells series.
There was consolidation of the recently established European Sales office, and its sales target was
exceeded by 20%. A fruitful relationship was established with the on-line retailer Amazon.com, which
rapidly became one of our top three customers. New sales representation was established in Latin
America and the United Kingdom and Ireland, and new distributors were appointed in Turkey, Egypt,
Singapore, Thailand, and Brazil. Three of our titles, on prions, stem cells, and bioinformatics, were
picked as Book of the Month Club Selections, and The Unfit was named Book of the Year in Scholarly
Publishing by Amazon.com.
Staff
The staff members of the Press (as of December 2001) are listed elsewhere in this volume. It is a plea-
sure to acknowledge the dedication and high standards they bring to their duties. A year of new begin-
nings and satisfactory outcomes is only made possible by their talent and willingness to shoulder extra
burdens.
In the spring, the Press moved to handsome new offices on the Woodbury campus that house 41
of our 47 staff members (we are a distributed organization, with staff at locations in San Diego, New
Mexico, and Connecticut; a warehouse in Hauppauge; and a sales and distribution center in Oxford,
UK). The transition from three separate sites to one center of administrative operations has been a
happy one, with significant gains in efficiency and communication. The complexities of the move were
admirably coordinated and executed by our colleagues in the Facilities Department.
In 2001, we welcomed several new members to the staff: Bill Keen as Finance Director, David Crotty
as Commissioning Editor, Bibiane Garite, and Michele Schoudel. Nora Rice became a full time mem-
ber of the Development staff.
Finally, I would like to say how grateful I am to the senior members of the Press staff: Jan Argentine,
Editorial Development Manager; Ingrid Benirschke, Marketing Manager; Kathryn Fitzpatrick, Marketing
Manager; Marcie Siconolfi, Advertising Sales Manager; Nancy Hodson, Operations Manager; Bill Keen,
Finance Director; Guy Keyes, Sales and Distribution Manager; Denise Weiss, Production Manager; the
editors of our journals, Terri Grodzicker at Genes & Development and Laurie Goodman at Genome
Research; and my versatile assistant Elizabeth Powers. Publishing is a team-based enterprise, in which
all functions are interdependent. The Press and the Laboratory are fortunate to have in key positions
individuals who carry out their duties with responsibility, intelligence, and grace.
John R. Inglis
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FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEETS
December 31, 2001 and 2000
Assets: 2001 2000
Cash and cash equivalents $ 25,917,330 27,456,990
Accounts receivable:
Publications 2,070,714 2,187,811
Other 1,396,569 937,537
Grants receivable 5,194,624 3,652,363
Contributions receivable 6,681,094 8,130,610
Publications inventory 2,027,130 2,327,313
Prepaid expenses and other assets 2,436,437 1,691,542
Investments 185,947,777 208,166,091
Investment in employee residences 4,495,774 3,047,429
Restricted use asset 1,400,000 -
Land, buildings and equipment, net 108,104,940 99,323,744
Total assets $ 345,672,389 356,921,430
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $ 5,928,294 7,928,869
Notes payable 202,154 227,932
Bonds payable 45,200,000 45,200,000
Deferred revenue 2,615,372 2,695,061
Total liabilities 53,945,820 56,051,862
Net assets:
Unrestricted 170,584,179 177,939,557
Temporarily restricted 13,179,303 9,796,302
Permanently restricted 107,963,087 113,133,709
Total net assets 291,726,569 300,869,568
Total liabilities and net assets $ 345,672,389 356,921,430
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2001
With comparative totals for the year ended December 31, 2000
Unrestricted
Temporarily
Restricted
Permanently
Restricted
2001
Total
2000
Total
Revenue and other support:
Public support (contributions and
non-government grant awards) $ 7,758,771 13,070,798 1,421,839 22,251,408 24,803,360
Government grant awards 20,728,880 - 20,728,880 20,097,385
Indirect cost allowances 14,274,887 14,274,887 12,885,076
Program fees 2,677,232 2,677,232 2,551,373
Publications sales 9,940,567 9,940,567 8,683,809
Dining services 2,628,965 - 2,628,965 2,616,113
Rooms and apartments 1,890,226 - 1,890,226 1,985,658
Royalty and licensing fees 2,234,554 - 2,234,554 1,093,573
Investment income (interest and
dividends) 8,285,120 - 8,285,120 8,132,622
Miscellaneous 541,080 - 541,080 547,831
Total revenue 70,960,282 13,070,798 1,421,839 85,452,919 83,396,800
Net assets released from restrictions 9,687,797 (9,687,797) -
Total revenue and other support 80,648,079 3,383,001 1,421,839 85,452,919 83,396,800
Expenses:
Research 39,464,156 - 39,464,156 35,923,808
Educational programs 11,490,571 - - 11,490,571 9,103,007
Publications 9,800,811 9,800,811 8,281,363
Banbury Center conferences 1,026,037 - 1,026,037 1,165,989
Dolan DNA Learning Center programs 1,468,244 - 1,468,244 1,105,658
Watson School of Biological Sciences
programs 1,104,729 1,104,729 698,779
General and administrative 9,739,917 - 9,739,917 9,252,253
Dining services 3,551,730 - 3,551,730 3,635,324
Total expenses 77,646,195 - 77,646,195 69,166,181
Excess of revenue and other support
over expenses 3,001,884 3,383,001 1,421,839 7,806,724 14,230,619
Other changes in net assets:
Net (depreciation) appreciation in fair
value of investments (10,357,262) (6,592,461) (16,949,723) 4,798,458
(Decrease) increase in net assets (7,355,378) 3,383,001 (5,170,622) (9,142,999) 19,029,077
Net assets at beginning of year 177,939,557 9,796,302 113,133,709 300,869,568 281,840,491
Net assets at end of year $ 170,584,179 13,179,303 107,963,087 291,726,569 300,869,568
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CONSOLIDATED STATEMENTS OF CASH FLOWS
Years ended December 31, 2001 and 2000
2001 2000
Cash flows from operating activities:
(Decrease) increase in net assets $ (9,142,999) 19,029,077
Adjustments to reconcile (decrease) increase in net assets
to net cash provided by operating activities:
Depreciation and amortization 4,620,198 3,974,311
Net depreciation (appreciation) in fair value of investments 16,949,723 (4,798,458)
Contributions restricted for long-term investment (7,504,820) (9,350,612)
Restricted use asset (1,400,000) -
Changes in assets and liabilities:
Increase in accounts receivable (341,935) (1,954,474)
Increase in grants receivable (1,542,261) (893,014)
Decrease (increase) in contributions receivable 1,425,568 (3,600,936)
Decrease (increase) in publications inventory 300,183 (188,439)
Increase in prepaid expenses and other assets (744,895) (370,229)
(Decrease) increase in accounts payable and accrued expenses (2,000,575) 3,088,218
Decrease in deferred revenue (79,689) (183,304)
Net cash provided by operating activities 538,498 4,752,140
Cash flows from investing activities:
Capital expenditures (13,401,394) (21,991,646)
Proceeds from sales and maturities of investments 58,387,861 71,313,900
Purchases of investments (53,119,270) (70,827,688)
Net change in investments in employee residences (1,448,345) (295,849)
Net cash used in investing activities (9,581,148) (21,801,283)
Cash flows from financing activities:
Permanently restricted contributions 1,421,839 5,625,670
Contributions restricted for investment in land, buildings and equipment 6,082,981 3,724,942
Decrease in contributions receivable 23,948 349,221
Repayment of notes payable (25,778) (23,986)
Net cash provided by financing activities 7,502,990 9,675,847
Net decrease in cash and cash equivalents (1,539,660) (7,373,296)
Cash and cash equivalents at beginning of year 27,456,990 34,830,286
Cash and cash equivalents at end of year $ 25,917,330 27,456,990
Supplemental disclosures:
Interest paid $ 1,671,874 2,063,031
Noncash investing and financing activities:
Contributed property $ 1,400,000
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COMPARATIVE OPERATING HISTORY 1997-2001
(Dollars in Thousands)
1997 1998 1999 2000 2001
Revenue:
Main Lab:
Grants and contracts $ 22,743 24,025 27,179 30,345 34,716
Indirect cost reimbursement 9,910 11,054 11,207 12,718 14,134
Other 8,472 9,441 9,426 10,618 12,528
CSHL Press 5,238 6,341 6,400 8,684 9,941
Banbury Center 1,495 1,444 1,848 1,856 1,666
Dolan DNA Learning Center 875 1,334 1,392 1,471 1,878
Watson School of Biological Sciences - 218 682 927
Total revenue 48,733 53,639 57,670 66,374 75,790
Expenses:
Main Lab:
Research and training 22,743 24,025 27,179 30,345 34,716
Operation and maintenance of plant 5,274 5,549 5,765 6,589 7,027
General and administrative 3,625 3,378 3,844 6,162 6,492
Other 5,759 7,328 7,863 7,075 9,505
CSHL Press 5,320 6,141 6,077 8,186 9,515
Banbury Center 1,437 1,321 1,614 1,702 1,536
Dolan DNA Learning Center 887 1,228 1,280 1,362 1,801
Watson School of Biological Sciences - 218 682 927
Total expenses, excluding depreciation
and amortization 45,045 48,970 53,840 62,103 71,519
Excess before depreciation, amortization,
and designation of funds 3,688 4,669 3,830 4,271 4,271
Depreciation and amortization (3,371) (3,443) (3,526) (3,974) (4,620)
(Designation) release of funds (2) - (750) (297) 349
Net operating excess $ 317 476 304
(1) The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(2) Funds designated to underwrite future direct and indirect expenses of the research programs.
COLD SPRING HARBOR LABORATORY Corporate Contributions
SOURCES OF REVENUE and Grants
YEAR ENDED DECEMBER 31, 2001 4.0%
Auxiliary Activities
20.1%
Interest and
- Miscellaneous
0.8% Royalty and Licensing
Fees
5.0%
Federal Grants
38.1%
Foundation and Private
Contributions and
Grants
22.9%
Endowments and Board
Designated Funds
9.1%
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the DNA Learning Center receive a substantial
portion of their funding through grants from the Federal Government and through grants, capital gifts,
and annual contributions from private foundations, corporations, and individuals. The following section
summarizes funding that occurred during 2001.
GRANTS January 1, 2001-December 31, 2001
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2001 Funding'
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Dr. Herr 1/92-12/01 $ 4,320,915
Dr. Stillman 8/90-7/05 3,580,211
Research Support Dr. Cline 12/99-11/04 467,478
Dr. Cline 3/98-2/01 444,611
Dr. Enikolopov 8/99-5/04 334,926
Dr. Enikolopov 9/94-11/03 352,630
Dr. Grewal 3/00-2/05 268,800
Dr. Hannon 9/00-8/05 282,484
Dr. Hannon 3/01-2/03 166,416
Dr. Helfman 9/99-8/04 386,119
Dr. Hengartner/Dr. Herr 5/00-4/04 231,395
Dr. Hernandez 7/00-6/04 199,500
Dr. Hirano 5/96-4/02 341,685
Dr. Hirano 7/01-6/05 292,355
Dr. Huang 8/01-6/06 415,521
Dr. Joshua-Tor 12/01-11/04 245,534
Dr. Joshua-Tor 5/01-3/06 378,522
Dr. Krainer 7/89-6/02 451,541
Dr. Krainer 6/01-5/06 409,100
Dr. Lowe 7/99-6/04 422,942
Dr. Malinow 5/00-4/05 518,529
Dr. Malinow 4/95-3/03 390,463
Dr. McCombie 1/99-12/03 445,131
Dr. McCombie 9/99-9/02 2,101,669
Dr. Neuwald 10/98-8/06 221,922
Dr. Skowronski 4/98-3/03 487,735
Dr. Spector 4/90-3/03 486,349
Dr. Stillman 6/00-5/04 521,562
Dr. Svoboda 12/98-11/03 395,180
Dr. Tonks 8/91-3/03 608,814
Dr. Tonks 5/99-6/05 349,125
Dr. Tully 4/94-3/02 363,034
Dr. Tully 10/00-9/03 266,917
Dr. Wig ler 7/98-4/02 934,450
Dr. Wig ler 9/00-7/03 752,766
Dr. Xu 1/98-12/02 302,854
Dr. Xu 8/01-7/06 290,636
*New Grants Awarded in 2001.
*Includes Direct & Indirect Cost.
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Grantor Program/Principal Investigator Duration of Grant 2001 Funding*
Dr. Yin 9/99-4/02 366,630
Dr. Zhang 9/00-8/03 465,416
Dr. Zhang 8/00-7/03 299,250
Dr. Zhong 6/00-5/04 290,938
Fellowships Dr. Bubulya 2/01-1/02 37,516 *
Dr. Sacco-Bubulya 7/00-1/02 20,098
E. Govek 5/01-4/03 22,860 *
Dr. Hofmann 12/00-12/02 44,212
Dr. Ronemus 12/01-11/04 41,996 *
Dr. Ruthazer 3/99-2/02 43,772
Training Support Training in Cancer Cell Biology and 7/94-12/03 329,702
Tumor Virology
Course Support Cancer Research Center Workshops 4/92-3/05 287,005
Neurobiology Short-term Training 5/82-4/01 160,527
Immunocytochemistry, In Situ Hybridization
and Live Cell Imaging
7/98-6/03 71,882
Advanced Genome Sequence Analysis 4/95-3/04 75,186
Cell and Developmental Biology of Xenopus 4/96-3/04 18,480
C. elegans 8/98-6/06 62,405
Macromolecular Crystallography 9/00-8/05 49,521
Cellular Biology of Addiction 4/01-3/02 40,000
Making and Using DNA Microarrays 9/99-6/04 49,609
Bioinformatics: Writing Software for Genome 7/00-6/05 47,086
Research
Meeting Support Genome Sequencing and Biology 4/90-3/02 37,026
The Cell Cycle 4/00-3/03 9,000
Telomeres and Telomerase 5/01-4/02 20,700 *
Learning and Memory 4/01-3/02 13,000 *
Proteolysis and Biological Control 4/01-3/06 11,000 *
Tyrosine Phosphorylation and Cell Signaling 4/01-3/06 7,000 *
66th CSHL Symposium on Quantitative Biology: 5/01-4/06 5,000 *
The Ribosome
Microbial Pathogenesis and Host Defense 7/01-6/02 12,000 *
Neurobiology of Drosophila 8/01-7/06 21,775 *
Eukaryotic DNA Replication 8/01-7/06 10,000 *
Mechanisms of Eukaryotic Transcription 8/01-7/06 8,000 *
Programmed Cell Death 8/01-7/02 12,000 *
NATIONAL SCIENCE FOUNDATION
Cooperative Agreement Dr. McCombie 2/99-1/02 271,526
Research Support Dr. Cline 5/99-8/03 115,000
Dr. Helfman 2/99-1/03 111,847
Dr. Martienssen 9/01-8/05 476,040 *
Training Support Undergraduate Research Program 6/00-5/03 58,000
Course Support Advanced Bacterial Genetics 5/99-4/02 64,929
Arabidopsis Molecular Genetics 4/00-3/03 67,062
Cell and Developmental Biology of Xenopus 9/98-8/02 21,396
Computational Neuroscience: Vision 8/00-7/02 18,679
*New Grants Awarded in 2001.
Includes Direct & Indirect Cost.
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Grantor Program/Principal Investigator Duration of Grant 2001 Funding*
Meeting Support Learning and Memory 3/01-2/02 10,588 *
Tyrosine Phosphorylation and Cell Signaling 4/01-3/02 6,000 *
Biology of Proteolysis 7/01-6/02 5,000 *
Neurobiology of Drosophila 7/01-6/02 15,745 *
Mechanisms of Eukaryotic Transcription 7/01-6/02 3,000 *
Eukaryotic DNA Replication 7/01-6/02 4,000 *
Eukaryotic mRNA Processing 7/01-6/02 3,000 *
UNITED STATES DEPARMENT OF AGRICULTURE
Research Support Dr. Martienssen 12/00-11/03 85,000
Dr. McCombie/Dr. Martienssen 9/01-9/03 500,000 *
Dr. Jackson 9/01-8/03 195,000 *
Dr. Stein 9/00-8/04 1,582,903
Dr. Stein 9/00-8/03 946,112
Dr. Timmermans 9/01-8/03 130,000 *
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 6/00-5/03 126,000
Dr. Helfman 7/99-6/02 117,600
Dr. Lazebnik 6/01-5/04 215,812 *
Dr. Van Aelst 7/99-6/02 117,600
Dr. Van Aelst 9/01-8/03 167,000 *
Dr. Zhong 9/99-8/02 247,892
Fellowship Support Dr. Du 11/01-10/03 49,000
Dr. Hamaguchi 4/00-3/04 59,000
Dr. Hannon 6/00-5/01 59,000
Dr. Jin 5/99-5/02 43,080
Dr. Kannanganattu 1/01-2/04 48,191
Dr. Mendez 7/99-6/02 42,000
Dr. Narita 7/01-6/04 48,004
Y. Seger 7/01-7/04 22,000
Meeting Support Microbial Pathogenesis and Host Defense 9/01-2/02 12,379
MISCELLANEOUS GRANTS
Research Support
AKC Canine Health Foundation Dr. McCombie/Dr. Hannon 7/01-6/02 34,000
Rita Allen Foundation Dr. Lowe 9/99-8/02 50,000
Dr. Hannon 10/00-9/03 50,000
Alzheimer's Association Dr. Malinow 8/99-7/02 60,000
American Cancer Society Dr. Wig ler, Professorship 1986-2012 70,000
Dr. Wig ler, Supply Allowance 2001 10,000
Andrew's Buddies Corporation Dr. Krainer 1/00-12/01 40,000
Michael Scott Barish Human Cancer Dr. Wig ler 2001 85,000
Grant sponsored by the
1 in 9: The Long Island Breast
Cancer Action Coalition
Chris-Craft Industries, Inc. Siegel Funds for Cancer Pharmacogenomics 6/01-5/03 175,000 *
Cleiman Memorial Foundation Dr. Tully 1/01-12/01 1,000 *
D.A.R.P.A./New York University Dr. Wig ler 9/01-9/03 79,367 *
Consortium Agreement
*New Grants Awarded in 2001.
*Includes Direct & Indirect Cost.
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Grantor Program/Principal Investigator Duration of Grant 2001 Funding'
William Theodore Dens low Dr. Tonks 2001 8,000
Foundation
Helen and Charles Dolan Institutional Advancement 6/01-11/02 750,000
Donaldson Charitable Trust Dr. Enikolopov 12/01-11/02 250,000
Genetica Dr. Hannon 11/00-10/01 68,217
Joseph G. Goldring Foundation Dr. Stillman 7/99-6/02 60,000
Gillespie Family Fund DNA Microarray Technology Support 8/01-12/01 351,376
Thomas S.T. Gimbel & Lesley B. Utrophin Medical Research Project 1/01-12/01 2,500
Gimbel Gift
Bernard F. and Alva B. Gimbel Utrophin Medical Research Project 1/01-12/01 6,000
Foundation
The Lorraine & Lloyd Glidden Dr. Van Aelst 4/01-3/02 25,000
Foundation-Neurofibromatosis Inc.
Irving A. Hansen Memorial Foundation Dr. Tansey 8/01-7/02 30,000
Helicon Therapeutics, Inc. Dr. Tully 7/01-6/02 168,000
Helen Hoffritz Charitable Trust Dr. Cline 2001 30,000
Human Frontier Science Dr. Tully 8/99-8/02 46,645
Program Organization (H.FS.P.)
Long Islanders Against Breast Cancer Dr. Wig ler 2001 93,652 *
Louis Morin Charitable Trust Dr. Joshua-Tor 12/01-11/02 125,000
Elizabeth McFarland Breast Cancer Dr. Wig ler 2001 26,010 *
Research Grant
March of Dimes Dr. Hengartner 6/01-5/02 54,402
G. Harold & Leila Y. Mathers Dr. Svoboda 3/99-6/02 290,140
Charitable Foundation
The Maxfield Foundation Dr. Lazabnik 12/00-11/01 10,000
Consortium Program
Neurofibromatosis Foundation, Arizona NF Target Discovery Group Support 6/01-5/02 5,000 *
Neurofibromatosis Foundation, Dr. Van Aelst 4/01-3/02 13,000 *
Massachusetts Bay Area
NIH/Baylor College of Medicine Dr. Mills 9/01-8/06 175,400 *
Consortium Agreement
NIH/Columbia University Consortium Dr. Lowe 9/00-7/05 498,416
Agreement
NIH/Cal Tech Consortium Agreement Dr. Stein 9/00-6/03 271,345
NIH/Nanoprobes, Inc., Consortium Dr. Spector 4/99-3/02 31,939
Agreement
NIH/Northwestern University Dr. Spector 7/01-12/02 33,300 *
Consortium Agreement
NIH/Downstate Medical Center Dr. Yin 9/01-6/06 90,000 *
Consortium Agreement
NIH/Sloan Kettering Consortium Dr. Van Aelst 8/01-4/02 48,143 *
Agreement
NIH/University of California, San Diego Dr. Zhang 9/01-8/04 122,722 *
Consortium Agreement
NIH/Washington University Consortium Dr. Stein 3/99-2/03 46,413
Agreement Dr. Stein 9/99-11/01 138,141
Dr. Stein 9/99-9/02 15,541 *
Mr. and Mrs. Edmond Nouri Dr. Tully 4/00-3/03 42,791
Novartis-Plant Consortium Program Dr. Martienssen 1/98-12/02 135,000
NSF/Clemson University Consortium Dr. Mc Combie 10/99-9/02 280,500
Agreement
NSF/University of California, Berkeley Dr. Jackson/Dr. Martienssen 10/01-9/06 218,320 "
Consortium Agreement
NSF/Rutgers University Consortium Drs. Spector/Martienssen/McCombie 10/00-9/05 336,819
Agreement
NSF/University of Wisconsin Dr. Martienssen 9/00-8/05 216,321
Consortium Agreement
*New Grants Awarded in 2001.
*Includes Direct & Indirect Cost.
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Grantor Program/Principal Investigator Duration of Grant 2001 Funding*
Promega Collaboration Dr. Krainer 2/01-12/01 6,000
Rankowitz/Heffron Dr. Zhong 4/98-3/02 25,000
Seraph Foundation Dr. Enikolopov 11/00-4/02 28,000
Ann and Herb Siegel Siegel Funds for Cancer Pharmacogenomics 6/01-5/03 500,000
SNP Consortium Dr. Stein 4/99-9/02 288,019
SunGene-Plant Consortium Dr. Martienssen 7/00-6/05 135,000
Tularik, Inc. Dr. Wigler 10/97-10/03 660,000
Tober Foundation Dr. Watson 11/01-10/02 10,000
U.S.D.A./Clemson University Dr. McCombie 10/99-9/02 280,500
Consortium Agreement
U.S.D.A./Yale University Consortium Dr. McCombie/Dr. Martienssen 9/01-9/03 24,690
Agreement
Westvaco-Plant Consortium Dr. Martienssen 1/99-12/02 135,000
Zeneca Ltd.-Plant Consortium Dr. Martienssen 7/99-7/03 135,000
Fellowships
Alzheimer's Association Dr. Barria 8/99-7/01 40,000
Dr. Zhu 9/01-11/01 7,699
American Cancer Society Dr. Drier 7/99-6/02 34,000
Dr. Hastings 1/00-12/02 32,000
Burroughs Wellcome Fund Dr. Mainen 9/97-8/02 121,000
Dr. Sabatini 9/01-8/02 59,000
Canadian Institutes of Health Dr. Querido 8/99-7/02 25,520
Research (C.I.H.R.)
Cancer Research Fund-Damon Dr. Z. Zhang 6/99-5/02 46,000
Runyon Walter Winchell
CSHL Association Fellowship and Start Up Fund Support 2001 203,761
Danish Academy of Technical Sciences Dr. Tonks/Dr. Andersen 2001 4,259
Deutsche Forschungsgeimeinschaft Dr. Egger 2001 30,240
Deutsche Forschungsgeimeinschaft Dr. Ehrlich 2001 25,678
Dorothy Rodbell Cohen Foundation Dr. Mittal 4/01-3/02 20,000
The Ellison Medical Foundation Dr. Grewal 9/99-9/03 50,000
Dr. Tong 1/01-12/01 10,000
EMBO Award Dr. Di Cristo 2001 27,655
Epilepsy Foundation Dr. Aizenman 7/01-6/02 40,000
Fraxa Research Foundation Dr. Margulies 3/01-2/02 38,000
Dr. Zhu 8/01-11/01 10,830
Johns Hopkins/Ellison Foundation Dr. Kass-Eisler 11/99-12/02 75,552
Helen Hay Whitney Foundation Dr. Sheu 4/01-3/03 36,500
Dr. Zito 7/01-6/02 41,000
Dr. Sabatini 4/99-3/02 39,000
James R. Hudson, Jr. Symposia Archives 5/01-5/02 60,000
Howard Hughes Medical Institute Graduate Student Support 9/00-8/02 67,650
Human Frontier Science Dr. Cuvier 10/01-6/02 35,000
Program Organization (H.F.S.P.O.) Dr. Davenne 5/00-4/02 35,000
Dr. de Stanchina 1/00-12/02 36,000
Japan Society for the Dr. Fukada 4/00-3/02 36,232
Promotion of Science (J.S.P.S.) Dr. N. Uchida 2001 41,000
Charles Henry Leach II Foundation Dr. Enikolopov 1/97-12/01 26,000
Lehrman Institute Dr. Svoboda 4/00-3/03 49,909
Dr. Watson Archives 4/00-3/03 95,250
The Leukemia & Lymphoma Society Dr. Duelli 12/00-12/03 35,000
Special Fellow Award Dr. Julien 7/99-6/02 33,250
Dr. Losada 7/01-6/04 50,000
Dr. Schmitt 7/00-12/01 6,225
Dr. Soengas 7/99-6/02 39,700
New Grants Awarded in 2001.
*Includes Direct & Indirect Cost.
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*
Grantor Program/Principal Investigator Duration of Grant 2001 Funding'
Dr. Speck 7/01-6/03 40,000
Dr. Tansey 7/01-6/06 100,000
Life Science Research Foundation Dr. Vollbrecht 6/99-5/02 38,000
Long Beach Breast Cancer Coalition Dr. Hamaguchi 11/01-10/02 4,000
NARSAD Dr. Zhu 7/00-11/01 6,709
N.C.I.D.A. Harbor Lecture Series 12/01-11/02 15,000
The David & Lucile Packard Foundation Drs. Chklovskii/Mainen/Zador 7/01-6/04 316,086
Pew Charitable Trust Dr. Svoboda 7/98-6/02 60,000
Quiagen Mangone/Medline Workbench 9/01-8/02 11,980
Searle Scholars Program Dr. Mainen 7/01-6/04 80,000
Alfred P. Sloan Foundation Dr. Zador 9/00-9/02 20,000
Lauri Strauss Leukemia Foundation Dr. Fridman/Dr. Tonks 4/01-3/02 15,000
St. Giles Foundation Dr. Hatchwell 8/98-7/02 182,837
Swartz Foundation Swartz Initiative for Computational 2001 32,314
Neuroscience Program
Tularik, Inc. Fellowship Support 1/98-12/03 150,000
Uehara Foundation Dr. M. Uchida 2001 25,233 *
The V Foundation Dr. Hamaguchi 4/00-3/02 50,000
The Wellcome Trust Dr. Akerman 10/01-9/03 42,700
Dr. Newey 10/01-9/03 65,302
Whitehall Foundation, Inc. Dr. Huang 8/01-8/04 75,000
Course Support
Howard Hughes Medical Institute Advanced Neurobiology Courses 2001 330,000
John Merck Fund Developmental Disabilities in Children 2001 23,000 *
Meeting Support
Abbott Laboratories Gene Expression and Signaling in the 2001 5,000 *
Immune System
Amersham Pharmacia Biotech Inc. Vector Targeting 2001 500 *
Amgen Gene Expression and Signaling in the 2001 2,500 *
Immune System
Berlex Biosciences Vector Targeting 2001 2,000
Boehringer Ingelheim Pharmaceuticals Gene Expression and Signaling in the 2001 3,000
Immune System
Bruker Axs, Inc. Structural Biology 2001 500
Canji, Inc. Vector Targeting 2001 1,000
Gilson, Inc. Structural Biology 2001 1,000
Digital Gene Technologies, Inc. Corporate Contribution Program 2001 6,000
Hampton Research Structural Biology 2001 1,000
Hoffmann-LaRoche, Inc. Structural Biology 2001 1,000
lmmunex, Inc. Gene Expression and Signaling in the 2001 1,000
Immune System
Klingenstein Foundation Genetic Basis of Neurological and Behavioral 2001 22,000 *
Disorders
Lehrman Institute Pathways to Alzheimer's Disease 2001 43,989
Merck Research Laboratories Vector Targeting 2001 1,000
MSC Molecular Structure Corp. Structural Biology 2001 750
Osiris Therapeutics, Inc. Stem Cell 2001 5,000
Pfizer Gene Expression and Signaling in the 2001 1,000
Immune System
Ruth & Milton Steinbach Genetic Basis of Neurological and Behavioral 2001 5,100
Foundation, Inc. Disorders
Vectorlogies, Inc. Vector Targeting 2001 500
Wyeth Ayerst Pharmaceuticals Gene Expression and Signaling in the 2001 3,000 *
Immune System
*New Grants Awarded in 2001.
*Includes Direct & Indirect Cost.
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BANBURY CENTER
Grantor Program/Principal Investigator
Duration
of Grant 2001 Funding*
FEDERAL SUPPORT
The Federal Judicial Center
NIH
NIH-National Institute on Deafness and
Other Communication Diseases
NIH-National Human Genome Research
Institute
NIH-National Human Genome Research
Institute
NIH-National Institute of Mental Health and
National Institute of Child Health and
Human Development (through a grant
to the University of Illinois, Urbana)
NONFEDERAL SUPPORT
Meeting Support
Affymetrix, Inc.
Burroughs Wellcome Fund
Cure Autism Now Foundation
Hoffmann-La Roche Inc.
McNeil Consumer Healthcare
National Alliance for Autism Research
(N.A.A.R.)
Marie H. Robertson Memorial Fund
for Neurobiology
Albert B. Sabin Vaccine Institute, Inc.
Senomyx, Inc.
Herbert J. Siegel Fund for Cancer
Pharmacogenomics
Herbert J. Siegel Fund for Cancer
Pharmacogenomics
The Swartz Foundation
UC Davis M.I.N.D. Institute
Yamanouchi USA Foundation
*New Grants Awarded in 2001.
*Includes Direct & Indirect Cost.
408
The Basic Issues of Science
Genomic Annotation Workshop: DNA Replication
Chemosensory Receptor Classification Workshop
2001
2001
2001
American Eugenics and the New Biology: Perspectives 2001
and Parallels
Meeting of the Editorial Advisory Panel: Digital Image 2001
Archive on the American Eugenics Movement
Understanding the Neural Basis of Fragile X 2001
Integrating Genomics Technologies in Healthcare: 2001
Practice and Policy Challenges
Integrating Genomics Technologies in Healthcare: 2001
Practice and Policy Challenges
Microbiology, Immunology, and Toxicology of Autism 2001
and Other Neurodevelopmental Disorders
Integrating Genomics Technologies in Healthcare: 2001
Practice and Policy Challenges
Microbiology, Immunology, and Toxicology of Autism 2001
and Other Neurodevelopmental Disorders
Microbiology, Immunology, and Toxicology of Autism 2001
and Other Neurodevelopmental Disorders
Cortical Maps 2001
Making Vaccines for the Developing World: Access 2001
to and Deployment of New Technologies
Molecular Biology of Chemosensory Receptors: 2001
The First Decade
Interferons: Biological Mechanisms and Disease 2001
Treatments I
Interferons: Biological Mechanisms and Disease 2001
Treatments II
Can a Machine Be Conscious? 2001 30,603 *
Microbiology, Immunology, and Toxicology of Autism 2001 5,000 *
and Other Neurodevelopmental Disorders
Stability and Reversal of the Differentiated State
$ 16,195 "
17,025
3,990 *
15,000
4,770
33,842 *
7,500 *
10,000 *
5,000 *
12,263 *
5,000 *
5,000 "
20,000
24,598 *
7,500 *
22,233
27,067
2001 22,065
DOLAN DNA LEARNING CENTER
Grantor Program/Principal Investigator Duration of Grant 2001 Funding'
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH Creation of a Digital Image Archive 3/98-3/01 $ 227,994
ELSI Research Program on the American Eugenics Movement
NATIONAL INSTITUTES OF HEALTH Creation of Inside Cancer 1/01-12/03 240,100
NATIONAL SCIENCE FOUNDATION A Partnership to Develop Advanced 8/97-7/01 47,644
Technology Units on Genomic Biology
DEPARTMENT OF ENERGY
NONFEDERAL GRANTS
Howard Hughes Medical Institute
Josiah Macy, Jr. Foundation
Pfizer Foundation
The Science and Issues of Human
DNA Polymorphisms: An ELSI
Training Program for High School
Biology Teachers
Precollege Science Education Initiative
for Biomedical Research Institutions
DNA from the Beginning/Your Genes,
Your Health
Leadership Institute in Human and
Molecular Genetics
1/97-9/01
9/99-8/03
10/97-9/02
1/01-12/01
The following schools each awarded a grant for the Genetics as a Model for Whole Learning Program:
Bellmore-Merrick Central High School District
Bethpage Union Free School District
Commack Union Free School District
Community School District #29
East Meadow Union Free School District
East Williston Union Free School District
Elwood Union Free School District
Farmingdale Union Free School District
Friends Academy
Garden City Union Free School District
Great Neck Union Free School District
Green Vale School
Harborfields Central School District
Half Hollow Hills Central School District
2,203
154,486
268,400
50,733
$ 5,305 Hebrew Academy
1,425 Jericho Union Free School District
250 Lawrence Union Free School District
33,375 Locust Valley Central School District
5,900 Merrick Union Free School District
1,400 New York City School District #17
3,115 Northport-East Northport Union Free School District
980 Old Westbury School of the Holy Child
6,940 Port Washington Union Free School District
5,545 Rockville Center Union Free School District
6,515 St. Dominic Elementary School
625 St. Edwards
9,595 South Huntington Union Free School District
4,000 Syosset Central School District
The following schools each awarded a grant for Curriculum Study:
Bethpage Union Free School District
Commack Union Free School District
East Meadow Union Free School District
Friends Academy
Garden City Union Free School District
Great Neck Union Free School District
Green Vale School
Half Hollow Hills Central School District
Herricks Union Free School District
Island Trees Union Free School District
Jericho Union Free School District
Lawrence Union Free School District
Levittown Union Free School District
$ 1,100 Locust Valley Central School District
1,100 North Shore Central School District
2,200 Oceanside Union Free School District
1,100 Plainedge Union Free School District
1,100 Plainview-Old Bethpage Central School District
2,200 Portledge School
1,100 Port Washington Union Free School District
1,100 Ramaz School
1,100 Roslyn Union Free School District
1,100 Sachem Central School District
1,100 South Huntington Union Free School District
1,100 Syosset Central School District
1,100 West Hempstead Union Free School District
1,325
6,075
6,230
16,000
1,125
250
6,160
1,650
12,710
4,525
2,450
2,025
5,040
20,250
1,100
1,100
1,100
2,200
1,100
1,100
1,100
1,100
1,100
2,200
2,200
1,100
1,100
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The generous commitments reported here make a real difference to advance the biomedical discovery
at Cold Spring Harbor Laboratory. Gifts from individuals, corporations, and foundations are especially
important to fund the innovation that will control cancer and improve our understanding of the brain.
Investment in the people and facilities at the Laboratory is rapidly changing how we think about dis-
ease, helping us to better life sooner, rather than later.
Rod Miller, Vice President for Institutional Advancement
The individuals, foundations, and corporations listed on the following pages are responsible for the
majority of research funding at Cold Spring Harbor Laboratory. Their commitment to our scientists is
testimony to their confidence in the dedication of the very best minds in science to cure disease and
improve the human condition. On behalf of our trustees and scientists, we sincerely thank these gen-
erous benefactors.
Diane Fagiola, Director of Development
Cold Spring Harbor Laboratory is a nonprofit research and educational institution chartered by the
University of the State of New York. Less than half of the Laboratory's annual revenues are derived from
Federal grants and contracts, and thus, we rely heavily on support from the private sector: foundations,
corporations, and individuals. Contributions from the private sector are tax exempt under the provisions
of Section 501(c)(3) of the Internal Revenue Code. In addition, the Laboratory is designated a "public
charity" and, therefore, is enabled to receive funds resulting from the termination of "private foundations."
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of Money can be made directly to Cold Spring Harbor Laboratory.
Securities: Stock certificates may be reassigned directly or transferred through your broker.
Appreciated securities should be given outright, which will avoid capital gains taxes on the appreci-
ated value. Securities that have decreased in value should be sold, and the proceeds donated. In this
way, a donor will receive a deduction for both the loss and the charitable contribution.
Life Insurance: You may designate the Laboratory as the beneficiary of an existing or new policy, or
irrevocably assign ownership of the policy. There are estate tax benefits in either case. If ownership is
assigned, there is an immediate tax deduction.
Pooled Income Funds: Combine gifts from a number of donors in a pool for attractive investment and
tax purposes.
Appreciated Real Estate or Personal Property: Sizable tax benefits can result from such donations;
the Laboratory can use some in its program and can sell others.
Charitable Remainder Trusts can be structured to suit the donor's specific desires as to extent, tim-
ing, and tax needs.
Bequests: Most wills probably need to be updated. Designating Cold Spring Harbor Laboratory as
beneficiary ensures that a bequest will be utilized as specified.
Conversion of Private Foundation to "Public" Status on Termination: This may be done by cre-
ating a separate fund within Cold Spring Harbor Laboratory whereby the assets of the private foun-
dation are accounted for as a separate fund and used for the purposes specified by the donor.
Alternatively, the private foundation can be established as a supporting organization of Cold Spring
Harbor Laboratory.
Matching Gifts: Many employers will match gifts to Cold Spring Harbor Laboratory and/or the Watson
School of Biological Sciences. Please check with your employer to augment your gift.
For additional information, please contact the Director of Development, Cold Spring Harbor Laboratory, One
Bungtown Road, Post Office Box 100, Cold Spring Harbor, NY 11724, 516-367-8840.
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CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 2001-December 31, 2001
Contributions of $5,000 and above, exclusive of Annual Fund
In 2001, Cold Spring Harbor Laboratory received significant support in the form of capital, program,
and gifts-in-kind contributions from individuals, foundations, and corporations.
Rita Allen Foundation, Inc.
Andrew's Buddies Corporation
Anonymous
Arrow Electronics
Banbury Fund #3
Michael Scott Barish Human Cancer Grant sponsored
by 1 in 9: The Long Island Breast Cancer Action
Coalition
Booth Ferris Foundation
The Breast Cancer Research Foundation
Brinkmann Instruments, Inc./Eppendorf AG
Dorothy Rodbell Cohen Foundation for Sarcoma
Research
The Ira W. De Camp Foundation
The William Theodore Dens low Foundation
Devgen N.V.
Helen and Charles Dolan
Oliver S. & Jennie R. Donaldson Charitable Trust
Ellison Medical Foundation
Epilepsy Foundation
Fisher Scientific International
Fraxa Research Foundation
Hon. Charles J. Fuschillo, Jr., Senator; and State of
New York
Mr. Kenyon Gillespie
Bernard F. and Alva B. Gimbel Foundation
The Lorraine and Lloyd Glidden Foundation
Goldfield Family Charitable Trust
Goldring Family Foundation
Irving A. Hansen Memorial Foundation
William Randolph Hearst Foundation
Estate of Mrs. Dorothy H. Hirshon
The Helen Hoffritz Foundation
Dr. James R. Hudson, Jr.
Illinois Neurofibromatosis, Inc.
JPC Contracting
Mr. Peter S. Kalikow
Sidney Kimmel Foundation for Cancer Research
Laurie J. Landeau, V.M.D.
Charles Henry Leach II Foundation
The Lehrman Institute
Long Islanders Against Breast Cancer (L.I.A.B.C.)
Marks Family Foundation
G. Harold & Leila Y. Mathers Charitable Foundation
The Maxfield Foundation
Breast Cancer Awareness Day in memory of Elizabeth
McFarland
Louis Morin Charitable Trust
NARSAD
Nassau County Industrial Development Agency
Neurofibromatosis of Arizona
Neurofibromatosis, Inc. Massachusetts Bay Area
David and Lucile Packard Foundation*
Pew Charitable Trust
The Pfizer Foundation, Inc.
William E. and Maude S. Pritchard Charitable Trust
Mr. Michael L. Rankowitz and Ms. Sheila Heffron
Mr. John R. Reese
Mr. and Mrs. Alan Seligson
The Seraph Foundation
Ann and Herb Siegel*
Alfred P. Sloan Foundation
SNP Consortium
State of New York Department of Health
St. Giles Foundation
Laurie Strauss Leukemia Foundation
Sun Gene GmbH & Co.
Swartz Foundation
Barbara and Donald Tober Foundation
Tularik, Inc.
The V Foundation
Dr. and Mrs. James D. Watson
Edwin S. Webster Foundation
Westvaco Corporation
The Whitehall Foundation*
Helen Hay Whitney Foundation
Zeneca, Ltd.
Total $11,627,919
* New Pledges Awarded in 2001.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
CAPITAL CAMPAIGN
January 1, 2001-December 31, 2001
Contributions and pledges, exclusive of Annual Fund
The Watson School of Biological Sciences at Cold Spring Harbor Laboratory was established for the
purpose of granting the Ph.D. degree. In its third year, the Watson School matriculated 6 additional stu-
dents bringing the total number to 20. In 2001, the Laboratory received significant support from indi-
viduals, foundations, trusts, and corporations.
Arnold and Mabel Beckman Arnold and Mabel Beckman Foundation
Graduate Studentship
Core Course
Dean's Chair
Faculty Lectureships
Fellowships
Pall Fund
Student Support
The Watson Fund for
Innovative Graduate
Education
Total
*New Pledges Awarded in 2001.
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Arnold and Mabel Beckman Foundation
Annenberg Foundation
Lita Annenberg Hazen Foundation
Mr. George W. Cutting
Mr. and Mrs. Norris Darrell, Jr.
The Esther A. and Joseph Klingenstein Fund, Inc.
Mrs. Mary D. Lindsay
Pfizer, Global Research and Development"
Quick & Reilly/Fleet Securities, Inc.
Dr. George B. Rathmann
Ziering Family Foundation"
Mr. and Mrs. David H. Koch
Mr. and Mrs. Alan Goldberg and Mr. and Mrs. Robert D. Lindsay
The Miller Family Foundation
Mr. Omos Maiers
Annette Kade Charitable Trust*
Affymetrix
Anonymous*
John Coleman/Solar Physics Corporation
Mr. and Mrs. Roderick H. Cushman
The William Stamps Farish Fund
Robert J. Glaser, M.D.
Mrs. Harriet D. Hershey
$3,397,228
Mrs. Gilbert Kahn
Mr. Henry Luce II
Dr. Thomas Maniatis
Mr. and Mrs. Julian H. Robertson
The Seraph Foundation
Michael Wig ler, Ph.D.
Mark J. Zoller, Ph.D. and Karen Johnson, Ph.D.
ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
For the first time in many years, we introduced a significant change in the structure of the Corporate
Sponsor Program by introducing a new category-Corporate Benefactor. Mergers in the pharmaceu-
tical and biotechnology industries are continuing to deplete the pool of companies that we can
approach, even as the remaining companies increase greatly in size. In the extreme case, five mem-
bers of the Program have, over the years, been combined to form a single company! The Corporate
Benefactor membership is set at $50,000 with a proportionate increase in benefits. We are delighted
that Pfizer Inc. became our first Benefactor, setting an example, we hope, to other companies.
The Corporate Sponsor Program continues to be critical to the vigorous meetings program held at
Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main Laboratory campus or at the
Banbury Center. Without the strong foundation provided by the Program, we could not plan with con-
fidence for the year's meetings, nor introduce new and unusual topics. We are, then, very grateful to
the companies that joined us in 2001, and they are listed below.
The members of the Program receive special privileges in acknowledgment of their contributions.
We waive all on-site fees for eight representatives of each company at our meetings. The number of
meetings continues to increase so that in 2001, no fewer than 19 meetings took place in Grace
Auditorium. Three scientists from each company may attend meetings at Banbury Center, where atten-
dance is otherwise only by invitation of the organizers. Corporate Sponsors receive gratis copies of
Cold Spring Harbor Laboratory Press publications including the journals Genes & Development,
Learning & Memory, Protein Science, and Genome Research. We acknowledge our Sponsors in all rel-
evant publications, including the books of abstracts given to each of the 7000 participants who come
to the meetings each year. The names of the sponsoring companies are listed on the poster describ-
ing the meetings; this is mailed to approximately 17,000 scientists throughout the world. In addition,
the companies are listed on the Cold Spring Harbor Laboratory Web Site and on the Meetings Office
and Banbury Center Web pages.
CORPORATE BENEFACTORS
Pfizer Inc.
CORPORATE SPONSORS
Abbott Bioresearch Center, Inc.
Amgen Inc.
Applied Biosystems
Aventis Pharma AG
BioVentures, Inc.
Bristol-Myers Squibb Company
Chiron Corporation
Chugai Research Institute for Molecular
Medicine, Inc.
Cogene BioTech Ventures, Ltd.
PLANT CORPORATE ASSOCIATES
Monsanto Company
Pioneer Hi-Bred International, Inc.
Torrey Mesa Research Institute
Westvaco Corporation
Diagnostic Products Corporation
DuPont Pharmaceuticals Company
Forest Laboratories, Inc.
Genentech, Inc.
Genetics Institute
GlaxoSmithKline
Hoffmann-La Roche Inc.
Johnson & Johnson
Kyowa Hakko Kogyo Co., Ltd.
CORPORATE AFFILIATES
Affymetrix, Inc.
Ceptyr, Inc.
Total $891,000
Eli Lilly and Company
Merck Research Laboratories
New England BioLabs, Inc.
Novartis Pharma Research
OSI Pharmaceuticals, Inc.
Pall Corporation
Pharmacia Corporation
Research Genetics, Inc.
Schering-Plough Corporation
FOUNDATIONS
Albert B. Sabin Vaccine Institute, Inc.
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Dolan DNALC Corporate Advisory Board Annual Fund
The Corporate Advisory Board, which was established in 1992, serves the Dolan DNA Learning Center as a
liaison to the corporate community and assists in securing unrestricted support. As a means of raising sup-
port and awareness, the Corporate Advisory Board conducts the annual Golf Tournament and the Annual
Fund. The proceeds benefit the Dolan DNA Learning Center and the Partners for the Future program. The
Partners program teaches principles and methods of basic scientific research to eight Long Island high
school seniors, who work with lab scientists for 10 hours a week after school, from October through March.
Chairman: Edward A. Chernoff, Motors & Armatures, Inc.
Vice Chairman: Christiaan B. Reynolds, McLagan Partners
CSHL Trustee Liaison: Arthur M. Spiro
Michael Aboff, Aboff's, Inc.
Andrew D. Ackerman, J.P. Morgan Chase & Co.
Brett Ashley, Cole Communications
Rocco S. Barrese, Esq., Dilworth and Barrese, LLP
Howard M. Blankman, The Blankman Group
Thomas J. Calabrese, Daniel Gale Agency
Richard A. Catalano, KPMG LLP
Paul Czeladnicki, Rivkin, Radler, and Kremer
Robert E. Diller, Brinkmann Instruments,
InclEppendorf AG
Candido E. Fuentes-Felix, M.D., F.A.C.S.
ANNUAL FUND CONTRIBUTORS
GENOME SUPPORTERS
Contributions of $10,000 or more
Mr. Edward A. Chemoff, Motors & Armatures, Inc.
Luitpold Pharmaceuticals, Inc.
Mr. and Mrs. Arthur M. Spiro
CHROMOSME SUPPORTERS
Contributions of $5,000 or more
Anonymous
Laurie J. Landeau, V.M.D.
Newsday
OSI Pharmaceuticals, Inc.
Pall Corporation
The Schiff Foundation
GENE SUPPORTERS
Contributions of $2,500 or more
Mr. and Mm. G. Morgan Browne
Citibank Private Bank
Mr. Arthur D. Herman
KPMG LLP
Rivkin, Radler and Kremer
EXON SUPPORTERS
Contributions of $1,000 or more
Aboff's, Inc.
The Blankman Group
Daniel Gale Agency
Dilworth and Barrese
Harweb Foundation
A.C. Israel Foundation, Inc.
Mrs. Claire Landeau
LG Management LLC
Rama Rao
Mr. and Mm. George A. Roche
Mr. and Mrs. William D. Roche
Mrs. Wendy Vander Poel Russell
Grace and Bruce Stillman
Mr. and Mrs. Donald J. Sutherland
INTRON SUPPORTERS
Contributions of $500 or more
Ms. Rosemary Bourne
Fortunato Sons, Inc.
Dr. and Mrs. Candido E. Fuentes-Felix
Mr. Andrew McNeill
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David Garbus, Huntington Business Products
Centre
John Henry
Arthur D. Herman, Herman Development Corp.
John C. Kean III, Kean Development Company
Laurie J. Landeau, V.M.D.
Ralf Lange, Luitpold Pharmaceuticals, Inc.
John J. Leahy, Citibank Private Bank
Lilo Leeds, Institute for Student Achievement
James E. Mattutat, ACI Capital Co., Inc.
Victoria Meagher, Pfizer Pharmaceuticals
Patricia Petersen, Daniel Gale Agency
Petunia Productions
Pitney Bowes
Sutton & Edwards, Inc.
The Tiller Family Foundation
TRIPLE CONDON SUPPORTERS
Contributions of $250 or mom
Adchem Corporation
Air Techniques Incorporated
Mr. and Mrs. John Aksak
CII Technologies
D. Reis Furniture Manufacturing Corp.
Mr. John Delalio and Ms. Julie Sutherland
The First National Bank of Long Island
Mr. Thomas Fitzsimmons
Mr. and Mm. Robert A. Gay
Mrs. Beatrice W. Ingham
Mr. and Mrs. James E. Mattutat
Mr. Stanley R. Orczyk
Ms. Aimee Reynolds
Mr. and Mrs. Bernard F Reynolds
Mr. Christiaan B. Reynolds
Dr. Shahin Shaikh
Zarley, McKee, Thomte, Voorhees and Sea.
NUCLEOTIDE PAIR SUPPORTERS
Contributions of $100 or more
Drs. John Amodio and Eileen Fontanetta
Astrorep Incorporated
Mr. Fred H. Baron
Mr. and Mrs. Pierre R. Beaubrun
Berger's Wholesale Meats, Inc.
Ms. Patricia Bossert
Bright's Centennial House, Inc.
Huimei Chang
Mr. and Mrs. Steven Corwin
Dr. and Mrs. Burke A. Cunha
Mrs. Marilyn DeLalic
Farmingdale Iron Works, Inc.
Dr. and Mm. Steven M. Goldberg
Gristmill Construction Company
Haft, Dougherty and Connell
J.W. Hirschfeld Agency, Inc.
Mr. Warren B. Lane
Mr. and Mm. Richard H. Leeds
Candido and Irene N. Llovera
Mr. and Mrs. Matthew Mallgrave
Total $122,354
William D. Roche
Wendy Vander Poel Russell
Horst K. Saalbach, Ph.D., Festo Corporation
Peter G. Schiff, Northwood Ventures LLC
Charles R. Schueler, Cablevision Systems Corp.
Dixie Scovel, Newsday
Kevin Seeley, Ph.D., Pall Corporation
Jeffrey K Tupper, U.S. Trust Company of New York
Robert Van Nostrand, OSI Pharmaceuticals, Inc.
Frederick Volp, Ph.D., CSH Central School District
William N. Wham, ISC Inc.
Mr. and Mrs. Donald Morrongiello
Mr. and Mrs. James J. Murphy
Ms. Stephanie G. Ovadia
Mr. and Mm. Thomas K. Reimels
Mr. Andrew Reynolds
Mr. Mauri Rosenthal and Ms. Nancy Taubenslag
Rubin & Rothman, LLC
Mr. and Mrs. Haresh Shah
Mr. Tom Singh
Mr. David E. Strahl
Tony's Fish and Seafood Corp.
Ms. Emily Tsunis
Mr. and Mrs. Gerald C. Wen
Mr. Joseph Willen
NUCLEOTIDE SUPPORTERS
Contributions of $50 or more
American Museum of Natural History
Mr. Carl J. Becker
Bill and Ted's Excellent Adventure, Inc.
Mr. and Mrs. Annada Das
Mr. John Debellis and Ms. Christina Jackowski
Forbes, Inc.
Mr. and Mrs. Daniel A. Golub
Mr. and Mrs. Gordon S. Hargraves
Mr. and Mrs. Warren J. Herman
Mr. and Mrs. Robert H. Hohhausen
Mr. James R. Jankowski
Dr. Myron I. Kleiner
Mr. Joel Lamm
Mr. and Mrs. William Lysaght
Mr. and Mrs. Richard MacDougall
Ms. Margaret D. Mazzeo
Mr. and Mrs. Oscar Michelen
Therese and Gary Nielsen
Ms. Arleta D. Pacheco
The Paniagua Family
Roman Concrete Corporation
Mr. Paul Rosenvold
Herbert Rude Associates, Inc.
Mr. and Mrs. Anthony J. Sabin
Ms. Dorothy Schumejda
Mr. and Mrs. Jeffrey Stern
Kris and Jai Subramani
Ms. Paige Sutherland
Mr. and Mrs. Dennis Whitley
EIGHTH ANNUAL GOLF TOURNAMENT SPONSORS
FOUNDING TOURNAMENT SPONSOR
J.P. Morgan Chase & Co.
MAJOR CORPORATE SPONSORS
Cablevision Systems Corporation
Fortunato Sons, Inc.
Luitpold Pharmaceuticals, Inc.
Quick & Reilly/Fleet Securities, Inc.
Marsh USA, Inc.
Motors & Armatures, Inc.
CORPORATE SPONSORS
Badge Agency, Inc.
KPMG LLP
GRAND AUCTION SPONSOR
Golf Holidays
Katherine and Larry Coppleman of Spinnaker
Travel
HOLE-IN-ONE-SPONSORS
Badge Agency, Inc.
Competition BMW of Smithtown
PRIZE SPONSOR
D & D West
REGISTRATION TABLE SPONSOR
U.S. Trust Company of New York
REFRESHMENT SPONSOR
OSI Pharmaceuticals, Inc.
PUTTING GREEN SPONSOR
Jack Berleth & Sons Inc.
GOLD PACKAGE SPONSORS
ASI Solutions, Inc.
Barnes & Noble College Bookstores, Inc.
Brinkmann Instruments, Inc./Eppendorf AG
Ciardullo Landscapes & Designs, Inc.
Citibank, N.A.
Cortel Business Systems, Inc.
Dilworth & Barrese, LLP
Total
Bectronix Systems Central Station Alarms, Inc.
Festo Corporation
Daniel Gale Agency
Herman Development Corporation
Kean Development Corporation Inc.
Huntington Business Products Centre
ISC, Inc.
Luitpold Pharmaceuticals, Inc.
Mintz, Levin, Cohn, Ferris, Glovsky &
Popeo PC
Northwood Ventures LLC
OSI Pharmaceuticals, Inc.
Rivkin, Radler & Kremer
The Seligson Foundation
UBS Warburg
U.S. Trust Company of New York
SILVER PACKAGE SPONSORS
Mr. and Mrs. Thomas J. Calabrese, Jr.
State Bank of Long Island
Syosset Limousine Company
U.S. Trust Company of New York
BRONZE PACKAGE SPONSORS
Aboff's, Inc.
Advantage Title Agency, Inc.
Air Techniques Inc.
Callan, Koster & Brady, Brennan, LLP
Cogswell Realty
Lazer, A,otheker, Feldman, Roselle & Yedid, P.C.
Bradley Marsh, DPM
Mr. Peter Marsh
Mr. Jack J. Ross
TEE AND GREEN SPONSORS
A Partymaker
Olympus America
GOLF CART SPONSOR
Lewisy Fuel Oil
RAFFLE PRIZES
Aboff's, Inc.
Broadway Cares
Foxwoods Resorts & Casino
$187,355
Total Dolan DNALC Annual Fund $309,709
Candido E. Fuentes-Felix, M.D., F.A.C.S.
Cold Spring Harbor Laboratory
Codfish Restaurant
Daniel Gale Agency
Huntington Business Products Centre
Huntington Hilton
London Jewelers
Marsh's of Huntington Village
Mill River Inn
New York Islanders
Mr. Bob Nystrom
OC Tanner
Reds Restaurant
Rivkin, Radler and Kremer
Mr. William D. Roche
Sharp Instruments
Syosset Limousine Company
Tease Restaurant
Texas Instruments
Tupelo Honey Restaurant
FAVOR BAG SUPPLIERS
Tee shirts courtesy of Barnes & Noble
College Bookstores, Inc.
Golf balls courtesy of Citibank, N.A.
Goff towels courtesy of Daniel Gale Agency
Golf balls courtesy of Festo Corporation
Fortune Magazine
Golf shirts courtesy of G.E. Industrial
Golf Tees courtesy of United Health Care
THANK YOU
Harold Betters Quartet
Mr. Howard M. Blankman
Boston Brewing Corporation
Coca Cola Bottling Company of New York
Cold Spring Harbor Laboratory volunteers
Dolan DNA Learning Center volunteers
Mr. Francis X. Harrington
Tourneau
EMCEE
Mr. Scott Feldman, News 12 Long Island
RAFFLE AUCTIONEER
Mr. Bob Nystrom
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Cold Spring Harbor Laboratory Association (CSHLA)
Officers
David H. Deming, President
Trudy H. Calabrese, First Vice-President
John S. Grace, Vice-President
Cathy Cyphers Soref, Secretary
Joseph T. Donohue, Treasurer
Directors
Nicholas J. Bartilucci Susan Ho llo
George W. Cutting, Jr. Allen D. Jebsen
Frances N. Elder Alan M. Kisner, M.D.
Robert A. Gay Mary Alice Kolodner
William F. Gerry Gilbert R. Ott, Jr.
Lynn M. Gray Eileen K.S. Pulling
Robin T Hadley Lawrence Remmel
Honorary Directors
John P. Cleary
Mary D. Lindsay
Anne R. Meier
President's Report
Henry Salzhauer
Ann C. Seifert
Susan Sheeline
Cynthia R. Stebbins
Bruce Stillman, Ph.D.
Marjorie von Stade
James D. Watson, Ph.D.
2001 was another active year for our Association. We expanded our special events program, enhanced
our community outreach effort, and continued our fund-raising in support of young scientists here at the
Laboratory. Support for this wonderful institution continues despite the turmoil in the world around us.
The support of generous donors enables the Laboratory to staff its various research laboratories
with top scientific research talent. A significant portion of the Annual Fund goes directly to support
promising postdoctoral fellows who are vital to the Laboratory's continuingsuccess. This year, the Cold
Spring Harbor Laboratory Association raised $799,912 in our Annual Fund.
Leadership is key to the Association. We welcome David Banker, Lori Garofalo, Michael O'Brien,
and Richard Torrenzano as new Directors. We thank Nick Bartilucci, Robin Hadley, and Eileen Pulling,
our retiring Directors, who gave their talent and devoted time and effort to the Association.
Our February 4 Annual Meeting was followed by dinner and featured Dr. Shirley M. Tilghman, then
the Howard A. Prior Professor of the Life Sciences at Princeton University and now the new President
of Princeton. Dr. Tilghman's speech entitled "Genomic Imprinting-A Genetic Arms Race" was fasci-
nating and enjoyed by all. Many thanks to Nick Bartilucci and Susan Sheeline who chaired this won-
derful event.
On April 21, the Laboratory was transformed into a "Jazz Club" for the evening, featuring great
music by the Harold Betters Quartet, Kenny Blake, and Eric Johnson, with a special guestappearance
by Sheena Berkley. What made this evening truly special was the live recording of the concert pre-
served on CD for a lasting memory. The concert was followed by a buffet dinner and a late-set perfor-
mance. A very special thanks is in order to the Committee co-chairs Mary Beth and Joe Donohue and
Lisa and Gil Ott, and the Underwriting co-chairs Susan and Mark Ho llo, Ginny and David Knott, and
Cathy and Doug Soref. We are especially grateful to our Jazz Underwriters listed below. With their sup-
port and generosity, we were able to triple our proceeds from last year's event.
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Premier Underwriters
Anonymous
Mr. and Mrs. Nicholas J. Bartilucci
Mr. and Mrs. David H. Deming
Helen and Charles Dolan
Mr. and Mrs. Stephen Garofalo (Garofalo
Foundation, Inc.)
Mr. and Mrs. Mark G. Ho llo
Lead Underwriters
Mr. and Mrs. Timothy Broadbent
Mr. and Mrs. Elliot Conway
Mr. and Mrs. George W. Cutting, Jr.
Daniel Gale Real Estate Companies
Mr. and Mrs. Daniel C. de Roulet
Mr. and Mrs. Joseph T Donohue
Mr. and Mrs. Joseph G. Fogg
Mr. and Mrs. Kellogg C. Gaines
Mr. and Mrs. Jack Grace
Mr. and Mrs. Austen T. Gray, Jr.
Mr. and Mrs. James B. Hoover
CSHLA President David H. Deming and guest
speaker Dr. Walter C. Willett taken at the CSHL
Association Annual Meeting in February.
Mr. and Mrs. David M. Knott
Mr. and Mrs. Stephen M. Lessing
Mr. Harold L. Rosenberg and Dr. Laurie
Sayet Rosenberg
Mr. and Mrs. Peter Schiff (The Schiff Foundation)
Mr. and Mrs. Douglas Soref
Dr. and Mrs. Alan M. Kisner
Mr. and Mrs. Michael L. Kolodner
Mrs. Mary D. Lindsay
Mr. and Mrs. Robert D. Lindsay
Mr. Barry Lites and Ms. Leigh Ann
Hutchinson
Mr. and Mrs. William A. Marino
Mrs. Irving Meltzer
Mr. and Mrs. Gonzalo M.
Mocorrea
Mr. and Mrs. J.W. Nick, Jr.
Mr. and Mrs. Hugh O'Kane, Jr.
Pall Corporation
Mr. Robert Pascucci and Ms. Lisa
Puntillo
Mr. and Mrs. Jon N. Santemma
Mr. and Mrs. Thomas L. Seifert
Mr. and Mrs. James F. Stebbins
Mr. and Mrs. Roland Tatzel
Mr. and Mrs. Walter C. Teagle III
Mr. and Mrs. Donald Textor
The Tilles Family Foundation
Mr. and Mrs. Charles S. Weiss
The Dorcas Cummings Lecture was held on June 3, 2001. Our guest speaker was Dr. Venki
Ramakrishnan of MRC Laboratory of Molecular Biology, Cambridge, England. The title of his engaging
lecture was "Protein Factories and Antibiotics." Our sincere thanks go to Cynthia Stebbins, Ann Seifert,
and Susan Sheeline for their hard work in organizing the dinner parties that followed the lecture. A very
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special thank you to the friends in our community who generously hosted these wonderful parties and
entertained our own Laboratory scientists, friends, and visiting scientists from around the country and
the world.
Mr. and Mrs. W. Dillaway Ayres, Jr.
Mr. and Mrs. John P. Cleary
Mr. and Mrs. Daniel de Roulet
Mr. and Mrs. John S. Grace
Mr. and Mrs. Austen T. Gray, Jr.
Dr. and Mrs. E. Rodney Hornbake
Mr. and Mrs. Michael Kolodner
Mrs. Mary D. Lindsay
Mr. and Mrs. Robert D. Lindsay
Mr. and Mrs. David L. Luke III
Mr. and Mrs. Robert O'Connor
Mrs. Barry H. Osborn
Mr. and Mrs. Gilbert R Ott, Jr.
Mrs. Wendy Vander Poel Russell
Mr. and Mrs. Henry E. Salzhauer
Mr. and Mrs. William E. Sheeline
Mr. and Mrs. Douglas Soref
Mr. and Mrs. John C. Stevenson
Mr. and Mrs. Daniel G. Tenney, Jr.
Mr. and Mrs. Thomas Vandeventer
Mr. and Mrs. Paul A. Vermylen, Jr.
Mr. and Mrs. Robert Walton
Two other past events reappeared this year to their great success and our delight. The CSHL
Association Partnership Picnic was held on September 23 at the home of Sandra and Stephen Lessing
of Cold Spring Harbor. Mr. and Mrs. Francis W. Murray Ill of Cold Spring Harbor were very generous to
host our Major Donor party on October 14. Many thanks to Mike and Judy as well as Frances Elder for
her assistance in helping to organize this event.
The Third Annual Biotechnology Luncheon hosted by the Laboratory and sponsored by U.S. Trust
Company was held on October 18. The guest speakers were Dr. Robert S. Kerbel, Head of Molecular
& Cellular Biology Research at Sunnybrook & Women's College Health Science Centre in Toronto and
the John & Elizabeth Tory Professor of Experimental Oncology at the University of Toronto; and Dr.
George D. Yancopoulos, President & Chief Scientific Officer of Regeneron Laboratories, Tarrytown,
New York. This year's topic was "Controlling Cancer: Anti-Angiogenic Therapy." Our guest speakers
were introduced by Bruce Stillman, who also moderated the event. Much appreciation to Larry Remmel
and Eileen Pulling for their hard work in making this event a sellout.
Many thanks to George W. Cutting, Jr., for hosting the first Partnership Program's "Oyster Fest" at
the Laboratory held on December 7. George hosted the program's community members and
Laboratory scientists for an informal social evening held in the Laboratory's Racker Room. George
arranged to fly in oysters and smoked salmon from Alaska for this event, along with oysters served from
the local area for a taste-test. A great time was had by all.
We thank each of you for your interest, time, and support. Have a great 2002.
David H. Deming
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James A. Eisenman
1922-2001
Jim Eisenman, a firm but gentle man, was long a supporter of Cold Spring Harbor
Laboratory. Together with his wife, Jan, and their three daughters, Jim had a vast impact
on the Laboratory and always had its best interests at heart.
A Pennsylvania native, Jim received his B.S. in Mechanical Engineering from Brown
University in 1943, one year ahead of schedule. After graduating, he worked as an engi-
neer with Sperry Gyroscope on Long Island, and left to serve in the United States
Merchant Marines during 1944 and 1945. He returned from World War II and graduat-
ed from St. John's Law School in Brooklyn in 1948; he married Janice Brackett in 1949.
Jim lived in Laurel Hollow for 47 years and was an active member of the local com-
munity. The land he purchased in Laurel Hollow was adjacent to Cold Spring Harbor
Laboratory. For several decades, Jim lived next door to Al and Jill Hershey, and quickly
developed an affection both for the Hershey family and for Cold Spring Harbor
Laboratory. But it was the Laboratory's then-director, John Cairns, who brought Jim "into
the fold" of Cold Spring Harbor Laboratory. In fact, the Cairns and Eisenmans were the
best of friends and that friendship ultimately benefited Cold Spring Harbor Laboratory, for
it was that camaraderie that cemented Jim's strong support of the Laboratory's mission
and goals.
Jim practiced law, first with the firm of Campbell, Brumbaugh, Free and Graves, and
then at his own patent law firm in Woodbury-Eisenman, Allsopp and Strack. In recent
years, he was of counsel to Payne, Wood
and Littlejohn, where he focused on corpo-
rate law and intellectual property. Jim also
served as the Village District Judge in
Laurel Hollow for more than two decades,
and was on the board of directors of the St.
John land Nursing Home
town.
Jim was a vital part of the Long Island
Biological Association for more than 30
years. LIBA-the fund-raising and former
governing body of Cold Spring Harbor
Laboratory-had supported research at
the Lab since its founding in 1924. Jim
served as Director of LIBA from 1963 to
1989, and as its Treasurer from 1966 to
1989. In these roles, he helped Cold Spring Harbor
Laboratory immeasurably-first to survive and then to aim
for greatness.
On Friday, November 16, 2001, Jim succumbed to
esophageal cancer at the age of 79. Survived by his wife,
Jan, his daughters, four grandchildren, and a brother,
Alvin, Jim was the heart of his family and of our communi-
ty. His last wish even included the Laboratory, as he stipu-
lated that donations be made in lieu of flowers to support
our cancer research. To the end, Jim Eisenman remained
a steadfast friend of Cold Spring Harbor Laboratory, of the
community he lived in, and of the many who were lucky
enough to know him. He will be sorely missed by us all.
Maria Hedges, Jim Watson, Ahmad Bukhari, Jim Eisenman
James D. Watson Rich Roberts, Jim Eisenman, Jan Eisenman
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Members of the Cold Spring Harbor Association
ANGELS
Contributions of $10,000 or more
The Ada Howe Kent Foundation
The Albert C. Bostwick
Foundation
Roger and Lori Bahnik
Mr. and Mrs. G. Morgan Browne
Clarkson Family Foundation
Mr. and Mrs. John P. Cleary
Mr. and Mrs. David H. Deming
The Dorothy Schiff Foundation
Fairchild Martindale Foundation
Mr. Robert B. Gardner, Jr.
Mrs. Oliver R. Grace
Mrs. Mary D. Lindsay
Mr. and Mrs. David L. Luke III
Mr. and Mrs. Eduardo G. Mestre
The Miller Family Foundation
Morris Charity Fund/Mr. and Mrs.
Douglas Mortis
The New York Community Trust-
George N. and Mary D.
Lindsay Fund
Mr. and Mrs. Hartley Rogers
Mrs. Ernest T. Turner
Universal Music Group
Dr. and Mrs. James D. Watson
Mr. Stuart Weisbrod-Merlin
BioMed Group
The William Stamps Fadsh Fund
BENEFACTORS
Contnbutions of $5,000 or more
The Alex J. Weinstein Foundation,
Inc.
Mr. and Mrs. W. Dillaway Ayres, Jr
Mr. and Mrs. Robert H.B. Baldwin
Pier and Hans Bosch
Mr. William Braden
Mrs. Helen M. Brooks
Mr. Peter B. Cannell
The Craigmyle Foundation
Mr. and Mrs. Norris Darrell, Jr.
Robin T Hadley
James McCullagh Co., Inc.
Mrs. John H. Livingston
Joyce and Robert Marcus
Dr. and Mrs. Wafter C. Meier
Mr. and Mrs. Jerry D. Olin
Joyce and John Phelan
Mr. and Mrs. Philip R. von Stade
PATRONS
Contributions of $2,500 or more
Abby and George O'Neill Trust
Marion S. Bannard
Mr. and Mm. Nicholas J. Bartilucci
The Richard A. & Amelia Bernstein
Foundation, Inc.
Mr. and Mrs. Thomas Calabrese
Helen and Charles Dolan
William H. Doremus
Steven T Florio
Mr. and Mrs. Stephen Garofalo
Mr. and Mrs. Robert A. Gay
Michael J. Griffin and Joyce A.
Bertoldo
James Goodwin
Mr. and Mrs. Barclay Jones
Joyce Green Family Foundation
Mr. and Mrs. Townsend J. Knight
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Mr. and Mrs. David M. Knott
Dr. Egon Kramer and Dr. Marcia
Kramer Mayer
Laurie J. Landeau, V.M.D.
Mr. and Mrs. Peter M. Lee
Mr. and Mrs. Stephen M. Lensing
Bridget and John Macaskill
Norwood Foundation, Inc./The
Bancroft Families
Mr. and Mrs. Preston V. Pumphrey
Hope and John Reese
Dr. Laurie Sayet Rosenberg and
Mr. Harold L. Rosenberg
Mr. and Mrs. Peter G. Schiff/The
Schiff Foundation
Mr. and Mrs. Douglas Soref
Mr. and Mrs. James L. Spingarn
Mr. and Mrs. James F. Stebbins
Grace and Bruce Stillman
Mr. and Mrs. Peter Tilles/The Tilles
Family Foundation
Mr. and Mrs. Douglas A. Warner III
Townsend Weekes and Diana
Collins
ASSOCIATES
Contributions of $1,000 or more
Mr. Warren S. Adams II
Mr. and Mrs. Robert F. Albertson
Robert H. Arnow
Banbury Fund/Mr. and Mrs.
William S. Robertson
Pamela and David Banker
Mr. Edmund Bartlett
Pam and Gene Bernstein
Mr. and Mrs. Allen L. Boorstein
Dr. David Botstein and Dr. Renee
Fitts
Mr. and Mm. Timothy Broadbent
Mr. and Mrs. Vincent Carosella
Phyllis and Leon Charash
Mr. and Mm. Harry Charlston
Mr. and Mm. Thomas H. Choate
The Christopher D. Smithers
Foundation
Mrs. Robert L. Clarkson, Jr.
Mr. James W. Cleary
Mr. and Mm. John H. Coleman
Mr. and Mm. Elliot Conway
Mr. and Mrs. Arthur M. Crocker
Mr. and Mrs. Richard T. Cunniff
Mr. and Mrs. Curtis Cushman
Daniel Gale Real Estate
Companies
The David G. Salten Foundation
Mr. and Mrs. Guy L. de Ghazal
Mr. and Mrs. Daniel C. de Roulet
Mr. and Mrs. Donald L. Deming
Mr. and Mrs. Joseph T Donohue
Dr. Lester Dubnick
Mr. and Mrs. William T Dunn
Mm. James A. Eisenman
Mr. and Mrs. Duncan Elder
Lisa and Johnston Evans
Mr. and Mrs. Kellogg C. Gaines
E.M. Geddes, Jr.
Mr. and Mrs. Elbridge T Gerry, Jr.
Mr. and Mrs. William F. Gerry
The Gilder Foundation
Mr. and Mrs. Jack Grace
Mr. and Mrs. Austen T. Gray, Jr.
Henry U. Harris, Jr.
Mr. Leonard Hess
Mrs. Albert L. Hoffman
Cathy and Christopher Hogg
Mr. and Mrs. James B. Hoover
The Howard Johnson Foundation
Mr. and Mrs. Waldo Hutchins III
Frederic B. Ingraham
Jeffrey Keller and Dolores Fredrich
Dr. and Mrs. Alan M. Kisser
Andrea B. and Peter D. Klein
Mr. and Mrs. Michael L. Kolodner
Mr. and Mrs. Gordon E. Lamb
Mr. Edward M. Lamont
Dana and Jesse Lehman
Mrs. Lois A. Lenahan
Leo Model Foundation, Inc.
Shirley and Eugene Levitt
Mrs. Georgie W. Lewis
Robert V. Lewis, M.D.
Mr. and Mm. Robert D. Lindsay
and Family
Mr. Barry Lites and Ms. Leigh Ann
Hutchinson
Mrs. Vladimir S. Littauer
David M. Livingston, M.D.
Luke D. Lynch, Jr.
Mr. and Mrs. William A. Marino
Anita K. Meltzer
Clarence F. Michalis
Mr. and Mrs. Rod Miller
Mr. and Mrs. Gonzalo M. Mocorrea
Mr. and Mrs. Keith M. Moffat
Mr. and Mm. Francis W. Murray III
Mr. and Mrs. William J. Nammack
Nastech Pharmaceutical
Company, Inc.
Mr. and Mrs. J.W. Nick, Jr.
Carol R. Noyes
Mr. and Mrs. Michael S. O'Brien
Mr. and Mm. Hugh O'Kane, Jr.
Pall Corporation
Mr. and Mrs. Philip F. Palmedo
Mr. and Mrs. Edward L. Palmer
Mr. Robert Pascucci and Ms. Lisa
Puntillo
Mr. and Mrs. Nicholas B.
Paumgarten
Mr. and Mrs. Robert A. Pilkington
Mrs. Richardson Pratt, Jr.
Mr. and Mrs. Richard I. Purnell
Frances S. Reese
Mr. and Mrs. Lawrence Remmel
Mr. and Mrs. Arthur M. Rogers, Jr.
The Richard M. Rossbach
Memorial Fund
Mr. and Mrs. J. Wright
Rumbough, Jr.
Mrs. William F. Russell
Salzhauer Family Fund
Carol and Jon Santemma
Ann and Thomas Seifert
Mr. and Mrs. Enrique F. Senior
Slant/Fin Corporation
Herbert A. Slater
Deborah K. Solbert
Mrs. Nita Soref
Mr. and Mrs. Erwin P. Staller
Fronds R. Storrs
Judith and Irwin Tantleff
Mr. and Mrs. Roland Tatzel
Mr. and Mrs. Walter C. Teagle III
The Textor Family Foundation
Mrs. Martin Victor
Walter B. James Fund #2
Melvyn I. Weiss
Wendy and Chad Weiss
Mrs. Taggart Whipple
Mr. Gerald I. White
The William Ewing Foundation
The General William Mayer
Foundation
Mr. and Mrs. Samuel H. Wolcott
Mr. Mayer Wolf
FRIENDS
Contributions of $300 or more
Mr. and Mrs. William Achenbaum
Mr. and Mrs. Alan M. Ades
Regina and Jonathan Adler
Albrecht, Viggiano, Zureck &
Company, P.C.
Jean E. Andersen
Kim ME and Jeffrey H. Miller
Mr. and Mrs. Richard Aurelio
Erica and Henry Babcock
Rebecca and Ted Bahr
Banker Construction Corp.
Mrs. George de B. Bell
John A. Bendo, M.D.
Mr. John Berejka and Dr. Diane
Moriarty
Berger, Torquato & Davis, LLP
Mr. John C. Bierwirth
Bladykas Engineering P.C.
Mary Lenore Blair
Rosemary Bourne
Mrs. Jean Cattier
Richard D. Colburn
Mr. and Mrs. Paul Coster
Jeanne C. and Lawrence L. Davis
Mrs. W. Tucker Dean
Molly and John Eckelberry
Julie C. Eichenberger
Mr. and Mrs. William Everdell
Mr. and Mrs. Robert W. Fagiola
Claire and Joel Fairman
Dr. Robert and Marjorie Feeney
Fort Hill Animal Hospital
Phyllis R. and Guy A. Fritts
William C. Gay, Jr.
Helen and Monte Get ler
Joseph L. Goldstein, M.D.
Mr. and Mm. Pierre Gonthier
Dr. and Mrs. Maurice Green
Mr. and Mrs. Harold W. Hawkey
Barbara and Murray Hazan
Melvin Heller
Mr. and Mrs. Robert V Henning
Holtz Family Foundation Inc.
Mrs. Bruce Duff Hooton
Sealy and Mark Hopkinson
Rodney and Deborah Hornbake
Rollin and Magda Hotchkiss
Mr. and Mrs. George H. Howard
lmowitz, Koenig & Co., LLP
Michael F. Ingham
Laura J. Ingraham
Thomas lovino/lovino Family
Foundation
Mr. and Mrs. Jeffrey Kelter
John Klingenstein
Drs. Barbara B. Knowles and
Davor Bolter
Mr. and Mrs. John W. Laps ley
Mrs. Richard H. Leeds
Maureen and Anthony Leness
George N. Lindsay, Jr. and Nancy
Metz
Mr. and Mrs. Robert V. Lindsay
Candido and Irene N. Llovera
Cynthia Johnson MacKay
Mrs. Jane N.P. Mallinson
Myra and Bill Mathers
Mrs. Cynthia R. Mead
George Milne, Jr.
George G. Montgomery, Jr.
Mr. and Mrs. John P Morgan II
Moser & Moser LLP
Libby and Matt O'Connell
Peter and Caroline O'Neill
Mr. and Mrs. Frank J. Olt, Jr.
Mrs. Batty M. Osborn
Mrs. Martha M. Osterhus
Mr. and Mrs. Gilbert R. Ott, Jr.
Anita H. Page
Mr. and Mrs. Barry E. Pieper
Mrs. Sterling Pile
Dr. and Mrs. John Post ley
Dr. and Mrs. Richard M. Powers
Dr. and Mrs. Scott Powers
Carol and George Pratt
Renaissance Alliance Publishing,
Inc.
Mr. and Mrs. Robert Rimsky
Pamela and Richard Rubinstein
Ms. Cathie Ryan
Erika and Michael Saffran
Steven M. Schlussel, Esq.
Katie and George Schwab
Mr. and Mrs. Alfred J. Seaman
Dr. and Mrs. John P. Sheehy
Dr. and Mrs. Peter W. Sherwood
Mr. and Mrs. Edward Shorin
Dr. and Mrs. Walter Shropshire, Jr.
Mary and Robert Sibert
Howard Simpson
Shirley Steere
Mr. Arnold Steinberg
Dr. and Mrs. John C. Stevenson
Mrs. David S. Taylor
Mr. and Mrs. Stanley S. Trotman,
Jr.
William and Elizabeth Walsh
Dr. Heidi Wang
Charles W.B. Wardell, Jr.
Lisa and Lewis Warren
Mr. and Mrs. John E. Welsh III
Mr. and Mrs. John R. Wierdsma
Sandra and James Wilbur
William Theodore Dens low
Foundation
Mr and Mrs. Douglas Williams
Mr. and Mrs. Frederick C. Witsell,
Jr.
Charles Yanofsky
Mr. and Mrs. Bernard Yatauro
BASIC MEMBERSHIP
Contributions of $75 or more
Anonymous
Action Remediation, Inc.
Mr. and Mrs. Charles 0. Ames
Mr. and Mrs. J. Bryan Anthony
Mrs. S. Reed Anthony
Helen and Daniel Barbiero
Dr. Henry H. Bard, M.D.
Kenneth G. Bartels
BDO Seidman, LLP
Mr. and Mrs. Robert E. Benson
Dr. Barbara S. Bergman
Marjorie M. Bhavnani
Mr. and Mrs. Nicholas Biddle, Jr.
Mrs. George P Bissell, Jr.
Mr. and Mrs. Peter H. Blohm
Adele S. Borden
Mr. and Mrs. James C. Bostwick
Lilias K. Bostwick
John and Shelley Broven
Catherine D. Brown
Penny Wise Budoff, M.D.
Dorothy and Bill Cappadona
Hanneke Cassel
Mr. and Mrs. Gilbert W. Chapman,
Jr.
Dr. and Mrs. Joseph B. Conolly,
Jr.
Mrs. Robert Copp
Cord Meyer Development
Company
Anne Cosulich
Mr. and Mrs. Miner D. Crary, Jr.
Robert L. Cummings III
Ms. Katya Davey
Dr. E. William Davis
Edward F. DelFoe III
Mr. and Mrs. John N. Deming
Dr. Robert Ditkoff and Mrs. Andi
Emerson-Ditkoff
Mr. and Mrs. Joseph P. Downer
Eileen and Chuck Dubroff
Mrs. William S. Eakins
Dr. and Mrs. Gerard L. Eastman
Stephen Ely
Mary English
Dr. and Mrs. N. Dennis Eryou
Dr. Fran Falco
Mr. and Mrs. John Falk
J. Barry Ferguson
Mr. and Mrs. James C. Ferrer
Lucy Fetterolf
Mr. and Mrs. Paul Forchelli
Zee and Norman Friedman
Mr. Charles R. Gabalis
Clarence E. Galston
Dr. Sam Gandy
Annette Gangitano
Dr. Martin Gellert
Mr. and Mrs. Roger M. Gerber
Mr. and Mrs. Stephen E. Gilhuley
Dr. Morton D. Glantz
Will and Maxine Glenn
Dr. and Mrs. Lewis Goldfinger
Mr. James M. Goldrick
Ms. Wendy L. Goldstein
Hope T. Goodwin
Harriet and George Gorelick
Elaine S. Gould, M.D. and Edward
J. Chimney, Jr.
Mr. and Mrs. Edward R. Greeff
Judith and Edward Greene-
Vigneau
Mr. and Mrs. Scott H. Greenfield
Mr. Bill Gross
Frank Gundersen
Adeeba Hamid
Hamilton, Levy, Miller & Co.
Hammond Heating & Cooling, Inc.
Francis Harrington
Mr. and Mrs. Charles L. Hatton
Ralph Heineman
Huyler C. Held
Harry C. Henderson Ill
Robert J. Henderson, D.C.
Anthony S. Hendrick
Charles A. Hickmann
Mr. and Mrs. Lawrence P Hubert
Mr. and Mrs. Charles R. Holcomb
Edna and Irving Holtzman
Elizabeth and Charles Hubbard
Philip and Gretchen Hull
Mr. John H. Humpstone, Jr.
Mr. and Mrs. Rudolf Hunermund
I. Janvey & Sons, Inc.
Mr. and Mrs. Richard M. Jackson
Mr. and Mrs. John F. Johnston II
Adrienne and Hugh Jones
Joseph P. O'Brien Agency
Polly Stover Kahn
Sandra and Howard Kane
Mr. and Mrs. Spencer Kellogg II
Mr. and Mrs. A. Claude Kemper
Doris Ketcham
Dr. Stanley Kitzis
Magdalene and Harry Koumas
Edward W. Kozlik
Marybeth Krummenacker
Mrs. Thomas LeBoutillier
Thomas and Linda Leon
Sheila and Thomas Lieber
Alice Link
Mrs. Angus C. Littlejohn
Mr. and Mrs. Brian E. Lonegan
Mr. and Mrs. Also J. Long
Mr. and Mrs. John B. LoRusso
Dr. and Mm. Richard Losick
J.I. Macinnes
Mr. and Mrs. Patrick H. Mackay
Wilfred G. Mackey
Omos Maiers
Michael S. Mamakos, M.D.,
F.A.C.S., P.C.
Mr. and Mrs. Joseph Mancino
Bart D. Marksohn and Jan M.
Lockett
Mr. and Mrs. William B. Matteson
Mr. and Mrs. Gregory Mc Mahon
Ms. Diane McGaw
Mr. and Mrs. Randall P McIntyre
Mr. and Mrs. Robert M. McLane
Mrs. Mary H. McLaughlin
Garfield L. Miller Ill
Mr. Lindley G. Miller
Mr. Steven S. Miller
William H. Miller
Dana Minutoli
Kunihiko F Miura
Mr. Jonathan Mogen
Mr. and Mrs. James A. Moose
Mr. and Mrs. Charles Morton
Monica and Brent Mowery
Mrs. Alfred E. Munier
Dr. and Mrs. Yakir Nass
Mr. and Mrs. F. Barry Nelson
Mrs. William S. Niven
Mr. and Mrs. John Noesen
Innis O'Rourke, Jr.
The Paniagua Family
Mr. and Mrs. Samuel D. Parkinson
Dr. Raj Patcha
Mr. and Mrs. Scott L. Paterson
Sarah Plimpton
Paul G. Pennoyer
Dr. Joseph Pipala
Mr. Graham L. Platt
Judge and Mrs. Thomas C. Platt
Martin Pollak
Stephen R. Porpora
Mr. and Mrs. Joseph D. Posillico,
Jr.
Mr. and Mrs. Edward Everett Post
Mr. Charles V. Prizzi
Sally and Drew Quale
Daren A. Rathkopf
Gerry Redmond
Cornelius J. Reid, Jr.
Mrs. Ewing W. Reilley
Charles J. Reina
Mr. and Mrs. Harold B. Richard/
The Richard Foundation
Arlene and Bernard Richards
Francis and Patricia Roberts
Mr. and Mrs. Samuel B. Rogers
Elizabeth Roosevelt
Dr. and Mrs. Emanuel J. Rubin
Charlene Russert
Dr. Marilyn Moffat Salant
Patricia P Sands
Phyllis Satz
Mr. and Mrs. T.V. Schiavoni
Dr. and Mrs. Seymour Schpoont
David and Jeanne Schwarz
Ann Scolnick and Bernard Musso
Mr. and Mrs. Frederick E. Seymour
Mr. and Mrs. Paul C. Sheeline
Dr. and Mrs. Edward M. Shepard
Mr. John D. Simpson
Mrs. William C. Simpson
Maxine Singer
Smith & Jung Land Surveyors
Mr. and Mrs. John C. Smith
Patti M. Smith, P.E.
Mr. and Mrs. Stan Smith
Mr. and Mrs. James
Sommermeyer
Georgette A. Spingarn
Dr. and Mrs. David Stacy
Tom and Susan Staudt
Mr. and Mrs. James Stewart
Dr. and Mrs. Joel Strom
John W. Taylor
Tectonic Engineering Consultants,
P.C.
Dudley B. Tenney
Mr. and Mrs. Edward M. Thomas
George M. Thomas
Mrs. Robert W. Tilney
Mr. and Mrs. Pascal Franchot Tone
Tri-State Consumer Insurance
Co., Inc.
Mr. and Mrs. Cornelius M. Ulman
Mr. and Mrs. Stephen Van R.
Ulman
Jourdan B. Urbach
Dr. and Mrs. Thornton Vandersall
Nicklaus and Ingrid Vetsch
Nancy and Gary Wadler
Charles H. Wagner
Mr. and Mrs. Colton P. Wagner
Mr. and Mrs. Robert P. Walton
Mrs. Bradford G. Weekes
Mr. and Mrs. L.B. Wehle, Jr.
Mr. and Mrs. W. Perry Welch
James K. Wheeler
Mary Louise Whitmarsh
Catherine Bostwick Wilson
Margaret W. Wright
Dr. Keith R. Yamamoto
Joan C. Zulch
421
CSHLA CORPORATE AND FOUNDATION MATCHING CONTRIBUTIONS
Bristol-Myers Squibb Foundation, Inc.
Deutsche Bank Americas Foundation
Dow Jones & Company, Inc.
CSHLA Annual Fund
Oppenheimer Funds, Inc.
Pfizer Matching Gift Center
Phelps Dodge Foundation
CSHLA Membership and Other Support
Angels, Benefactors, Patrons, Associates
Friends, Basic
Other*
Total
$657,475
$65,776
$76,661
$799,912
The Chase Manhattan Foundation
United Way of Long Island
Verizon Foundation
MEMORIAL AND GIFT IN HONOR CONTRIBUTORS
Dr. and Mrs. Glenn Anderson
Mr. and Mrs. William Appleby
Mr. Esteban Araya
Mr. and Mrs. Frederick Baum
Mr. Dominic P Bencivenga
Mr. John Cleary
Mr. and Mrs. Peter Copp
Ms. Jane D. Crary
Mr. Jacques Crouzet-Pascal and Ms.
Pat Feder
Mr. and Mrs. Andrea Farace di
Villaforesta
Ms. Helena Gaviola
Mr. and Mrs. Robert N. Getz
Mr. and Mrs. Oliver R. Grace, Jr.
IN MEMORY OF
Mrs. Sharon Blank
Ms. Beverly Buxton
Ms. Judy Clark
Mrs. Fernand Crouzet-Pascal
Mrs. Vivienne Darenberg
Mr. James Eisenman
Mrs. liam Ellenoff
Panagiotis Gazouleas
Richard and Susan Grausman
The H. Frederick Krimendahl II
Foundation
Dr. and Mrs. Donald S. Kent
Mr. G. Bruce Leib
Mr. H. David Lunger
Mrs. William E. Mahoney
Monterey Fund, Inc.
Mr. and Mrs. Edwin N.B. Nal le
Mr. and Mrs. Basil Northam
Olin Family Foundation, Inc.-Sue and
Gerry Olin
Phi lene Foundation
Helene and Philip Herzig
Julie and Robert Desnick
Mr. Ben Hasnas
Mr. Lindsay Herkness III
Ms. Audrey Leff
Mrs. Gilds Ludovico
Mr. John Niven
Ms. Carol Ann L. Poe
Mr. Sherwood Waldron
Mrs. Grace Walsh
Mr. and Mrs. John Gardiner Pieper
Mr. and Mrs. Man Pifko
Salzhauer Family Fund
Ms. Rose V. Sapelli
Carol and Norman Schulman
Ms. Ann G. Seidler
Mr. and Mrs. Daniel S. Shapiro
Mr. and Mrs. Myron Stein
The Selz Foundation, Inc.
Mrs. Beverly S. VanderPoel
Waldron Memorial Fund
Mrs. Ichabod T. Williams
Mr. and Mrs. Samuel D. Williams
IN HONOR OF
Ms. Donna M. Autuod
The Cleary Family
The Frank Family
Dennis and Serena Freres
Ms. Irene Kleila
Jean and Walter Montaigne
Mr. Howard Ross
Mr. James L. Spingarn
*Includes "Memorial" and "In Honor of Gifts"; Proceeds from Special Events; Annual Fund EndowmentIncome; and Nonmember Gifts.
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President's Council
The President's Council was formed eight years ago to bring together leaders from business, research,
and biotechnology who are interested in science and Cold Spring Harbor Laboratory's research.
President's Council members support the Laboratory's research fellowships, which allow promising
young researchers to pursue their own high-level, independent research rather than assisting estab-
lished scientists. The following were members of the 2001 President's Council:
Mr. Abraham Appel
Mr. Donald Everett Axinn
Mr. Peter Bloom
Dr. Stefan Englehorn
Mr. John Friedman
Dr. Leo A. Guthart
Mr. Charles E. Harris
Mr. Walter B. Kissinger
Total
Mr. Kenneth Lipper
Mr. Thomas J. McGrath
Mr. Robert B. Menschel
Mr. Donald A. Pels
Mr. James H. Simons
Mr. Randall Smith
Dr. Charles L. Stone, Jr.
Ms. Margaret Geer Walker
$289,085
N.C. Etcoff, G.S. Roth, S. Harris
W.C. Willett
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The Harbor Society
One of the most personal and meaningful ways of saying, "I believe in Cold Spring Harbor Laboratory's
mission" is to make a planned gift. A planned gift takes many forms, such as a bequest in your will, a
charitable remainder trust, or a gift of real estate, securities, life insurance, retiremant plan, or other
assets.
The Harbor Society, now in its sixth year, is a distinguished group of 56 individuals who have made
planned gifts to the Laboratory and have given us permission to list their names. In 2001, the follow-
ing individuals made contributions to the Laboratory.
CONTRIBUTORS
Robert B. Gardner, Jr.
Kenyon Gillespie
Estate of Lindsay C. Herkness III
Undergraduate Research Program
The Undergraduate Research Program introduces college students to the skills they need to become
research scientists. Approximately 25 participants work under the guidance of staff scientists for 10
weeks each summer on projects of mutual interest.
CONTRIBUTORS ENDOWMENTS
Mr. and Mrs. Cornelius N. Bliss III
Dorcas Cummings
The Reverend Linda P. Hancock
Jephson Educational Trust
National Science Foundation
Mrs. Pamela P. Post
Mrs. Joan P Tilney
Total
Emanuel ,6,x Fund
Burroughs Wellcome Fund
Garfield Fellowship
H. Bentley Glass Fellowship
Libby Fellowship
Robert H.P. Memorial Olney Fund
Joan Redmond Read Fund
William Shakespeare Fellowship
Frederica von Stade Fund
$225,107
Total All Annual Funds $17,539,960
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LABORATORY STAFF
Bruce W. Stillman, Director and Chief Executive
Officer
James D. Watson, President
Winship Herr, Assistant Director/Dean, Watson School
of Biological Sciences
W. Dil laway Ayres Jr., Chief Operating Officer
G. Morgan Browne, Chief Financial Officer
Lad Russo, Comptroller
John Maroney, Director, Office of Technology Transfer/
In-House Council
Terri I. Grodzicker, Assistant Director for Academic
Affairs
Jan A. Witkowski, Director of Banbury Center
David A. Mick los, Director of DNA Learning Center
John R. Inglis, Executive Director of CSHL Press
David J. Stewart, Director of Meetings and Courses
FACULTY
Professors
Hollis Cline
David Helfman
Nouria Hernandez*
Adrian Krainer
Scott Lowe
Roberto Malinow
Robert Martienssen
W. Richard McCombie
David Spector
Nicholas Tonks
Timothy Tully
Michael Wig ler
Associate Professors
Grigori Enikolopov
Shivinder Grewal
Gregory Hannon
Michael Hengartner
Tatsuya Hirano
David Jackson
Leemor Joshua-Tor
Yuri Lazebnik
Andrew Neuwald
Jacek Skowronski
Lincoln Stein
Arne Stenlund
Karel Svoboda"
William Tansey
Linda Van Aelst
Rui-Ming Xu
Jerry Yin
Michael Zhang
Yi Zhong
Assistant Professors
Carlos Brody
Dmitri Chklovskii
Masaaki Hamaguchi
Z. Josh Huang
Robert Lucito
Zachary Mainen
Alea Mills
Vivek Mittal
Senthil Muthuswamy
Michael Myers
Marja Timmermans
Anthony Zador
Cold Spring Harbor
Laboratory Fellows
Gilbert Henry
Terence Strick
Research Investigators
Nei lay Dedhia
Natalia Peunova
Mona Spector
Adjunct Professors
Bhubaneswar Mishra
Investigator
Eli Hatchwell
Computer Scientists
Andrew Reiner
Ravi Sachidanandam
Adjunct Associate
Professors
Scott Powers
Craig Ogata"
Visiting Scientists
Vladimir Bourtchouladze
Ann-Shyn Chiang
Boris Kuzin
Mirjana Maletic-Savatic
Tatyana Michurina
Vladimir Scheinker
Tilak Sharma
Xiaomin Wang
Senior Fellow
Luca Cartegni
Postdoctoral Fellows
Carlos Aizenman
Colin Akerman
Eric Allemand
Jannik Andersen
Andres Barria-Roman
Benjamin Boettner
Katherine Braun
Athanasios Bubulya
Paula Bubulya
Deirdre Buckley
Ingrid Bureau
Mary Byrne
Isabel Cantallops
Maoyen Chi
Douglas Conklin
Olivier Cuvier
Marc Davenne
Elisa De Stanchina
Robert Del Vecchio
Michael Deweese
Graziella Di Cristo
Eric Drier
Jian Du
Joshua Dubnau
Dominik Duelli
Veronica Egger
Ingrid Ehrlich
Viola Ellison
Eric Enemark
Jose Esteban
Yuda Fang
Robert Filipkowski
Jordan Fridman
Toshiyuki Fukada
Supriya Gangadharan
Peter Gillespie
Anna Giulini
Hilde Grasmo-Wendler
No Grosse
Hui-Fu Guo
Hirac Gurden
Kurt Haas
Frances Hannan
Todd Harris
Michelle Hastings
Naoya Hata
Andreas Herbst
Maarten Hoek
Edward Hofmann
Junjiro Horiuchi
Kanae lijima
Koichi lima
Susan Janicki
Eric Julien
Natarajan Kannan
Prasanth Kumar
Kannanganattu
Guy Karger
Alla Karpova*
Alyson Kass-Eisler
Catherine Kidner
Jae-Yean Kim
Peter Krasnov
Sandra Kuhlman
Prakash Kumar
Rajeev Kumar
Patrice Lassus
Ana Losada
Miguel Maravall
Carla Margulies
Bruce May
Shanmugam Mayilvahanan*
Juan Mendez
Tzu-Ching Meng
Jinrong Min
Naoki Nakaya
Masashi Narita
Sarah Newey
Esther Nimchinsky
Kenichi Noma
Thomas Oertner
Pol O'Fearghail
Michael Packer
Helena Palka-Hamblin
Lance Palmer
Xiaokang Pan
Geraldine Pawlak
*Employee of the Howard Hughes Medical Institute.
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Tara Phelps-Durr Bidisha Chattopadhyaya Thomas Tubon Lyzette WilliamsAntonella Piccini Brian Chen Kathryn Tworkowski Madeline WisnewskiEmmanuelle Querido Hsu Hsin Chen Xiaorong Wang
Michael Quirk Michelle Cilia Joseph West Research AssistantPablo Rabinowicz Laureen Connell Joanna Wysocka
Jyotishankar Raychaudhuri Catherine Cormier Min Yu Tomasz Swigut
Michael Regulski Ahmet Den li Chih-Chi Yuan
David Roberts Yi-Chieh Du Ming Ming Zhao Laboratory Technicians
Francesc Roca Elena Ejkova Zhengwei Zhu Joan AlexanderJose Rodriguez Farida Emran Dana AmodeoMichael Ronemus Rebecca Ewald Research Programmers Esteban ArayaSimon Rumpel Claudia Feierstein Kuan Yuan Chang Juana ArroyoEdward Ruthazer Elvin Garcia Gengxin Chen Deborah AufieroKalpana Samudre Eve-Ellen Govek Sujit Dike Joshua BakerAravinthan Samuel Ira Hall Stephanie Edgar Vivekanand BalijaLaura Schramm* Jill Hemish John Healy Jody BarditchKenneth Seidenman Brian Hill Jerzy Kakol Matthew BlennauGurumurthy Shun Ho Elizabeth Nickerson Amy BradyShankaranarayana Tomas Hromadka Andrew O'Shaughnessy Kimberly BronsonGordon Shepherd* Ping Hu Aleksandar Poleksic Barry Burbach*Yi-Jun Sheu Sanae Irimura Steven Schmidt Nancy Dawkins-PisaniJose Silva Ajit Janardhan Leonid Teytelman Melissa de la BastidePhilip Smith Ashkan Javaherian Gudmundur Thorisson Margaret FalkowskiMaria Soengas Kendall Jensen Doreen Ware Kristin FerraroChristian Speck Michelle Juarez Wei Zhao Eugenia FriedmanYuri Stasiv Flavio Kamenetz Charles Youens-Clark Scott GossweilerArmen Stepanyants Manpreet Katari Lori GradyTakuya Takahashi Edward Kim Research Associates Karen GreenwoodJoshua Trachtenberg So Young Kim Inessa HakkerMitsuko Uchida Charles Kopec Lisa Manche Michiko HiranoNaoshige Uchida Arlinda Lee Mi la Mc Currach Frederick KatzenbergerAnne Vaahtokari Sungwoo Lee Linda Rodgers Tatsuhiko KawaguchiMatthew Vaughn Shih-Chieh Lin Simone Salghetti Lisa KingErik Vollbrecht Zachary Lippman Patrick Smith Jonathan KuiThomas Volpe Asra Malikzay Cristina Yordan Kathy KuitJinhua Wang Marco Mangone Carmelita Bautista Kimberly La VineQun Wang Anagha Matapurkar Patricia Wendel Gayle LarkYalin Wang Troy Messick Stacy LopezMichael Wehr John Mignone Lab Facility Managers Beicong Ma*Shouzhen Xia Masafumi Muratani Diane Esposito Jennifer MethZhenyu Xuan Zaher Nahle Sang Yong Kim Beth MillerCanzhu Yang Sabrina Nunez Timothy Mulligan Barbara MishRyohei Yasuda Patrick Paddison Spencer Teplin Ophelia MorrisLitang Zhang Thomas Pologruto Ming Wang Stephanie MullerQing-Shuo Zhang Sachin Ranade Regina Whitaker Masako NaritaZhiguo Zhang Patrick Reilly Lidia NascimentoXinyang Zhao* Emiliano Rial Verde Laboratory Manager Aigoul NourjanovaXuemei Zhao Andrew Samuelson Peter O'BrienAhmad Zia* Ashish Saxena Martha Daddario Ximena Opitz-ArayaJack Zilfou Yvette Seger Ronnie PackerKaren Zito Stephanie Shaw Scientific Administrators Timothy Pal
Hang Shi Dianne Ackerina Anthony PirroGraduate Students Khalid Siddiqui Sadie Arana Raymond Preston
Ji-Joon Song Patricia Bird Yi QinAnitra Auster Hongjae Sunwoo Idea Mallardi Sagarika RayNilanjana Banerjee Lung-Hao Tai Carol Marcincuk Michael RiggsEmily Bernstein Marcela Tello-Ruiz Anita Matthes Dongyon RohMichelle Carmel] Dougal Tervo Barbara Matusik Christine RosenthalAmy Gaudy Elizabeth Thomas Colleen Michael Seth RostanSantanu Chakraborty Niraj Tolia Jane Reader Lee SantosKenneth Chang Jiayuan Tong Carol Sekunda* Lise Lotte Schmidt
*Employee of the Howard Hughes Medical Institute.
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Joseph Simorowski
Lori Spiegel
Izabela Sujka
Yu ling Sun*
Julie Thomas
Jennifer Troge
Rachel von Roeschlaub
Jeanne Wiggins
Priscilla Wu
Guoping Xiao
Mianjia Ye
Lewis Yesner
Zhuang Yuan
Erik Zarkowslv
Xiaoqun Zhang*
Hui Zhou
Ying-hua Zhu
Theresa Zutavern
Media Makers/Laboratory
Aides
June Blanchford
Patricia Brady
Florinda Chaves
Terrance Chisum
Janice Douglas
James Gaudet
Salvador Henriquez
Marcela Lara
Vincent Meschan
Hong Jie Shen
Rulan Shen
Philip Sullivan
Jinghong Tang-Qiu
Ramu Umamaheswari
Margaret Wallace
Sharon Witt
Xiu-Xia Zhang
Research Administration
Maureen Bell
Denise Roberts
Watson School of
Biological Sciences
Winship Herr, Dean
Lilian Gann
Janet Duffy
Janet Silver
DEPARTMENTS
Comptrollers Office and
Accounting
Lari Russo, Comptroller
Sharon Bense
Karine Boyce
Damian Desiderio
Karen Rlasky
Mary Ellen Goldstein
Laura Guterman
Elizabeth Janow
William Keen
Patricia Maroney
Alison Mc Dermott
Mary Ann Miceli
Corazon Palma
Kari Pavlovsky
Patricia Urena
Noreen Vance
Matthew Voss
Art
Phil Renna
James Duffy
Geoffrey Chrones
Banbury
Jan Witkowski, Director
Katya Davey
Eleanor Sidorenko
Beatrice To liver
Central Administration
Maureen Berejka
Delia King
Elizabeth Panagot
Charles Prizzi
Roberta Sa lant
Judith Smith
CSHL Press
John Inglis, Executive Director
Acquisition
David Crotty
Alexander Gann
Elizabeth Powers
Journals Editorial
Laurie Goodman
Terri Grodzicker
Margaret Calicchia
Heather Cosel-Pieper
Bibiane Garite
Michele Mc Donough
Finance
William Keen
Elizabeth Baron
Nancy Hodson
Editorial Development
Janet Argentine
Mary Cozza
*Employee of the Howard Hughes Medical Institute.
Judith Cuddihy
Mary liz Dickerson
Joan Ebert
Kaaren Janssen
Nora Rice
Inez Sialiano
Production
Denise Weiss
Patricia Barker
Dorothy Brown
Daniel deBruin
Male Mazzu llo
Nora Ruth
Laurie Saukas
Susan Schaefer
Michele Shoudel
Peri Zeenkov
Advertising Sales
Marcie Siconolfi
Alison Herlihy
Marketing
Ingrid Benirschke Perkins
Kathryn Fitzpatrick
Sales and Distribution
Guy Keyes
Oscar Montalvo
Sharon Story
Christopher Vacca
Customer Service
Geraldine Jaitin
Kathleen Cirone
Jill Manero
Jacqueline Matura
Joan Pepperman
Mary Saba la
DNA Learning Center
David Mick los
Jennifer Aizenman
Adrian Arva
Scott Bronson
Elna Carrasco
Shirley Chan
Maureen Cowan
Judy Cumella-Korabik
Nancy Daidola
Uwe Hilgert
Yan Liang Huang
Eun-Sook Jeong
Susan Lauter
Tricia Maskiell
Amanda Mc Brien
Danielle Sixsmith
Bronwyn Terrill
Gisella Walter
Wen-Bin We
Chun-hua Yang
Hong Zhou
Facilities
Arthur Brings
Christopher Hubert
Frank Russo
Peter Stahl
Leslie Allen
Russell Allen
Kim Gronachan
Christine Hurson
Randal Jones
Marlene Rubino
Charles Schneider
Danielle Zullin
Carpentry and Painting
Peter Schwind
Edwin Bennett
Michael Demers
Paul Edwards
Romulo Estrella
John Meyer
Joseph Pirnak
Wilson Ramones
John Schindler
Arthur Strachan
Benjamin Veneable III
Harry Wozniak
Custodial/Housekeeping
Lawrence Giordano
Carol Bowden
Dessie Carter
Ming-Kai Chan
Eduardo Forero
Leo Franz
Steven Goer ler
Erick Greene
Leo Greene
Theresa Herbst
Adriana Hincapie
Joseph Houser
Louis Hunter
Joseph Judge
Oscar Lastra
Christina Lazar
Patricia Le Strange
Sandra Lopez
Susanne MacPherson
Patricia McAdams
Janeth Mejia
Dora Merlino
Maria Mosquera
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Mary Muno
Wayne Pay
Ronald Romani
Claudia Schmid
Manuel Sisalima
Danuta Slodkowska
Steven Tang
Yew Teo
Roger Vereen
Electrical
James Decker
Jerry Armstrong
Louis Jagoda
Jeffrey Goldblum
Environmental Health and
Safety
John Pisciotta
Paul Cannava
Steven Sallese
Equipment Design,
Fabrication, and Repair
Clifford Sutkevich
Robert Eifert
Christopher Hulsen
George Newell III
James Robey
Grounds
Daniel Miller
Edward Anderson
Santo Bel lino
William Burch
Drew Comer
Paul Draser
Joseph Ellis
Edward Haab
Matthew Hoyer
Christopher Mc Evoy
Hector Roman
Andrew Sauer
Stanley Schwarz
Anthony Terrizzi
Yu liana Yevoushok
Laboratory Animal Resources
Lisa Bianco
Kelly Brings
Amy Burrows
Jodi Coblentz
Charlene De Poto
Nandor Jordon
Andrea Knussman
Lea Mamet
Ingrid Scmelzer
Cindy Schreibman
Jill Steigerwald
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Cheryl Sunderland
Halina Swidzinski
Ryszard Swidzinski
Shank land Woodroffe
Mechanical Services
Robert Collins
William Bishop
Robert Dickerson
Wesley Dreusike
Criag Hubbs
Jeffrey Klaverweiden
Wesley Myers
Lane Smith
John Sundman
Security
Robert Gensel
Frank Carberry
Stephen Gregorovic
Neal Mc Hale
Michael Minghilo
Lee Young
Shipping and Receiving
Daniel Jusino
Kevin Donohue
Jeffrey DuPree
Christopher Sutkevich
Leslie Wenzel
Curtis Williams
Food Service
James Hope
Carlos Alfaro
Jeannette Amato
Jaime Bonilla
Francis Bowdren
Guiditta Carino
William Carmona
Rosa Ciurleo
Laurin Clark
Jose Cubes
Henry De Leon
Joan Doxey
Julie Ehrlich
Barbara Gordon
Jennifer Gordon
Carlos Hernandez
Marco Hernandez
Quintin Irizarry
Pierre Jean-Baptiste
Jesus Magana
Thomas Mcllvaine
Frederik Munter
Ronald Padden
Carlos Perez
Teodosio Perez
Jorge Ramirez
Susana Roman
Greogory Stanton
Suzanne Tavernese
Keith Wieczorek
Cathy van Deurs-Smith
Grants
Susan Schultz
Sandra Altieri
Wendy Crowley
Maureen Davies
Carol DuPree
Diane Errico
Patricia Kurfess
William Mahoney
Karen McKeon
Kathleen Wall-Rooney
Human Resources
Katie Raftery
Christie De Rosa lia
Jennifer Donovan
Jan Eisenman
Joanne Lambert
Sandra Neuwald
Barbara Purcell
Merilyn Simkins
Zoe Viola
Rita Wienclaw
Information Technology
Mark Kilarjian
James Bense
Jason Brandenburg
Michael Cannavaro
John Diffley
James Dunleavy
Salvatore Familia
James Gergel
Vsevolod Ilyushchenko
Derek Johnson
Louis Malfi
Robert Pace
Barbara Peters
Salvatore Serafino
Russell Strine
David Trimboli
John Uhl
Peter Van Buren
Lee Wilbur
Anthony Zane llo
Steven Zielinski
Institutional Advancement
Rodney Miller
Institutional Advancement
Alicia Dragomani
Development
Diane Fagiola
Jill Barton
Annette Gangitano
Kristin Harper
Donna Harrington
Jerome Holubek
Julie Sutherland
Public Affairs
Jeffrey Picarello
Margot Bennett
Miriam Chua
Lynn Hardin
Laura Hyman
Peter Sherwood
John Verity
Library
Ludmila Pollock
Paula Abisognio
Ellen Brenner
Cara Brick
Clare Bunce
Margaret Henderson
Helena Johnson
Teresa Kruger
Gail Sherman
Claudia Zago
Meeting and Courses
David Stewart
Edward Campodonico
Joseph Carrieri
William Dickerson
Michael Glaessgen
Gerald Mc Closkey
Andrew Mendelsohn
Maureen Morrow
Andrea Newell
Jonathan Parsons
James Parsons
Mary Smith
Margaret Stellabotte
Andrea Stephenson
Nancy Weeks
Jenna Williams
Barbara Zane
Purchasing
Philip Lembo
Margaret Brock
Carol Brower
Susan De Angelo
Karen Fabian
Bruce Fahlbusch
Christopher Oravitz
Susan Rose
Barbara Santos
Leonard Sposato
Wanda Stolen
Technology Transfer
John Maroney
Barry Braunstein
Carol Dempster
Lorraine Mclnerny
Research Staff Departures
during 2001
Associate Professors
Ryuji Kobayashi
Research Investigator
Clifford Yen
Visiting Scientists
Vincent Co lot
Edith Heard
Antonius Holtmaat
Mary Sabatini
Senior Fellow
Edward Stern
Postdoctoral Fellows
Harsh Bal
Joseph Donovan
Gerardo Ferbeyre
Francisco Ferrezuelo
Lisa Foa
Michael Greenberg
Hiroyuki Higashiyama
Sangeet Honey
Jianping Jin
Wen-Chuan Lin
David Mac Callum
Stephen Macknik
Olaf Merkel
Stuart Milstein
Jun-ichi Nakayama
Takashi Odawara
Shannon Pendergrast
Bernardo Sabatini
Noriko Saitoh
Cyril Sanders
Clemens Schmitt
Arndt Schmitz
Lidia Serina
Songhai Shi
Wun Chey Sin
Tatjana Singer
Yu Shen
Michael Stebbins
Guanming Wu
Tong Tong Zhang
Jun Julius Zhu
Graduate Students
Andrea Calixto
Jeffrey Christensen
Lavina Faleiro
Jennia Hizver
Jason Kinchen
Ying Ying Koh
Soyoung Lee
Zheng Li
Irina Pugach
Josema Torres
Jun Zhu
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